PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Katsuno, M; Adachi, H; Kume, A; Li, M; Nakagomi, Y; Niwa, H; Sang, C; Kobayashi, Y; Doyu, M; Sobue, G				Katsuno, M; Adachi, H; Kume, A; Li, M; Nakagomi, Y; Niwa, H; Sang, C; Kobayashi, Y; Doyu, M; Sobue, G			Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy	NEURON			English	Article							ANDROGEN RECEPTOR-GENE; RECESSIVE BULBOSPINAL NEURONOPATHY; CAG-REPEAT EXPANSION; CREB-BINDING PROTEIN; HUNTINGTONS-DISEASE; TRINUCLEOTIDE REPEAT; POLYGLUTAMINE TRACT; EXPANDED POLYGLUTAMINE; AGGREGATE FORMATION; TRANSCRIPTIONAL ACTIVATION	Spinal and bulbar muscular atrophy (SBMA) is a polyglutamine disease caused by the expansion of a CAG repeat in the androgen receptor (AR) gene. We generated a transgenic mouse model carrying a full-length AR containing 97 CAGs. Three of the five lines showed progressive muscular atrophy and weakness as well as diffuse nuclear staining and nuclear inclusions consisting of the mutant AR. These phenotypes were markedly pronounced in male transgenic mice, and dramatically rescued by castration. Female transgenic mice showed only a few manifestations that markedly deteriorated with testosterone administration. Nuclear translocation of the mutant AR by testosterone contributed to the phenotypic difference with gender and the effects of hormonal interventions. These results suggest the therapeutic potential of hormonal intervention for SBMA.	Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan; Aichi Med Univ, Electron Microscopy Lab, Nagakute, Aichi 4801195, Japan	Nagoya University; Aichi Medical University	Sobue, G (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	sobueg@med.nagoya-u.ac.jp	Adachi, Hiroaki/AAM-7812-2020; KATSUNO, MASAHISA/I-7502-2014	Adachi, Hiroaki/0000-0002-9302-4663; KATSUNO, MASAHISA/0000-0001-9453-9311				Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Adachi H, 2001, HUM MOL GENET, V10, P1039, DOI 10.1093/hmg/10.10.1039; Andreassen OA, 2001, NEUROBIOL DIS, V8, P479, DOI 10.1006/nbdi.2001.0406; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; DANEK A, 1994, CLIN INVESTIGATOR, V72, P892; DOYU M, 1992, ANN NEUROL, V32, P707, DOI 10.1002/ana.410320517; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Goldenberg JN, 1996, J NEUROL SCI, V135, P158, DOI 10.1016/0022-510X(95)00285-A; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; IGARASHI S, 1992, NEUROLOGY, V42, P2300, DOI 10.1212/WNL.42.12.2300; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Kobayashi Y, 1998, BIOCHEM BIOPH RES CO, V252, P145, DOI 10.1006/bbrc.1998.9624; La Spada AR, 1998, HUM MOL GENET, V7, P959, DOI 10.1093/hmg/7.6.959; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li I, 1998, AM J PATHOL, V153, P695, DOI 10.1016/S0002-9440(10)65612-X; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; MACLEAN HE, 1995, MOL CELL ENDOCRINOL, V112, P133, DOI 10.1016/0303-7207(95)03608-A; Mariotti C, 2000, NEUROMUSCULAR DISORD, V10, P391, DOI 10.1016/S0960-8966(99)00132-7; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; MCPHAUL MJ, 1993, J CLIN ENDOCR METAB, V76, P17, DOI 10.1210/jc.76.1.17; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Merry D. E., 1996, American Journal of Human Genetics, V59, pA271; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; Morrison JR, 2000, AM J HUM GENET, V67, P51; Nakajima H, 1996, J NEUROL SCI, V142, P12, DOI 10.1016/0022-510X(96)00142-6; NeuschmidKaspar F, 1996, MOL CELL ENDOCRINOL, V117, P149, DOI 10.1016/0303-7207(95)03741-1; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 2000, BRAIN PATHOL, V10, P293, DOI 10.1111/j.1750-3639.2000.tb00263.x; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; SOBUE G, 1993, J NEUROL SCI, V117, P74, DOI 10.1016/0022-510X(93)90157-T; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; SYMS AJ, 1985, J BIOL CHEM, V260, P455; Tanaka F, 1999, AM J HUM GENET, V65, P966, DOI 10.1086/302578; Terao S, 1996, ACTA NEUROPATHOL, V92, P109, DOI 10.1007/s004010050497; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; ZHOU ZX, 1994, RECENT PROG HORM RES, V49, P249; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	62	349	365	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 29	2002	35	5					843	854		10.1016/S0896-6273(02)00834-6	http://dx.doi.org/10.1016/S0896-6273(02)00834-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372280	Bronze			2022-12-28	WOS:000177779800008
J	Field, GD; Rieke, F				Field, GD; Rieke, F			Mechanisms regulating variability of the single photon responses of mammalian rod photoreceptors	NEURON			English	Article							OUTER SEGMENTS; RETINAL RODS; PHOSPHORYLATION SITES; GUANYLATE-CYCLASE; RHODOPSIN KINASE; DARK NOISE; ARRESTIN; PROTEIN; CALCIUM; MEMBRANE	Variability in the single photon responses of rod photoreceptors limits the accuracy with which the number and timing of photon absorptions are encoded. We investigated how much single photon responses of mammalian rods fluctuate and what mechanisms control these fluctuations. Mammalian rods, like those of toads, generated responses to single photons with trial-to-trial fluctuations 3-4 times smaller than other familiar signals produced by single molecules. We used the properties of the measured fluctuations to constrain models for how the single photon responses are regulated. Neither feedback control of rhodopsin's activity nor saturation within the transduction cascade were consistent with experiment. The measured responses, however, could be explained by multistep shutoff of rhodopsin or a combination of multistep shutoff and saturation.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.		Field, Greg/AAI-1428-2021	Field, Greg/0000-0001-5942-2679	NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11850] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BENNETT N, 1988, BIOCHEMISTRY-US, V27, P1710, DOI 10.1021/bi00405a049; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BOHM SK, 1997, BIOCHEM J, V15, P1; BURNS ME, 2002, IN PRESS NEURON; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; DEVRIES H, 1961, PRINCIPLES SENSORY C, P159; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Felber S, 1996, BIOPHYS J, V71, P3051, DOI 10.1016/S0006-3495(96)79499-7; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gibson SK, 2000, BIOCHEMISTRY-US, V39, P5738, DOI 10.1021/bi991857f; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; MATTHEWS HR, 1991, J PHYSIOL-LONDON, V436, P93, DOI 10.1113/jphysiol.1991.sp018541; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; MENINI A, 1995, NATURE, V373, P435, DOI 10.1038/373435a0; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P695, DOI 10.1113/jphysiol.1988.sp016942; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 1998, REV MOD PHYS, V70, P1027, DOI 10.1103/RevModPhys.70.1027; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; SAKITT B, 1972, J PHYSIOL-LONDON, V223, P131, DOI 10.1113/jphysiol.1972.sp009838; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068	39	96	98	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					733	747		10.1016/S0896-6273(02)00822-X	http://dx.doi.org/10.1016/S0896-6273(02)00822-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194872	Bronze			2022-12-28	WOS:000177521000013
J	Hindges, R; McLaughlin, T; Genoud, N; Henkemeyer, M; O'Leary, DDM				Hindges, R; McLaughlin, T; Genoud, N; Henkemeyer, M; O'Leary, DDM			EphB forward signaling controls directional branch extension and arborization required for dorsal-ventral retinotopic mapping	NEURON			English	Article							RECEPTOR TYROSINE KINASES; RETINAL AXON GUIDANCE; VISUAL-SYSTEM; TRANSMEMBRANE LIGANDS; RETINOCOLLICULAR PROJECTION; RETINOTECTAL PROJECTION; ADHESIVE SPECIFICITY; SUPERIOR COLLICULUS; COMMISSURAL AXONS; TOPOGRAPHIC ORDER	We report that EphB receptors direct unique axonal behaviors required for mapping the dorsal-ventral (D-V) retinal axis along the lateral-medial (L-M) axis of the superior colliculus (SC). EphBs are expressed in a D-V gradient, ephrin-B1 in a L-M gradient in SC, and ephrin-B3 at its midline. EphBs and ephrin-Bs are expressed in countergradients in retina and SC. Developmental analyses reveal that retinal axons lack D-V ordering along the L-M axis, but directionally extend branches along it to establish ordered arbors. Directed branch extension is disrupted in EphB2; EphB3-deficient mice resulting in lateral ectopic arbors. Mice with kinase-inactive EphB2 have similar D-V mapping defects indicating that forward signaling dominates over reverse signaling. Our data suggest that branches of EphB expressing axons are attracted medially by ephrin-B1, and provide molecular mechanisms for D-V mapping in visual centers.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	Salk Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	doleary@salk.edu	Hindges, Robert/C-5344-2009	Hindges, Robert/0000-0003-0095-7913; Henkemeyer, Mark/0000-0002-7525-1061	NATIONAL EYE INSTITUTE [R01EY007025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY 07025] Funding Source: Medline; NIMH NIH HHS [R01 MH066332, R01 MH 66332] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Birgbauer E, 2000, DEVELOPMENT, V127, P1231; BONHOEFFER F, 1982, EMBO J, V1, P427, DOI 10.1002/j.1460-2075.1982.tb01186.x; BONHOEFFER F, 1985, NATURE, V315, P408, DOI 10.1038/315409a0; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; GIERER A, 1987, DEVELOPMENT, V101, P479; GOTTLIEB DI, 1976, P NATL ACAD SCI USA, V73, P410, DOI 10.1073/pnas.73.2.410; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holash JA, 1995, DEV BIOL, V172, P683, DOI 10.1006/dbio.1995.8039; Holash JA, 1997, DEV BIOL, V182, P256, DOI 10.1006/dbio.1996.8496; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hollander E, 1997, CNS SPECTRUMS, V2, P16, DOI DOI 10.1017/S1092852900011068; HOMBERGER MR, 1999, NEURON, V22, P731; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; MARCHASE RB, 1977, J CELL BIOL, V75, P237, DOI 10.1083/jcb.75.1.237; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; MARCUS RC, 1995, J NEUROSCI, V15, P6389; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Mui SH, 2002, DEVELOPMENT, V129, P797; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; OLEARY DDM, 1986, J NEUROSCI, V6, P3692; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Schulte D, 1999, NEURON, V24, P541, DOI 10.1016/S0896-6273(00)81111-3; SIMON DK, 1992, DEV BRAIN RES, V69, P167, DOI 10.1016/0165-3806(92)90155-P; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; WALTER J, 1987, DEVELOPMENT, V101, P685; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9	49	244	245	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					475	487		10.1016/S0896-6273(02)00799-7	http://dx.doi.org/10.1016/S0896-6273(02)00799-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165470	Bronze			2022-12-28	WOS:000177331200009
J	Palmer, TD				Palmer, TD			Adult neurogenesis and the vascular Nietzsche	NEURON			English	Editorial Material							FEMALE CANARY BRAIN; DENTATE GYRUS; DIFFERENTIATION; PROLIFERATION; DECREASE	Adult neurogenesis is mediated by immature neural precursors that divide within the residual germinal matrices of the brain. In the paper by Louissaint et al. (2002) in this issue of Neuron, the "cause and effect" of adult neurogenesis takes a major step forward with the description of a vascular signaling network that influences neuronal precursor migration and fate.	Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University	Palmer, TD (corresponding author), Stanford Univ, Dept Neurosurg, MSLS P309,Mail Code 5487, Stanford, CA 94305 USA.		Palmer, Theo/GSI-6635-2022	Palmer, Theo/0000-0002-6266-1862				Cameron HA, 1998, NEUROSCIENCE, V82, P349; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; HIDALGO A, 1995, J NEUROBIOL, V27, P470, DOI 10.1002/neu.480270404; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; NOTTEBOHM F, 1985, ANN NY ACAD SCI, V457, P143, DOI 10.1111/j.1749-6632.1985.tb20803.x; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Tanapat P, 1998, INT J DEV NEUROSCI, V16, P235, DOI 10.1016/S0736-5748(98)00029-X; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a	13	48	51	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					856	858		10.1016/S0896-6273(02)00738-9	http://dx.doi.org/10.1016/S0896-6273(02)00738-9			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086632	Bronze			2022-12-28	WOS:000176249700003
J	Schlag, JD				Schlag, JD			Neurons that program what to do and in what order	NEURON			English	Editorial Material							SUPPLEMENTARY EYE FIELD	In this issue of Neuron, Lu et al. (2002) describe the activity of single neurons in the SEF of monkeys, an oculomotor area of the frontal lobe, during the performance of stereotyped sequences of saccades. The monkey had to look at one of two identical stimuli, but the only way to choose the "correct" stimulus was to learn and remember its position in each presentation of the sequence. SEF neurons could do it.	Univ Calif Los Angeles, Ctr Hlth Sci, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schlag, JD (corresponding author), Univ Calif Los Angeles, Ctr Hlth Sci, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.							CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Lu XF, 2002, NEURON, V34, P317, DOI 10.1016/S0896-6273(02)00657-8; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; NORTON D, 1971, SCIENCE, V171, P308; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; TANJI J, 1994, NATURE, V408, P857; Tobler PN, 2002, NEUROREPORT, V13, P253, DOI 10.1097/00001756-200202110-00016; Tremblay L, 2002, J NEUROPHYSIOL, V87, P333, DOI 10.1152/jn.00356.2001; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	12	4	4	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					177	178		10.1016/S0896-6273(02)00668-2	http://dx.doi.org/10.1016/S0896-6273(02)00668-2			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970859	Bronze			2022-12-28	WOS:000174976200003
J	Cloutier, JF; Giger, RJ; Koentges, G; Dulac, C; Kolodkin, AL; Ginty, DD				Cloutier, JF; Giger, RJ; Koentges, G; Dulac, C; Kolodkin, AL; Ginty, DD			Neuropilin-2 mediates axonal fasciculation, zonal segregation, but not axonal convergence, of primary accessory olfactory neurons	NEURON			English	Article							PUTATIVE PHEROMONE RECEPTORS; VOMERONASAL SYSTEM; SEMAPHORIN-III; SECRETED SEMAPHORINS; MULTIGENE FAMILY; EXPRESSION; GUIDANCE; BULB; ORGANIZATION; MAMMALS	The mechanisms that underlie axonal pathfinding of vomeronasal neurons from the vomeronasal organ (VNO) in the periphery to select glomeruli in the accessory olfactory bulb (AOB) are not well understood. Neuropilin-2, a receptor for secreted semaphorins, is expressed in V1R- and V3R-expressing, but not V2R-expressing, postnatal vomeronasal neurons. Analysis of the vomeronasal nerve in neuropilin-2 (npn-2) mutant mice reveals pathfinding defects at multiple choice points. Vomeronasal sensory axons are severely defasciculated and a subset innervates the main olfactory bulb (MOB). While most axons of V1R-expressing neurons reach the AOB and converge into distinct glomeruli in stereotypic locations, they are no longer restricted to their normal anterior AOB target zone. Thus, Npn-2 and candidate pheromone receptors play distinct and complementary roles in promoting the wiring and patterning of sensory neurons in the accessory olfactory system.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Harvard Univ, Howard Hughes Med Inst, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Harvard University; Howard Hughes Medical Institute	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Cloutier, Jean-François/K-2003-2012	Dulac, Catherine/0000-0001-5024-5418	NIMH NIH HHS [R01MH59199] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059199] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Berghard A, 1996, J NEUROSCI, V16, P909; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; de Castro F, 1999, J NEUROSCI, V19, P4428; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; HE S, 1997, CELL, V90, P739; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; JONES DT, 1987, J BIOL CHEM, V262, P14241; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Knoll B, 2001, DEVELOPMENT, V128, P895; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nagao H, 2000, NEUROREPORT, V11, P3023, DOI 10.1097/00001756-200009110-00039; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Pasterkamp RJ, 1999, CELL MOL BIOL, V45, P763; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Renzi MJ, 2000, NEURON, V28, P437, DOI 10.1016/S0896-6273(00)00123-9; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Schwarting GA, 2000, J NEUROSCI, V20, P7691; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tanaka M, 1999, P NATL ACAD SCI USA, V96, P14106, DOI 10.1073/pnas.96.24.14106; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; vonCampenhausen H, 1997, NEUROREPORT, V8, P2607, DOI 10.1097/00001756-199707280-00037; Williams-Hogarth LC, 2000, J COMP NEUROL, V423, P565, DOI 10.1002/1096-9861(20000807)423:4<565::AID-CNE3>3.0.CO;2-F; Yoshihara Y, 1997, J NEUROSCI, V17, P5830	48	110	110	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					877	892		10.1016/S0896-6273(02)00635-9	http://dx.doi.org/10.1016/S0896-6273(02)00635-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906695	Bronze			2022-12-28	WOS:000174389600006
J	Marques, G; Bao, H; Haerry, TE; Shimell, MJ; Duchek, P; Zhang, B; O'Connor, MB				Marques, G; Bao, H; Haerry, TE; Shimell, MJ; Duchek, P; Zhang, B; O'Connor, MB			The Drosophila BMP type II receptor wishful thinking regulates neuromuscular synapse morphology and function	NEURON			English	Article							PRIMARY PULMONARY-HYPERTENSION; GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEINS; TGF-BETA; GENETIC DISSECTION; NERVOUS-SYSTEM; SYMPATHETIC NEURONS; GLUTAMATE RECEPTORS; GERMLINE MUTATIONS; DENDRITIC GROWTH	Proper synaptic development is critical for establishing all aspects of neural function including learning, memory, and locomotion. Here, we describe the phenotypic consequences of mutations in the wishful thinking (wit) gene, the Drosophila homolog of the vertebrate BMP type II receptor. Mutations in wit result in pharate lethality that can be rescued by expression of a wit transgene in motor neurons but not in muscles. Mutant larvae exhibit small synapses, severe defects in evoked junctional potentials, a lower frequency of spontaneous vesicle release, and an alteration in the ultrastructure of synaptic active zones. These results reveal a novel role for BMP signaling in regulating Drosophila neuromuscular junction synapse assembly and activity and may indicate that similar pathways could govern vertebrate synapse development.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA; Univ Texas, Inst Mol & Cellular Biol, Neurobiol Sect, Patterson Labs 227, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Sect Mol Cellular & Dev Biol, Patterson Labs 227, Austin, TX 78712 USA	University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.		O'Connor, Michael B/C-9977-2014	O'Connor, Michael B/0000-0002-3067-5506				Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; BAARENDS WM, 1994, DEVELOPMENT, V120, P189; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1995, J PHYSIOLOGY-PARIS, V89, P59, DOI 10.1016/0928-4257(96)80552-3; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; BUDNIK V, 1990, J NEUROSCI, V10, P3754; BUDNIK V, 1999, INT REV NEUROBIOLOGY, V43; Cameron JS, 1998, NEURON, V21, P1045, DOI 10.1016/S0896-6273(00)80622-4; Cameron JS, 1999, DEVELOPMENT, V126, P4157; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Chin J, 1999, LEARN MEMORY, V6, P317; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Frisch A, 1998, DEVELOPMENT, V125, P431; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hannan F, 1999, INT REV NEUROBIOL, V43, P119, DOI 10.1016/S0074-7742(08)60543-7; HARRISON SD, 1995, GENETICS, V139, P1701; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Jiang YY, 2000, J NEUROSCI RES, V62, P809, DOI 10.1002/1097-4547(20001215)62:6<809::AID-JNR7>3.3.CO;2-W; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; KULKARNI SJ, 1994, MOL GEN GENET, V243, P555, DOI 10.1007/BF00284204; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Landgraf M, 1997, J NEUROSCI, V17, P9642; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIU F, 1995, MOL CELL BIOL, V15, P3479; Liu QR, 1997, J NEUROSCI, V17, P755; Lo PCH, 1999, MECH DEVELOP, V86, P171, DOI 10.1016/S0925-4773(99)00108-2; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Lorentzon M, 1996, EXP NEUROL, V142, P351, DOI 10.1006/exnr.1996.0204; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCDONALD KL, 1994, METHOD CELL BIOL, V44, P411, DOI 10.1016/S0091-679X(08)60926-7; MCLENNAN IS, 1994, NEUROSCI LETT, V177, P151, DOI 10.1016/0304-3940(94)90889-3; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Newfeld SJ, 1999, GENETICS, V152, P783; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; Stewart BA, 1996, J NEUROSCI, V16, P3877; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	71	243	249	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					529	543		10.1016/S0896-6273(02)00595-0	http://dx.doi.org/10.1016/S0896-6273(02)00595-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856528	Bronze			2022-12-28	WOS:000173911100007
J	Taddese, A; Bean, BP				Taddese, A; Bean, BP			Subthreshold sodium current from rapidly inactivating sodium channels drives spontaneous firing of tuberomammillary neurons	NEURON			English	Article							RAT SUPRACHIASMATIC NUCLEUS; CEREBELLAR PURKINJE NEURONS; ACTIVATED CATION CURRENT; PERSISTENT NA+ CURRENT; NEOCORTICAL NEURONS; HIPPOCAMPAL-NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; SINGLE-CHANNEL; IONIC CURRENTS; MEMBRANE-PROPERTIES	A role for "persistent," subthreshold, TTX-sensitive sodium current in driving the pacemaking of many central neurons has been proposed, but this has been impossible to test pharmacologically. Using isolated tuberomammillary neurons, we assessed the role of subthreshold sodium current in pacemaking by performing voltage-clamp experiments using a cell's own pacemaking cycle as voltage command. TTX-sensitive sodium current flows throughout the pacemaking cycle, even at voltages as negative as -70 mV, and this current is sufficient to drive spontaneous firing. When sodium channels underlying transient current were driven into slow inactivation by rapid stimulation, persistent current decreased in parallel, suggesting that persistent sodium current originates from subthreshold gating of the same sodium channels that underlie the phasic sodium current. This behavior of sodium channels may endow all neurons with an intrinsic propensity for rhythmic, spontaneous firing.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Bean, BP (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.							Agrawal N, 2001, NEUROSCIENCE, V102, P53, DOI 10.1016/S0306-4522(00)00455-3; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ALZHEIMER C, 1993, J NEUROSCI, V13, P660; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Bergles DE, 1996, J NEUROSCI, V16, P572; Bevan MD, 1999, J NEUROSCI, V19, P7617, DOI 10.1523/JNEUROSCI.19-17-07617.1999; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; BROWN AM, 1994, J NEUROPHYSIOL, V71, P2562, DOI 10.1152/jn.1994.71.6.2562; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Butera RJ, 1999, J NEUROPHYSIOL, V82, P382, DOI 10.1152/jn.1999.82.1.382; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; COHEN CJ, 1984, CIRC RES, V54, P636, DOI 10.1161/01.RES.54.6.636; Conti F, 1996, BIOPHYS J, V71, P1295, DOI 10.1016/S0006-3495(96)79330-X; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.ph.58.030196.002025; CUMMINS TR, 1994, J NEUROPHYSIOL, V71, P1052, DOI 10.1152/jn.1994.71.3.1052; D'Angelo E, 1998, J NEUROPHYSIOL, V80, P493, DOI 10.1152/jn.1998.80.2.493; Dickson CT, 1997, NEUROSCIENCE, V81, P937, DOI 10.1016/S0306-4522(97)00263-7; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DOERR T, 1989, PFLUG ARCH EUR J PHY, V413, P599, DOI 10.1007/BF00581808; Eaholtz G, 1999, J GEN PHYSIOL, V113, P279, DOI 10.1085/jgp.113.2.279; Fleidervish IA, 1996, J NEUROPHYSIOL, V76, P2125, DOI 10.1152/jn.1996.76.3.2125; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; FURUKAWA K, 1994, J NEUROPHYSIOL, V71, P868, DOI 10.1152/jn.1994.71.3.868; HAAS HL, 1988, J PHYSIOL-LONDON, V399, P633; Hammarstrom AKM, 1999, J PHYSIOL-LONDON, V520, P451, DOI 10.1111/j.1469-7793.1999.t01-1-00451.x; Hammarstrom AKM, 1998, J PHYSIOL-LONDON, V510, P735, DOI 10.1111/j.1469-7793.1998.735bj.x; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOTSON JR, 1979, J NEUROPHYSIOL, V42, P889, DOI 10.1152/jn.1979.42.3.889; HUANG RC, 1993, J NEUROPHYSIOL, V70, P1692, DOI 10.1152/jn.1993.70.4.1692; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P698, DOI 10.1152/jn.1996.76.2.698; KAMONDI A, 1991, J NEUROPHYSIOL, V66, P1902, DOI 10.1152/jn.1991.66.6.1902; Kay AR, 1998, J NEUROPHYSIOL, V80, P1167, DOI 10.1152/jn.1998.80.3.1167; KUO CC, 1994, NEURON, V12, P819, DOI 10.1016/0896-6273(94)90335-2; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS RR, 1992, J NEUROPHYSIOL, V68, P1307, DOI 10.1152/jn.1992.68.4.1307; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Madeja M, 2000, EUR J NEUROSCI, V12, P1, DOI 10.1046/j.1460-9568.2000.00871.x; Magistretti J, 1998, BIOPHYS J, V74, P831, DOI 10.1016/S0006-3495(98)74007-X; Magistretti J, 1999, J NEUROSCI, V19, P7334, DOI 10.1523/JNEUROSCI.19-17-07334.1999; Magistretti J, 1999, J GEN PHYSIOL, V114, P491, DOI 10.1085/jgp.114.4.491; Magistretti J, 1996, TRENDS NEUROSCI, V19, P530, DOI 10.1016/S0166-2236(96)40004-2; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Parri HR, 1998, J NEUROSCI, V18, P854; PATEL BT, 1986, NEUROSCI LETT, V63, P185, DOI 10.1016/0304-3940(86)90059-5; PATTON DE, 1991, NEURON, V7, P637, DOI 10.1016/0896-6273(91)90376-B; Pennartz CMA, 1997, J NEUROPHYSIOL, V78, P1811, DOI 10.1152/jn.1997.78.4.1811; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Raman IM, 2000, J NEUROSCI, V20, P9004; Raman IM, 1999, J NEUROSCI, V19, P1663; REINER PB, 1987, NEUROSCI LETT, V73, P43, DOI 10.1016/0304-3940(87)90028-0; Schwarz C, 1997, J NEUROPHYSIOL, V78, P3323, DOI 10.1152/jn.1997.78.6.3323; Smith MR, 1998, J NEUROSCI, V18, P6093; STAFSTROM CE, 1982, BRAIN RES, V236, P221, DOI 10.1016/0006-8993(82)90050-6; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stevens DR, 1996, J PHYSIOL-LONDON, V493, P747, DOI 10.1113/jphysiol.1996.sp021419; Takakusaki K, 1997, NEUROSCIENCE, V78, P771, DOI 10.1016/S0306-4522(96)00540-4; UTESHEV V, 1995, NEUROSCIENCE, V66, P143, DOI 10.1016/0306-4522(94)00593-T; WADA H, 1991, TRENDS NEUROSCI, V14, P415, DOI 10.1016/0166-2236(91)90034-R; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wu NP, 2001, J NEUROSCI, V21, P3729, DOI 10.1523/JNEUROSCI.21-11-03729.2001; Zaza A, 1997, J PHYSIOL-LONDON, V505, P677, DOI 10.1111/j.1469-7793.1997.677ba.x	76	232	240	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					587	600		10.1016/S0896-6273(02)00574-3	http://dx.doi.org/10.1016/S0896-6273(02)00574-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856532	Bronze			2022-12-28	WOS:000173911100011
J	Simon, O; Mangin, JF; Cohen, L; Le Bihan, D; Dehaene, S				Simon, O; Mangin, JF; Cohen, L; Le Bihan, D; Dehaene, S			Topographical layout of hand, eye, calculation, and language-related areas in the human parietal lobe	NEURON			English	Article							FUNCTIONAL-ANATOMY; INTRAPARIETAL AREA; VISUAL GUIDANCE; HUMAN-BRAIN; CORTEX; MONKEY; ATTENTION; REPRESENTATIONS; NEURONS; MOTOR	To identify subdivisions of the human parietal cortex, we collected fMRI data while ten subjects performed six tasks: grasping, pointing, saccades, attention, calculation, and phoneme detection. Examination of task intersections revealed a systematic anterior-to-posterior organization of activations associated with grasping only, grasping and pointing, all visuomotor tasks, attention and saccades, and saccades only. Calculation yielded two distinct activations: one unique to calculation in the bilateral anterior IPS mesial to the supramarginal gyrus and the other shared with phoneme detection in the left IPS mesial to the angular gyrus. These results suggest human homologs of the monkey areas AIP, MIP, V6A, and LIP and imply a large cortical expansion of the inferior parietal lobule correlated with the development of human language and calculation abilities.	CEA DSV, Serv Hosp Frederic Joliot, INSERM, U334, Orsay, France; CEA DSV, Serv Hosp Frederic Joliot, IFR 49, Unite Neuroact Fonct, Orsay, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dehaene, S (corresponding author), CEA DSV, Serv Hosp Frederic Joliot, INSERM, U334, Orsay, France.		Mangin, Jean-Francois/AAI-8983-2020	cohen, laurent/0000-0002-5010-9085				Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 1995, MATH COGNITION, P83, DOI DOI 10.1155/2014/461647; Disbrow E, 2000, J COMP NEUROL, V418, P1, DOI 10.1002/(SICI)1096-9861(20000228)418:1<1::AID-CNE1>3.0.CO;2-P; EIDELBERG D, 1984, ARCH NEUROL-CHICAGO, V41, P843, DOI 10.1001/archneur.1984.04050190049013; Faillenot I, 1997, CEREB CORTEX, V7, P77, DOI 10.1093/cercor/7.1.77; Fletcher PC, 1996, BRAIN, V119, P1587, DOI 10.1093/brain/119.5.1587; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; Galletti C, 1999, EUR J NEUROSCI, V11, P3922, DOI 10.1046/j.1460-9568.1999.00817.x; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iriki A, 1996, NEUROREPORT, V7, P2325; Jonides J, 1998, J NEUROSCI, V18, P5026; Kawashima R, 1996, NEUROREPORT, V7, P1253, DOI 10.1097/00001756-199605170-00006; Lee KM, 2000, ANN NEUROL, V48, P657, DOI 10.1002/1531-8249(200010)48:4<657::AID-ANA13>3.3.CO;2-B; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Muri RM, 1996, J NEUROL NEUROSUR PS, V60, P445, DOI 10.1136/jnnp.60.4.445; Nobre AC, 2000, NEUROIMAGE, V11, P210, DOI 10.1006/nimg.2000.0539; Pallier C, 1997, BEHAV RES METH INS C, V29, P322, DOI 10.3758/BF03200583; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Portin K, 1999, P ROY SOC B-BIOL SCI, V266, P981, DOI 10.1098/rspb.1999.0733; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697	49	589	602	2	49	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					475	487		10.1016/S0896-6273(02)00575-5	http://dx.doi.org/10.1016/S0896-6273(02)00575-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832233	Bronze			2022-12-28	WOS:000173643200016
J	Price, MP; McIlwrath, SL; Xie, JH; Cheng, C; Qiao, J; Tarr, DE; Sluka, KA; Brennan, TJ; Lewin, GR; Welsh, MJ				Price, MP; McIlwrath, SL; Xie, JH; Cheng, C; Qiao, J; Tarr, DE; Sluka, KA; Brennan, TJ; Lewin, GR; Welsh, MJ			The DRASIC cation channel contributes to the detection of cutaneous touch and acid stimuli in mice	NEURON			English	Article							EPITHELIAL NA+ CHANNEL; ROOT GANGLION NEURONS; SENSORY NEURONS; TISSUE ACIDOSIS; ION CHANNELS; HAIRY SKIN; MECHANOSENSORY NEURONS; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; FINE-STRUCTURE	Cation channels in the DEG/ENaC family are proposed to detect cutaneous stimuli in mammals. We localized one such channel, DRASIC, in several different specialized sensory nerve endings of skin, suggesting it might participate in mechanosensation and/or acid-evoked nociception. Disrupting the mouse DRASIC gene altered sensory transduction in specific and distinct ways. Loss of DRASIC increased the sensitivity of mechanoreceptors detecting light touch, but it reduced the sensitivity of a mechanoreceptor responding to noxious pinch and decreased the response of acid- and noxious heat-sensitive nociceptors. The data suggest that DRASIC subunits participate in heteromultimeric channel complexes in sensory neurons. Moreover, in different cellular contexts, DRASIC may respond to mechanical stimuli or to low pH to mediate normal touch and pain sensation.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Grad Program Phys Therapy, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Anesthesia, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Max Delbruck Ctr Mol Med, Dept Neurosci, Growth Factors & Regenerat Grp, D-13092 Berlin, Germany	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Welsh, MJ (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA.	glewin@mdc.berlin.de; mjwelsh@blue.weeg.ulowa.edu	Lewin, Gary R/B-8028-2011	Lewin, Gary/0000-0002-2890-6352; Sluka, Kathleen/0000-0003-0207-8728; Welsh, Michael/0000-0002-1646-6206; Brennan, Timothy/0000-0002-0150-5145; Tarr, Ellen/0000-0003-1604-4545	NIDDK NIH HHS [DK25295] Funding Source: Medline; NINDS NIH HHS [NS39734] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039734] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Benson CJ, 1999, CIRC RES, V84, P921; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; Burgess PR, 1973, HDB SENSORY PHYSIOLO, VII, P29; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Cervero F, 1996, PAIN, V68, P13, DOI 10.1016/S0304-3959(96)03165-X; Cesare P, 1997, CURR OPIN NEUROBIOL, V7, P493, DOI 10.1016/S0959-4388(97)80028-1; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Darian-Smith I., 1984, HDB PHYSL 2 1, VIII, P739; Diamond J, 1988, Prog Brain Res, V74, P51; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Drummond HA, 2000, BRAIN RES, V884, P1, DOI 10.1016/S0006-8993(00)02831-6; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; Fricke B, 2000, CELL TISSUE RES, V299, P327; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; GORMAN C, 1983, SCIENCE, V221, P551, DOI 10.1126/science.6306768; HALATA Z, 1993, J INVEST DERMATOL, V101, pS75, DOI 10.1111/1523-1747.ep12362877; Hamill OP, 1996, TRENDS NEUROSCI, V19, P258, DOI 10.1016/S0166-2236(96)30009-X; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; IDE C, 1976, AM J ANAT, V147, P329, DOI 10.1002/aja.1001470307; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247, DOI 10.1113/jphysiol.1994.sp020292; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; Kinkelin I, 1999, EUR J NEUROSCI, V11, P3963, DOI 10.1046/j.1460-9568.1999.00822.x; KOCHER L, 1987, PAIN, V29, P363, DOI 10.1016/0304-3959(87)90051-0; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; KRUGER L, 1981, J COMP NEUROL, V198, P137, DOI 10.1002/cne.901980112; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; LeMaster AM, 1999, J NEUROSCI, V19, P5919, DOI 10.1523/JNEUROSCI.19-14-05919.1999; Lewin G.R., 2000, MOL BASIS PAIN INDUC, P129; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Mansikka H, 1999, ANESTHESIOLOGY, V90, P1643, DOI 10.1097/00000542-199906000-00021; Martin J. H., 1991, PRINCIPLES NEURAL SC, V3, P341; MCCARTHY PW, 1989, NEUROSCIENCE, V28, P745, DOI 10.1016/0306-4522(89)90019-5; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; McDonald FJ, 1999, P NATL ACAD SCI USA, V96, P1727, DOI 10.1073/pnas.96.4.1727; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; MUNGER BL, 1988, ARCH HISTOL CYTOL, V51, P1, DOI 10.1679/aohc.51.1; Perl ER, 1992, SENSORY NEURONS DIVE, P3; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Sinclair D., 1981, MECH CUTANEOUS SENSA; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; STEEN KH, 1993, NEUROSCI LETT, V154, P113, DOI 10.1016/0304-3940(93)90184-M; STEEN KH, 1992, J NEUROSCI, V12, P86; Stucky CL, 1999, J NEUROSCI, V19, P6497; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; SZOLCSANYI J, 1988, BRAIN RES, V446, P262, DOI 10.1016/0006-8993(88)90885-2; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M; Woolf Clifford J., 1994, Current Opinion in Neurobiology, V4, P525, DOI 10.1016/0959-4388(94)90053-1; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6	73	462	486	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					1071	1083		10.1016/S0896-6273(01)00547-5	http://dx.doi.org/10.1016/S0896-6273(01)00547-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754838	Bronze			2022-12-28	WOS:000172886800013
J	Haarmeier, T; Bunjes, F; Lindner, A; Berret, E; Thier, P				Haarmeier, T; Bunjes, F; Lindner, A; Berret, E; Thier, P			Optimizing visual motion perception during eye movements	NEURON			English	Article							OPTIC FLOW STIMULI; FILEHNE ILLUSION; SELF-MOTION; RESPONSE SELECTIVITY; PATH PERCEPTION; FIELD STIMULI; MST NEURONS; SENSITIVITY; MECHANISMS; JUDGMENTS	We usually perceive a stationary, stable world and we are able to correctly estimate the direction of heading from optic flow despite coherent visual motion induced by eye movements. This astonishing example of perceptual invariance results from a comparison of visual information with internal reference signals predicting the visual consequences of an eye movement. Here we demonstrate that the reference signal predicting the consequences of smooth-pursuit eye movements is continuously calibrated on the basis of direction-selective interactions between the pursuit motor command and the rotational flow induced by the eye movement, thereby minimizing imperfections of the reference signal and guaranteeing an ecologically optimal interpretation of visual motion.	Univ Tubingen, Dept Cognit Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Dept Gen Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Thier, P (corresponding author), Univ Tubingen, Dept Cognit Neurol, D-72076 Tubingen, Germany.			Lindner, Axel/0000-0002-8201-788X; Thier, Peter/0000-0001-5909-4222				BANKS MS, 1996, VISION RES, V36, P413; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Freeman TCA, 2000, PERCEPT PSYCHOPHYS, V62, P900, DOI 10.3758/BF03212076; Freeman TCA, 1999, VISION RES, V39, P2659, DOI 10.1016/S0042-6989(98)00293-4; Gibson JJ, 1950, PERCEPTION VISUAL WO; Haarmeier T, 1998, J COGNITIVE NEUROSCI, V10, P464, DOI 10.1162/089892998562870; Haarmeier T, 1997, NATURE, V389, P849, DOI 10.1038/39872; Haarmeier T, 1996, VISION RES, V36, P741, DOI 10.1016/0042-6989(95)00154-9; KOENDERINK JJ, 1976, J OPT SOC AM, V66, P717, DOI 10.1364/JOSA.66.000717; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; LIEBERMAN HR, 1982, BEHAV RES METH INSTR, V14, P21, DOI 10.3758/BF03202110; LONGUETHIGGINS HC, 1980, PROC R SOC SER B-BIO, V208, P385, DOI 10.1098/rspb.1980.0057; MACK A, 1973, Q J EXP PSYCHOL, V25, P71, DOI 10.1080/14640747308400324; MCKEE SP, 1985, PERCEPT PSYCHOPHYS, V37, P286, DOI 10.3758/BF03211350; RIEGER JH, 1985, J OPT SOC AM A, V2, P354, DOI 10.1364/JOSAA.2.000354; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; Shenoy KV, 1999, J NEUROPHYSIOL, V81, P2764, DOI 10.1152/jn.1999.81.6.2764; SMITH AT, 1990, VISION RES, V30, P1467, DOI 10.1016/0042-6989(90)90027-I; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; THIER P, 1992, EUR J NEUROSCI, V4, P539, DOI 10.1111/j.1460-9568.1992.tb00904.x; THOMPSON P, 1982, VISION RES, V22, P377, DOI 10.1016/0042-6989(82)90153-5; VANDENBERG AV, 1994, NATURE, V371, P700, DOI 10.1038/371700a0; VANDENBERG AV, 1992, VISION RES, V32, P1285, DOI 10.1016/0042-6989(92)90223-6; VANDENBERG AV, 1993, NATURE, V365, P497, DOI 10.1038/365497a0; vandenBerg AV, 1996, VISION RES, V36, P2337, DOI 10.1016/0042-6989(95)00247-2; von Helmholtz H, 1962, PHYSL OPTICS, VIII; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; WERTHEIM AH, 1987, PERCEPTION, V16, P299, DOI 10.1068/p160299; WERTHEIM AH, 1994, BEHAV BRAIN SCI, V17, P293, DOI 10.1017/S0140525X00034646	34	61	61	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					527	535		10.1016/S0896-6273(01)00486-X	http://dx.doi.org/10.1016/S0896-6273(01)00486-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709162	Bronze			2022-12-28	WOS:000172119100017
J	Maurel-Zaffran, C; Suzuki, T; Gahmon, G; Treisman, JE; Dickson, BJ				Maurel-Zaffran, C; Suzuki, T; Gahmon, G; Treisman, JE; Dickson, BJ			Cell-autonomous and nonautonomous functions of LAR in R7 photoreceptor axon targeting	NEURON			English	Article							ABL TYROSINE KINASE; PHOSPHATASE CRYP-ALPHA; DROSOPHILA EMBRYO; IN-VIVO; GUIDANCE; PROTEIN; DOMAIN; GROWTH; DELTA; MORPHOGENESIS	During Drosophila visual system development, photoreceptors R7 and R8 project axons to targets in distinct layers of the optic lobe. We show here that the LAR receptor tyrosine phosphatase is required in the eye for correct targeting of R7 axons. In LAR mutants, R7 axons initially project to their correct target layer, but then retract to the R8 target layer. This targeting defect can be fully rescued by transgenic expression of LAR in R7, and partially rescued by expression of LAR in R8. The phosphatase domains of LAR are required for its activity in R7, but not in R8. These data suggest that LAR can act both as a receptor in R7, and as a ligand provided by R8. Genetic interactions implicate both Enabled and Trio in LAR signal transduction.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria	New York University; New York University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Treisman, JE (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.		Suzuki, Takashi/D-3651-2019; Dickson, Barry/AAE-7632-2019	Suzuki, Takashi/0000-0001-9093-2562; Dickson, Barry/0000-0003-0715-892X; Treisman, Jessica/0000-0002-7453-107X				Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; BASLER K, 1989, DEVELOPMENT, V107, P723; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Fogerty FJ, 1999, ONCOGENE, V18, P219, DOI 10.1038/sj.onc.1202239; Frydman HM, 2001, DEVELOPMENT, V128, P3209; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Haj F, 1999, MOL CELL NEUROSCI, V14, P225, DOI 10.1006/mcne.1999.0785; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Ledig MM, 1999, J CELL BIOL, V147, P375, DOI 10.1083/jcb.147.2.375; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Maurel-Zaffran C, 2000, DEVELOPMENT, V127, P1007; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; Sommer L, 1997, DEV DYNAM, V208, P48, DOI 10.1002/(SICI)1097-0177(199701)208:1<48::AID-AJA5>3.0.CO;2-1; Stoker AW, 1995, DEV BRAIN RES, V90, P129, DOI 10.1016/0165-3806(96)83493-6; Sun Q, 2000, DEVELOPMENT, V127, P801; Sun Q, 2001, MOL CELL NEUROSCI, V17, P274, DOI 10.1006/mcne.2000.0939; Sun QL, 2000, MOL CELL NEUROSCI, V16, P686, DOI 10.1006/mcne.2000.0893; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang J, 1999, MOL CELL NEUROSCI, V14, P370, DOI 10.1006/mcne.1999.0789; White NM, 2000, DEVELOPMENT, V127, P1681; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9	40	107	108	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					225	235		10.1016/S0896-6273(01)00471-8	http://dx.doi.org/10.1016/S0896-6273(01)00471-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683993	Bronze			2022-12-28	WOS:000171893700008
J	Morgan, JR; Prasad, K; Jin, SP; Augustine, GJ; Lafer, EM				Morgan, JR; Prasad, K; Jin, SP; Augustine, GJ; Lafer, EM			Uncoating of clathrin-coated vesicles in presynaptic terminals: Roles for Hsc70 and auxilin	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; PEPTIDE BINDING-PROTEIN; G-ASSOCIATED KINASE; J-DOMAIN; IN-VIVO; MOLECULAR CHAPERONE; ATPASE ACTIVITY; ANTIGEN PRESENTATION; ALPHA-ADAPTIN; ENDOCYTOSIS	We have examined the roles of Hsc70 and auxilin in the uncoating of clathrin-coated vesicles (CCVs) during neuronal endocytosis. We identified two peptides that inhibit the ability of Hsc70 and auxilin to uncoat CCVs in vitro. When injected into nerve terminals, these peptides inhibited both synaptic transmission and CCV uncoating. Mutation of a conserved HPD motif within the J domain of auxilin prevented binding to Hsc70 in vitro and injecting this mutant protein inhibited CCV uncoating in vivo, demonstrating that the interaction of auxilin with Hsc70 is critical for CCV uncoating. These studies establish that auxilin and Hsc70 participate in synaptic vesicle recycling in neurons and that an interaction between these proteins is required for CCV uncoating.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78245 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	Duke University; University of Texas System; University of Texas Health San Antonio; Marine Biological Laboratory - Woods Hole	Augustine, GJ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	georgea@neuro.duke.edu	Augustine, George James/J-9228-2013	Lafer, Eileen/0000-0002-0493-6522	NINDS NIH HHS [NS21624, NS29051, R01 NS029051] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029051, R56NS029051, R01NS021624] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; BAROUCH W, 1994, J BIOL CHEM, V269, P28563; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BRAELL WA, 1984, J CELL BIOL, V99, P734, DOI 10.1083/jcb.99.2.734; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Burns ME, 1998, J GEN PHYSIOL, V111, P243, DOI 10.1085/jgp.111.2.243; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; De Camilli P, 2001, SYNAPSES, P217; Gall WE, 2000, CURR BIOL, V10, P1349, DOI 10.1016/S0960-9822(00)00771-5; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; GREENE LE, 1995, J BIOL CHEM, V270, P2967, DOI 10.1074/jbc.270.7.2967; GREENE LE, 1990, J BIOL CHEM, V265, P6682; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; Greener T, 2001, NAT CELL BIOL, V3, P215, DOI 10.1038/35055137; Han CJ, 2000, J BIOMOL NMR, V17, P281, DOI 10.1023/A:1008353226591; Hannan LA, 1998, MOL BIOL CELL, V9, P2217, DOI 10.1091/mbc.9.8.2217; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holstein SEH, 1996, J CELL BIOL, V135, P925, DOI 10.1083/jcb.135.4.925; Jiang RF, 1997, J BIOL CHEM, V272, P6141, DOI 10.1074/jbc.272.10.6141; Kanaoka Y, 1997, FEBS LETT, V402, P73, DOI 10.1016/S0014-5793(96)01484-6; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kimura SH, 1997, GENOMICS, V44, P179, DOI 10.1006/geno.1997.4873; LAKEY EK, 1987, P NATL ACAD SCI USA, V84, P1659, DOI 10.1073/pnas.84.6.1659; Lemmon SK, 2001, CURR BIOL, V11, pR49, DOI 10.1016/S0960-9822(01)00010-0; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Mayer MP, 1998, BIOL CHEM, V379, P261; Morgan JR, 2000, J NEUROSCI, V20, P8667; Morgan JR, 1999, J NEUROSCI, V19, P10201; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Pishvaee B, 1998, CELL, V95, P443, DOI 10.1016/S0092-8674(00)81611-6; Pishvaee B, 2000, NAT CELL BIOL, V2, P958, DOI 10.1038/35046619; PRASAD K, 1993, J BIOL CHEM, V268, P23758; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SANCHEZ ME, 1990, J EXP BIOL, V152, P369; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; VANBUSKIRK A, 1989, J EXP MED, V170, P1799, DOI 10.1084/jem.170.6.1799; WALL D, 1994, J BIOL CHEM, V269, P5446; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang H, 1999, J CELL SCI, V112, P1345; Zhao XH, 2001, J CELL SCI, V114, P353	55	91	93	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					289	300		10.1016/S0896-6273(01)00467-6	http://dx.doi.org/10.1016/S0896-6273(01)00467-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683998	Bronze			2022-12-28	WOS:000171893700013
J	Isaacson, JS; Murphy, GJ				Isaacson, JS; Murphy, GJ			Glutamate-mediated extrasynaptic inhibition: Direct coupling of NMDA receptors to Ca2+-activated K+ channels	NEURON			English	Article							ACTIVATED POTASSIUM CHANNEL; RAT HIPPOCAMPAL-NEURONS; CA2+ CHANNELS; OLFACTORY-BULB; ION CHANNELS; CALCIUM; CONDUCTANCE; MODULATION; HYPERPOLARIZATIONS; SPILLOVER	NMDA receptors (NMDARs) typically contribute to excitatory synaptic transmission in the CNS. While Ca2+ influx through NMDARs plays a critical role in synaptic plasticity, direct actions of NMDAR-mediated Ca2+ influx on neuronal excitability have not been well established. Here we show that Ca2+ influx through NMDARs is directly coupled to activation of BK-type Ca2+-activated K+ channels in outside-out membrane patches from rat olfactory bulb granule cells. Repetitive stimulation of glutamatergic synapses in olfactory bulb slices evokes a slow inhibitory postsynaptic current (IPSC) in granule cells that requires both NMDARs and BK channels. The slow IPSO is enhanced by glutamate uptake blockers, suggesting that extrasynaptic NMDARs underlie the response. These findings reveal a novel inhibitory action of extrasynaptic NMDARs in the brain.	Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Grad Program Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Isaacson, JS (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA.			Murphy, Gabe/0000-0002-9321-8556	NIGMS NIH HHS [GM 08107] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Chavis P, 1998, EUR J NEUROSCI, V10, P2322, DOI 10.1046/j.1460-9568.1998.00243.x; Dutar P, 2000, J NEUROPHYSIOL, V84, P2284, DOI 10.1152/jn.2000.84.5.2284; EGAN TM, 1993, J NEUROPHYSIOL, V69, P1433, DOI 10.1152/jn.1993.69.5.1433; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GOLA M, 1993, NEURON, V10, P689, DOI 10.1016/0896-6273(93)90170-V; Grillner S, 2001, J PHYSIOL-LONDON, V533, P23, DOI 10.1111/j.1469-7793.2001.0023b.x; HILL RH, 1989, BRAIN RES, V499, P388, DOI 10.1016/0006-8993(89)90790-7; Hille B., 1992, IONIC CHANNELS EXCIT; Holmes KH, 1996, J NEUROPHYSIOL, V76, P3059, DOI 10.1152/jn.1996.76.5.3059; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Knaus HG, 1996, J NEUROSCI, V16, P955; Knoflach F, 1998, J PHYSIOL-LONDON, V509, P347, DOI 10.1111/j.1469-7793.1998.347bn.x; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1987, J NEUROSCI, V7, P3230; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; Naraghi M, 1997, J NEUROSCI, V17, P6961; NICOLL RA, 1981, SCIENCE, V212, P957, DOI 10.1126/science.6262912; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; RANDALL A, 1995, J NEUROSCI, V15, P2995; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; WALLEN P, 1987, J NEUROSCI, V7, P2745; ZORUMSKI CF, 1989, NEUROSCI LETT, V99, P293, DOI 10.1016/0304-3940(89)90462-X; [No title captured]	34	115	121	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					1027	1034		10.1016/S0896-6273(01)00428-7	http://dx.doi.org/10.1016/S0896-6273(01)00428-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580901	Bronze			2022-12-28	WOS:000171281300016
J	Neitz, J; Carroll, J; Yamauchi, Y; Neitz, M; Williams, DR				Neitz, J; Carroll, J; Yamauchi, Y; Neitz, M; Williams, DR			Color perception is mediated by a plastic neural mechanism that is adjustable in adults	NEURON			English	Article							CORTICAL MAPS; VISION; REORGANIZATION; RED; SENSITIVITY; EXPRESSION; OPPONENCY; PIGMENTS; ABSENCE; CORTEX	An intensely debated issue concerning visual-experience-dependent neural plasticity is whether experience is required only to maintain function or whether information from experience is used actively, relieving the necessity to hard-wire all connections and allowing adaptive adjustments. Here, an active role for experience is demonstrated in circuits for color vision. Chromatic experience was altered using colored filters. Over days there was a shift in color perception, as measured by the wavelength of unique yellow, which persisted 1-2 weeks after the filters were discontinued. Moreover, color-deficient adults were shown to have altered weightings of inputs to chromatic channels, demonstrating a large neural adjustment to their inherited photopigment defect. Thus, a neural normalization mechanism for color perception, determined by visual experience, operates to compensate for large genetic differences in retinal architecture and for changes in chromatic environment.	Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Rochester	Neitz, J (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	jneitz@mcw.edu		Neitz, Jay/0000-0003-3877-6712; Neitz, Maureen/0000-0002-5404-3343	NEI NIH HHS [EY01931, EY09303, EY09620, EY04367, EY01319] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY001319, R01EY009620, R01EY004367, P30EY001931, R01EY009303] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Albright TD, 2000, CELL, V100, pS1; ANDREWS DP, 1964, Q J EXP PSYCHOL, V16, P104, DOI 10.1080/17470216408416355; [Anonymous], 1991, COMPUTATIONAL MODELS, DOI [10.7551/mitpress/2002.003.0010, DOI 10.7551/MITPRESS/2002.003.0010]; [Anonymous], 1988, EYE BRAIN VISION; Balding SD, 1998, VISION RES, V38, P3359, DOI 10.1016/S0042-6989(97)00440-9; Baseler HA, 2002, NAT NEUROSCI, V5, P364, DOI 10.1038/nn817; Baseler HA, 1999, J NEUROSCI, V19, P2619; Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carroll J, 2001, COLOR RES APPL, V26, pS106, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL24>3.0.CO;2-F; Carroll J, 2000, J OPT SOC AM A, V17, P499, DOI 10.1364/JOSAA.17.000499; CARROLL J, 2002, THESIS MED COLL WISC; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; CICERONE CM, 1987, FARBE, V34, P59; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; EISNER A, 1982, PERCEPT PSYCHOPHYS, V31, P169, DOI 10.3758/BF03206217; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Hagstrom SA, 1998, NEUROREPORT, V9, P1963, DOI 10.1097/00001756-199806220-00009; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HURVICH LM, 1964, PSYCHON SCI, V1, P11, DOI 10.3758/BF03342763; Jacobs GH, 1996, J OPT SOC AM A, V13, P641, DOI 10.1364/JOSAA.13.000641; JAMESON D, 1979, P NATL ACAD SCI USA, V76, P3034, DOI 10.1073/pnas.76.6.3034; Jordan G, 1997, DOC OPHTH P, V59, P67; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kraft JM, 1999, P NATL ACAD SCI USA, V96, P307, DOI 10.1073/pnas.96.1.307; Kremers J, 2000, J OPT SOC AM A, V17, P517, DOI 10.1364/JOSAA.17.000517; Lennie P, 2000, CURR BIOL, V10, pR589, DOI 10.1016/S0960-9822(00)00632-1; Martin PR, 2001, NATURE, V410, P933, DOI 10.1038/35073587; Miyahara E, 1998, VISION RES, V38, P601, DOI 10.1016/S0042-6989(97)88334-4; Mollon JD, 1999, P NATL ACAD SCI USA, V96, P4743, DOI 10.1073/pnas.96.9.4743; MOLLON JD, 1982, ANNU REV PSYCHOL, V33, P41, DOI 10.1146/annurev.ps.33.020182.000353; Mollon JD, 2000, VANC ST COG, V9, P10; MOLLON JD, 1991, PIGMENTS PERCEPTION, P35; Neitz J, 1996, SCIENCE, V274, P801, DOI 10.1126/science.274.5288.801; NEITZ M, 1995, VISION RES, V35, P2395, DOI 10.1016/0042-6989(95)00008-9; Neitz M, 2001, COLOR RES APPL, V26, pS239, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL51>3.0.CO;2-L; Nelson JH, 1938, P PHYS SOC, V50, P661, DOI 10.1088/0959-5309/50/5/305; Otake S, 2000, J OPT SOC AM A, V17, P615, DOI 10.1364/JOSAA.17.000615; PAULUS W, 1983, VISION RES, V23, P529, DOI 10.1016/0042-6989(83)90128-1; POKORNY J, 1991, NATO ADV SCI I A-LIF, V203, P23; POKORNY J, 1987, APPL OPTICS, V26, P1437, DOI 10.1364/AO.26.001437; POKORNY J, 1977, J OPT SOC AM, V67, P1196, DOI 10.1364/JOSA.67.001196; Polyak S., 1957, VERTEBRATE VISUAL SY; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; RUBIN ML, 1961, AM J OPHTHALMOL, V52, P166, DOI 10.1016/0002-9394(61)91112-6; SCHEFRIN BE, 1990, J OPT SOC AM A, V7, P305, DOI 10.1364/JOSAA.7.000305; SCHEFRIN BE, 1991, CLIN VISION SCI, V6, P219; Shevell SK, 1998, VISION RES, V38, P3371, DOI 10.1016/S0042-6989(97)00434-3; SNODDERLY DM, 1979, BEHAV SIGNIFICANCE C, P238; Stromeyer C. F., 1978, PERCEPTION, P97, DOI [10.1007/978-3-642-46354-9_4, DOI 10.1007/978-3-642-46354-9_4]; Sumner P, 2000, J EXP BIOL, V203, P1987; Wang Y, 1999, P NATL ACAD SCI USA, V96, P5251, DOI 10.1073/pnas.96.9.5251; WESNER MF, 1991, VISION RES, V31, P1021, DOI 10.1016/0042-6989(91)90207-L; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; Yuste R, 1999, J NEUROBIOL, V41, P1, DOI 10.1002/(SICI)1097-4695(199910)41:1<1::AID-NEU1>3.0.CO;2-2	59	172	177	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					783	792		10.1016/S0896-6273(02)00818-8	http://dx.doi.org/10.1016/S0896-6273(02)00818-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194876	Bronze			2022-12-28	WOS:000177521000017
J	Logothetis, NK; Merkle, H; Augath, M; Trinath, T; Ugurbil, K				Logothetis, NK; Merkle, H; Augath, M; Trinath, T; Ugurbil, K			Ultra high-resolution fMRI in monkeys with implanted RF coils	NEURON			English	Article							HIGH-SPATIAL-RESOLUTION; HUMAN BRAIN ACTIVATION; MULTIPLE VISUAL AREAS; HIGH MAGNETIC-FIELDS; FUNCTIONAL MRI; SURFACE COIL; SENSORY STIMULATION; TITANIUM IMPLANTS; NONHUMAN-PRIMATES; BLOOD OXYGENATION	Spatiotemporally resolved functional MRI (fMRI) in animals can reveal how wide-spread neural networks are organized and accompanying electrophysiological recordings can show how small neural assemblies contribute to this organization. Here we present a novel technique that yields high-resolution structural and functional images of the monkey brain with small, tissue-compatible, intraosteally implantable radiofrequency coils. Voxel sizes as small as 0.0113 mul with high signal-to-noise and contrast-to-noise ratios were obtained, revealing both structural and functional cortical architecture in great detail. Up to a certain point, contrast sensitivity increased with decreasing voxel size, probably because of the decreased partial volume effects. Spatial specificity was demonstrated by the lamina-specific activation in experiments comparing responses to moving and flickering stimuli. The implications of this technique for combined fMRI/electrophysiology experiments and its limitations in terms of spatial coverage are discussed.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA	Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	nikos.logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Ugurbil, Kamil/AAD-6058-2022		NCRR NIH HHS [RR08079] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9; BUTTS K, 1994, MAGNET RESON MED, V31, P67, DOI 10.1002/mrm.1910310111; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; CLARK VP, 1992, CEREB CORTEX, V2, P417, DOI 10.1093/cercor/2.5.417; Cochran DL, 1997, J PERIODONTOL, V68, P186, DOI 10.1902/jop.1997.68.2.186; Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Disbrow E, 1999, BRAIN RES, V829, P167, DOI 10.1016/S0006-8993(99)01297-4; Disbrow EA, 2000, P NATL ACAD SCI USA, V97, P9718, DOI 10.1073/pnas.170205497; DOW BM, 1974, J NEUROPHYSIOL, V37, P927, DOI 10.1152/jn.1974.37.5.927; Dubowitz DJ, 2001, J NEUROSCI METH, V107, P71, DOI 10.1016/S0165-0270(01)00353-3; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Duong TQ, 2001, P NATL ACAD SCI USA, V98, P10904, DOI 10.1073/pnas.191101098; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4; FARMER THR, 1990, INVEST RADIOL, V25, P552, DOI 10.1097/00004424-199005000-00013; FEINBERG DA, 1986, RADIOLOGY, V161, P527, DOI 10.1148/radiology.161.2.3763926; FRAHM J, 1993, MAGNET RESON MED, V29, P139, DOI 10.1002/mrm.1910290126; Fransson P, 1997, NMR BIOMED, V10, P204, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<204::AID-NBM452>3.0.CO;2-J; GARWOOD M, 1989, MAGNET RESON MED, V9, P25, DOI 10.1002/mrm.1910090105; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P542, DOI 10.1152/jn.1972.35.4.542; Gosain AK, 1999, J CRANIOFAC SURG, V10, P404, DOI 10.1097/00001665-199909000-00006; Grinvald A, 2000, NAT NEUROSCI, V3, P105, DOI 10.1038/72045; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; Gross U M, 1988, Int J Oral Implantol, V5, P37; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Gruetter R, 1990, NMR BIOMED, V3, P265, DOI 10.1002/nbm.1940030605; HAACKE EM, 1994, NMR BIOMED, V7, P54, DOI 10.1002/nbm.1940070109; HAACKE EM, 1994, NMR BIOMED, V7, P374; HAREL N, 2002, P INT SCO MAG RES ME, V10, P9; HAWKEN MJ, 1988, J NEUROSCI, V8, P3541; HENDRICH K, 1994, MAGNET RESON MED, V31, P541, DOI 10.1002/mrm.1910310511; Hyde JS, 2001, MAGN RESON MED, V46, P114, DOI 10.1002/mrm.1166; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LEE JH, 1995, MAGN RESON MED, V34, P308, DOI 10.1002/mrm.1910340305; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; LopezVillegas D, 1996, NMR BIOMED, V9, P297, DOI 10.1002/(SICI)1099-1492(199610)9:7<297::AID-NBM433>3.0.CO;2-4; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; MCARDLE CB, 1986, AM J NEURORADIOL, V7, P885; MCKINNON GC, 1993, MAGNET RESON MED, V30, P609, DOI 10.1002/mrm.1910300512; MERBOLDT KD, 1995, MAGNET RESON MED, V34, P639, DOI 10.1002/mrm.1910340423; MERKLE H, 1999, P 16 ANN M EUR SOC M; MERKLE H, 2000, P 8 ANN SCI M INT SO; MERKLE H, 1999, P 7 M INT SOC NMR MI; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; RUDIN M, 1987, MAGNET RESON MED, V5, P443, DOI 10.1002/mrm.1910050505; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SILVA AC, 2002, P ISMRM 10 M HON HAW, P11; Snowden RJ, 1994, VISUAL DETECTION MOT, P51; SUMMERS RM, 1995, MAGNET RESON MED, V33, P785, DOI 10.1002/mrm.1910330607; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Ugurbil K, 1999, PHILOS T R SOC B, V354, P1195, DOI 10.1098/rstb.1999.0474; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; VON R, 1981, CRC CRIT R BIOMED EN, V5, P37; WALKER PM, 1991, MAGN RESON IMAGING, V9, P927, DOI 10.1016/0730-725X(91)90537-V; Weil A, 1928, ARCH NEURO PSYCHIATR, V20, P392, DOI 10.1001/archneurpsyc.1928.02210140160013; ZEKI SM, 1969, BRAIN RES, V14, P271, DOI 10.1016/0006-8993(69)90110-3; ZEKI SM, 1969, BRAIN RES, V13, P197, DOI 10.1016/0006-8993(69)90282-0; Zhang ZM, 2000, BRAIN RES, V852, P290, DOI 10.1016/S0006-8993(99)02243-X; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	80	122	125	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					227	242		10.1016/S0896-6273(02)00775-4	http://dx.doi.org/10.1016/S0896-6273(02)00775-4			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160742	Bronze			2022-12-28	WOS:000177034200004
J	Lorenz, J; Cross, DJ; Minoshima, S; Morrow, TJ; Paulson, PE; Casey, KL				Lorenz, J; Cross, DJ; Minoshima, S; Morrow, TJ; Paulson, PE; Casey, KL			A unique representation of heat allodynia in the human brain	NEURON			English	Article							INDUCED SECONDARY HYPERALGESIA; LAMINA-I NEURONS; CAPSAICIN-RECEPTOR; DORSAL HORN; CEREBRAL ACTIVATION; PAIN; RESPONSES; MECHANISMS; STEM; NEUROSCIENCE	Skin inflammation causes innocuous heat to become painful. This condition, called heat allodynia, is a common feature of pathological pain states. Here, we show that heat allodynia is functionally and neuroanatomically distinct from normal heat pain. We subtracted positron emission tomography scans obtained during painful heating of normal skin from scans during equally intense but normally innocuous heating of capsaicin-treated skin. This comparison reveals the specific activation of a medial thalamic pathway to the frontal lobe during heat allodynia. The results suggest that different central pathways mediate the intensity and certain qualitative aspects of pain. In making this differentiation, the brain recognizes unique physiological features of different painful conditions, thus permitting adaptive responses to different pain states.	Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Vet Affairs Med Ctr, Neurol Res Labs, Ann Arbor, MI 48105 USA; Univ Hamburg, Inst Physiol, D-20246 Hamburg, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Hamburg	Casey, KL (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	kencasey@umich.edu	Cross, Donna/GWZ-5049-2022; Lorenz, Juergen/H-1888-2018	Lorenz, Juergen/0000-0002-8561-6714; Cross, Donna/0000-0003-1918-2214; Minoshima, Satoshi/0000-0002-0043-3047	NICHD NIH HHS [P01HD33986, P01 HD033986-04] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD033986] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADLER RJ, 1976, ANN PROBAB, V4, P1, DOI 10.1214/aop/1176996176; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; [Anonymous], 1979, Pain, V6, P249; Baron R, 1999, NEUROLOGY, V53, P548, DOI 10.1212/WNL.53.3.548; BAUMANN TK, 1991, J NEUROPHYSIOL, V66, P212, DOI 10.1152/jn.1991.66.1.212; Beason-Held LL, 1999, J CEREBR BLOOD F MET, V19, P843, DOI 10.1097/00004647-199908000-00003; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Bernard JF, 1996, PROG BRAIN RES, V107, P243; Bourgeais L, 2001, J NEUROSCI, V21, P2159, DOI 10.1523/JNEUROSCI.21-06-02159.2001; Casey KL, 2001, J NEUROPHYSIOL, V85, P951, DOI 10.1152/jn.2001.85.2.951; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; CRAIG AD, 1995, J COMP NEUROL, V361, P225, DOI 10.1002/cne.903610204; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; CRAIG AD, 1999, TXB PAIN, P183; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Denton D, 1999, P NATL ACAD SCI USA, V96, P5304, DOI 10.1073/pnas.96.9.5304; Derbyshire SWG, 1998, PAIN, V76, P127, DOI 10.1016/S0304-3959(98)00034-7; Dougherty PM, 1999, NEUROSCIENCE, V90, P1377, DOI 10.1016/S0306-4522(98)00551-X; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Fuster J., 2015, PREFRONTAL CORTEX, V5th; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; HANDWERKER HO, 1994, PROG PAIN RES MANAG, V3, P195; Hsieh JC, 1996, PAIN, V64, P303, DOI 10.1016/0304-3959(95)00129-8; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; HYLDEN JLK, 1989, PAIN, V37, P229, DOI 10.1016/0304-3959(89)90135-8; Iadarola MJ, 1998, BRAIN, V121, P931, DOI 10.1093/brain/121.5.931; Lane RD, 1997, AM J PSYCHIAT, V154, P926; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; MACLEAN PD, 1955, PSYCHOSOM MED, V17, P355, DOI 10.1097/00006842-195509000-00003; MACLEAN PD, 1957, ANNU REV PHYSIOL, V19, P397, DOI 10.1146/annurev.ph.19.030157.002145; MELZACK R, 1968, P423; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; Nakano Katsuma, 2000, Journal of Neurology, V247, DOI 10.1007/PL00007778; Paulson PE, 1998, PAIN, V76, P223, DOI 10.1016/S0304-3959(98)00048-7; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; PRICE DD, 1977, PAIN, V3, P307, DOI 10.1016/0304-3959(77)90063-X; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; RAJA SN, 1999, TXB PAIN, P00011; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Ringkamp M, 2001, J NEUROSCI, V21, P4460, DOI 10.1523/JNEUROSCI.21-12-04460.2001; Rosen SD, 1996, ANN INTERN MED, V124, P939, DOI 10.7326/0003-4819-124-11-199606010-00001; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; Silverman DHS, 1997, GASTROENTEROLOGY, V112, P64, DOI 10.1016/S0016-5085(97)70220-8; Stucky CL, 2001, P NATL ACAD SCI USA, V98, P11845, DOI 10.1073/pnas.211373398; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Westlund KN, 1996, EXP BRAIN RES, V110, P151; WOOLF CJ, 1988, J PHYSIOL-PARIS, V83, P255; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6	63	170	179	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					383	393		10.1016/S0896-6273(02)00767-5	http://dx.doi.org/10.1016/S0896-6273(02)00767-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160755	Bronze			2022-12-28	WOS:000177034200017
J	Goda, Y				Goda, Y			Cadherins communicate structural plasticity of presynaptic and postsynaptic terminals	NEURON			English	Editorial Material							DENDRITIC SPINES; N-CADHERIN; POTENTIATION; ADHESION; LTP		UCL, MRC, Cell Biol Unit, London WC1E 6BT, England; UCL, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Goda, Y (corresponding author), UCL, MRC, Cell Biol Unit, Gower St, London WC1E 6BT, England.							Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Bruses JL, 2000, CURR OPIN CELL BIOL, V12, P593, DOI 10.1016/S0955-0674(00)00137-X; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; NERING H, 2001, NAT REV NEUROSCI, V2, P880; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	11	41	41	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					1	3		10.1016/S0896-6273(02)00765-1	http://dx.doi.org/10.1016/S0896-6273(02)00765-1			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123599	Bronze			2022-12-28	WOS:000176601800001
J	Watase, K; Weeber, EJ; Xu, BS; Antalffy, B; Yuva-Paylor, L; Hashimoto, K; Kano, M; Atkinson, R; Sun, YL; Armstrong, DL; Sweatt, JD; Orr, HT; Paylor, R; Zoghbi, HY				Watase, K; Weeber, EJ; Xu, BS; Antalffy, B; Yuva-Paylor, L; Hashimoto, K; Kano, M; Atkinson, R; Sun, YL; Armstrong, DL; Sweatt, JD; Orr, HT; Paylor, R; Zoghbi, HY			A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration	NEURON			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; TRANSGENIC MICE; EXPANDED POLYGLUTAMINE; HUNTINGTONS-DISEASE; TERM POTENTIATION; UBIQUITIN LIGASE; BINDING PROTEIN; PURKINJE-CELLS; EXPRESSION; DEFICITS	To faithfully recreate the features of the human neurodegenerative disease spinocerebellar ataxia type 1 (SCA1) in the mouse, we targeted 154 CAG repeats into the endogenous mouse locus. Sca1(154Q/2Q) mice developed a progressive neurological disorder that resembles human SCA1, featuring motor incoordination, cognitive deficits, wasting, and premature death, accompanied by Purkinje cell loss and age-related hippocampal synaptic dysfunction. Mutant ataxin-1 solubility varied with brain region, being most soluble in the neurons most vulnerable to degeneration. Solubility decreased overall as the mice aged; Purkinje cells, the most affected in SCA1, did not form aggregates of mutant protein until an advanced stage of disease. It appears that those neurons that cannot sequester the mutant protein efficiently and thereby curb its toxicity suffer the worst damage from polyglutamine-induced toxicity.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Kanazawa Univ, Grad Sch Med Sci, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Kanazawa University; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu	Weeber, Edwin J/A-5396-2012	Kano, Masanobu/0000-0002-0725-3292; Orr, Harry/0000-0001-6118-741X; Hashimoto, Kouichi/0000-0002-3884-8213; Zoghbi, Huda/0000-0002-0700-3349; Sweatt, J. David/0000-0003-3567-485X	NINDS NIH HHS [NS22920, NS27699] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R37NS022920, R01NS027699] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Burk S, 2001, EUR NEUROL, V46, P43, DOI 10.1159/000050755; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Clark HB, 1997, J NEUROSCI, V17, P7385; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; GENIS D, 1995, NEUROLOGY, V45, P24, DOI 10.1212/WNL.45.1.24; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; KISH SJ, 1988, ANN NEUROL, V24, P200, DOI 10.1002/ana.410240205; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Lin X, 1999, NEURON, V24, P499, DOI 10.1016/S0896-6273(00)81104-6; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; Lorenzetti D, 2000, HUM MOL GENET, V9, P779, DOI 10.1093/hmg/9.5.779; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; ZOGHBI HY, 1995, SEMIN CELL BIOL, V6, P29, DOI 10.1016/1043-4682(95)90012-8	39	234	243	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					905	919		10.1016/S0896-6273(02)00733-X	http://dx.doi.org/10.1016/S0896-6273(02)00733-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086639	Bronze			2022-12-28	WOS:000176249700009
J	Duhamel, JR				Duhamel, JR			Multisensory integration in cortex: Shedding light on prickly issues	NEURON			English	Editorial Material							TOUCH		CNRS, Inst Cognit Sci, F-75700 Paris, France	Centre National de la Recherche Scientifique (CNRS)	Duhamel, JR (corresponding author), CNRS, Inst Cognit Sci, F-75700 Paris, France.		Duhamel, Jean-René/M-4723-2017	Duhamel, Jean-René/0000-0003-0210-1027				Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; FALCHIER A, 2002, IN PRESS J NEUROSCI; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; Jousmaki V, 1998, CURR BIOL, V8, pR190, DOI 10.1016/S0960-9822(98)70120-4; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Macaluso E, 2002, NEURON, V34, P647, DOI 10.1016/S0896-6273(02)00678-5; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; Stein BE., 1993, MERGING SENSES	13	3	3	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					493	495		10.1016/S0896-6273(02)00709-2	http://dx.doi.org/10.1016/S0896-6273(02)00709-2			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062031	Bronze			2022-12-28	WOS:000175665700002
J	Muller, T; Brohmann, H; Pierani, A; Heppenstall, PA; Lewin, GR; Jessell, TM; Birchmeier, C				Muller, T; Brohmann, H; Pierani, A; Heppenstall, PA; Lewin, GR; Jessell, TM; Birchmeier, C			The homeodomain factor Lbx1 distinguishes two major programs of neuronal differentiation in the dorsal spinal cord	NEURON			English	Article							VENTRAL NEURAL-TUBE; MOTOR-NEURON; ROOF PLATE; INTERNEURON SPECIFICATION; IDENTITY; MOUSE; NEUROGENESIS; REQUIREMENT; PROTEIN; FATES	Dorsal horn neurons in the spinal cord integrate and relay sensory information. Here, we show that the expression of the homeobox gene Lbx1 distinguishes two major neuronal classes generated in the dorsal spinal cord. The Lbx1 (class A) and Lbx1(+) (class B) neurons differ in their dependence on roof plate BMP signals for specification and settle in the deep and superficial dorsal horn, respectively. Lbx1 misexpression blocks the differentiation of class A neurons. Conversely, in Lbx1 mutant mice, class B neurons assume the identity of class A neurons. As a consequence, the morphology and neuronal circuitry of the dorsal horn are aberrant. We conclude that Lbx1 distinguishes two major neuronal classes in the dorsal spinal cord and is an important determinant of their distinct differentiation programs.	Max Delbruck Ctr Mol Med, Dept Med Genet, D-13122 Berlin, Germany; Max Delbruck Ctr Mol Med, Dept Neurosci, D-13122 Berlin, Germany; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Columbia University; Howard Hughes Medical Institute	Birchmeier, C (corresponding author), Max Delbruck Ctr Mol Med, Dept Med Genet, Robert Rossle Str 10, D-13122 Berlin, Germany.		Lewin, Gary R/B-8028-2011; Pierani, Alessandra/O-6136-2017	Pierani, Alessandra/0000-0002-4872-4791; Lewin, Gary/0000-0002-2890-6352; Muller, Thomas/0000-0001-8096-1853				Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Brohmann H, 2000, DEVELOPMENT, V127, P437; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Heppenstall PA, 2001, P NATL ACAD SCI USA, V98, P8107, DOI 10.1073/pnas.141015098; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; JAHR CE, 1986, J PHYSIOL-LONDON, V370, P515, DOI 10.1113/jphysiol.1986.sp015948; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; LAING I, 1994, NEUROSCIENCE, V61, P123, DOI 10.1016/0306-4522(94)90065-5; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Ma QF, 1997, J NEUROSCI, V17, P3644; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1; Ozaki S, 1997, J COMP NEUROL, V380, P215; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Saueressig H, 1999, DEVELOPMENT, V126, P4201; Schubert FR, 2001, MECH DEVELOP, V101, P181, DOI 10.1016/S0925-4773(00)00537-2; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SOMOGYI R, 1995, J NEUROSCI, V15, P2575; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3	41	271	275	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					551	562		10.1016/S0896-6273(02)00689-X	http://dx.doi.org/10.1016/S0896-6273(02)00689-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062039	Bronze			2022-12-28	WOS:000175665700009
J	Bianchi, L; Driscoll, M				Bianchi, L; Driscoll, M			Protons at the gate: DEG/ENaC ion channels help us feel and remember	NEURON			English	Review							CAENORHABDITIS-ELEGANS; NEURONS; FAMILY; MEMBER	The DEG/ENaC ion channel family contributes to channels of striking functional diversity. Neuronally expressed family members include the C. elegans degenerins that mediate touch and are thought to be mechanically gated, and the mammalian ASICs, which are gated by protons. ASICs affect a range of sensory functions that includes perception of gentle touch, harsh touch, heat, sour taste, and pain. Family member ASIC1 is now implicated in long-term potentiation, suggesting that minute fluxes in synaptic pH may activate ASICs to enhance learning.	Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Biol Labs A232, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Driscoll, M (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Biol Labs A232, 604 Allison Rd, Piscataway, NJ 08854 USA.							Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; CANESSA CM, 1993, NATURE, V349, P588; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X	16	107	125	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					337	340		10.1016/S0896-6273(02)00687-6	http://dx.doi.org/10.1016/S0896-6273(02)00687-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988165	Bronze			2022-12-28	WOS:000175214700005
J	Bahner, M; Frechter, S; Da Silva, N; Minke, B; Paulsen, R; Huber, A				Bahner, M; Frechter, S; Da Silva, N; Minke, B; Paulsen, R; Huber, A			Light-regulated subcellular translocation of Drosophila TRPL channels induces long-term adaptation and modifies the light-induced current	NEURON			English	Article							PDZ-DOMAIN PROTEIN; INAD SIGNALING COMPLEX; CA2+ CHANNEL; PHOTORECEPTOR MEMBRANE; LIMULUS PHOTORECEPTORS; FLY PHOTORECEPTORS; SENSITIVE CHANNELS; CATION CHANNEL; CALCIUM; MUTANT	Drosophila phototransduction results in the opening of two classes of cation channels, composed of the channel subunits transient receptor potential (TRP), TRP-like (TRPL), and TRPgamma. Here, we report that one of these subunits, TRPL, is translocated back and forth between the signaling membrane and an intracellular compartment by a light-regulated mechanism. A high level of rhabdomeral TRPL, characteristic of dark-raised flies, is functionally manifested in the properties of the light-induced current. These flies are more sensitive than flies with no or reduced TRPL level to dim background lights, and they respond to a wider range of light intensities, which fit them to function better in darkness or dim background illumination. Thus, TRPL translocation represents a novel mechanism to fine tune visual responses.	Univ Karlsruhe, Inst Zool, Dept Cell & Neurobiol, D-76128 Karlsruhe, Germany; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Kuhne Minerva Ctr Studies Visual Transduct, IL-91120 Jerusalem, Israel	Helmholtz Association; Karlsruhe Institute of Technology; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Huber, A (corresponding author), Univ Karlsruhe, Inst Zool, Dept Cell & Neurobiol, Kaiserstr 12, D-76128 Karlsruhe, Germany.	dc05@rz.uni-karlsruhe.de	Da Silva, Nicolas/T-3528-2019; Huber, Armin/GYU-6322-2022	Huber, Armin/0000-0003-3977-089X	NEI NIH HHS [EY 03529] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003529] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bahner M, 2000, J BIOL CHEM, V275, P2901, DOI 10.1074/jbc.275.4.2901; BLEST AD, 1978, PROC R SOC SER B-BIO, V200, P463, DOI 10.1098/rspb.1978.0027; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; CHAMBERLAIN SC, 1979, SCIENCE, V206, P361, DOI 10.1126/science.482946; CHAMBERLAIN SC, 1984, J NEUROSCI, V4, P2792; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Hardie RC, 1996, J NEUROSCI, V16, P2924; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HOCHSTRATE P, 1989, J COMP PHYSIOL A, V166, P179, DOI 10.1007/BF00193462; Huber A, 1998, FEBS LETT, V425, P317, DOI 10.1016/S0014-5793(98)00248-8; Huber A, 1996, J BIOL CHEM, V271, P11710, DOI 10.1074/jbc.271.20.11710; HUBER A, 1994, EUR J CELL BIOL, V63, P219; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Huber A, 2000, EUR J NEUROSCI, V12, P3909, DOI 10.1046/j.1460-9568.2000.00276.x; HUBER A, 2001, IN PRESS EUR J NEURO; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; KLEINSCHMIDT J, 1975, J GEN PHYSIOL, V66, P617, DOI 10.1085/jgp.66.5.617; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER H, 1962, NATURE, V194, P111, DOI 10.1038/194111b0; Leung HT, 2000, J NEUROSCI, V20, P6797, DOI 10.1523/JNEUROSCI.20-18-06797.2000; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; Minke B, 2000, HDB BIOL PHYSICS, V3; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NAESSEL DR, 1979, J COMP PHYSL, V131, P205; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Pak W.L., 1979, P67; PAULSEN R, 1984, J COMP PHYSIOL, V155, P47, DOI 10.1007/BF00610930; Paulsen R, 2000, PFLUG ARCH EUR J PHY, V439, pR181, DOI 10.1007/s004240000138; PERETZ A, 1994, J GEN PHYSIOL, V104, P1057, DOI 10.1085/jgp.104.6.1057; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; RANGANATHAN R, 1994, NEURON, V13, P837, DOI 10.1016/0896-6273(94)90250-X; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; SCOTT K, 1997, CELL, V91, P373; SUSSTOBY E, 1991, J GEN PHYSIOL, V98, P849, DOI 10.1085/jgp.98.4.849; Tsunoda S, 1999, CELL CALCIUM, V26, P165, DOI 10.1054/ceca.1999.0070; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5	45	112	118	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 28	2002	34	1					83	93		10.1016/S0896-6273(02)00630-X	http://dx.doi.org/10.1016/S0896-6273(02)00630-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931743	Bronze			2022-12-28	WOS:000174695100011
J	Aberle, H; Haghighi, AP; Fetter, RD; McCabe, BD; Magalhaes, TR; Goodman, CS				Aberle, H; Haghighi, AP; Fetter, RD; McCabe, BD; Magalhaes, TR; Goodman, CS			wishful thinking encodes a BMP type II receptor that regulates synaptic growth in Drosophila	NEURON			English	Article							BONE MORPHOGENETIC PROTEINS; RAT SYMPATHETIC NEURONS; DENDRITIC GROWTH; NEUROMUSCULAR-JUNCTIONS; FUNCTIONAL COMPONENTS; OSTEOGENIC PROTEIN-1; SIGNAL-TRANSDUCTION; TRANSMITTER RELEASE; GENETIC DISSECTION; PLASTICITY	We conducted a large-scale screen for Drosophila mutants that have structural abnormalities of the larval neuromuscular junction (NMJ). We recovered mutations in wishful thinking (wit), a gene that positively regulates synaptic growth. wit encodes a BMP type II receptor. In wit mutant larvae, the size of the NMJs is greatly reduced relative to the size of the muscles. wit NMJs have reduced evoked excitatory junctional potentials, decreased levels of the synaptic cell adhesion molecule Fasciclin II, and synaptic membrane detachment at active zones. Wit is expressed by a subset of neurons, including motoneurons. The NMJ phenotype is specifically rescued by transgenic expression of Wit only in motoneurons. Thus, Wit appears to function as a presynaptic receptor that regulates synaptic size at the Drosophila NMJ.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Renovis Inc, 270 Littlefield Ave, San Francisco, CA 94080 USA.		Aberle, Hermann/L-8461-2017	Aberle, Hermann/0000-0002-4864-6105; R Magalhaes, Tiago/0000-0002-5528-2119; McCabe, Brian/0000-0003-1620-0501				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Guo X, 1998, NEUROSCI LETT, V245, P131, DOI 10.1016/S0304-3940(98)00192-X; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jiang Y, 2000, NEUROSCIENCE, V97, P735, DOI 10.1016/S0306-4522(00)00084-1; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIU F, 1995, MOL CELL BIOL, V15, P3479; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; ROBERTSON HM, 1988, GENETICS, V118, P461; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	43	392	401	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					545	558		10.1016/S0896-6273(02)00589-5	http://dx.doi.org/10.1016/S0896-6273(02)00589-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856529	Bronze			2022-12-28	WOS:000173911100008
J	Sobolevsky, AI; Beck, C; Wollmuth, LP				Sobolevsky, AI; Beck, C; Wollmuth, LP			Molecular Rearrangements of the extracellular vestibule in NMDAR channels during gating	NEURON			English	Article							RAT HIPPOCAMPAL-NEURONS; GLUTAMATE-RECEPTOR; SUBSTITUTED CYSTEINES; ION CHANNELS; M2 SEGMENT; K+ CHANNEL; BLOCK; ACCESSIBILITY; MEMANTINE; BINDING	Many N-methyl-D-aspartate receptor (NMDAR) channel blockers that have therapeutic potential can be trapped in the closed state. Using a combination of the substituted cysteine accessibility method and open channel blockers, we found that the M3 segment forms the core of the extracellular vestibule, including a deep site for trapping blockers. The M3 segment, as well as more superficial parts of the extracellular vestibule, undergo extensive remodeling during channel closure, but do not define the activation gate, which is located deeper in the pore. Rather, the pore walls lining the extracellular vestibule constrict during channel closure. This movement is essential for coupling ligand binding to activation gate opening and accounts for the different mechanisms of open channel block, including trapping.	SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; Max Planck Inst Med Res, Abt Mol Neurobiol, D-69120 Heidelberg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Max Planck Society	Sobolevsky, AI (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.			Wollmuth, Lonnie/0000-0002-8179-1259	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039102] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS39102] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonov SM, 1998, NAT NEUROSCI, V1, P451, DOI 10.1038/2167; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; BENVENISTE M, 1995, J PHYSIOL-LONDON, V483, P367, DOI 10.1113/jphysiol.1995.sp020591; Blanpied TA, 1997, J NEUROPHYSIOL, V77, P309, DOI 10.1152/jn.1997.77.1.309; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen HSV, 1997, J PHYSIOL-LONDON, V499, P27, DOI 10.1113/jphysiol.1997.sp021909; COSTA ACS, 1994, J PHARMACOL EXP THER, V268, P503; Dingledine R, 1999, PHARMACOL REV, V51, P7; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Sobolevsky A, 1998, BIOPHYS J, V74, P1305, DOI 10.1016/S0006-3495(98)77844-0; Sobolevsky AI, 2000, J PHYSIOL-LONDON, V526, P493, DOI 10.1111/j.1469-7793.2000.t01-2-00493.x; Sobolevsky AI, 1999, BBA-BIOMEMBRANES, V1416, P69, DOI 10.1016/S0005-2736(98)00211-9; Sobolevsky AI, 1998, J PHYSIOL-LONDON, V512, P47, DOI 10.1111/j.1469-7793.1998.047bf.x; Sobolevsky AI, 1999, J NEUROSCI, V19, P10611, DOI 10.1523/JNEUROSCI.19-24-10611.1999; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; YEH JZ, 1978, NATURE, V273, P387, DOI 10.1038/273387a0; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448	32	97	98	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					75	85		10.1016/S0896-6273(01)00560-8	http://dx.doi.org/10.1016/S0896-6273(01)00560-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779481	Bronze			2022-12-28	WOS:000173106200011
J	Wang, ZW; Saifee, O; Nonet, ML; Salkoff, L				Wang, ZW; Saifee, O; Nonet, ML; Salkoff, L			SLO-1 potassium channels control quantal content of neurotransmitter release at the C-. elegans neuromuscular junction	NEURON			English	Article							CA2+-ACTIVATED K+ CHANNELS; PRESYNAPTIC ACTIVE ZONES; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; LARGE-CONDUCTANCE; BETA-SUBUNIT; ION CHANNELS; ACETYLCHOLINE-RELEASE; CALCIUM SENSITIVITY; NERVE-TERMINALS	Six mutants of SLO-1, a large-conductance, Ca2+-activated K+ channel of C. elegans, were obtained in a genetic screen for regulators of neurotransmitter release. Mutants were isolated by their ability to suppress lethargy of an unc-64 syntaxin mutant that restricts neurotransmitter release. We measured evoked postsynaptic currents at the neuromuscular junction in both wild-type and mutants and observed that the removal of SLO-1 greatly increased quanta[ content primarily by increasing duration of release. The selective isolation of slo-1 as the only ion channel mutant derived from a whole genomic screen to detect regulators of neurotransmitter release suggests that SLO-1 plays an important, if not unique, role in regulating neurotransmitter release.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Salkoff, L (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	salkoffl@thalamus.wustl.edu						ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; ANDERSON AJ, 1988, BRIT J PHARMACOL, V95, P1329, DOI 10.1111/j.1476-5381.1988.tb11772.x; Avery L, 1995, METHOD CELL BIOL, V48, P251; AVERY L, 1993, J EXP BIOL, V175, P283; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; DiChiara TJ, 1997, J NEUROSCI, V17, P4942; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; ESGUERRA M, 1994, NATURE, V369, P563, DOI 10.1038/369563a0; Fischer HS, 1999, NEUROSCI LETT, V263, P208, DOI 10.1016/S0304-3940(99)00116-0; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; GENGYOANDO K, 1993, NEURON, V11, P703, DOI 10.1016/0896-6273(93)90080-B; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HERMAN RK, 1980, NEMATODES BIOL MODEL, V1, P227; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; KATZ E, 1995, J PHYSIOL-LONDON, V486, P695, DOI 10.1113/jphysiol.1995.sp020845; Knaus HG, 1996, J NEUROSCI, V16, P955; KNAUS HG, 1995, J BIOL CHEM, V270, P22434, DOI 10.1074/jbc.270.38.22434; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; LINDGREN CA, 1989, J PHYSIOL-LONDON, V414, P201, DOI 10.1113/jphysiol.1989.sp017684; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; MARSHALL DL, 1994, TOXICON, V32, P1433, DOI 10.1016/0041-0101(94)90415-4; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; Maryon EB, 1998, J CELL SCI, V111, P2885; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meir A, 1999, PHYSIOL REV, V79, P1019, DOI 10.1152/physrev.1999.79.3.1019; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; MORITA K, 1990, J NEUROSCI, V10, P2614; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OKKEMA PG, 1993, GENETICS, V135, P385; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Pattillo JM, 2001, NEUROSCIENCE, V102, P229, DOI 10.1016/S0306-4522(00)00453-X; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Rand James B., 1997, Cold Spring Harbor Monograph Series, V33, P611; RAND JB, 1985, PSYCHOPHARMACOL BULL, V21, P623; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; Richards D, 1999, BRIT DENT J, V1, P3; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Salkoff L, 1999, CURR TOP MEMBR, V46, P9; SALKOFF L, 1985, J PHYSIOL-PARIS, V80, P275; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SIVARAMAKRISHNAN S, 1991, J GEN PHYSIOL, V98, P1161, DOI 10.1085/jgp.98.6.1161; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sun XP, 1999, J PHYSIOL-LONDON, V518, P639, DOI 10.1111/j.1469-7793.1999.0639p.x; TABTI N, 1989, PFLUG ARCH EUR J PHY, V413, P395, DOI 10.1007/BF00584489; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; VATANPOUR H, 1995, BRIT J PHARMACOL, V114, P1502, DOI 10.1111/j.1476-5381.1995.tb13377.x; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; WANG G, 1992, J PHYSIOL-LONDON, V457, P47, DOI 10.1113/jphysiol.1992.sp019364; Wang ZW, 1997, J GEN PHYSIOL, V110, P35, DOI 10.1085/jgp.110.1.35; Wang ZW, 1996, AM J PHYSIOL-LUNG C, V271, pL100, DOI 10.1152/ajplung.1996.271.1.L100; WANGEMANN P, 1993, HEARING RES, V66, P123, DOI 10.1016/0378-5955(93)90133-L; Warbington L, 1996, INVERTEBR NEUROSCI, V2, P51, DOI 10.1007/BF02336660; Waterston R., 1988, NEMATODE C ELEGANS, P281; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; WILLIAMS BD, 1992, GENETICS, V131, P609; Xia XM, 1998, J NEUROSCI, V18, P2360; Xia XM, 2000, J NEUROSCI, V20, P4890; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737; Yazejian B, 1997, J NEUROSCI, V17, P2990; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4	85	173	181	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2001	32	5					867	881		10.1016/S0896-6273(01)00522-0	http://dx.doi.org/10.1016/S0896-6273(01)00522-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738032	Bronze			2022-12-28	WOS:000172700700013
J	Ross, CA				Ross, CA			Polyglutamine pathogenesis: Emergence of unifying mechanisms for Huntington's disease and related disorders	NEURON			English	Review							CREB-BINDING PROTEIN; NEURODEGENERATIVE DISEASES; STRIATAL NEURONS; TOXICITY; TRANSCRIPTION	The mechanisms of neurodegeneration in the CAG repeat polyglutamine diseases, including Spinal and Bulbar Muscular Atrophy (SBMA), Huntington's disease (HD), DentatoRubral and PallidoLuysian Atrophy (DRPLA), and Spino-Cerebellar Ataxia (SCA), have been controversial. Issues have included the role of polyglutamine aggregation and possible amyloid formation, localization in the cell nucleus, and possible proteolytic processing. Proposed mechanisms have included activation of caspases or other triggers of apoptosis, mitochondrial or metabolic toxicity, and interference with gene transcription. Recent studies using transgenic mouse and Drosophila models have helped resolve some of these issues and raise hopes for development of therapeutic targets.	Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA	Johns Hopkins University	Ross, CA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA.	caross@jhu.edu	Ross, Christopher A/H-8395-2013					Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Dyer RB, 2001, NAT GENET, V29, P270, DOI 10.1038/ng745; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Margolis RL, 2001, TRENDS MOL MED, V7, P479, DOI 10.1016/S1471-4914(01)02179-7; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Merry DE, 2001, BRAIN RES BULL, V56, P203, DOI 10.1016/S0361-9230(01)00594-9; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; POIRIER MA, 2002, IN PRESS J BIOL CHEM; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Toneff T, 2002, J NEUROCHEM, V82, P84, DOI 10.1046/j.1471-4159.2002.00940.x; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503	26	404	424	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 29	2002	35	5					819	822		10.1016/S0896-6273(02)00872-3	http://dx.doi.org/10.1016/S0896-6273(02)00872-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372277	Green Published, Bronze			2022-12-28	WOS:000177779800005
J	Neumann, S; Bradke, F; Tessier-Lavigne, M; Basbaum, AI				Neumann, S; Bradke, F; Tessier-Lavigne, M; Basbaum, AI			Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; NEURITE GROWTH; CNS MYELIN; ADULT; RAT; NEURONS; LESION; SCAR; PROJECTIONS	The peripheral branch of primary sensory neurons regenerates after injury, but there is no regeneration when their central branch is severed by spinal cord injury. Here we show that microinjection of a membrane-permeable analog of cAMP in lumbar dorsal root ganglia markedly increases the regeneration of injured central sensory branches. The injured axons regrow into the spinal cord lesion, often traversing the injury site. This result mimics the effect of a conditioning peripheral nerve lesion. We also demonstrate that sensory neurons exposed to cAMP in vivo, when subsequently cultured in vitro, show enhanced growth of neurites and an ability to overcome inhibition by CNS myelin. Thus, stimulating cAMP signaling increases the intrinsic growth capacity of injured sensory axons. This approach may be useful in promoting regeneration after spinal cord injury.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Sci Biol, 371 Serra Mall, Stanford, CA 94305 USA.			Bradke, Frank/0000-0002-0345-3772				Andersen PL, 2000, EXP NEUROL, V166, P153, DOI 10.1006/exnr.2000.7485; Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; BENFEY M, 1985, J NEUROCYTOL, V14, P279, DOI 10.1007/BF01258453; Blesch A, 1999, J NEUROSCI, V19, P3556; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; DEHOOP MJ, 1997, CELL BIOL LAB HDB, P154; FAWCETT JW, 1992, TRENDS NEUROSCI, V15, P5, DOI 10.1016/0166-2236(92)90338-9; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; KALDERON N, 1990, P NATL ACAD SCI USA, V87, P10058, DOI 10.1073/pnas.87.24.10058; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; OUDEGA M, 1994, EXP NEUROL, V129, P194, DOI 10.1006/exnr.1994.1161; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; RAMONYCAJAL S, 1991, DEGENERATION REGENER; RICHARDSON PM, 1986, J NEUROCYTOL, V15, P585, DOI 10.1007/BF01611859; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; ROBERTSON B, 1989, J NEUROCYTOL, V18, P77, DOI 10.1007/BF01188426; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SHAW G, 1986, EUR J CELL BIOL, V42, P1; Smith DS, 1997, J NEUROSCI, V17, P646; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515	37	436	481	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					885	893		10.1016/S0896-6273(02)00702-X	http://dx.doi.org/10.1016/S0896-6273(02)00702-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086637	Bronze			2022-12-28	WOS:000176249700007
J	Huang, X; Cheng, HJ; Tessier-Lavigne, M; Jin, YS				Huang, X; Cheng, HJ; Tessier-Lavigne, M; Jin, YS			MAX-1, a novel PH/MyTH4/FERM domain cytoplasmic protein implicated in netrin-mediated axon repulsion	NEURON			English	Article							GROWTH CONE MIGRATIONS; C-ELEGANS; CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; TRANSMEMBRANE PROTEIN; GUIDANCE RECEPTORS; LATERAL POSITION; ROBO RECEPTORS; GENE-TRANSFER; GUIDES CELL	The netrin UNC-6 repels motor axons by activating the UNC-5 receptor alone or in combination with the UNC-40/DCC receptor. In a genetic screen for C. elegans mutants exhibiting partial defects in motor axon projections, we isolated the max-1 gene (required for motor neuron axon guidance). max-1 loss-of-function mutations cause fully penetrant but variable axon guidance defects. Mutations in unc-5 and unc-6, but not in unc-40 dominantly enhance the mutant phenotypes of max-1, whereas overexpression of unc-5 or unc-6, but not of unc-40, bypasses the requirement for max-1. MAX-1 proteins contain PH, MyTH4, and FERM domains and appear to be localized to neuronal processes. Human MAX-1 and UNC5H2 colocalize in discrete subcellular regions of transfected cells. Our results suggest a possible role for MAX-1 in netrin-induced axon repulsion by modulating the UNC-5 receptor signaling pathway.	Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Sinsheimer Labs, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; Stanford University	Jin, YS (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.	jin@biology.ucsc.edu	Cheng, Hwai-Jong/AAY-5067-2021	Cheng, Hwai-Jong/0000-0003-0647-0567; Jin, Yishi/0000-0002-9371-9860; Huang, Xun/0000-0002-2653-8293	NINDS NIH HHS [NS35546] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035546, R01NS035546] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Berg JS, 2000, J CELL SCI, V113, P3439; Bloom L., 1993, THESIS MIT CAMBRIDGE; BRENNER S, 1974, GENETICS, V77, P71; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; CHISHOLM AD, 1989, GENE DEV, V3, P1413, DOI 10.1101/gad.3.9.1413; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Forrester WC, 1997, DEVELOPMENT, V124, P1831; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jin YS, 1999, J NEUROSCI, V19, P539; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kikuno R, 2000, NUCLEIC ACIDS RES, V28, P331, DOI 10.1093/nar/28.1.331; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Kussel-Andermann P, 2000, J BIOL CHEM, V275, P29654, DOI 10.1074/jbc.M004393200; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; MADURO M, 1995, GENETICS, V141, P977; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Muramatsu T, 1998, INT J MOL MED, V1, P55; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; SONG H, 2001, NAT CELL BIOL, V3, pEB1; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tuxworth RI, 2001, CURR BIOL, V11, P318, DOI 10.1016/S0960-9822(01)00097-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Woollard A, 2000, GENE DEV, V14, P596; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; [No title captured]	60	89	109	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 16	2002	34	4					563	576		10.1016/S0896-6273(02)00672-4	http://dx.doi.org/10.1016/S0896-6273(02)00672-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062040	Bronze			2022-12-28	WOS:000175665700010
J	Hibino, H; Pironkova, R; Onwumere, O; Vologodskaia, M; Hudspeth, AJ; Lesage, F				Hibino, H; Pironkova, R; Onwumere, O; Vologodskaia, M; Hudspeth, AJ; Lesage, F			RIM binding proteins (RBPs) couple Rab3-interacting molecules (RIMs) to voltage-gated Ca2+ channels	NEURON			English	Article							COCHLEAR HAIR-CELLS; CALCIUM CHANNELS; NEUROTRANSMITTER RELEASE; SUBCELLULAR-LOCALIZATION; ALPHA(1D) SUBUNIT; SYNAPTIC VESICLES; CHICKENS COCHLEA; KINETIC-ANALYSIS; RAB3 EFFECTOR; ACTIVE ZONES	Ca2+ influx through voltage-gated channels initiates the exocytotic fusion of synaptic vesicles to the plasma membrane. Here we show that RIM binding proteins (RBPs), which associate with Ca2+ channels in hair cells, photoreceptors, and neurons, interact with a,p (L type) and alpha(1B) (N type) Ca2+ channel subunits. RBPs contain three Src homology 3 domains that bind to proline-rich motifs in a, subunits and Rab3-interacting molecules (RIMs). Overexpression in PC12 cells of fusion proteins that suppress the interactions of RBPs with RIMs and a, augments the exocytosis triggered by depolarization. RBPs may regulate the strength of synaptic transmission by creating a functional link between the synaptic-vesicle tethering apparatus, which includes RIMS and Rab3, and the fusion machinery, which includes Ca2+ channels and the SNARE complex.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Hudspeth, AJ (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.		Lesage, Florian/P-9780-2019; Lesage, Florian/D-5097-2011	Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000241, F32DC000317] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [F32 DC000317, R01 DC000241-26, R01 DC000241, DC 00317] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Galiegue S, 1999, J BIOL CHEM, V274, P2938, DOI 10.1074/jbc.274.5.2938; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; HAMA K, 1980, J NEUROCYTOL, V9, P845, DOI 10.1007/BF01205023; Haynes LP, 2001, J BIOL CHEM, V276, P9726, DOI 10.1074/jbc.M006959200; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Heller S, 1998, P NATL ACAD SCI USA, V95, P11400, DOI 10.1073/pnas.95.19.11400; Hibino H, 1997, J NEUROSCI, V17, P4711; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14889, DOI 10.1073/pnas.94.26.14889; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14883, DOI 10.1073/pnas.94.26.14883; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Liu HY, 1996, J NEUROSCI, V16, P7557; Lloyd TE, 2001, NAT NEUROSCI, V4, P965, DOI 10.1038/nn1001-965; Mayer BJ, 2001, J CELL SCI, V114, P1253; Mochida S, 2000, NEUROSCI RES, V36, P175, DOI 10.1016/S0168-0102(99)00128-5; Morgans CW, 1998, J NEUROSCI, V18, P2467; Morgans CW, 1999, EUR J NEUROSCI, V11, P2989, DOI 10.1046/j.1460-9568.1999.00719.x; Nishi R, 1996, METHOD CELL BIOL, V51, P249, DOI 10.1016/S0091-679X(08)60632-9; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Yang HD, 2002, J COMP NEUROL, V443, P275, DOI 10.1002/cne.10116; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; ZIDANIC M, 1995, BIOPHYS J, V68, P1323, DOI 10.1016/S0006-3495(95)80305-X	44	192	199	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					411	423		10.1016/S0896-6273(02)00667-0	http://dx.doi.org/10.1016/S0896-6273(02)00667-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988172	Bronze, Green Accepted			2022-12-28	WOS:000175214700012
J	Araneda, RC; Firestein, SJ				Araneda, RC; Firestein, SJ			Action potentials that go the distance	NEURON			English	Editorial Material									Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Araneda, RC (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.		Araneda, Ricardo/AAN-1051-2020	Araneda, Ricardo/0000-0001-8728-3063				Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Xiong WH, 2002, NEURON, V34, P115, DOI 10.1016/S0896-6273(02)00628-1	9	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					5	6		10.1016/S0896-6273(02)00646-3	http://dx.doi.org/10.1016/S0896-6273(02)00646-3			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931735	Bronze			2022-12-28	WOS:000174695100003
J	Kopan, R; Goate, A				Kopan, R; Goate, A			Aph-2/nicastrin: An essential component of gamma-secretase and regulator of notch signaling and presenilin localization	NEURON			English	Review								The Notch signaling pathway plays a role in cell fate specification in many metazoans. A critical aspect of Notch activation involves proteolysis of the Notch receptor. This cleavage event requires Presenilin as a component of a large multiprotein complex, gamma-secretase. This complex mediates a similar cleavage event of the beta-amyloid precursor protein (APP). The transmembrane protein Nicastrin has been found to associate with Presenilin, Notch, and APP. Recent biochemical and genetic studies have focused on elucidating the function of this protein.	Washington Univ, Sch Med, Dept Pharmacol & Mol Biol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kopan, R (corresponding author), Washington Univ, Sch Med, Dept Pharmacol & Mol Biol, St Louis, MO 63110 USA.		Kopan, Raphael/AFG-3275-2022; Kopan, Raphael/AAF-1357-2022	Kopan, Raphael/0000-0002-0350-2730; Goate, Alison/0000-0002-0576-2472				Beher D, 2001, J BIOL CHEM, V276, P45394, DOI 10.1074/jbc.M103075200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Chung HM, 2001, NAT CELL BIOL, V3, P1129, DOI 10.1038/ncb1201-1129; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Goutte C, 2000, DEVELOPMENT, V127, P2481; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Levitan D, 2001, DEV BIOL, V240, P654, DOI 10.1006/dbio.2001.0486; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lopez-Schier H, 2002, DEV CELL, V2, P79, DOI 10.1016/S1534-5807(01)00109-5; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; SAXENA MT, 2001, IN PRESS J BIOL CHEM; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	20	72	74	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					321	324		10.1016/S0896-6273(02)00585-8	http://dx.doi.org/10.1016/S0896-6273(02)00585-8			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832221	Bronze			2022-12-28	WOS:000173643200004
J	Bunge, SA; Dudukovic, NM; Thomason, ME; Vaidya, CJ; Gabrieli, JDE				Bunge, SA; Dudukovic, NM; Thomason, ME; Vaidya, CJ; Gabrieli, JDE			Immature frontal lobe contributions to cognitive control in children: Evidence from fMRI	NEURON			English	Article							DEVELOPMENTAL-CHANGES; INHIBITORY MECHANISM; CORTEX; ACTIVATION; AGE; GO; INTERFERENCE; INFORMATION; MATURATION; CHILDHOOD	Event-related fMRI was employed to characterize differences in brain activation between children ages 8-12 and adults related to two forms of cognitive control: interference suppression and response inhibition. Children were more susceptible to interference and less able to inhibit inappropriate responses than were adults. Effective interference suppression in children was associated with prefrontal activation in the opposite hemisphere relative to adults. In contrast, effective response inhibition in children was associated with activation of posterior, but not prefrontal, regions activated by adults. Children failed to activate a region in right ventrolateral prefrontal cortex that was recruited for both types of cognitive control by adults. Thus, children exhibited immature prefrontal activation that varied according to the type of cognitive control required.	Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Georgetown Univ, Dept Psychol, Washington, DC 20057 USA	Stanford University; Stanford University; Georgetown University	Bunge, SA (corresponding author), MIT, Dept Brain & Cognit Sci, NE20-351, Cambridge, MA 02139 USA.	sbunge@mit.edu	Gabrieli, John/AAJ-2869-2020; Thomason, Moriah E/AAW-9511-2021		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061426] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH061426] Funding Source: Medline; PHS HHS [61426] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Bunge SA, 2000, P NATL ACAD SCI USA, V97, P3573, DOI 10.1073/pnas.050583797; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; COSTANTINI AF, 1973, J GENET PSYCHOL, V123, P309, DOI 10.1080/00221325.1973.10532690; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; DIAMOND A, 1988, CHILD DEV, V59, P523, DOI 10.1111/j.1467-8624.1988.tb01486.x; DIAMOND A, 2002, IN PRESS FRONTAL LOB; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; DRONKERS NF, 2000, NEW COGNITIVE NEUROS, P949; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gaillard WD, 2001, NEUROIMAGE, V13, P239, DOI 10.1006/nimg.2000.0681; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Harnishfeger K.K., 1993, EMERGING THEMES COGN, P28, DOI DOI 10.1007/978-1-4613-9220-0_; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; HOLMES AP, 1998, 4 INT C FUNCT MAPP H, V7, pS754; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JERNIGAN TL, 1991, BIOL PSYCHIAT, V29, P55, DOI 10.1016/0006-3223(91)90210-D; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Lorsbach TC, 1997, J EXP CHILD PSYCHOL, V64, P317, DOI 10.1006/jecp.1996.2350; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; LURLA AR, 1966, HIGHER CORTICAL FUNC; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Muzik O, 2000, NEUROIMAGE, V12, P538, DOI 10.1006/nimg.2000.0651; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Ridderinkhof KR, 1997, J EXP CHILD PSYCHOL, V65, P315, DOI 10.1006/jecp.1997.2367; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Spreen O, 1998, COMPENDIUM NEUROPSYC; Stuss D.T., 1986, FRONTAL LOBES; TIPPER SP, 1989, J EXP CHILD PSYCHOL, V48, P353, DOI 10.1016/0022-0965(89)90047-7; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; Wechsler D., 1991, WISC 3 WECHSLER INTE; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; WOODCOCK RW, 1998, WOODCOCK READING MYS; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	51	954	971	1	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					301	311		10.1016/S0896-6273(01)00583-9	http://dx.doi.org/10.1016/S0896-6273(01)00583-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	513PU	11804576	Green Accepted, Bronze			2022-12-28	WOS:000173387700016
J	Guillery, RW; Sherman, SM				Guillery, RW; Sherman, SM			Thalamic relay functions and their role in corticocortical communication: Generalizations from the visual system	NEURON			English	Review							LATERAL GENICULATE-NUCLEUS; METABOTROPIC GLUTAMATE RECEPTORS; CONTRAST GAIN-CONTROL; ELECTRON-MICROSCOPIC ANALYSIS; POSTERIOR-PULVINAR COMPLEX; STRIATE-RECIPIENT ZONE; CORTICOTHALAMIC PROJECTIONS; SUPERIOR COLLICULUS; MACAQUE MONKEY; PHA-L	All neocortical areas receive thalamic inputs. Some thalamocortical pathways relay information from ascending pathways (first order thalamic relays) and others relay information from other cortical areas (higher order thalamic relays), thus serving a role in corticocortical communication. Most, possibly all, afferents reaching thalamus, ascending and cortical, are branches of axons that innervate lower (motor) centers, so that thalamocortical pathways can be viewed generally as monitors of ongoing motor instructions. In terms of numbers, the thalamic relay is dominated by synapses that modulate the relay functions. One of the roles of these modulatory pathways is to change the transfer of information through the thalamus, in accord with current attentional demands. Other roles remain to be explored. These modulatory functions can be expected to act on corticocortical communication in addition to their action on ascending pathways.	SUNY Stony Brook, Dept Neurobiol, Stony Brook, NY 11794 USA; Univ Wisconsin, Sch Med, Dept Anat, Madison, WI 53706 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wisconsin System; University of Wisconsin Madison	Sherman, SM (corresponding author), SUNY Stony Brook, Dept Neurobiol, Stony Brook, NY 11794 USA.	s.sherman@sunysb.edu			NATIONAL EYE INSTITUTE [R01EY011494, R01EY011409, R01EY012936] Funding Source: NIH RePORTER; NEI NIH HHS [EY11409, EY12936, EY11494, EY0308] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adams MM, 2000, J COMP NEUROL, V419, P377, DOI 10.1002/(SICI)1096-9861(20000410)419:3<377::AID-CNE9>3.0.CO;2-E; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; ALLISON JD, 1993, VISUAL NEUROSCI, V10, P1129, DOI 10.1017/S0952523800010233; Bartlett EL, 2000, NEUROSCIENCE, V100, P811, DOI 10.1016/S0306-4522(00)00340-7; BENDER DB, 1983, BRAIN RES, V279, P258, DOI 10.1016/0006-8993(83)90188-9; BENDER DB, 1981, J NEUROPHYSIOL, V46, P672, DOI 10.1152/jn.1981.46.3.672; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; BOWLING DB, 1984, J NEUROSCI, V4, P198; BROWN AG, 1978, J PHYSIOL-LONDON, V274, P111, DOI 10.1113/jphysiol.1978.sp012137; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CASANOVA C, 1993, EXP BRAIN RES, V96, P247; CHALUPA LM, 1989, J NEUROSCI, V9, P347; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; Darian-Smith C, 1999, J COMP NEUROL, V410, P211, DOI 10.1002/(SICI)1096-9861(19990726)410:2<211::AID-CNE4>3.0.CO;2-X; DESCHENES M, 1994, BRAIN RES, V664, P215, DOI 10.1016/0006-8993(94)91974-7; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Erisir A, 1997, J COMP NEUROL, V377, P535; Feig S, 1998, J COMP NEUROL, V395, P281, DOI 10.1002/(SICI)1096-9861(19980808)395:3<281::AID-CNE2>3.0.CO;2-Z; Felisberti F, 1999, VISUAL NEUROSCI, V16, P943, DOI 10.1017/S0952523899165143; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Godwin DW, 1996, J NEUROSCI, V16, P8181; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; Guillery RW, 2001, J COMP NEUROL, V438, P66, DOI 10.1002/cne.1302; GUILLERY RW, 1961, CYTOLOGY NERVOUS TIS, P64; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; HARDING BN, 1973, BRAIN RES, V54, P341, DOI 10.1016/0006-8993(73)90058-9; Harting JK, 2000, BRAIN RES, V881, P244, DOI 10.1016/S0006-8993(00)02849-3; Hendry SHC, 1998, TRENDS NEUROSCI, V21, P344, DOI 10.1016/S0166-2236(98)01245-4; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HOOGLAND PV, 1991, EXP BRAIN RES, V87, P159, DOI 10.1007/BF00228517; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Hughes SW, 1999, J PHYSIOL-LONDON, V517, P805, DOI 10.1111/j.1469-7793.1999.0805s.x; HUTCHINS B, 1989, J COMP NEUROL, V285, P350, DOI 10.1002/cne.902850306; IRVIN GE, 1993, VISUAL NEUROSCI, V10, P363, DOI 10.1017/S0952523800003758; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Jones EG, 1985, THALAMUS; KAAS JH, 1995, CURR BIOL, V5, P1126, DOI 10.1016/S0960-9822(95)00228-4; Kakei S, 2001, J COMP NEUROL, V437, P170, DOI 10.1002/cne.1277; KALIL RE, 1970, J NEUROPHYSIOL, V33, P459, DOI 10.1152/jn.1970.33.3.459; Kandel E., 2000, PRINCIPLES NEURAL SC; KOLLIKER A, 1996, HDB GERWEBELEHRE MEN, V2; KULTASILINSKY K, 1991, J COMP NEUROL, V314, P319, DOI 10.1002/cne.903140209; Latawiec D, 2000, J COMP NEUROL, V419, P306, DOI 10.1002/(SICI)1096-9861(20000410)419:3<306::AID-CNE4>3.0.CO;2-2; LU SM, 1993, VISUAL NEUROSCI, V10, P631, DOI 10.1017/S0952523800005332; MAATTANEN LM, 1991, EXP BRAIN RES, V87, P205; MATHERS LH, 1972, J COMP NEUROL, V146, P43, DOI 10.1002/cne.901460104; MATHERS LH, 1971, BRAIN RES, V35, P357; MCCLURKIN JW, 1994, VISUAL NEUROSCI, V11, P601, DOI 10.1017/S0952523800002492; MCCLURKIN JW, 1984, J PHYSIOL-LONDON, V348, P135, DOI 10.1113/jphysiol.1984.sp015103; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; MCCREA RA, 1978, J COMP NEUROL, V181, P397, DOI 10.1002/cne.901810210; MOTT DD, 1994, INT REV NEUROBIOL, V36, P97, DOI 10.1016/S0074-7742(08)60304-9; Murphy PC, 1999, SCIENCE, V286, P1552, DOI 10.1126/science.286.5444.1552; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OGREN MP, 1979, J COMP NEUROL, V188, P179, DOI 10.1002/cne.901880113; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; OJIMA H, 1994, CEREB CORTEX, V4, P646, DOI 10.1093/cercor/4.6.646; PARTLOW GD, 1977, J COMP NEUROL, V171, P285, DOI 10.1002/cne.901710302; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PIN JP, 1995, CURR OPIN NEUROBIOL, V5, P342, DOI 10.1016/0959-4388(95)80047-6; Przybyszewski AW, 2000, VISUAL NEUROSCI, V17, P485, DOI 10.1017/S0952523800174012; RECASENS M, 1995, ANN NY ACAD SCI, V757, P418, DOI 10.1111/j.1749-6632.1995.tb17501.x; ROBSON JA, 1977, J COMP NEUROL, V173, P355, DOI 10.1002/cne.901730210; Rouiller EM, 1998, J COMP NEUROL, V396, P169, DOI 10.1002/(SICI)1096-9861(19980629)396:2<169::AID-CNE3>3.0.CO;2-Z; ROUILLER EM, 1991, HEARING RES, V56, P179, DOI 10.1016/0378-5955(91)90168-9; Rouiller EM, 2000, BRAIN RES BULL, V53, P727, DOI 10.1016/S0361-9230(00)00364-6; SCHWARTZ ML, 1991, J COMP NEUROL, V309, P289, DOI 10.1002/cne.903090302; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; SHERMAN SM, 1985, PROG PSYCHOB PHYSIOL, V11, P233; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; SHINODA Y, 1988, BEHAV BRAIN RES, V28, P59, DOI 10.1016/0166-4328(88)90076-9; Shore SE, 1998, HEARING RES, V116, P33, DOI 10.1016/S0378-5955(97)00207-4; SOMOGYI G, 1978, EXP BRAIN RES, V31, P417; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M., 1990, THALAMIC OSCILLATION; SUR M, 1987, J NEUROPHYSIOL, V58, P1; TAMAMAKI N, 1995, J COMP NEUROL, V354, P583, DOI 10.1002/cne.903540408; Tassinari G, 1997, BRAIN RES BULL, V43, P127, DOI 10.1016/S0361-9230(96)00215-8; Truchard AM, 2000, J NEUROSCI, V20, P3017; UPDYKE BV, 1983, J COMP NEUROL, V219, P143, DOI 10.1002/cne.902190204; UPDYKE BV, 1981, J COMP NEUROL, V201, P477, DOI 10.1002/cne.902010403; Van Horn SC, 2000, J COMP NEUROL, V416, P509; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; VETTER DE, 1993, HEARING RES, V70, P173, DOI 10.1016/0378-5955(93)90156-U; VIDNYANSZKY Z, 1994, J COMP NEUROL, V349, P259, DOI 10.1002/cne.903490208; Vidnyanszky Z, 1996, EXP BRAIN RES, V109, P63; Wang ST, 2001, J COMP NEUROL, V440, P321, DOI 10.1002/cne.1389; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Xu XM, 2001, J PHYSIOL-LONDON, V531, P203, DOI 10.1111/j.1469-7793.2001.0203j.x	98	445	450	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					163	175		10.1016/S0896-6273(01)00582-7	http://dx.doi.org/10.1016/S0896-6273(01)00582-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804565	Bronze			2022-12-28	WOS:000173387700005
J	Lu, HC; Gonzalez, E; Crair, MC				Lu, HC; Gonzalez, E; Crair, MC			Barrel cortex critical period plasticity is independent of changes in NMDA receptor subunit composition	NEURON			English	Article							DEPENDENT SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; OCULAR DOMINANCE PLASTICITY; D-ASPARTATE RECEPTOR; MICE LACKING; FUNCTIONAL-PROPERTIES; VISUAL-CORTEX; DEVELOPMENTAL REGULATION; SOMATOSENSORY CORTEX; NEURONAL PATTERNS	The regulation of NMDA receptor (NMDAR) subunit composition and expression during development is thought to control the process of thalamocortical afferent innervation, segregation, and plasticity. Thalamocortical synaptic plasticity in the mouse is dependent on NMDARs containing the NR2B subunit, which are the dominant form during the "critical period" window for plasticity. Near the end of the critical period there is a gradual increase in the contribution of NR2A subunits that happens in parallel to changes in NMDAR-mediated current kinetics. However, no extension of the critical period occurs in NR2A knockout mice, despite the fact that NMDA subunit composition and current kinetics remain immature past the end of the critical period. These data suggest that regulation of NMDAR subunit composition is not essential for closing the critical period plasticity window in mouse somatosensory barrel cortex.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Crair, MC (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza,S-603, Houston, TX 77030 USA.	mcrair@bcm.tmc.edu			NIMH NIH HHS [MH62639] Funding Source: Medline; NINDS NIH HHS [F32 NS011034, NS11034] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011034] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; Agmon A, 1996, J NEUROSCI, V16, P4684; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; BEAR MF, 1990, J NEUROSCI, V10, P909; Bear MF, 1996, J PHYSIOL-PARIS, V90, P223, DOI 10.1016/S0928-4257(97)81428-3; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Cao ZP, 2000, BRAIN RES, V859, P26, DOI 10.1016/S0006-8993(99)02450-6; Cao ZP, 2000, BRAIN RES, V868, P296, DOI 10.1016/S0006-8993(00)02343-X; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Catalano SM, 1997, J NEUROSCI, V17, P8376; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Flint AC, 1997, J NEUROSCI, V17, P2469; FOX K, 1992, J NEUROSCI, V12, P2672; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; FOX K, 1994, J NEUROSCI, V14, P7665; FOX K, 1989, J NEUROSCI, V9, P2443; Fox Kevin, 1994, Current Opinion in Neurobiology, V4, P112, DOI 10.1016/0959-4388(94)90040-X; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Glazewski S, 1999, CEREB CORTEX, V9, P249, DOI 10.1093/cercor/9.3.249; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Kiyama Y, 1998, J NEUROSCI, V18, P6704; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KOMATSU Y, 1994, J NEUROSCI, V14, P6488; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Livingston FS, 2000, NAT NEUROSCI, V3, P482, DOI 10.1038/74857; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Ramoa AS, 1997, DEV BRAIN RES, V101, P165, DOI 10.1016/S0165-3806(97)00061-8; Rema V, 1998, J NEUROSCI, V18, P10196; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SCHOEPFER R, 1994, PROG NEUROBIOL, V42, P353, DOI 10.1016/0301-0082(94)90076-0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; STROMINGER RN, 1987, J NEUROSCI METH, V22, P113, DOI 10.1016/0165-0270(87)90004-5; Sun LX, 2000, SYNAPSE, V35, P212, DOI 10.1002/(SICI)1098-2396(20000301)35:3<212::AID-SYN6>3.0.CO;2-O; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2000, J NEUROPHYSIOL, V83, P616, DOI 10.1152/jn.2000.83.1.616; Umemiya M, 2001, J NEUROSCI, V21, P1, DOI 10.1523/JNEUROSCI.21-01-00001.2001; Vallano ML, 1996, J NEUROSCI, V16, P631; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Wallace H, 2001, J NEUROSCI, V21, P3881, DOI 10.1523/JNEUROSCI.21-11-03881.2001; WANG YH, 1995, J NEUROCHEM, V65, P176; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Woolsey T.A., 1990, P461; ZHONG J, 1995, J NEUROCHEM, V64, P531	86	146	150	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					619	634		10.1016/S0896-6273(01)00501-3	http://dx.doi.org/10.1016/S0896-6273(01)00501-3			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719203	Bronze			2022-12-28	WOS:000172363900009
J	Martinez, LM; Alonso, JM				Martinez, LM; Alonso, JM			Construction of complex receptive fields in cat primary visual cortex	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; CROSS-CORRELATION ANALYSIS; CORTICAL SIMPLE CELLS; STRIATE CORTEX; SPATIAL STRUCTURE; FUNCTIONAL CONNECTIVITY; ORIENTATION SELECTIVITY; PYRAMIDAL NEURONS; THALAMIC CONTROL; RAT NEOCORTEX	In primary visual cortex, neurons are classified into simple cells and complex cells based on their response properties. Although the role of these two cell types in vision is still unknown, an attractive hypothesis is that simple cells are necessary to construct complex receptive fields. This hierarchical model puts forward two main predictions. First, simple cells should connect monosynaptically to complex cells. Second, complex cells should become silent when simple cells are inactivated. We have recently provided evidence for the first prediction, and here we do the same for the second. In summary, our results suggest that the receptive fields of most layer 2+3 complex cells are generated by a mechanism that requires simple cell inputs.	Rockefeller Univ, Neurobiol Lab, New York, NY 10021 USA; Univ A Coruna, Neurosci & Motor Control Grp Neurocom, La Coruna 15006, Spain; Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA	Rockefeller University; Universidade da Coruna; University of Connecticut	Alonso, JM (corresponding author), Rockefeller Univ, Neurobiol Lab, New York, NY 10021 USA.							ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; AKAOKA H, 1992, J NEUROSCI METH, V42, P119, DOI 10.1016/0165-0270(92)90142-Z; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; Boyd JD, 1996, J COMP NEUROL, V365, P659; Brody CD, 1998, J NEUROPHYSIOL, V80, P3345, DOI 10.1152/jn.1998.80.6.3345; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1251, DOI 10.1152/jn.1979.42.5.1251; BURKE W, 1992, VISUAL NEUROSCI, V9, P47, DOI 10.1017/S0952523800006362; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; DENO RL, 1955, PHYSL NERVOUS SYSTEM; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; FERSTER D, 1990, VISUAL NEUROSCI, V4, P115, DOI 10.1017/S0952523800002285; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FERSTER D, 1978, J COMP NEUROL, V182, P923, DOI 10.1002/cne.901820510; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FERSTER D, 1990, VISUAL NEUROSCI, V4, P135, DOI 10.1017/S0952523800002297; Fregnac Y, 1996, J PHYSIOL-PARIS, V90, P113, DOI 10.1016/S0928-4257(97)81412-X; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HOFFMANN KP, 1971, BRAIN RES, V32, P460, DOI 10.1016/0006-8993(71)90340-4; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; Hupe JM, 1999, J NEUROSCI METH, V86, P129, DOI 10.1016/S0165-0270(98)00162-9; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Lee C, 1998, VISUAL NEUROSCI, V15, P27, DOI 10.1017/S0952523898146151; LEVAY S, 1979, BRAIN RES, V164, P304, DOI 10.1016/0006-8993(79)90026-X; LEVAY S, 1977, J COMP NEUROL, V172, P563, DOI 10.1002/cne.901720402; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; MALPELI JG, 1983, J NEUROPHYSIOL, V49, P595, DOI 10.1152/jn.1983.49.3.595; MALPELI JG, 1986, J NEUROPHYSIOL, V56, P1062, DOI 10.1152/jn.1986.56.4.1062; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MASON A, 1991, J NEUROSCI, V11, P72; Mel BW, 1998, J NEUROSCI, V18, P4325; MIGNARD M, 1991, SCIENCE, V251, P1249, DOI 10.1126/science.1848727; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; MULLIKIN WH, 1984, J NEUROPHYSIOL, V52, P350, DOI 10.1152/jn.1984.52.2.350; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; ORBAN GA, 1984, NEURONAL OPERATIONSV; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Sakai K, 2000, VISION RES, V40, P855, DOI 10.1016/S0042-6989(99)00230-8; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; SHERMAN SM, 1985, FUNCTIONAL ORG W X Y; SINGER W, 1975, J NEUROPHYSIOL, V38, P1080, DOI 10.1152/jn.1975.38.5.1080; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SPITZER H, 1988, PROG NEUROBIOL, V31, P285, DOI 10.1016/0301-0082(88)90016-0; STONE J, 1979, BRAIN RES REV, V1, P345, DOI 10.1016/0165-0173(79)90010-9; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Sutter E.E., 1992, NONLINEAR VISION, P171, DOI [10.1201/9781351075060-6, DOI 10.1201/9781351075060-6]; SZULBORSKI RG, 1990, VISION RES, V30, P249, DOI 10.1016/0042-6989(90)90040-R; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; Ziburkus J, 2000, VISUAL NEUROSCI, V17, P187, DOI 10.1017/S0952523800172013	70	62	62	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					515	525		10.1016/S0896-6273(01)00489-5	http://dx.doi.org/10.1016/S0896-6273(01)00489-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709161	Bronze			2022-12-28	WOS:000172119100016
J	Xu, KL; Tavernarakis, N; Driscoll, M				Xu, KL; Tavernarakis, N; Driscoll, M			Necrotic cell death in C-elegans requires the function of calreticulin and regulators of Ca2+ release from the endoplasmic reticulum	NEURON			English	Article							CAENORHABDITIS-ELEGANS; DEPENDENT EXCITOTOXICITY; NEURONAL DEGENERATION; CORTICAL-NEURONS; CALCIUM; BRAIN; CHANNEL; GENES; NEURODEGENERATION; IDENTIFICATION	In C. elegans, a hyperactivated MEC-4(d) ion channel induces necrotic-like neuronal death that is distinct from apoptosis. We report that null mutations in calreticulin suppress both mec-4(d)-induced cell death and the necrotic cell death induced by expression of a constitutively activated Gas subunit. RNAi-mediated knockdown of calnexin, mutations in the ER Ca2+ release channels unc-68 (ryanodine receptor) or itr-1 (inositol 1,4,5 triphosphate receptor), and pharmacological manipulations that block ER Call release also suppress death. Conversely, thapsigargin-induced ER Ca2+ release can restore mec-4(d)-induced cell death when calreticulin is absent. We conclude that high [Ca2+](i) is a requirement for necrosis in C. elegans and suggest that an essential step in the death mechanism is release of ER-based Ca2+ stores. ER-driven Ca2+ release has previously been implicated in mammalian necrosis, suggesting necrotic death mechanisms may be conserved.	Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Biol Labs, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Driscoll, M (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Biol Labs, A232,604 Allison Rd, Piscataway, NJ 08855 USA.	driscoll@mbcl.rutgers.edu	Tavernarakis, Nektarios/B-9684-2013	Tavernarakis, Nektarios/0000-0002-5253-1466	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034435] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 34435] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; BAKSH S, 1995, FEBS LETT, V376, P53, DOI 10.1016/0014-5793(95)01246-4; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Barger AJ, 1998, J NEUROSCI, V18, P2871; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; DRISCOLL M, 1995, METHOD CELL BIOL, V46, P323; FRANDSEN A, 1991, J NEUROCHEM, V56, P1075, DOI 10.1111/j.1471-4159.1991.tb02031.x; FRANDSEN A, 1993, J NEUROCHEM, V60, P1202, DOI 10.1111/j.1471-4159.1993.tb03278.x; Garcia-Anoveros J, 1998, NEURON, V20, P1231, DOI 10.1016/S0896-6273(00)80503-6; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; Hall DH, 1997, J NEUROSCI, V17, P1033; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; HERMAN RK, 1987, GENETICS, V116, P377; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Korswagen HC, 1997, GENE DEV, V11, P1493, DOI 10.1101/gad.11.12.1493; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LEI SHZ, 1992, BRAIN RES, V598, P196, DOI 10.1016/0006-8993(92)90183-A; Leist M, 1998, REV PHYSIOL BIOCH P, V132, P79, DOI 10.1007/BFb0004986; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Llewellyn David H., 2000, Trends in Cell Biology, V10, P399, DOI 10.1016/S0962-8924(00)01796-7; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; MATSUOKA K, 1994, BIOCHEM J, V298, P435, DOI 10.1042/bj2980435; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; MITANI S, 1993, DEVELOPMENT, V119, P773; MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7; Nagatomo I, 2001, BRAIN RES, V888, P306, DOI 10.1016/S0006-8993(00)03101-2; Park BJ, 2001, MOL BIOL CELL, V12, P2835, DOI 10.1091/mbc.12.9.2835; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; SEGAL M, 1992, J PHYSIOL-LONDON, V448, P655, DOI 10.1113/jphysiol.1992.sp019063; SHREFFLER W, 1995, GENETICS, V139, P1261; Smith M.J., 1992, DNA Sequence, V2, P235, DOI 10.3109/10425179209020808; SONG SK, 1993, P NATL ACAD SCI USA, V90, P3933, DOI 10.1073/pnas.90.9.3933; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; THOMAS JH, 1990, GENETICS, V124, P855; Treinin M, 1998, P NATL ACAD SCI USA, V95, P15492, DOI 10.1073/pnas.95.26.15492; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; WILLIAMS BD, 1992, GENETICS, V131, P609; ZHANG L, 1993, NEUROSCI LETT, V158, P105, DOI 10.1016/0304-3940(93)90623-S	64	203	211	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2001	31	6					957	971		10.1016/S0896-6273(01)00432-9	http://dx.doi.org/10.1016/S0896-6273(01)00432-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580896	Bronze			2022-12-28	WOS:000171281300011
J	Del Punta, K; Puche, A; Adams, NC; Rodriguez, I; Mombaerts, P				Del Punta, K; Puche, A; Adams, NC; Rodriguez, I; Mombaerts, P			A divergent pattern of sensory axonal projections is rendered convergent by second-order neurons in the accessory olfactory bulb	NEURON			English	Article							PUTATIVE PHEROMONE RECEPTORS; VOMERONASAL SYSTEM; MULTIGENE FAMILY; G-PROTEINS; MOUSE; ORGANIZATION; EXPRESSION; MAMMALS; GENES; MAP	The mammalian vomeronasal system is specialized in pheromone detection. The neural circuitry of the accessory olfactory bulb (AOB) provides an anatomical substrate for the coding of pheromone information. Here, we describe the axonal projection pattern of vomeronasal sensory neurons to the AOB and the dendritic connectivity pattern of second-order neurons. Genetically traced sensory neurons expressing a given gene of the V2R class of vomeronasal receptors project their axons to six to ten glomeruli distributed in globally conserved areas of the AOB, a theme similar to V1R-expressing neurons. Surprisingly, second-order neurons tend to project their dendrites to glomeruli innervated by axons of sensory neurons expressing the same V1R or the same V2R gene. Convergence of receptor type information in the olfactory bulb may represent a common design in olfactory systems.	Rockefeller Univ, New York, NY 10021 USA; Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	Rockefeller University; University System of Maryland; University of Maryland Baltimore	Mombaerts, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.			rodriguez, ivan/0000-0002-6468-0565	NIDCD NIH HHS [DC000347] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Berghard A, 1996, J NEUROSCI, V16, P909; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brennan PA, 1999, NEUROSCIENCE, V90, P1463, DOI 10.1016/S0306-4522(98)00556-9; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Del Punta K, 2000, GENOME RES, V10, P1958, DOI 10.1101/gr.10.12.1958; Dudley CA, 1999, NEUROSCIENCE, V91, P1549, DOI 10.1016/S0306-4522(98)00711-8; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Halem HA, 2001, J NEUROSCI, V21, P2474, DOI 10.1523/JNEUROSCI.21-07-02474.2001; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Jia CP, 1997, NEUROREPORT, V8, P1887, DOI 10.1097/00001756-199705260-00019; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Kumar A, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0003.1999; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Schaefer ML, 2001, J COMP NEUROL, V436, P351; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; TAKAMI S, 1991, J COMP NEUROL, V311, P65, DOI 10.1002/cne.903110106; TAKAMI S, 1990, BRAIN RES, V510, P339, DOI 10.1016/0006-8993(90)91387-V; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; vonCampenhausen H, 1997, NEUROREPORT, V8, P2607, DOI 10.1097/00001756-199707280-00037; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	44	116	117	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1057	1066		10.1016/S0896-6273(02)00904-2	http://dx.doi.org/10.1016/S0896-6273(02)00904-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354396	Bronze			2022-12-28	WOS:000178040000007
J	Pennetta, G; Hiesinger, PR; Fabian-Fine, R; Meinertzhagen, IA; Bellen, HJ				Pennetta, G; Hiesinger, PR; Fabian-Fine, R; Meinertzhagen, IA; Bellen, HJ			Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner	NEURON			English	Article							SYNAPTIC PLASTICITY; FUNCTIONAL COMPONENTS; GENETIC DISSECTION; ENDOPLASMIC-RETICULUM; MICROTUBULE-BINDING; AXONAL-TRANSPORT; PROTEIN; EXPRESSION; HOMOLOG; DYNEIN	Aplysia VAP-33 (VAMP-associated protein) has been previously proposed to be involved in the control of neurotransmitter release. Here, we show that a Drosophila homolog of VAP-33, DVAP-33A, is localized to neuromuscular junctions. Loss of DVAP-33A causes a severe decrease in the number of boutons and a corresponding increase in bouton size. Conversely, presynaptic overexpression of DVAP-33A induces an increase in the number of boutons and a decrease in their size. Gain-of-function experiments show that the presynaptic dose of DVAP-33A tightly modulates the number of synaptic boutons. Our data also indicate that the presynaptic microtubule architecture is severely compromised in DVAP-33A mutants. We propose that a DVAP-33A-mediated interaction between microtubules and presynaptic membrane plays a pivotal role during bouton budding.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Dalhousie Univ, Life Sci Ctr, Inst Neurosci, Halifax, NS B3H 4J1, Canada	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Dalhousie University	Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, 1 Baylor Plaza, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu		Bellen, Hugo/0000-0001-5992-5989	NEI NIH HHS [EY-03592] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003592] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Ausubel FM, 1998, CURRENT PROTOCOLS MO; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BELLEN HJ, 2000, DROSOPHILA LAB MANUA; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bloom K, 2001, CURR BIOL, V11, pR326, DOI 10.1016/S0960-9822(01)00176-2; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Budnik V, 1999, NEUROMUSCULAR JUNCTI; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Estes PS, 1996, J NEUROSCI, V16, P5443; Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251; Galaud JP, 1997, BBA-PROTEIN STRUCT M, V1341, P79, DOI 10.1016/S0167-4838(97)00063-0; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hafen E., 1997, NATURE, V389, P559; Heil-Chapdelaine RA, 2000, J CELL BIOL, V151, P1337, DOI 10.1083/jcb.151.6.1337; Hiesinger PR, 2001, J COMP NEUROL, V429, P277, DOI 10.1002/1096-9861(20000108)429:2<277::AID-CNE8>3.0.CO;2-8; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Italiano JE, 1996, CELL, V84, P105, DOI 10.1016/S0092-8674(00)80997-6; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lantz VA, 1998, J CELL BIOL, V140, P897, DOI 10.1083/jcb.140.4.897; Lapierre LA, 1999, J CELL SCI, V112, P3723; Laurent F, 2000, BIOCHEM BIOPH RES CO, V270, P286, DOI 10.1006/bbrc.2000.2387; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Miller A., 1950, BIOL DROSOPHILA, P420; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Roberts TM, 2000, J CELL BIOL, V149, P7, DOI 10.1083/jcb.149.1.7; ROBERTSON HM, 1988, GENETICS, V118, P461; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Sone M, 2000, DEVELOPMENT, V127, P4157; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Stewart BA, 1996, J NEUROSCI, V16, P3877; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Torroja L, 1999, J NEUROSCI, V19, P7793; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	59	161	163	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					291	306		10.1016/S0896-6273(02)00769-9	http://dx.doi.org/10.1016/S0896-6273(02)00769-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160747	Bronze			2022-12-28	WOS:000177034200009
J	Lopes, CMB; Zhang, HL; Rohacs, T; Jin, TH; Yang, J; Logothetis, DE				Lopes, CMB; Zhang, HL; Rohacs, T; Jin, TH; Yang, J; Logothetis, DE			Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies	NEURON			English	Article							PROTEIN-KINASE-A; INOSITOL 1,4,5-TRISPHOSPHATE; PHOSPHOINOSITIDE BINDING; STRUCTURAL DETERMINANTS; POTASSIUM CHANNELS; ANCHORING PROTEIN; K+ CHANNELS; PIP2; ROMK; SPECIFICITY	Inwardly rectifying K+ (Kir) channels are important regulators of resting membrane potential and cell excitability. The activity of Kir channels is critically dependent on the integrity of channel interactions with phosphatidylinositol 4,5-bisphosphate (PlP(2)). Here we identify and characterize channel-PIP2 interactions that are conserved among Kir family members. We find basic residues that interact with PIP2, two of which have been associated with Andersen's and Bartter's syndromes. We show that several naturally occurring mutants decrease channel-PIP2 interactions, leading to disease.	NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Icahn School of Medicine at Mount Sinai; New York University; Hebei Medical University; Columbia University	Logothetis, DE (corresponding author), NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA.	diomedes@inka.mssm.edu			NHLBI NIH HHS [HL58552, HL59949] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949, R01HL058552] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ali S, 1998, P NATL ACAD SCI USA, V95, P10274, DOI 10.1073/pnas.95.17.10274; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Chanchevalap S, 2000, J BIOL CHEM, V275, P7811, DOI 10.1074/jbc.275.11.7811; Choe H, 1999, BIOPHYS J, V76, P1988, DOI 10.1016/S0006-3495(99)77357-1; Dart C, 2001, J BIOL CHEM, V276, P20499, DOI 10.1074/jbc.M101425200; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hilgemann DW, 1997, ANNU REV PHYSIOL, V59, P193, DOI 10.1146/annurev.physiol.59.1.193; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Karolyi L, 1997, HUM MOL GENET, V6, P17; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Liou HH, 1999, P NATL ACAD SCI USA, V96, P5820, DOI 10.1073/pnas.96.10.5820; Lu T, 1999, P NATL ACAD SCI USA, V96, P9926, DOI 10.1073/pnas.96.17.9926; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Lupu VD, 1998, J BIOL CHEM, V273, P14067, DOI 10.1074/jbc.273.23.14067; Mao YX, 2001, CELL, V104, P433, DOI 10.1016/S0092-8674(01)00230-6; Perets T, 1996, FEBS LETT, V384, P189, DOI 10.1016/0014-5793(96)00303-1; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Qu ZQ, 2000, J BIOL CHEM, V275, P31573, DOI 10.1074/jbc.M003473200; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Schwalbe RA, 1998, HUM MOL GENET, V7, P975, DOI 10.1093/hmg/7.6.975; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Xu ZC, 1996, J BIOL CHEM, V271, P9313, DOI 10.1074/jbc.271.16.9313; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang Y, 1999, TUMOR TARGET, V4, P158	40	305	312	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					933	944		10.1016/S0896-6273(02)00725-0	http://dx.doi.org/10.1016/S0896-6273(02)00725-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086641	Bronze			2022-12-28	WOS:000176249700011
J	Louissaint, A; Rao, S; Leventhal, C; Goldman, SA				Louissaint, A; Rao, S; Leventhal, C; Goldman, SA			Coordinated interaction of Neurogenesis and angiogenesis in the adult songbird brain	NEURON			English	Article							ENDOTHELIAL GROWTH-FACTOR; ESTROGEN-RECEPTOR-BETA; NEWLY GENERATED NEURONS; MESSENGER-RNA; FACTOR VEGF; CONTROL NUCLEUS; BLOOD-VESSELS; ANDROGEN RECEPTOR; N-CADHERIN; EXPRESSION	Neurogenesis proceeds throughout life in the higher vocal center (HVC) of the adult songbird neostriatum. Testosterone induces neuronal addition and endothelial division in HVC. We asked if testosterone-induced angiogenesis might contribute importantly to HVC neuronal recruitment. Testosterone upregulated both VEGF and its endothelial receptor, VEGF-R2/Quek1/ KDR, in HVC. This yielded a burst in local HVC angiogenesis. FACS-isolated HVC endothelial cells produced BDNF in a testosterone-dependent manner. In vivo, HVC BDNF rose by the third week after testosterone, lagging by over a week the rise in VEGF and VEGF-R2. In situ hybridization revealed that much of this induced BDNF mRNA was endothelial. In vivo, both angiogenesis and neuronal addition to HVC were substantially diminished by inhibition of VEGF-R2 tyrosine kinase. These findings suggest a causal interaction between testosterone-induced angiogenesis and neurogenesis in the adult forebrain.	Cornell Univ, Med Ctr, Dept Neurol & Neurosci, New York, NY 10021 USA	Cornell University	Goldman, SA (corresponding author), Cornell Univ, Med Ctr, Dept Neurol & Neurosci, 1300 York Ave, New York, NY 10021 USA.	sgoldm@mail.med.cornell.edu		Goldman, Steven/0000-0002-5498-4303	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS029813, R01NS033106] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07739] Funding Source: Medline; NINDS NIH HHS [R01NS33106, R37/R01NS29813] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALITALO K, 1982, J CELL BIOCHEM, V18, P25, DOI 10.1002/jcb.1982.240180104; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; Andersson C, 2001, J ENDOCRINOL, V169, P241, DOI 10.1677/joe.0.1690241; ARAUJO DM, 1993, BRAIN RES, V600, P49, DOI 10.1016/0006-8993(93)90400-H; Balthazart J, 1996, J NEUROBIOL, V31, P129, DOI 10.1002/(SICI)1097-4695(199610)31:2<129::AID-NEU1>3.3.CO;2-2; BARAMI K, 1994, NEURON, V13, P567, DOI 10.1016/0896-6273(94)90026-4; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Behar TN, 1997, EUR J NEUROSCI, V9, P2561, DOI 10.1111/j.1460-9568.1997.tb01685.x; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bernard DJ, 1999, ENDOCRINOLOGY, V140, P4633, DOI 10.1210/en.140.10.4633; BIEGEL D, 1995, BRAIN RES, V692, P183, DOI 10.1016/0006-8993(95)00511-N; BIRO S, 1994, CIRC RES, V74, P485, DOI 10.1161/01.RES.74.3.485; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; BREIER G, 1992, DEVELOPMENT, V114, P521; CaulinGlaser T, 1996, J CLIN INVEST, V98, P36, DOI 10.1172/JCI118774; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199; Fusani L, 2001, J NEUROBIOL, V49, P1, DOI 10.1002/neu.1061; GAHR M, 1990, J COMP NEUROL, V294, P30, DOI 10.1002/cne.902940104; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; Goldman S A., 1995, NEUROSCIENTIST, V1, P338; GOLDMAN SA, 1992, J NEUROSCI, V12, P2532; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Goldman SA, 1998, J NEUROBIOL, V36, P267, DOI 10.1002/(SICI)1097-4695(199808)36:2<267::AID-NEU12>3.3.CO;2-N; Goldman SA, 1998, TRENDS NEUROSCI, V21, P107, DOI 10.1016/S0166-2236(97)01191-0; GOLDMAN SA, 1990, J NEUROSCI, V10, P2931; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hennequin LF, 1999, J MED CHEM, V42, P5369, DOI 10.1021/jm990345w; HIDALGO A, 1995, J NEUROBIOL, V27, P470, DOI 10.1002/neu.480270404; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Iafrati MD, 1997, NAT MED, V3, P545, DOI 10.1038/nm0597-545; Jain RK, 1998, P NATL ACAD SCI USA, V95, P10820, DOI 10.1073/pnas.95.18.10820; Jiang JW, 1998, J NEUROBIOL, V36, P1, DOI 10.1002/(SICI)1097-4695(199807)36:1<1::AID-NEU1>3.0.CO;2-6; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JOHNSON F, 1995, J NEUROBIOL, V26, P87, DOI 10.1002/neu.480260108; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; LEGAN SJ, 1975, ENDOCRINOLOGY, V96, P50, DOI 10.1210/endo-96-1-50; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Levine AC, 1998, ENDOCRINOLOGY, V139, P4672, DOI 10.1210/en.139.11.4672; Li XC, 2000, P NATL ACAD SCI USA, V97, P8584, DOI 10.1073/pnas.140222497; Lindner V, 1998, CIRC RES, V83, P224, DOI 10.1161/01.RES.83.2.224; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Mizisin AP, 1997, J NEUROPATH EXP NEUR, V56, P1290, DOI 10.1097/00005072-199712000-00004; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; NASTIUK KL, 1995, J NEUROBIOL, V26, P213, DOI 10.1002/neu.480260206; NORDEEN EJ, 1989, DEV BRAIN RES, V49, P27, DOI 10.1016/0165-3806(89)90056-4; NOTTEBOHM F, 1985, ANN NY ACAD SCI, V457, P143, DOI 10.1111/j.1749-6632.1985.tb20803.x; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; PALMER T, 2000, ADV DRUG DELIF REV, V15, P5; Proescholdt MA, 1999, J NEUROPATH EXP NEUR, V58, P613, DOI 10.1097/00005072-199906000-00006; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; ROBERTSON PL, 1985, DEV BRAIN RES, V23, P219, DOI 10.1016/0165-3806(85)90044-6; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; SHEN P, 1995, J COMP NEUROL, V360, P172, DOI 10.1002/cne.903600113; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WALSH FS, 1992, COLD SPRING HARB SYM, V57, P431, DOI 10.1101/SQB.1992.057.01.048; Wedge SR, 2000, CANCER RES, V60, P970; Wilting J, 1997, CELL TISSUE RES, V288, P207, DOI 10.1007/s004410050807; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang XJ, 1996, J NEUROSCI, V16, P6089; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684; [No title captured]	74	585	612	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					945	960		10.1016/S0896-6273(02)00722-5	http://dx.doi.org/10.1016/S0896-6273(02)00722-5			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086642	Bronze			2022-12-28	WOS:000176249700012
J	Ritz, T; Dommer, DH; Phillips, JB				Ritz, T; Dommer, DH; Phillips, JB			Shedding light on vertebrate magnetoreception	NEURON			English	Review							MAGNETIC COMPASS ORIENTATION; DEPENDENT MAGNETORECEPTION; ANIMALS; FIELDS; BIRDS	We review the challenges and recent progress in elucidating the physiological basis of animal magnetoreception. Behavioral and theoretical studies suggest a link between photoreception and magnetoreception in some animals. Neurophysiological studies have the potential to prove this link and identify the location of and the mechanism underlying the magnetoreception system.	Virginia Polytech Inst & State Univ, Dept Biol, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Phillips, JB (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol, Blacksburg, VA 24061 USA.		Ritz, Thorsten/B-5260-2008	Ritz, Thorsten/0000-0002-2713-539X				DEMAINE C, 1985, NEUROSCI LETT, V62, P119, DOI 10.1016/0304-3940(85)90294-0; Deutschlander ME, 1999, J EXP BIOL, V202, P891; DODT E, 1962, J NEUROPHYSIOL, V25, P405, DOI 10.1152/jn.1962.25.3.405; Eveson RW, 2000, INT J RADIAT BIOL, V76, P1509, DOI 10.1080/09553000050176270; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; Lohmann KJ, 2000, TRENDS NEUROSCI, V23, P153, DOI 10.1016/S0166-2236(99)01542-8; Lohmann KJ, 2001, SCIENCE, V294, P364, DOI 10.1126/science.1064557; Marhold S, 1997, NATURWISSENSCHAFTEN, V84, P421, DOI 10.1007/s001140050422; Nemec P, 2001, SCIENCE, V294, P366, DOI 10.1126/science.1063351; PHILLIPS JB, 1993, J COMP PHYSIOL A, V172, P303, DOI 10.1007/BF00216612; PHILLIPS JB, 1992, NATURE, V359, P142, DOI 10.1038/359142a0; Phillips JB, 2001, J EXP BIOL, V204, P2543; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; SEMM P, 1986, J COMP PHYSIOL A, V159, P619, DOI 10.1007/BF00612035; SEMM P, 1984, J COMP PHYSIOL, V155, P283, DOI 10.1007/BF00610581; Wiltschko R., 1995, TIEROSYCHOL; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; Wiltschko W, 2000, NATURWISSENSCHAFTEN, V87, P36, DOI 10.1007/s001140050006	18	62	65	4	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					503	506		10.1016/S0896-6273(02)00707-9	http://dx.doi.org/10.1016/S0896-6273(02)00707-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062034	Bronze			2022-12-28	WOS:000175665700005
J	Montgomery, JM; Madison, DV				Montgomery, JM; Madison, DV			State-dependent heterogeneity in synaptic depression between pyramidal cell pairs	NEURON			English	Article							LONG-TERM DEPRESSION; HIPPOCAMPAL SLICE CULTURES; NMDA-RECEPTOR; GLUTAMATE RECEPTORS; SILENT SYNAPSES; RAT HIPPOCAMPUS; CA1 REGION; AMPA RECEPTORS; AREA CA1; POTENTIATION	Paired recordings between CA3 pyramidal neurons were used to study the properties of synaptic plasticity in active and silent synapses. Synaptic depression is accompanied by decreases in both AMPAR and NMDAR function. The mechanisms of synaptic depression, and the potential to undergo activity-dependent plastic changes in efficacy, differ depending on whether a synapse is active, recently silent, or potentiated. These results suggest that silent and active synapses represent distinct synaptic "states," and that once unsilenced, synapses express plasticity in a graded manner. The state in which a synapse resides, and the states recently visited, determine its potential and mechanism for undergoing subsequent plastic changes.	Stanford Univ, Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Madison, DV (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.		Madison, Daniel/F-9341-2017	Madison, Daniel/0000-0002-0718-5373	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108, R01MH065541, R01MH056454] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH065541, MH48108, MH56454] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; BASHIR ZI, 1994, EXP BRAIN RES, V100, P437, DOI 10.1007/BF02738403; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chung HJ, 2000, J NEUROSCI, V20, P7258; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Debanne D, 1999, J NEUROSCI, V19, P10664, DOI 10.1523/JNEUROSCI.19-24-10664.1999; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Hansel C, 1996, J PHYSIOLOGY-PARIS, V90, P317, DOI 10.1016/S0928-4257(97)87906-5; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim CH, 2001, J NEUROSCI, V21, P4188, DOI 10.1523/JNEUROSCI.21-12-04188.2001; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Miles R, 1996, CURR OPIN NEUROBIOL, V6, P387, DOI 10.1016/S0959-4388(96)80124-3; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Pavlidis P, 1999, J NEUROPHYSIOL, V81, P2787, DOI 10.1152/jn.1999.81.6.2787; Pavlidis P, 2000, J NEUROSCI, V20, P4497, DOI 10.1523/JNEUROSCI.20-12-04497.2000; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Rumpel S, 1998, J NEUROSCI, V18, P8863; SELIG DK, 1995, J NEUROPHYSIOL, V74, P1075, DOI 10.1152/jn.1995.74.3.1075; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TOVAR KR, 2002, IN PRESS NEURON; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; XIAO MY, 1994, EUR J NEUROSCI, V6, P1055, DOI 10.1111/j.1460-9568.1994.tb00600.x; XIAO MY, 1995, J NEUROSCI, V15, P4496; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	65	112	114	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					765	777		10.1016/S0896-6273(02)00606-2	http://dx.doi.org/10.1016/S0896-6273(02)00606-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879653	Bronze			2022-12-28	WOS:000174286200012
J	Fischl, B; Salat, DH; Busa, E; Albert, M; Dieterich, M; Haselgrove, C; van der Kouwe, A; Killiany, R; Kennedy, D; Klaveness, S; Montillo, A; Makris, N; Rosen, B; Dale, AM				Fischl, B; Salat, DH; Busa, E; Albert, M; Dieterich, M; Haselgrove, C; van der Kouwe, A; Killiany, R; Kennedy, D; Klaveness, S; Montillo, A; Makris, N; Rosen, B; Dale, AM			Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain	NEURON			English	Article							EARLY ALZHEIMERS-DISEASE; HUMAN CEREBRAL-CORTEX; OBSESSIVE-COMPULSIVE DISORDER; HIPPOCAMPAL VOLUME REDUCTIONS; MAGNETIC-RESONANCE IMAGES; DEFORMABLE SURFACE MODEL; MEDIAL TEMPORAL ATROPHY; AGE-RELATED-CHANGES; MR-IMAGES; IN-VIVO	We present a technique for automatically assigning a neuroanatomical label to each voxel in an MRI volume based on probabilistic information automatically estimated from a manually labeled training set. In contrast to existing segmentation procedures that only label a small number of tissue classes, the current method assigns one of 37 labels to each voxel, including left and right caudate, putamen, pallidum, thalamus, lateral ventricles, hippocampus, and amygdala. The classification technique employs a registration procedure that is robust to anatomical variability, including the ventricular enlargement typically associated with neurological diseases and aging. The technique is shown to be comparable in accuracy to manual labeling, and of sufficient sensitivity to robustly detect changes in the volume of noncortical structures that presage the onset of probable Alzheimer's disease.	Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; Massachusetts Gen Hosp, Ctr Neurosci, Ctr Morphometr Anal, Charlestown, MA 02129 USA; Univ Penn, Dept Comp Sci, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Massachusetts General Hospital; University of Pennsylvania	Dale, AM (corresponding author), Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Rm 2328,Bldg 149,13th St, Charlestown, MA 02129 USA.	dale@nmr.mgh.harvard.edu	Kennedy, David N/H-3627-2012; anand, amit/A-7222-2009; Kennedy, Kristen M/B-4699-2008; Killiany, Ronald/Y-7251-2019; Dale, Anders M/A-5180-2010	Kennedy, Kristen M/0000-0001-5373-9026; Killiany, Ronald/0000-0003-4740-2181; Haselgrove, Christian/0000-0002-4438-0637	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075, R01RR013609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034189, R01NS039581] Funding Source: NIH RePORTER; NCRR NIH HHS [R01-RR13609, P41-RR14075] Funding Source: Medline; NINDS NIH HHS [R01-NS39581, R01-NS34189] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albert MS, 1996, P NATL ACAD SCI USA, V93, P13547, DOI 10.1073/pnas.93.24.13547; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; BAJCSY R, 1983, J COMPUT ASSIST TOMO, V7, P618, DOI 10.1097/00004728-198308000-00008; BALL MJ, 1985, LANCET, V1, P14; Ballester MAG, 2000, MED IMAGE ANAL, V4, P189, DOI 10.1016/S1361-8415(00)00013-X; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BREITER HC, 1994, ARCH GEN PSYCHIAT, V51, P663; BURT PJ, 1983, IEEE T COMMUN, V31, P532, DOI 10.1109/TCOM.1983.1095851; CAVINESS VS, 1992, BRAIN DEV-JPN, V14, pS80; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Caviness VS, 1996, J COGNITIVE NEUROSCI, V8, P566, DOI 10.1162/jocn.1996.8.6.566; CAVINESS VS, 1989, BRAIN DEV-JPN, V11, P1; Cho S, 1997, MAGN RESON IMAGING, V15, P1133, DOI 10.1016/S0730-725X(97)00202-6; Christensen GE, 1996, IEEE T IMAGE PROCESS, V5, P1435, DOI 10.1109/83.536892; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; Convit A, 1997, NEUROBIOL AGING, V18, P131, DOI 10.1016/S0197-4580(97)00001-8; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Daly E, 2000, ARCH NEUROL-CHICAGO, V57, P675, DOI 10.1001/archneur.57.5.675; Davatzikos C, 1996, IEEE T MED IMAGING, V15, P785, DOI 10.1109/42.544496; De Toledo-Morrell L, 2000, ANN NY ACAD SCI, V911, P240, DOI 10.1111/j.1749-6632.2000.tb06730.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Double KL, 1996, NEUROBIOL AGING, V17, P513; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Forstl H, 1995, BRIT J PSYCHIAT, V167, P739, DOI 10.1192/bjp.167.6.739; Fox P.T., 1994, FUNCTIONAL NEUROIMAG, P95; FOX PT, 1984, J CEREBR BLOOD F MET, V4, P634, DOI 10.1038/jcbfm.1984.91; Frisoni GB, 1996, AM J NEURORADIOL, V17, P913; GEE JC, 1994, MED IMAGING 1994 IMA; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Germond L, 2000, ARTIF INTELL MED, V20, P77, DOI 10.1016/S0933-3657(00)00054-3; Ghanei A, 1998, COMPUT BIOL MED, V28, P239, DOI 10.1016/S0010-4825(98)00007-9; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; Halliday GM, 1998, EXP NEUROL, V154, P663, DOI 10.1006/exnr.1998.6919; Held K, 1997, IEEE T MED IMAGING, V16, P878, DOI 10.1109/42.650883; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; JACK CR, 1992, NEUROLOGY, V42, P183, DOI 10.1212/WNL.42.1.183; JACKSON GD, 1993, NEUROLOGY, V43, P1793, DOI 10.1212/WNL.43.9.1793; Jenike MA, 1996, ARCH GEN PSYCHIAT, V53, P625; JERNIGAN TL, 1991, BIOL PSYCHIAT, V29, P68, DOI 10.1016/0006-3223(91)90211-4; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; KAPUR T, 1998, MED IMAGING COMPUTIN; Kaye JA, 1997, NEUROLOGY, V48, P1297, DOI 10.1212/WNL.48.5.1297; KENNEDY DN, 1989, IEEE T MED IMAGING, V8, P1, DOI 10.1109/42.20356; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; KILLIANY RJ, 1993, ARCH NEUROL-CHICAGO, V50, P949, DOI 10.1001/archneur.1993.00540090052010; LAAKSO MP, 1995, J NEURAL TRANSM-PARK, V9, P73, DOI 10.1007/BF02252964; LEAHY RM, 1991, INF PROC MED IM 12 I; LEHTOVIRTA M, 1995, NEUROSCIENCE, V67, P65, DOI 10.1016/0306-4522(95)00014-A; LUXENBERG JS, 1987, NEUROLOGY, V37, P1135, DOI 10.1212/WNL.37.7.1135; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Magnotta VA, 1999, RADIOLOGY, V211, P781, DOI 10.1148/radiology.211.3.r99ma07781; Makris N, 1997, ANN NEUROL, V42, P951, DOI 10.1002/ana.410420617; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; MILLER MI, 1993, P NATL ACAD SCI USA, V90, P11944, DOI 10.1073/pnas.90.24.11944; Mizuno K, 2000, J NEUROL SCI, V173, P18, DOI 10.1016/S0022-510X(99)00289-0; MURPHY DGM, 1993, BIOL PSYCHIAT, V34, P612, DOI 10.1016/0006-3223(93)90153-5; Ogg RJ, 1998, MAGNET RESON MED, V40, P749, DOI 10.1002/mrm.1910400516; OSullivan RL, 1997, BIOL PSYCHIAT, V42, P39, DOI 10.1016/S0006-3223(96)00297-1; Pedersen NL, 1999, DEMENT GERIATR COGN, V10, P51, DOI 10.1159/000017097; Powell A L, 1993, J Geriatr Psychiatry Neurol, V6, P217; Press W., 1994, NUMERICAL RECIPES C; Puri BK, 1999, INT J PSYCHOPHYSIOL, V34, P207, DOI 10.1016/S0167-8760(99)00078-1; RADEMACHER J, 1992, J COGNITIVE NEUROSCI, V4, P352, DOI 10.1162/jocn.1992.4.4.352; ROSEN BR, 1984, J COMPUT ASSIST TOMO, V8, P195; Ruan S, 2000, IEEE T MED IMAGING, V19, P1179, DOI 10.1109/42.897810; Sandor S, 1997, IEEE T MED IMAGING, V16, P41, DOI 10.1109/42.552054; Seidman LJ, 1999, BIOL PSYCHIAT, V46, P941, DOI 10.1016/S0006-3223(99)00075-X; Small SA, 2000, MICROSC RES TECHNIQ, V51, P101, DOI 10.1002/1097-0029(20001001)51:1<101::AID-JEMT11>3.0.CO;2-H; Steen RG, 2000, MAGN RESON IMAGING, V18, P361, DOI 10.1016/S0730-725X(00)00123-5; Suckling J, 1999, MAGN RESON IMAGING, V17, P1065, DOI 10.1016/S0730-725X(99)00055-7; Talairach J, 1967, ATLAS ANATOMIE STERE; Talairach J., 1988, COPLANAR STEREOTAXIC; Tang H, 2000, COMPUT MED IMAG GRAP, V24, P349, DOI 10.1016/S0895-6111(00)00037-9; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Thompson PM, 1997, J COMPUT ASSIST TOMO, V21, P567, DOI 10.1097/00004728-199707000-00008; Thompson PM, 1996, NEUROIMAGE, V3, P19, DOI 10.1006/nimg.1996.0003; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; VanEssen DC, 1997, J NEUROSCI, V17, P7079; VANNIER MW, 1994, FUNCTIONAL NEUROIMAG, P217; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang Y, 1998, IEEE T IMAGE PROCESS, V7, P1165, DOI 10.1109/83.704309; Warfield S, 1996, PATTERN RECOGN LETT, V17, P713, DOI 10.1016/0167-8655(96)00036-0; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Wolf H, 2001, NEUROBIOL AGING, V22, P177, DOI 10.1016/S0197-4580(00)00238-4; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Xu CY, 1999, IEEE T MED IMAGING, V18, P467, DOI 10.1109/42.781013; Zeng XL, 1999, IEEE T MED IMAGING, V18, P927, DOI 10.1109/42.811276; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	99	5620	5661	19	306	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					341	355		10.1016/S0896-6273(02)00569-X	http://dx.doi.org/10.1016/S0896-6273(02)00569-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832223	Bronze			2022-12-28	WOS:000173643200006
J	Burrone, J; Neves, G; Gomis, A; Cooke, A; Lagnado, L				Burrone, J; Neves, G; Gomis, A; Cooke, A; Lagnado, L			Endogenous calcium buffers regulate fast exocytosis in the synaptic terminal of retinal bipolar cells	NEURON			English	Article							SACCULAR HAIR-CELLS; NEUROTRANSMITTER RELEASE; PRESYNAPTIC TERMINALS; CA2+ MICRODOMAINS; GOLDFISH; CALRETININ; KINETICS; DYNAMICS; LOCALIZATION; SYNAPSES	Calcium-triggered exocytosis at the synapse is suppressed by addition of calcium chelators, but the effects of endogenous Ca2+ buffers have not been tested. We find that 80% of Ca2+ binding sites in the synaptic terminal of retinal bipolar cells were associated with mobile molecules that suppressed activation of Ca2+, sensitive K+ channels with an efficiency equivalent to similar to1.2 mM BAPTA. Removing these buffers caused a 30-fold increase In the number of vesicles released by Ca2+ tail currents lasting similar to0.5 ms and a 2-fold increase in the rapidly releasable pool of vesicles (RRP). The effects of BAPTA and EGTA indicate that vesicles comprising the RRP were docked at variable distances from Ca2+ channels. We propose that endogenous Ca2+ buffers regulate the size of the RRP by suppressing the release of vesicles toward the periphery of the active zone.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lagnado, L (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Burrone, Juan/C-5654-2009; Gomis, Ana/S-1854-2017; Cooke, Anne/E-8709-2012; Neves, Guilherme/G-8957-2011	Gomis, Ana/0000-0003-4651-7673; Neves, Guilherme/0000-0001-6463-6997; Cooke, Anne/0000-0001-5562-6869; Burrone, Juan/0000-0003-1233-668X				ADLER EM, 1991, J NEUROSCI, V11, P1496; ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P115, DOI 10.1113/jphysiol.1980.sp013155; Bertram R, 1999, BIOPHYS J, V76, P735, DOI 10.1016/S0006-3495(99)77240-1; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P211, DOI 10.1113/jphysiol.1978.sp012229; Goda Y, 1997, CURR OPIN CELL BIOL, V9, P513, DOI 10.1016/S0955-0674(97)80027-0; Gomis A, 1999, J NEUROSCI, V19, P6309; Hack NJ, 2000, J NEUROSCI, V20; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; KATZ B, 1967, PROC R SOC SER B-BIO, V167, P23, DOI 10.1098/rspb.1967.0011; LAGNADO L, 1992, J PHYSIOL-LONDON, V455, P111, DOI 10.1113/jphysiol.1992.sp019293; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Naraghi M, 1997, J NEUROSCI, V17, P6961; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Neves G, 2001, J PHYSIOL-LONDON, V535, P809, DOI 10.1111/j.1469-7793.2001.t01-1-00809.x; OKADA T, 1995, NEUROSCI RES, V23, P297, DOI 10.1016/0168-0102(95)00955-8; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Sabatini BL, 1997, J NEUROSCI, V17, P3425; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Sakaba T, 1997, NEUROSCI RES, V27, P219, DOI 10.1016/S0168-0102(97)01155-3; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Schwaller B, 1997, J BIOL CHEM, V272, P29663, DOI 10.1074/jbc.272.47.29663; Tank DW, 1995, J NEUROSCI, V15, P7940; Tucker TR, 1996, J PHYSIOL-LONDON, V494, P613, DOI 10.1113/jphysiol.1996.sp021519; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Weruaga E, 2000, J CHEM NEUROANAT, V19, P1, DOI 10.1016/S0891-0618(00)00046-6; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	42	75	75	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					101	112		10.1016/S0896-6273(01)00565-7	http://dx.doi.org/10.1016/S0896-6273(01)00565-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779483	Bronze			2022-12-28	WOS:000173106200013
J	Frith, U				Frith, U			Mind blindness and the brain in autism	NEURON			English	Review							ANTERIOR CINGULATE; PERCEPTION; AMYGDALA; REPRESENTATION; IMPAIRMENTS; ACTIVATION; CHILDREN; CORTEX; GAZE; FACE	Experimental evidence shows that the inability to attribute mental states, such as desires and beliefs, to self and others (mentalizing) explains the social and communication impairments of individuals with autism. Brain imaging studies in normal volunteers highlight a circumscribed network that is active during mentalizing and links medial prefrontal regions with posterior superior temporal sulcus and temporal poles. The brain abnormality that results in mentalizing failure in autism may involve weak connections between components of this system.	UCL Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London	Frith, U (corresponding author), UCL Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.		Frith, Uta/C-1757-2008	Frith, Uta/0000-0002-9063-4466				Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Asperger H., 1944, AUTISM ASPERGER SYND, P37; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; Baird G, 2000, J AM ACAD CHILD PSY, V39, P694, DOI 10.1097/00004583-200006000-00007; Baldwin DA, 1996, CHILD DEV, V67, P3135, DOI 10.1111/j.1467-8624.1996.tb01906.x; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baron -Cohen S., 1997, MINDBLINDNESS ESSAY; Baron-Cohen Simon, 1996, British Journal of Psychiatry, V168, P158, DOI 10.1192/bjp.168.2.158; BaronCohen S, 1997, CHILD DEV, V68, P48; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BARONCOHEN S, 1986, BRIT J DEV PSYCHOL, V4, P113, DOI 10.1111/j.2044-835X.1986.tb01003.x; BARONCOHEN S, 1999, UNDERSTANDING OTHER, V2; Bauman M.L, 1994, NEUROBIOLOGY AUTISM, P119; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Black Ira B., 1998, Neuron, V20, P1073, DOI 10.1016/S0896-6273(00)80489-4; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Bonda E, 1996, J NEUROSCI, V16, P3737; BRETHERTON I, 1992, SOCIAL REFERENCING I; Brothers L., 1997, FRIDAYS FOOTPRINT SO; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Cheney D. L., 1990, MONKEYS SEE WORLD IN; de Waal Frans B.M., 1992, Evolutionary Anthropology, V1, P86, DOI 10.1002/evan.1360010306; Dolan RS, 2000, NEUROIMAGE, V11, P203, DOI 10.1006/nimg.2000.0538; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Frith C.D., 2000, UNDERSTANDING OTHER, P335; FRITH U, 1991, TRENDS NEUROSCI, V14, P433, DOI 10.1016/0166-2236(91)90041-R; Frith U, 1998, DEVELOPMENTAL SCI, V1, P267, DOI 10.1111/1467-7687.00041; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Grezes J, 1999, BRAIN, V122, P1875, DOI 10.1093/brain/122.10.1875; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Happe F, 2001, NEUROPSYCHOLOGIA, V39, P83, DOI 10.1016/S0028-3932(00)00093-2; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Happe F, 1996, BRAIN, V119, P1377, DOI 10.1093/brain/119.4.1377; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; Hobson P., 1993, AUTISM DEV MIND; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Howard MA, 2000, NEUROREPORT, V11, P2931, DOI 10.1097/00001756-200009110-00020; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; KANNER L, 1968, ACTA PAEDOPSYCHIATR, V35, P100; Kawashima R, 1999, NEUROIMAGE, V10, P209, DOI 10.1006/nimg.1999.0452; Kesler ML, 2001, COGNITIVE BRAIN RES, V11, P213, DOI 10.1016/S0926-6410(00)00073-2; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; LESLIE AM, 1992, COGNITION, V43, P225, DOI 10.1016/0010-0277(92)90013-8; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Maestrini E, 2000, NEURON, V28, P19, DOI 10.1016/S0896-6273(00)00081-7; McGuire PK, 1996, BRAIN, V119, P907, DOI 10.1093/brain/119.3.907; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Nakamura K, 2000, BRAIN, V123, P1903, DOI 10.1093/brain/123.9.1903; Nimchinsky EA, 1999, P NATL ACAD SCI USA, V96, P5268, DOI 10.1073/pnas.96.9.5268; PERRETT DI, 1989, J EXP BIOL, V146, P87; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Puce A, 1998, J NEUROSCI, V18, P2188; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Repacholi BM, 1998, DEV PSYCHOL, V34, P1017, DOI 10.1037/0012-1649.34.5.1017; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Russell J., 1998, AUTISM EXECUTIVE DIS; Scheuffgen K, 2000, DEV PSYCHOPATHOL, V12, P83, DOI 10.1017/S095457940000105X; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Sigman M, 1997, CHILDREN AUTISM DEV; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Toni I, 2001, NEUROIMAGE, V14, pS110, DOI 10.1006/nimg.2001.0841; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; WHO, 1992, ICD10 CLASS MENT BEH; Wicker B, 1998, NEUROIMAGE, V8, P221, DOI 10.1006/nimg.1998.0357; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288	83	398	408	2	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					969	979		10.1016/S0896-6273(01)00552-9	http://dx.doi.org/10.1016/S0896-6273(01)00552-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	504ZT	11754830	Bronze			2022-12-28	WOS:000172886800006
J	Sakaba, T; Neher, E				Sakaba, T; Neher, E			Calmodulin mediates rapid recruitment of fast-releasing synaptic vesicles at a calyx-type synapse	NEURON			English	Article							PRESYNAPTIC CALCIUM CURRENT; READILY RELEASABLE POOL; LONG-TERM POTENTIATION; LIGHT-CHAIN KINASE; TRANSMITTER RELEASE; RECEPTOR DESENSITIZATION; DEVELOPMENTAL-CHANGES; GLUTAMATE RELEASE; RESIDUAL CALCIUM; AUDITORY SYNAPSE	In many synapses, depletion and recruitment of releasable synaptic vesicles contribute to use-dependent synaptic depression and recovery. Recently it has been shown that high-frequency presynaptic stimulation enhances recovery from depression, which may be mediated by Ca2+. We addressed this issue by measuring quantal release rates at the calyx of Held synapse and found that transmission is mediated by a heterogeneous population of vesicles, with one subset releasing rapidly and recovering slowly and another one releasing reluctantly and recovering rapidly. Ca2+ promotes refilling of the rapidly releasing synaptic vesicle pool and calmodulin inhibitors block this effect. We propose that calmodulin-dependent refilling supports recovery from synaptic depression during high-frequency trains in concert with rapid recovery of the slowly releasing vesicles.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Neher, E (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany.	eneher@gwdg.de	Neher, Erwin/A-2109-2013	Sakaba, Takeshi/0000-0003-0688-7717				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1994, ADV SEC MESS PHOSPH, V29, P139; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chuhma N, 1998, J NEUROSCI, V18, P512; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DELANEY K, 1991, J NEUROSCI, V11, P2631; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dittman JS, 2000, J NEUROSCI, V20, P1374; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Gomis A, 1999, J NEUROSCI, V19, P6309; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hopfield JJ, 2001, P NATL ACAD SCI USA, V98, P1282, DOI 10.1073/pnas.031567098; Huang EP, 1997, J NEUROPHYSIOL, V78, P2870, DOI 10.1152/jn.1997.78.6.2870; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; Ishikawa T, 2001, J PHYSIOL-LONDON, V533, P423, DOI 10.1111/j.1469-7793.2001.0423a.x; Iwasaki S, 1998, J PHYSIOL-LONDON, V509, P419, DOI 10.1111/j.1469-7793.1998.419bn.x; Iwasaki S, 2001, J PHYSIOL-LONDON, V534, P861, DOI 10.1111/j.1469-7793.2001.00861.x; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; Otis T, 1996, J NEUROSCI, V16, P7496; Park JB, 1997, J BIOL CHEM, V272, P20857, DOI 10.1074/jbc.272.33.20857; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Quetglas S, 2000, P NATL ACAD SCI USA, V97, P9695, DOI 10.1073/pnas.97.17.9695; RAMAN IM, 1995, BIOPHYS J, V68, P137, DOI 10.1016/S0006-3495(95)80168-2; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Ryan TA, 1999, J NEUROSCI, V19, P1317; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Taschenberger H, 2000, J NEUROSCI, V20, P9162; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Tsodyks M, 2000, J NEUROSCI, V20; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; VONGERSDORFF H, 1997, J NEUROSCI, V17, P115; WALMSLEY B, 1988, J NEUROPHYSIOL, V60, P889, DOI 10.1152/jn.1988.60.3.889; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Weis S, 1999, BIOPHYS J, V77, P2418, DOI 10.1016/S0006-3495(99)77079-7; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wu LG, 1999, J NEUROSCI, V19, P726; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297; YAZAWA M, 1992, BIOCHEMISTRY-US, V31, P3171, DOI 10.1021/bi00127a018; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	79	272	274	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					1119	1131		10.1016/S0896-6273(01)00543-8	http://dx.doi.org/10.1016/S0896-6273(01)00543-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754842	Green Published, Bronze			2022-12-28	WOS:000172886800017
J	Demb, JB; Zaghloul, K; Sterling, P				Demb, JB; Zaghloul, K; Sterling, P			Cellular basis for the response to second-order motion cues in Y retinal ganglion cells	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; CAT VISUAL-CORTEX; 2ND-ORDER MOTION; MACAQUE MONKEY; AREA MT; CONTRAST ENHANCEMENT; SALAMANDER RETINA; SPATIAL SUMMATION; ORIENTATION BIAS; PERCEIVED SPEED	We perceive motion when presented with spatiotemporal changes in contrast (second-order cue). This requires linear signals to be rectified and then summed in temporal order to compute direction. Although both operations have been attributed to cortex, rectification might occur in retina, prior to the ganglion cell. Here we show that the Y ganglion cell does indeed respond to spatiotemporal contrast modulations of a second-order motion stimulus. Responses in an OFF ganglion cell are caused by an EPSP/IPSP sequence evoked from within the dendritic field; in ON cells inhibition is indirect. Inhibitory effects, which are blocked by tetrodotoxin, clamp the response near resting potential thus preventing saturation. Apparently the computation for second-order motion can be initiated by Y cells and completed by cortical cells that sum outputs of multiple Y cells in a directionally selective manner.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Demb, JB (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.			Demb, Jonathan/0000-0003-2227-9041	NATIONAL EYE INSTITUTE [T32EY007035, R01EY000828, F32EY006850] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY00828, F32-EY06850, T32-EY07035] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; Baker CL, 1999, CURR OPIN NEUROBIOL, V9, P461, DOI 10.1016/S0959-4388(99)80069-5; BILOTTA J, 1989, VISUAL NEUROSCI, V2, P3, DOI 10.1017/S0952523800004260; Blakemore MR, 2000, VISION RES, V40, P629, DOI 10.1016/S0042-6989(99)00214-X; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burkhardt DA, 1998, J NEUROPHYSIOL, V80, P1070, DOI 10.1152/jn.1998.80.3.1070; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P257, DOI 10.1113/jphysiol.1978.sp012232; Calkins DJ, 1998, J NEUROSCI, V18, P3373; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHILCHILNISKY EJ, 1999, NAT NEUROSCI, V2, P889; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; COHEN E, 1992, EUR J NEUROSCI, V4, P506, DOI 10.1111/j.1460-9568.1992.tb00901.x; COOK PB, 1994, J NEUROSCI, V14, P3852; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Demb JB, 1999, J NEUROSCI, V19, P9756; DEMONASTERIO FM, 1978, J NEUROPHYSIOL, V41, P1394, DOI 10.1152/jn.1978.41.6.1394; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Dougherty RF, 1999, NEURON, V24, P893, DOI 10.1016/S0896-6273(00)81036-3; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; FERSTER D, 1990, VISUAL NEUROSCI, V4, P115, DOI 10.1017/S0952523800002285; FERSTER D, 1991, J NEUROPHYSIOL, V66, P1667, DOI 10.1152/jn.1991.66.5.1667; FERSTER D, 1990, VISUAL NEUROSCI, V4, P135, DOI 10.1017/S0952523800002297; Freed MA, 2000, J NEUROPHYSIOL, V83, P2956, DOI 10.1152/jn.2000.83.5.2956; GRAHAM N, 1992, VISION RES, V32, P719, DOI 10.1016/0042-6989(92)90188-O; He S, 1998, VISION RES, V38, P985, DOI 10.1016/S0042-6989(97)00290-3; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; KAPLAN E, 1982, J PHYSIOL-LONDON, V330, P125, DOI 10.1113/jphysiol.1982.sp014333; LANKHEET MJM, 1989, VISION RES, V29, P505, DOI 10.1016/0042-6989(89)90037-0; LEVENTHAL AG, 1983, J COMP NEUROL, V220, P465, DOI 10.1002/cne.902200408; LEVICK WR, 1980, NATURE, V286, P389, DOI 10.1038/286389a0; MACLEOD DIA, 1992, VISION RES, V32, P347, DOI 10.1016/0042-6989(92)90144-8; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Mareschal I, 1999, VISUAL NEUROSCI, V16, P527, DOI 10.1017/S0952523899163132; Mareschal I, 1998, NAT NEUROSCI, V1, P150, DOI 10.1038/401; MARROCCO RT, 1982, J NEUROSCI, V2, P1275; Movshon JA, 1996, J NEUROSCI, V16, P7733; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; PEICHL L, 1987, PROC R SOC SER B-BIO, V231, P169, DOI 10.1098/rspb.1987.0040; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2427, DOI 10.1016/0306-4522(82)90205-6; Scott-Samuel NE, 1999, VISION RES, V39, P2853, DOI 10.1016/S0042-6989(98)00316-2; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; Smith AT, 1997, VISION RES, V37, P45, DOI 10.1016/S0042-6989(96)00147-2; Smith AT, 1998, J NEUROSCI, V18, P3816; SOODAK RE, 1987, J NEUROPHYSIOL, V58, P267, DOI 10.1152/jn.1987.58.2.267; Stafford DK, 1997, VISUAL NEUROSCI, V14, P507, DOI 10.1017/S0952523800012165; STEVENS JK, 1980, SCIENCE, V207, P317, DOI 10.1126/science.7350663; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; THIBOS LN, 1985, EXP BRAIN RES, V58, P1; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; Wolfe J, 1998, VISUAL NEUROSCI, V15, P653, DOI 10.1017/S0952523898154068; Yabuta NH, 1998, J NEUROSCI, V18, P9489; Zhou YX, 1996, J NEUROPHYSIOL, V75, P1038, DOI 10.1152/jn.1996.75.3.1038; ZHOU YX, 1994, J NEUROPHYSIOL, V72, P2134, DOI 10.1152/jn.1994.72.5.2134	61	60	61	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					711	721		10.1016/S0896-6273(01)00484-6	http://dx.doi.org/10.1016/S0896-6273(01)00484-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719210	Bronze			2022-12-28	WOS:000172363900016
J	Frankfort, BJ; Nolo, R; Zhang, ZH; Bellen, H; Mardon, G				Frankfort, BJ; Nolo, R; Zhang, ZH; Bellen, H; Mardon, G			senseless repression of rough is required for R8 photoreceptor differentiation in the developing Drosophila eye	NEURON			English	Article							EGF RECEPTOR; PRONEURAL GENE; CELL-FATE; OMMATIDIA DEVELOPMENT; PATTERN-FORMATION; ORGAN DEVELOPMENT; DEVELOPING RETINA; EXPRESSION; NOTCH; HOMOLOG	An outstanding model to study how neurons differentiate from among a field of equipotent undifferentiated cells is the process of R8 photoreceptor differentiation during Drosophila eye development. We show that in senseless mutant tissue, R8 differentiation fails and the presumptive R8 cell adopts the R2/R5 fate. We identify senseless repression of rough in R8 as an essential mechanism of R8 cell fate determination and demonstrate that misexpression of senseless in non-R8 photoreceptors results in repression of rough and induction of the R8 fate. Surprisingly, there is no loss of ommatidial clusters in senseless mutant tissue and all outer photoreceptor subtypes can be recruited, suggesting that other photoreceptors can substitute for R8 to initiate recruitment and that R8-specific signaling is not required for outer photoreceptor subtype assignment. A genetic model of R8 differentiation is presented.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Mardon, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gmardon@bcm.tmc.edu		Bellen, Hugo/0000-0001-5992-5989	NEI NIH HHS [R01 EY11232-01, P30 EY002520, R01 EY011232, R01 EY011232-10, EY02520] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY002520, R01EY011232] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; BAKER NE, 1995, MECH DEVELOP, V49, P173, DOI 10.1016/0925-4773(94)00314-D; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K; CAGAN R, 1993, DEVELOPMENT, P19; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Chen KC, 1999, P NATL ACAD SCI USA, V96, P5055, DOI 10.1073/pnas.96.9.5055; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; DAVIS I, 1995, DEV BIOL, V170, P726, DOI 10.1006/dbio.1995.1251; DICKSON B, 1992, GENE DEV, V6, P2327, DOI 10.1101/gad.6.12a.2327; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; Dominguez M, 1999, DEVELOPMENT, V126, P2345; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; FREEMAN M, 1994, MECH DEVELOP, V48, P25, DOI 10.1016/0925-4773(94)90003-5; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Grimes HL, 1996, P NATL ACAD SCI USA, V93, P14569, DOI 10.1073/pnas.93.25.14569; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; HEBERLEIN U, 1991, DEVELOPMENT, V112, P703; Huang YZ, 1996, DEVELOPMENT, V122, P3207; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Jia YW, 1997, DEVELOPMENT, V124, P2063; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; Kumar JP, 1998, DEVELOPMENT, V125, P3875; LAWRENCE PA, 1979, DEV BIOL, V71, P142, DOI 10.1016/0012-1606(79)90088-5; Lee EC, 2000, CURR BIOL, V10, P931, DOI 10.1016/S0960-9822(00)00622-9; Lee EC, 1996, MOL CELL BIOL, V16, P1179; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Powell PA, 2001, NATURE, V409, P626, DOI 10.1038/35054566; Raabe T, 2000, BBA-MOL CELL RES, V1496, P151, DOI 10.1016/S0167-4889(00)00020-3; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Spencer SA, 1998, DEVELOPMENT, V125, P4777; Sun Y, 2000, P NATL ACAD SCI USA, V97, P6815, DOI 10.1073/pnas.110154497; Tio M, 1997, DEVELOPMENT, V124, P343; TIO M, 1994, MECH DEVELOP, V48, P13, DOI 10.1016/0925-4773(94)90002-7; TOMLINSON A, 1988, CELL, V55, P771, DOI 10.1016/0092-8674(88)90133-X; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; VANDOREN M, 1992, GENE DEV, V6, P2592, DOI 10.1101/gad.6.12b.2592; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; Wasserman JD, 2000, GENE DEV, V14, P1651; Wolff Tanya, 1993, P1277; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; XU T, 1993, DEVELOPMENT, V117, P1223; Yang LH, 2001, DEVELOPMENT, V128, P1183; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	57	99	101	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2001	32	3					403	414		10.1016/S0896-6273(01)00480-9	http://dx.doi.org/10.1016/S0896-6273(01)00480-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709152	Green Accepted, Bronze			2022-12-28	WOS:000172119100007
J	Frye, MA; Dickinson, MH				Frye, MA; Dickinson, MH			Fly flight: A model for the neural control of complex behavior	NEURON			English	Review							MOTION-DETECTION CIRCUITS; INTERNEURONS; DROSOPHILA; CALLIPHORA; FLIES; INPUT	Flies exhibit a repertoire of aerial acrobatics unmatched in robustness and aerodynamic sophistication. The exquisite control of this complex behavior emerges from encoding intricate patterns of optic flow, and the translation of these visual signals into the mechanical language of the motor system. Recent advances in experimental design toward more naturalistic visual and mechanosensory stimuli have served to reinforce fly flight as a key model system for understanding how feedback from multiple sensory modalities is integrated to control complex and robust motor behaviors across taxa.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Frye, MA (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.			Frye, Mark/0000-0003-3277-3094				Buschbeck EK, 1996, J NEUROSCI, V16, P4563; Chan WP, 1998, SCIENCE, V280, P289, DOI 10.1126/science.280.5361.289; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; Douglass JK, 1996, J NEUROSCI, V16, P4551; Fayyazuddin A, 1996, J NEUROSCI, V16, P5225; Gilbert C, 1998, J EXP BIOL, V201, P2735; Haag J, 2001, J NEUROSCI, V21, P5685, DOI 10.1523/JNEUROSCI.21-15-05685.2001; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; Hengstenberg Roland, 1993, Reviews of Oculomotor Research, V5, P285; Kern R, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-08-j0001.2001; Kimmerle B, 2000, J NEUROSCI, V20, P6256, DOI 10.1523/JNEUROSCI.20-16-06256.2000; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; NALBACH G, 1993, J COMP PHYSIOL A, V173, P293, DOI 10.1007/BF00212693; Schilstra C, 1998, NATURE, V395, P654, DOI 10.1038/27114; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Trimarchi JR, 1997, J NEUROSCI, V17, P4700	20	61	63	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					385	388		10.1016/S0896-6273(01)00490-1	http://dx.doi.org/10.1016/S0896-6273(01)00490-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709150	Bronze			2022-12-28	WOS:000172119100005
J	Ethell, IM; Irie, F; Kalo, MS; Couchman, JR; Pasquale, EB; Yamaguchi, Y				Ethell, IM; Irie, F; Kalo, MS; Couchman, JR; Pasquale, EB; Yamaguchi, Y			EphB/syndecan-2 signaling in dendritic spine morphogenesis	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; FRAGILE-X-SYNDROME; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DOMAIN; EPHB RECEPTORS; COMMISSURAL AXONS; PDZ PROTEIN; PHOSPHORYLATION; PLASTICITY; SYNAPSES	We previously reported that the cell surface proteoglycan syndecan-2 can induce dendritic spine formation in hippocampal neurons. We demonstrate here that the EphB2 receptor tyrosine kinase phosphorylates syndecan-2 and that this phosphorylation event is crucial for syndecan-2 clustering and spine formation. Syndecan-2 is tyrosine phosphorylated and forms a complex with EphB2 in mouse brain. Dominant-negative inhibition of endogenous EphB receptor activities blocks clustering of endogenous syndecan-2 and normal spine formation in cultured hippocampal neurons. This is the first evidence that Eph receptors play a physiological role in dendritic spine morphogenesis. Our observations suggest that spine morphogenesis is triggered by the activation of Eph receptors, which causes tyrosine phosphorylation of target molecules, such as syndecan-2, in presumptive spines.	Burnham Inst, La Jolla, CA 92037 USA; Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Alabama System; University of Alabama Birmingham	Yamaguchi, Y (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Ethell, Iryna/0000-0002-1324-6611	NICHD NIH HHS [HD25938] Funding Source: Medline; NIGMS NIH HHS [GM50194] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andersen P, 1999, NATURE, V399, P19, DOI 10.1038/19857; Asundi VK, 1997, BIOCHEM BIOPH RES CO, V240, P502, DOI 10.1006/bbrc.1997.7684; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Boxer AL, 1999, J NEUROPHYSIOL, V82, P3367, DOI 10.1152/jn.1999.82.6.3367; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; COUCHMAN JR, 2000, PROTEOGLYCANS STRUCT, P147; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Drescher U, 2000, CELL, V103, P1005, DOI 10.1016/S0092-8674(00)00204-X; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Fiala JC, 1998, J NEUROSCI, V18, P8900; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; HISAJIMA H, 1992, J NEUROSCI RES, V31, P549, DOI 10.1002/jnr.490310319; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Hsueh YP, 1998, NEURON, V21, P1227, DOI 10.1016/S0896-6273(00)80641-8; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kalo MS, 1999, BIOCHEMISTRY-US, V38, P14396, DOI 10.1021/bi991628t; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; Murphy DD, 1997, P NATL ACAD SCI USA, V94, P1482, DOI 10.1073/pnas.94.4.1482; Oh ES, 1997, ARCH BIOCHEM BIOPHYS, V344, P67, DOI 10.1006/abbi.1997.0180; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; PAPA M, 1995, J NEUROSCI, V15, P1; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; Segal M, 2000, TRENDS NEUROSCI, V23, P53, DOI 10.1016/S0166-2236(99)01499-X; SHAO HN, 1994, J BIOL CHEM, V269, P26606; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	45	251	260	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					1001	1013		10.1016/S0896-6273(01)00440-8	http://dx.doi.org/10.1016/S0896-6273(01)00440-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580899	Bronze			2022-12-28	WOS:000171281300014
J	Orr, HT				Orr, HT			Lurcher, nPIST, and autophagy	NEURON			English	Editorial Material							CELL-DEATH; NEURODEGENERATION; PROTEIN; DEGRADATION		Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Orr, HT (corresponding author), Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA.			Orr, Harry/0000-0001-6118-741X				CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Doughty ML, 2000, J NEUROSCI, V20, P3687; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Seeburg PH, 1997, NATURE, V388, P716, DOI 10.1038/41880; Selimi F, 2000, J NEUROSCI, V20, P5339, DOI 10.1523/JNEUROSCI.20-14-05339.2000; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	12	8	8	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					813	814		10.1016/S0896-6273(02)00871-1	http://dx.doi.org/10.1016/S0896-6273(02)00871-1			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372273	Bronze			2022-12-28	WOS:000177779800001
J	Priebe, NJ; Ferster, D				Priebe, NJ; Ferster, D			A new mechanism for neuronal gain control (or how the gain in brains has mainly been explained)	NEURON			English	Editorial Material							VISUAL-CORTEX; STOCHASTIC RESONANCE; SHUNTING INHIBITION; CORTICAL-NEURONS; ATTENTION; NOISE	One of the more prosaic but necessary features of almost any information processing system is gain control. All such systems must have some way to adjust the relationship between input, which can vary dramatically depending on changes in the environment, and output, which is almost always required to remain within a limited range of amplitudes. While the volume control on a radio or the brightness control on a computer monitor are not the most exciting or highly touted features, imagine such devices without these forms of gain control. Many an engineer can attest to the large effort required to design automatic gain controls in telephones, cameras, and radio transmitters.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60202 USA	Northwestern University	Priebe, NJ (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60202 USA.							Anderson JS, 2001, J NEUROSCI, V21, P2104, DOI 10.1523/JNEUROSCI.21-06-02104.2001; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BULSARA A, 1991, J THEOR BIOL, V152, P531, DOI 10.1016/S0022-5193(05)80396-0; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0	12	22	22	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					602	604		10.1016/S0896-6273(02)00829-2	http://dx.doi.org/10.1016/S0896-6273(02)00829-2			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194862	Bronze			2022-12-28	WOS:000177521000003
J	Hashimoto, R; Sakai, KL				Hashimoto, R; Sakai, KL			Specialization in the left prefrontal cortex for sentence comprehension	NEURON			English	Article							SHORT-TERM-MEMORY; EVENT-RELATED FMRI; VERBAL WORKING-MEMORY; ANTERIOR CINGULATE; BRAIN ACTIVATION; NEURAL BASIS; LANGUAGE; DISSOCIATION; REGIONS; LOCALIZATION	Using functional magnetic resonance imaging (fMRI), we examined cortical activation under syntactic decision tasks and a short-term memory task for sentences, focusing on essential properties of syntactic processing. By comparing activation in these tasks with a short-term memory task for word lists, we found that two regions in the left prefrontal cortex showed selective activation for syntactic processing: the dorsal prefrontal cortex (DPFC) and the inferior frontal gyrus (IFG). Moreover, the left DPFC showed more prominent activation under the short-term memory task for sentences than that for word lists, which cannot be explained by general cognitive factors such as task difficulty and verbal short-term memory. These results support the proposal of specialized systems for sentence comprehension in the left prefrontal cortex.	Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, Tokyo 1538902, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Sakai, KL (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	sakai@mind.c.u-tokyo.ac.jp		Hashimoto, Ryu-ichiro/0000-0002-9661-3412				Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Bunge SA, 2000, P NATL ACAD SCI USA, V97, P3573, DOI 10.1073/pnas.050583797; Cabeza R, 1997, NEURON, V19, P863, DOI 10.1016/S0896-6273(00)80967-8; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Caplan D, 1999, NEUROIMAGE, V9, P343, DOI 10.1006/nimg.1998.0412; Chein JM, 2001, CEREB CORTEX, V11, P1003, DOI 10.1093/cercor/11.11.1003; Chomsky N., 1984, MODULAR APPROACHES S; Chomsky N, 1980, RULES REPRESENTATION; Clark CR, 2000, HUM BRAIN MAPP, V9, P42, DOI 10.1002/(SICI)1097-0193(2000)9:1<42::AID-HBM5>3.0.CO;2-6; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Coltheart M, 1999, TRENDS COGN SCI, V3, P115, DOI 10.1016/S1364-6613(99)01289-9; Comrie B., 1989, LANGUAGE UNIVERSALS, V2nd; Cooke A, 2002, HUM BRAIN MAPP, V15, P80, DOI 10.1002/hbm.10006; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; Dick F, 2001, PSYCHOL REV, V108, P759, DOI 10.1037//0033-295X.108.4.759; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Fiebach CJ, 2001, J PSYCHOLINGUIST RES, V30, P321, DOI 10.1023/A:1010447102554; Fiez JA, 1996, J NEUROSCI, V16, P808; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Fodor J. A, 1983, MODULARITY MIND; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; FRIEDERICI AD, 1993, COGNITIVE BRAIN RES, V1, P183, DOI 10.1016/0926-6410(93)90026-2; Gunter TC, 1999, PSYCHOPHYSIOLOGY, V36, P126, DOI 10.1017/S004857729997155X; Haegeman L., 1994, INTRO GOVT BINDING T, V2; Homae F, 2002, NEUROIMAGE, V16, P883, DOI 10.1006/nimg.2002.1138; Indefrey P, 2001, NEUROIMAGE, V14, P546, DOI 10.1006/nimg.2001.0867; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Kang AM, 1999, NEUROIMAGE, V10, P555, DOI 10.1006/nimg.1999.0493; KLUENDER R, 1993, J COGNITIVE NEUROSCI, V5, P196, DOI 10.1162/jocn.1993.5.2.196; MARTIN RC, 1993, MEM COGNITION, V21, P176, DOI 10.3758/BF03202730; MARTIN RC, 1987, BRAIN LANG, V32, P159, DOI 10.1016/0093-934X(87)90122-2; MASHUETZ C, 2000, J COGNITIVE NEUROSCI, V12, P130; MCCARTHY RA, 1987, BRAIN, V110, P1545, DOI 10.1093/brain/110.6.1545; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Moro A, 2001, NEUROIMAGE, V13, P110, DOI 10.1006/nimg.2000.0668; MUNTE TF, 1993, J COGNITIVE NEUROSCI, V5, P335, DOI 10.1162/jocn.1993.5.3.335; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Newman AJ, 2001, J PSYCHOLINGUIST RES, V30, P339, DOI 10.1023/A:1010499119393; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PETRIDES M, 1995, P NATL ACAD SCI USA, V92, P5803, DOI 10.1073/pnas.92.13.5803; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; POTTER MC, 1993, MEM COGNITION, V21, P156, DOI 10.3758/BF03202727; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Rosler F, 1998, J MEM LANG, V38, P150, DOI 10.1006/jmla.1997.2551; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Sakai KL, 2001, NEUROSCI RES, V39, P1, DOI 10.1016/S0168-0102(00)00205-4; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; TSIMPLI Ianthi-Maria, 1995, MIND SAVANT LANGUAGE; Tsujimura N., 1996, INTRO JAPANESE LINGU; Vos SH, 2001, PSYCHOPHYSIOLOGY, V38, P41, DOI 10.1111/1469-8986.3810041; WATERS G, 1991, COGNITIVE NEUROPSYCH, V8, P81, DOI 10.1080/02643299108253368; WATERS GS, 1995, COGN NEUROPSYCHOL, V12, P1, DOI 10.1080/02643299508251990	62	93	95	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					589	597		10.1016/S0896-6273(02)00788-2	http://dx.doi.org/10.1016/S0896-6273(02)00788-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	582CB	12165479	Bronze			2022-12-28	WOS:000177331200018
J	Dawson, TM; Mandir, AS; Lee, MK				Dawson, TM; Mandir, AS; Lee, MK			Animal models of PD: Pieces of the same puzzle?	NEURON			English	Review							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; DROSOPHILA; MICE		Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21287 USA.		Lee, Michael K/D-9491-2013	Lee, Michael K/0000-0001-5865-9682				Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Lee MK, 2001, CLIN NEUROSCI RES, V1, P456, DOI 10.1016/S1566-2772(01)00024-X; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600	20	117	119	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					219	222		10.1016/S0896-6273(02)00780-8	http://dx.doi.org/10.1016/S0896-6273(02)00780-8			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160740	Bronze			2022-12-28	WOS:000177034200002
J	Wang, Q; Bardgett, ME; Wong, M; Wozniak, DF; Lou, JY; McNeil, BD; Chen, C; Nardi, A; Reid, DC; Yamada, K; Ornitz, DM				Wang, Q; Bardgett, ME; Wong, M; Wozniak, DF; Lou, JY; McNeil, BD; Chen, C; Nardi, A; Reid, DC; Yamada, K; Ornitz, DM			Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14	NEURON			English	Article							FACTOR HOMOLOGOUS FACTORS; BEHAVIORAL-RESPONSES; DOPAMINE-RECEPTORS; GENE-EXPRESSION; ANIMAL-MODELS; SYNAPSIN I; COCAINE; STRIATUM; AMPHETAMINE; DYSTONIA	Fibroblast growth factor 14 (FGF14) belongs to a distinct subclass of FGFs that is expressed in the developing and adult CNS. We disrupted the Fgf14 gene and introduced an Fgf(14N-beta-Gal) allele that abolished Fgf14 expression and generated a fusion protein (FGF14N-beta-gal) containing the first exon of FGF14 and P-galactosidase. Fgf14-deficient mice were viable, fertile, and anatomically normal, but developed ataxia and a paroxysmal hyperkinetic movement disorder. Neuropharmacological studies showed that Fgf14-deficient mice have reduced responses to dopamine agonists. The paroxysmal hyperkinetic movement disorder phenocopies a form of dystonia, a disease often associated with dysfunction of the putamen. Strikingly, the FGF14N-beta-gal chimeric protein was efficiently transported into neuronal processes in the basal ganglia and cerebellum. Together, these studies identify a novel function for FGF14 in neuronal signaling and implicate FGF14 in axonal trafficking and synaptosomal function.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ornitz, DM (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	dornitz@pcg.wustl.edu	Nardi, Antonio E/A-7335-2014	Nardi, Antonio E/0000-0002-2152-4669; Chen, Chen/0000-0001-9159-4489; Ornitz, David/0000-0003-1592-7629; Bardgett, Mark/0000-0001-7028-2603; McNeil, Benjamin/0000-0001-7545-3598	NATIONAL CANCER INSTITUTE [R01CA060673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011355] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKIMOTO K, 1990, BRAIN RES, V507, P344, DOI 10.1016/0006-8993(90)90295-M; Alonso R, 1999, EUR J NEUROSCI, V11, P967, DOI 10.1046/j.1460-9568.1999.00506.x; Bahn S, 1997, P NATL ACAD SCI USA, V94, P9417, DOI 10.1073/pnas.94.17.9417; Bardgett ME, 1997, PSYCHOPHARMACOLOGY, V133, P142, DOI 10.1007/s002130050384; Bhatia KP, 1999, J NEUROL, V246, P149, DOI 10.1007/s004150050325; BrosnanWatters G, 1996, PHARMACOL BIOCHEM BE, V53, P701, DOI 10.1016/0091-3057(95)02073-X; BUTCHER SP, 1988, J NEUROCHEM, V50, P346, DOI 10.1111/j.1471-4159.1988.tb02919.x; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen JF, 2000, NEUROSCIENCE, V97, P195, DOI 10.1016/S0306-4522(99)00604-1; CLARK M, 1992, BRAIN RES, V582, P101, DOI 10.1016/0006-8993(92)90322-Z; Dawson TM, 2000, CELL, V101, P115, DOI 10.1016/S0092-8674(00)80629-7; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; FERGUSON IA, 1991, J COMP NEUROL, V313, P693, DOI 10.1002/cne.903130412; FISHER RS, 1989, BRAIN RES REV, V14, P245, DOI 10.1016/0165-0173(89)90003-9; Frantz KJ, 1999, PHARMACOL BIOCHEM BE, V64, P821, DOI 10.1016/S0091-3057(99)00162-8; Gernert M, 2000, J NEUROSCI, V20, P7052, DOI 10.1523/JNEUROSCI.20-18-07052.2000; GERSHANIK O, 1983, NEUROLOGY, V33, P1489, DOI 10.1212/WNL.33.11.1489; GeterDouglass B, 1997, J PHARMACOL EXP THER, V283, P7; Goldfarb M., 2001, SCI STKE, V106, ppe37; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jarman PR, 1998, J MED GENET, V35, P314, DOI 10.1136/jmg.35.4.314; Jones A, 1997, J NEUROSCI, V17, P1350; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KEEFE KA, 1995, NEUROSCIENCE, V66, P903, DOI 10.1016/0306-4522(95)00024-D; LeMoine C, 1997, J NEUROSCI, V17, P8038; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; LOSCHER W, 1989, MOVEMENT DISORD, V4, P219, DOI 10.1002/mds.870040304; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Moratalla R, 1996, P NATL ACAD SCI USA, V93, P14928, DOI 10.1073/pnas.93.25.14928; Munoz-Sanjuan I, 2000, J BIOL CHEM, V275, P2589, DOI 10.1074/jbc.275.4.2589; Naski MC, 1998, DEVELOPMENT, V125, P4977; Nobrega JN, 1996, NEUROSCIENCE, V71, P927, DOI 10.1016/0306-4522(95)00511-0; Nobrega JN, 1999, NEUROSCIENCE, V92, P211, DOI 10.1016/S0306-4522(98)00753-2; Obeso JA, 2000, ANN NEUROL, V47, pS22; Ornitz DM, 2001, GENOME BIOL, V2; Pellet JB, 2000, EUR J NEUROSCI, V12, P621, DOI 10.1046/j.1460-9568.2000.00945.x; Rehders JH, 2000, NEUROSCIENCE, V97, P267, DOI 10.1016/S0306-4522(00)00073-7; Richter A, 1998, PROG NEUROBIOL, V54, P633, DOI 10.1016/S0301-0082(97)00089-0; ROBERTSON GS, 1995, NEUROSCIENCE, V64, P1019, DOI 10.1016/0306-4522(94)00426-6; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; Sheehan D.C., 1980, THEORY PRACTICE HIST; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Smith Y, 2000, TRENDS NEUROSCI, V23, pS28, DOI 10.1016/S1471-1931(00)00023-9; Surmeier D J, 1998, Adv Pharmacol, V42, P1020; Swanson CJ, 1997, PHARMACOL BIOCHEM BE, V58, P933, DOI 10.1016/S0091-3057(97)00043-9; Todd RD, 1998, MOL NEUROBIOL, V16, P135, DOI 10.1007/BF02740641; USHIJIMA I, 1995, PHARMACOL BIOCHEM BE, V52, P737, DOI 10.1016/0091-3057(95)00167-U; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Vidailhet Marie, 2000, Current Opinion in Neurology, V13, P457, DOI 10.1097/00019052-200008000-00015; Vitek JL, 2000, ANN NEUROL, V47, pS131; Waddington J.L., 1993, D1 D2 DOPAMINE RECEP; Wang Q, 2000, MECH DEVELOP, V90, P283, DOI 10.1016/S0925-4773(99)00241-5; Wang YY, 2000, J NEUROSCI, V20, P8305, DOI 10.1523/JNEUROSCI.20-22-08305.2000; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wozniak DF, 1996, BRAIN RES, V707, P165, DOI 10.1016/0006-8993(95)01230-3; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; Xu M, 2000, BRAIN RES, V852, P198, DOI 10.1016/S0006-8993(99)02258-1; Yamamoto S, 1998, BBA-GENE STRUCT EXPR, V1398, P38, DOI 10.1016/S0167-4781(98)00050-5; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	67	133	137	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					25	38		10.1016/S0896-6273(02)00744-4	http://dx.doi.org/10.1016/S0896-6273(02)00744-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123606	Bronze			2022-12-28	WOS:000176601800008
J	Logan, JM; Sanders, AL; Snyder, AZ; Morris, JC; Buckner, RL				Logan, JM; Sanders, AL; Snyder, AZ; Morris, JC; Buckner, RL			Under-recruitment and nonselective recruitment: Dissociable neural mechanisms associated with aging	NEURON			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INFERIOR PREFRONTAL CORTEX; EPISODIC MEMORY; FRONTAL-CORTEX; RECOGNITION MEMORY; FUNCTIONAL MRI; BRAIN ACTIVITY; DIVIDED ATTENTION; AGE-DIFFERENCES; WORKING-MEMORY	Frontal contributions to cognitive decline in aging were explored using functional MRI. Frontal regions active in younger adults during self-initiated (intentional) memory encoding were under-recruited in older adults. Older adults showed less activity in anterior-ventral regions associated with controlled use of semantic information. Under-recruitment was reversed by requiring semantic elaboration suggesting it stemmed from difficulty in spontaneous recruitment of available frontal resources. In addition, older adults recruited multiple frontal regions in a nonselective manner for both verbal and nonverbal materials. Lack of selectivity was not reversed during semantically directed encoding even when under-recruitment was diminished. These findings suggest two separate forms of age-associated change in frontal cortex: under-recruitment and nonselective recruitment. The former is reversible and potentially amenable to cognitive training; the latter may reflect a less malleable change associated with cognitive decline in advanced aging.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Buckner, RL (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.		Kennedy, Kristen M/B-4699-2008; Morris, John C/A-1686-2012	Kennedy, Kristen M/0000-0001-5373-9026; 	NIA NIH HHS [AG05681, AG03991] Funding Source: Medline; NIMH NIH HHS [MH57506] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, P01AG003991] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson ND, 2000, J COGNITIVE NEUROSCI, V12, P775, DOI 10.1162/089892900562598; Backman L, 1997, J COGNITIVE NEUROSCI, V9, P378, DOI 10.1162/jocn.1997.9.3.378; Baker JT, 2001, NEUROREPORT, V12, P1251, DOI 10.1097/00001756-200105080-00039; Balota D. A., 2000, OXFORD HDB MEMORY, P395, DOI DOI 10.1037/A0015086; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P1249, DOI 10.1073/pnas.93.3.1249; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; Buckner RL, 2001, J COGNITIVE NEUROSCI, V13, P406, DOI 10.1162/08989290151137430; BUCKNER RL, 2002, COGNITIVE NEUROSCIEN; Cabeza R, 1997, J NEUROSCI, V17, P391; CABEZA R, 2002, IN PRESS PSYCHOL AGI; Camp C., 2000, COGNITIVE REHABILITA, P224; Cao Y, 1999, STROKE, V30, P2331, DOI 10.1161/01.STR.30.11.2331; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Craik F. I., 1982, AGING COGNITIVE PROC, P191, DOI DOI 10.1007/978-1-4684-4178-9_11; Craik F. I. M., 1977, HDB PSYCHOL AGING; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Craik FIM, 1980, P GEORG TALL MEM C N; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P168; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; Dixit N.K., 2000, NEUROIMAGE, V11, pS94; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Gold BT, 2000, BRAIN LANG, V73, P456, DOI 10.1006/brln.2000.2317; GOODGLASS H, 1983, BOSTON NAMING TEST S; Grady CL, 1999, CEREB CORTEX, V9, P805, DOI 10.1093/cercor/9.8.805; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Greenwood PM, 2000, J INT NEUROPSYCH SOC, V6, P705, DOI 10.1017/S1355617700666092; Hasher L, 1999, ATTENTION PERFORM, V17, P653; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Honda M, 1997, J NEUROL SCI, V146, P117, DOI 10.1016/S0022-510X(96)00291-2; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; HULICKA IM, 1966, J GENET PSYCHOL, V109, P135, DOI 10.1080/00221325.1966.10533690; Iidaka T, 2000, J COGNITIVE NEUROSCI, V12, P267, DOI 10.1162/089892900562093; Iidaka T, 2001, COGNITIVE BRAIN RES, V11, P1, DOI 10.1016/S0926-6410(00)00058-6; Kapur S, 1996, COGNITIVE BRAIN RES, V4, P243, DOI 10.1016/S0926-6410(96)00058-4; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; KAUSLER DH, 1988, AM J PSYCHOL, V101, P207, DOI 10.2307/1422835; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Knoke D, 1998, BRAIN COGNITION, V38, P261, DOI 10.1006/brcg.1998.1042; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Kucera H., 1967, COMPUTATIONAL ANAL P; Madden DJ, 1999, HUM BRAIN MAPP, V7, P115, DOI 10.1002/(SICI)1097-0193(1999)7:2<115::AID-HBM5>3.0.CO;2-N; Madden DJ, 1999, J COGNITIVE NEUROSCI, V11, P511, DOI 10.1162/089892999563571; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; McIntosh AR, 1999, CURR BIOL, V9, P1275, DOI 10.1016/S0960-9822(99)80512-0; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Moscovitch M, 1995, ANN NY ACAD SCI, V769, P119, DOI 10.1111/j.1749-6632.1995.tb38135.x; MYERSON J, 1990, PSYCHOL REV, V97, P475, DOI 10.1037/0033-295X.97.4.475; NIELSON KA, 2002, IN PRESS PSYCHOL AGI; Nyberg L., 1996, J GERONTOL B-PSYCHOL, V51, P234; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Ohyama M, 1996, STROKE, V27, P897, DOI 10.1161/01.STR.27.5.897; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; Park DC, 1996, PSYCHOL AGING, V11, P621, DOI 10.1037/0882-7974.11.4.621; PARK DC, 1990, J GERONTOL B-PSYCHOL, V45, P52; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Reuter-Lorenz PA, 2001, EUR J COGN PSYCHOL, V13, P257, DOI 10.1080/09541440125972; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; Sohlberg M., 2001, COGNITIVE REHABILITA; Stuss DT, 1996, PSYCHOL AGING, V11, P387, DOI 10.1037/0882-7974.11.3.387; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Talairach J., 1988, COPLANAR STEREOTAXIC; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; Thurstone L., 1949, EXAMINER MANUAL SRT; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wechsler D, 1973, MANUAL WECHSLER MEMO; Wechsler D, 1955, WAIS MANUAL; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; ZAGAR R, 1984, J CLIN PSYCHOL, V40, P1466, DOI 10.1002/1097-4679(198411)40:6<1466::AID-JCLP2270400635>3.0.CO;2-5	91	553	560	0	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					827	840		10.1016/S0896-6273(02)00612-8	http://dx.doi.org/10.1016/S0896-6273(02)00612-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	529EC	11879658	Bronze			2022-12-28	WOS:000174286200017
J	Liu, JP; Laufer, E; Jessell, TM				Liu, JP; Laufer, E; Jessell, TM			Assigning the positional identity of spinal motor neurons: Rostrocaudal patterning of Hox-c expression by FGFs, Gdf11, and retinoids	NEURON			English	Article							FIBROBLAST-GROWTH-FACTOR; SUBTYPE IDENTITY; SONIC HEDGEHOG; NEURAL-TUBE; TARGETED DISRUPTION; INDUCTIVE SIGNALS; ACID SYNTHESIS; SPECIFICATION; CORD; HINDBRAIN	Subclasses of motor neurons are generated at different positions along the rostrocaudal axis of the spinal cord. One feature of the rostrocaudal organization of spinal motor neurons is a position-dependent expression of Hox genes, but little is known about how this aspect of motor neuron subtype identity is assigned. We have used the expression profile of Hox-c proteins to define the source and identity of patterning signals that impose motor neuron positional identity along the rostrocaudal axis of the spinal cord. We provide evidence that the convergent activities of FGFs, Gdf11, and retinoid signals originating from Hensen's node and paraxial mesoderm establish and refine the Hox-c positional identity of motor neurons in the developing spinal cord.	Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; University of Virginia	Jessell, TM (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, 701 W 168th St, New York, NY 10032 USA.	tmj1@columbia.edu		Laufer, Edward/0000-0002-4933-1017				Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168; Belting HG, 1998, J EXP ZOOL, V282, P196, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;196::AID-JEZ22&gt;3.0.CO;2-R; Berggren K, 1999, DEV BIOL, V210, P288, DOI 10.1006/dbio.1999.9286; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Carpenter EM, 1997, DEVELOPMENT, V124, P4505; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; de la Cruz CC, 1999, DEV BIOL, V216, P595, DOI 10.1006/dbio.1999.9528; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; FOREHAND CJ, 1994, J NEUROSCI, V14, P231; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Gavalas A, 1997, DEVELOPMENT, V124, P3693; Gavalas A, 2000, CURR OPIN GENET DEV, V10, P380, DOI 10.1016/S0959-437X(00)00100-3; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; GrapinBotton A, 1997, DEVELOPMENT, V124, P849; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; Isaacs HV, 1998, EMBO J, V17, P3413, DOI 10.1093/emboj/17.12.3413; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jungbluth S, 1999, DEVELOPMENT, V126, P2751; Kalyani AJ, 1998, J NEUROSCI, V18, P7856; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; KINTNER CR, 1991, DEVELOPMENT, V113, P1495; Lance-Jones C, 2001, DEVELOPMENT, V128, P2255; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; LASKOWSKI MB, 1987, J NEUROSCI, V7, P252; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Liem KF, 2000, DEVELOPMENT, V127, P4855; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Liu JP, 1998, DEVELOPMENT, V125, P5055; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Maden M, 1998, DEVELOPMENT, V125, P4133; MAHMOOD R, 1995, CURR BIOL, V5, P797, DOI 10.1016/S0960-9822(95)00157-6; MAHMOOD R, 1995, DEVELOPMENT, V121, P1399; Marom K, 1997, MECH DEVELOP, V64, P41, DOI 10.1016/S0925-4773(97)00043-9; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Matise MP, 1996, DEVELOPMENT, V122, P659; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Niederreither K, 2000, DEVELOPMENT, V127, P75; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; NISWANDER L, 1992, DEVELOPMENT, V114, P755; Patten I, 2000, CELL MOL LIFE SCI, V57, P1695, DOI 10.1007/PL00000652; Pownall ME, 1996, DEVELOPMENT, V122, P3881; RIESE J, 1995, MECH DEVELOP, V49, P13, DOI 10.1016/0925-4773(94)00296-Y; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; SCHOENWOLF GC, 1992, ANAT REC, V233, P281, DOI 10.1002/ar.1092330211; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Storey KG, 1998, DEVELOPMENT, V125, P473; STOREY KG, 1992, DEVELOPMENT, V114, P729; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Tiret L, 1998, DEVELOPMENT, V125, P279; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0	68	232	244	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					997	1012		10.1016/S0896-6273(01)00544-X	http://dx.doi.org/10.1016/S0896-6273(01)00544-X			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754833	Bronze			2022-12-28	WOS:000172886800008
J	Ma, JX; Znoiko, S; Othersen, KL; Ryan, JC; Das, J; Isayama, T; Kono, M; Oprian, DD; Corson, DW; Cornwall, MC; Cameron, DA; Harosi, FI; Makino, CL; Crouch, RK				Ma, JX; Znoiko, S; Othersen, KL; Ryan, JC; Das, J; Isayama, T; Kono, M; Oprian, DD; Corson, DW; Cornwall, MC; Cameron, DA; Harosi, FI; Makino, CL; Crouch, RK			A visual pigment expressed in both rod and cone photoreceptors	NEURON			English	Article							TIGER SALAMANDER RETINA; PROTEIN BETA-SUBUNIT; MOLECULAR-CLONING; LINEAR DICHROISM; BOVINE RHODOPSIN; GAMMA-SUBUNIT; DARK NOISE; CELLS; GREEN; IDENTIFICATION	Rods and cones contain closely related but distinct G protein-coupled receptors, opsins, which have diverged to meet the differing requirements of night and day vision. Here, we provide evidence for an exception to that rule. Results from immunohistochemistry, spectrophotometry, and single-cell RT-PCR demonstrate that, in the tiger salamander, the green rods and blue-sensitive cones contain the same opsin. In contrast, the two cells express distinct G protein transducin a subunits: rod a transducin in green rods and cone a transducin in blue-sensitive cones. The different transducins do not appear to markedly affect photon sensitivity or response kinetics in the green rod and blue-sensitive cone. This suggests that neither the cell topology or the transducin is sufficient to differentiate the rod and the cone response.	Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Pathol, Charleston, SC 29425 USA; Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Boston Univ, Sch Med, Dept Physiol, Boston, MA 02118 USA; Marine Biol Lab, Lab Sensory Physiol, Woods Hole, MA 02543 USA	Medical University of South Carolina; Medical University of South Carolina; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Brandeis University; Brandeis University; Boston University; Marine Biological Laboratory - Woods Hole	Ma, JX (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 171 Ashley Ave, Charleston, SC 29425 USA.		Ryan, James/W-2269-2019; Kono, Masahiro/AAT-2265-2021; Makino, Clint Lawrence/H-8428-2019; Znoyko, Sergey/E-1294-2013	Kono, Masahiro/0000-0001-7377-1664; Makino, Clint Lawrence/0000-0002-6005-9069; Znoyko, Sergey/0000-0003-1265-328X; Lockman, Kashelle/0000-0001-8017-8084; Ryan, James/0000-0002-1101-3785; Cornwall, M./0000-0002-0847-939X	NEI NIH HHS [EY04939, EY11358, EY04876, EY12600, P30 EY12196, EY01157, R01 EY011358, EY12231, EY07543, R01 EY012231, R01 EY004939] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007543, R29EY011358, R01EY009514, R01EY004939, R01EY011358, P30EY012196, R01EY012231, R01EY001157, R01EY004876, R01EY012600] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABRAHAMSON EW, 1974, EXP EYE RES, V18, P51, DOI 10.1016/0014-4835(74)90043-8; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BOLL F, 1877, ARCH ANAT PHYSIOL  P, P4; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Chen N, 1996, INVEST OPHTH VIS SCI, V37, P1907; CRAFT CM, 1994, J BIOL CHEM, V269, P4613; Dartnall H. J. A., 1965, Vision Research, V5, P81, DOI 10.1016/0042-6989(65)90057-X; DARTNALL HJA, 1972, VISION RES, V8, P339; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Fung K.Y., 1992, COMPUT GRAPH FORUM, V3, P267; Govardovski VI, 1987, SENS SYST, V1, P28; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; HAROSI FI, 1974, J OPT SOC AM, V64, P903, DOI 10.1364/JOSA.64.000903; HAROSI FI, 1982, COLOR RES APPL, V7, P135, DOI 10.1002/col.5080070216; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; HAROSI FI, 1987, J GEN PHYSIOL, V89, P717, DOI 10.1085/jgp.89.5.717; Heath LA, 1997, GENE, V204, P121, DOI 10.1016/S0378-1119(97)00531-3; HENBEST HB, 1955, J CHEM SOC, P2765, DOI 10.1039/jr9550002765; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; HURWITZ RL, 1985, J BIOL CHEM, V260, P568; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kawamura S, 1999, GENETICS, V153, P1839; KOJIMA D, 1992, P NATL ACAD SCI USA, V89, P6841, DOI 10.1073/pnas.89.15.6841; LEE RH, 1992, J BIOL CHEM, V267, P24776; LEREA CL, 1986, SCIENCE, V234, P77, DOI 10.1126/science.3529395; LEREA CL, 1989, NEURON, V3, P367, DOI 10.1016/0896-6273(89)90261-4; Liebman P.A., 1972, PHOTOCHEMISTRY VISIO, P481; LIEBMAN PA, 1968, VISION RES, V8, P761, DOI 10.1016/0042-6989(68)90128-4; Ma JX, 1998, BBA-GENE STRUCT EXPR, V1443, P255, DOI 10.1016/S0167-4781(98)00221-8; Ma JX, 2001, VISUAL NEUROSCI, V18, P393, DOI 10.1017/S0952523801183057; MacNichol E. F.  Jr., 1978, Frontiers in Visual Science, P194; Makino CL, 1999, BIOPHYS J, V77, P1024, DOI 10.1016/S0006-3495(99)76953-5; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; MARIANI AP, 1986, PROC R SOC SER B-BIO, V227, P483, DOI 10.1098/rspb.1986.0035; MATTHEWS G, 1983, J PHYSIOL-LONDON, V342, P347, DOI 10.1113/jphysiol.1983.sp014855; MUNTZ WRA, 1963, J EXP BIOL, V40, P371; MUNTZ WRA, 1962, J NEUROPHYSIOL, V25, P712, DOI 10.1152/jn.1962.25.6.712; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; NILSSON SEG, 1964, J ULTRA MOL STRUCT R, V10, P390, DOI 10.1016/S0022-5320(64)80018-6; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; OPRIAN DD, 1993, METH NEUROSCI, V15, P301; PENG YW, 1992, P NATL ACAD SCI USA, V89, P10882, DOI 10.1073/pnas.89.22.10882; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; REUTER T, 1966, VISION RES, V6, P15, DOI 10.1016/0042-6989(66)90011-3; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Ryan JC, 2000, VISUAL NEUROSCI, V17, P847, DOI 10.1017/S0952523800176047; Sherry DM, 1998, VISUAL NEUROSCI, V15, P1175, DOI 10.1017/S0952523898156201; SILLMAN AJ, 1991, P ROY SOC B-BIOL SCI, V243, P93, DOI 10.1098/rspb.1991.0016; TSUKIDA K, 1977, J CHROMATOGR, V134, P331; WALD G, 1955, J GEN PHYSIOL, V38, P623, DOI 10.1085/jgp.38.5.623; WANG SZ, 1992, BIOCHEMISTRY-US, V31, P3309, DOI 10.1021/bi00128a002; WITKOVSKY P, 1981, VISION RES, V21, P875, DOI 10.1016/0042-6989(81)90188-7; Xu L, 1998, Mol Vis, V4, P10; YEN L, 1984, VISION RES, V24, P1555, DOI 10.1016/S0042-6989(84)80005-X	62	84	86	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					451	461		10.1016/S0896-6273(01)00482-2	http://dx.doi.org/10.1016/S0896-6273(01)00482-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709156	Bronze			2022-12-28	WOS:000172119100011
J	Karlin, A				Karlin, A			Of snakes, snails, and surrogates	NEURON			English	Editorial Material							NICOTINIC ACETYLCHOLINE-RECEPTOR; ALPHA-BUNGAROTOXIN BINDING; EPSILON-SUBUNIT; GAMMA-SUBUNIT; DELTA-SUBUNIT; RESIDUES; IDENTIFICATION; NEUROTOXINS; AGONIST; SITE	The high-resolution structure of a synthetic 13-residue peptide in a tight complex with a-bungarotoxin conforms to the beta hairpin structure of a closely related segment in the ACh binding protein and reveals how the ACh binding protein and the homologous nicotinic ACh receptors bind a-bungarotoxin at their ACh binding sites.	Columbia Univ, Ctr Mol Recognit, New York, NY 10032 USA	Columbia University	Karlin, A (corresponding author), Columbia Univ, Ctr Mol Recognit, 630 W 168th St, New York, NY 10032 USA.			KARLIN, ARTHUR/0000-0002-4813-752X				Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Osaka H, 2000, J BIOL CHEM, V275, P5478, DOI 10.1074/jbc.275.8.5478; Samson AO, 2001, BIOCHEMISTRY-US, V40, P5464, DOI 10.1021/bi0022689; Sine SM, 1997, J BIOL CHEM, V272, P23521, DOI 10.1074/jbc.272.38.23521; Spura A, 1999, BIOCHEMISTRY-US, V38, P4912, DOI 10.1021/bi982656z; Spura A, 2000, J BIOL CHEM, V275, P22452, DOI 10.1074/jbc.M001283200; Sullivan DA, 2000, J BIOL CHEM, V275, P12651, DOI 10.1074/jbc.275.17.12651; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x	13	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					173	174		10.1016/S0896-6273(01)00473-1	http://dx.doi.org/10.1016/S0896-6273(01)00473-1			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683986	Bronze			2022-12-28	WOS:000171893700001
J	Grossman, ED; Blake, R				Grossman, ED; Blake, R			Brain areas active during visual perception of biological motion	NEURON			English	Article							FUSIFORM FACE AREA; 3-DIMENSIONAL STRUCTURE; FUNCTIONAL MRI; OBJECT; CORTEX; ACTIVATION; ATTENTION; SYSTEMS; COLOR; SHAPE	Theories of vision posit that form and motion are represented by neural mechanisms segregated into functionally and anatomically distinct pathways. Using point-light animations of biological motion, we examine the extent to which form and motion pathways are mutually involved in perceiving figures depicted by the spatio-temporal integration of local motion components. Previous work discloses that viewing biological motion selectively activates a region on the posterior superior temporal sulcus (STSp). Here we report that the occipital and fusiform face areas (OFA and FFA) also contain neural signals capable of differentiating biological from nonbiological motion. EBA and LOC, although involved in perception of human form, do not contain neural signals selective for biological motion. Our results suggest that a network of distributed neural areas in the form and motion pathways underlie the perception of biological motion.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA	Vanderbilt University	Grossman, ED (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA.	e.grossman@vanderbilt.edu						Ahlstrom V, 1997, PERCEPTION, V26, P1539, DOI 10.1068/p261539; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Bonda E, 1996, J NEUROSCI, V16, P3737; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; CORBETTA M, 1991, J NEUROSCI, V11, P2383; CUTTING JE, 1978, J EXP PSYCHOL HUMAN, V4, P357, DOI 10.1037/0096-1523.4.3.357; DONER J, 1984, J EXP PSYCHOL HUMAN, V10, P1; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Friston KJ, 1995, HUM BRAIN MAPP, V3, P302, DOI 10.1002/hbm.460030405; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Goodale MA, 1998, COGNITION, V67, P181, DOI 10.1016/S0010-0277(98)00017-1; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HOFFMAN E, 2000, NAT NEUROSCI, V2, P574; Howard RJ, 1996, CURR BIOL, V6, P1015, DOI 10.1016/S0960-9822(02)00646-2; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; KULIKOWSKI JJ, 1973, J PHYSIOL-LONDON, V232, P149, DOI 10.1113/jphysiol.1973.sp010261; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MATHER G, 1992, P ROY SOC B-BIOL SCI, V249, P149, DOI 10.1098/rspb.1992.0097; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; O'Toole AJ, 2002, TRENDS COGN SCI, V6, P261, DOI 10.1016/S1364-6613(02)01908-3; ORBAN GA, 1995, P NATL ACAD SCI USA, V92, P993, DOI 10.1073/pnas.92.4.993; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Puce A, 1998, J NEUROSCI, V18, P2188; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; VanOostende S, 1997, CEREB CORTEX, V7, P690, DOI 10.1093/cercor/7.7.690; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028	51	510	513	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1167	1175		10.1016/S0896-6273(02)00897-8	http://dx.doi.org/10.1016/S0896-6273(02)00897-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	594GC	12354405	Bronze			2022-12-28	WOS:000178040000016
J	Fyhn, M; Molden, S; Hollup, S; Moser, MB; Moser, EI				Fyhn, M; Molden, S; Hollup, S; Moser, MB; Moser, EI			Hippocampal neurons responding to first-time dislocation of a target object	NEURON			English	Article							SINGLE UNIT-ACTIVITY; FREELY-MOVING RAT; PLACE CELLS; PYRAMIDAL CELLS; ENSEMBLE CODE; GOAL LOCATION; TASK; SPACE; MEMORY; BACKPROPAGATION	To examine how hippocampal neurons respond to a mismatch between retrieved and actual experience, we trained rats to find a hidden platform at a particular location in an annular watermaze and then moved the platform. Several cells that were silent at the new platform location before the move fired vigorously when the rat found the goal. The new activity was paralleled by reduced discharge in a subset of simultaneously recorded interneurons. The pattern of activity returned toward its original configuration as the rat learned the new location. The activation of specific hippocampal neurons following dislocation of a target object may be essential for synaptic plasticity and adaptive modification of the animal's representation of the environment.	Norwegian Univ Sci & Technol, Neurosci Unit, NO-7489 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Psychol, NO-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Neurosci Unit, NO-7489 Trondheim, Norway.	edvard.moser@svt.ntnu.no						BREESE CR, 1989, J NEUROSCI, V9, P1097; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Deadwyler SA, 1996, J NEUROSCI, V16, P354; EICHENBAUM H, 1987, J NEUROSCI, V7, P716; FRENCH AS, 1971, KYBERNETIK, V8, P165, DOI 10.1007/BF00291117; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hollup SA, 2001, J NEUROSCI, V21, P4505, DOI 10.1523/JNEUROSCI.21-12-04505.2001; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Honey RC, 1998, J NEUROSCI, V18, P2226; Kay S. M., 1988, MODERN SPECTRAL ESTI; Knierim JJ, 2001, J NEUROPHYSIOL, V85, P105, DOI 10.1152/jn.2001.85.1.105; Kobayashi T, 1997, J NEUROPHYSIOL, V78, P597, DOI 10.1152/jn.1997.78.2.597; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MOSER EI, 1994, LEARN MEMORY, V1, P55; Moser EI, 1996, J NEUROSCI, V16, P1247; MULLER RU, 1994, J NEUROSCI, V14, P7235; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Thinus-Blanc C, 1991, Hippocampus, V1, P365, DOI 10.1002/hipo.450010404; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; TULVING E, 1994, NEUROREPORT, V5, P2525, DOI 10.1097/00001756-199412000-00030; VINOGRADOVA OS, 1971, SHORT TERM CHANGES N, P95; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Zinyuk L, 2000, P NATL ACAD SCI USA, V97, P3771, DOI 10.1073/pnas.050576397	40	137	138	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					555	566		10.1016/S0896-6273(02)00784-5	http://dx.doi.org/10.1016/S0896-6273(02)00784-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165476	Bronze			2022-12-28	WOS:000177331200015
J	Ikeda, SR; Kammermeier, PJ				Ikeda, SR; Kammermeier, PJ			M current mystery messenger revealed?	NEURON			English	Editorial Material							RAT SYMPATHETIC NEURONS; M-CHANNEL	The identity of signaling elements that couple muscarinic acetylcholine receptor (mAChR) activation to M current (KCNQ K+ channels) modulation has remained unknown despite decades of study. Suh and Hille (in this issue of Neuron) demonstrate that activation of phospholipase C (PLC) initiates M current modulation and that recovery requires ATP and phosphoinositide 4-kinase (PI4-K). These data suggest that breakdown of phosphotidylinositol 4,5-bisphosphate (PIP2) is a crucial determinant of M channel modulation.	NIAAA, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Ikeda, SR (corresponding author), NIAAA, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA.			Ikeda, Stephen/0000-0002-4088-9508	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000430, Z01AA000430] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P263, DOI 10.1113/jphysiol.1982.sp014412; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; HILGEMANN DW, 2002, SCI STKE, V111, pRE19; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; SHAPIRO MS, 1994, NEURON, V12, P1319, DOI 10.1016/0896-6273(94)90447-2; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890	10	11	12	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					411	412		10.1016/S0896-6273(02)00792-4	http://dx.doi.org/10.1016/S0896-6273(02)00792-4			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165463	Bronze			2022-12-28	WOS:000177331200002
J	Avidan, G; Behrmann, M				Avidan, G; Behrmann, M			Correlations between the fMRI BOLD signal and visual perception	NEURON			English	Editorial Material							OBJECT; RECOGNITION; ACTIVATION; HUMANS		Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Ctr Neural Basis Cognit, Mellon Inst 115, Pittsburgh, PA 15213 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Avidan, G (corresponding author), Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, POB 1255, IL-91904 Jerusalem, Israel.		Avidan, Galia/B-9347-2011	Avidan, Galia/0000-0003-2293-3859; Behrmann, Marlene/0000-0002-3814-1015				Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; James TW, 2000, CURR BIOL, V10, P1017, DOI 10.1016/S0960-9822(00)00655-2; Kleinschmidt A, 2002, NEURON, V34, P659, DOI 10.1016/S0896-6273(02)00694-3; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Ono T., 1996, PERCEPTION MEMORY EM, P601; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873	11	3	3	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					495	497		10.1016/S0896-6273(02)00708-0	http://dx.doi.org/10.1016/S0896-6273(02)00708-0			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	553FT	12062032	Bronze			2022-12-28	WOS:000175665700003
J	Ishikawa, T; Sahara, Y; Takahashi, T				Ishikawa, T; Sahara, Y; Takahashi, T			A single packet of transmitter does not saturate postsynaptic glutamate receptors	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; PYRAMIDAL CELLS; NMDA RECEPTORS; MULTIVESICULAR RELEASE; QUANTAL COMPONENTS; AUDITORY SYNAPSE; RAT HIPPOCAMPUS; MEDIAL NUCLEUS; TRAPEZOID BODY	Neurotransmitter is stored in synaptic vesicles and released by exocytosis into the synaptic cleft. One of the fundamental questions in central synaptic transmission is whether a quantal packet of transmitter saturates postsynaptic receptors. To address this question, we loaded the excitatory transmitter L-glutamate via whole-cell recording pipettes into the giant nerve terminal, the calyx of Held, in rat brainstem slices. This caused marked potentiations of both quantal and action potential-evoked EPSCs mediated by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) or N-methyl-D-aspartate (NMDA) receptors. These results directly demonstrate that neither AMPA nor NMDA receptors are saturated by a single packet of transmitter, and indicate that vesicular transmitter content is an important determinant of synaptic efficacy.	Univ Tokyo, Grad Sch Med, Dept Neurobiol, Tokyo 1130033, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Div Biochem & Cellular Biol, Tokyo, Japan	University of Tokyo; National Center for Neurology & Psychiatry - Japan	Takahashi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurobiol, Tokyo 1130033, Japan.		Ishikawa, Taro/AAX-9928-2020; Takahashi, Tomoyuki/G-5951-2015	Ishikawa, Taro/0000-0003-2335-439X; Takahashi, Tomoyuki/0000-0002-8771-7666				Auger C, 1998, J NEUROSCI, V18, P4532; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; CARPENTER RS, 1980, BIOCHEMISTRY-US, V19, P4373, DOI 10.1021/bi00559a034; Chuhma N, 1998, J NEUROSCI, V18, P512; Clements JD, 1998, J NEUROSCI, V18, P119; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DAN Y, 1994, NEURON, V13, P909, DOI 10.1016/0896-6273(94)90256-9; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Diamond JS, 1997, J NEUROSCI, V17, P4672; Frerking M, 1996, CURR OPIN NEUROBIOL, V6, P395, DOI 10.1016/S0959-4388(96)80125-5; Futai K, 2001, J NEUROSCI, V21, P3342, DOI 10.1523/JNEUROSCI.21-10-03342.2001; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; Holmes WR, 1995, BIOPHYS J, V69, P1734, DOI 10.1016/S0006-3495(95)80043-3; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Ishikawa T, 2001, J PHYSIOL-LONDON, V533, P423, DOI 10.1111/j.1469-7793.2001.0423a.x; Iwasaki S, 2001, J PHYSIOL-LONDON, V534, P861, DOI 10.1111/j.1469-7793.2001.00861.x; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; LAAKE JH, 1995, J NEUROCHEM, V65, P871; LARKMAN A, 1991, NATURE, V350, P344, DOI 10.1038/350344a0; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; MARC RE, 1990, J NEUROSCI, V10, P4006, DOI 10.1523/JNEUROSCI.10-12-04006.1990; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Rusakov DA, 1998, NEUROPHARMACOLOGY, V37, P513, DOI 10.1016/S0028-3908(98)00023-9; Sahara Y, 2001, J PHYSIOL-LONDON, V536, P189, DOI 10.1111/j.1469-7793.2001.00189.x; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; SHUPLIAKOV O, 1995, J NEUROSCI, V15, P7168; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; TABB JS, 1991, J NEUROSCI, V11, P1822; Takahashi T, 2000, SCIENCE, V289, P460, DOI 10.1126/science.289.5478.460; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Umemiya M, 1999, J PHYSIOL-LONDON, V521, P113, DOI 10.1111/j.1469-7793.1999.00113.x; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	50	118	123	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					613	621		10.1016/S0896-6273(02)00692-X	http://dx.doi.org/10.1016/S0896-6273(02)00692-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062044	Bronze			2022-12-28	WOS:000175665700014
J	Moore, KB; Schneider, ML; Vetter, ML				Moore, KB; Schneider, ML; Vetter, ML			Posttranslational mechanisms control the timing of bHLH function and regulate retinal cell fate	NEURON			English	Article							LOOP-HELIX GENES; XENOPUS-EMBRYOS; AMACRINE CELLS; ACHAETE-SCUTE; NEURONAL DIFFERENTIATION; VERTEBRATE RETINA; PRONEURAL GENES; NERVOUS-SYSTEM; EXPRESSION; LAEVIS	During central nervous system development, neurons are often born in a precise temporal sequence. Basic helix-loop-helix (bHLH) transcription factors are required for the development of specific subpopulations of neurons, but how they contribute to their ordered genesis is unclear. We show that the ability of bHLH factors to regulate the development of distinct neuronal subtypes in the Xenopus retina depends upon the timing of their function. In addition, we find that the timing of bHLH function can be regulated post-translationally, so that bHLH factors with overlapping expression can function independently. Specifically, XNeuroD function in the retina can be inhibited by glycogen synthase kinase 3beta (GSK3beta), while Xath5 function can be inhibited by Notch. Thus, the potential of bHLH factors to regulate the development of neuronal subtypes depends upon the context in which they function.	Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Vetter, ML (corresponding author), Univ Utah, Dept Neurobiol & Anat, 20 N 1900 E, Salt Lake City, UT 84132 USA.			Moore, Kathryn/0000-0002-6993-152X; Vetter, Monica/0000-0001-6262-8504	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010096, R01EY012274] Funding Source: NIH RePORTER; NCI NIH HHS [2P30CA42014] Funding Source: Medline; NEI NIH HHS [EY12274, EY10096] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTSHULER DM, 1991, CELL LINEAGE CELL FA, P37; BeleckyAdams T, 1997, INVEST OPHTH VIS SCI, V38, P1293; Bray S, 2000, NEURON, V25, P1, DOI 10.1016/S0896-6273(00)80862-4; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Cai L, 2000, DEVELOPMENT, V127, P3021; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; Chitnis A, 1996, DEVELOPMENT, V122, P2295; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Faber J., 1994, NORMAL TABLE XENOPUS, P2; FERREIRO B, 1993, MECH DEVELOP, V40, P25, DOI 10.1016/0925-4773(93)90085-C; Fode C, 2000, GENE DEV, V14, P67; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; HISCOCK J, 1990, DEV BRAIN RES, V54, P105, DOI 10.1016/0165-3806(90)90070-F; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; HUANG S, 1993, J NEUROSCI, V13, P3193; Huang S, 1997, J COMP NEUROL, V387, P42; Huang S, 1998, VISUAL NEUROSCI, V15, P969, DOI 10.1017/S0952523898155153; Hutcheson DA, 2001, DEV BIOL, V232, P327, DOI 10.1006/dbio.2001.0178; Jasoni CL, 1996, J COMP NEUROL, V369, P319; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Marcus EA, 1998, MOL CELL NEUROSCI, V12, P269, DOI 10.1006/mcne.1998.0713; Mastick GS, 1997, DEVELOPMENT, V124, P1985; Matter-Sadzinski L, 2001, DEVELOPMENT, V128, P217; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MOODY SA, 1987, DEV BIOL, V119, P560, DOI 10.1016/0012-1606(87)90059-5; Morrow EM, 1999, DEVELOPMENT, V126, P23; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; OHNUMA S, 2002, IN PRESS DEVELOPMENT; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; PIERCE SB, 1995, DEVELOPMENT, V121, P755; RAYBORN ME, 1981, J COMP NEUROL, V195, P585, DOI 10.1002/cne.901950404; Schneider ML, 2001, MOL CELL NEUROSCI, V18, P458, DOI 10.1006/mcne.2001.1040; Sun Y, 2000, P NATL ACAD SCI USA, V97, P6815, DOI 10.1073/pnas.110154497; Tomita K, 1996, GENES CELLS, V1, P765, DOI 10.1111/j.1365-2443.1996.tb00016.x; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; ZHU BS, 1993, ANAT EMBRYOL, V187, P549, DOI 10.1007/BF00214433	59	90	95	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					183	195		10.1016/S0896-6273(02)00666-9	http://dx.doi.org/10.1016/S0896-6273(02)00666-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970861	Bronze			2022-12-28	WOS:000174976200005
J	Tsuda, H; Sasai, N; Matsuo-Takasaki, M; Sakuragi, M; Murakami, Y; Sasai, Y				Tsuda, H; Sasai, N; Matsuo-Takasaki, M; Sakuragi, M; Murakami, Y; Sasai, Y			Dorsalization of the neural tube by Xenopus Tiarin, a novel patterning factor secreted by the flanking nonneural head ectoderm	NEURON			English	Article							BONE MORPHOGENETIC PROTEIN-4; SONIC HEDGEHOG; HOMEOBOX GENE; MOTOR-NEURON; FLOOR PLATE; SPINAL-CORD; CELL PATTERN; ROOF PLATE; TRANSCRIPTION FACTOR; DISTINCT EXPRESSION	We have isolated a novel secreted dorsalizing factor of the neural tube, Xenopus Tiarin, which belongs to the olfactomedin-related family. Tiarin expression starts at the late gastrula stage in the nonneural ectoderm adjacent to the anterior neural plate. Overexpression of Tiarin in the embryo causes expansion of dorsal neural markers and suppression of ventral markers. In the eye-forming field, Tiarin overexpression induces the retinal markers and represses optic stalk markers. Tiarin directly dorsalizes neural tissues in the absence of mesodermal tissues and antagonizes the ventralizing activity of Sonic hedghog (Shh). Unlike BMP4, another dorsalizing factor, Tiarin does not display antineuralizing activity on the ectoderm or mesoderm-ventralizing activity. These findings show that Tiarin is a novel patterning signal candidate acting in the specification of the dorsal neural tube.	Kyoto Univ, Inst Frontier Med Sci, Dept Med Embryol & Neurobiol, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Inst Frontier Med Sci, Dept Reparat Mat, Sakyo Ku, Kyoto 6068507, Japan; RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan	Kyoto University; Kyoto University; RIKEN	Sasai, Y (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Med Embryol & Neurobiol, Sakyo Ku, Kyoto 6068507, Japan.			Sasai, Noriaki/0000-0003-0360-1138				Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; ALTABA ARI, 1993, P NATL ACAD SCI USA, V90, P8268, DOI 10.1073/pnas.90.17.8268; Bang AG, 1997, DEVELOPMENT, V124, P2075; Barbieri AM, 1999, P NATL ACAD SCI USA, V96, P10729, DOI 10.1073/pnas.96.19.10729; Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Barth KA, 1999, DEVELOPMENT, V126, P4977; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; DALE L, 1992, DEVELOPMENT, V115, P573; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; Dosch R, 1997, DEVELOPMENT, V124, P2325; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; FAINSOD A, 1994, EMBO J, V13, P5015, DOI 10.1002/j.1460-2075.1994.tb06830.x; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Golden JA, 1999, P NATL ACAD SCI USA, V96, P2439, DOI 10.1073/pnas.96.5.2439; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; GURDON JB, 1976, J EMBRYOL EXP MORPH, V36, P523; Hardcastle Z, 2000, DEVELOPMENT, V127, P1303; HARRIS WA, 1991, NEURON, V6, P499, DOI 10.1016/0896-6273(91)90053-3; Heller N, 1997, MECH DEVELOP, V69, P83, DOI 10.1016/S0925-4773(97)00158-5; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JONES CM, 1992, DEVELOPMENT, V115, P639; KNECHT AK, 1995, DEVELOPMENT, V121, P1927; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; KU M, 1993, DEVELOPMENT, V119, P1161; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lee J, 1997, DEVELOPMENT, V124, P2537; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li HS, 1997, DEVELOPMENT, V124, P603; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Matsui M, 2000, P NATL ACAD SCI USA, V97, P5291, DOI 10.1073/pnas.090020497; MAYOR R, 1995, DEVELOPMENT, V121, P767; Meyer D, 1997, INT J DEV BIOL, V41, P607; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Nagano T, 1998, MOL BRAIN RES, V53, P13, DOI 10.1016/S0169-328X(97)00271-4; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Perea-Gomez A, 2001, INT J DEV BIOL, V45, P311; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Placzek M, 2000, CURR OPIN NEUROBIOL, V10, P15, DOI 10.1016/S0959-4388(99)00060-4; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; SAHA MS, 1993, DEVELOPMENT, V118, P193; Saha MS, 1997, DEV BIOL, V187, P209, DOI 10.1006/dbio.1997.8625; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sasai N, 2001, DEVELOPMENT, V128, P2525; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; SIVE HL, 2000, EARLY DEV XENOPUS LA, P166; Small EM, 2000, MECH DEVELOP, V96, P259, DOI 10.1016/S0925-4773(00)00400-7; SNYDER DA, 1991, BIOCHEMISTRY-US, V30, P9143, DOI 10.1021/bi00102a004; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Sussel L, 1999, DEVELOPMENT, V126, P3359; Suzuki A, 1997, DEVELOPMENT, V124, P3037; Takabatake T, 2000, MECH DEVELOP, V98, P99, DOI 10.1016/S0925-4773(00)00436-6; Tashiro K, 1999, METHOD ENZYMOL, V303, P479; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; WOLDA SL, 1993, DEV BIOL, V155, P46, DOI 10.1006/dbio.1993.1005; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655	92	48	48	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					515	528		10.1016/S0896-6273(02)00590-1	http://dx.doi.org/10.1016/S0896-6273(02)00590-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856527	Bronze			2022-12-28	WOS:000173911100006
J	Lauwereyns, J; Takikawa, Y; Kawagoe, R; Kobayashi, S; Koizumi, M; Coe, B; Sakagami, M; Hikosaka, O				Lauwereyns, J; Takikawa, Y; Kawagoe, R; Kobayashi, S; Koizumi, M; Coe, B; Sakagami, M; Hikosaka, O			Feature-based anticipation of cues that predict reward in monkey caudate nucleus	NEURON			English	Article							SACCADIC EYE-MOVEMENTS; PRIMATE PREFRONTAL NEURONS; MACAQUE VISUAL-CORTEX; BASAL GANGLIA; FUNCTIONAL-PROPERTIES; ORBITOFRONTAL CORTEX; BEHAVING MONKEY; AREA V4; ATTENTION; RESPONSES	A subset of caudate neurons fires before cues that instruct the monkey what he should do. To test the hypothesis that the anticipatory activity of such neurons depends on the context of stimulus-reward mapping, we examined their activity while the monkeys performed a memory-guided saccade task in which either the position or the color of a cue indicated presence or absence of reward. Some neurons showed anticipatory activity only when a particular position was associated with reward, while others fired selectively for color-reward associations. The functional segregation suggests that caudate neurons participate in feature-based anticipation of visual information that predicts reward. This neuronal code influences the general activity level in response to visual features without improving the quality of visual discrimination.	Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; Tamagawa Univ, Brain Sci Res Ctr, Tokyo 1948610, Japan	Juntendo University; University of Tokyo	Hikosaka, O (corresponding author), Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, Hongo 2-1-1, Tokyo 1130033, Japan.	hikosaka@med.juntendo.ac.jp	Kobayashi, Shunsuke/C-2551-2008	Kobayashi, Shunsuke/0000-0002-6868-9313; Lauwereyns, Jan/0000-0003-0551-2550; Coe, Brian/0000-0002-3985-0163	NATIONAL EYE INSTITUTE [Z01EY000415, ZIAEY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; AOSAKI T, 1994, J NEUROSCI, V14, P3969; APICELLA P, 1992, J NEUROPHYSIOL, V68, P945, DOI 10.1152/jn.1992.68.3.945; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; BINDRA D, 1968, PSYCHOL REV, V75, P1, DOI 10.1037/h0025306; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; DIVAC I, 1967, J COMP PHYSIOL PSYCH, V63, P184, DOI 10.1037/h0024348; Dorris MC, 1998, J NEUROSCI, V18, P7015; DOWNING CJ, 1988, J EXP PSYCHOL HUMAN, V14, P188, DOI 10.1037/0096-1523.14.2.188; FISHER RS, 1986, BRAIN RES, V398, P148, DOI 10.1016/0006-8993(86)91260-6; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; GROVES PM, 1994, NEUROSCIENCE, V58, P593, DOI 10.1016/0306-4522(94)90084-1; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HAWKINS HL, 1990, J EXP PSYCHOL HUMAN, V16, P802, DOI 10.1037/0096-1523.16.4.802; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1993, EXP BRAIN RES, V95, P457; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KATO M, 1995, J NEUROSCI, V15, P912; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; KOBAYASHI S, 2002, IN PRESS J NEUROPHYS; Kusama T., 1970, STEREOTAXIC ATLAS BR; Lauwereyns J, 2000, J EXP PSYCHOL ANIM B, V26, P352, DOI 10.1037/0097-7403.26.3.352; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Levy R, 1997, J NEUROSCI, V17, P3870; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rainer G, 1999, J NEUROSCI, V19, P5493; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROLLS ET, 1983, BEHAV BRAIN RES, V7, P179, DOI 10.1016/0166-4328(83)90191-2; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; ROLLS ET, 1999, BRAIN EMOTION; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tinklepaugh OL, 1928, J COMP PSYCHOL, V8, P197, DOI 10.1037/h0075798; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0	57	97	100	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					463	473		10.1016/S0896-6273(02)00571-8	http://dx.doi.org/10.1016/S0896-6273(02)00571-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	518AG	11832232	Bronze			2022-12-28	WOS:000173643200015
J	Xia, ZG; Storm, DR				Xia, ZG; Storm, DR			CaRF: A neuronal transcription factor that CaREs	NEURON			English	Editorial Material							BDNF EXPRESSION; CREB; MEMORY; STIMULATION; INDUCTION; LTP	In this issue of Neuron, Tao et al. (2002) report the discovery of a new transcription factor, CaRF, that contributes to calcium stimulation of the BDNF gene through CaRE1, one of several calcium response elements found in the promoter of the BDNF gene. The CaRF/CaRE1 transcriptional pathway may control the expression of genes critical for activity-dependent, long-term changes in the central nervous system (CNS).	Univ Washington, Dept Environm Hlth & Toxicol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Xia, ZG (corresponding author), Univ Washington, Dept Environm Hlth & Toxicol, Seattle, WA 98195 USA.							Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tully T, 1998, NAT NEUROSCI, V1, P543, DOI 10.1038/2780; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	12	5	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					315	316		10.1016/S0896-6273(02)00578-0	http://dx.doi.org/10.1016/S0896-6273(02)00578-0			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832218	Bronze			2022-12-28	WOS:000173643200001
J	Lee, SJ; Montell, C				Lee, SJ; Montell, C			Regulation of the rhodopsin protein phosphatase, RDGC, through interaction with calmodulin	NEURON			English	Article							DEGENERATION-C RDGC; RETINAL-DEGENERATION; PHOTORECEPTOR CELL; BINDING PROTEIN; DROSOPHILA PHOTORECEPTORS; CALCIUM CHANNELS; VISUAL ARRESTIN; SCALLOP MYOSIN; CA2+ CHANNEL; TRP	Hundreds of G protein-coupled receptors (GPCRs) and at least six GPCR kinases have been identified, but the only GPCR phosphatase that has been definitively demonstrated is the rhodopsin phosphatase encoded by the rdgC locus of Drosophila. Mutations in rdgC result in defects in termination of the light response and cause severe retinal degeneration. In the current work, we demonstrate that RDGC binds to calmodulin, and a mutation in an IQ motif that eliminates the calmodulin/RDGC interaction prevents dephosphorylation of rhodopsin in vivo and disrupts termination of the photoresponse. Our data indicate that RDGC is a novel calmodulin-dependent protein phosphatase and raise the possibility that regulation of other GPCRs through dephosphorylation may be controlled by calmodulin-dependent protein phosphatases related to RDGC.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.		Lee, Seung Jae V/E-2468-2019; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482	NATIONAL EYE INSTITUTE [R01EY008117, R01EY010852] Funding Source: NIH RePORTER; NEI NIH HHS [EY10852, EY08117] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; Andreeva AV, 1999, CELL SIGNAL, V11, P555, DOI 10.1016/S0898-6568(99)00032-7; ANTONIW JF, 1976, EUR J BIOCHEM, V68, P45, DOI 10.1111/j.1432-1033.1976.tb10763.x; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; CHAPMAN ER, 1991, J BIOL CHEM, V266, P207; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; HARDIE RC, 1995, J NEUROSCI, V15, P889; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Huang XZ, 1998, J BIOL CHEM, V273, P1462, DOI 10.1074/jbc.273.3.1462; Kahn ES, 1997, J NEUROCHEM, V68, P169; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; LEONARD DS, 1992, J NEUROBIOL, V23, P605, DOI 10.1002/neu.480230602; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Li HS, 1998, J NEUROSCI, V18, P9601; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; MATSUMOTO H, 1984, SCIENCE, V223, P184, DOI 10.1126/science.6419348; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; MINKE B, 2000, MOL MECH VISUAL TRAN, P449; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montini E, 1997, HUM MOL GENET, V6, P1137, DOI 10.1093/hmg/6.7.1137; Munshi HG, 1996, BIOCHEMISTRY-US, V35, P15883, DOI 10.1021/bi962107y; PAK WL, 1995, INVEST OPHTH VIS SCI, V36, P2340; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Sherman PM, 1997, P NATL ACAD SCI USA, V94, P11639, DOI 10.1073/pnas.94.21.11639; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; WALLACE RW, 1980, BIOCHEMISTRY-US, V19, P1831, DOI 10.1021/bi00550a016; Warr CG, 1996, BIOCHEM J, V314, P497, DOI 10.1042/bj3140497; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	60	38	38	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1097	1106		10.1016/S0896-6273(01)00538-4	http://dx.doi.org/10.1016/S0896-6273(01)00538-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754840	Bronze			2022-12-28	WOS:000172886800015
J	Stuart, GJ				Stuart, GJ			Determinants of spike timing-dependent synaptic plasticity	NEURON			English	Editorial Material								Recent studies show that the precise timing of presynaptic inputs and postsynaptic action potentials influences the strength and sign of synaptic plasticity. In this issue of Neuron, Sjostrom and colleagues (2001) determine how this so-called spike timing-dependent plasticity depends on the frequency and strength of the presynaptic inputs.	Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Stuart, GJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.		stuart, greg j/F-7328-2011	stuart, greg/0000-0001-9395-2219				BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910	8	4	4	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					966	968		10.1016/S0896-6273(01)00541-4	http://dx.doi.org/10.1016/S0896-6273(01)00541-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754829	Bronze			2022-12-28	WOS:000172886800005
J	Annaert, WG; Esselens, C; Baert, V; Boeve, C; Snellings, G; Cupers, P; Craessaerts, K; De Strooper, B				Annaert, WG; Esselens, C; Baert, V; Boeve, C; Snellings, G; Cupers, P; Craessaerts, K; De Strooper, B			Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins	NEURON			English	Article							FAMILIAL ALZHEIMERS-DISEASE; GAMMA-SECRETASE ACTIVITY; CAENORHABDITIS-ELEGANS; HIPPOCAMPAL-NEURONS; BETA-PROTEIN; INTRAMEMBRANE PROTEOLYSIS; SUBCELLULAR-LOCALIZATION; SIGNAL-TRANSDUCTION; MISSENSE MUTATIONS; TRANSFECTED CELLS	The carboxyl terminus of presenilin 1 and 2 (PS1 and PS2) binds to the neuron-specific cell adhesion molecule telencephalin (TLN) in the brain. PS1 deficiency results in the abnormal accumulation of TLN in a yet unidentified intracellular compartment. The first transmembrane domain and carboxyl terminus of PS1 form a binding pocket with the transmembrane domain of TLN. Remarkably, APP binds to the same regions via part of its transmembrane domain encompassing the critical residues mutated in familial Alzheimer's disease. Our data surprisingly indicate a spatial dissociation between the binding site and the proposed catalytic site near the critical aspartates in PSs. They provide important experimental evidence to support a ring structure model for PS.	Katholieke Univ Leuven VIB, Gasthuisberg, Dept Human Genet, Lab Neuronal Cell Biol, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Annaert, WG (corresponding author), Katholieke Univ Leuven VIB, Gasthuisberg, Dept Human Genet, Lab Neuronal Cell Biol, B-3000 Louvain, Belgium.	ad@med.kuleuven.ac.be	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819; Esselens, Cary/0000-0001-8876-634X				Annaert W, 1999, TRENDS NEUROSCI, V22, P439, DOI 10.1016/S0166-2236(99)01455-1; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Arduengo PM, 1998, J CELL SCI, V111, P3645; Benson DL, 1998, J NEUROSCI RES, V52, P43, DOI 10.1002/(SICI)1097-4547(19980401)52:1<43::AID-JNR5>3.3.CO;2-A; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cruts M, 1998, HUM MUTAT, V11, P183, DOI 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.3.CO;2-M; Culvenor JG, 1997, J NEUROSCI RES, V49, P719, DOI 10.1002/(SICI)1097-4547(19970915)49:6<719::AID-JNR6>3.0.CO;2-A; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 2001, J CELL BIOL, V152, pF17, DOI 10.1083/jcb.152.4.F17; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Kim SH, 2000, NEUROBIOL DIS, V7, P99, DOI 10.1006/nbdi.1999.0280; Kim TW, 1997, J BIOL CHEM, V272, P11006; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li XJ, 1998, P NATL ACAD SCI USA, V95, P7109, DOI 10.1073/pnas.95.12.7109; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lukinova NI, 1999, GENETICS, V153, P1789; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; OKOCHI M, 2000, J BIOL CHEM, V275, P6365; Pradier L, 1999, NEUROBIOL DIS, V6, P43, DOI 10.1006/nbdi.1998.0212; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SISODIA S, 2001, TRENDS NEUROSCI, V24, P52; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tian L, 2000, EUR J IMMUNOL, V30, P810, DOI 10.1002/1521-4141(200003)30:3<810::AID-IMMU810>3.3.CO;2-O; Tian L, 2000, J CELL BIOL, V150, P243, DOI 10.1083/jcb.150.1.243; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Verdile G, 2000, J BIOL CHEM, V275, P20794, DOI 10.1074/jbc.C000208200; Weidemann A, 1997, NAT MED, V3, P328, DOI 10.1038/nm0397-328; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; YOSHIHARA Y, 1994, NEURON, V12, P541, DOI 10.1016/0896-6273(94)90211-9; YOSHIHARA Y, 1994, NEUROSCI RES, V21, P119, DOI 10.1016/0168-0102(94)90153-8; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2	72	174	177	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					579	589		10.1016/S0896-6273(01)00512-8	http://dx.doi.org/10.1016/S0896-6273(01)00512-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719200	Bronze			2022-12-28	WOS:000172363900006
J	del Camino, D; Yellen, G				del Camino, D; Yellen, G			Tight steric closure at the intracellular activation gate of a voltage-gated K+ channel	NEURON			English	Article							SHAKER POTASSIUM CHANNELS; ION CHANNELS; PORE; INACTIVATION; RECEPTOR; REGION; SITE; SELECTIVITY; PERMEATION; OCCUPANCY	In voltage-gated K+ channels (Kv), an intracellular gate regulates access from the cytoplasm to the pore by organic channel blockers and by chemical modifiers. But is ion flow itself controlled instead by constriction of the narrow selectivity filter near the extracellular surface? We find that the intracellular gate of Kv channels is capable of regulating access even by the small cations Cd2+ and Ag+. It can also exclude small neutral or negatively charged molecules, indicating that the gate operates by steric exclusion rather than electrostatically. Just intracellular to the gated region, channel closure does not restrict access even to very large reagents. Either these Kv channels have a broader inner entrance than seen in the KcsA crystal, even in the closed state, or the region is highly flexible (but nevertheless remains very securely closed nearby).	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yellen, G (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.			Yellen, Gary/0000-0003-4228-7866	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 29693, R01 NS029693] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; ARMSTRONG CM, 1975, QUART REV BIOPH, V7, P179; CHANDLER WK, 1965, J PHYSIOL-LONDON, V180, P788, DOI 10.1113/jphysiol.1965.sp007732; Chapman ML, 1997, BIOPHYS J, V72, P708, DOI 10.1016/S0006-3495(97)78707-1; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1992, IONIC CHANNELS EXCIT; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Marcus Y., 1997, ION PROPERTIES; NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549; NEYTON J, 1991, J GEN PHYSIOL, V97, P641, DOI 10.1085/jgp.97.4.641; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Townsend C, 1997, J GEN PHYSIOL, V110, P11, DOI 10.1085/jgp.110.1.11; VanDongen AM, 2001, BIOPHYS J, V80, p175A; Webster SM, 2001, BIOPHYS J, V80, p16A; YEH JZ, 1978, NATURE, V273, P387, DOI 10.1038/273387a0; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	37	221	225	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					649	656		10.1016/S0896-6273(01)00487-1	http://dx.doi.org/10.1016/S0896-6273(01)00487-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719205	Bronze			2022-12-28	WOS:000172363900011
J	Berke, JD; Sgambato, V; Zhu, PP; Lavoie, B; Vincent, M; Krause, M; Hyman, SE				Berke, JD; Sgambato, V; Zhu, PP; Lavoie, B; Vincent, M; Krause, M; Hyman, SE			Dopamine and glutamate induce distinct striatal splice forms of ania-6, an RNA polymerase II-associated cyclin	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; C-TERMINAL DOMAIN; REGULATORY SUBUNIT; TRANSCRIPTION; EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; ISOFORMS; ADHESION	Control of neuronal gene expression by drugs or neurotransmitters is a critical step in long-term neural plasticity. Here, we show that a gene induced in the striatum by cocaine or direct dopamine stimulation, ania-6, is a member of a novel family of cyclins with homology to cyclins K/T/H/C. Further, different types of neurotransmitter stimulation cause selective induction of distinct ania-6 isoforms, through alternative splicing. The longer Ania-6 protein colocalizes with nuclear speckles and is associated with key elements of the RNA elongation/processing complex, including the hyperphosphorylated form of RNA polymerase II, the splicing factor SC-35, and the p110 PITSLRE cyclin-dependent kinase. Distinct types of neuronal stimulation may therefore differentially modulate nuclear RNA processing, through altered transcription and splicing of ania-6.	NINCDS, Mol Plast Sect, Bethesda, MD 20892 USA; NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA; NIMH, Bethesda, MD 20892 USA; Harvard Univ, Neurosci Program, Boston, MA 02115 USA; Univ Laval, CREFSIP, Quebec City, PQ G1K 7P4, Canada; Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Laval University; Laval University	Hyman, SE (corresponding author), NINCDS, Mol Plast Sect, Bethesda, MD 20892 USA.	shyman@helix.nih.gov	Sgambato, Véronique/G-9062-2017	Sgambato, Véronique/0000-0002-8792-8586; Krause, Michael/0000-0001-6127-3940	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036117] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Berke JD, 1998, J NEUROSCI, V18, P5301, DOI 10.1523/JNEUROSCI.18-14-05301.1998; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Black DL, 1998, NEURON, V20, P165, DOI 10.1016/S0896-6273(00)80444-4; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Bregman DB, 2000, FRONT BIOSCI, V5, pD244, DOI 10.2741/Bregman; Busser J, 1998, J NEUROSCI, V18, P2801; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; COLE AJ, 1992, J NEUROCHEM, V58, P1420, DOI 10.1111/j.1471-4159.1992.tb11358.x; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; FROHMAN MA, 1994, PCR METH APPL, V4, pS40; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Gao CY, 1997, BIOESSAYS, V19, P307, DOI 10.1002/bies.950190408; Gomi H, 1999, J NEUROSCI, V19, P9530; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; Herrmann CH, 2001, J CELL SCI, V114, P1491; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; KERYER G, 1993, P NATL ACAD SCI USA, V90, P5418, DOI 10.1073/pnas.90.12.5418; Kim E, 1997, J CELL BIOL, V136, P19, DOI 10.1083/jcb.136.1.19; Koushika SP, 1996, CURR BIOL, V6, P1634, DOI 10.1016/S0960-9822(02)70787-2; Loyer P, 1998, J CELL SCI, V111, P1495; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Misteli T, 2000, J CELL SCI, V113, P1841; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Neugebauer KM, 1997, GENE DEV, V11, P3279, DOI 10.1101/gad.11.24.3279; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Okabe S, 1999, J NEUROSCI, V19, P7781; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Peng JM, 1998, J BIOL CHEM, V273, P13855, DOI 10.1074/jbc.273.22.13855; PowellCoffman JA, 1996, DEV BIOL, V178, P472, DOI 10.1006/dbio.1996.0232; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; Rodger J, 1998, J NEUROCHEM, V71, P666; ROSS ME, 1994, J NEUROSCI, V14, P6384; Schacher S, 2000, J NEUROBIOL, V45, P152, DOI 10.1002/1097-4695(20001115)45:3<152::AID-NEU3>3.0.CO;2-0; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; SCHIAVI SC, 1992, BIOCHIM BIOPHYS ACTA, V1114, P95, DOI 10.1016/0304-419X(92)90009-N; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shippenberg TS, 1997, PHARMACOL BIOCHEM BE, V57, P449, DOI 10.1016/S0091-3057(96)00450-9; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Vincent M, 1996, NUCLEIC ACIDS RES, V24, P4649, DOI 10.1093/nar/24.23.4649; Vogelezang MG, 1999, J NEUROSCI RES, V56, P323, DOI 10.1002/(SICI)1097-4547(19990515)56:4<323::AID-JNR1>3.0.CO;2-6; Vreugdenhil E, 1999, J NEUROBIOL, V39, P41, DOI 10.1002/(SICI)1097-4695(199904)39:1<41::AID-NEU4>3.0.CO;2-X; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; White NM, 1997, CURR OPIN NEUROBIOL, V7, P164, DOI 10.1016/S0959-4388(97)80004-9; XIANG JL, 1994, J BIOL CHEM, V269, P15786; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Zacharias DA, 1996, CURR BIOL, V6, P1642, DOI 10.1016/S0960-9822(02)70788-4	61	80	96	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					277	287		10.1016/S0896-6273(01)00465-2	http://dx.doi.org/10.1016/S0896-6273(01)00465-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683997	Bronze			2022-12-28	WOS:000171893700012
J	Detwiler, P				Detwiler, P			Open the loop: Dissecting feedback regulation of a second messenger transduction cascade	NEURON			English	Editorial Material							ACTIVATION; ADAPTATION; VERTEBRATE; RODS	Single photon responses were compared in wild-type and transgenic retinal rods with and without guanylate cyclase activating protein (GCAP) to disrupt Ca2+-dependent feedback regulation of guanylate cyclase (see Burns et al. in this issue of Neuron). The results provided new insights into the molecular mechanisms underlying phototransduction.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Detwiler, P (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.			Detwiler, Peter/0000-0003-3910-2023				Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Detwiler PB, 1996, CURR OPIN NEUROBIOL, V6, P440, DOI 10.1016/S0959-4388(96)80047-X; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9	8	12	12	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					3	4		10.1016/S0896-6273(02)00940-6	http://dx.doi.org/10.1016/S0896-6273(02)00940-6			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367499	Bronze			2022-12-28	WOS:000178295100002
J	Sasaki, Y; Murakami, I; Cavanagh, P; Tootell, RHB				Sasaki, Y; Murakami, I; Cavanagh, P; Tootell, RHB			Human brain activity during illusory visual jitter as revealed by functional magnetic resonance imaging	NEURON			English	Article							RAT FOREPAW STIMULATION; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; AREA MT; EYE-MOVEMENTS; MACAQUE MONKEY; BLOOD-FLOW; MOTION; V1; ACTIVATION	One central problem in vision is how to compensate for retinal slip. A novel illusion (visual jitter) suggests the compensation mechanism is based solely on retinal motion. Adaptation to visual noise attenuates the motion signals used by the compensation stage, producing illusory jitter due to the undercompensation of retinal slip. Here, we investigated the neural substrate of retinal slip compensation during this illusion using high-field fMRI and retinotopic mapping in flattened cortical format. When jitter perception occurred, MR signal decreased in lower stages of the visual system but increased prominently in area MT+. In conclusion, visual areas as early as V1 are responsible for the adaptation stage, and MT+ is involved in the compensation stage. The present finding suggests the pathway from V1 to MT+ has an important role in stabilizing the visual world.	Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; NTT Corp, NTT Commun Sci Labs, Human & Informat Sci Lab, Kanagawa 2430198, Japan; Harvard Univ, Dept Psychol, Vis Sci Lab, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Nippon Telegraph & Telephone Corporation; Harvard University	Sasaki, Y (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, 149 13th St, Charlestown, MA 02129 USA.			Sasaki, Yuka/0000-0002-0061-0250	NEI NIH HHS [EY07980] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007980] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Culham JC, 1999, J NEUROPHYSIOL, V81, P388, DOI 10.1152/jn.1999.81.1.388; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1997, HUM BRAIN MAPP, V5, P326; Demb JB, 1998, J NEUROSCI, V18, P6939; Demb JB, 1997, P NATL ACAD SCI USA, V94, P13363, DOI 10.1073/pnas.94.24.13363; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; GALLETTI C, 1984, BRAIN RES, V301, P95, DOI 10.1016/0006-8993(84)90406-2; GATTASS R, 1988, J NEUROSCI, V8, P1831; Gur M, 1997, J NEUROSCI, V17, P2914; GUR M, 1987, VISION RES, V27, P2081, DOI 10.1016/0042-6989(87)90122-2; Gur M, 1997, VISION RES, V37, P257, DOI 10.1016/S0042-6989(96)00182-4; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; He S, 1998, CURR BIOL, V8, P1215, DOI 10.1016/S0960-9822(07)00512-X; Hoge RD, 1999, NEUROIMAGE, V9, P573, DOI 10.1006/nimg.1999.0443; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; IBBOTSON MR, 1994, EXP BRAIN RES, V99, P148; Ilg UJ, 1996, EUR J NEUROSCI, V8, P1156; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Kruger G, 1999, NEUROREPORT, V10, P2939; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; McCarthy G., 1994, HUM BRAIN MAPP, V2, P234, DOI [10.1002/hbm.460020405, DOI 10.1002/HBM.460020405]; Mendola JD, 1999, J NEUROSCI, V19, P8560; Murakami I, 2001, VISION RES, V41, P173, DOI 10.1016/S0042-6989(00)00237-6; MURAKAMI I, 1995, VISION RES, V35, P1041, DOI 10.1016/0042-6989(94)00201-V; Murakami I, 1998, NATURE, V395, P798, DOI 10.1038/27435; SCHNEIDER W, 1993, NATURE, V365, P150, DOI 10.1038/365150a0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; TANAKA K, 1986, J NEUROSCI, V6, P134; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Tootell RBH, 1997, J NEUROSCI, V17, P7060; WADE NJ, 1993, PERCEPTION, V22, P1365, DOI 10.1068/p221365; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wohlgemuth A., 1911, AFTER EFFECT SEEN MO, V1; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068	62	25	25	3	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1147	1156		10.1016/S0896-6273(02)00899-1	http://dx.doi.org/10.1016/S0896-6273(02)00899-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354403	Bronze			2022-12-28	WOS:000178040000014
J	Reuveny, E				Reuveny, E			Trapping the sensor	NEURON			English	Editorial Material							SHAKER K+ CHANNEL; POTASSIUM CHANNEL; VOLTAGE SENSOR; S4 SEGMENT; MOVEMENT		Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reuveny, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.							Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Schonherr R, 2002, NEURON, V35, P935, DOI 10.1016/S0896-6273(02)00869-3; Silverman WR, 2000, J GEN PHYSIOL, V116, P663, DOI 10.1085/jgp.116.5.663; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6	10	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					814	815		10.1016/S0896-6273(02)00868-1	http://dx.doi.org/10.1016/S0896-6273(02)00868-1			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372274	Bronze			2022-12-28	WOS:000177779800002
J	Domeniconi, M; Cao, ZU; Spencer, T; Sivasankaran, R; Wang, KC; Nikulina, E; Kimura, N; Cai, H; Deng, KW; Gao, Y; He, ZG; Filbin, MT				Domeniconi, M; Cao, ZU; Spencer, T; Sivasankaran, R; Wang, KC; Nikulina, E; Kimura, N; Cai, H; Deng, KW; Gao, Y; He, ZG; Filbin, MT			Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth	NEURON			English	Article							AXONAL REGENERATION; ADULT-RAT; GROWTH; MAG; IDENTIFICATION; PROTEIN; GANGLIOSIDES; ADHESION; ANTIBODY; LIGANDS	Myelin inhibitors of axonal regeneration, like Nogo and MAG, block regrowth after injury to the adult CNS. While a GPI-linked receptor for Nogo (NgR) has been identified, MAG's receptor is unknown. We show that MAG inhibits regeneration by interaction with NgR. Binding of and inhibition by MAG are lost if neuronal GPI-linked proteins are cleaved. Binding of MAG to NgR-expressing cells is GPI dependent and sialic acid independent. Conversely, NgR binds to MAG-expressing cells. MAG, but not a truncated MAG that binds neurons but does not inhibit regeneration, precipitates NgR from NgR-expressing cells, DRG, and cerebellar neurons, Importantly, NgR antibody, soluble NgR, or dominant-negative NgR each prevent inhibition of neurite outgrowth by MAG. Also, MAG and Nogo66 compete for binding to NgR. These results suggest redundancy in myelin inhibitors and indicate therapies for CNS injuries.	CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	City University of New York (CUNY) System; Hunter College (CUNY); Harvard University; Boston Children's Hospital; Harvard Medical School	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	filbin@genectr.hunter.cuny.edu	Spencer, Tim/AAK-2094-2020		NINDS NIH HHS [NS41073, NS 37060] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041073, R01NS037060, R37NS037060] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Cheng K, 2000, PSYCHOL SCI, V11, P403, DOI 10.1111/1467-9280.00278; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Collins BE, 1997, J BIOL CHEM, V272, P1248, DOI 10.1074/jbc.272.2.1248; Crocker P R, 1998, Glycobiology, V8, pv; De Bellard M, 1999, J NEUROSCI RES, V56, P213, DOI 10.1002/(SICI)1097-4547(19990415)56:2<213::AID-JNR11>3.3.CO;2-L; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; FAHRIG T, 1987, EMBO J, V6, P2875, DOI 10.1002/j.1460-2075.1987.tb02590.x; Filbin MT, 1996, MOL CELL NEUROSCI, V8, P84, DOI 10.1006/mcne.1996.0047; Fitch MT, 1999, CNS REGENERATION BAS, P55; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Franzen R, 2001, J CELL BIOL, V155, P893, DOI 10.1083/jcb.200108137; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Huber AB, 2002, J NEUROSCI, V22, P3553; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.3.CO;2-W; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MIKOL DD, 1990, J CELL BIOL, V110, P471, DOI 10.1083/jcb.110.2.471; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Quarles RH, 1997, J MOL NEUROSCI, V8, P1, DOI 10.1007/BF02736858; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1993, EUR J NEUROSCI, V5, P1156, DOI 10.1111/j.1460-9568.1993.tb00970.x; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Tang S, 2001, MOL CELL NEUROSCI, V18, P259, DOI 10.1006/mcne.2001.1020; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TRAPP BD, 1988, J CELL BIOL, V107, P675, DOI 10.1083/jcb.107.2.675; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814	47	467	517	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					283	290		10.1016/S0896-6273(02)00770-5	http://dx.doi.org/10.1016/S0896-6273(02)00770-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160746	Bronze			2022-12-28	WOS:000177034200008
J	Houart, C; Caneparo, L; Heisenberg, CP; Barth, KA; Take-Uchi, M; Wilson, SW				Houart, C; Caneparo, L; Heisenberg, CP; Barth, KA; Take-Uchi, M; Wilson, SW			Establishment of the telencephalon during gastrulation by local antagonism of Wnt signaling	NEURON			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; FOREBRAIN DEVELOPMENT; ZEBRAFISH GASTRULA; SPEMANN ORGANIZER; MOUSE FOREBRAIN; HEAD INDUCTION; NEURAL PLATE; BETA-CATENIN; XENOPUS; MESODERM	Cells at the anterior boundary of the neural plate (ANB) can induce telencephalic gene expression when transplanted to more posterior regions. Here, we identify a secreted Frizzled-related Wnt antagonist, Tic, that is expressed in ANB cells and can cell nonautonomously promote telencephalic gene expression in a concentration-dependent manner. Moreover, abrogation of Tlc function compromises telencephalic development. We also identify Wnt8b as a locally acting modulator of regional fate in the anterior neural plate and a likely target for antagonism by Tic. Finally, we show that tlc expression is regulated by signals that establish early antero-posterior and dorso-ventral ectodermal pattern. From these studies, we propose that local antagonism of Wnt activity within the anterior ectoderm is required to establish the telencephalon.	Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 9RT, England; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; King's College London; University of London; University College London	Houart, C (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, New Hunts House, London SE1 9RT, England.	corinne.houart@kcl.ac.uk; s.wilson@ucl.ac.uk	Caneparo, Luca/B-6620-2008; Houart, Corinne/B-5128-2009; Zebrafish, UCL/A-3125-2009; Wilson, Stephen W/B-9404-2008	Houart, Corinne/0000-0002-2062-3964; Wilson, Stephen W/0000-0002-8557-5940; Heisenberg, Carl-Philipp/0000-0002-0912-4566				Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Barth KA, 1999, DEVELOPMENT, V126, P4977; Brand M, 1996, DEVELOPMENT, V123, P179; Brault V, 2001, DEVELOPMENT, V128, P1253; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Erter CE, 2001, DEVELOPMENT, V128, P3571; Gamse D, 2000, BIOESSAYS, V22, P976; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Houart C, 1998, NATURE, V391, P788, DOI 10.1038/35853; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Joubin K, 2001, INT J DEV BIOL, V45, P165; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; KELLY GM, 1995, DEVELOPMENT, V121, P1787; KELLY GM, 1995, DEV GENET, V17, P129, DOI 10.1002/dvg.1020170205; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lumsden A, 1999, NAT CELL BIOL, V1, pE83, DOI 10.1038/12078; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Masai I, 1997, NEURON, V18, P43, DOI 10.1016/S0896-6273(01)80045-3; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Monuki ES, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn752; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Rasmussen JT, 2001, P NATL ACAD SCI USA, V98, P3861, DOI 10.1073/pnas.071586298; Redies C, 2001, BIOESSAYS, V23, P1100, DOI 10.1002/bies.10014; Reifers F, 1998, DEVELOPMENT, V125, P2381; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shinya M, 2001, DEVELOPMENT, V128, P4153; Sirotkin HI, 2000, DEVELOPMENT, V127, P2583; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; van de Water S, 2001, DEVELOPMENT, V128, P3877; Varga ZM, 1999, DEVELOPMENT, V126, P5533; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1	50	241	246	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					255	265		10.1016/S0896-6273(02)00751-1	http://dx.doi.org/10.1016/S0896-6273(02)00751-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160744	Bronze			2022-12-28	WOS:000177034200006
J	Togashi, H; Abe, K; Mizoguchi, A; Takaoka, K; Chisaka, O; Takeichi, M				Togashi, H; Abe, K; Mizoguchi, A; Takaoka, K; Chisaka, O; Takeichi, M			Cadherin regulates dendritic spine morphogenesis	NEURON			English	Article							LONG-TERM POTENTIATION; CELL-CELL ADHESION; ALPHA-CATENIN; N-CADHERIN; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; CYTOPLASMIC DOMAIN; JUNCTIONAL COMPLEX; BINDING-ACTIVITY; IN-VIVO	Synaptic remodeling has been postulated as a mechanism underlying synaptic plasticity, and cadherin adhesion molecules are thought to be a regulator of such a process. We examined the effects of cadherin blockage on synaptogenesis in cultured hippocampal neurons. This blockade resulted in alterations of dendritic spine morphology, such as filopodia-like elongation of the spine and bifurcation of its head structure, along with concomitant disruption of the distribution of postsynaptic proteins. The accumulation of synapsin at presynaptic sites and synaptic vesicle recycling were also perturbed, although these synaptic responses to the cadherin blockade became less evident upon the maturation of the synapses. These findings suggest that cadherin regulates dendritic spine morphogenesis and related synaptic functions, presumably cooperating with cadherin-independent adhesive mechanisms to maintain spine-axon contacts.	Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Fac Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; Kyoto University; RIKEN	Takeichi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.		Abe, Kentaro/A-6197-2008; Takeichi, Masatoshi/G-5903-2012; Abe, Kentaro/T-2247-2019	Takeichi, Masatoshi/0000-0002-9931-3378; Abe, Kentaro/0000-0002-3923-6323; Togashi, Hideru/0000-0002-3967-5940				Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Benson DL, 1998, J NEUROSCI, V18, P6892; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Bruses JL, 2000, CURR OPIN CELL BIOL, V12, P593, DOI 10.1016/S0955-0674(00)00137-X; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; Goslin K., 1998, CULTURING NERVE CELL, P339; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Honjo Y, 2000, GENES CELLS, V5, P309, DOI 10.1046/j.1365-2443.2000.00327.x; Horikawa K, 1999, DEV BIOL, V215, P182, DOI 10.1006/dbio.1999.9463; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; Huntley GW, 1999, J COMP NEUROL, V407, P453; Inoue T, 1998, DEV DYNAM, V211, P338, DOI 10.1002/(SICI)1097-0177(199804)211:4<338::AID-AJA5>3.3.CO;2-R; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Janssens B, 2001, J CELL SCI, V114, P3177; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pradhan D, 2001, J BIOL CHEM, V276, P4175, DOI 10.1074/jbc.M009259200; Rao A, 1998, J NEUROSCI, V18, P1217; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Roe S, 1998, CELL ADHES COMMUN, V5, P283, DOI 10.3109/15419069809040298; Rusakov DA, 1997, HIPPOCAMPUS, V7, P489, DOI 10.1002/(SICI)1098-1063(1997)7:5<489::AID-HIPO5>3.0.CO;2-C; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Scotti AL, 2001, P NATL ACAD SCI USA, V98, P3489, DOI 10.1073/pnas.061028798; SHIMOYAMA Y, 1992, CANCER RES, V52, P5770; Spacek J, 1998, J COMP NEUROL, V393, P58, DOI 10.1002/(SICI)1096-9861(19980330)393:1<58::AID-CNE6>3.0.CO;2-P; SPACEK J, 1985, ANAT EMBRYOL, V171, P235, DOI 10.1007/BF00341418; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	71	409	417	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					77	89		10.1016/S0896-6273(02)00748-1	http://dx.doi.org/10.1016/S0896-6273(02)00748-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123610	Bronze			2022-12-28	WOS:000176601800012
J	Blazquez, PM; Fujii, N; Kojima, J; Graybiel, AM				Blazquez, PM; Fujii, N; Kojima, J; Graybiel, AM			A network representation of response probability in the striaturn	NEURON			English	Article							TONICALLY ACTIVE NEURONS; NEOSTRIATAL CHOLINERGIC INTERNEURONS; REFLEX BLINK HYPEREXCITABILITY; POSITRON-EMISSION TOMOGRAPHY; BASAL GANGLIA; MONKEY STRIATUM; DOPAMINE NEURONS; DISCHARGING NEURONS; PARKINSONS-DISEASE; PRIMATES STRIATUM	The striatum of the basal ganglia is considered a key structure in the learning circuitry of the brain. To analyze neural signals that underlie striatal plasticity, we recorded from an identifiable class of striatal interneurons as macaque monkeys underwent training in a range of conditioning and non-associative learning paradigms, and recorded eyeblink electromyographs as the measure of behavioral response. We found that the responses of these striatal interneurons were modifiable under all training conditions and that their population responses were tightly correlated with the probability that a given stimulus would evoke a behavioral response. Such a network signal, proportional to current response probability, could be crucial to the learning and decision functions of the basal ganglia.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA; Sayama Neurol Hosp, Sayama, Saitama 3501302, Japan	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Washington University (WUSTL)	Graybiel, AM (corresponding author), MIT, Dept Brain & Cognit Sci, 45 Carleton St,E25-618, Cambridge, MA 02139 USA.	graybiel@mit.edu		Graybiel, Ann/0000-0002-4326-7720; Sanchez Blazquez, Pilar/0000-0002-7211-4504	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025529] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS25529] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKINS PT, 1990, NATURE, V344, P240, DOI 10.1038/344240a0; Alcantara AA, 2001, J COMP NEUROL, V434, P445, DOI 10.1002/cne.1186; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; Aosaki T, 1996, J NEUROSCI, V16, P5141; AOSAKI T, 1994, J NEUROSCI, V14, P3969; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Apicella P, 1996, NEUROSCI LETT, V203, P147, DOI 10.1016/0304-3940(96)12328-4; Apicella P, 1997, EXP BRAIN RES, V116, P456, DOI 10.1007/PL00005773; Basso MA, 1996, J NEUROSCI, V16, P7318; Basso MA, 1996, J NEUROSCI, V16, P7308, DOI 10.1523/jneurosci.16-22-07308.1996; BASSO MA, 1993, EXP BRAIN RES, V94, P88; Bennett BD, 1998, J NEUROSCI, V18, P8539; Bennett BD, 1999, J NEUROSCI, V19, P5586; Blaxton TA, 1996, J NEUROSCI, V16, P4032; BLUMENTHAL TD, 1991, PSYCHOPHYSIOLOGY, V28, P296, DOI 10.1111/j.1469-8986.1991.tb02198.x; BOLAM JP, 1986, BRAIN RES, V397, P279, DOI 10.1016/0006-8993(86)90629-3; Calabresi P, 2000, PROG NEUROBIOL, V61, P231, DOI 10.1016/S0301-0082(99)00030-1; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; CHANG HT, 1992, BRAIN RES, V574, P307, DOI 10.1016/0006-8993(92)90830-3; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; CRUTCHER MD, 1984, EXP BRAIN RES, V53, P233, DOI 10.1007/BF00238153; Denny-Brown D, 1976, Res Publ Assoc Res Nerv Ment Dis, V55, P115; DICHIARA G, 1994, TRENDS NEUROSCI, V17, P228, DOI 10.1016/0166-2236(94)90005-1; Djurfeldt M, 1999, NEUROCOMPUTING, V26-7, P997, DOI 10.1016/S0925-2312(99)00096-X; EVINGER C, 1993, EXP BRAIN RES, V92, P507; FLAHERTY AW, 1994, J NEUROSCI, V14, P599; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Graybiel A. M., 1995, MODELS INFORMATION P, P103; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Graybiel AM, 1997, SCHIZOPHRENIA BULL, V23, P459, DOI 10.1093/schbul/23.3.459; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Grunewald A, 1999, J NEUROPHYSIOL, V82, P330, DOI 10.1152/jn.1999.82.1.330; Hikosaka O, 1998, NEUROBIOL LEARN MEM, V70, P137, DOI 10.1006/nlme.1998.3844; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; HOWE AR, 1995, J NEUROSCI, V15, P458; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; LAPPER SR, 1992, NEUROSCIENCE, V51, P533, DOI 10.1016/0306-4522(92)90293-B; LOGAN CG, 1995, P NATL ACAD SCI USA, V92, P7500, DOI 10.1073/pnas.92.16.7500; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Parthasarathy HB, 1997, J NEUROSCI, V17, P2477; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Ravel S, 1999, EXP BRAIN RES, V128, P531, DOI 10.1007/s002210050876; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; RICHARDSON RT, 1985, BRAIN RES, V332, P219, DOI 10.1016/0006-8993(85)90591-8; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; ROLLS ET, 1983, BEHAV BRAIN RES, V7, P179, DOI 10.1016/0166-4328(83)90191-2; Sardo P, 2000, EUR J NEUROSCI, V12, P1801, DOI 10.1046/j.1460-9568.2000.00068.x; Schall JD, 1998, CURR OPIN NEUROBIOL, V8, P211, DOI 10.1016/S0959-4388(98)80142-6; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schneider J. S., 1987, BASAL GANGLIA BEHAVI, P103; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Shidara M, 1998, J NEUROSCI, V18, P2613; Shimo Y, 2001, J NEUROSCI, V21, P7804, DOI 10.1523/JNEUROSCI.21-19-07804.2001; STEINMETZ JE, 1991, EMOTION AFFECTION, P97; Thomas TM, 2000, SYNAPSE, V37, P252, DOI 10.1002/1098-2396(20000915)37:4<252::AID-SYN2>3.0.CO;2-A; Thompson RF, 1996, P NATL ACAD SCI USA, V93, P13438, DOI 10.1073/pnas.93.24.13438; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WHITE IM, 1994, EXP BRAIN RES, V99, P179; WILSON CJ, 1990, J NEUROSCI, V10, P508	71	93	94	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 14	2002	33	6					973	982		10.1016/S0896-6273(02)00627-X	http://dx.doi.org/10.1016/S0896-6273(02)00627-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906702	Bronze			2022-12-28	WOS:000174389600013
J	Hamann, M; Rossi, DJ; Attwell, D				Hamann, M; Rossi, DJ; Attwell, D			Tonic and spillover inhibition of granule cells control information flow through cerebellar cortex	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; SUBUNIT MESSENGER-RNAS; GABA(A) RECEPTORS; A RECEPTOR; RAT CEREBELLUM; NEUROSTEROID MODULATION; ALPHA-6 SUBUNIT; NMDA RECEPTORS; OLFACTORY-BULB; CURRENTS	We show that information flow through the adult cerebellar cortex, from the mossy fiber input to the Purkinje cell output, is controlled by furosemide-sensitive, diazepam- and neurosteroid-insensitive GABA(A) receptors on granule cells, which are activated both tonically and by GABA spillover from synaptic release sites. Tonic activation of these receptors contributes a 3-fold larger mean inhibitory conductance than GABA released synaptically by high-frequency stimulation. Tonic and spillover inhibition reduce the fraction of granule cells activated by mossy fiber input, generating an increase of coding sparseness, which is predicted to improve the information storage capacity of the cerebellum.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Attwell, D (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	d.attwell@ucl.ac.uk	Attwell, David/ABE-6750-2020; Hamann, Martine/P-8054-2014	Hamann, Martine/0000-0002-9142-6773				ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Fancsik A, 2000, J NEUROSCI, V20, P3067, DOI 10.1523/JNEUROSCI.20-09-03067.2000; GABBIANI F, 1994, J NEUROPHYSIOL, V72, P999, DOI 10.1152/jn.1994.72.2.999; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jechlinger M, 1998, J NEUROSCI, V18, P2449; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; KORPI ER, 1995, MOL PHARMACOL, V47, P283; Korpi ER, 1997, BRIT J PHARMACOL, V120, P741, DOI 10.1038/sj.bjp.0700922; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Nusser Z, 1999, EUR J NEUROSCI, V11, P1685, DOI 10.1046/j.1460-9568.1999.00581.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; OTIS TS, 1992, NEUROSCIENCE, V49, P13, DOI 10.1016/0306-4522(92)90073-B; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; QUIRK K, 1994, J BIOL CHEM, V269, P16020; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; ROSSI DJ, 1993, NEUROPHARMACOLOGY, V32, P1239, DOI 10.1016/0028-3908(93)90018-X; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Saxena NC, 1996, MOL PHARMACOL, V49, P567; Sigel E, 2000, J NEUROCHEM, V74, P2590, DOI 10.1046/j.1471-4159.2000.0742590.x; Thompson SA, 1999, MOL PHARMACOL, V55, P993, DOI 10.1124/mol.55.6.993; Tia S, 1996, J NEUROSCI, V16, P3630; Tia S, 1996, NEUROPHARMACOLOGY, V35, P1375, DOI 10.1016/S0028-3908(96)00018-4; TYRRELL T, 1992, PHILOS T ROY SOC B, V336, P239, DOI 10.1098/rstb.1992.0059; Uusi-Oukari M, 2000, MOL CELL NEUROSCI, V16, P34, DOI 10.1006/mcne.2000.0856; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Wisden W, 1996, NEUROPHARMACOLOGY, V35, P1139, DOI 10.1016/S0028-3908(96)00076-7; WOHLFARTH KM, 2002, IN PRESS J NEUROSCI; Zhu WJ, 1996, J NEUROSCI, V16, P6648; Zhu WJ, 1997, J NEUROSCI, V17, P4022	38	275	281	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					625	633		10.1016/S0896-6273(02)00593-7	http://dx.doi.org/10.1016/S0896-6273(02)00593-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856535	Bronze			2022-12-28	WOS:000173911100014
J	Chen, XC; Tomchick, DR; Kovrigin, E; Arac, D; Machius, M; Sudhof, TC; Rizo, J				Chen, XC; Tomchick, DR; Kovrigin, E; Arac, D; Machius, M; Sudhof, TC; Rizo, J			Three-dimensional structure of the complexin/SNARE complex	NEURON			English	Article							N-TERMINAL DOMAIN; MEMBRANE-FUSION; SNARE COMPLEX; HYDROGEN-EXCHANGE; PROTEIN; EXOCYTOSIS; CRYSTALLOGRAPHY; SYNTAXIN; PROGRAM; PATHWAY	During neurotransmitter release, the neuronal SNARE proteins synaptobrevin/VAMP, syntaxin, and SNAP-25 form a four-helix bundle, the SNARE complex, that pulls the synaptic vesicle and plasma membranes together possibly causing membrane fusion. Complexin binds tightly to the SNARE complex and is essential for efficient Ca2+-evoked neurotransmitter release. A combined X-ray and TROSY-based NMR study now reveals the atomic structure of the complexin/SNARE complex. Complexin binds in an antiparallel alpha-helical conformation to the groove between the synaptobrevin and syntaxin helices. This interaction stabilizes the interface between these two helices, which bears the repulsive forces between the apposed membranes. These results suggest that complexin stabilizes the fully assembled SNARE complex as a key step that enables the exquisitely high speed of Ca2+-evoked neurotransmitter release.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Rizo, J (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Tomchick, Diana/HGV-2018-2022	Tomchick, Diana/0000-0002-7529-4643	NINDS NIH HHS [NS37200] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037200] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CCP4, 1994, ACTA CRYSTALLOGR D, V50, P70; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Eastwood SL, 2000, MOL PSYCHIATR, V5, P425, DOI 10.1038/sj.mp.4000741; Englander SW, 2001, METHOD ENZYMOL, V334, P342; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; FASSHAUER D, 1999, INT M TRANSP PROT ME; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM KS, 1993, BIOCHEMISTRY-US, V32, P9600, DOI 10.1021/bi00088a012; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Misura KMS, 2001, J BIOL CHEM, V276, P41301, DOI 10.1074/jbc.M106853200; Morton AJ, 2001, J NEUROCHEM, V76, P166, DOI 10.1046/j.1471-4159.2001.00059.x; Naday I, 1998, OPT ENG, V37, P1235, DOI 10.1117/1.601789; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yang DW, 1999, J AM CHEM SOC, V121, P2571, DOI 10.1021/ja984056t; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	49	312	327	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					397	409		10.1016/S0896-6273(02)00583-4	http://dx.doi.org/10.1016/S0896-6273(02)00583-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832227	Green Published, Bronze			2022-12-28	WOS:000173643200010
J	Barg, S; Olofsson, CS; Schriever-Abeln, J; Wendt, A; Gebre-Medhin, S; Renstrom, E; Rorsman, P				Barg, S; Olofsson, CS; Schriever-Abeln, J; Wendt, A; Gebre-Medhin, S; Renstrom, E; Rorsman, P			Delay between fusion pore opening and peptide release from large dense-core vesicles in neuroendocrine cells	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; INSULIN SECRETORY GRANULE; ADRENAL CHROMAFFIN CELLS; PANCREATIC B-CELLS; EXOCYTOTIC EVENT; CALCIUM; DOCKING; CA2+; ESTABLISHMENT; MICROSCOPY	Peptidergic neurotransmission is slow compared to that mediated by classical neurotransmitters. We have studied exocytotic membrane fusion and cargo release by simultaneous capacitance measurements and confocal imaging of single secretory vesicles in neuroendocrine cells. Depletion of the readily releasable pool (RRP) correlated with exocytosis of 10%-20% of the docked vesicles. Some remaining vesicles became releasable after recovery of RRP. Expansion of the fusion pore, seen as an increase in luminal pH, occurred after similar to0.3 s, and peptide release was delayed by another 1-10 s. We conclude that (1) RRP refilling involves chemical modification of vesicles already in place, (2) the release of large neuropeptides via the fusion pore is negligible and only proceeds after complete fusion, and (3) sluggish peptidergic transmission reflects the time course of vesicle emptying.	Lund Univ, Biomed Ctr F11, Inst Physiol Sci, Dept Cellular & Mol Physiol, SE-22184 Lund, Sweden	Lund University	Barg, S (corresponding author), Lund Univ, Biomed Ctr F11, Inst Physiol Sci, Dept Cellular & Mol Physiol, SE-22184 Lund, Sweden.		Tuluc, Petronel/C-2527-2011; Barg, Sebastian/F-9523-2010; Rorsman, Patrik/A-4331-2016	Barg, Sebastian/0000-0003-4661-5724; Rorsman, Patrik/0000-0001-7578-0767; Vikman, Jenny/0000-0001-5082-8867; Olofsson, Charlotta/0000-0001-8824-3151; Wendt, Anna/0000-0001-8807-5979				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; Angleson JK, 1999, NAT NEUROSCI, V2, P440, DOI 10.1038/8107; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Augustine GJ, 1996, ANNU REV PHARMACOL, V36, P659, DOI 10.1146/annurev.pa.36.040196.003303; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Calakos N, 1996, PHYSIOL REV, V76, P1; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Eliasson L, 1997, J PHYSIOL-LONDON, V503, P399, DOI 10.1111/j.1469-7793.1997.399bh.x; FERNANDEZCHACON R, 1995, FEBS LETT, V363, P221, DOI 10.1016/0014-5793(95)00319-5; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; Han WP, 1999, J NEUROSCI, V19, P900; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; KATZ B, 1966, NERVE MUSCLE SYNAPSE, P139; Lang JC, 1997, EMBO J, V16, P5837, DOI 10.1093/emboj/16.19.5837; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; LEVITAN IB, 1991, NEURON CELL MOL BIOL, P167; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lollike K, 1998, BIOPHYS J, V75, P53, DOI 10.1016/S0006-3495(98)77494-6; LUKINIUS A, 1989, DIABETOLOGIA, V32, P240, DOI 10.1007/BF00285291; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ninomiya Y, 1997, EMBO J, V16, P929, DOI 10.1093/emboj/16.5.929; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Oheim M, 1999, EUR BIOPHYS J BIOPHY, V28, P91, DOI 10.1007/s002490050188; Ohnuma K, 2001, J PHYSIOL-LONDON, V535, P647, DOI 10.1111/j.1469-7793.2001.00647.x; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Pouli AE, 1998, BIOCHEM J, V333, P193, DOI 10.1042/bj3330193; SALAMA G, 1980, J GEN PHYSIOL, V75, P109, DOI 10.1085/jgp.75.2.109; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; SCHELLER RH, 1962, INTRO MOL NEUROBIOLO, P119; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Wasmeier C, 1996, J BIOL CHEM, V271, P18161, DOI 10.1074/jbc.271.30.18161; Williams RM, 2000, J CELL SCI, V113, P3839; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	51	155	159	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					287	299		10.1016/S0896-6273(02)00563-9	http://dx.doi.org/10.1016/S0896-6273(02)00563-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804575	Bronze			2022-12-28	WOS:000173387700015
J	McAllister, AK				McAllister, AK			Conserved cues for axon and dendrite growth in the developing cortex	NEURON			English	Editorial Material							SLIT PROTEINS; REPELLENT; GUIDANCE	The cellular and molecular mechanisms that guide axonal and dendritic differentiation in the cerebral cortex are just beginning to be defined. Many of the molecular signals that guide axons also, and sometimes simultaneously, influence dendritic growth. Whitford et al. (2002 [this issue of Neuron]) demonstrate that in addition to their roles in axon guidance and cell migration cue, Slit proteins can also regulate dendritic growth.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95616 USA.			McAllister, A. Kimberley/0000-0001-9177-9889				Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; McAllister AK, 2001, CELL MOL LIFE SCI, V58, P1054, DOI 10.1007/PL00000920; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9	14	20	23	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					2	4		10.1016/S0896-6273(01)00577-3	http://dx.doi.org/10.1016/S0896-6273(01)00577-3			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779471	Bronze			2022-12-28	WOS:000173106200002
J	Rosenbluth, D; Allman, JM				Rosenbluth, D; Allman, JM			The effect of gaze angle and fixation distance on the responses of neurons in V1, V2, and V4	NEURON			English	Article							PRIMARY VISUAL-CORTEX; EYE POSITION; MONKEY; PROJECTIONS; MACAQUE; CONNECTIONS; MODULATION; MEMORY; FIELDS; AREAS	What we see depends on where we look. This paper characterizes the modulatory effects of point of regard in three-dimensional space on responsiveness of visual cortical neurons in areas V1, V2, and V4. Such modulatory effects are both common, affecting 85% of cells, and strong, frequently producing changes of mean firing rate by a factor of 10. The prevalence of neurons in area V4 showing a preference for near distances may be indicative of the involvement of this area in close scrutiny during object recognition. We propose that eye-position signals can be exploited by visual cortex as classical conditioning stimuli, enabling the perceptual learning of systematic relationships between point of regard and the structure of the visual environment.	Telcordia Technol, Adv Network Syst Res Lab, Morristown, NJ 07960 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Ericsson; Telcordia Technologies; California Institute of Technology	Rosenbluth, D (corresponding author), Telcordia Technol, Adv Network Syst Res Lab, 445 South St,Room 1A-732-B, Morristown, NJ 07960 USA.				NATIONAL EYE INSTITUTE [R01EY011759] Funding Source: NIH RePORTER; NEI NIH HHS [EY11759] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Allman J. M., 1998, EVOLVING BRAINS; Altmann S.A., 1998, FORAGING SURVIVAL, DOI University of Chicago Press; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; ANDERSEN RA, 1988, CAN J PHYSIOL PHARM, V66, P488, DOI 10.1139/y88-078; Andersen Richard A., 1995, P519; BUISSERET P, 1977, EXP BRAIN RES, V28, P421; Bullier J, 1996, BEHAV BRAIN RES, V76, P89, DOI 10.1016/0166-4328(95)00182-4; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; EVARTS EV, 1976, J NEUROPHYSIOL, V39, P1069, DOI 10.1152/jn.1976.39.5.1069; Gamlin PDR, 1996, EYE, V10, P167, DOI 10.1038/eye.1996.42; GROSS C, 1973, HDV SENSORY PHYSL, V7; Hering E., 1942, SPATIAL SENSE MOVEME; Hinkle DA, 2001, NEUROREPORT, V12, P365, DOI 10.1097/00001756-200102120-00036; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; HUMPHREY N, 1969, Q J EXP PSYCHOL, V2, P225; JAMPEL RS, 1960, J COMP NEUROL, V115, P371, DOI 10.1002/cne.901150306; Kohler I, 1964, FORMATION TRANSFORMA; LAL R, 1990, J NEUROPHYSIOL, V63, P502, DOI 10.1152/jn.1990.63.3.502; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; LeDoux J. E., 1996, EMOTIONAL BRAIN; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MILNER AD, 1996, VISUAL BRAIN ACTION; MORRISON J, 1998, HDB CHEM NEUROANAT 2, V14; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; Sejnowski TJ, 1999, NEURON, V24, P773, DOI 10.1016/S0896-6273(00)81025-9; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; TROTTER Y, 1992, SCIENCE, V257, P1279, DOI 10.1126/science.1519066; UNGERLEIDER LG, 1977, EXP BRAIN RES, V27, P251; WEYAND TG, 1993, J NEUROPHYSIOL, V69, P2258, DOI 10.1152/jn.1993.69.6.2258; ZEIGLER HP, 1957, AM J PSYCHOL, V70, P106, DOI 10.2307/1419238	36	73	74	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					143	149		10.1016/S0896-6273(01)00559-1	http://dx.doi.org/10.1016/S0896-6273(01)00559-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779487	Bronze			2022-12-28	WOS:000173106200017
J	Claridge-Chang, A; Wijnen, H; Naef, F; Boothroyd, C; Rajewsky, N; Young, MW				Claridge-Chang, A; Wijnen, H; Naef, F; Boothroyd, C; Rajewsky, N; Young, MW			Circadian regulation of gene expression systems in the Drosophila head	NEURON			English	Article							MESSENGER-RNA; BEHAVIORAL RHYTHMS; MUTANT DROSOPHILA; CLOCK GENE; MEDIATED ENDOCYTOSIS; ECTOPIC EXPRESSION; MOLECULAR ANALYSIS; NEUROPEPTIDE GENE; PROTEIN; PERIOD	Mechanisms composing Drosophila's clock are conserved within the animal kingdom. To learn how such clocks influence behavioral and physiological rhythms, we determined the complement of circadian transcripts in adult Drosophila heads. High-density oligonucleotide arrays were used to collect data in the form of three 12-point time course experiments spanning a total of 6 days. Analyses of 24 hr Fourier components of the expression patterns revealed significant oscillations for similar to 400 transcripts. Based on secondary filters and experimental verifications, a subset of 158 genes showed particularly robust cycling and many oscillatory phases. Circadian expression was associated with genes involved in diverse biological processes, including learning and memory/synapse function, vision, olfaction, locomotion, detoxification, and areas of metabolism. Data collected from three different clock mutants (per(o), tim(o1), and Clk(Jrk)), are consistent with both known and novel regulatory mechanisms controlling circadian transcription.	Rockefeller Univ, Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Phys Math Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Theoret Condensed Matter Phys, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, 1230 York Ave, New York, NY 10021 USA.	young@mail.rookefeller.edu	Wijnen, Herman/B-8860-2013; Wijnen, Herman/N-8391-2019; Naef, Felix/C-9527-2011; , 机智的马小跳和机智的羊不愁/ABC-5169-2020	Wijnen, Herman/0000-0002-8710-5176; Wijnen, Herman/0000-0002-8710-5176; Rajewsky, Nikolaus/0000-0002-4785-4332; Naef, Felix/0000-0001-9786-3037; Claridge-Chang, Adam/0000-0002-4583-3650	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054339, R37GM054339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH063579] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54339] Funding Source: Medline; NIMH NIH HHS [MH63579, F32 MH063579-01, F32 MH063579] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Andretic R, 2000, P NATL ACAD SCI USA, V97, P1873, DOI 10.1073/pnas.97.4.1873; Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; BECKER MN, 1995, J NEUROSCI, V15, P6250; Benveniste RJ, 1998, DEVELOPMENT, V125, P4757; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Brunel CA, 1998, DEV GENES EVOL, V208, P327, DOI 10.1007/s004270050188; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; CHEN DM, 1992, VISUAL NEUROSCI, V9, P125, DOI 10.1017/S0952523800009585; Chen X, 2000, GENETICS, V156, P1829; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; Ehlen JC, 2001, J NEUROSCI, V21, P5351, DOI 10.1523/JNEUROSCI.21-14-05351.2001; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Gutteridge JMC, 2000, ANN NY ACAD SCI, V899, P136, DOI 10.1111/j.1749-6632.2000.tb06182.x; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hartman SJ, 2001, MOL VIS, V7, P95; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Horikawa K, 2000, J NEUROSCI, V20, P5867, DOI 10.1523/JNEUROSCI.20-15-05867.2000; Hovemann BT, 1998, GENE, V221, P1, DOI 10.1016/S0378-1119(98)00440-5; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; INOUE S, 1995, BEHAV BRAIN RES, V69, P91, DOI 10.1016/0166-4328(95)00014-K; Isaac RE, 2000, BIOCHEM SOC T, V28, P460, DOI 10.1042/0300-5127:0280460; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kandel E., 2000, PRINCIPLES NEURAL SC; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Lynch G, 1998, NEUROBIOL LEARN MEM, V70, P82, DOI 10.1006/nlme.1998.3840; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; NEWBY LM, 1991, J NEUROGENET, V7, P85, DOI 10.3109/01677069109066213; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Park JH, 1998, J BIOL RHYTHM, V13, P219, DOI 10.1177/074873098129000066; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Ripperger JA, 2001, CURR OPIN CELL BIOL, V13, P357, DOI 10.1016/S0955-0674(00)00220-9; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Salinas AE, 1999, CURR MED CHEM, V6, P279; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schibler U, 2001, SCIENCE, V293, P437, DOI 10.1126/science.1063296; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Stryer L., 1988, BIOCHEMISTRY-US; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; Truman James W., 1993, P1245; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Voet D VJ, 1990, BIOCHEMISTRY; Walter MF, 1996, ARCH INSECT BIOCHEM, V31, P219, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;219::AID-ARCH9&gt;3.0.CO;2-U; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yin D, 2000, MED HYPOTHESES, V54, P519, DOI 10.1054/mehy.1999.0889; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4	85	365	375	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					657	671		10.1016/S0896-6273(01)00515-3	http://dx.doi.org/10.1016/S0896-6273(01)00515-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719206	Bronze			2022-12-28	WOS:000172363900012
J	Cheng, HJ; Bagri, A; Yaron, A; Stein, E; Pleasure, SJ; Tessier-Lavigne, M				Cheng, HJ; Bagri, A; Yaron, A; Stein, E; Pleasure, SJ; Tessier-Lavigne, M			Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections	NEURON			English	Article							PERIPHERAL-NERVE PROJECTION; CAJAL-RETZIUS CELLS; GUIDANCE; NEUROPILIN-2; RECEPTORS; MICE; CONNECTIONS; RESPONSES; GROWTH; TRANSMEMBRANE	Plexins are receptors implicated in mediating signaling by semaphorins, a family of axonal chemorepellents. The role of specific plexins in mediating semaphorin function in vivo has not, however, yet been examined in vertebrates. Here, we show that plexin-A3 is the most ubiquitously expressed plexin family member within regions of the developing mammalian nervous system known to contain semaphorin-responsive neurons. Using a chimeric receptor construct, we provide evidence that plexin-A3 can transduce a repulsive signal in growth cones in vitro. Analysis of plexin-A3 knockout mice shows that plexin-A3 contributes to Sema3F and Sema3A signaling and that plexin-A3 regulates the development of hippocampal axonal projections in vivo.	Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, Neurodev Disorders Lab, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA.		Cheng, Hwai-Jong/AAY-5067-2021; Stein, Elke/E-8107-2013	Cheng, Hwai-Jong/0000-0003-0647-0567; Stein, Elke/0000-0001-8965-5692	NINDS NIH HHS [5 K08 NS02208] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS002208] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barallobre MJ, 2000, DEVELOPMENT, V127, P4797; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Borrell V, 1999, EXP NEUROL, V156, P268, DOI 10.1006/exnr.1999.7022; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; SCHWEGLER H, 1990, NEUROSCIENCE, V34, P293, DOI 10.1016/0306-4522(90)90139-U; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; White FA, 2000, DEV BIOL, V225, P79, DOI 10.1006/dbio.2000.9822; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; ZIMMER J, 1978, J COMP NEUROL, V179, P581, DOI 10.1002/cne.901790309	32	168	173	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					249	263		10.1016/S0896-6273(01)00478-0	http://dx.doi.org/10.1016/S0896-6273(01)00478-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683995	Bronze			2022-12-28	WOS:000171893700010
J	Quirk, JC; Reinhart, PH				Quirk, JC; Reinhart, PH			Identification of a novel tetramerization domain in large conductance K-Ca channels	NEURON			English	Article							ACTIVATED POTASSIUM CHANNELS; BETA-SUBUNIT; CALCIUM SENSITIVITY; TERMINAL DOMAIN; ION CHANNELS; RAT-BRAIN; VOLTAGE; PROTEINS; SHAKER; STOICHIOMETRY	More than 50 genes are known to encode K+ channel monomers and can coassemble to form hetero-tetrameric K+ channels. However, only a subset of possible monomer combinations come together to form functional ion channels. The assembly and tetramerization of appropriate channel monomers is mediated by association domains (ADs). To identify such domains in human large-conductance Ca2(+)-activated K+ channels (hSlo1), we screened hSlo1 domains for self-association using yeast two-hybrid assays. Putative ADs were subjected to functional assays in Xenopus oocytes and further characterized by co precipitation, native gel electrophoresis, and sucrose density gradient centrifugation assays. This led to the identification of a single intracellular association domain localized near the channel pore and required for channel function. We conclude that this novel tetramerization domain, referred to as BK-T1, promotes the assembly of hSlo1 monomers into functional Kc channels.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Reinhart, PH (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, POB 3209, Durham, NC 27710 USA.				NIMH NIH HHS [MH011753] Funding Source: Medline; NINDS NIH HHS [NS031253, NS041866] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031253, R01NS041866, R29NS031253] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott GW, 1997, BBA-PROTEIN STRUCT M, V1341, P71, DOI 10.1016/S0167-4838(97)00062-9; BIELEFELDT K, 1994, BIOPHYS J, V66, P1904, DOI 10.1016/S0006-3495(94)80984-1; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Bond CT, 1999, ANN NY ACAD SCI, V868, P370, DOI 10.1111/j.1749-6632.1999.tb11298.x; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P141; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; Favre I, 2000, BIOCHEMISTRY-US, V39, P2001, DOI 10.1021/bi992140v; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; GLOWATZKI E, 1995, P ROY SOC B-BIOL SCI, V261, P251, DOI 10.1098/rspb.1995.0145; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Kaczorowski GJ, 1999, CURR OPIN CHEM BIOL, V3, P448, DOI 10.1016/S1367-5931(99)80066-0; Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7; Knaus HG, 1996, J NEUROSCI, V16, P955; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Koster JC, 1998, BIOPHYS J, V74, P1821, DOI 10.1016/S0006-3495(98)77892-0; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Lim HH, 1999, GENE, V240, P35, DOI 10.1016/S0378-1119(99)00398-4; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MILEDI R, 1984, J PHYSIOL-LONDON, V357, P173, DOI 10.1113/jphysiol.1984.sp015495; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; North RA, 2000, TRENDS NEUROSCI, V23, P234, DOI 10.1016/S0166-2236(00)01592-7; Papazian DM, 1999, NEURON, V23, P7, DOI 10.1016/S0896-6273(00)80746-1; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; REINHART PH, 1995, J NEUROSCI, V15, P4572; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Roeper J, 1996, CURR OPIN NEUROBIOL, V6, P338, DOI 10.1016/S0959-4388(96)80117-6; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Sheng ZF, 1998, METHOD ENZYMOL, V293, P17; Sheng ZF, 1997, BIOCHEMISTRY-US, V36, P15501; Taylor PM, 1999, J NEUROSCI, V19, P6360; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wallner M, 1999, CURR TOP MEMBR, V46, P117; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Yang J, 1995, NEURON, V15, P1441, DOI 10.1016/0896-6273(95)90021-7; YU XM, 1991, NATURE, V352, P64, DOI 10.1038/352064a0; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Zagotta WN, 2001, NEURON, V29, P547, DOI 10.1016/S0896-6273(01)00227-6	61	57	60	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					13	23		10.1016/S0896-6273(01)00444-5	http://dx.doi.org/10.1016/S0896-6273(01)00444-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604135	Bronze			2022-12-28	WOS:000171525200005
J	Zamorano, PL; Garner, CC				Zamorano, PL; Garner, CC			Unwebbing the presynaptic web	NEURON			English	Editorial Material							NERVOUS-SYSTEM; RAT-BRAIN; COMPONENTS; SYNAPSE	The release of neurotransmitter from nerve terminals occurs at a specialized region of the presynaptic plasma membrane called the active zone. A dense matrix of proteins associated with the active zone, called the presynaptic web, is thought to play a fundamental role in defining these neurotransmitter release sites. In this issue of Neuron, Phillips et al. have identified conditions for the biochemical purification of the presynaptic web and show that the web is comprised of proteins involved in the docking, fusion, and recycling of synaptic vesicles.	Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Zamorano, PL (corresponding author), Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA.			Garner, Craig/0000-0003-1970-5417				COTMAN CW, 1974, J CELL BIOL, V63, P441, DOI 10.1083/jcb.63.2.441; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; ICHIMURA T, 1988, J NEUROCYTOL, V17, P3, DOI 10.1007/BF01735373; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Langnaese K, 1996, MOL BRAIN RES, V42, P118, DOI 10.1016/S0169-328X(96)00147-7; MATUS AI, 1978, PROC R SOC SER B-BIO, V203, P135, DOI 10.1098/rspb.1978.0097; Peters A., 1991, FINE STRUCTURE NERVO; Shapiro L, 1998, CURR OPIN NEUROBIOL, V8, P593, DOI 10.1016/S0959-4388(98)80086-X; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540	12	6	7	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					3	6		10.1016/S0896-6273(01)00458-5	http://dx.doi.org/10.1016/S0896-6273(01)00458-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604132	Bronze			2022-12-28	WOS:000171525200002
J	Kikyo, H; Ohki, K; Miyashita, Y				Kikyo, H; Ohki, K; Miyashita, Y			Neural correlates for feeling-of-knowing: An fMRl parametric analysis	NEURON			English	Article							PREFRONTAL CORTEX; EPISODIC RETRIEVAL; CUE-FAMILIARITY; ANTERIOR CINGULATE; RECOGNITION MEMORY; ACCURACY; RECALL; INFORMATION; METAMEMORY; JUDGMENTS	The "feeling-of-knowing" (FOK) is a subjective sense of knowing a word before recalling it, and the FOK provides us clues to understanding the mechanisms of human metamemory systems. We investigated neural correlates for the FOK based on the recall-judgment-recognition paradigm. Event-related functional magnetic resonance imaging with a parametric analysis was used. We found activations in left dorsolateral, left anterior, bilateral inferior, and medial prefrontal cortices that significantly increased as the FOK became greater, and the activations remained significant even when the potentially confounding factor of the response latency was removed. Furthermore, we demonstrated that the FOK region in the right inferior frontal gyrus and a subset of the FOK region in the left inferior frontal gyrus are not recruited for successful recall processes, suggesting their particular role in metamemory processing.	Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan; TOYOTA RIKEN, Nagakute, Aichi 4801192, Japan; Natl Inst Physiol Sci, Cognit Neurosci Lab, Aichi 4448585, Japan	University of Tokyo; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Miyashita, Yasushi/B-7171-2019	Miyashita, Yasushi/0000-0003-3496-8637				BLAKE M, 1973, J VERB LEARN VERB BE, V12, P311, DOI 10.1016/S0022-5371(73)80075-1; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; COHEN G, 1995, MEMORY REAL WORLD, P179; COSTERMANS J, 1992, J EXP PSYCHOL LEARN, V18, P142, DOI 10.1037/0278-7393.18.1.142; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; FRISTON KJ, 1997, HUMAN BRAIN FUNCTION, P141; GRUNEBERG MM, 1974, ACTA PSYCHOL, V38, P257, DOI 10.1016/0001-6918(74)90010-9; HART JT, 1965, J EDUC PSYCHOL, V56, P208, DOI 10.1037/h0022263; HART JT, 1967, J VERB LEARN VERB BE, V6, P685, DOI 10.1016/S0022-5371(67)80072-0; Henson RNA, 1999, J NEUROSCI, V19, P3962; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; Kikyo H, 2001, EUR J NEUROSCI, V14, P887, DOI 10.1046/j.0953-816x.2001.01711.x; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; KORIAT A, 1993, PSYCHOL REV, V100, P609, DOI 10.1037/0033-295X.100.4.609; Koriat A, 2001, J EXP PSYCHOL LEARN, V27, P34, DOI 10.1037//0278-7393.27.1.34; LACHMAN JL, 1979, DEV PSYCHOL, V15, P543, DOI 10.1037/0012-1649.15.5.543; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maril A, 2001, NEURON, V31, P653, DOI 10.1016/S0896-6273(01)00396-8; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503; METCALFE J, 1986, J EXP PSYCHOL LEARN, V12, P288, DOI 10.1037/0278-7393.12.2.288; METCALFE J, 1993, J EXP PSYCHOL LEARN, V19, P851, DOI 10.1037/0278-7393.19.4.851; METCALFE J, 1993, PSYCHOL REV, V100, P3, DOI 10.1037/0033-295X.100.1.3; METCALFE J, 2000, OXFORD HDB MEMORY; Miyashita Y, 2000, CURR OPIN NEUROBIOL, V10, P187, DOI 10.1016/S0959-4388(00)00071-4; MIYASHITA Y, 1999, NEW COGNITIVE NEUROS, P379; Nelson T. O., 1988, PRACTICAL ASPECTS ME, V1, P190; NELSON TO, 1984, J EXP PSYCHOL GEN, V113, P282, DOI 10.1037/0096-3445.113.2.282; NELSON TO, 1980, J VERB LEARN VERB BE, V19, P338, DOI 10.1016/S0022-5371(80)90266-2; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Nelson TO., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; REDER LM, 1987, COGNITIVE PSYCHOL, V19, P90, DOI 10.1016/0010-0285(87)90005-3; REDER LM, 1992, J EXP PSYCHOL LEARN, V18, P435, DOI 10.1037/0278-7393.18.3.435; Ricci PT, 1999, NEUROIMAGE, V9, P88, DOI 10.1006/nimg.1998.0386; SCHACTER DL, 1983, J EXP PSYCHOL LEARN, V9, P39, DOI 10.1037/0278-7393.9.1.39; SCHWARTZ BL, 1994, PSYCHON B REV, V1, P357, DOI 10.3758/BF03213977; SCHWARTZ BL, 1992, J EXP PSYCHOL LEARN, V18, P1074, DOI 10.1037/0278-7393.18.5.1074; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Talairach J., 1988, COPLANAR STEREOTAXIC; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	51	113	120	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					177	186		10.1016/S0896-6273(02)00939-X	http://dx.doi.org/10.1016/S0896-6273(02)00939-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	598UP	12367516	Bronze			2022-12-28	WOS:000178295100017
J	Gold, BT; Buckner, RL				Gold, BT; Buckner, RL			Common prefrontal regions coactivate with dissociable posterior regions during controlled semantic and phonological tasks	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; NONSPATIAL WORKING-MEMORY; INFERIOR FRONTAL-CORTEX; FUNCTIONAL MRI; HUMAN BRAIN; READING ALOUD; RETRIEVAL; WORD; ACTIVATION; PET	One of the most ubiquitous findings in functional neuroimaging research is activation of left inferior prefrontal cortex (LIPC) during tasks requiring controlled semantic retrieval. Here we show that LIPC participates in the controlled retrieval of nonsemantic representations as well as semantic representations. Results also demonstrate that LIPC coactivates with dissociable posterior regions depending on the information retrieved: activating with left temporal cortex during the controlled retrieval of semantics and with left posterior frontal and parietal cortex during the controlled retrieval of phonology. Correlation of performance to LIPC activation suggests a processing role associated with mapping relatively ambiguous stimulus-to-representation relationships during both semantic and phonological tasks. These findings suggest that LIPC participates in controlled processing across multiple information domains collaborating with dissociable posterior regions depending upon the kind of information retrieved.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Gold, BT (corresponding author), Washington Univ, Dept Psychol, 1 Brookings Dr, St Louis, MO 63130 USA.	bgold@artsci.wustl.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057506] Funding Source: NIH RePORTER; NIMH NIH HHS [MH57506] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; BARDE LHF, 2002, IN PRESS J COGN NEUR; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fiez JA, 1996, J NEUROSCI, V16, P808; FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Fletcher PC, 2000, NEUROIMAGE, V12, P404, DOI 10.1006/nimg.2000.0633; FRIEDMAN RB, 1992, BRAIN LANG, V43, P400, DOI 10.1016/0093-934X(92)90109-R; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; FRITH CD, 1991, NEUROPSYCHOLOGIA, V29, P1137, DOI 10.1016/0028-3932(91)90029-8; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; GLUSHKO RJ, 1979, J EXP PSYCHOL HUMAN, V5, P674, DOI 10.1037/0096-1523.5.4.674; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Hagoort P, 1999, J COGNITIVE NEUROSCI, V11, P383, DOI 10.1162/089892999563490; Herbster AN, 1997, HUM BRAIN MAPP, V5, P84, DOI 10.1002/(SICI)1097-0193(1997)5:2<84::AID-HBM2>3.0.CO;2-I; HOWARD D, 1992, BRAIN, V115, P1769, DOI 10.1093/brain/115.6.1769; Jonides J, 1998, J NEUROSCI, V18, P5026; Kapur S, 1996, COGNITIVE BRAIN RES, V4, P243, DOI 10.1016/S0926-6410(96)00058-4; Kucera H., 1967, COMPUTATIONAL ANAL P; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Milner B., 1964, FRONTAL GRANULAR COR, P313; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Owen AM, 1998, P NATL ACAD SCI USA, V95, P7721, DOI 10.1073/pnas.95.13.7721; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Petrides M, 1994, HDB NEUROPSYCHOLOGY, V9, P59; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Poldrack RA, 2001, J COGNITIVE NEUROSCI, V13, P687, DOI 10.1162/089892901750363235; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1999, J COGNITIVE NEUROSCI, V11, P371, DOI 10.1162/089892999563481; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Roskies AL, 2001, J COGNITIVE NEUROSCI, V13, P829, DOI 10.1162/08989290152541485; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	69	308	312	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					803	812		10.1016/S0896-6273(02)00800-0	http://dx.doi.org/10.1016/S0896-6273(02)00800-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194878	Bronze			2022-12-28	WOS:000177521000019
J	Barria, A; Malinow, R				Barria, A; Malinow, R			Subunit-specific NMDA receptor trafficking to synapses	NEURON			English	Article							D-ASPARTATE RECEPTOR; ER RETENTION SIGNAL; LONG-TERM DEPRESSION; NR1 SPLICE VARIANTS; AMPA RECEPTOR; VISUAL-CORTEX; THALAMOCORTICAL SYNAPSES; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; CRITICAL PERIOD	To elucidate mechanisms controlling the number and subunit composition of synaptic NMDA-Rs in hippocampal slice neurons, the NR1, NR2A, and NR2B subunits were optically and electrophysiologically tagged. The NR2 subunit directs delivery of receptors to synapses with different rules controlling NR2A and NR2B. Synaptic incorporation of NR2B-containing receptors is not limited by synaptic transmission nor enhanced by increased subunit expression. NR2A-containing receptors whose expression normally increases with age replace synaptic NR2B-containing receptors. Replacement is enhanced by increased NR2A expression and requires synaptic activity. Surprisingly, spontaneously released transmitter acting on synaptic NMDARs is sufficient for replacement and reduces NMDA-R responses. Thus, as with AMPA-Rs, synaptic trafficking of NMDA-Rs is tightly regulated and has subunit-specific rules with functionally important consequences.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Malinow, R (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.							Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Calver AR, 2001, J NEUROSCI, V21, P1203; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dingledine R, 1999, PHARMACOL REV, V51, P7; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Flint AC, 1997, J NEUROSCI, V17, P2469; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1992, NATURE, V358, P673, DOI 10.1038/358673a0; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Pagano A, 2001, J NEUROSCI, V21, P1189; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; PICCINI A, 2002, IN PRESS J NEUROSCI; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Single FN, 2000, J NEUROSCI, V20, P2558; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	54	397	411	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					345	353		10.1016/S0896-6273(02)00776-6	http://dx.doi.org/10.1016/S0896-6273(02)00776-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160751	Bronze			2022-12-28	WOS:000177034200013
J	Akaaboune, M; Grady, RM; Turney, S; Sanes, JR; Lichtman, JW				Akaaboune, M; Grady, RM; Turney, S; Sanes, JR; Lichtman, JW			Neurotransmitter receptor dynamics studied in vivo by reversible photo-unbinding of fluorescent ligands	NEURON			English	Article							EXTRAJUNCTIONAL ACETYLCHOLINE-RECEPTORS; DYSTROPHIN-GLYCOPROTEIN COMPLEX; DUCHENNE MUSCULAR-DYSTROPHY; UTROPHIN-DEFICIENT MICE; NEUROMUSCULAR-JUNCTIONS; SKELETAL-MUSCLE; INVIVO VISUALIZATION; CILIARY GANGLION; RAPSYN; SYNAPSE	We show that fluorescently tagged ligands with high affinity for their targets can be reversibly unbound by focused laser excitation. By sequential unbinding and relabeling with different colors of alpha-bungarotoxin, we selectively labeled adjacent pools of acetylcholine receptors [AChRs) at neuromuscular junctions of adult mice. Timelapse imaging in vivo revealed that synaptic AChRs completely intermingle over similar to4 days and many extrasynaptic AChRs are incorporated into the synapse each day. In mice that lacked alpha-dystrobrevin, a component of the dystrophin-glycoprotein complex, rates of AChR turnover, and intermingling were increased similar to4- to 5-fold. These results demonstrate remarkable molecular dynamism underlying macroscopic stability of the postsynaptic membrane, and establish alpha-dystrobrevin as a key control point for regulation of mobility and turnover.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.							Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; [Anonymous], 1991, MODERN MOL PHOTOCHEM; APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; AXELROD D, 1978, BIOCHIM BIOPHYS ACTA, V511, P23, DOI 10.1016/0005-2736(78)90062-7; Balasubramanian S, 1998, FEBS LETT, V432, P133, DOI 10.1016/S0014-5793(98)00804-7; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; Bartoli M, 2001, J BIOL CHEM, V276, P24911, DOI 10.1074/jbc.M103258200; BETZ H, 1982, J BIOL CHEM, V257, P1390; BEWICK GS, 1994, P ROY SOC B-BIOL SCI, V258, P201, DOI 10.1098/rspb.1994.0163; BRENNER HR, 1976, J PHYSIOL-LONDON, V260, P159, DOI 10.1113/jphysiol.1976.sp011509; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Cartaud A, 1998, J BIOL CHEM, V273, P11321, DOI 10.1074/jbc.273.18.11321; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; ENGEL AG, 1982, CIBA F SYMP, V90, P197; Enigk RE, 2001, FRONT BIOSCI, V6, pD53, DOI 10.2741/enigk; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; GARDNER JM, 1979, CELL, V16, P661, DOI 10.1016/0092-8674(79)90039-4; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871; GREEN DPL, 1975, PHILOS T R SOC B, V270, P551, DOI 10.1098/rstb.1975.0031; JACOB MH, 1987, J CELL BIOL, V105, P1847, DOI 10.1083/jcb.105.4.1847; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; KUROMI H, 1985, DEV BIOL, V109, P165, DOI 10.1016/0012-1606(85)90357-4; Liang F, 2001, J NEUROCHEM, V77, P1626, DOI 10.1046/j.1471-4159.2001.00377.x; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; Mohamed AS, 2001, J NEUROSCI, V21, P3806, DOI 10.1523/JNEUROSCI.21-11-03806.2001; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; RICH M, 1989, NEURON, V3, P677, DOI 10.1016/0896-6273(89)90236-5; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; ROUSSELET A, 1982, EMBO J, V1, P439, DOI 10.1002/j.1460-2075.1982.tb01188.x; SALPETER MM, 1988, J CELL BIOL, V106, P2087, DOI 10.1083/jcb.106.6.2087; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SOLER G, 1983, ARCH BIOCHEM BIOPHYS, V225, P872, DOI 10.1016/0003-9861(83)90100-5; STOUT AL, 1995, PHOTOCHEM PHOTOBIOL, V62, P239, DOI 10.1111/j.1751-1097.1995.tb05264.x; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; STYA M, 1984, J NEUROSCI, V4, P70; STYA M, 1983, J CELL BIOL, V97, P48, DOI 10.1083/jcb.97.1.48; Turney SG, 1996, J NEUROSCI METH, V64, P199, DOI 10.1016/0165-0270(95)00135-2; VANMIER P, 1994, J NEUROSCI, V14, P5672; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230	53	85	87	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					865	876		10.1016/S0896-6273(02)00739-0	http://dx.doi.org/10.1016/S0896-6273(02)00739-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086635	Bronze			2022-12-28	WOS:000176249700005
J	MacColl, G; Bouloux, P; Quinton, R				MacColl, G; Bouloux, P; Quinton, R			Kallmann syndrome: Adhesion, afferents, and anosmia	NEURON			English	Review							HYPOGONADOTROPIC HYPOGONADISM; MIRROR MOVEMENTS; EPIDERMAL MORPHOGENESIS; C-ELEGANS; GENETICS; NEURONS; FORM	Three new studies into the function of human anosmin-1 and related proteins in C. elegans and rodents show that these influence axon branching and axon targeting. The rodent anosmin appears to work at two stages of development, initially promoting axon outgrowth from the olfactory bulb and then stimulating branching from axons into the olfactory cortex. CeKal-1 further influences morphogenesis, and, as the human and nematode anosmins are functionally conserved, these studies provide insights into the pathogenesis of Kallmann syndrome (KS).	UCL Royal Free & Univ Coll Med Sch, Dept Med, Neuroendocrine Unit, London NW3 2PF, England; Newcastle Univ, Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Newcastle Univ, Sch Clin Med Sci, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of London; University College London; UCL Medical School; Newcastle University - UK; Newcastle University - UK	MacColl, G (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Neuroendocrine Unit, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	gmaccoll@rfc.uci.ac.uk		MacColl, Gavin/0000-0001-5032-7018				Bulow HE, 2002, P NATL ACAD SCI USA, V99, P6346, DOI 10.1073/pnas.092128099; Chin-Sang ID, 2000, TRENDS GENET, V16, P544, DOI 10.1016/S0168-9525(00)02143-0; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Hardelin JP, 1999, DEV DYNAM, V215, P26, DOI 10.1002/(SICI)1097-0177(199905)215:1<26::AID-DVDY4>3.3.CO;2-4; Krams M, 1997, BRAIN, V120, P1217, DOI 10.1093/brain/120.7.1217; Krams M, 1999, NEUROLOGY, V52, P816, DOI 10.1212/WNL.52.4.816; MacColl G, 2002, TRENDS ENDOCRIN MET, V13, P112, DOI 10.1016/S1043-2760(01)00545-8; Mayston MJ, 1997, BRAIN, V120, P1199, DOI 10.1093/brain/120.7.1199; Oliveira LMB, 2001, J CLIN ENDOCR METAB, V86, P1532, DOI 10.1210/jc.86.4.1532; Pitteloud N, 2002, J CLIN ENDOCR METAB, V87, P152, DOI 10.1210/jc.87.1.152; Quinton R, 1996, J CLIN ENDOCR METAB, V81, P3010, DOI 10.1210/jc.81.8.3010; Quinton R, 1997, J CLIN ENDOCR METAB, V82, P309, DOI 10.1210/jc.82.1.309; Quinton R, 2001, CLIN ENDOCRINOL, V55, P163, DOI 10.1046/j.1365-2265.2001.01277.x; Robertson A, 2001, BIOCHEM J, V357, P647, DOI 10.1042/0264-6021:3570647; Rugarli EI, 2002, DEVELOPMENT, V129, P1283; Schwanzel-Fukuda M, 1999, MICROSC RES TECHNIQ, V44, P2, DOI 10.1002/(SICI)1097-0029(19990101)44:1<2::AID-JEMT2>3.0.CO;2-4; SCHWOB JE, 1993, ANN OTO RHINOL LARYN, V102, P117, DOI 10.1177/000348949310200208; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; Soussi-Yanicostas N, 1998, J CELL SCI, V111, P2953; SoussiYanicostas N, 1996, J CELL SCI, V109, P1749	20	46	53	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					675	678		10.1016/S0896-6273(02)00720-1	http://dx.doi.org/10.1016/S0896-6273(02)00720-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062015	Bronze			2022-12-28	WOS:000175951800004
J	Gilmour, DT; Maischein, HM; Nusslein-Volhard, C				Gilmour, DT; Maischein, HM; Nusslein-Volhard, C			Migration and function of a glial subtype in the vertebrate peripheral nervous system	NEURON			English	Article							NEURAL CREST DEVELOPMENT; HIRSCHSPRUNG-DISEASE; TRACT FORMATION; AXON GUIDANCE; MOUSE MODEL; DANIO-RERIO; ZEBRAFISH; SOX10; MUTATIONS; DROSOPHILA	Glia-axon interactions are essential for the development and function of the nervous system. We combine in vivo imaging and genetics to address the mechanism by which the migration of these cells is coordinated during embryonic development. Using stable transgenic lines, we have followed the migration of one subset of glial cells and their target axons in living zebrafish embryos. These cells coalesce at an early stage and remain coupled throughout migration, with axons apparently pathfinding for glia. Mutant analysis demonstrates that axons provide instructive cues that are sufficient to control glial guidance. Furthermore, mutations in the transcription factor Sox10/cls uncouple the migration of axons and glia. Finally, genetic ablation of this glial subtype reveals an essential role in nerve fasciculation.	Max Planck Inst Entwicklungsbiol, Genet Abt, D-72076 Tubingen, Germany	Max Planck Society	Gilmour, DT (corresponding author), Max Planck Inst Entwicklungsbiol, Genet Abt, Spemannstr 35, D-72076 Tubingen, Germany.			Gilmour, Darren/0000-0001-7613-090X				Auld V, 1999, CELL MOL LIFE SCI, V55, P1377, DOI 10.1007/s000180050378; BHATTACHARYYA A, 1994, DEVELOPMENT, V120, P1411; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; BRONNERFRASER M, 1993, BIOESSAYS, V15, P221, DOI 10.1002/bies.950150402; CARPENTER EM, 1992, DEV BIOL, V150, P144, DOI 10.1016/0012-1606(92)90014-8; Dutton KA, 2001, DEVELOPMENT, V128, P4113; GIANGRANDE A, 1994, DEVELOPMENT, V120, P523; GILMOUR DT, 2002, IN PRESS ZEBRAFISH P; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Hidalgo A, 2000, DEVELOPMENT, V127, P393; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, DEVELOPMENT, V127, P515; Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LEDOURAIN N, 1999, NEURAL CREST; MARCUS RC, 1995, J COMP NEUROL, V359, P365, DOI 10.1002/cne.903590302; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Noordermeer JN, 1998, NEURON, V21, P991, DOI 10.1016/S0896-6273(00)80618-2; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Shoji W, 1998, DEVELOPMENT, V125, P1275; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; STREISINGER G, 1986, GENETICS, V112, P311; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wulf P, 1999, J NEUROSCI RES, V57, P467, DOI 10.1002/(SICI)1097-4547(19990815)57:4<467::AID-JNR6>3.3.CO;2-V	31	230	231	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					577	588		10.1016/S0896-6273(02)00683-9	http://dx.doi.org/10.1016/S0896-6273(02)00683-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062041	Bronze			2022-12-28	WOS:000175665700011
J	Pelkey, KA; Askalan, R; Paul, S; Kalia, LV; Nguyen, TH; Pitcher, GM; Salter, MW; Lombroso, PJ				Pelkey, KA; Askalan, R; Paul, S; Kalia, LV; Nguyen, TH; Pitcher, GM; Salter, MW; Lombroso, PJ			Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation	NEURON			English	Article							D-ASPARTATE RECEPTOR; NMDA RECEPTOR; MOLECULAR CHARACTERIZATION; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; SPINAL-CORD; SRC FAMILY; 2B SUBUNIT; PHOSPHORYLATION; KINASE	The functional roles of protein tyrosine phosphatases (PTPs) in the developed CNS have been enigmatic. Here we show that striatal enriched tyrosine phosphatase (STEP) is a component of the N-methyl-D-aspartate receptor (NMDAR) complex. Functionally, exogenous STEP depressed NMDAR single-channel activity in excised membrane patches. STEP also depressed NMDAR-mediated synaptic currents whereas inhibiting endogenous STEP enhanced these currents. In hippocampal slices, administering STEP into CA1 neurons did not affect basal glutamatergic transmission evoked by Schaffer collateral stimulation but prevented tetanus-induced long-term potentiation (LTP). Conversely, inhibiting STEP in CA1 neurons enhanced transmission and occluded LTP induction through an NMDAR-, Src-, and Ca2+-dependent mechanism. Thus, STEP acts as a tonic brake on synaptic transmission by opposing Src-dependent upregulation of NMDARs.	Hosp Sick Children, Dept Physiol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada; Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Yale University	Salter, MW (corresponding author), Hosp Sick Children, Dept Physiol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.			Kalia, Lorraine/0000-0002-9384-1305				Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Arregui CO, 2000, NEUROCHEM RES, V25, P95, DOI 10.1023/A:1007595617447; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Boxall AR, 1996, NEURON, V16, P805, DOI 10.1016/S0896-6273(00)80100-2; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P495; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; Hironaka K, 2000, J BIOL CHEM, V275, P16167, DOI 10.1074/jbc.M909302199; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lin SY, 1999, MOL BRAIN RES, V70, P18, DOI 10.1016/S0169-328X(99)00122-9; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; MACDONALD JF, 1982, BRAIN RES, V237, P248, DOI 10.1016/0006-8993(82)90575-3; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Naegele Janice R., 1994, Critical Reviews in Neurobiology, V9, P105; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; OYAMA T, 1995, NEUROSCIENCE, V69, P869, DOI 10.1016/0306-4522(95)00278-Q; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rosenblum K, 1997, J NEUROSCI, V17, P5129; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; SALTER MW, 1994, J NEUROSCI, V14, P1563, DOI 10.1523/JNEUROSCI.14-03-01563.1994; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Stoker A, 1998, BIOESSAYS, V20, P463, DOI 10.1002/(SICI)1521-1878(199806)20:6<463::AID-BIES4>3.0.CO;2-N; Stoker AW, 2001, CURR OPIN NEUROBIOL, V11, P95, DOI 10.1016/S0959-4388(00)00179-3; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	41	159	169	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					127	138		10.1016/S0896-6273(02)00633-5	http://dx.doi.org/10.1016/S0896-6273(02)00633-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931747	Bronze			2022-12-28	WOS:000174695100015
J	Akassoglou, K; Yu, WM; Akpinar, P; Strickland, S				Akassoglou, K; Yu, WM; Akpinar, P; Strickland, S			Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation	NEURON			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXTRACELLULAR-MATRIX MOLECULES; DEFICIENT MICE; IN-VITRO; PLASMINOGEN-ACTIVATOR; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; KINASE KINASE; BASAL LAMINA; LEWIS RATS	Remyelination is a critical step for functional nerve regeneration. Here we show that fibrin deposition in the peripheral nervous system after injury is a key regulator of remyelination. After sciatic nerve crush, fibrin is deposited and its clearance correlates with remyelination. Fibrin induces phosphorylation of ERK1/2 and production of p75 NGF low-affinity receptor in Schwann cells and maintains them in a nonmyelinating state, suppresses fibronectin production, and prevents synthesis of myelin proteins. In mice depleted of fibrin(ogen), remyelination of myelinated axons is accelerated due to the faster transition of the Schwann cells to a myelinating state. Regulation of fibrin clearance and/or deposition could be a key regulatory mechanism for Schwann differentiation after nerve damage.	Rockefeller Univ, Lab Neurobiol & Genet, New York, NY 10021 USA	Rockefeller University	Strickland, S (corresponding author), Rockefeller Univ, Lab Neurobiol & Genet, 1230 York Ave, New York, NY 10021 USA.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Strickland, Sidney/0000-0002-3072-9244; Akassoglou, Katerina/0000-0002-2632-1465	NINDS NIH HHS [R01 NS035704] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035704] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akassoglou K, 2000, J CELL BIOL, V149, P1157, DOI 10.1083/jcb.149.5.1157; Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; ANTON ES, 1994, DEV BIOL, V164, P133, DOI 10.1006/dbio.1994.1186; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BELL WR, 1978, J LAB CLIN MED, V91, P592; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; Blakemore WF, 1999, J NEUROIMMUNOL, V98, P69, DOI 10.1016/S0165-5728(99)00083-1; BRADLEY W G, 1970, Experimental Neurology, V26, P275, DOI 10.1016/0014-4886(70)90125-1; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; Busso N, 1998, J CLIN INVEST, V102, P41, DOI 10.1172/JCI2312; CHEN QM, 1994, J BIOL CHEM, V269, P26602; Chen R, 1971, Biochemistry, V10, P4487; Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; CLARK MB, 1991, GLIA, V4, P514, DOI 10.1002/glia.440040511; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; FERNANDEZVALLE C, 1994, J NEUROBIOL, V25, P1207, DOI 10.1002/neu.480251004; Friedmann I, 1999, FASEB J, V13, P533, DOI 10.1096/fasebj.13.3.533; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; HO MK, 1982, J IMMUNOL, V128, P2281; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; HSIEH ST, 1994, J NEUROSCI, V14, P6392; Hughes PM, 1998, BRAIN, V121, P481, DOI 10.1093/brain/121.3.481; Inoue A, 1996, J NEUROIMMUNOL, V71, P131, DOI 10.1016/S0165-5728(96)00150-6; Jessen KR, 1999, ADV EXP MED BIOL, V468, P3; Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5; Kieseier BC, 1999, NEUROLOGY, V53, P20, DOI 10.1212/WNL.53.1.20; Kioussi C, 1996, TRENDS GENET, V12, P84, DOI 10.1016/0168-9525(96)81411-9; Kitching AR, 1997, J EXP MED, V185, P963, DOI 10.1084/jem.185.5.963; KOH CS, 1993, J NEUROIMMUNOL, V47, P141, DOI 10.1016/0165-5728(93)90024-S; Kuhlmann T, 2001, J NEUROSCI, V21, P3401, DOI 10.1523/JNEUROSCI.21-10-03401.2001; Lansink M, 1998, BLOOD, V92, P927; LEFCORT F, 1992, DEVELOPMENT, V116, P767; LEMKE G, 1988, DEVELOPMENT, V102, P499; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; LISAK RP, 1994, J NEUROIMMUNOL, V55, P171, DOI 10.1016/0165-5728(94)90007-8; LORAND L, 1969, BIOCHEM BIOPH RES CO, V37, P219, DOI 10.1016/0006-291X(69)90722-0; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; Milner R, 1997, DEV BIOL, V185, P215, DOI 10.1006/dbio.1997.8547; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; Ng DCH, 2001, J BIOL CHEM, V276, P29490, DOI 10.1074/jbc.M100699200; PATERSON PY, 1976, FED PROC, V35, P2428; PEREZ RL, 1995, J IMMUNOL, V154, P1879; Perez RL, 1999, AM J RESP CELL MOL, V20, P1059, DOI 10.1165/ajrcmb.20.5.3281; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; RICHARDSON PM, 1994, J NEUROL, V242, pS57, DOI 10.1007/BF00939244; Robertson AM, 1997, J ANAT, V190, P423, DOI 10.1046/j.1469-7580.1997.19030423.x; Rutkowski JL, 1999, J NEUROIMMUNOL, V101, P47, DOI 10.1016/S0165-5728(99)00132-0; SCHERER SS, 1994, J NEUROSCI RES, V38, P575, DOI 10.1002/jnr.490380510; SHAW G, 1985, EUR J CELL BIOL, V39, P205; Siebert H, 2000, J NEUROIMMUNOL, V110, P177, DOI 10.1016/S0165-5728(00)00343-X; Sobel RA, 1998, J NEUROPATH EXP NEUR, V57, P205, DOI 10.1097/00005072-199803000-00001; Soilu-Hanninen M, 1999, J NEUROSCI, V19, P4828; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Syroid DE, 2000, J NEUROSCI, V20, P5741, DOI 10.1523/JNEUROSCI.20-15-05741.2000; TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147; Thiagarajan P, 1996, BIOCHEMISTRY-US, V35, P4169, DOI 10.1021/bi952532b; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Vogelezang MG, 1999, J NEUROSCI RES, V56, P323, DOI 10.1002/(SICI)1097-4547(19990515)56:4<323::AID-JNR1>3.0.CO;2-6; WOOLF CJ, 1990, NEUROSCIENCE, V34, P465, DOI 10.1016/0306-4522(90)90155-W; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289; Zorick TS, 1996, CURR OPIN CELL BIOL, V8, P870, DOI 10.1016/S0955-0674(96)80090-1; Zorick TS, 1999, DEVELOPMENT, V126, P1397	76	144	158	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					861	875		10.1016/S0896-6273(02)00617-7	http://dx.doi.org/10.1016/S0896-6273(02)00617-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906694	Bronze			2022-12-28	WOS:000174389600005
J	Ma, D; Zerangue, N; Raab-Graham, K; Fried, SR; Jan, YN; Jan, LY				Ma, D; Zerangue, N; Raab-Graham, K; Fried, SR; Jan, YN; Jan, LY			Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart	NEURON			English	Article							RECTIFIER K+ CHANNEL; ENDOPLASMIC-RETICULUM; SUBUNIT STOICHIOMETRY; MOLECULAR-CLONING; MESSENGER-RNAS; GIRK1; EXPRESSION; LOCALIZATION; SIGNALS; FAMILY	G protein-activated inwardly rectifying potassium channels (Kir3, GIRK) provide an important mechanism for neurotransmitter regulation of membrane excitability. GIRK channels are tetramers containing various combinations of Kir3 subunits (Kir3.1-Kir3.4). We find that different combinations of Kir3 subunits exhibit a surprisingly complex spectrum of trafficking phenotypes. Kir3.2 and Kir3.4, but not Kir3.1, contain ER export signals that are important for plasma membrane expression of Kir3.1/Kir3.2 and Kir3.1/Kir3.4 heterotetramers, the GIRK channels found in the brain and the heart, respectively. Additional motifs in Kir3.2 and Kir3.4 control the trafficking between endosome and plasma membrane. In contrast, the Kir3.3 subunit potently inhibits plasma membrane expression by diverting the heterotetrameric channels to lysosomes. Such rich trafficking behaviors provide a mechanism for dynamic regulation of GIRK channel density in the plasma membrane.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	gkw@itsa.ucsf.edu		/0000-0002-6129-2938; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Raab-Graham, Kimberly/0000-0001-6502-057X				Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chen SC, 1997, BRAIN RES, V778, P251, DOI 10.1016/S0006-8993(97)00896-2; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Doring F, 1998, J NEUROSCI, V18, P8625; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Helenius A, 2001, PHILOS T ROY SOC B, V356, P147, DOI 10.1098/rstb.2000.0759; Hille B., 1992, IONIC CHANNELS EXCIT; Inanobe A, 1999, J PHYSIOL-LONDON, V521, P19, DOI 10.1111/j.1469-7793.1999.00019.x; Inanobe A, 1999, J NEUROSCI, V19, P1006; Isomoto S, 1997, JPN J PHYSIOL, V47, P11, DOI 10.2170/jjphysiol.47.11; Isomoto S, 1996, BIOCHEM BIOPH RES CO, V218, P286, DOI 10.1006/bbrc.1996.0050; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Karschin C, 1996, J NEUROSCI, V16, P3559; Kennedy ME, 1996, NEUROPHARMACOLOGY, V35, P831, DOI 10.1016/0028-3908(96)00132-3; Kennedy ME, 1999, J BIOL CHEM, V274, P2571, DOI 10.1074/jbc.274.4.2571; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Liao YJ, 1996, J NEUROSCI, V16, P7137; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nelson CS, 1997, MOL BRAIN RES, V46, P185, DOI 10.1016/S0169-328X(96)00301-4; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Partiseti M, 1998, FEBS LETT, V434, P171, DOI 10.1016/S0014-5793(98)00972-7; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Waites CL, 2001, J CELL BIOL, V152, P1159, DOI 10.1083/jcb.152.6.1159; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wei JJ, 1998, GENOMICS, V51, P379, DOI 10.1006/geno.1998.5369; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614; Yamada M, 1998, PHARMACOL REV, V50, P723; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198	49	173	174	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					715	729		10.1016/S0896-6273(02)00614-1	http://dx.doi.org/10.1016/S0896-6273(02)00614-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879649	Bronze			2022-12-28	WOS:000174286200008
J	Dragoi, V; Turcu, CM; Sur, M				Dragoi, V; Turcu, CM; Sur, M			Stability of cortical responses and the statistics of natural scenes	NEURON			English	Article							PRIMARY VISUAL-CORTEX; CROSS-CORRELATION ANALYSIS; RETINAL GANGLION-CELLS; MONKEY STRIATE CORTEX; FUNCTIONAL ARCHITECTURE; ORIENTATION SENSITIVITY; HORIZONTAL INTERACTIONS; PATTERN ADAPTATION; ORIENTED CONTOURS; OCULAR DOMINANCE	The primary visual cortex (V1) of higher mammals contains maps of stimulus features; how these maps influence vision remains unknown. We have examined the functional significance of an asymmetry in the orientation map in cat V1, i.e., the fact that a larger area of V1 is preferentially activated by vertical and horizontal contours than by contours at oblique orientations. Despite the fact that neurons tuned to cardinal and oblique orientations have indistinguishable tuning characteristics, cardinal neurons remain more stable in their response properties after selective perturbation induced by adaptation. Similarly, human observers report different adaptation-induced changes in orientation tuning between cardinal and oblique axes. We suggest that the larger cortical area devoted to cardinal orientations imposes stability on the processing of cardinal contours during visual perception, by retaining invariant cortical responses along cardinal axes.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Dragoi, V (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.				NEI NIH HHS [EY07023] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBUS K, 1975, EXP BRAIN RES, V24, P181, DOI 10.1007/BF00234062; ANDREWS DP, 1967, VISION RES, V7, P975, DOI 10.1016/0042-6989(67)90014-4; Arakawa K, 2000, EXP BRAIN RES, V131, P121, DOI 10.1007/s002219900274; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BAUER JA, 1979, PERCEPTION, V8, P247, DOI 10.1068/p080247; BISHOP PO, 1962, J PHYSIOL-LONDON, V163, P466, DOI 10.1113/jphysiol.1962.sp006990; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BOLTZ RL, 1979, SCIENCE, V205, P511, DOI 10.1126/science.109923; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V198, P237, DOI 10.1113/jphysiol.1968.sp008604; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; COPPOLA DM, 2000, ABSTR SOC NEUR, V26; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DEBRUYN EJ, 1980, VISION RES, V20, P315, DOI 10.1016/0042-6989(80)90018-8; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; DRAGOI V, 1999, ABSTR SOC NEUROSCI, V25, P1548; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; GANZ L, 1966, PSYCHOL REV, V73, P128, DOI 10.1037/h0022952; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GREENLEE MW, 1987, VISION RES, V27, P1041, DOI 10.1016/0042-6989(87)90017-4; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HATA Y, 1991, J PHYSIOL-LONDON, V441, P593, DOI 10.1113/jphysiol.1991.sp018769; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBENER M, 1997, J NEUROSCI, V17, P1270; Hughes A., 1977, VISUAL SYSTEM VERTEB, P613; KENNEDY H, 1979, J PHYSIOL-LONDON, V296, pP61; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; LEVENTHAL AG, 1983, J COMP NEUROL, V220, P465, DOI 10.1002/cne.902200408; LEVENTHAL AG, 1977, P NATL ACAD SCI USA, V74, P1272, DOI 10.1073/pnas.74.3.1272; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MITCHELL DE, 1976, VISION RES, V16, P609, DOI 10.1016/0042-6989(76)90007-9; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Muller T, 2000, NEURAL COMPUT, V12, P2573, DOI 10.1162/089976600300014854; NELSON SB, 1991, J NEUROSCI, V11, P344; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; PETTIGREW JD, 1968, EXP BRAIN RES, V6, P373; Rao SC, 1997, J COMP NEUROL, V387, P358; ROSE D, 1974, EXP BRAIN RES, V20, P1; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; SIMONCELLI EP, 1999, ADV NEURAL INFORMATI, V11; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; SWITKES E, 1978, VISION RES, V18, P1393, DOI 10.1016/0042-6989(78)90232-8; TSO DY, 1986, J NEUROSCI, V6, P1160; VANDENBUSSCHE E, 1980, ARCH INT PHYSIOL BIO, V88, pP11; WASSLE H, 1975, J COMP NEUROL, V159, P419, DOI 10.1002/cne.901590308; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; WOLFE JM, 1986, INVEST OPHTH VIS SCI, V27, P538; WORGOTTER F, 1991, EXP BRAIN RES, V83, P665; Yarbus A.L., 1967, EYE MOVEMENT VISION	66	46	49	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1181	1192		10.1016/S0896-6273(01)00540-2	http://dx.doi.org/10.1016/S0896-6273(01)00540-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754846	Bronze			2022-12-28	WOS:000172886800021
J	Grunwald, IC; Korte, M; Wolfer, D; Wilkinson, GA; Unsicker, K; Lipp, HP; Bonhoeffer, T; Klein, D				Grunwald, IC; Korte, M; Wolfer, D; Wilkinson, GA; Unsicker, K; Lipp, HP; Bonhoeffer, T; Klein, D			Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; COMMISSURAL AXONS; EPHRIN LIGANDS; PROTEIN-KINASE; MUTANT MICE; MEMORY; LTP; DEPOTENTIATION; STIMULATION; ACTIVATION	During development, Eph receptors mediate the repulsive axon guidance function of ephrins, a family of membrane attached ligands with their own receptorlike signaling potential. In cultured glutamatergic neurons, EphB2 receptors were recently shown to associate with NMDA receptors at synaptic sites and were suggested to play a role in synaptogenesis. Here we show that Eph receptor stimulation in cultured neurons modulates signaling pathways implicated in synaptic plasticity, suggesting cross-talk with NMDA receptor-activated pathways. Mice lacking EphB2 have normal hippocampal synapse morphology, but display defects in synaptic plasticity. In EphB2(-/-) hippocampal slices, protein synthesis-dependent long-term potentiation (LTP) was impaired, and two forms of synaptic depression were completely extinguished. Interestingly, targeted expression of a carboxy-terminally truncated form of EphB2 rescued the EphB2 null phenotype, indicating that EphB2 kinase signaling is not required for these EphB2-mediated functions.	Max Planck Inst Neurobiol, Dept Mol Neurobiol, D-82152 Martinsried, Germany; Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Martinsried, Germany; Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; Univ Zurich, Ctr Neurosci, CH-8057 Zurich, Switzerland; Univ Heidelberg, Dept Anat & Cell Biol 3, D-69120 Heidelberg, Germany	Max Planck Society; Max Planck Society; University of Zurich; University of Zurich; Ruprecht Karls University Heidelberg	Klein, D (corresponding author), Max Planck Inst Neurobiol, Dept Mol Neurobiol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Bonhoeffer, Tobias/B-9481-2009; Wolfer, David P/B-3293-2016; Klein, Ruediger/C-6147-2008	Bonhoeffer, Tobias/0000-0001-7897-6634; Wolfer, David P/0000-0002-5957-1401; Klein, Ruediger/0000-0002-3109-0163; Grunwald Kadow, Ilona/0000-0002-9085-4274				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Drescher U, 2000, CELL, V103, P1005, DOI 10.1016/S0092-8674(00)00204-X; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gao WQ, 1998, MOL CELL NEUROSCI, V11, P247, DOI 10.1006/mcne.1998.0696; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gerlai R, 1999, J NEUROSCI, V19, P9538; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kawasaki H, 1999, J BIOL CHEM, V274, P13498, DOI 10.1074/jbc.274.19.13498; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Meyer BU, 1998, J NEUROL, V245, P106, DOI 10.1007/s004150050187; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; O'Dell T J, 1994, Learn Mem, V1, P129; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; TAKASU MA, 2002, IN PRESS SCIENCE; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wagner JJ, 1996, HIPPOCAMPUS, V6, P24, DOI 10.1002/(SICI)1098-1063(1996)6:1<24::AID-HIPO5>3.0.CO;2-7; Wilkinson DG, 2000, CURR BIOL, V10, pR447, DOI 10.1016/S0960-9822(00)00530-3; Yu XM, 1999, P NATL ACAD SCI USA, V96, P7697, DOI 10.1073/pnas.96.14.7697; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	48	234	247	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1027	1040		10.1016/S0896-6273(01)00550-5	http://dx.doi.org/10.1016/S0896-6273(01)00550-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754835	Bronze			2022-12-28	WOS:000172886800010
J	Sjostrom, PJ; Turrigiano, GG; Nelson, SB				Sjostrom, PJ; Turrigiano, GG; Nelson, SB			Rate, timing, and cooperativity jointly determine cortical synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; NEOCORTICAL PYRAMIDAL NEURONS; AREA CA1; COINCIDENCE DETECTION; DENDRITIC SPINES; NMDA RECEPTORS; DEPRESSION; HIPPOCAMPUS; INDUCTION; SYNAPSES	Cortical long-term plasticity depends on firing rate, spike timing, and cooperativity among inputs, but how these factors interact during realistic patterns of activity is unknown. Here we monitored plasticity while systematically varying the rate, spike timing, and number of coincident afferents. These experiments demonstrate a novel form of cooperativity operating even when postsynaptic firing is evoked by current injection, and reveal a complex dependence of LTP and LTD on rate and timing. Based on these data, we constructed and tested three quantitative models of cortical plasticity. One of these models, in which spike-timing relationships causing LTP "win" out over those favoring LTD, closely fits the data and accurately predicts the build-up of plasticity during random firing. This provides a quantitative framework for predicting the impact of in vivo firing patterns on synaptic strength.	Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University	Nelson, SB (corresponding author), Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Mailstop 008 415 South St, Waltham, MA 02454 USA.	nelson@brandeis.edu	Sjöström, Per Jesper/B-9696-2019	Sjöström, Per Jesper/0000-0001-7085-2223; Nelson, Sacha/0000-0002-0108-8599	NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058754] Funding Source: NIH RePORTER; NEI NIH HHS [EY11116] Funding Source: Medline; NIMH NIH HHS [MH58754] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P593, DOI 10.1111/j.1469-7793.2000.t01-1-00593.x; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Christie BR, 2000, HIPPOCAMPUS, V10, P673, DOI 10.1002/1098-1063(2000)10:6<673::AID-HIPO1005>3.0.CO;2-O; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Debanne D, 1996, P NATL ACAD SCI USA, V93, P11225, DOI 10.1073/pnas.93.20.11225; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DOUGLAS RM, 1982, BRAIN RES, V240, P259, DOI 10.1016/0006-8993(82)90221-9; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MALSBURG CV, 1973, KYBERNETIK, V14, P85, DOI 10.1007/BF00288907; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Senn W, 2001, NEURAL COMPUT, V13, P35, DOI 10.1162/089976601300014628; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	67	730	742	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					1149	1164		10.1016/S0896-6273(01)00542-6	http://dx.doi.org/10.1016/S0896-6273(01)00542-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754844	Bronze			2022-12-28	WOS:000172886800019
J	Gunawardena, S; Goldstein, LSB				Gunawardena, S; Goldstein, LSB			Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; FAMILIAL ALZHEIMERS-DISEASE; A-BETA PEPTIDE; TRANSGENIC MICE; BIOLOGICAL FUNCTIONS; SIGNAL-TRANSDUCTION; KINESIN; GENE; DEFICITS; RECEPTOR	We tested the hypothesis that amyloid precursor protein (APP) and its relatives function as vesicular receptor proteins for kinesin-I. Deletion of the Drosophila APP-like gene (Appl) or overexpression of human APP695 or APPL constructs caused axonal transport phenotypes similar to kinesin and dynein mutants. Genetic reduction of kinesin-I expression enhanced while genetic reduction of dynein expression suppressed these phenotypes. Deletion of the C terminus of APP695 or APPL, including the kinesin binding region, disrupted axonal transport of APP695 and APPL and abolished the organelle accumulation phenotype. Neuronal apoptosis was induced only by overexpression of constructs containing both the C-terminal and A beta regions of APP695. We discuss the possibility that axonal transport disruption may play a role in the neurodegenerative pathology of Alzheimer's disease.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Goldstein, LSB (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.			gunawardena, shermali/0000-0001-8776-9397	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035252] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35252] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Bowman AB, 1999, J CELL BIOL, V146, P165; BRAND A, 1995, TRENDS GENET, V11, P324, DOI 10.1016/S0168-9525(00)89091-5; BUXBAUM JD, 1993, BIOCHEM BIOPH RES CO, V197, P639, DOI 10.1006/bbrc.1993.2527; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Strooper B, 2000, J CELL SCI, V113, P1857; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Galvin JE, 2000, EXP NEUROL, V165, P77, DOI 10.1006/exnr.2000.7461; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 2001, SCIENCE, V291, P2102, DOI 10.1126/science.1059766; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Heber S, 2000, J NEUROSCI, V20, P7951; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hurd DD, 1996, GENETICS, V144, P1075; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kang DE, 1997, NEUROLOGY, V49, P56, DOI 10.1212/WNL.49.1.56; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Masliah E, 1996, J NEUROSCI, V16, P5795; Moechars D, 1999, NEUROSCIENCE, V91, P819, DOI 10.1016/S0306-4522(98)00599-5; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Reese EL, 2000, J CELL BIOL, V151, P155, DOI 10.1083/jcb.151.1.155; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Storey E, 1999, NEUROPATH APPL NEURO, V25, P81; SWANSON JA, 1992, J CELL SCI, V103, P201; Takahashi M, 2000, NEURON, V28, P461, DOI 10.1016/S0896-6273(00)00125-2; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tesseur I, 2000, AM J PATHOL, V157, P1495, DOI 10.1016/S0002-9440(10)64788-8; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Torroja L, 1999, J NEUROSCI, V19, P7793; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; WASCO W, 1993, ANN NY ACAD SCI, V695, P203, DOI 10.1111/j.1749-6632.1993.tb23053.x; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	55	330	345	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					389	401		10.1016/S0896-6273(01)00496-2	http://dx.doi.org/10.1016/S0896-6273(01)00496-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709151	Bronze			2022-12-28	WOS:000172119100006
J	Tanzi, RE; Bertram, L				Tanzi, RE; Bertram, L			New frontiers in Alzheimer's disease genetics	NEURON			English	Review							ALPHA-2-MACROGLOBULIN GENE; APOLIPOPROTEIN-E; ONSET; AGE; METAANALYSIS; ASSOCIATION; PRESENILINS; GENOTYPE	Alzheimer's disease (AD) is a genetically complex disorder that accounts for the majority of dementia in the elderly population. Over 100 rare, highly penetrant mutations have been described in three genes (APP, PSEN1, PSEN2) for early-onset familial AD. In the more common late-onset form, a polymorphism in the apolipoprotein E gene has been associated with increased susceptibility. However, recent studies suggest that these four genes account for less than 30% of the genetic variance for AD and that more genetic factors remain to be identified. In this review, we present a brief history of AD genetics and preview some of the next frontiers in Alzheimer gene discovery primarily focusing on chromosomes 12, 10, and 9.	Massachusetts Gen Hosp, Dept Neurol, Ctr Aging Genet & Neurodegenerat, Genet & Aging Res Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Ctr Aging Genet & Neurodegenerat, Genet & Aging Res Unit, 114 16th St, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Bertram, Lars/K-3889-2015; Tanzi, Rudolph/AAE-9622-2019	Bertram, Lars/0000-0002-0108-124X; Tanzi, Rudolph/0000-0002-7032-1454				Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bertram L, 2001, Curr Neurol Neurosci Rep, V1, P442, DOI 10.1007/s11910-001-0104-9; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; HYSLOP PHS, 2000, BIOL PSYCHIAT, V47, P183; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Koster MN, 2000, NEUROLOGY, V55, P678, DOI 10.1212/WNL.55.5.678; Meyer MR, 1998, NAT GENET, V19, P321, DOI 10.1038/1206; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Pericak-Vance MA, 2000, EXP GERONTOL, V35, P1343, DOI 10.1016/S0531-5565(00)00196-0; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Poirier J, 2000, ANN NY ACAD SCI, V924, P81; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tanzi RE, 1999, J CLIN INVEST, V104, P1175, DOI 10.1172/JCI8593; Verpillat P, 2000, ANN NEUROL, V48, P400, DOI 10.1002/1531-8249(200009)48:3<400::AID-ANA22>3.0.CO;2-L	22	362	376	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					181	184		10.1016/S0896-6273(01)00476-7	http://dx.doi.org/10.1016/S0896-6273(01)00476-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683989	Bronze			2022-12-28	WOS:000171893700004
J	Hu, HL; Marton, TF; Goodman, CS				Hu, HL; Marton, TF; Goodman, CS			Plexin B mediates axon guidance in Drosophila by simultaneously inhibiting active rac and enhancing RhoA signaling	NEURON			English	Article							GROWTH-CONE COLLAPSE; SEMAPHORIN RECEPTOR; SMALL GTPASES; TRANSMEMBRANE; NEUROPILIN; FAMILY; OUTGROWTH; MOTOR; CHEMOREPELLENT; MORPHOGENESIS	Plexins are neuronal receptors for the repulsive axon guidance molecule Semaphorins. Previous studies showed that Plexin B (PlexB) binds directly to the active, GTP-bound form of the Rac GTPase. Here, we define a seven amino acid sequence in PlexB required for Rac ITP binding. The interaction of PlexB with Rac(GTP) is necessary for Plexin-mediated axon guidance in vivo. A different region of PlexB binds to RhoA. Dosage-sensitive genetic interactions suggest that PlexB suppresses Rac activity and enhances RhoA activity. Biochemical evidence indicates that PlexB sequesters RacGTP from its downstream effector PAK. These results suggest a model whereby PlexB mediates repulsion by coordinately regulating two small GTPases in opposite directions: PlexB binds to Rac(GTP) and downregulates its output by blocking its access to PAK and, at the same time, binds to and increases the output of RhoA.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Renovis Inc, 270 Littlefield Ave, San Francisco, CA 94080 USA.	goodman@uclink4.berkeley.edu		Hu, Hailan/0000-0002-0425-5057	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021294, R37HD021294] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; BILLUART P, 2001, IN PRESS CELL; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Jin Z, 1997, J NEUROSCI, V17, P6256; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Magie CR, 1999, DEVELOPMENT, V126, P5353; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wong JTW, 1997, DEVELOPMENT, V124, P3597; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	53	162	168	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					39	51		10.1016/S0896-6273(01)00453-6	http://dx.doi.org/10.1016/S0896-6273(01)00453-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604137	Bronze			2022-12-28	WOS:000171525200007
J	Huk, AC; Ress, D; Heeger, DJ				Huk, AC; Ress, D; Heeger, DJ			Neuronal basis of the motion aftereffect reconsidered	NEURON			English	Article							HUMAN VISUAL-CORTEX; CAT STRIATE CORTEX; DIRECTION-SELECTIVE ADAPTATION; POSITRON EMISSION TOMOGRAPHY; AREA MT; ATTENTIONAL MODULATION; FUNCTIONAL MRI; CORTICAL AREAS; SPEED SENSITIVITY; ORTHOGONAL MOTION	Several fMRI studies have reported MT+ response increases correlated with perception of the motion aftereffect (MAE). However, attention can strongly affect MT+ responses, and subjects may naturally attend more to the MAE than control trials without MAE. We found that requiring subjects to attend to motion on both MAE and control trials produced equal levels of MT+ response, suggesting that attention may have confounded the interpretation of previous experiments; in our data, attention accounts for the entire effect. After eliminating this confound, we observed that direction-selective motion adaptation produced a direction-selective imbalance in MT+ responses (and earlier visual areas), and yielded a corresponding asymmetry in speed discrimination thresholds. These findings provide physiological evidence that population level response imbalances underlie the MAE, and quantify the relative proportions of direction-selective neurons across human visual areas.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Huk, AC (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.		Huk, Alexander/A-8031-2016	Huk, Alexander/0000-0003-1430-6935	NATIONAL EYE INSTITUTE [R01EY012741, F32EY006952] Funding Source: NIH RePORTER; NEI NIH HHS [F32-EY06952, R01-EY12741] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; ALBRIGHT TD, 1993, VISUAL MOTION ITS RO, P177; BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; Bex PJ, 1999, J OPT SOC AM A, V16, P2817, DOI 10.1364/JOSAA.16.002817; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; CHAUDHURI A, 1990, NATURE, V344, P60, DOI 10.1038/344060a0; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Chawla D, 1998, NEUROIMAGE, V7, P86, DOI 10.1006/nimg.1997.0319; Chawla D, 1999, NEUROIMAGE, V9, P508, DOI 10.1006/nimg.1999.0432; Clifford CWG, 1999, VISION RES, V39, P4324, DOI 10.1016/S0042-6989(99)00151-0; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Culham JC, 1999, J NEUROPHYSIOL, V81, P388, DOI 10.1152/jn.1999.81.1.388; Demb JB, 1998, J NEUROSCI, V18, P6939; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Efron B., 1994, MONOGRAPHS STAT APPL; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GIASCHI D, 1993, J NEUROPHYSIOL, V70, P2024, DOI 10.1152/jn.1993.70.5.2024; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grunewald A, 1996, NATURE, V384, P358, DOI 10.1038/384358a0; HAMMOND P, 1985, EXP BRAIN RES, V60, P411; HAMMOND P, 1986, VISION RES, V26, P1055, DOI 10.1016/0042-6989(86)90039-8; HAMMOND P, 1988, EXP BRAIN RES, V72, P1, DOI 10.1007/BF00248495; Hautzel H, 2001, BRAIN RES, V892, P281, DOI 10.1016/S0006-8993(00)03224-8; He S, 1998, CURR BIOL, V8, P1215, DOI 10.1016/S0960-9822(07)00512-X; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; HOTSON J, 1994, VISION RES, V34, P2115, DOI 10.1016/0042-6989(94)90321-2; Huk AC, 2000, J NEUROPHYSIOL, V83, P3525, DOI 10.1152/jn.2000.83.6.3525; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MARLIN SG, 1988, J NEUROPHYSIOL, V59, P1314, DOI 10.1152/jn.1988.59.4.1314; MATHER G, 1980, PERCEPTION, V9, P379, DOI 10.1068/p090379; Mather G, 1998, MOTION AFTEREFFECT, P157; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; PANTIE A, 1974, VISION RES, V11, P943; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PETERSEN SE, 1985, BRAIN RES, V346, P146, DOI 10.1016/0006-8993(85)91105-9; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; SAWYERGLOVER AM, 1998, P SMRT 7 ANN M SYDN, P69; Scannell JW, 1999, P ROY SOC B-BIOL SCI, V266, P875, DOI 10.1098/rspb.1999.0718; SCHNEIDER W, 1993, NATURE, V365, P150, DOI 10.1038/365150a0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SHULMAN GL, 1993, PERCEPTION, V22, P947, DOI 10.1068/p220947; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Smith AT, 1998, J NEUROSCI, V18, P3816; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; SUTHERLAND NS, 1961, Q J EXP PSYCHOL, V13, P222, DOI 10.1080/17470216108416498; Taylor JG, 2000, NEUROIMAGE, V11, P257, DOI 10.1006/nimg.1999.0529; TEUE S, 2000, NAT NEUROSCI, V3, P270; THOMPSON P, 1994, PERCEPTION, V23, P1233, DOI 10.1068/p231233; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Vaina LM, 1999, HUM BRAIN MAPP, V7, P67, DOI 10.1002/(SICI)1097-0193(1999)7:1<67::AID-HBM6>3.0.CO;2-K; VANWEZEL RJA, 2001, IN PRESS NEUROSCI; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; VERSTRATEN FAJ, 1994, VISION RES, V34, P1149, DOI 10.1016/0042-6989(94)90297-6; VONDERHEYDT R, 1978, ARCH ITAL BIOL, V116, P248; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WENDEROTH P, 1988, PERCEPTION, V17, P81, DOI 10.1068/p170081; WRIGHT MJ, 1985, VISION RES, V25, P1947, DOI 10.1016/0042-6989(85)90019-7; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	88	224	228	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					161	172		10.1016/S0896-6273(01)00452-4	http://dx.doi.org/10.1016/S0896-6273(01)00452-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604147	Bronze			2022-12-28	WOS:000171525200017
J	Chiu, CY; Weliky, M				Chiu, CY; Weliky, M			Relationship of correlated spontaneous activity to functional ocular dominance columns in the developing visual cortex	NEURON			English	Article							HORIZONTAL CONNECTIONS; IN-VIVO; FERRET; ORGANIZATION; PLASTICITY; NEURONS; MAPS	Utilizing a multielectrode array to record spontaneous and visually evoked activity of cortical neurons in area 17, we investigate the relationship between long-range correlated spontaneous activity and functional ocular dominance columns during early ferret postnatal development (P24-P29). In regions of visual cortex containing alternating ocular dominance patches, periodic fluctuations in correlated activity are observed in which spontaneous activity is most highly correlated between cortical patches exhibiting the same eye preference. However, these fluctuations are present even within large contralateral eye-dominated bands which lack any periodic alternations in ocular dominance. Thus, the organization of ocular dominance columns cannot fully account for the patterns of correlated activity we observe. Our results suggest that patterns of long-range correlated activity reflect an intrinsic periodicity of cortical connectivity that is constrained by segregated eye-specific LGN afferents.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Rochester, Interdepartmental Program Neurosci, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Weliky, M (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	weliky@cvs.rochester.edu		Chiu, Chiayu/0000-0001-5809-6306				[Anonymous], [No title captured]; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HERRMANN K, 1994, EUR J NEUROSCI, V6, P1729, DOI 10.1111/j.1460-9568.1994.tb00565.x; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; LAW MI, 1988, J COMP NEUROL, V278, P157, DOI 10.1002/cne.902780202; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Ruthazer ES, 1999, J COMP NEUROL, V407, P151; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Schwartz TH, 1998, NEURON, V20, P541, DOI 10.1016/S0896-6273(00)80993-9; Snedecor GW., 1989, STAT METHODS, P177; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; von der Malsburg C., 1976, EXP BRAIN RES, V(Suppl 1), P463; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379	25	43	43	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1123	1134		10.1016/S0896-6273(02)00867-X	http://dx.doi.org/10.1016/S0896-6273(02)00867-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354401	Bronze			2022-12-28	WOS:000178040000012
J	Spiridon, M; Kanwisher, N				Spiridon, M; Kanwisher, N			How distributed is visual category information in human occipito-temporal cortex? An fMRI study	NEURON			English	Article							HUMAN EXTRASTRIATE CORTEX; AREA; FACES; REPRESENTATION; RECOGNITION; FUSIFORM; OBJECTS	We used fMRI to study the distribution of object category information in the ventral visual pathway. Extending the findings of Haxby et al. (2001), we find that categories of stimuli can be distinguished by the pattern of activation they elicit across this entire pathway, even when the stimuli within a category differ in viewpoint, exemplar, or image format. However, regions within the ventral visual pathway are neither interchangeable nor equipotential. Although the FFA and PPA permit excellent discrimination between preferred versus nonpreferred stimuli (e.g., faces-bottles and houses-bottles, respectively), we find that neither region alone permits accurate discrimination between pairs of nonpreferred stimuli (e.g., bottles-shoes). These findings indicate that the ventral visual pathway is not homogeneous, but contains some regions (including FFA and PPA) that are primarily involved in the analysis of a single class of stimulus.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Spiridon, M (corresponding author), MIT, Dept Brain & Cognit Sci, NE20-464, Cambridge, MA 02139 USA.				NEI NIH HHS [EY13455] Funding Source: Medline; NIMH NIH HHS [MH59150] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059150] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.3.CO;2-X; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P604; Puce A, 1996, J NEUROSCI, V16, P5205; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; Wada Y, 2001, J NEUROL NEUROSUR PS, V71, P254, DOI 10.1136/jnnp.71.2.254	17	220	226	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1157	1165		10.1016/S0896-6273(02)00877-2	http://dx.doi.org/10.1016/S0896-6273(02)00877-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354404	Bronze			2022-12-28	WOS:000178040000015
J	Palmer, MJ; von Gersdorff, H				Palmer, MJ; von Gersdorff, H			Phasic transmitter release from tonic neurons	NEURON			English	Editorial Material							ACETYLCHOLINE	Graded and prolonged presynaptic depolarizations trigger the tonic release of neurotransmitters from sensory neurons. In this issue of Neuron, Simmons (2002a) reports that postsynaptic responses of locust interneuron synpapses are determined by the rate rather than the amplitude of presynaptic depolarization, suggesting a mechanism for increasing the signaling capabilities of this synapse with respect to visual processing.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Palmer, MJ (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Rd, Portland, OR 97201 USA.			Palmer, Mary/0000-0002-5539-6052				Eliasof S, 1997, VISUAL NEUROSCI, V14, P13, DOI 10.1017/S0952523800008713; Ferragamo MJ, 2002, J NEUROPHYSIOL, V87, P2262, DOI 10.1152/jn.00587.2001; Leitinger G, 2000, J COMP NEUROL, V416, P345; Leitinger G, 2002, J NEUROBIOL, V50, P93, DOI 10.1002/neu.10018; LIN JW, 2002, IN PRESS TRENDS NEUR, V25; Ohnuma K, 2001, J PHYSIOL-LONDON, V535, P647, DOI 10.1111/j.1469-7793.2001.00647.x; Simmons PJ, 2002, MICROSC RES TECHNIQ, V56, P270, DOI 10.1002/jemt.10030; Simmons PJ, 2002, NEURON, V35, P749, DOI 10.1016/S0896-6273(02)00791-2	8	1	1	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					600	602		10.1016/S0896-6273(02)00833-4	http://dx.doi.org/10.1016/S0896-6273(02)00833-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194861	Bronze			2022-12-28	WOS:000177521000002
J	Mann, F; Ray, S; Harris, WA; Holt, CE				Mann, F; Ray, S; Harris, WA; Holt, CE			Topographic mapping in dorsoventral axis of the xenopus retinotectal system depends on signaling through ephrin-13 ligands	NEURON			English	Article							RECEPTOR TYROSINE KINASES; EPH RECEPTORS; CELL-ADHESION; GROWTH CONES; TRANSMEMBRANE LIGANDS; CYTOPLASMIC DOMAIN; COMMISSURAL AXONS; INTEGRIN FUNCTION; RETINAL AXONS; EXPRESSION	Ephrin-B and EphB are distributed in matching dorsoventral gradients in the embryonic Xenopus visual system with retinal axons bearing high levels of ligand (dorsal) projecting to tectal regions with high receptor expression (ventral). In vitro stripe assays show that dorsal retinal axons prefer to grow on EphB receptor stripes supporting an attractive guidance mechanism. In vivo disruption of EphB/ephrin-B function by application of exogenous EphB or expression of dominant-negative ephrin-B ligand in dorsal retinal axons causes these axons to shift dorsally in the tectum, while misexpression of wild-type ephrin-B in ventral axons causes them to shift ventrally. These dorsoventral targeting errors are consistent with the hypothesis that an attractive mechanism that requires ephrin-B cytoplasmic domain is critical for retinotectal mapping in this axis.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Mann, F (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	fm222@cam.ac.uk	Mann, Fanny/G-2786-2016; Ray, Samiran/AAZ-4916-2020	Mann, Fanny/0000-0003-4839-4347; Ray, Samiran/0000-0002-3738-4672; Holt, Christine Elizabeth/0000-0003-2829-121X				Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Baier H, 1996, DEVELOPMENT, V123, P415; Barbieri AM, 1999, P NATL ACAD SCI USA, V96, P10729, DOI 10.1073/pnas.96.19.10729; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Birgbauer E, 2001, DEVELOPMENT, V128, P3041; Bohme B, 1996, J BIOL CHEM, V271, P24747, DOI 10.1074/jbc.271.40.24747; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; BRANDLI AW, 1995, DEV DYNAM, V203, P119; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; CHIEN CB, 1995, DEVELOPMENT, V121, P2621; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096; EAGLESON G, 1995, J NEUROBIOL, V28, P146, DOI 10.1002/neu.480280203; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Helbling PM, 1999, DEV DYNAM, V216, P361, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<361::AID-DVDY5>3.0.CO;2-W; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holash JA, 1995, DEV BIOL, V172, P683, DOI 10.1006/dbio.1995.8039; Holash JA, 1997, DEV BIOL, V182, P256, DOI 10.1006/dbio.1996.8496; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Irie A, 2002, DEVELOPMENT, V129, P61; Jones TL, 1997, ONCOGENE, V14, P2159, DOI 10.1038/sj.onc.1201082; JONES TL, 1995, ONCOGENE, V10, P1111; Jones TL, 1998, P NATL ACAD SCI USA, V95, P576, DOI 10.1073/pnas.95.2.576; Klein R, 1999, CURR BIOL, V9, pR691, DOI 10.1016/S0960-9822(99)80441-2; Knoll B, 2001, DEVELOPMENT, V128, P895; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Li HS, 1997, DEVELOPMENT, V124, P603; Liu Y, 2001, MECH DEVELOP, V100, P115, DOI 10.1016/S0925-4773(00)00505-0; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Mann F, 1998, J NEUROSCI, V18, P9409; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; Meima L, 1997, MOL CELL NEUROSCI, V9, P314, DOI 10.1006/mcne.1997.0621; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; SCALES JB, 1995, ONCOGENE, V11, P1745; Schulte D, 1999, NEURON, V24, P541, DOI 10.1016/S0896-6273(00)81111-3; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Tanaka M, 1998, ONCOGENE, V17, P1509, DOI 10.1038/sj.onc.1202068; Trowe T, 1996, DEVELOPMENT, V123, P439; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	68	162	163	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					461	473		10.1016/S0896-6273(02)00786-9	http://dx.doi.org/10.1016/S0896-6273(02)00786-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165469	Bronze			2022-12-28	WOS:000177331200008
J	Pun, S; Sigrist, M; Santos, AF; Ruegg, MA; Sanes, JR; Jessell, TM; Arber, S; Caroni, P				Pun, S; Sigrist, M; Santos, AF; Ruegg, MA; Sanes, JR; Jessell, TM; Arber, S; Caroni, P			An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles	NEURON			English	Article							ACETYLCHOLINE-RECEPTORS; SYNAPTIC EFFICACY; TRANSGENIC MICE; IN-VIVO; AGRIN; MUSK; RAPSYN; CELLS; OVEREXPRESSION; EXPRESSION	We analyzed the formation of neuromuscular junctions (NMJs) in individual muscles of the mouse embryo. Skeletal muscles can be assigned to one of two distinct classes of muscles, termed "Fast Synapsing" (FaSyn) and "Delayed Synapsing" (DeSyn) muscles, which differ significantly with respect to the initial focal clustering of postsynaptic AChRs, the timing of presynaptic maturation, and the maintenance of NMJs in young adult mice. Differences between classes were intrinsic to the muscles and manifested in the absence of innervation or agrin. Paralysis or denervation of young adult muscles resulted in disassembly of AChR clusters on DeSyn muscles, whereas those on FaSyn muscles were preserved. Our results show that postsynaptic differentiation processes intrinsic to FaSyn and DeSyn muscles influence the formation of NMJs during development and their maintenance in the adult.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Biozentrum, Dept Cell Biol, CN-4056 Basel, Switzerland; Biozentrum, Dept Pharmacol, CN-4056 Basel, Switzerland; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Columbia Univ HHSC, Dept Biochem & Mol Biophys, HHMI, New York, NY 10032 USA	Friedrich Miescher Institute for Biomedical Research; Washington University (WUSTL); Columbia University; Howard Hughes Medical Institute	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Arber, Silvia/0000-0002-6261-250X				AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Burke RE, 1994, MYOLOGY, P464; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 2000, NEURON, V26, P551, DOI 10.1016/S0896-6273(00)81190-3; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Frank E, 1977, Soc Gen Physiol Ser, V32, P285; Frey D, 2000, J NEUROSCI, V20, P2534; Fuhrer C, 1999, J NEUROSCI, V19, P6405; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; HARRIS A J, 1981, Philosophical Transactions of the Royal Society of London B Biological Sciences, V293, P287, DOI 10.1098/rstb.1981.0078; JONES CL, 1979, J MORPHOL, V162, P275, DOI 10.1002/jmor.1051620207; Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; REYNOLDS ML, 1992, J NEUROCYTOL, V21, P50, DOI 10.1007/BF01206897; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Skorpen J, 1999, MOL CELL NEUROSCI, V13, P192, DOI 10.1006/mcne.1999.0743; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	36	95	96	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					357	370		10.1016/S0896-6273(02)00670-0	http://dx.doi.org/10.1016/S0896-6273(02)00670-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988168	Bronze			2022-12-28	WOS:000175214700008
J	Lu, XF; Matsuzawa, M; Hikosaka, O				Lu, XF; Matsuzawa, M; Hikosaka, O			A neural correlate of oculomotor sequences in supplementary eye field	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PRESUPPLEMENTARY MOTOR AREAS; MEMORY-GUIDED SACCADES; NEURONAL-ACTIVITY; TEMPORAL ORGANIZATION; MOVEMENTS; HAND; COORDINATION; ACTIVATION; CORTEX	Complex learned motor sequences can be composed of a combination of a small number of elementary actions. To investigate how the brain represents such sequences, we devised an oculomotor sequence task in which the monkey had to choose the target solely by the sequential context, not by the current stimulus combination. We found that many neurons in the supplementary eye field (SEF) became active with a specific target direction (D neuron) or a specific target/distractor combination (C neuron). Furthermore, such activity was often selective for one among several sequences that included the combination (S neuron). These results suggest that the SEF contributes to the generation of saccades in many learned sequences.	Juntendo Univ, Sch Med, Dept Physiol, Tokyo 1138421, Japan	Juntendo University	Hikosaka, O (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 49,Room 2A50, Bethesda, MD 20892 USA.				NATIONAL EYE INSTITUTE [ZIAEY000415, Z01EY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; BALLARD DH, 1992, PHILOS T R SOC B, V337, P331, DOI 10.1098/rstb.1992.0111; BASHINSKI HS, 1980, PERCEPT PSYCHOPHYS, V28, P241, DOI 10.3758/BF03204380; CARNAHAN H, 1991, J MOTOR BEHAV, V23, P109, DOI 10.1080/00222895.1991.9942028; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Clower WT, 1998, J NEUROPHYSIOL, V80, P1562, DOI 10.1152/jn.1998.80.3.1562; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; EPELBOIM J, 1995, VISION RES, V35, P3401, DOI 10.1016/0042-6989(95)00080-X; GAYMARD B, 1990, ANN NEUROL, V28, P622, DOI 10.1002/ana.410280504; HIKOSAKA O, 1995, J NEUROPHYSIOL, V74, P1652, DOI 10.1152/jn.1995.74.4.1652; HIKOSAKA O, 1999, NEW COGNITIVE NEUROS, P553; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kawashima R, 1998, EXP BRAIN RES, V122, P1, DOI 10.1007/s002210050485; Lu XF, 1998, J NEUROPHYSIOL, V79, P2245, DOI 10.1152/jn.1998.79.5.2245; Miyashita K, 1996, J NEUROPHYSIOL, V76, P1361, DOI 10.1152/jn.1996.76.2.1361; MURI RM, 1994, EXP BRAIN RES, V101, P521; MURI RM, 1995, EXP BRAIN RES, V104, P163; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; Petit L, 1996, J NEUROSCI, V16, P3714; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; Sakai K, 1998, J NEUROSCI, V18, P1827; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; van Donkelaar P, 2000, EXP BRAIN RES, V133, P414, DOI 10.1007/s002210000422; WURTZ RH, 1980, PROGR PSYCHOBIOLOGY, V9, P43	30	74	74	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					317	325		10.1016/S0896-6273(02)00657-8	http://dx.doi.org/10.1016/S0896-6273(02)00657-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970872	Bronze			2022-12-28	WOS:000174976200016
J	Tsvetkov, E; Carlezon, WA; Benes, FM; Kandel, ER; Bolshakov, VY				Tsvetkov, E; Carlezon, WA; Benes, FM; Kandel, ER; Bolshakov, VY			Fear conditioning occludes LTP-induced presynaptic enhancement of synaptic transmission in the cortical pathway to the lateral amygdala	NEURON			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTORS; FREQUENCY STIMULATION; NMDA RECEPTORS; LATE-PHASE; MEMORY; EXPRESSION; PLASTICITY; INDUCTION; NUCLEUS	Auditory information critical for fear conditioning, a model of emotional learning, is conveyed to the lateral nucleus of the amygdala via two routes: directly from the medial geniculate nucleus and indirectly from the auditory cortex. Here we show in the cortico-amygdala pathway that learned fear occludes electrically induced long-term potentiation (LTP). Quantal analysis of the expression of LTP in this pathway reveals a significant presynaptic component reflected in an increase in probability of transmitter release. Conditioned fear also is accompanied by the enhancement in transmitter release at this cortico-amygdala synapse. These results indicate that the synaptic projections from the auditory cortex to the lateral amygdala are modified during the acquisition and expression of fear to auditory stimulation, thus further strengthening the proposed link between LTP in the auditory pathways to the amygdala and learned fear.	Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02478 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Physiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Biophys, New York, NY 10032 USA	Harvard University; McLean Hospital; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Bolshakov, VY (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, 115 Mill St, Belmont, MA 02478 USA.	vadimb@mclean.harvard.edu	anand, amit/A-7222-2009; Tsvetkov, Evgeny A/B-6573-2016; Tsvetkov, Evgeny/C-1085-2016	Tsvetkov, Evgeny A/0000-0002-6784-0907; Tsvetkov, Evgeny/0000-0001-9339-1677; /0000-0002-4162-3947	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012736] Funding Source: NIH RePORTER; NIDA NIH HHS [DA12736] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Bauer EP, 2001, NAT NEUROSCI, V4, P687, DOI 10.1038/89465; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; BORDI F, 1992, J NEUROSCI, V12, P2493; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Campeau S, 1997, NEUROSCIENCE, V78, P1087, DOI 10.1016/S0306-4522(96)00632-X; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; EICHENBAUM H, 1995, NATURE, V378, P131, DOI 10.1038/378131a0; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Gewirtz JC, 1997, NATURE, V388, P471, DOI 10.1038/41325; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; KAPP B S, 1992, P229; Kapp BS, 1984, NEUROPSYCHOLOGY MEMO, P473; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; O'Dell T J, 1994, Learn Mem, V1, P129; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Regehr WG, 2001, SYNAPSES, P135; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	50	251	258	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 11	2002	34	2					289	300		10.1016/S0896-6273(02)00645-1	http://dx.doi.org/10.1016/S0896-6273(02)00645-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970870	Bronze			2022-12-28	WOS:000174976200014
J	Kaufmann, N; DeProto, J; Ranjan, R; Wan, H; Van Vactor, D				Kaufmann, N; DeProto, J; Ranjan, R; Wan, H; Van Vactor, D			Drosophila liprin-alpha and the receptor phosphatase Dlar control synapse morphogenesis	NEURON			English	Article							ABL TYROSINE KINASE; EXCHANGE FACTOR; NEUROMUSCULAR-JUNCTION; AXON GUIDANCE; PTP-DELTA; GROWTH; LAR; BRAIN; PHOSPHORYLATION; ULTRASTRUCTURE	Here, we examine the synaptic function of the receptor protein tyrosine phosphatase (RPTP), Dlar, and an associated intracellular protein, Dliprin-alpha, at the Drosophila larval neuromuscular junction. We show that Dliprin-alpha and Dlar are required for normal synaptic morphology. We also find that synapse complexity is proportional to the amount of Dlar gene product, suggesting that Dlar activity determines synapse size. Ultrastructural analysis reveals that Dliprin-alpha and Dlar are required to define the size and shape of the presynaptic active zone. Accordingly, there is a concomitant decrease in synaptic transmission in both mutants. Finally, epistasis analysis indicates that Dliprin-alpha is required for Dlar's action at the synapse. These data suggest a model where Dliprin-alpha and Dlar cooperate to regulate the formation and/or maintenance of a network of presynaptic proteins.	Harvard Univ, Sch Med, Dept Cell Biol, Program Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, DFCI Harvard Canc Ctr, Boston, MA 02115 USA; Childrens Hosp, Div Neurol, Boston, MA 02115 USA; Renovis Inc, San Francisco, CA 94080 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Van Vactor, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Program Neurosci, Boston, MA 02115 USA.	davie@hms.harvard.edu		Van Vactor, Jr., David L./0000-0001-8156-9482	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035909, P01NS040043] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 40043, NS 35909] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BATE M, 1995, NEURON, V15, P513, DOI 10.1016/0896-6273(95)90141-8; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; CHANG HG, 1994, J PHYSIOL-LONDON, V476, P1; Coussens CM, 2000, NEUROPHARMACOLOGY, V39, P2267, DOI 10.1016/S0028-3908(00)00087-3; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; LEBEUX YJ, 1975, CELL TISSUE RES, V160, P37; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Rodesch CK, 2000, NEUROREPORT, V11, pR45, DOI 10.1097/00001756-200012180-00002; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Sheng MHT, 2001, SYNAPSES, P315; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Stoker AW, 2001, CURR OPIN NEUROBIOL, V11, P95, DOI 10.1016/S0959-4388(00)00179-3; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Van Vactor D, 1999, ADV MOLEC BIOL, P490; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Zampighi GA, 1997, J STRUCT BIOL, V119, P347, DOI 10.1006/jsbi.1997.3882; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	45	225	230	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 28	2002	34	1					27	38		10.1016/S0896-6273(02)00643-8	http://dx.doi.org/10.1016/S0896-6273(02)00643-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931739	Bronze			2022-12-28	WOS:000174695100007
J	Gold, JI				Gold, JI			Good vibrations	NEURON			English	Editorial Material								How and where the brain forms associations between sensation and action are crucial questions in the field of cognitive neuroscience. In this issue of Neuron, Hernandez and colleagues (2002) add to an already impressive body of work elucidating the neural mechanisms responsible for forming categorical decisions about vibrotactile stimuli that guide behavior. Here they show that single neurons in premotor cortex represent, remarkably, what appears to be the entire temporal evolution of the decision process-from representation of the sensory stimulus, to formation of the discrimination, to the choice of behavioral output.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Reg Primate Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gold, JI (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.			Gold, Joshua/0000-0002-6018-0483				Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; MOUNTCASTLE VB, 1972, J NEUROPHYSIOL, V35, P122, DOI 10.1152/jn.1972.35.1.122; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301	10	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					842	844		10.1016/S0896-6273(02)00629-3	http://dx.doi.org/10.1016/S0896-6273(02)00629-3			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906691	Bronze			2022-12-28	WOS:000174389600002
J	Ibanez-Tallon, I; Miwa, JM; Wang, HL; Adams, NC; Crabtree, GW; Sine, SM; Heintz, N				Ibanez-Tallon, I; Miwa, JM; Wang, HL; Adams, NC; Crabtree, GW; Sine, SM; Heintz, N			Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1	NEURON			English	Article							FRONTAL-LOBE EPILEPSY; ALPHA-BUNGAROTOXIN BINDING; IMMUNOCYTOCHEMICAL LOCALIZATION; PATCH-CLAMP; SUBUNIT; MUTATION; BRAIN; GENE; BETA-2-SUBUNIT; NEUROTOXINS	We previously identified lynx1 as a neuronal membrane molecule related to snake alpha-neurotoxins able to modulate nAChRs. Here, we show that lynx1 colocalizes with nAChRs on CNS neurons and physically associates with nAChRs. Single-channel recordings show that lynx1 promotes the largest of three current amplitudes elicited by ACh through alpha(4)beta(2) nAChRs and that lynx1 enhances desensitization. Macroscopic recordings quantify the enhancement of desensitization onset by lynx1 and further show that it slows recovery from desensitization and increases the EC50. These experiments establish that direct interaction of lynx1 with nAChRs can result in a novel type of functional modulation and suggest that prototoxins may play important roles in vivo by modulating functional properties of their cognate CNS receptors.	Rockefeller Univ, Mol Biol Lab, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA; Mayo Clin & Mayo Fdn, Receptor Biol Lab, Dept Physiol & Biophys, Rochester, MN 55905 USA; Columbia Univ, Dept Cell Biol & Anat, Ctr Neurobiol & Behav, New York, NY 10032 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Mayo Clinic; Columbia University	Heintz, N (corresponding author), Rockefeller Univ, Mol Biol Lab, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	heintz@rockefeller.edu		Miwa, Julie/0000-0002-4418-3756	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031744, R01NS031744, P01NS030532, R01NS022061] Funding Source: NIH RePORTER; NCI NIH HHS [CA 09673] Funding Source: Medline; NINDS NIH HHS [P01 NS30532, NS-22061, NS-31744] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Buisson B, 2000, NEUROPHARMACOLOGY, V39, P2561, DOI 10.1016/S0028-3908(00)00158-1; Buisson B, 1996, J NEUROSCI, V16, P7880; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Changeux JP, 1998, BRAIN RES REV, V26, P198, DOI 10.1016/S0165-0173(97)00040-4; Chou JH, 2001, GENETICS, V157, P211; DELTORO ED, 1994, J COMP NEUROL, V349, P325, DOI 10.1002/cne.903490302; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Figl A, 1998, J PHYSIOL-LONDON, V513, P655, DOI 10.1111/j.1469-7793.1998.655ba.x; FLORES CM, 1992, MOL PHARMACOL, V41, P31; GERZANICH V, 1996, J PHARMACOL EXP THER, V286, P311; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; Hall ZW, 1999, NEURON, V23, P4, DOI 10.1016/S0896-6273(00)80745-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILL JA, 1993, J NEUROSCI, V13, P1551; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Lukas RJ, 1999, PHARMACOL REV, V51, P397; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; NAKAYAMA H, 1995, MOL BRAIN RES, V32, P321, DOI 10.1016/0169-328X(95)00092-7; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Phillips HA, 2001, AM J HUM GENET, V68, P225, DOI 10.1086/316946; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Rogers SW, 1998, J NEUROSCI, V18, P4825; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; Sine SM, 1997, J BIOL CHEM, V272, P23521, DOI 10.1074/jbc.272.38.23521; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Wang HL, 2000, J GEN PHYSIOL, V116, P449, DOI 10.1085/jgp.116.3.449; Weiland S, 1996, FEBS LETT, V398, P91, DOI 10.1016/S0014-5793(96)01215-X; White JD, 1998, ORG SYN TH, V4, P53; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	38	162	174	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 14	2002	33	6					893	903		10.1016/S0896-6273(02)00632-3	http://dx.doi.org/10.1016/S0896-6273(02)00632-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906696	Bronze			2022-12-28	WOS:000174389600007
J	Busciglio, J; Pelsman, A; Wong, C; Pigino, G; Yuan, ML; Mori, H; Yankner, BA				Busciglio, J; Pelsman, A; Wong, C; Pigino, G; Yuan, ML; Mori, H; Yankner, BA			Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome	NEURON			English	Article							HUMAN PRIMARY NEURON; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; INTRACELLULAR ACCUMULATION; SECRETED FORMS; CELL-DEATH; A-BETA; HIPPOCAMPAL-NEURONS; TRANSFECTED CELLS; DECREASED LEVELS	Most Down's syndrome (DS) patients develop Alzheimer's disease (AD) neuropathology. Astrocyte and neuronal cultures derived from fetal DS brain show alterations in the processing of amyloid beta precursor protein (AbetaPP), including increased levels of APPP and C99, reduced levels of secreted AbetaPP (AbetaPPs) and C83, and intracellular accumulation of insoluble Abeta42. This pattern of AbetaPP processing is recapitulated in normal astrocytes by inhibition of mitochondrial metabolism, consistent with impaired mitochondrial function in DS astrocytes. Intracellular Abeta42 and reduced AbetaPPs are also detected in DS and AD brains. The survival of DS neurons is markedly increased by recombinant or astrocyte-produced AbetaPPs, suggesting that AbetaPPs may be a neuronal survival factor. Thus, mitochondrial dysfunction in DS may lead to intracellular deposition of Abeta42, reduced levels of AbetaPPs, and a chronic state of increased neuronal vulnerability.	Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Osaka City Univ, Sch Med, Dept Neurosci, Abeno Ku, Osaka 5458585, Japan	University of Connecticut; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Osaka Metropolitan University	Busciglio, J (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.	busciglio@nso1.uchc.edu	Pigino, Gustavo/L-7002-2019		NICHD NIH HHS [HD38466] Funding Source: Medline; NINDS NIH HHS [NS30352, NS33325] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030352, R01NS033325] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barger SW, 1996, MOL BRAIN RES, V40, P116; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; BLASS JP, 1991, REV NEUROL, V147, P513; BOWES MP, 1994, EXP NEUROL, V129, P112, DOI 10.1006/exnr.1994.1152; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Busciglio J, 1997, J NEUROSCI, V17, P5101, DOI 10.1523/jneurosci.17-13-05101.1997; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; BUSCIGLIO J, 1993, J NEUROCHEM, V61, P1565, DOI 10.1111/j.1471-4159.1993.tb13658.x; BUSH ML, 1995, P NATL ACAD SCI USA, V92, P1861, DOI 10.1073/pnas.92.6.1861; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; COYLE JT, 1986, BRAIN RES BULL, V16, P773, DOI 10.1016/0361-9230(86)90074-2; Druzhyna N, 1998, MUTAT RES-DNA REPAIR, V409, P81, DOI 10.1016/S0921-8777(98)00042-1; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; FRIES E, 1980, P NATL ACAD SCI-BIOL, V77, P3870, DOI 10.1073/pnas.77.7.3870; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; Gasparini L, 1997, NEUROSCI LETT, V231, P113, DOI 10.1016/S0304-3940(97)00536-3; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Kim SH, 2000, CELL MOL LIFE SCI, V57, P1810, DOI 10.1007/PL00000661; Krapfenbauer K, 1999, J NEURAL TRANSM-SUPP, P211; LeBlanc A, 1995, J NEUROSCI, V15, P7837; LeBlanc AC, 1997, J NEUROCHEM, V68, P1183; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lippiello L, 1999, ARTHRITIS RHEUM, V42, pS256; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705; MANN DMA, 1988, MECH AGEING DEV, V43, P99, DOI 10.1016/0047-6374(88)90041-3; MARTIN BL, 1995, J BIOL CHEM, V270, P26727, DOI 10.1074/jbc.270.45.26727; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McConlogue L, 1996, J BIOL CHEM, V271, P1343, DOI 10.1074/jbc.271.3.1343; Misonou H, 2000, BIOCHEMISTRY-US, V39, P6951, DOI 10.1021/bi000169p; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nunomura A, 2000, J NEUROPATH EXP NEUR, V59, P1011, DOI 10.1093/jnen/59.11.1011; Odetti P, 1998, BIOCHEM BIOPH RES CO, V243, P849, DOI 10.1006/bbrc.1998.8186; Ohyagi Y, 2000, NEUROREPORT, V11, P167, DOI 10.1097/00001756-200001170-00033; Perez RG, 1997, J NEUROSCI, V17, P9407; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pigino G, 2001, J NEUROSCI, V21, P834, DOI 10.1523/JNEUROSCI.21-03-00834.2001; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; ROCH JM, 1992, J BIOL CHEM, V267, P2214; Schuchmann S, 2000, J NEUROCHEM, V74, P1205; Schuchmann S, 1998, J NEUROSCI, V18, P7216; Schupf N, 2001, NEUROSCI LETT, V301, P199, DOI 10.1016/S0304-3940(01)01657-3; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shi B, 1996, J CLIN INVEST, V98, P1979, DOI 10.1172/JCI119002; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Teller JK, 1996, NAT MED, V2, P93, DOI 10.1038/nm0196-93; Valla J, 2001, J NEUROSCI, V21, P4923, DOI 10.1523/JNEUROSCI.21-13-04923.2001; VANNOSTRAND WE, 1992, P NATL ACAD SCI USA, V89, P2551, DOI 10.1073/pnas.89.7.2551; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; YAMAMOTO K, 1994, J NEUROBIOL, V25, P585, DOI 10.1002/neu.480250510; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	69	289	296	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					677	688		10.1016/S0896-6273(02)00604-9	http://dx.doi.org/10.1016/S0896-6273(02)00604-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879646	Bronze			2022-12-28	WOS:000174286200005
J	Usachev, YM; DeMarco, SJ; Campbell, C; Strehler, EE; Thayer, SA				Usachev, YM; DeMarco, SJ; Campbell, C; Strehler, EE; Thayer, SA			Bradykinin and ATP accelerate Ca2+ efflux from rat sensory neurons via protein kinase C and the plasma membrane Ca2+ pump isoform 4	NEURON			English	Article							CALMODULIN-BINDING DOMAIN; ROOT GANGLION NEURONS; CALCIUM-PUMP; CELLS; CA2+-ATPASE; RECEPTORS; CULTURE; MECHANISMS; ANTIBODIES; STORES	Modulation of Ca2+, channels by neurotransmitters; provides critical control of neuronal excitability and synaptic strength. Little is known about regulation of the Ca2+ efflux pathways that counterbalance Call influx in neurons. We demonstrate that bradykinin and ATP significantly facilitate removal of action potential-induced Ca2+ loads by stimulating plasma membrane Ca2+-ATPases (PMCAs) in rat sensory neurons. This effect was mimicked in the soma and axonal varicosities by phorbol esters and was blocked by antagonists of protein kinase C (PKC). Reduced expression of PMCA isoform 4 abolished, and overexpression of isoform 4b enhanced, PKC-dependent facilitation of Ca2+ efflux. This acceleration of PMCA4 underlies the shortening of the action potential afterhyperpolarization produced by activation of bradykinin and purinergic receptors. Thus, isoform-specific modulation of PMCA-mediated Ca2+ efflux represents a novel mechanism to control excitability in sensory neurons.	Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; Mayo Clin & Mayo Grad Sch Med, Dept Biochem & Mol Biol, Mayo Clin, Rochester, MN 55905 USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Thayer, SA (corresponding author), Univ Minnesota, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.			Usachev, Yuriy/0000-0002-6948-4627	NIA NIH HHS [AG16678] Funding Source: Medline; NIDA NIH HHS [DA09293, DA07304] Funding Source: Medline; NIDCD NIH HHS [DC04200] Funding Source: Medline; NIGMS NIH HHS [GM58710] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009293, R37DA007304, R01DA007304] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abrahams LG, 1999, J NEUROCHEM, V73, P50, DOI 10.1046/j.1471-4159.1999.0730050.x; BALASUBRAMANYAM M, 1995, CELL CALCIUM, V18, P526, DOI 10.1016/0143-4160(95)90015-2; BENHAM CD, 1992, J PHYSIOL-LONDON, V455, P567, DOI 10.1113/jphysiol.1992.sp019316; Boyer JL, 1996, MOL PHARMACOL, V50, P1323; Brandt PC, 1996, P NATL ACAD SCI USA, V93, P13843, DOI 10.1073/pnas.93.24.13843; BURGESS GM, 1989, J NEUROSCI, V9, P3314; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Cordoba-Rodriguez R, 1999, P NATL ACAD SCI USA, V96, P7650, DOI 10.1073/pnas.96.14.7650; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; Elwess NL, 1997, J BIOL CHEM, V272, P17981, DOI 10.1074/jbc.272.29.17981; Enyedi A, 1997, J BIOL CHEM, V272, P27525, DOI 10.1074/jbc.272.44.27525; Enyedi A, 1996, J BIOL CHEM, V271, P32461, DOI 10.1074/jbc.271.50.32461; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Garcia ML, 2001, J NEUROSCI RES, V64, P661, DOI 10.1002/jnr.1120; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Hille B., 1992, IONIC CHANNELS EXCIT; Hillman DE, 1996, NEUROSCIENCE, V72, P315, DOI 10.1016/0306-4522(95)00518-8; JIN WZ, 1994, J NEUROSCI, V14, P1920; Juhaszova M, 2000, EUR J NEUROSCI, V12, P839, DOI 10.1046/j.1460-9568.2000.00974.x; Kessler F, 1999, PAIN, V83, P289, DOI 10.1016/S0304-3959(99)00108-6; Kim CC, 1998, MET MATER INT, V4, P95, DOI 10.1007/BF03026025; KoskKosicka D, 1997, MOL CELL BIOCHEM, V173, P79, DOI 10.1023/A:1006832603134; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Krizaj D, 1998, NEURON, V21, P249, DOI 10.1016/S0896-6273(00)80531-0; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; Nakamura F, 1996, P NATL ACAD SCI USA, V93, P10465, DOI 10.1073/pnas.93.19.10465; Ralevic V, 1998, PHARMACOL REV, V50, P413; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; SCHWIENING CJ, 1993, P ROY SOC B-BIOL SCI, V253, P285, DOI 10.1098/rspb.1993.0115; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; STUCKY CL, 1996, NEUROSCIENCE, V74, P111; Svichar N, 1997, NEUROREPORT, V8, P1555, DOI 10.1097/00001756-199705060-00002; THAYER SA, 1988, J NEUROSCI, V8, P4089; THOMAS D, 1994, METHOD CELL BIOL, V40, P65; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Usachev YM, 2000, PFLUG ARCH EUR J PHY, V439, P730, DOI 10.1007/s004249900240; Usachev YM, 2001, J NEUROCHEM, V76, P1756, DOI 10.1046/j.1471-4159.2001.00169.x; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; Verma AK, 1999, J BIOL CHEM, V274, P527, DOI 10.1074/jbc.274.1.527; Wang GJ, 1998, MOL PHARMACOL, V53, P88, DOI 10.1124/mol.53.1.88; Wang K K, 1992, Trends Cell Biol, V2, P46, DOI 10.1016/0962-8924(92)90162-G; WANG KKW, 1991, ARCH BIOCHEM BIOPHYS, V289, P103, DOI 10.1016/0003-9861(91)90448-R; WERTH JL, 1994, J NEUROSCI, V14, P348; Werth JL, 1996, J NEUROSCI, V16, P1008; Yamoah EN, 1998, J NEUROSCI, V18, P610; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5	51	84	84	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					113	122		10.1016/S0896-6273(01)00557-8	http://dx.doi.org/10.1016/S0896-6273(01)00557-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779484	Bronze			2022-12-28	WOS:000173106200014
J	Henderson, JT; Georgiou, J; Jia, ZP; Robertson, J; Elowe, S; Roder, JC; Pawson, T				Henderson, JT; Georgiou, J; Jia, ZP; Robertson, J; Elowe, S; Roder, JC; Pawson, T			The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function	NEURON			English	Article							LONG-TERM POTENTIATION; NEURAL DEVELOPMENT; EPHRIN LIGANDS; RAT; PROTEIN; PHOSPHORYLATION; NEUROSCIENCE; MECHANISMS; EXPRESSION; SYNAPSES	Members of the Eph family of receptor tyrosine kinases control many aspects of cellular interactions during development, including axon guidance. Here, we demonstrate that EphB2 also regulates postnatal synaptic function in the mammalian CNS. Mice lacking the EphB2 intracellular kinase domain showed wildtype levels of LTP, whereas mice lacking the entire EphB2 receptor had reduced LTP at hippocampal CA1 and dentate gyrus synapses. Synaptic NMDA-mediated current was reduced in dentate granule neurons in EphB2 null mice, as was synaptically localized NR1 as revealed by immunogold localization. Finally, we show that EphB2 is upregulated in hippocampal pyramidal neurons in vitro and in vivo by stimuli known to induce changes in synaptic structure. Together, these data demonstrate that EphB2 plays an important role in regulating synaptic function.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Henderson, JT (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		Pawson, Tony J/E-4578-2013; Jia, zhengping/AAZ-4190-2021; Georgiou, John/E-9873-2013; Roder, John/G-6468-2013; Georgiou, John/ABA-1687-2020	Georgiou, John/0000-0003-4503-6384; Georgiou, John/0000-0003-4503-6384				Ausubel FM., 2006, ENZYMATIC MANIPULATI; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Brownlee H, 2000, J COMP NEUROL, V425, P315, DOI 10.1002/1096-9861(20000918)425:2<315::AID-CNE12>3.0.CO;2-#; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Cao ZP, 2000, BRAIN RES, V859, P26, DOI 10.1016/S0006-8993(99)02450-6; CARPENTER MK, 1995, J NEUROSCI RES, V42, P199, DOI 10.1002/jnr.490420207; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DOUCETTE R, 1987, J COMP NEUROL, V261, P592, DOI 10.1002/cne.902610410; DRESCHER U, 1997, CURR BIOL, V7, P799; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Finney EM, 1998, J NEUROSCI, V18, P8826; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gao PP, 1999, P NATL ACAD SCI USA, V96, P4073, DOI 10.1073/pnas.96.7.4073; Gerlai R, 1999, J NEUROSCI, V19, P9538; Gomperts SN, 2000, J NEUROSCI, V20, P2229; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hollander E, 1997, CNS SPECTRUMS, V2, P16, DOI DOI 10.1017/S1092852900011068; Jia ZP, 1998, LEARN MEMORY, V5, P331; Lee S, 1997, MET MATER-KOREA, V3, P183, DOI 10.1007/BF03025960; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Matsunaga T, 2000, EUR J NEUROSCI, V12, P1599, DOI 10.1046/j.1460-9568.2000.00051.x; Meima L, 1997, EUR J NEUROSCI, V9, P177, DOI 10.1111/j.1460-9568.1997.tb01365.x; Milner TA, 2001, BRAIN RES BULL, V54, P131, DOI 10.1016/S0361-9230(00)00415-9; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Rudge JS, 1998, EXP NEUROL, V149, P398, DOI 10.1006/exnr.1997.6737; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SLOVITER RS, 1982, BRAIN RES BULL, V8, P771, DOI 10.1016/0361-9230(82)90104-6; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wang S, 1997, NEUROSCIENCE, V79, P117, DOI 10.1016/S0306-4522(96)00638-0; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452	46	251	262	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1041	1056		10.1016/S0896-6273(01)00553-0	http://dx.doi.org/10.1016/S0896-6273(01)00553-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754836	Bronze			2022-12-28	WOS:000172886800011
J	Kullmann, DM				Kullmann, DM			Presynaptic kainate receptors in the hippocampus: Slowly emerging from obscurity	NEURON			English	Review							EXCITATORY SYNAPTIC-TRANSMISSION; MOSSY FIBER SYNAPSES; RELEASE; INTERNEURONS; INHIBITION; PLASTICITY; MODULATION; GABA; CA3	Kainate receptor agonists depress transmitter release at several synapses in the hippocampus. Distinct mechanisms appear to underlie this phenomenon at different synapses, Recently, it has emerged that presynaptic kainate receptors can also potentiate the release of both GABA and glutamate and that axonal kainate receptors can trigger ectopic action potentials in interneurons. Because synaptically released glutamate mimics many of the actions of exogenous agonists, presynaptic kainate receptors potentially play an extensive role in hippocampal signaling.	UCL, Neurol Inst, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL, Neurol Inst, Queen Square, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009	Kullmann, Dimitri M/0000-0001-6696-3545				Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Cunha RA, 2000, FEBS LETT, V469, P159; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; Huettner JE, 2001, TRENDS NEUROSCI, V24, P365, DOI 10.1016/S0166-2236(00)01830-0; Jiang L, 2001, NEURON, V30, P503, DOI 10.1016/S0896-6273(01)00298-7; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Schmitz D, 2001, P NATL ACAD SCI USA, V98, P11003, DOI 10.1073/pnas.191351498; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Semyanov A, 2001, NAT NEUROSCI, V4, P718, DOI 10.1038/89506; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8	20	71	71	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					561	564		10.1016/S0896-6273(01)00507-4	http://dx.doi.org/10.1016/S0896-6273(01)00507-4			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719198	Bronze			2022-12-28	WOS:000172363900004
J	Schoppa, NE; Westbrook, GL				Schoppa, NE; Westbrook, GL			NMDA receptors turn to another channel for inhibition	NEURON			English	Editorial Material							CA2+-ACTIVATED K+ CHANNELS; OLFACTORY-BULB; GABA RELEASE; NEURONS	Activation of glutamate receptors generally increases neuronal excitability. However, Isaacson and Murphy show in olfactory bulb granule cells that NMDA receptor-mediated calcium influx couples to large conductance (BK) calcium-activated potassium channels. The resulting inhibition is long lasting, which may be critical to the operation of the dynamic circuitry of the bulb.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Schoppa, NE (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.							ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Grillner S, 2001, J PHYSIOL-LONDON, V533, P23, DOI 10.1111/j.1469-7793.2001.0023b.x; Halabisky B, 2000, J NEUROSCI, V20, P5124; Knaus HG, 1996, J NEUROSCI, V16, P955; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932	9	6	7	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					877	879		10.1016/S0896-6273(01)00442-1	http://dx.doi.org/10.1016/S0896-6273(01)00442-1			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580888	Bronze			2022-12-28	WOS:000171281300003
J	Blasi, V; Young, AC; Tansy, AP; Petersen, SE; Snyder, AZ; Corbetta, M				Blasi, V; Young, AC; Tansy, AP; Petersen, SE; Snyder, AZ; Corbetta, M			Word retrieval learning modulates right frontal cortex in patients with left frontal damage	NEURON			English	Article							LEFT PREFRONTAL CORTEX; VISUAL WORKING-MEMORY; RIGHT-HEMISPHERE; FUNCTIONAL MRI; POSTSTROKE APHASIA; BRAIN PLASTICITY; RECOVERY; ANATOMY; LANGUAGE; SPEECH	Previous studies have suggested that recovery or compensation of language function after a lesion in the left hemisphere may depend on mechanisms in the right hemisphere. However, a direct relationship between performance and right hemisphere activity has not been established. Here, we show that patients with left frontal lesions and partially recovered aphasia learn, at a normal rate, a novel word retrieval task that requires the damaged cortex. Verbal learning is accompanied by specific response decrements in right frontal and right occipital cortex, strongly supporting the compensatory role of the right hemisphere. Furthermore, responses in left occipital cortex are abnormal and not modulated by practice. These findings indicate that frontal cortex is a source of top-down signals during learning.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	mau@npg.wustl.edu	blasi, valeria/AAA-6407-2019; Corbetta, Maurizio/AAZ-5219-2020; Petersen, Steve/ABF-1368-2020	blasi, valeria/0000-0002-8395-0452; CORBETTA, MAURIZIO/0000-0001-8295-3304	NINDS NIH HHS [NS06833] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS006833, P50NS006833] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER MP, 1989, ARCH NEUROL-CHICAGO, V46, P885, DOI 10.1001/archneur.1989.00520440075023; ALEXANDER MP, 1997, BEHAV NEUROLOGY NEUR, P133; BALOTA DA, 1994, HDB PSYCHOLINGUISTIC, P303; BASSO A, 1989, CORTEX, V25, P555, DOI 10.1016/S0010-9452(89)80017-6; Belin P, 1996, NEUROLOGY, V47, P1504, DOI 10.1212/WNL.47.6.1504; BLUMSTEIN SE, 1995, SPEECH LANGUAGE COMM, P339; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P1249, DOI 10.1073/pnas.93.3.1249; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; CAPPA SF, 1992, APHASIOLOGY, V6, P359, DOI 10.1080/02687039208248607; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; DERENZI E, 1987, CORTEX, V23, P575, DOI 10.1016/S0010-9452(87)80050-3; Desmond JE, 1998, NEUROIMAGE, V7, P368, DOI 10.1006/nimg.1998.0340; DRINKERS NF, 2000, NEW COGNITIVE NEUROS, P949; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; GAZZANIGA MS, 1983, AM PSYCHOL, V38, P525, DOI 10.1037/0003-066X.38.5.525; Goodglass H., 1964, CORTEX, V1, P133, DOI [10.1016/S0010-9452(64)80018-6, DOI 10.1016/S0010-9452(64)80018-6]; Gowers WR, 1887, LECT DIAGNOSIS DIS B; Heiss WD, 1999, ANN NEUROL, V45, P430, DOI 10.1002/1531-8249(199904)45:4<430::AID-ANA3>3.0.CO;2-P; Hodges JR, 2001, PHILOS T R SOC B, V356, P1423, DOI 10.1098/rstb.2001.0943; Karbe H, 1998, BRAIN LANG, V64, P215, DOI 10.1006/brln.1998.1961; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KERTESZ A, 1977, BRAIN, V100, P1, DOI 10.1093/brain/100.1.1; KINSBOURNE M, 1971, ARCH NEUROL-CHICAGO, V25, P302, DOI 10.1001/archneur.1971.00490040028003; Kinsbourne M, 1977, Adv Neurol, V18, P41; KNIGHT RT, 1989, BRAIN RES, V504, P338, DOI 10.1016/0006-8993(89)91381-4; Leff A, 2002, ANN NEUROL, V51, P553, DOI 10.1002/ana.10181; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Miller EK, 1996, J NEUROSCI, V16, P5154; MOHR JP, 1978, NEUROLOGY, V28, P311, DOI 10.1212/WNL.28.4.311; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; Ojemann JG, 1998, HUM BRAIN MAPP, V6, P203, DOI 10.1002/(SICI)1097-0193(1998)6:4<203::AID-HBM2>3.0.CO;2-7; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; PETERSEN SE, 1993, ANNU REV NEUROSCI, V16, P509, DOI 10.1146/annurev.ne.16.030193.002453; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Rijntjes M, 2002, PROG NEUROBIOL, V66, P109, DOI 10.1016/S0301-0082(01)00027-2; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; Swick D, 1998, ATTENTIVE BRAIN, P143; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wernicke K., 1908, MODERN CLIN MED DIS; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; YAMAGUCHI S, 1990, BRAIN RES, V521, P281, DOI 10.1016/0006-8993(90)91553-S; ZAIDEL E, 1981, BRAIN LANG, V14, P205, DOI 10.1016/0093-934X(81)90077-8	57	130	131	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					159	170		10.1016/S0896-6273(02)00936-4	http://dx.doi.org/10.1016/S0896-6273(02)00936-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367514	Bronze			2022-12-28	WOS:000178295100015
J	Burns, ME; Mendez, A; Chen, J; Baylor, DA				Burns, ME; Mendez, A; Chen, J; Baylor, DA			Dynamics of cyclic GMP synthesis in retinal rods	NEURON			English	Article							CYTOPLASMIC CALCIUM-CONCENTRATION; PHOTORECEPTOR LIGHT ADAPTATION; GUANYLATE-CYCLASE; OUTER SEGMENTS; SALAMANDER RODS; PHOTOTRANSDUCTION CASCADE; SENSITIVE CONDUCTANCE; PLASMA-MEMBRANE; GATED CHANNELS; DARK NOISE	In retinal rods, Ca2+ exerts negative feedback control on cGMP synthesis by guanylate cyclase (GC). This feedback loop was disrupted in mouse rods lacking guanylate cyclase activating proteins GCAP1 and GCAP2 (GCAPs(-/-)). Comparison of the behavior of wild-type and GCAPs(-/-) rods allowed us to investigate the role of the feedback loop in normal rod function. We have found that regulation of GC is apparently the only Ca2+ feedback loop operating during the single photon response. Analysis of the rods' light responses and cellular dark noise suggests that GC normally responds to light-driven changes in [Ca2+] rapidly and highly cooperatively. Rapid feedback to GC speeds the rod's temporal responsiveness and improves its signal-to-noise ratio by minimizing fluctuations in cGMP.	Stanford Univ, Med Ctr, Dept Neurobiol, Stanford, CA 94305 USA; Univ So Calif, Keck Sch Med, Doheny Eye Inst, Mary D Allen Lab Vis Res, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; Univ Calif Davis, Dept Psychiat, Davis, CA 95616 USA; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	Stanford University; Doheny Eye Institute; University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Davis; University of California System; University of California Davis	Burns, ME (corresponding author), Stanford Univ, Med Ctr, Dept Neurobiol, Stanford, CA 94305 USA.		Méndez, Ana/F-9729-2016	Méndez, Ana/0000-0001-6393-1644	NATIONAL EYE INSTITUTE [R01EY012703, R01EY014047, R01EY005750] Funding Source: NIH RePORTER; NEI NIH HHS [EY05750, EY12703, R01 EY014047-02, R01 EY012703, R01 EY014047] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; Calvert PD, 2002, J GEN PHYSIOL, V119, P129, DOI 10.1085/jgp.119.2.129; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; Detwiler PB, 2000, METHOD ENZYMOL, V316, P133; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; DODD RL, 1998, THESIS STANFORD U ST; FAIN GL, 1989, J PHYSIOL-LONDON, V416, P215, DOI 10.1113/jphysiol.1989.sp017757; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Karpen JW, 1996, J GEN PHYSIOL, V107, P169, DOI 10.1085/jgp.107.2.169; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P863, DOI 10.1085/jgp.106.5.863; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P891, DOI 10.1085/jgp.106.5.891; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; Lyubarsky A, 1996, J GEN PHYSIOL, V107, P19, DOI 10.1085/jgp.107.1.19; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; MATTHEWS HR, 1995, J PHYSIOL-LONDON, V484, P267, DOI 10.1113/jphysiol.1995.sp020664; Matthews HR, 2000, METHOD ENZYMOL, V316, P146; MCCARTHY ST, 1994, BIOPHYS J, V67, P2076, DOI 10.1016/S0006-3495(94)80691-5; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P731, DOI 10.1113/jphysiol.1988.sp016943; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; Olshevskaya EV, 1999, J BIOL CHEM, V274, P10823, DOI 10.1074/jbc.274.16.10823; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Ruiz M, 1999, BIOCHEMISTRY-US, V38, P10642, DOI 10.1021/bi990532w; Sampath AP, 1998, J GEN PHYSIOL, V111, P53, DOI 10.1085/jgp.111.1.53; TORRE V, 1986, P NATL ACAD SCI USA, V83, P7109, DOI 10.1073/pnas.83.18.7109; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738; YAU KW, 1984, NATURE, V311, P661, DOI 10.1038/311661a0; YAU KW, 1985, NATURE, V317, P252, DOI 10.1038/317252a0; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0	56	179	180	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					81	91		10.1016/S0896-6273(02)00911-X	http://dx.doi.org/10.1016/S0896-6273(02)00911-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367508	Bronze			2022-12-28	WOS:000178295100009
J	Mata, NL; Radu, RA; Clemmons, RS; Travis, GH				Mata, NL; Radu, RA; Clemmons, RS; Travis, GH			Isomerization and oxidation of vitamin a in cone-dominant retinas: A novel pathway for visual-pigment regeneration in daylight	NEURON			English	Article							RETINALDEHYDE-BINDING PROTEIN; MONKEY MACACA-FASCICULARIS; ROD OUTER SEGMENTS; IMMUNOCYTOCHEMICAL LOCALIZATION; ACYLTRANSFERASE ACTIVITY; VERTEBRATE RETINA; SMALL-INTESTINE; CHICKEN RETINA; ACYL-COENZYME; EPITHELIUM	The first step toward light perception is 11-cis to all-trans photoisomerization of the retinaldehyde chromophore in a rod or cone opsin-pigment molecule. Light sensitivity of the opsin pigment is restored through a multistep pathway called the visual cycle, which effects all-trans to 11-cis re-isomerization of the retinoid chromophore. The maximum throughput of the known visual cycle, however, is too slow to explain sustained photosensitivity in bright light. Here, we demonstrate three novel enzymatic activities in cone-dominant ground-squirrel and chicken retinas: an all-trans-retinol isomerase, an 11-cis-retinyl-ester synthase, and an 11-cis-retinol dehydrogenase. Together these activities comprise a novel pathway that regenerates opsin photopigments at a rate 20-fold faster than the known visual cycle. We suggest that this pathway is responsible for sustained daylight vision in vertebrates.	Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75235 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Travis, GH (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.		Radu, Roxana A./K-8924-2019; Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493; Radu, Roxana/0000-0002-5064-6403	NEI NIH HHS [R01 EY011713-13, R01 EY011713] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011713] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER AJ, 1991, EXP EYE RES, V53, P337, DOI 10.1016/0014-4835(91)90239-B; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BOK D, 1984, INVEST OPHTH VIS SCI, V25, P877; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; CHEN Y, 1994, BIOCHEMISTRY-US, V33, P10658, DOI 10.1021/bi00201a013; Cideciyan AV, 2000, VISUAL NEUROSCI, V17, P667, DOI 10.1017/S0952523800175029; Cornwall MC, 2000, INVEST OPHTH VIS SCI, V41, pS598; Crabb JW, 1998, PROTEIN SCI, V7, P746, DOI 10.1002/pro.5560070324; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; DEFOE DM, 1983, INVEST OPHTH VIS SCI, V24, P1211; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; DEUTSCH J, 1994, ANAL BIOCHEM, V220, P321, DOI 10.1006/abio.1994.1344; FUKADA Y, 1990, BIOCHEMISTRY-US, V29, P3133, DOI 10.1021/bi00464a033; FULTON BS, 1987, BIOCHEMISTRY-US, V26, P7938, DOI 10.1021/bi00398a059; GOLDSTEIN EB, 1973, VISION RES, V13, P527, DOI 10.1016/0042-6989(73)90022-9; GULCAN HG, 1993, INVEST OPHTH VIS SCI, V34, P3187; GUPTA BD, 1990, J PHYSIOL-LONDON, V430, P483, DOI 10.1113/jphysiol.1990.sp018303; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; HELGERUD P, 1983, J CLIN INVEST, V71, P747, DOI 10.1172/JCI110822; HOOD DC, 1973, VISION RES, V13, P1943, DOI 10.1016/0042-6989(73)90065-5; Jang GF, 2001, J BIOL CHEM, V276, P32456, DOI 10.1074/jbc.M104949200; Jang GF, 2000, J BIOL CHEM, V275, P28128; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kefalov VJ, 2001, INVEST OPHTH VIS SCI, V42, pS119; Krebs WK I.P., 1982, STRUCTURE EYE, P175; LAI YL, 1982, NATURE, V298, P848, DOI 10.1038/298848a0; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; LIN ZS, 1989, VISION RES, V29, P1699, DOI 10.1016/0042-6989(89)90152-1; MACDONALD PN, 1988, J BIOL CHEM, V263, P12478; MAKINO CL, 1991, J PHYSIOL-LONDON, V442, P761, DOI 10.1113/jphysiol.1991.sp018818; MATA NL, 1992, J BIOL CHEM, V267, P9794; MEYER DB, 1973, EXP EYE RES, V17, P347, DOI 10.1016/0014-4835(73)90244-3; Mondal MS, 2000, BIOCHEMISTRY-US, V39, P5215, DOI 10.1021/bi9929554; NICOTRA CMA, 1994, MOL CELL BIOCHEM, V132, P45, DOI 10.1007/BF00925674; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; PUGH EN, 2000, HDB BIOL PHYSICS, P184; RANDO RR, 1983, J AM CHEM SOC, V105, P2879, DOI 10.1021/ja00347a058; RASMUSSEN KE, 1975, EXP EYE RES, V20, P151, DOI 10.1016/0014-4835(75)90153-0; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rodieck R.W., 1998, 1 STEPS SEEING; RODRIGUEZ KA, 1989, AM J PHYSIOL, V256, pR255, DOI 10.1152/ajpregu.1989.256.1.R255; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Saari J. C., 1994, Retinoids: from basic science to clinical applications., P43; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SAARI JC, 1988, J BIOL CHEM, V263, P8084; SAARI JC, 1987, J BIOL CHEM, V262, P7618; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; SAARI JC, 1993, BIOCHEM J, V291, P697, DOI 10.1042/bj2910697; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; SHI YQ, 1993, BIOCHEMISTRY-US, V32, P1257, DOI 10.1021/bi00056a009; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; TARDI PG, 1992, LIPIDS, V27, P65, DOI 10.1007/BF02537062; TREHAN A, 1990, BIOCHEMISTRY-US, V29, P309, DOI 10.1021/bi00454a001; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; WEST RW, 1975, J COMP NEUROL, V159, P439, DOI 10.1002/cne.901590402; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; YOUNG RW, 1971, J ULTRA MOL STRUCT R, V34, P190, DOI 10.1016/S0022-5320(71)90014-1	65	286	296	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					69	80		10.1016/S0896-6273(02)00912-1	http://dx.doi.org/10.1016/S0896-6273(02)00912-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367507	Bronze, Green Accepted			2022-12-28	WOS:000178295100008
J	Chatterjee, S; Callaway, EM				Chatterjee, S; Callaway, EM			S cone contributions to the magnocellular visual pathway in macaque monkey	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; BLUE-SENSITIVE CONES; PRIMATE RETINA; STRIATE CORTEX; CHROMATIC MECHANISMS; PHYSIOLOGICAL-BASIS; RECEPTIVE-FIELDS; HORIZONTAL CELLS; SINGLE NEURONS	The magnocellular visual pathway is believed to receive input from long (L) and middle (M), but not short (S), wavelength-sensitive cones. Recording from neurons in magnocellular layers of lateral geniculate nucleus (LGN) in macaque monkeys, we found that magnocellular neurons were unequivocally responsive to S cone-isolating stimuli. A quantitative analysis suggests that S cones provided about 10% of the input to these cells, on average, while L:M ratios were far more variable. S cone signals influenced responses with the same sign as L and M cone inputs (i.e., no color opponency). Magnocellular afferent recordings following inactivation of primary visual cortex demonstrated that S cone signals were feedforward in nature and did not arise from cortical feedback to LGN.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; Univ Calif San Diego, Neurosci Program, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Chatterjee, S (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267	NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NEI NIH HHS [EY10742] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aguilar M., 1954, OPT ACTA, V1, DOI [10.1080/713818657, DOI 10.1080/713818657]; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Bumsted K, 1999, J COMP NEUROL, V403, P502; Calkins DJ, 2001, PROG RETIN EYE RES, V20, P255, DOI 10.1016/S1350-9462(00)00026-4; Calkins DJ, 2000, J OPT SOC AM A, V17, P597, DOI 10.1364/JOSAA.17.000597; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CAVANAGH P, 1991, VISION RES, V31, P2109, DOI 10.1016/0042-6989(91)90169-6; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; CHICHILNISKY EJ, 1993, VISION RES, V33, P2113, DOI 10.1016/0042-6989(93)90010-T; Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; Cottaris NP, 1998, NATURE, V395, P896, DOI 10.1038/27666; CREUTZFELDT OD, 1979, EXP BRAIN RES, V35, P527; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2000, J OPT SOC AM A, V17, P589, DOI 10.1364/JOSAA.17.000589; Dacey DM, 1996, SCIENCE, V271, P656, DOI 10.1126/science.271.5249.656; DEMONASTERIO FM, 1981, SCIENCE, V213, P1278, DOI 10.1126/science.7268439; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; Dobkins KR, 2000, J OPT SOC AM A, V17, P545, DOI 10.1364/JOSAA.17.000545; Dobkins KR, 2000, NEURON, V25, P15, DOI 10.1016/S0896-6273(00)80867-3; Dougherty RF, 1999, NEURON, V24, P893, DOI 10.1016/S0896-6273(00)81036-3; DRUM B, 1983, VISION RES, V23, P1433, DOI 10.1016/0042-6989(83)90155-4; EISNER A, 1980, J OPT SOC AM, V70, P121, DOI 10.1364/JOSA.70.000121; FITZPATRICK D, 1994, VISUAL NEUROSCI, V11, P307, DOI 10.1017/S0952523800001656; GEGENFURTNER KR, 1994, VISUAL NEUROSCI, V11, P455, DOI 10.1017/S095252380000239X; Goodchild AK, 1996, J COMP NEUROL, V366, P55, DOI 10.1002/(SICI)1096-9861(19960226)366:1<55::AID-CNE5>3.0.CO;2-J; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HOOD DC, 1986, HDB PERCEPTION HUMAN; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; KAISER PK, 1990, J PHYSIOL-LONDON, V422, P153, DOI 10.1113/jphysiol.1990.sp017978; KLUG KY, 1993, INVEST OPHTH VIS SCI, V34, pA1398; LEE BB, 1989, J PHYSIOL-LONDON, V414, P223, DOI 10.1113/jphysiol.1989.sp017685; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; Lee BB, 1997, VISION RES, V37, P2813, DOI 10.1016/S0042-6989(97)00108-9; LEE J, 1989, J PHYSIOL-LONDON, V413, P563, DOI 10.1113/jphysiol.1989.sp017669; LENNIE P, 1993, J OPT SOC AM A, V10, P1283, DOI 10.1364/JOSAA.10.001283; LENNIE P, 1990, J NEUROSCI, V10, P649; LEVITT JB, 1994, J COMP NEUROL, V342, P551, DOI 10.1002/cne.903420405; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; MARIMONT DH, 1994, J OPT SOC AM A, V11, P3113, DOI 10.1364/JOSAA.11.003113; Martin PR, 1998, J PHYSIOL-LONDON, V513, P631, DOI 10.1111/j.1469-7793.1998.631ba.x; Martin PR, 1999, J COMP NEUROL, V406, P1, DOI 10.1002/(SICI)1096-9861(19990329)406:1<1::AID-CNE1>3.0.CO;2-1; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Mullen KT, 1996, VISION RES, V36, P1995, DOI 10.1016/0042-6989(95)00261-8; NOTHDURFT HC, 1982, EXP BRAIN RES, V48, P43; Packer OS, 1996, J NEUROSCI, V16, P2251; PADMOS P, 1975, VISION RES, V15, P617, DOI 10.1016/0042-6989(75)90311-9; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Rodieck R.W., 1998, 1 STEPS SEEING; Roorda A, 2001, VISION RES, V41, P1291, DOI 10.1016/S0042-6989(01)00043-8; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; SCHILLER PH, 1978, J NEUROPHYSIOL, V41, P788, DOI 10.1152/jn.1978.41.3.788; SCHNEEWEISS A, 1988, GERIATR CARDIOVASC, V1, P255; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; SHAPIRO MB, 1985, J AM STAT ASSOC, V80, P803, DOI 10.2307/2288535; SHAPLEY R, 1986, TRENDS NEUROSCI, V9, P229, DOI 10.1016/0166-2236(86)90064-0; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P674; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; STOCKMAN A, 1993, J OPT SOC AM A, V10, P1396, DOI 10.1364/JOSAA.10.001396; Teufel HJ, 2000, J OPT SOC AM A, V17, P994, DOI 10.1364/JOSAA.17.000994; VERDON W, 1987, J OPT SOC AM A, V4, P91, DOI 10.1364/JOSAA.4.000091; VOS JJ, 1990, VISION RES, V30, P937, DOI 10.1016/0042-6989(90)90059-T; Wandell B., 1995, FDN VISION; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; WIKLER KC, 1990, J NEUROSCI, V10, P3390; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916	73	88	89	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1135	1146		10.1016/S0896-6273(02)00874-7	http://dx.doi.org/10.1016/S0896-6273(02)00874-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354402	Bronze			2022-12-28	WOS:000178040000013
J	Buckner, RL				Buckner, RL			Frontally mediated control processes contribute to source memory retrieval	NEURON			English	Editorial Material							LOBE		Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Radiol, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Buckner, RL (corresponding author), Washington Univ, Dept Psychol, 1 Brookings Dr, St Louis, MO 63130 USA.							Burgess PW, 1996, MEMORY, V4, P359, DOI 10.1080/096582196388906; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fletcher PC, 2000, NEUROIMAGE, V12, P404, DOI 10.1006/nimg.2000.0633; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; MILNER B, 1985, HUM NEUROBIOL, V4, P137; Moscovitch M., 1989, VARIETIES MEMORY CON, P133; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; Schacter DL, 1996, NEUROPSYCHOLOGIA, V34, P793, DOI 10.1016/0028-3932(95)00165-4; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792	12	8	8	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					817	818		10.1016/S0896-6273(02)00866-8	http://dx.doi.org/10.1016/S0896-6273(02)00866-8			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372276	Bronze			2022-12-28	WOS:000177779800004
J	Thiel, CM; Friston, KJ; Dolan, RJ				Thiel, CM; Friston, KJ; Dolan, RJ			Cholinergic modulation of experience-dependent plasticity in human auditory cortex	NEURON			English	Article							RECEPTIVE-FIELD PLASTICITY; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-BLOOD-FLOW; NUCLEUS BASALIS; PHYSIOLOGICAL MEMORY; GUINEA-PIG; SCOPOLAMINE; STIMULATION; BRAIN; FEAR	The factors that influence experience-dependent plasticity in the human brain are unknown. We used event-related functional magnetic resonance imaging (fMRI) and a pharmacological manipulation to measure cholinergic modulation of experience-dependent plasticity in human auditory cortex. In a differential aversive conditioning paradigm, subjects were presented with high (1600 Hz) and low tones (400 Hz), one of which was conditioned by pairing with an electrical shock. Prior to presentation, subjects were given either a placebo or an anticholinergic drug (0.4 mg iv scopolamine). Experience-dependent plasticity, expressed as a conditioning-specific enhanced BOLD response, was evident in auditory cortex in the placebo group, but not with scopolamine. This study provides in vivo evidence that experience-dependent plasticity, evident in hemodynamic changes in human auditory cortex, is modulated by acetylcholine.	Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1 3BG, England; Royal Free Hosp, Sch Med, London NW3 2PF, England; Forschungszentrum Julich, Inst Med, D-52425 Julich, Germany	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Helmholtz Association; Research Center Julich	Thiel, CM (corresponding author), Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1 3BG, England.	c.thiel@fz-juelich.de	Friston, Karl/D-9230-2011	Friston, Karl/0000-0001-7984-8909; , Christiane/0000-0003-4788-4301; Dolan, Ray/0000-0001-9356-761X				Acquas E, 1996, J NEUROSCI, V16, P3089; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; Bakin JS, 1996, BEHAV NEUROSCI, V110, P905, DOI 10.1037/0735-7044.110.5.905; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; CURRAN HV, 1991, PSYCHOPHARMACOLOGY, V103, P83; DIAMOND DM, 1986, BRAIN RES, V372, P357, DOI 10.1016/0006-8993(86)91144-3; Ebert U, 1998, J CLIN PHARMACOL, V38, P720, DOI 10.1002/j.1552-4604.1998.tb04812.x; Edeline JM, 1999, PROG NEUROBIOL, V57, P165, DOI 10.1016/S0301-0082(98)00042-2; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P82, DOI 10.1037/0735-7044.107.1.82; FREY KA, 1992, J CEREBR BLOOD F MET, V12, P147, DOI 10.1038/jcbfm.1992.18; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Golding JF, 1997, BRIT J CLIN PHARMACO, V43, P633, DOI 10.1046/j.1365-2125.1997.00606.x; GONZALEZLIMA F, 1986, BEHAV BRAIN RES, V20, P281, DOI 10.1016/0166-4328(86)90228-7; HARS B, 1993, NEUROSCIENCE, V56, P61, DOI 10.1016/0306-4522(93)90562-T; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; METHERATE R, 1989, BRAIN RES, V480, P372, DOI 10.1016/0006-8993(89)90210-2; Miasnikov AA, 2001, NEUROREPORT, V12, P1537, DOI 10.1097/00001756-200105250-00047; MOLCHAN SE, 1994, P NATL ACAD SCI USA, V91, P8122, DOI 10.1073/pnas.91.17.8122; Morris JS, 1998, P ROY SOC B-BIOL SCI, V265, P649, DOI 10.1098/rspb.1998.0343; PUTCHA L, 1989, PHARMACEUT RES, V6, P481, DOI 10.1023/A:1015916423156; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; SAFER DJ, 1971, BIOL PSYCHIAT, V3, P347; SANNITA WG, 1987, DOC OPHTHALMOL, V67, P379, DOI 10.1007/BF00143956; Schreurs BG, 1997, J NEUROPHYSIOL, V77, P2153, DOI 10.1152/jn.1997.77.4.2153; Talairach J., 1988, COPLANAR STEREOTAXIC; Thiel CM, 2000, BRAIN RES, V882, P112, DOI 10.1016/S0006-8993(00)02842-0; Thiel CM, 2001, J NEUROSCI, V21, P6846, DOI 10.1523/JNEUROSCI.21-17-06846.2001; Tsukada H, 1997, BRAIN RES, V749, P10, DOI 10.1016/S0006-8993(96)01028-1; Vitiello B, 1997, NEUROPSYCHOPHARMACOL, V16, P15, DOI 10.1016/S0893-133X(96)00134-0; Weinberger NM, 1998, NEUROBIOL LEARN MEM, V70, P226, DOI 10.1006/nlme.1998.3850; ZILLES K, 2001, NEUROIMAGE, V14, P8	38	99	99	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					567	574		10.1016/S0896-6273(02)00801-2	http://dx.doi.org/10.1016/S0896-6273(02)00801-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165477	Bronze, Green Published			2022-12-28	WOS:000177331200016
J	Kuromi, H; Kidokoro, Y				Kuromi, H; Kidokoro, Y			Selective replenishment of two vesicle pools depends on the source of Ca2+ at the Drosophila synapse	NEURON			English	Article							DISTINCT POOLS; CALCIUM; ENDOCYTOSIS; INHIBITION; TRANSMITTER; METABOLISM; MEMBRANE; MUTANT; FIBER	After synaptic vesicles (SVs) undergo exocytosis, SV pools are replenished by recycling SVs at nerve terminals. At Drosophila neuromuscular synapses, there are two distinct SV pools (i.e., the exo/endo cycling pool (ECP), which primarily maintains synaptic transmission, and the reserve pool (RP), which participates in synaptic transmission only during tetanic stimulation). Labeling endocytosed vesicular structures with a fluorescent styryl dye, FM1-43, and measuring intracellular Call concentrations with a Ca2+ indicator, rhod-2, we show here that the ECP is replenished by SVs endocytosed during stimulation, and this process depends on external Ca2+. In contrast, the RP is refilled after cessation of tetanus by a process mediated by Ca2+ released from internal stores.	Gunma Univ, Sch Med, Inst Behav Sci, Maebashi, Gumma 3718511, Japan	Gunma University	Kuromi, H (corresponding author), Gunma Univ, Sch Med, Inst Behav Sci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	kuromi@med.gunma-u.ac.jp						AIUCHI T, 1985, BIOCHIM BIOPHYS ACTA, V843, P20, DOI 10.1016/0304-4165(85)90044-3; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Dittman JS, 1998, J NEUROSCI, V18, P6147; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; KOENIG JH, 1993, J NEUROSCI, V13, P2313, DOI 10.1523/JNEUROSCI.13-06-02313.1993; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; MELAMED N, 1993, J NEUROSCI, V13, P632; NARAHASHI T, 1974, PHYSIOL REV, V54, P813, DOI 10.1152/physrev.1974.54.4.813; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Tabb JS, 1998, J CELL SCI, V111, P3221; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1	36	73	76	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					333	343		10.1016/S0896-6273(02)00777-8	http://dx.doi.org/10.1016/S0896-6273(02)00777-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160750	Bronze			2022-12-28	WOS:000177034200012
J	Kleinfeld, D; Sachdev, RNS; Merchant, LM; Jarvis, MR; Ebner, FF				Kleinfeld, D; Sachdev, RNS; Merchant, LM; Jarvis, MR; Ebner, FF			Adaptive filtering of vibrissa input in motor cortex of rat	NEURON			English	Article							BARREL FIELD CORTEX; CORTICOTHALAMIC PROJECTIONS; SOMATOSENSORY CORTEX; WHISKER STIMULATION; RESPONSE PROPERTIES; RECEPTIVE-FIELDS; CEREBRAL-CORTEX; SENSORY INPUT; AWAKE RATS; ADULT-RATS	We studied the transformation of sensory input as it progresses from vibrissa primary sensor (S1) to motor (M1) cortex. Single-unit activity was obtained from alert adult rats that did not to whisk upon application of punctate, rhythmic stimulation of individual vibrissae. The spike response of units in S1 cortex largely reproduced the shape of the stimulus. In contrast, the spiking output of units in M1 cortex were modulated solely as a sinusoid at the repetition rate of the stimulus for frequencies between 5 and 15 Hz; this range corresponds to that of natural whisking. Thus, the S1 to M1 transformation extracts the fundamental frequency from a spectrally rich stimulus. We discuss our results in terms of a band-pass filter with a center frequency that adapts to the change in stimulation rate.	Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Vanderbilt University; California Institute of Technology	Kleinfeld, D (corresponding author), Univ Calif San Diego, Dept Phys, 9500 Gilman Drive 0319, La Jolla, CA 92093 USA.			Sachdev, Robert/0000-0002-6627-0199	NIMH NIH HHS [MH59867] Funding Source: Medline; NINDS NIH HHS [NS13031] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013031] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; ANDERSSON G, 1995, ACTA PHYSIOL SCAND, V153, P381, DOI 10.1111/j.1748-1716.1995.tb09876.x; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1988, EXP BRAIN RES, V70, P155; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; ASANUMA H, 1980, EXP BRAIN RES, V38, P349; Bermejo R, 1996, SOMATOSENS MOT RES, V13, P225, DOI 10.3109/08990229609052578; Best RE., 1984, PHASE LOCKED LOOPS T; Bruehl C, 1998, EPILEPSY RES, V32, P379, DOI 10.1016/S0920-1211(98)00066-7; CARVELL GE, 1991, SOMATOSENS MOT RES, V8, P159, DOI 10.3109/08990229109144740; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; CASSELLA JV, 1987, J NEUROSCI METH, V19, P105, DOI 10.1016/0165-0270(87)90025-2; CHAPIN JK, 1981, BRAIN RES BULL, V6, P63, DOI 10.1016/S0361-9230(81)80069-X; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; CHIAIA NL, 1991, J COMP NEUROL, V314, P217, DOI 10.1002/cne.903140203; Dayan P., 2002, THEORETICAL NEUROSCI; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; DONOGHUE JP, 1988, J NEUROSCI, V8, P3221; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Farkas T, 1999, NEUROSCIENCE, V90, P353, DOI 10.1016/S0306-4522(98)00451-5; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; GIOANNI Y, 1985, BRAIN RES, V344, P49, DOI 10.1016/0006-8993(85)91188-6; HERMAN D, 1985, EXP BRAIN RES, V57, P598; HESS WJ, 1982, PHONETICA, V39, P219, DOI 10.1159/000261664; IZRAELI R, 1995, EXP BRAIN RES, V104, P41; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Keller A, 1996, NEUROREPORT, V7, P2373, DOI 10.1097/00001756-199610020-00019; Kim U, 1999, J COMP NEUROL, V408, P489; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; KLEINFELD D, 1997, J COMP NEUROL, V378; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; MAYS LE, 1980, SCIENCE, V208, P1163, DOI 10.1126/science.6769161; MCCALL RB, 1979, BRAIN RES, V169, P11, DOI 10.1016/0006-8993(79)90370-6; MIYASHITA E, 1994, EXP BRAIN RES, V99, P223; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; O'Connor SM, 2002, J NEUROPHYSIOL, V87, P2137, DOI 10.1152/jn.00229.2001; PARRY TJ, 1993, PHYSIOL BEHAV, V53, P1011, DOI 10.1016/0031-9384(93)90283-L; PERCIVAL DB, 1993, SPECTRAL ANAL PHYSIC; PIERCE JR, 1991, J ACOUST SOC AM, V90, P1889, DOI 10.1121/1.401667; Sachdev RNS, 2000, J NEUROPHYSIOL, V84, P1497, DOI 10.1152/jn.2000.84.3.1497; SANDERSON KJ, 1984, BRAIN RES, V292, P251, DOI 10.1016/0006-8993(84)90761-3; SHARP FR, 1982, J COMP NEUROL, V208, P255, DOI 10.1002/cne.902080305; SIMONS DJ, 1983, BRAIN RES, V276, P178, DOI 10.1016/0006-8993(83)90561-9; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; SOMPOLINSKY H, 1990, P NATL ACAD SCI USA, V87, P7200, DOI 10.1073/pnas.87.18.7200; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; SWADLOW HA, 1994, J NEUROPHYSIOL, V71, P437, DOI 10.1152/jn.1994.71.2.437; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Veinante P, 2000, J COMP NEUROL, V424, P197, DOI 10.1002/1096-9861(20000821)424:2<197::AID-CNE1>3.0.CO;2-6; WEISS DS, 1994, CEREB CORTEX, V4, P205, DOI 10.1093/cercor/4.2.205; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WONGRILEY MTT, 1976, BRAIN RES, V108, P257, DOI 10.1016/0006-8993(76)90185-2; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	62	84	84	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					1021	1034		10.1016/S0896-6273(02)00732-8	http://dx.doi.org/10.1016/S0896-6273(02)00732-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086648	Bronze			2022-12-28	WOS:000176249700018
J	Peretz, D; Williamson, RA; Legname, G; Matsunaga, Y; Vergara, J; Burton, DR; DeArmond, SJ; Prusiner, SB; Scott, MR				Peretz, D; Williamson, RA; Legname, G; Matsunaga, Y; Vergara, J; Burton, DR; DeArmond, SJ; Prusiner, SB; Scott, MR			A change in the conformation of prions accompanies the emergence of a new prion strain	NEURON			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; SECONDARY STRUCTURE; MOLECULAR-BASIS; SCRAPIE AGENT; PRP ISOFORMS; CELLULAR PRP; PROTEIN; MICE; TRANSMISSION	To investigate the role of the pathogenic prion protein (PrPSc) in controlling susceptibility to foreign prions, two Syrian hamster (SHa) prion strains, Sc237 and DY, were transmitted to transgenic mice expressing chimeric SHa/mouse PrP genes, Tg(MH2M), First passage of SHa(Sc237) prions exhibited prolonged incubation times, diagnostic of a species barrier. PrPSc of the new MH2M(Sc237) strain possessed different structural properties from those of SHa(Sc237), as demonstrated by relative conformational stability measurements. This change was accompanied by a disease phenotype different from the SHa(Sc237) strain. Conversely, transmission of SHa(DY) prions to Tg(MH2M) mice showed no species barrier, and the MH2M(DY) strain retained the conformational and disease-specific properties of SHa(DY). These results suggest a causal relationship between species barriers, changes in PrPSc conformation, and the emergence of new prion strains.	Scripps Res Inst, Res Inst, Dept Immunol & Mol Biol, La Jolla, CA 92037 USA; Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prusiner, SB (corresponding author), Scripps Res Inst, Res Inst, Dept Immunol & Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ind@itsa.ucsf.edu	Legname, Giuseppe/C-1723-2012	Legname, Giuseppe/0000-0003-0716-4393				Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BASTIDAS RB, 1997, J MOL BIOL, V273, P614; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CARTER P, 1992, BIO-TECHNOL, V10, P163, DOI 10.1038/nbt0292-163; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; COUSENS SN, 1990, J NEUROL NEUROSUR PS, V53, P459, DOI 10.1136/jnnp.53.6.459; DeArmond SJ, 1999, COLD SPRING HARBOR M, V38, P585; Dickinson A. G., 1976, Slow virus diseases of animals and man,, P209; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Ironside JW, 1997, AMYLOID, V4, P66, DOI 10.3109/13506129708995272; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; KIMBERLIN RH, 1979, SLOW TRANSMISSIBLE D, V2, P33; KITAMOTO T, 1987, LAB INVEST, V57, P230; Kuwajima Kunihiro, 1995, V40, P115; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; MALMGREN R, 1979, SLOW TRANSMISSIBLE D, V1, P93; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MURAMOTO T, 1992, AM J PATHOL, V140, P1411; OESCH B, 1994, BIOCHEMISTRY-US, V33, P5926, DOI 10.1021/bi00185a033; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan T, 2001, J BIOL CHEM, V276, P37284, DOI 10.1074/jbc.M107358200; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; PATTISON IH, 1966, RES VET SCI, V7, P207; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Pergami P, 1996, ANAL BIOCHEM, V236, P63, DOI 10.1006/abio.1996.0132; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1999, COLD SPRING HARBOR M, V38, P67; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P2793, DOI 10.1073/pnas.90.7.2793; PRUSINER SB, 1987, PRION NOVEL INFECT P; Ridley RM, 1996, NEURODEGENERATION, V5, P219, DOI 10.1006/neur.1996.0030; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Scott MR, 1997, J VIROL, V71, P9032, DOI 10.1128/JVI.71.12.9032-9044.1997; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; Somerville RA, 1997, NATURE, V386, P564, DOI 10.1038/386564a0; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	69	175	181	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					921	932		10.1016/S0896-6273(02)00726-2	http://dx.doi.org/10.1016/S0896-6273(02)00726-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086640	Bronze			2022-12-28	WOS:000176249700010
J	Zeron, MM; Hansson, O; Chen, NS; Wellington, CL; Leavitt, BR; Brundin, P; Hayden, MR; Raymond, LA				Zeron, MM; Hansson, O; Chen, NS; Wellington, CL; Leavitt, BR; Brundin, P; Hayden, MR; Raymond, LA			Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease	NEURON			English	Article							RAT STRIATAL NEURONS; MUTANT HUNTINGTIN; CELL-DEATH; PROJECTION NEURONS; TERMINAL FRAGMENTS; QUINOLINIC ACID; TRANSGENIC MICE; NERVOUS-SYSTEM; PROTEIN-KINASE; LOCALIZATION	Previous work suggests N-methyl-D-aspartate receptor (NMDAR) activation may be involved in degeneration of medium-sized spiny striatal neurons in Huntington's disease (HD). Here we show that these neurons are more vulnerable to NMDAR-mediated death in a YAC transgenic FVB/N mouse model of HD expressing full-length mutant huntingtin, compared with wild-type FVB/N mice. Excitotoxic death of these neurons was increased after intrastriatal injection of quinolinate in vivo, and after NMDA but not AMPA exposure in culture. NMDA-induced cell death was abolished by an NR2B subtype-specific antagonist. In contrast, NMDAR-mediated death of cerebellar granule neurons was not enhanced, consistent with cell-type and NMDAR subtype specificity. Moreover, increased NMDA-evoked current amplitude and caspase-3 activity were observed in transgenic striatal neurons. Our data support a role for NR2B-subtype NMDAR activation as a trigger for selective neuronal degeneration in HD.	Lund Univ, Kinsmen Lab Neurol Res, Dept Psychiat, Biomed Ctr A10, S-22184 Lund, Sweden; Lund Univ, Sect Neuronal Survival, Wallenberg Neurosci Ctr, Biomed Ctr A10, S-22184 Lund, Sweden; Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Physiol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Div Neurol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada	Lund University; Lund University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Raymond, LA (corresponding author), Lund Univ, Kinsmen Lab Neurol Res, Dept Psychiat, Biomed Ctr A10, S-22184 Lund, Sweden.		Leavitt, Blair R/G-1934-2012; Raymond, Lynn A./R-6707-2016; Raymond, Lynn A/A-6664-2010; Hayden, Michael R/D-8581-2011; Chen, Nansheng/E-6450-2012; Hansson, Oskar/A-7134-2013	Raymond, Lynn A./0000-0002-8610-1042; Raymond, Lynn A/0000-0002-8610-1042; Hayden, Michael R/0000-0001-5159-1419; Hansson, Oskar/0000-0001-8467-7286				ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BRORSON JR, 1995, J NEUROSCI, V15, P4515; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Calabresi P, 2000, PROG NEUROBIOL, V61, P231, DOI 10.1016/S0301-0082(99)00030-1; CALABRESI P, 1987, NEUROSCIENCE, V20, P293, DOI 10.1016/0306-4522(87)90021-2; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Cepeda C, 2001, EUR J NEUROSCI, V14, P1577, DOI 10.1046/j.0953-816x.2001.01783.x; Cepeda C, 1998, DEV NEUROSCI-BASEL, V20, P1, DOI 10.1159/000017294; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Chen NS, 1999, J NEUROCHEM, V72, P1890, DOI 10.1046/j.1471-4159.1999.0721890.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DIFIGLIA M, 1990, TRENDS NEUROSCI, V13, P286, DOI 10.1016/0166-2236(90)90111-M; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; GREENE JG, 1993, J NEUROCHEM, V61, P1151, DOI 10.1111/j.1471-4159.1993.tb03634.x; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Hansson O, 2001, EUR J NEUROSCI, V14, P1492, DOI 10.1046/j.0953-816x.2001.01767.x; HANTRAYE P, 1990, EXP NEUROL, V108, P91, DOI 10.1016/0014-4886(90)90014-J; Harper PS, 1991, HUNTINGTONS DIS; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOWE AR, 1995, J NEUROSCI, V15, P458; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Kovacs AD, 2001, EXP NEUROL, V168, P47, DOI 10.1006/exnr.2000.7576; Kuppenbender KD, 1999, J COMP NEUROL, V415, P204; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; LANDWEHRMEYER GB, 1995, J NEUROSCI, V15, P5297; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li SH, 1999, J NEUROSCI, V19, P5159; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; MCGEER EG, 1976, NATURE, V263, P517, DOI 10.1038/263517a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Thompson CL, 2000, NEUROSCI LETT, V283, P85, DOI 10.1016/S0304-3940(00)00930-7; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Trump BF, 1997, TOXICOL PATHOL, V25, P82, DOI 10.1177/019262339702500116; Vallano ML, 1996, J NEUROSCI, V16, P631; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 2000, CLIN GENET, V57, P1, DOI 10.1034/j.1399-0004.2000.570101.x; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; YOUNG AB, 1988, SCIENCE, V241, P981, DOI 10.1126/science.2841762; Zeron MM, 2001, MOL CELL NEUROSCI, V17, P41, DOI 10.1006/mcne.2000.0909	64	481	501	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					849	860		10.1016/S0896-6273(02)00615-3	http://dx.doi.org/10.1016/S0896-6273(02)00615-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906693	Bronze			2022-12-28	WOS:000174389600004
J	Kuhara, A; Inada, H; Katsura, I; Mori, I				Kuhara, A; Inada, H; Katsura, I; Mori, I			Negative regulation and gain control of sensory neurons by the C-elegans calcineurin TAX-6	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NUCLEOTIDE-GATED CHANNEL; GLR-1 GLUTAMATE-RECEPTOR; S-MODULIN; RHODOPSIN PHOSPHORYLATION; CAPSAICIN-RECEPTOR; DEFECTIVE-MUTANTS; ION-CHANNEL; RAT-BRAIN; IN-VIVO	Animals sense and adapt to variable environments by regulating appropriate sensory signal transduction pathways. Here, we show that calcineurin plays a key role in regulating the gain of sensory neuron responsiveness across multiple modalities. C. elegans animals bearing a loss-of-function mutation in TAX-6, a calcineurin A subunit, exhibit pleiotropic abnormalities, including many aberrant sensory behaviors. The tax-6 mutant defect in thermosensation is consistent with hyperactivation of the AFD thermosensory neurons. Conversely, constitutive activation of TAX-6 causes a behavioral phenotype consistent with inactivation of AFD neurons. In olfactory neurons, the impaired olfactory response of tax-6 mutants to an AWC-sensed odorant is caused by hyperadaptation, which is suppressible by a mutation causing defective olfactory adaptation. Taken together, our results suggest that stimulus-evoked calcium entry activates calcineurin, which in turn negatively regulates multiple aspects of sensory signaling.	Nagoya Univ, Japan Sci & Technol Corp, PRESTO, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan	Japan Science & Technology Agency (JST); Nagoya University; Nagoya University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Mori, I (corresponding author), Nagoya Univ, Japan Sci & Technol Corp, PRESTO, Nagoya, Aichi 4648602, Japan.	m46920a@nucc.cc.nagoya-u.ac.jp	Inada, Hitoshi/T-2773-2019; Kuhara, Atsushi/S-5855-2018; Inada, Hitoshi/GQH-1084-2022	Inada, Hitoshi/0000-0002-6121-3830; Kuhara, Atsushi/0000-0003-2994-8658; Inada, Hitoshi/0000-0002-6121-3830				AITKEN A, 1984, EUR J BIOCHEM, V139, P663, DOI 10.1111/j.1432-1033.1984.tb08055.x; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BLUMENTHAL T, 1995, TRENDS GENET, V11, P132, DOI 10.1016/S0168-9525(00)89026-5; BRENNER S, 1974, GENETICS, V77, P71; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; CULOTTI JG, 1978, GENETICS, V90, P243; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; DUSENBERY DB, 1975, GENETICS, V80, P297; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hong CS, 1996, GENETICS, V142, P879; Huang T, 2001, MOL CELL BIOL, V21, P1111, DOI 10.1128/MCB.21.4.1111-1120.2001; ITO A, 1989, BIOCHEM BIOPH RES CO, V163, P1492, DOI 10.1016/0006-291X(89)91148-0; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KAWAMURA S, 1993, J BIOL CHEM, V268, P14579; KINCAID RL, 1990, J BIOL CHEM, V265, P11312; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; KUNO T, 1992, J NEUROCHEM, V58, P1643, DOI 10.1111/j.1471-4159.1992.tb10036.x; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; OKKEMA PG, 1993, GENETICS, V135, P385; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Tachibanaki S, 2000, J BIOL CHEM, V275, P3313, DOI 10.1074/jbc.275.5.3313; Take-uchi M, 1998, P NATL ACAD SCI USA, V95, P11775, DOI 10.1073/pnas.95.20.11775; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	56	107	118	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					751	763		10.1016/S0896-6273(02)00607-4	http://dx.doi.org/10.1016/S0896-6273(02)00607-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879652	Bronze			2022-12-28	WOS:000174286200011
J	Sereno, ME; Trinath, T; Augath, M; Logothetis, NK				Sereno, ME; Trinath, T; Augath, M; Logothetis, NK			Three-dimensional shape representation in monkey cortex	NEURON			English	Article							SUPERIOR TEMPORAL SULCUS; STRUCTURE-FROM-MOTION; VISUAL AREA MT; CORTICAL CONNECTIONS; RHESUS-MONKEY; INFEROTEMPORAL CORTEX; SURFACE ORIENTATION; POLYSENSORY AREA; MACAQUE; NEURONS	Using fMRI in anesthetized monkeys, this study investigates how the primate visual system constructs representations of three-dimensional (3D) shape from a variety of cues. Computer-generated 3D objects defined by shading, random dots, texture elements, or silhouettes were presented either statically or dynamically (rotating). Results suggest that 3D shape representations are highly localized, although widely distributed, in occipital, temporal, parietal, and frontal cortices and may involve common brain regions regardless of shape cue. This distributed network of areas cuts across both "what" and "where" processing streams, reflecting multiple uses for 3D shape representation in perception, recognition, and action.	Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA; Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	University of Oregon; Max Planck Society	Sereno, ME (corresponding author), Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA.	margaret.sereno@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019					ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; BAYLIS GC, 1987, J NEUROSCI, V7, P330; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BURKE DS, 1986, ARBOVIRUSES EPIDEMIO, V3, P63; CUTTING JE, 1984, J EXP PSYCHOL GEN, V113, P198, DOI 10.1037/0096-3445.113.2.198; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gibson JJ, 1950, PERCEPTION VISUAL WO; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Lyon DC, 2001, J NEUROSCI, V21, P249, DOI 10.1523/JNEUROSCI.21-01-00249.2001; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MISTLIN AJ, 1990, EXP BRAIN RES, V82, P437; Moore C, 2001, NEURON, V29, P277, DOI 10.1016/S0896-6273(01)00197-0; MOREL A, 1990, VISUAL NEUROSCI, V4, P555, DOI 10.1017/S0952523800005769; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; O Scalaidhe SP, 1999, CEREB CORTEX, V9, P459, DOI 10.1093/cercor/9.5.459; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Ringach DL, 1996, VISION RES, V36, P1479, DOI 10.1016/0042-6989(95)00285-5; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; Saleem KS, 2000, J NEUROSCI, V20, P5083; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SELEMON LD, 1988, J NEUROSCI, V8, P4049; SELTZER B, 1989, J COMP NEUROL, V290, P451, DOI 10.1002/cne.902900402; Seltzer B, 1996, J COMP NEUROL, V370, P173, DOI 10.1002/(SICI)1096-9861(19960624)370:2<173::AID-CNE4>3.0.CO;2-#; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; SELTZER B, 1989, J COMP NEUROL, V281, P97, DOI 10.1002/cne.902810108; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno M. E., 1993, NEURAL COMPUTATION P; Sereno ME, 1999, J EXP PSYCHOL HUMAN, V25, P1834; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Xiao DK, 1997, EUR J NEUROSCI, V9, P956, DOI 10.1111/j.1460-9568.1997.tb01446.x; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	65	133	135	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 14	2002	33	4					635	652		10.1016/S0896-6273(02)00598-6	http://dx.doi.org/10.1016/S0896-6273(02)00598-6			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856536	Bronze			2022-12-28	WOS:000173911100015
J	Eberwine, J				Eberwine, J			Molecular biology of axons: "A turning point..."	NEURON			English	Editorial Material							ACTIN MESSENGER-RNA; LOCAL PROTEIN-SYNTHESIS; GROWTH CONES; RECEPTOR	Previous studies have shown that dendrites and axons contain both mRNAs and the machinery for local protein translation. While a number of studies in recent years have focused on the functional role of protein synthesis in dendrites, relatively less is know about the role of local translation in axons. Campbell and Holt (this issue of Neuron) show that local protein synthesis and degradation are required for proper chemotropic turning responses of isolated retinal growth cones.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Eberwine, J (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 36th & Hamilton Walk, Philadelphia, PA 19104 USA.		Eberwine, James/B-2247-2010					Bassell GJ, 1998, J NEUROSCI, V18, P251; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Eberwine J, 2001, P NATL ACAD SCI USA, V98, P7080, DOI 10.1073/pnas.121146698; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Job C, 2001, P NATL ACAD SCI USA, V98, P13037, DOI 10.1073/pnas.231485698; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spencer GE, 2000, J NEUROBIOL, V44, P72, DOI 10.1002/1097-4695(200007)44:1<72::AID-NEU7>3.0.CO;2-#; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59	14	10	10	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					959	960		10.1016/S0896-6273(01)00555-4	http://dx.doi.org/10.1016/S0896-6273(01)00555-4			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754825	Bronze			2022-12-28	WOS:000172886800001
J	Alvarez, V; Arttamangkul, S; Williams, JT				Alvarez, V; Arttamangkul, S; Williams, JT			A RAVE about opioid withdrawal	NEURON			English	Editorial Material							DEPENDENCE; TOLERANCE; RECEPTORS		Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Harvard University; Harvard Medical School; Oregon Health & Science University	Alvarez, V (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.		Alvarez, Veronica A/E-9745-2015	Alvarez, Veronica A/0000-0003-2611-8675				Chavkin C, 2001, MOL PHARMACOL, V60, P20, DOI 10.1124/mol.60.1.20; Chieng B, 1998, J NEUROSCI, V18, P7033; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Hurle MA, 2001, J NEUROCHEM, V77, P486, DOI 10.1046/j.1471-4159.2001.00268.x; Ingram SL, 1998, J NEUROSCI, V18, P10269; JOHNSON SM, 1989, PHARMACOL REV, V41, P435; Noble F, 2000, MOL PHARMACOL, V58, P159, DOI 10.1124/mol.58.1.159; Stafford K, 2001, PHARMACOL BIOCHEM BE, V69, P233, DOI 10.1016/S0091-3057(01)00525-1; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	12	21	24	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					761	763		10.1016/S0896-6273(01)00530-X	http://dx.doi.org/10.1016/S0896-6273(01)00530-X			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738021	Bronze			2022-12-28	WOS:000172700700002
J	Culham, JC; Cavanagh, P; Kanwisher, NG				Culham, JC; Cavanagh, P; Kanwisher, NG			Attention response functions: Characterizing brain areas using fMRI activation during parametric variations of attentional load	NEURON			English	Article							FRONTAL EYE-FIELD; POSITRON EMISSION TOMOGRAPHY; HUMAN VISUAL-CORTEX; SPATIAL ATTENTION; WORKING-MEMORY; CEREBRAL-CORTEX; SINGLE NEURONS; SACCADES; MOVEMENTS; MODULATION	We derived attention response functions for different cortical areas by plotting neural activity (measured by fMRI) as a function of attentional load in a visual tracking task. In many parietal and frontal cortical areas, activation increased with load over the entire range of loads tested, suggesting that these areas are directly involved in attentional processes. However, in other areas (FEF and parietal area 7), strong activation was observed even at the lowest attentional load (compared to a passive baseline using identical stimuli), but little or no additional activation was seen with increasing load. These latter areas appear to play a different role, perhaps supporting task-relevant functions that do not vary with load, such as the suppression of eye movements.	Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, NMR Ctr, Charlestown, MA 02129 USA	Western University (University of Western Ontario); Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Culham, JC (corresponding author), Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada.		Culham, Jody C./A-9863-2013	Culham, Jody C./0000-0003-0754-2999	NIMH NIH HHS [MH56037] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056037] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSEN RA, 1989, NEUROBIOLOGY SACCADI; BIZZI E, 1968, EXP BRAIN RES, V6, P69; Broadbent D.E., 1958, PERCEPTION COMMUNICA; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buchel C, 1996, NEUROIMAGE, V4, P60, DOI 10.1006/nimg.1996.0029; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; BUSH G, 1996, NEUROIMAGE, V3, pS55; Caminiti R, 1996, CEREB CORTEX, V6, P319, DOI 10.1093/cercor/6.3.319; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; CULHAM JC, 1997, SOC NEUR NEW ORL LA; GOLDBERG ME, 1981, J NEUROPHYSIOL, V46, P773, DOI 10.1152/jn.1981.46.4.773; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1976, VISION RES, V16, P99, DOI 10.1016/0042-6989(76)90083-3; INTRILIGATOR JM, 2001, IN PRESS COGNIT PSYC; INTRILIGATOR JM, 1997, SPATIAL RESOLUTION V; Klein R. M., 1980, ATTENTION PERFORM, P259, DOI DOI 10.1037/E665402011-424; KLEIN RM, 1994, ATTENTION PERFORM, V15, P333; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; LANG W, 1994, NEUROREPORT, V5, P921, DOI 10.1097/00001756-199404000-00017; McPeek RM, 2000, VISION RES, V40, P2499, DOI 10.1016/S0042-6989(00)00102-4; Olson C, 1993, NEUROBIOLOGY CINGULA, P366; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; Ono M, 1990, ATLAS CEREBRAL SULCI; PAUS T, 1995, J NEUROPHYSIOL, V74, P2179, DOI 10.1152/jn.1995.74.5.2179; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; PETIT L, 1995, EUR J NEUROSCI, V7, P169, DOI 10.1111/j.1460-9568.1995.tb01031.x; PRIORI A, 1993, BRAIN, V116, P355, DOI 10.1093/brain/116.2.355; PYLYSHYN Z, 1994, COGNITION, V50, P363, DOI 10.1016/0010-0277(94)90036-1; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; Schlaug G, 1996, NEUROREPORT, V7, P879, DOI 10.1097/00001756-199603220-00009; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treisman A., 1993, ATTENTION SELECTION, P5; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	53	243	248	2	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					737	745		10.1016/S0896-6273(01)00499-8	http://dx.doi.org/10.1016/S0896-6273(01)00499-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	495WT	11719212	Bronze			2022-12-28	WOS:000172363900018
J	Murthy, VN; Schikorski, T; Stevens, CF; Zhu, YL				Murthy, VN; Schikorski, T; Stevens, CF; Zhu, YL			Inactivity produces increases in neurotransmitter release and synapse size	NEURON			English	Article							BARREL FIELD CORTEX; HIPPOCAMPAL SYNAPSES; DENDRITIC SPINES; QUANTAL ANALYSIS; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; NEURONS; RECEPTOR; AMPA; EXPRESSION	When hippocampal synapses in culture are pharmacologically silenced for several days, synaptic strength increases. The structural correlate of this change in strength is an increase in the size of the synapses, with all synaptic components-active zone, postsynaptic density, and bouton-becoming larger. Further, the number of docked vesicles and the total number of vesicles per synapse increases, although the number of docked vesicles per area of active zone is unchanged. In parallel with these anatomical changes, the physiologically measured size of the readily releasable pool (RRP) and the release probability are increased. Ultrastructural analysis of individual synapses in which the RRP was previously measured reveals that, within measurement error, the same number of vesicles are docked as are estimated to be in the RRP.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Harvard University; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.			Schikorski, Thomas/0000-0003-3902-2461; Murthy, Venkatesh/0000-0003-2443-4252				ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Benson DL, 1996, J NEUROSCI, V16, P6424; BUHL EH, 1995, EUR J NEUROSCI, V7, P1989, DOI 10.1111/j.1460-9568.1995.tb00721.x; Cannon WB, 1939, AM J MED SCI, V198, P737, DOI 10.1097/00000441-193912000-00001; Casey DE, 2000, J CLIN PSYCHIAT, V61, P5; CLARK CV, 1989, EYE, V3, P349, DOI 10.1038/eye.1989.50; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; FAMBROUGH DM, 1970, SCIENCE, V168, P372, DOI 10.1126/science.168.3929.372; GRAMPP W, 1972, J PHYSIOL-LONDON, V221, P743, DOI 10.1113/jphysiol.1972.sp009780; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Mackinnon P, 2000, AUSTRALAS J AGEING, V19, P3; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nusser Z, 1998, J NEUROSCI, V18, P1693; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schikorski T, 1997, J NEUROSCI, V17, P5858; SHARPLESS SK, 1964, ANNU REV PHYSIOL, V26, P357, DOI 10.1146/annurev.ph.26.030164.002041; SHARPLESS SK, 1975, DEV NEUROPSYCHOL, P125; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7	52	451	457	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					673	682		10.1016/S0896-6273(01)00500-1	http://dx.doi.org/10.1016/S0896-6273(01)00500-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719207	Bronze			2022-12-28	WOS:000172363900013
J	Rotshtein, P; Malach, R; Hadar, U; Graif, M; Hendler, T				Rotshtein, P; Malach, R; Hadar, U; Graif, M; Hendler, T			Feeling or features: Different sensitivity to emotion in high-order visual cortex and amygdala	NEURON			English	Article							OBJECT-PROCESSING STAGES; FACIAL EXPRESSIONS; NEURAL MECHANISMS; AVERSIVE STIMULI; RECOGNITION; AREAS; ACTIVATION; PROSOPAGNOSIA; PERCEPTION; NEURONS	Emotionally loaded visual stimuli have shown increased activation in visual and cortex limbic areas. However, differences in visual features of such images could confound these findings. In order to manipulate valence of stimuli while keeping visual features largely unchanged, we took advantage of an "expressional transfiguration" (ET) effect of faces. In addition, we used repetition effects, which enabled us to test more incisively the impact of the ET effect. Using the ET manipulation, we have shown that the activation in lateral occipital complex (LOC) was unaffected by valence attributes, but produced significant modulation of fMR adaptation. Contrary to LOC, amygdala activation was increased by ET manipulation unrelated to the adaptation. A correlation between amygdala and LOC adaptation points to a possible modulatory role of the amygdala upon visual cortex short-term plasticity.	Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel; Tel Aviv Univ, Fac Med, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Tel Aviv University; Weizmann Institute of Science	Hendler, T (corresponding author), Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel.	talma@tasmc.health.gov.il	hendler, talma/C-7677-2012	Rotshtein, Pia/0000-0002-0301-9511				ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Aggleton J.P., 2000, SER AFFECTIVE SCI, P106; AMARAL D G, 1992, P1; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; [Anonymous], 2000, SER AFFECTIVE SCI; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; BAUER RM, 1984, NEUROPSYCHOLOGIA, V22, P457, DOI 10.1016/0028-3932(84)90040-X; Bechara A, 1999, J NEUROSCI, V19, P5473; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BORDI F, 1992, J NEUROSCI, V12, P2493; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; BROADBEN.DE, 1967, NATURE, V215, P581, DOI 10.1038/215581a0; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Burt DM, 1997, NEUROPSYCHOLOGIA, V35, P685, DOI 10.1016/S0028-3932(96)00111-X; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Carmon A., 1978, ASYMMETRICAL FUNCTIO, P86; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; Critchley HD, 2000, J NEUROSCI, V20, P3033; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Gelder B, 2000, BRAIN COGNITION, V44, P425, DOI 10.1006/brcg.1999.1203; Derryberry D, 1994, HEARTS EYE EMOTIONAL, P166; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DOLAN RJ, 2000, SER AFFECTIVE SCI, P225; Fischer H, 2000, NEUROREPORT, V11, P123, DOI 10.1097/00001756-200001170-00024; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 2000, P NATL ACAD SCI USA, V97, P7591, DOI 10.1073/pnas.97.13.7591; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Goebel R, 1998, NEUROREPORT, V9, P713, DOI 10.1097/00001756-199803090-00028; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; ISHAI A, 1997, NEUROIMAGE, V5, pS149; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kosslyn SM, 1996, NEUROREPORT, V7, P1569, DOI 10.1097/00001756-199607080-00007; LABAR KS, 1995, J NEUROSCI, V15, P6846; Lane R., 1997, NEUROIMAGE, V5, pS115; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Lane Richard D, 2000, COGNITIVE NEUROSCIEN; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; LANG PJ, 1996, NEUROIMAGE, V3, pS231; LEDOUX J, 2000, SER AFFECTIVE SCI, P129; LeDoux J.E., 1996, EMOTIONAL BRAIN MYST; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MILLER EK, 1993, J NEUROSCI, V13, P1460; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Moscovitch M, 2000, COGNITIVE NEUROPSYCH, V17, P201, DOI 10.1080/026432900380571; NEBES RD, 1978, ASYMMETRICAL FUNCTIO, P99; Ohman A, 1974, Biol Psychol, V2, P85, DOI 10.1016/0301-0511(74)90017-9; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Pizzagalli D, 1998, NEUROPSYCHOLOGIA, V36, P323, DOI 10.1016/S0028-3932(97)00117-6; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; ROLLS ET, 1977, BRAIN RES, V130, P229, DOI 10.1016/0006-8993(77)90272-4; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; ROLLS ET, 1999, BRAIN EMOTION; Royet JP, 2000, J NEUROSCI, V20, P7752; SERGENT J, 1989, BRAIN, V112, P975, DOI 10.1093/brain/112.4.975; Sergent J., 1994, VIS COGN, V1, P349, DOI [10.1080/13506289408402305, DOI 10.1080/13506289408402305]; SILBERMAN EK, 1986, BRAIN COGNITION, V5, P322, DOI 10.1016/0278-2626(86)90035-7; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; Taylor SF, 2000, NEUROPSYCHOLOGIA, V38, P1415, DOI 10.1016/S0028-3932(00)00032-4; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; TRANEL D, 1988, BEHAV BRAIN RES, V30, P235, DOI 10.1016/0166-4328(88)90166-0; WATT CA, 1995, PERS INDIV DIFFER, V19, P635, DOI 10.1016/0191-8869(95)00102-C; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; YOUNG AW, 1993, BRAIN, V116, P941, DOI 10.1093/brain/116.4.941; Young AW, 1996, NEUROPSYCHOLOGIA, V34, P31, DOI 10.1016/0028-3932(95)00062-3; YOUNG AW, 1995, BRAIN, V118, P15, DOI 10.1093/brain/118.1.15	87	120	124	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					747	757		10.1016/S0896-6273(01)00513-X	http://dx.doi.org/10.1016/S0896-6273(01)00513-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	495WT	11719213	Bronze			2022-12-28	WOS:000172363900019
J	Wachowiak, M; Cohen, LB				Wachowiak, M; Cohen, LB			Representation of odorants by receptor neuron input to the mouse olfactory bulb	NEURON			English	Article							PRESYNAPTIC INHIBITION; RESPONSE PROPERTIES; GLOMERULAR LAYER; RAT; DISCRIMINATION; COMBINATORIAL; ORGANIZATION; TOPOGRAPHY; EXPRESSION; STIMULUS	To visualize odorant representations by receptor neuron input to the mouse olfactory bulb, we loaded receptor neurons with calcium-sensitive dye and imaged odorant-evoked responses from their axon terminals. Fluorescence increases reflected activation of receptor neuron populations converging onto individual glomeruli. We report several findings. First, five glomeruli were identifiable across animals based on their location and odorant responsiveness; all five showed complex response specificities. Second, maps of input were chemotopically organized at near-threshold concentrations but, at moderate concentrations, involved many widely distributed glomeruli. Third, the dynamic range of input to a glomerulus was greater than that reported for individual receptor neurons. Finally, odorant activation slopes could differ across glomeruli, and for different odorants activating the same glomerulus. These results imply a high degree of complexity in odorant representations at the level of olfactory bulb input.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	Yale University; Marine Biological Laboratory - Woods Hole	Wachowiak, M (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	matt.wachowiak@yale.edu			NIDCD NIH HHS [DC00378-03, DC05259] Funding Source: Medline; NINDS NIH HHS [NS08437] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005259, R56DC005259] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADAMEK GD, 1984, BRAIN RES, V310, P87, DOI 10.1016/0006-8993(84)90012-X; ADRIAN ED, 1953, ACTA PHYSIOL SCAND, V29, P5, DOI 10.1111/j.1748-1716.1953.tb00990.x; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Bozza TC, 1998, J NEUROSCI, V18, P4560; Cleland TA, 1999, NEURAL COMPUT, V11, P1673, DOI 10.1162/089976699300016188; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; JASPER JR, 1992, BIOCHEM PHARMACOL, V43, P119, DOI 10.1016/0006-2952(92)90268-N; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; KAUER JS, 1991, TRENDS NEUROSCI, V14, P79, DOI 10.1016/0166-2236(91)90025-P; Kent PF, 1996, J NEUROSCI, V16, P345; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; LAMANTIA AS, 1992, J NEUROSCI, V12, P976; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; ODONOVAN MJ, 1993, J NEUROSCI METH, V46, P91, DOI 10.1016/0165-0270(93)90145-H; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Schaefer ML, 2001, J NEUROSCI, V21, P2481, DOI 10.1523/JNEUROSCI.21-07-02481.2001; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Trotier Didier, 1994, Seminars in Cell Biology, V5, P47, DOI 10.1006/scel.1994.1007; Tsau Y, 1996, J NEUROSCI METH, V70, P121, DOI 10.1016/S0165-0270(96)00109-4; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; WACHOWIAK M, 2000, CHEM SENSES, V25, P675; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; YAWS C, 1994, HDB VAPOR PRESSURES; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; YOUNGENTOB SL, 1990, PHYSIOL BEHAV, V47, P1053, DOI 10.1016/0031-9384(90)90352-5	45	360	366	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					723	735		10.1016/S0896-6273(01)00506-2	http://dx.doi.org/10.1016/S0896-6273(01)00506-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719211	Bronze, Green Submitted			2022-12-28	WOS:000172363900017
J	Hashimoto, M; Rockenstein, E; Mante, M; Mallory, M; Masliah, E				Hashimoto, M; Rockenstein, E; Mante, M; Mallory, M; Masliah, E			beta-synuclein inhibits alpha-synuclein aggregation: A possible role as an anti-parkinsonian factor	NEURON			English	Article							ABNORMAL PROTEIN AGGREGATION; ALZHEIMERS-DISEASE; LEWY-BODY; NACP/ALPHA-SYNUCLEIN; OXIDATIVE STRESS; IN-VITRO; A-BETA; SELF-OLIGOMERIZATION; PRESYNAPTIC PROTEIN; PRECURSOR PROTEIN	We characterized beta -synuclein, the non-amyloidogenic homolog of alpha -synuclein, as an inhibitor of aggregation of alpha -synuclein, a molecule implicated in Parkinson's disease. For this, doubly transgenic mice expressing human (h)alpha- and beta -synuclein were generated. In doubly transgenic mice, beta -synuclein ameliorated motor deficits, neurodegenerative alterations, and neuronal alpha -synuclein accumulation seen in h alpha -synuclein transgenic mice. Similarly, cell lines transfected with beta -synuclein were resistant to alpha -synuclein accumulation. h alpha -synuclein was coimmunoprecipitated with h beta -synuclein in the brains of doubly transgenic mice and in the double-transfected cell lines. Our results raise the possibility that beta -synuclein might be a natural negative regulator of alpha -synuclein aggregation and that a similar class of endogenous factors might regulate the aggregation state of other molecules involved in neurodegeneration. Such an anti-amyloidogenic property of beta -synuclein might also provide a novel strategy for the treatment of neurodegenerative disorders.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	emasliah@ucsd.edu			NATIONAL INSTITUTE ON AGING [R37AG018440, P50AG005131, R01AG010689, R01AG018440] Funding Source: NIH RePORTER; NIA NIH HHS [AG5131, AG10689, AG18440] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; El-Agnaf OMA, 2000, J STRUCT BIOL, V130, P300, DOI 10.1006/jsbi.2000.4262; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ferrigno P, 2000, NEURON, V26, P9, DOI 10.1016/S0896-6273(00)81132-0; Forloni G, 2000, ANN NEUROL, V47, P632, DOI 10.1002/1531-8249(200005)47:5<632::AID-ANA11>3.3.CO;2-E; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hashimoto M, 1999, J BIOL CHEM, V274, P28849, DOI 10.1074/jbc.274.41.28849; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; Iwai A, 2000, BBA-MOL BASIS DIS, V1502, P95, DOI 10.1016/S0925-4439(00)00036-3; Iwata A, 2001, J NEUROCHEM, V77, P239, DOI 10.1046/j.1471-4159.2001.t01-1-00232.x; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jenner P, 1996, PATHOL BIOL, V44, P57; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Jia TL, 1999, CANCER RES, V59, P742; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kanda S, 2000, NEUROSCIENCE, V97, P279, DOI 10.1016/S0306-4522(00)00077-4; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Masliah E, 1996, AM J PATHOL, V148, P201; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MASLIAH E, 1998, NEUROSCI NEWS, V1, P14; Masliah E., 2001, J ALZHEIMERS DIS, V3, P1; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; NAKAJO S, 1993, EUR J BIOCHEM, V217, P1057, DOI 10.1111/j.1432-1033.1993.tb18337.x; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; NOGUCHI CT, 1989, ANN NY ACAD SCI, V565, P75, DOI 10.1111/j.1749-6632.1989.tb24152.x; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Paik SR, 1998, FEBS LETT, V421, P73, DOI 10.1016/S0014-5793(97)01537-8; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ramassamy C, 1999, FREE RADICAL BIO MED, V27, P544, DOI 10.1016/S0891-5849(99)00102-1; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Surguchov A, 1999, MOL CELL NEUROSCI, V13, P95, DOI 10.1006/mcne.1999.0735; Tabrizi SJ, 2000, HUM MOL GENET, V9, P2683, DOI 10.1093/hmg/9.18.2683; Takeda A, 1998, AM J PATHOL, V152, P367; Takenouchi T, 2001, MOL CELL NEUROSCI, V17, P141, DOI 10.1006/mcne.2000.0923; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; YOSHIMOTO M, 1995, P NATL ACAD SCI USA, V92, P9141, DOI 10.1073/pnas.92.20.9141; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	60	333	352	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					213	223		10.1016/S0896-6273(01)00462-7	http://dx.doi.org/10.1016/S0896-6273(01)00462-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683992	Bronze			2022-12-28	WOS:000171893700007
J	Song, S; Abbott, LF				Song, S; Abbott, LF			Cortical development and remapping through spike timing-dependent plasticity	NEURON			English	Article							OCULAR DOMINANCE; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; BARREL CORTEX; EXPERIENCE; MAPS; REORGANIZATION; POTENTIATION; DEPRESSION; COINCIDENCE	Long-term modification of synaptic efficacy can depend on the timing of pre- and postsynaptic action potentials. In model studies, such spike timing-dependent plasticity (STDP) introduces the desirable features of competition among synapses and regulation of postsynaptic firing characteristics. STDP strengthens synapses that receive correlated input, which can lead to the formation of stimulus-selective columns and the development, refinement, and maintenance of selectivity maps in network models. The temporal asymmetry of STDP suppresses strong destabilizing self-excitatory loops and allows a group of neurons that become selective early in development to direct other neurons to become similarly selective. STDP, acting alone without further hypothetical global constraints or additional forms of plasticity, can also reproduce the remapping seen in adult cortex following afferent lesions.	Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Abbott, LF (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA.	abbott@bradeis.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058754] Funding Source: NIH RePORTER; NIMH NIH HHS [MH58754] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BENUSKOVA L, 1994, P NATL ACAD SCI USA, V91, P4791, DOI 10.1073/pnas.91.11.4791; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLENENSTOCK EL, 1982, J NEUROSCI, V2, P32; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Gilbert CD, 1996, CURR OPIN NEUROBIOL, V6, P269, DOI 10.1016/S0959-4388(96)80083-3; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Grajski KA, 1990, NEURAL COMPUT, V2, P71, DOI 10.1162/neco.1990.2.1.71; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hubener M, 1999, NAT NEUROSCI, V2, P1043, DOI 10.1038/15964; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Miller K. D., 1996, MODELS NEURAL NETWOR, P55, DOI [10.1007/978-1-4612-0723-8_2, DOI 10.1007/978-1-4612-0723-8_2]; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; Purves, 1985, PRINCIPLES NEURAL DE; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; STRYKER MP, 1986, BIOL CHANGE OTOLARYN, P211; SUTTON GG, 1994, NEURAL COMPUT, V6, P1, DOI 10.1162/neco.1994.6.1.1; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; WALL JT, 1988, TRENDS NEUROSCI, V11, P549, DOI 10.1016/0166-2236(88)90184-1; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Yuste R, 1999, J NEUROBIOL, V41, P1, DOI 10.1002/(SICI)1097-4695(199910)41:1<1::AID-NEU1>3.0.CO;2-2; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	45	363	368	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					339	350		10.1016/S0896-6273(01)00451-2	http://dx.doi.org/10.1016/S0896-6273(01)00451-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11684002	Bronze			2022-12-28	WOS:000171893700017
J	Osborne, SL; Meunier, FA; Schiavo, G				Osborne, SL; Meunier, FA; Schiavo, G			Phosphoinositides as key regulators of synaptic function	NEURON			English	Review							ACTIN CYTOSKELETON; ENDOCYTOSIS	Phosphoinositides have recently emerged as key regulators of a variety of synaptic processes, including neurosecretory vesicle targeting, exo-endocytosis, and ion channel modulation. These pleiotropic activities derive from their ability to serve either as membrane targeting sites for cytosolic factors, as allosteric ligands, or as nucleation points for coat proteins and cytoskeletal elements. This versatility depends upon the existence of highly diversified enzymatic machinery for their synthesis and degradation, which governs, both temporally and spatially, their appearance in the microenvironment of the synapse.	Imperial Canc Res Fund, Mol NeuroPathoBiol Lab, London WC2A 3PX, England	Cancer Research UK	Schiavo, G (corresponding author), Imperial Canc Res Fund, Mol NeuroPathoBiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.		Osborne, Shona/C-8290-2009; Meunier, Frederic A/C-8161-2009	Meunier, Frederic A/0000-0001-6400-1107; Osborne, Shona/0000-0002-7012-9278; Schiavo, Giampietro/0000-0002-4319-8745				Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cremona O, 2001, J CELL SCI, V114, P1041; Doussau F, 2000, BIOCHIMIE, V82, P353, DOI 10.1016/S0300-9084(00)00217-0; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Hilton JM, 2001, J BIOL CHEM, V276, P16341, DOI 10.1074/jbc.M011122200; Hisatsune C, 1999, GENES CELLS, V4, P657, DOI 10.1046/j.1365-2443.1999.00287.x; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jan LY, 2000, NAT CELL BIOL, V2, pE165, DOI 10.1038/35023646; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858	23	54	58	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					9	12		10.1016/S0896-6273(01)00455-X	http://dx.doi.org/10.1016/S0896-6273(01)00455-X			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604134	Bronze			2022-12-28	WOS:000171525200004
J	Donaldson, DI; Petersen, SE; Buckner, RL				Donaldson, DI; Petersen, SE; Buckner, RL			Dissociating memory retrieval processes using fMRI: Evidence that priming does not support recognition memory	NEURON			English	Article							FUNCTIONAL-MRI EVIDENCE; PREFRONTAL CORTEX; IMPLICIT MEMORY; FAMILIARITY; RECOLLECTION; ACTIVATION; COMPONENTS; JUDGMENTS; SUCCESS; TRIALS	We employed event-related fMRI to constrain cognitive accounts of memory retrieval. Studies of explicit retrieval reveal that lateral and medial parietal, dorsal middle frontal gyrus, and anterior prefrontal cortex respond more for studied than new words, reflecting a correlate of "retrieval success." Studies of implicit memory suggest left temporal cortex, ventral and dorsal inferior frontal gyrus respond less for studied than new words, reflecting a correlate of "conceptual priming." In the present study, responses for old and new items were compared during performance on explicit recognition (old/new judgement) and semantic (abstract/concrete judgement) tasks. Regions associated with priming were only modulated during the semantic task, whereas regions associated with retrieval success were modulated during both tasks. These findings constrain functional-anatomic accounts of the networks, suggesting that processes associated with priming do not support explicit recognition judgments.	Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; Washington Univ, Dept Psychol, St Louis, MO 63108 USA; Washington Univ, Dept Neurol, St Louis, MO 63108 USA; Washington Univ, Dept Radiol, St Louis, MO 63108 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63108 USA; Washington Univ, Howard Hughes Med Inst, St Louis, MO 63108 USA	University of Stirling; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Donaldson, DI (corresponding author), Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland.	did1@stir.ac.uk	Petersen, Steve/ABF-1368-2020; Donaldson, David I/A-5249-2009	Donaldson, David I/0000-0002-8036-3455	NIMH NIH HHS [MH 57506] Funding Source: Medline; NINDS NIH HHS [NS 32979] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032979] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atkinson R.C., 1973, ATTENTION PERFORM, P583; BLAXTON TA, 1989, J EXP PSYCHOL LEARN, V15, P657, DOI 10.1037/0278-7393.15.4.657; Blaxton TA, 1996, CAN J EXP PSYCHOL, V50, P42, DOI 10.1037/1196-1961.50.1.42; BOWERS JS, 1990, J EXP PSYCHOL LEARN, V16, P404, DOI 10.1037/0278-7393.16.3.404; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; DEMB JB, 1995, J NEUROSCI, V15, P5870; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; DONALDSON DI, 2001, IN PRESS FUNCTIONAL; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Gabrieli JDE, 1999, J EXP PSYCHOL GEN, V128, P479, DOI 10.1037/0096-3445.128.4.479; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; Gardiner John M., 1993, P163; Habib R, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P265; Hamann SB, 1997, J COGNITIVE NEUROSCI, V9, P699, DOI 10.1162/jocn.1997.9.6.699; Henson RNA, 1999, J NEUROSCI, V19, P3962; HINTZMAN DL, 1994, J MEM LANG, V33, P1, DOI 10.1006/jmla.1994.1001; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Koutstaal W, 2001, NEUROPSYCHOLOGIA, V39, P184, DOI 10.1016/S0028-3932(00)00087-7; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; MAYES AR, 1991, NEUROPSYCHOLOGY CONS; McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503; McElree B, 1999, J EXP PSYCHOL LEARN, V25, P563, DOI 10.1037/0278-7393.25.3.563; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Nolde SF, 1998, TRENDS COGN SCI, V2, P399, DOI 10.1016/S1364-6613(98)01233-9; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; ROEDIGER HL, 1990, AM PSYCHOL, V45, P1043, DOI 10.1037/0003-066X.45.9.1043; ROEDIGER HL, 1993, HDB NEUROPSYCHOLOGY, V8; ROEDIGER HL, 1989, VARIEITES MEMORY CON; Rugg MD, 1996, BRAIN, V119, P2073, DOI 10.1093/brain/119.6.2073; SANDERS AL, 2000, J COGN NEUROSCI A S, V50; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SCHACTER DL, 1994, MEMORY SYSTEMS, V94; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; Stark CEL, 2000, BEHAV NEUROSCI, V114, P459, DOI 10.1037/0735-7044.114.3.459; Talairach J., 1998, COPLANAR STEREOTAXIC; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Vaidya CJ, 1997, J EXP PSYCHOL LEARN, V23, P1324, DOI 10.1037/0278-7393.23.6.1324; Wagner AD, 1998, BRAIN, V121, P1985, DOI 10.1093/brain/121.10.1985; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Wagner AD, 1997, J EXP PSYCHOL LEARN, V23, P305, DOI 10.1037/0278-7393.23.2.305; Yonelinas AP, 1996, CONSCIOUS COGN, V5, P131, DOI 10.1006/ccog.1996.0008; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	54	119	122	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2001	31	6					1047	1059		10.1016/S0896-6273(01)00429-9	http://dx.doi.org/10.1016/S0896-6273(01)00429-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	477JW	11580903	Bronze			2022-12-28	WOS:000171281300018
J	Rizzolatti, G; Luppino, G				Rizzolatti, G; Luppino, G			The cortical motor system	NEURON			English	Review							VENTRAL PREMOTOR CORTEX; MACAQUE MONKEY; NEURONAL-ACTIVITY; PARIETAL CORTEX; INFERIOR AREA-6; FRONTAL-LOBE; CORTICOSPINAL PROJECTIONS; TOPOGRAPHIC ORGANIZATION; FUNCTIONAL-ORGANIZATION; VISUAL GUIDANCE	The cortical motor system of primates is formed by a mosaic of anatomically and functionally distinct areas. These areas are not only involved in motor functions, but also play a role in functions formerly attributed to higher order associative cortical areas. In the present review, we discuss three types of higher functions carried out by the motor cortical areas: sensory-motor transformations, action understanding, and decision processing regarding action execution. We submit that generating internal representations of actions is central to cortical motor function. External contingencies and motivational factors determine then whether these action representations are transformed into actual actions.	Univ Parma, Ist Fisiol Umana, I-43100 Parma, Italy	University of Parma	Rizzolatti, G (corresponding author), Univ Parma, Ist Fisiol Umana, Via Volturno 39, I-43100 Parma, Italy.	fisioum@symbolic.parma.it	Galantucci, Bruno/E-5770-2010	Luppino, Giuseppe/0000-0002-0220-0618				ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Fogassi L., 1998, Society for Neuroscience Abstracts, V24, P654; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Freund HJ, 1996, ADV NEUROL, V70, P17; GALEA MP, 1994, CEREB CORTEX, V4, P166, DOI 10.1093/cercor/4.2.166; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; GODSCHALK M, 1984, EXP BRAIN RES, V56, P410; HE SQ, 1995, J NEUROSCI, V15, P3284; HE SQ, 1993, J NEUROSCI, V13, P952; HEPPREYMOND MC, 1994, CAN J PHYSIOL PHARM, V72, P571, DOI 10.1139/y94-081; HIKOSAKA O, 1999, NEW COGNITIVE NEUROS, P553; Hoshi E, 2000, NATURE, V408, P466, DOI 10.1038/35044075; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; KEIZER K, 1989, EXP BRAIN RES, V74, P311; LEINONEN L, 1979, EXP BRAIN RES, V34, P321; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; MATSUMURA M, 1979, NEUROSCI LETT, V11, P241, DOI 10.1016/0304-3940(79)90001-6; Matsuzaka Y, 1996, J NEUROPHYSIOL, V76, P2327, DOI 10.1152/jn.1996.76.4.2327; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; MUAKKASSA KF, 1979, BRAIN RES, V177, P176, DOI 10.1016/0006-8993(79)90928-4; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; PERRETT DI, 1989, J EXP BIOL, V146, P87; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Porter R, 1993, CORTICOSPINAL FUNCTI; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; RIZZOLATTI G, 1990, EXP BRAIN RES, V82, P337; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Sakai K, 1999, J NEUROSCI, V19, P10074; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Schieber MH, 1998, J NEUROSCI, V18, P9038; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tanji J, 1996, COGNITIVE BRAIN RES, V5, P117, DOI 10.1016/S0926-6410(96)00047-X; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470	47	944	953	0	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2001	31	6					889	901		10.1016/S0896-6273(01)00423-8	http://dx.doi.org/10.1016/S0896-6273(01)00423-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580891	Bronze			2022-12-28	WOS:000171281300006
J	Suzuki, S; Grabowecky, M				Suzuki, S; Grabowecky, M			Evidence for perceptual "trapping" and adaptation in multistable binocular rivalry	NEURON			English	Article							MONKEY INFEROTEMPORAL CORTEX; MOTION PERCEPTION; VISUAL-CORTEX; REAL IMAGES; OBJECT; RESPONSES; NEURONS; VISION; SHAPE; ORIENTATION	When a different pattern is presented to each eye, the perceived image spontaneously alternates between the two patterns (binocular rivalry); the dynamics of these bistable alternations are known to be stochastic. Examining multistable binocular rivalry (involving four dominant percepts), we demonstrated path dependence and on-line adaptation, which were equivalent whether perceived patterns were formed by single-eye dominance or by mixed-eye dominance. The spontaneous perceptual transitions tended to get trapped within a pair of related global patterns (e.g., opponent shapes and symmetric patterns), and during such trapping, the probability of returning to the repeatedly experienced patterns gradually decreased (postselection pattern adaptation). These results suggest that the structure of global shape coding and its adaptation play a critical role in directing spontaneous alternations of visual awareness in perceptual multistability.	Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA	Northwestern University	Suzuki, S (corresponding author), Northwestern Univ, Dept Psychol, 2029 Sheridan Rd, Evanston, IL 60208 USA.	satoru@northwestern.edu						ATTNEAVE F, 1971, SCI AM, V225, P62, DOI 10.1038/scientificamerican1271-62; BLAKE R, 1980, PERCEPTION, V9, P223, DOI 10.1068/p090223; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; BLAKE R, 1990, PERCEPT PSYCHOPHYS, V48, P593, DOI 10.3758/BF03211605; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 1998, J COGNITIVE NEUROSCI, V10, P46, DOI 10.1162/089892998563770; BLAKE R, 1974, VISION RES, V14, P687, DOI 10.1016/0042-6989(74)90065-0; BLAKE RR, 1971, J EXP PSYCHOL, V88, P327, DOI 10.1037/h0030877; Bonneh Y, 2001, VISION RES, V41, P981, DOI 10.1016/S0042-6989(01)00013-X; Bonneh Y, 1999, VISION RES, V39, P271, DOI 10.1016/S0042-6989(98)00112-6; BORSELLINO A, 1972, KYBERNETIK, V10, P139, DOI 10.1007/BF00290512; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; COGAN R, 1973, J GEN PSYCHOL, V89, P297, DOI 10.1080/00221309.1973.9710832; COGAN R, 1972, PERCEPT MOTOR SKILL, V35, P569, DOI 10.2466/pms.1972.35.2.569; DIAZCANEJA E, 1928, PHILOS T R SOC LON B, V353, P1801; FOX R, 1967, PERCEPT PSYCHOPHYS, V2, P432, DOI 10.3758/BF03208783; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Hikosaka K, 1999, BEHAV BRAIN RES, V100, P67, DOI 10.1016/S0166-4328(98)00114-4; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lack L.C., 1978, SELECTIVE ATTENTION; LACK LC, 1974, PERCEPT PSYCHOPHYS, V15, P193, DOI 10.3758/BF03205846; LATHROP RG, 1966, J EXP PSYCHOL, V72, P120, DOI 10.1037/h0023314; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; LEHKY SR, 1995, P ROY SOC B-BIOL SCI, V259, P71, DOI 10.1098/rspb.1995.0011; Levelt WJM, 1965, BINOCULAR RIVALRY; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; MILLER EK, 1993, J NEUROSCI, V13, P1460; Morita M, 2002, COGNITIVE BRAIN RES, V13, P169, DOI 10.1016/S0926-6410(01)00109-4; PETERSON MA, 1991, J EXP PSYCHOL HUMAN, V17, P1075, DOI 10.1037/0096-1523.17.4.1075; PETERSON MA, 1991, J EXP PSYCHOL HUMAN, V17, P170, DOI 10.1037/0096-1523.17.1.170; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; RAMACHANDRAN VS, 1983, NATURE, V304, P529, DOI 10.1038/304529a0; REGAN D, 1992, VISION RES, V32, P1845, DOI 10.1016/0042-6989(92)90046-L; Renart A, 2001, NEUROCOMPUTING, V38, P1525, DOI 10.1016/S0925-2312(01)00548-3; RICHARDS W, 1994, BIOL CYBERN, V70, P345, DOI 10.1007/BF00200331; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; SUGIE N, 1982, BIOL CYBERN, V43, P13, DOI 10.1007/BF00337283; Suzuki S, 2001, VISION RES, V41, P3883, DOI 10.1016/S0042-6989(01)00249-8; Suzuki S, 1998, J EXP PSYCHOL HUMAN, V24, P1315, DOI 10.1037/0096-1523.24.5.1315; Suzuki S, 2000, PSYCHOL SCI, V11, P202, DOI 10.1111/1467-9280.00242; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TAYLOR MM, 1974, PERCEPT PSYCHOPHYS, V16, P9, DOI 10.3758/BF03203243; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; VOGELS R, 1995, VISUAL NEUROSCI, V12, P207, DOI 10.1017/S0952523800007884; WADE NJ, 1974, PERCEPT PSYCHOPHYS, V15, P227, DOI 10.3758/BF03213937; WADE NJ, 1975, PERCEPT PSYCHOPHYS, V17, P571, DOI 10.3758/BF03203971; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; YU K, 1992, J EXP PSYCHOL HUMAN, V18, P1158, DOI 10.1037/0096-1523.18.4.1158	59	65	65	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					143	157		10.1016/S0896-6273(02)00934-0	http://dx.doi.org/10.1016/S0896-6273(02)00934-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	598UP	12367513	Bronze			2022-12-28	WOS:000178295100014
J	Koechlin, E; Danek, A; Brunod, Y; Grafman, J				Koechlin, E; Danek, A; Brunod, Y; Grafman, J			Medial prefrontal and subcortical mechanisms underlying the acquisition of motor and cognitive action sequences in humans	NEURON			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ANTERIOR CINGULATE CORTEX; VENTRAL STRIATUM; BASAL GANGLIA; PARKINSONS-DISEASE; NEURONAL-ACTIVITY; WORKING-MEMORY; REWARD; MONKEY; ORGANIZATION	The anterior media[ prefrontal cortex (AMPC) in humans is involved in affect and in regulating goal-directed behaviors. The precise function of the AMPC, however, is poorly understood. Using magnetic resonance imaging, we found that bilateral regions in the AMPC were selectively recruited to compute the reliability of subjects' expectations that developed when subjects were learning sequences of cognitive tasks. In contrast, regions similarly recruited in learning sequences of motor acts were found in the ventral striatum. Our results show that beyond the execution of motor acts, the AMPC is selectively engaged in computing the relevance of cognitive goals that subjects intend to achieve. This indicates that the fronto-striatal circuit, including the ventral striatum and AMPC, subserves hierarchically distinct evaluative processes mediating the human ability to build behavioral plans, ranging from motor to cognitive action plans.	Univ Paris 06, INSERM, U483, F-75005 Paris, France; NINDS, Cognit Neurosci Sect, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Koechlin, E (corresponding author), Univ Paris 06, INSERM, U483, 9 Quai St Bernard, F-75005 Paris, France.	koechlin@ccr.jussieu.fr	Koechlin, Etienne/AAF-5717-2021; Koechlin, Etienne/E-5061-2016; Danek, Adrian/G-7339-2011	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; Danek, Adrian/0000-0001-8857-5383; Grafman, Jordan H./0000-0001-8645-4457				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; APICELLA P, 1991, EXP BRAIN RES, V85, P491; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; BENES FM, 1993, SCHIZOPHRENIA BULL, V19, P537, DOI 10.1093/schbul/19.3.537; BROWN RG, 1988, BRAIN, V111, P323, DOI 10.1093/brain/111.2.323; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DICKINSON A, 1980, CON ANIMAL LEARNING; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Furey ML, 1997, P NATL ACAD SCI USA, V94, P6512, DOI 10.1073/pnas.94.12.6512; Fuster J.M., 1989, PREFRONTAL CORTEX; Gordon AM, 1998, EXP BRAIN RES, V121, P153, DOI 10.1007/s002210050447; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Graybiel A. M., 1995, MODELS INFORMATION P, P103; Graybiel AM, 1997, SCHIZOPHRENIA BULL, V23, P459, DOI 10.1093/schbul/23.3.459; HABER SN, 1995, J NEUROSCI, V15, P4851; Hertz JA, 2018, INTRO THEORY NEURAL; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; LEWIS DA, 1988, BRAIN RES, V449, P225, DOI 10.1016/0006-8993(88)91040-2; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pallier C, 1997, BEHAV RES METH INS C, V29, P322, DOI 10.3758/BF03200583; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SCHULTZ W, 1995, MODELS INFORMATION P, P11; Shidara M, 1998, J NEUROSCI, V18, P2613; SHIDARA M, 2002, IN PRESS SCIENCE; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P683, DOI 10.1073/pnas.98.2.683; Strange BA, 2001, CEREB CORTEX, V11, P1040, DOI 10.1093/cercor/11.11.1040; TALAIRACH J, 1988, COPLANAR STEREOAXIC; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Worsley KJ, 2000, STAT PROBABIL LETT, V47, P135, DOI 10.1016/S0167-7152(99)00149-2	50	68	68	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					371	381		10.1016/S0896-6273(02)00742-0	http://dx.doi.org/10.1016/S0896-6273(02)00742-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	576YF	12160754	Bronze			2022-12-28	WOS:000177034200016
J	Rilling, JK; Gutman, DA; Zeh, TR; Pagnoni, G; Berns, GS; Kilts, CD				Rilling, JK; Gutman, DA; Zeh, TR; Pagnoni, G; Berns, GS; Kilts, CD			A neural basis for social cooperation	NEURON			English	Article							REPEATED PRISONERS-DILEMMA; ORBITOFRONTAL CORTEX; ANTERIOR CINGULATE; RECIPROCAL ALTRUISM; PREFRONTAL CORTEX; REWARD; BRAIN; EVOLUTION; RESPONSES; EMOTION	Cooperation based on reciprocal altruism has evolved in only a small number of species, yet it constitutes the core behavioral principle of human social life. The iterated Prisoner's Dilemma Game has been used to model this form of cooperation. We used fMRI to scan 36 women as they played an iterated Prisoner's Dilemma Game with another woman to investigate the neurobiological basis of cooperative social behavior. Mutual cooperation was associated with consistent activation in brain areas that have been linked with reward processing: nucleus accumbens, the caudate nucleus, ventromedial frontal/orbitofrontal cortex, and rostral anterior cingulate cortex. We propose that activation of this neural network positively reinforces reciprocal altruism, thereby motivating subjects to resist the temptation to selfishly accept but not reciprocate favors.	Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	Emory University	Rilling, JK (corresponding author), Princeton Univ, Green Hall, Princeton, NJ 08544 USA.		Tudusciuc, Oana/C-1339-2011; Gutman, David/U-2713-2018; Pagnoni, Giuseppe/F-3398-2015	Gutman, David/0000-0002-1386-8701; Pagnoni, Giuseppe/0000-0002-8272-8091	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061010] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00367] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline; NIMH NIH HHS [MH61010] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Aziz Q, 2000, J NEUROSCI, V20, P2657; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BOYD R, 1988, ETHOL SOCIOBIOL, V9, P211, DOI 10.1016/0162-3095(88)90022-2; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Frank R. H., 1988, PASSIONS REASON STRA; Friston K, 1995, HUM BRAIN MAPP, V2, P1; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; HOTTES JH, 1974, J PERS, V42, P260, DOI 10.1111/j.1467-6494.1974.tb00673.x; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Lee Richard, 1968, MAN HUNTER; Nesse R M, 1990, Hum Nat, V1, P261, DOI 10.1007/BF02733986; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Rapoport A., 1965, PRISONERS DILEMMA ST; Ridley Matt, 1996, ORIGINS VIRTUE; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; ROLLS ET, 1999, BRAIN EMOTION; Sahlins MarshallD., 1972, STONE AGE EC; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; SKOTKO V, 1974, J CONFLICT RESOLUT, V18, P707, DOI 10.1177/002200277401800411; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Trivers R. L., 1985, SOCIAL EVOLUTION; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0	38	860	878	9	207	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					395	405		10.1016/S0896-6273(02)00755-9	http://dx.doi.org/10.1016/S0896-6273(02)00755-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	576YF	12160756	Bronze			2022-12-28	WOS:000177034200018
J	Graziano, MSA; Taylor, CSR; Moore, T				Graziano, MSA; Taylor, CSR; Moore, T			Complex movements evoked by microstimulation of precentral cortex	NEURON			English	Article							DORSOMEDIAL FRONTAL-CORTEX; MONKEY MOTOR CORTEX; ELECTRICAL-STIMULATION; PREMOTOR CORTEX; EYE-MOVEMENTS; SUPERIOR COLLICULUS; MACAQUE MONKEYS; RHESUS-MONKEYS; ARM MOVEMENTS; SPINAL-CORD	Electrical microstimulation was used to study primary motor and premotor cortex in monkeys. Each stimulation train was 500 ms in duration, approximating the time scale of normal reaching and grasping movements and the time scale of the neuronal activity that normally accompanies movement. This stimulation on a behaviorally relevant time scale evoked coordinated, complex postures that involved many joints. For example, stimulation of one site caused the mouth to open and also caused the hand to shape into a grip posture and move to the mouth. Stimulation of this site always drove the joints toward this final posture, regardless of the direction of movement required to reach the posture. Stimulation of other cortical sites evoked different postures. Postures that involved the arm were arranged across cortex to form a map of hand positions around the body. This stimulation-evoked map encompassed both primary motor and the adjacent premotor cortex. We suggest that these regions fit together into a single map of the workspace around the body.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Graziano, MSA (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	graziano@princeton.edu			NATIONAL EYE INSTITUTE [R01EY011347] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11347] Funding Source: Medline; NIMH NIH HHS [MH-12336] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ASANUMA H, 1976, EXP BRAIN RES, V26, P443; BIZZI E, 1989, HDB NEUROPSYCHOLOGY, V2, P229; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; CAGGIULA AR, 1966, SCIENCE, V153, P1284, DOI 10.1126/science.153.3741.1284; COLBY CL, 1988, J COMP NEUROL, V269, P392, DOI 10.1002/cne.902690307; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DONOGHUE JP, 1992, EXP BRAIN RES, V89, P1; DUM RP, 1991, J NEUROSCI, V11, P667; Dum RP, 1996, J NEUROSCI, V16, P6513; Evarts EV, 1981, HDB PHYSL NERVOUS SY, VII, P1083; Ferrier D, 1873, Br Med J, V1, P457; FETZ EE, 1980, J NEUROPHYSIOL, V43, P1070, DOI 10.1152/jn.1980.43.4.1070; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Freedman EG, 1996, J NEUROPHYSIOL, V76, P927, DOI 10.1152/jn.1996.76.2.927; FRITSCH G, 1870, CEREB CORTEX, P73; Fulton JF, 1935, BRAIN, V58, P311, DOI 10.1093/brain/58.2.311; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GISZTER SF, 1993, J NEUROSCI, V13, P467; GOTTLIEB JP, 1993, J NEUROPHYSIOL, V69, P786, DOI 10.1152/jn.1993.69.3.786; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Graziano MSA, 2000, EXP BRAIN RES, V135, P259, DOI 10.1007/s002210000518; HOEBEL BG, 1969, ANN NY ACAD SCI, V157, P758, DOI 10.1111/j.1749-6632.1969.tb12919.x; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KENNEDY H, 1986, J COMP NEUROL, V247, P398, DOI 10.1002/cne.902470309; KURATA K, 1989, EXP BRAIN RES, V77, P245, DOI 10.1007/BF00274982; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P313, DOI 10.1098/rspb.1976.0082; Maier MA, 2002, CEREB CORTEX, V12, P281, DOI 10.1093/cercor/12.3.281; Moran DW, 2000, NAT NEUROSCI, V3, P963, DOI 10.1038/79880; MORASSO P, 1981, EXP BRAIN RES, V42, P223; OKADA E, 1991, PHYSIOL BEHAV, V50, P229, DOI 10.1016/0031-9384(91)90525-S; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Preuss TM, 1996, J COMP NEUROL, V371, P649, DOI 10.1002/(SICI)1096-9861(19960805)371:4<649::AID-CNE12>3.0.CO;2-E; QUAADE F, 1974, ACTA NEUROCHIR, V30, P111, DOI 10.1007/BF01405759; Reina GA, 2001, J NEUROPHYSIOL, V85, P2576, DOI 10.1152/jn.2001.85.6.2576; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; Russo GS, 2000, J NEUROPHYSIOL, V84, P2605, DOI 10.1152/jn.2000.84.5.2605; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SANES JN, 1995, SCIENCE, V268, P1775, DOI 10.1126/science.7792606; SATO KC, 1989, J NEUROPHYSIOL, V62, P959, DOI 10.1152/jn.1989.62.4.959; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; Scott SH, 2000, NAT NEUROSCI, V3, P964, DOI 10.1038/79888; SESSLE BJ, 1982, J PHYSIOL-LONDON, V323, P245, DOI 10.1113/jphysiol.1982.sp014071; Stanford TR, 1996, J NEUROPHYSIOL, V76, P3360, DOI 10.1152/jn.1996.76.5.3360; STRICK PL, 1978, BRAIN RES, V154, P366, DOI 10.1016/0006-8993(78)90707-2; TEHOVNIK EJ, 1993, EXP BRAIN RES, V96, P430; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; TEHOVNIK EJ, 1995, BEHAV BRAIN RES, V67, P147, DOI 10.1016/0166-4328(94)00151-5; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; WEINRICH M, 1982, J NEUROSCI, V2, P1329; WOOLSEY CN, 1950, RES PUBL ASSOC RES N, V30, P238; Wu CWH, 2000, J COMP NEUROL, V423, P140, DOI 10.1002/1096-9861(20000717)423:1<140::AID-CNE12>3.0.CO;2-3	59	607	628	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					841	851		10.1016/S0896-6273(02)00698-0	http://dx.doi.org/10.1016/S0896-6273(02)00698-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062029	Bronze			2022-12-28	WOS:000175951800017
J	Kahn, I; Yeshurun, Y; Rotshtein, P; Fried, I; Ben-Bashat, D; Hendler, T				Kahn, I; Yeshurun, Y; Rotshtein, P; Fried, I; Ben-Bashat, D; Hendler, T			The role of the amygdala in signaling prospective outcome of choice	NEURON			English	Article							ORBITAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; EMOTIONAL RESPONSES; NEUROTOXIC LESIONS; FACIAL EXPRESSIONS; LATERAL AMYGDALA; FUNCTIONAL MRI; FEAR; ACTIVATION	Can brain activity reveal a covert choice? Making a choice often evokes distinct emotions that accompany decision processes. Amygdala has been implicated in choice behavior that is guided by a prospective negative outcome. However, its specific involvement in emotional versus cognitive processing of choice behavior has been a subject of controversy. In this study, the human amygdala was monitored by functional magnetic resonance imaging (fMRI) while subjects were playing in a naturalistic choice paradigm against the experimenter. In order to win, players had to occasionally choose to bluff their opponent, risk "getting caught," and suffer a loss. A critical period, when choice has been made but outcome was still unknown, activated the amygdala preferentially following the choice that entailed risk of loss. Thus, the response of the amygdala differentiated between subject's covert choice of either playing fair or foul. These results support a role of the amygdala in choice behavior, both in the appraisal of inherent value of choice and the signaling of prospective negative outcomes.	Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, IL-64239 Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sch Comp Sci, Sackler Fac Exact Sci, IL-69978 Tel Aviv, Israel; Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hendler, T (corresponding author), Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, 6 Weizmann St, IL-64239 Tel Aviv, Israel.		hendler, talma/C-7677-2012	Ben Bashat, Dafna/0000-0001-8396-1031; Kahn, Itamar/0000-0002-1895-8677; Rotshtein, Pia/0000-0002-0301-9511				Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Baxter MG, 2000, J NEUROSCI, V20, P4311; Bechara A, 1999, J NEUROSCI, V19, P5473; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 1997, NEUROPSYCHOLOGIA, V35, P1395, DOI 10.1016/S0028-3932(97)00055-9; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Hatfield T, 1996, J NEUROSCI, V16, P5256; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Kluver H, 1997, J NEUROPSYCH CLIN N, V9, P606; Knight DC, 1999, NEUROREPORT, V10, P3665, DOI 10.1097/00001756-199911260-00037; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LeDoux J.E., 1996, EMOTIONAL BRAIN MYST; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; LOOMES G, 1986, REV ECON STUD, V53, P271, DOI 10.2307/2297651; LOOMES G, 1989, ECON J, V99, P140, DOI 10.2307/2234076; Malkova L, 1997, J NEUROSCI, V17, P6011; Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037/0096-3445.128.3.332; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Meunier M, 1999, EUR J NEUROSCI, V11, P4403, DOI 10.1046/j.1460-9568.1999.00854.x; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Pare D, 2000, J NEUROSCI, V20, P2701; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; ROLLS ET, 1999, BRAIN EMOTION; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; Schneider F, 1997, PSYCHIAT RES-NEUROIM, V76, P75, DOI 10.1016/S0925-4927(97)00063-2; Schneider F, 2000, NEUROPSYCHOBIOLOGY, V42, P192, DOI 10.1159/000026693; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Talairach J, 1988, CO PLANAR STEREOTAXI; TRANEL D, 1990, ARCH NEUROL-CHICAGO, V47, P349, DOI 10.1001/archneur.1990.00530030131029; Whalen PJ, 1998, J NEUROSCI, V18, P411; Zalla T, 2000, EUR J NEUROSCI, V12, P1764, DOI 10.1046/j.1460-9568.2000.00064.x; Zola-Morgan S, 1991, Hippocampus, V1, P207, DOI 10.1002/hipo.450010208	52	75	75	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					983	994		10.1016/S0896-6273(02)00626-8	http://dx.doi.org/10.1016/S0896-6273(02)00626-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	530ZK	11906703	Bronze			2022-12-28	WOS:000174389600014
J	Di Paolo, G; Sankaranarayanan, S; Wenk, MR; Daniell, L; Perucco, E; Caldarone, BJ; Flavell, R; Picciotto, MR; Ryan, TA; Cremona, O; De Camilli, P				Di Paolo, G; Sankaranarayanan, S; Wenk, MR; Daniell, L; Perucco, E; Caldarone, BJ; Flavell, R; Picciotto, MR; Ryan, TA; Cremona, O; De Camilli, P			Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; SH3 DOMAIN; DROSOPHILA AMPHIPHYSIN; ACTIN CYTOSKELETON; POOL MOBILIZATION; BINDING-PROTEIN; DYNAMIN; INTERACTS; MEMBRANE; BRAIN	The function of the clathrin coat in synaptic vesicle endocytosis is assisted by a variety of accessory factors, among which amphiphysin (amphiphysin 1 and 2) is one of the best characterized. A putative endocytic function of amphiphysin was supported by dominant-negative interference studies. We have now generated amphiphysin 1 knockout mice and found that lack of amphiphysin 1 causes a parallel dramatic reduction of amphiphysin 2 selectively in brain. Cell-free assembly of endocytic protein scaffolds is defective in mutant brain extracts. Knockout mice exhibit defects in synaptic vesicle recycling that are unmasked by stimulation and suggest impairments at multiple stages of the cycle. These defects correlate with increased mortality due to rare irreversible seizures and with major learning deficits, suggesting a critical role of amphiphysin for higher brain functions.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Univ Piemonte Orientale, Dipartimento Sci Med, I-28100 Novara, Italy; Univ Vita Salute San Raffaele Milano, San Raffaele Sci Inst, I-20132 Milan, Italy	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Cornell University; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Cremona, Ottavio/AAB-8793-2019; Ryan, Timothy/AAO-8286-2020; Picciotto, Marina R./F-8747-2012; Wenk, Markus Rene/D-1441-2014	Cremona, Ottavio/0000-0001-9462-1040; Picciotto, Marina R./0000-0002-4404-1280; Ryan, Timothy/0000-0003-2533-9548	NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH025642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER; NCI NIH HHS [CA46128] Funding Source: Medline; NIDA NIH HHS [DA00436] Funding Source: Medline; NIGMS NIH HHS [GM61925] Funding Source: Medline; NIMH NIH HHS [MH25642] Funding Source: Medline; NINDS NIH HHS [NS24692, NS36251] Funding Source: Medline; Telethon [D.111] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Banker G., 1991, CULTURING NERVE CELL; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Burger KNJ, 2000, BIOCHEMISTRY-US, V39, P12485, DOI 10.1021/bi000971r; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Caldarone BJ, 2000, NEUROPHARMACOLOGY, V39, P2779, DOI 10.1016/S0028-3908(00)00137-4; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Cousin MA, 2000, J NEUROCHEM, V75, P1645, DOI 10.1046/j.1471-4159.2000.0751645.x; Cousin MA, 1998, NEUROSCI LETT, V253, P1, DOI 10.1016/S0304-3940(98)00610-7; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; CROUZET M, 1991, YEAST, V7, P727, DOI 10.1002/yea.320070708; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; DECAMILLI P, 1993, J EXP MED, V178, P2219, DOI 10.1084/jem.178.6.2219; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dunaevsky A, 2000, J NEUROSCI, V20, P6007, DOI 10.1523/JNEUROSCI.20-16-06007.2000; Elliott K, 1999, ONCOGENE, V18, P3564, DOI 10.1038/sj.onc.1202670; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Ge K, 2000, GENOMICS, V67, P210, DOI 10.1006/geno.2000.6216; Geli MI, 1998, J CELL SCI, V111, P1031; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Kadlec L, 1997, P NATL ACAD SCI USA, V94, P12390, DOI 10.1073/pnas.94.23.12390; Kittler JT, 2000, J NEUROSCI, V20, P7972; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Leventis PA, 2001, TRAFFIC, V2, P839; Lombardi R, 2001, J BIOL CHEM, V276, P6016, DOI 10.1074/jbc.M008735200; Luthi A, 2001, J NEUROSCI, V21, P9101, DOI 10.1523/JNEUROSCI.21-23-09101.2001; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Modregger J, 2000, J CELL SCI, V113, P4511; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; Mundigl O, 1998, J NEUROSCI, V18, P93; Navarro P, 1997, BBA-PROTEIN STRUCT M, V1343, P187, DOI 10.1016/S0167-4838(97)00108-8; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Owen DJ, 2000, CURR OPIN CELL BIOL, V12, P467, DOI 10.1016/S0955-0674(00)00118-6; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Ramjaun AR, 1999, J BIOL CHEM, V274, P19785, DOI 10.1074/jbc.274.28.19785; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; Razzaq A, 2000, GENE, V241, P167, DOI 10.1016/S0378-1119(99)00451-5; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Routhier EL, 2001, J BIOL CHEM, V276, P21670, DOI 10.1074/jbc.M101096200; Ryan TA, 1999, J NEUROSCI, V19, P1317; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Teng HB, 2000, J NEUROSCI, V20, P7986; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Varela JA, 1999, J NEUROSCI, V19, P4293; Wasiak S, 2001, J BIOL CHEM, V276, P26622, DOI 10.1074/jbc.M100591200; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Zelhof AC, 2001, DEVELOPMENT, V128, P5005	83	170	172	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					789	804		10.1016/S0896-6273(02)00601-3	http://dx.doi.org/10.1016/S0896-6273(02)00601-3			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879655	Bronze			2022-12-28	WOS:000174286200014
J	Fisahn, A; Yamada, M; Duttaroy, A; Gan, JW; Deng, CX; McBain, CJ; Wess, J				Fisahn, A; Yamada, M; Duttaroy, A; Gan, JW; Deng, CX; McBain, CJ; Wess, J			Muscarinic induction of hippocampal gamma oscillations requires coupling of the M1 receptor to two mixed cation currents	NEURON			English	Article							CURRENT I-H; HYPERPOLARIZATION-ACTIVATED CURRENTS; VOLTAGE-CLAMP ANALYSIS; ACETYLCHOLINE-RECEPTOR; FREQUENCY OSCILLATIONS; NETWORK OSCILLATIONS; RAT HIPPOCAMPUS; MODULATION; PACEMAKER; MEMORY	Oscillatory network activity at gamma frequencies is assumed to be of major importance in cortical information processing. Whereas the synaptic mechanisms of gamma oscillations have been studied in detail, the ionic currents involved at the cellular level remain to be elucidated. Here we show that in vitro gamma oscillations induced by muscarine require activation of M1 receptors on hippocampal CA3 pyramidal neurons and are absent in M1 receptor-deficient mice. M1 receptor activation depolarizes pyramidal neurons by increasing the mixed Na+/K+ current I-h and the Ca2+-dependent nonspecific cation current I-cat, but not by modulation of I-M. Our data provide important insight into the molecular basis of gamma oscillations by unequivocally establishing a novel role for muscarinic modulation Of I-h and I-cat in rhythmic network activity.	NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; NIDDKD, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; NIDDKD, Biochem & Metab Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	McBain, CJ (corresponding author), NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA.	chrismcb@codon.nih.gov	Duttaroy, Asim K./J-9499-2016; deng, chuxia/N-6713-2016	Duttaroy, Asim K./0000-0003-1619-3778; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056001, Z01DK056001, Z01DK032003] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; BRAGIN A, 1995, J NEUROSCI, V15, P47; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; COLINO A, 1993, EUR J NEUROSCI, V5, P1198, DOI 10.1111/j.1460-9568.1993.tb00974.x; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; FISAHN A, 1999, THESIS OXFORD U OXFO; Gasparini S, 1999, EUR J NEUROSCI, V11, P3093, DOI 10.1046/j.1460-9568.1999.00728.x; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; GRIFFITHS PD, 1994, NEUROSCI LETT, V169, P68, DOI 10.1016/0304-3940(94)90358-1; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; HAROUTUNIAN V, 1994, SCHIZOPHR RES, V12, P137, DOI 10.1016/0920-9964(94)90071-X; HASSELMO ME, 1992, J NEUROPHYSIOL, V67, P1230, DOI 10.1152/jn.1992.67.5.1230; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; LEVEY AI, 1995, J NEUROSCI, V15, P4077; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; MADISON DV, 1987, J NEUROSCI, V7, P733; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Rouse ST, 2000, NEUROSCI LETT, V278, P61, DOI 10.1016/S0304-3940(99)00914-3; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; STERIADE M, 1991, P NATL ACAD SCI USA, V88, P4396, DOI 10.1073/pnas.88.10.4396; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Yamada M, 2001, P NATL ACAD SCI USA, V98, P14096, DOI 10.1073/pnas.251542998	47	186	191	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 14	2002	33	4					615	624		10.1016/S0896-6273(02)00587-1	http://dx.doi.org/10.1016/S0896-6273(02)00587-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856534	Bronze			2022-12-28	WOS:000173911100013
J	Sabatini, BL; Oertner, TG; Svoboda, K				Sabatini, BL; Oertner, TG; Svoboda, K			The life cycle of Ca2+ ions in dendritic spines	NEURON			English	Article							LONG-TERM POTENTIATION; BOVINE CHROMAFFIN CELLS; HIPPOCAMPAL-NEURONS; CALCIUM DYNAMICS; SINGLE SPINES; SYNAPTIC TRANSMISSION; PYRAMIDAL NEURONS; PURKINJE NEURONS; NMDA RECEPTORS; AREA CA1	Spine Ca2+ is critical for the induction of synaptic plasticity, but the factors that control Ca2+ handling in dendritic spines under physiological conditions are largely unknown. We studied [Ca2+] signaling in dendritic spines of CA1 pyramidal neurons and find that spines are specialized structures with low endogenous Ca2+ buffer capacity that allows large and extremely rapid [Ca2+] changes. Under physiological conditions, Ca2+ diffusion across the spine neck is negligible, and the spine head functions as a separate compartment on long time scales, allowing localized Ca2+ buildup during trains of synaptic stimuli. Furthermore, the kinetics of Ca2+ sources governs the time course of [Ca2+] signals and may explain the selective activation of long-term synaptic potentiation (LTP) and long-term depression (LTD) by NMDA-R-mediated synaptic Ca2+.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.org	Oertner, Thomas/F-2214-2010	Oertner, Thomas/0000-0002-2312-7528				ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hollingworth S, 1996, J GEN PHYSIOL, V108, P455, DOI 10.1085/jgp.108.5.455; Holmes WR, 2000, J COMPUT NEUROSCI, V8, P65, DOI 10.1023/A:1008969032563; HOLMES WR, 1990, BRAIN RES, V519, P338, DOI 10.1016/0006-8993(90)90098-V; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KOCH C, 1993, J NEUROSCI, V13, P413; Koester HJ, 1999, BIOPHYS J, V77, P2226, DOI 10.1016/S0006-3495(99)77063-3; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Majewska A, 2000, J NEUROSCI, V20, P1722; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; PHILIPSON K, 1999, CALCIUM CELLULAR REG, P249; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; STORM JF, 1990, PROG BRAIN RES, V83, P161; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tank DW, 1995, J NEUROSCI, V15, P7940; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	57	514	518	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					439	452		10.1016/S0896-6273(02)00573-1	http://dx.doi.org/10.1016/S0896-6273(02)00573-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832230	Green Submitted, Bronze			2022-12-28	WOS:000173643200013
J	Peretz, I; Ayotte, J; Zatorre, RJ; Mehler, J; Ahad, P; Penhune, VB; Jutras, B				Peretz, I; Ayotte, J; Zatorre, RJ; Mehler, J; Ahad, P; Penhune, VB; Jutras, B			Congenital amusia: A disorder of fine-grained pitch discrimination	NEURON			English	Article							AUDITORY-CORTEX; MUSIC AGNOSIA; INFORMATION; PERCEPTION; PATTERNS; MELODIES	We report the first documented case of congenital amusia. This disorder refers to a musical disability that cannot be explained by prior brain lesion, hearing loss, cognitive deficits, socioaffective disturbance, or lack of environmental stimulation. This musical impairment Is diagnosed in a middle-aged woman, hereafter referred to as Monica, who lacks most basic musical abilities, including melodic discrimination and recognition, despite normal audiometry and above-average intellectual, memory, and language skills. The results of psychophysical tests show that Monica has severe difficulties with detecting pitch changes. The data suggest that music-processing difficulties may result from problems in fine-grained discrimination of pitch, much in the same way as many language-processing difficulties arise from deficiencies in auditory temporal resolution.	Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; Inst Univ Geriatrie Montreal, Res Ctr, Montreal, PQ H3W 1W5, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; Scuola Int Super Studi Avanzati, I-34014 Trieste, Italy; LSCP, F-75006 Paris, France; McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; Concordia Univ, Dept Psychol, Montreal, PQ H4B 1R6, Canada	Universite de Montreal; Universite de Montreal; McGill University; International School for Advanced Studies (SISSA); McGill University; Concordia University - Canada	Peretz, I (corresponding author), Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	isabelle.peretz@umontreal.ca	Cabrera, Mariel/GMX-2706-2022					Ayotte J, 2000, BRAIN, V123, P1926, DOI 10.1093/brain/123.9.1926; GESCHWIND N, 1984, ANN DYSLEXIA, V34, P319, DOI 10.1007/BF02663629; GRANTALLEN, 1878, MIND, V10, P157; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; KAZEZ D, 1985, MUSIC EDUC J, V71, P46, DOI 10.2307/3396499; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; Marin O.S.M., 1999, PSYCHOL MUSIC, P653; OLSHO LW, 1982, DEV PSYCHOL, V18, P721; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; PERETZ I, 1990, BRAIN, V113, P1185, DOI 10.1093/brain/113.4.1185; PERETZ I, 1993, COGNITIVE NEUROPSYCH, V10, P21, DOI 10.1080/02643299308253455; PERETZ I, 1995, CAN J EXP PSYCHOL, V49, P211, DOI 10.1037/1196-1961.49.2.211; Peretz I, 1996, J COGNITIVE NEUROSCI, V8, P481, DOI 10.1162/jocn.1996.8.6.481; PERETZ I, 1993, HDB NEUROPSYCHOLOGY, V8, P373; SAMSON S, 1992, NEUROPSYCHOLOGIA, V30, P815, DOI 10.1016/0028-3932(92)90085-Z; StuddertKennedy M, 1995, PSYCHON B REV, V2, P508, DOI 10.3758/BF03210986; TALLAL P, 1973, NATURE, V241, P468, DOI 10.1038/241468a0; Tramo M J, 1990, J Cogn Neurosci, V2, P195, DOI 10.1162/jocn.1990.2.3.195; VOS PG, 1989, MUSIC PERCEPT, V6, P383; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; ZATORRE RJ, 1985, NEUROPSYCHOLOGIA, V23, P31, DOI 10.1016/0028-3932(85)90041-7	22	241	248	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					185	191		10.1016/S0896-6273(01)00580-3	http://dx.doi.org/10.1016/S0896-6273(01)00580-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804567	Bronze			2022-12-28	WOS:000173387700007
J	Richards, LJ				Richards, LJ			Surrounded by slit - How forebrain commissural axons can be led astray	NEURON			English	Editorial Material							GUIDANCE	In Drosophila, Slit acts as a barrier preventing roundabout expressing axons from entering the midline and sorting contralaterally from ipsilaterally projecting axons. Hutson and Chien, Plump et al., and Bagri et al. (all in this issue of Neuron) use Slit knockout mice and zebrafish astray/Robo2 mutants to show that in vertebrates, Robo/Slit function to channel axons into specific pathways and determine where decussation points occur. Ipsilaterally and contralaterally projected axons are equally affected.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Richards, LJ (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 685 W Baltimore St, Baltimore, MD 21201 USA.		Richards AO, Linda/P-6372-2014	Richards AO, Linda/0000-0002-7590-7390				Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Erskine L, 2000, J NEUROSCI, V20, P4975; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Keynes R, 1997, NEURON, V18, P889, DOI 10.1016/S0896-6273(00)80329-3; Niclou SP, 2000, J NEUROSCI, V20, P4962; Patel K, 2001, DEVELOPMENT, V128, P5031; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	13	14	14	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					153	155		10.1016/S0896-6273(02)00566-4	http://dx.doi.org/10.1016/S0896-6273(02)00566-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804561	Bronze			2022-12-28	WOS:000173387700001
J	Fricker, D; Miles, R				Fricker, D; Miles, R			Interneurons, spike timing, and perception	NEURON			English	Review							HIPPOCAMPUS; RAT; EXPRESSION; NEURONS	Rhythmic gamma oscillations at 30-70 Hz in cortical and hippocampal slices depend on a maintained excitation and on interactions between interneurons and pyramidal cells. These interactions include gap-junctional connections between inhibitory cells and fast excitatory and inhibitory chemical synapses. Spike timing with precision in the range of several ms may be assured by biphasic signaling mechanisms operating at these different connections. Such temporal precision may be important in cognitive processing.	Univ Paris 05, CNRS, FRE 2199, F-75006 Paris, France; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine	Fricker, D (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.		Fricker, Desdemona/ABD-2279-2020	Fricker, Desdemona/0000-0001-7328-9480				Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; BRAGIN A, 1995, J NEUROSCI, V15, P47; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Traub RD, 1999, FAST OSCILLATIONS CO; van Hooft JA, 2000, J NEUROSCI, V20, P3544, DOI 10.1523/JNEUROSCI.20-10-03544.2000; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097	20	74	76	2	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					771	774		10.1016/S0896-6273(01)00528-1	http://dx.doi.org/10.1016/S0896-6273(01)00528-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738024	Bronze			2022-12-28	WOS:000172700700005
J	Sigworth, FJ				Sigworth, FJ			Potassium channel mechanics	NEURON			English	Editorial Material							K+-CHANNEL	What is the moving part that switches an ion channel's current on and off? In this issue of Neuron, del Camino and Yellen (2001) exploit scanning cysteine mutagenesis and sulfhydryl reagents to show that the intracellular end of the S6 helices forms a mechanical gate for the Shaker potassium channel.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Sigworth, FJ (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.							AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Cannon SC, 2000, KIDNEY INT, V57, P772, DOI 10.1046/j.1523-1755.2000.00914.x; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	11	7	7	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					555	556		10.1016/S0896-6273(01)00509-8	http://dx.doi.org/10.1016/S0896-6273(01)00509-8			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719196	Bronze			2022-12-28	WOS:000172363900002
J	Frey, S; Petrides, M				Frey, S; Petrides, M			Orbitofrontal cortex and memory formation	NEURON			English	Article							PREFRONTAL CORTEX; RHESUS-MONKEY; VISUAL RECOGNITION; CORTICAL AFFERENTS; FRONTAL-CORTEX; HUMAN BRAIN; LESIONS; REGISTRATION; LOCALIZATION; CONNECTIONS	Which one of the many regions of the anatomically heterogeneous prefrontal cortex is part of the critical core of the neural circuit for encoding? This positron emission tomography (PET) experiment measured changes in cerebral blood flow (CBF) in normal human participants during the presentation of abstract visual information in four conditions that varied in their encoding demands. As encoding increased across the different conditions, there was an increase in activity in the right orbitofrontal cortex and the right parahippocampal region. No significant activation peaks were present in any other region of the frontal or temporal lobe. These findings indicate that the orbitofrontal cortex, which is massively connected to the medial temporal cortex, is a critical frontal region for memory formation.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Frey, S (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.							BACHEVALIER J, 1986, BEHAV BRAIN RES, V20, P249, DOI 10.1016/0166-4328(86)90225-1; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Barbas H, 1995, HIPPOCAMPUS, V5, P511, DOI 10.1002/hipo.450050604; Brodmann K, 1909, VERGLEICHENDE LOCALI; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Frey S, 2000, P NATL ACAD SCI USA, V97, P8723, DOI 10.1073/pnas.140543497; GAZZANIG.MS, 1965, BRAIN, V88, P221, DOI 10.1093/brain/88.2.221; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; Milner B, 1972, Clin Neurosurg, V19, P421; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; MISHKIN M, 1982, PHILOS T R SOC B, V298, P85, DOI 10.1098/rstb.1982.0074; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Petrides M, 2002, P NATL ACAD SCI USA, V99, P5649, DOI 10.1073/pnas.072092299; Petrides M., 2000, HDB NEUROPSYCHOLOGY; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY; RAICHLE ME, 1983, J NUCL MED, V24, P790; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SUZUKI WA, 1993, J NEUROSCI, V13, P2430, DOI 10.1523/JNEUROSCI.13-06-02430.1993; Talairach J., 1988, COPLANAR STEREOTAXIC; TULVING E, 1994, NEUROREPORT, V5, P2525, DOI 10.1097/00001756-199412000-00030; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	37	85	85	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					171	176		10.1016/S0896-6273(02)00901-7	http://dx.doi.org/10.1016/S0896-6273(02)00901-7			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367515	Bronze			2022-12-28	WOS:000178295100016
J	Bhave, G; Zhu, WG; Wang, HB; Brasier, DJ; Oxford, GS; Gereau, RW				Bhave, G; Zhu, WG; Wang, HB; Brasier, DJ; Oxford, GS; Gereau, RW			cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation	NEURON			English	Article							ROOT GANGLION NEURONS; RAT SENSORY NEURONS; VANILLOID RECEPTOR-1; TRANSDUCTION CASCADE; PAIN; HYPERALGESIA; ANANDAMIDE; ACTIVATION; CURRENTS; MUTATION	The capsaicin receptor, VR1 (also known as TRPV1), is a ligand-gated ion channel expressed on nociceptive sensory neurons that responds to noxious thermal and chemical stimuli. Capsaicin responses in sensory neurons exhibit robust potentiation by cAMP-dependent protein kinase (PKA). In this study, we demonstrate that PKA reduces VR1 desensitization and directly phosphorylates VR1. In vitro phosphorylation, phosphopeptide mapping, and protein sequencing of VR1 cytoplasmic domains delineate several candidate PKA phosphorylation sites. Electrophysiological analysis of phosphorylation site mutants clearly pinpoints Ser116 as the residue responsible for PKA-dependent modulation of VR1. Given the significant roles of VR1 and PKA in inflammatory pain hypersensitivity, VR1 phosphorylation at Ser116 by PKA may represent an important molecular mechanism involved in the regulation of VR1 function after tissue injury.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gereau, RW (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042595, R01NS018788, P01NS039420] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH60230] Funding Source: Medline; NINDS NIH HHS [P01NS39420, R01NS42595, R01NS18788] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHOLEWINSKI A, 1993, NEUROSCIENCE, V55, P1015, DOI 10.1016/0306-4522(93)90315-7; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; De Petrocellis L, 2001, J NEUROCHEM, V77, P1660, DOI 10.1046/j.1471-4159.2001.00406.x; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Gereau RW, 1998, NEURON, V20, P143, DOI 10.1016/S0896-6273(00)80442-0; HINGTGEN CM, 1995, J NEUROSCI, V15, P5411; HU HJ, 2002, IN PRESS J NEUROSCI; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Koplas PA, 1997, J NEUROSCI, V17, P3525; Kuzhikandathil EV, 2001, J NEUROSCI, V21, P8697, DOI 10.1523/JNEUROSCI.21-22-08697.2001; Lee YS, 2000, NEUROSCI LETT, V288, P57, DOI 10.1016/S0304-3940(00)01208-8; LEVINE JD, 1989, NEUROSCIENCE, V32, P571, DOI 10.1016/0306-4522(89)90279-0; Levine JD, 1999, TXB PAIN, P59; Liu SW, 1996, GEOL J U, p[2, 75 ]; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Malmberg AB, 1997, J NEUROSCI, V17, P7462; Mammen A L, 1999, Methods Enzymol, V294, P353; Piper AS, 1999, J PHYSIOL-LONDON, V518, P721, DOI 10.1111/j.1469-7793.1999.0721p.x; Szallasi A, 1999, PHARMACOL REV, V51, P159; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	29	448	476	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					721	731		10.1016/S0896-6273(02)00802-4	http://dx.doi.org/10.1016/S0896-6273(02)00802-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194871	Green Published, Bronze			2022-12-28	WOS:000177521000012
J	Myat, A; Henry, P; McCabe, V; Flintoft, L; Rotin, D; Tear, G				Myat, A; Henry, P; McCabe, V; Flintoft, L; Rotin, D; Tear, G			Drosophila Nedd4, a ubiquitin ligase, is recruited by commissureless to control cell surface levels of the roundabout receptor	NEURON			English	Article							GROWTH CONE GUIDANCE; CENTRAL-NERVOUS-SYSTEM; AXON GUIDANCE; CNS MIDLINE; PROTEASOME PATHWAY; GENETIC-ANALYSIS; SYNAPTIC GROWTH; PROTEIN LIGASES; FLOOR PLATE; WW DOMAIN	Crossing the midline produces changes in axons such that they are no longer attracted to the midline. In Drosophila, Roundabout reaches high levels on axons once they have crossed the midline, and this prohibits recrossing. Roundabout protein levels are regulated by Commissureless. We show that Commissureless binds to and is regulated by the ubiquitin ligase DNedd4. We further show that the ability of Commissureless to regulate Roundabout protein levels requires an intact DNedd4 binding site and ubiquitin acceptor sites within the Commissureless protein. The ability of Commissureless to regulate Robo in the embryo also requires a Commissureless/DNedd4 interaction. Our results show that changes in axonal sensitivity to external cues during pathfinding across the midline makes use of ubiquitin-dependent mechanisms to regulate transmembrane protein levels.	Kings Coll London, MRC, Ctr Dev Neurobiol, Mol Neurobiol Grp, London SE1 1UL, England; Kings Coll London, MRC, Ctr Dev Neurobiol, Dept Dev Neurobiol, London SE1 1UL, England; Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada	University of London; King's College London; University of London; King's College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Tear, G (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, Mol Neurobiol Grp, New Hunts House,Guys Campus, London SE1 1UL, England.	guy.tear@kcl.ac.uk	Tear, Guy/C-5444-2009	Tear, Guy/0000-0002-3114-7537				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Cornell M, 1999, GENETICS, V152, P567; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; O'Connor TP, 1999, CELL MOL LIFE SCI, V55, P1358, DOI 10.1007/s000180050376; OH CE, 1994, J NEUROSCI, V14, P3166; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Siegel S., 1988, NONPARAMETRIC STAT B; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; Tear G, 1999, CELL MOL LIFE SCI, V55, P1365, DOI 10.1007/s000180050377; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wolf B, 1998, DEVELOPMENT, V125, P3853; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	51	134	138	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					447	459		10.1016/S0896-6273(02)00795-X	http://dx.doi.org/10.1016/S0896-6273(02)00795-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165468	Bronze			2022-12-28	WOS:000177331200007
J	Sterling, P				Sterling, P			Needle from a haystack: Optimal signaling by a nonlinear synapse	NEURON			English	Editorial Material							ROD PHOTORECEPTORS; MAMMALIAN RETINA; GANGLION-CELLS; PATHWAY; NOISE	Commonly, a neuron must separate a small, rare event carried by one of its inputs from the noise carried by many others. In this issue of Neuron, Field and Rieke (2002) demonstrate that to solve this problem, the rod bipolar neuron in mouse retina selectively amplifies a rod's single-photon signal only when it is larger than average. This nonlinearity rejects nearly three-fourths of the single-photon signals. Yet, by also rejecting noise, it provides nearly optimal filtering near absolute visual threshold.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Sterling, P (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 123 Anat Chem Bldg, Philadelphia, PA 19104 USA.							Barlow H B, 1971, Vision Res, VSuppl 3, P87; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; SMITH RG, 1986, J NEUROSCI, V6, P3505; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; van Rossum MCW, 1998, VISUAL NEUROSCI, V15, P809, DOI 10.1017/S0952523898155037	10	1	1	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					670	672		10.1016/S0896-6273(02)00727-4	http://dx.doi.org/10.1016/S0896-6273(02)00727-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062013	Bronze			2022-12-28	WOS:000175951800002
J	Baran, R; Jin, YS				Baran, R; Jin, YS			Getting a GRIP on liprins	NEURON			English	Editorial Material							PROTEIN-TYROSINE-PHOSPHATASE; COMPLEX; LAR		Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Baran, R (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.			Jin, Yishi/0000-0002-9371-9860				Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	13	10	10	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					1	2		10.1016/S0896-6273(02)00649-9	http://dx.doi.org/10.1016/S0896-6273(02)00649-9			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931733	Bronze			2022-12-28	WOS:000174695100001
J	Hardie, R				Hardie, R			Adaptation through translocation	NEURON			English	Editorial Material							EXPRESSION; TRANSDUCIN		Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Hardie, R (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.							Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Lamb TD, 1996, P NATL ACAD SCI USA, V93, P566, DOI 10.1073/pnas.93.2.566; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Pulvermuller A, 2002, MOL CELL BIOL, V22, P2194, DOI 10.1128/MCB.22.7.2194-2203.2002; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; ROOF DJ, 1988, SCIENCE, V241, P845, DOI 10.1126/science.3136548; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216	12	13	13	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					3	5		10.1016/S0896-6273(02)00650-5	http://dx.doi.org/10.1016/S0896-6273(02)00650-5			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931734	Bronze			2022-12-28	WOS:000174695100002
J	Beck, G; Fainzilber, M				Beck, G; Fainzilber, M			Genetic models meet trophic mechanisms: EGF family members are gliatrophins in Drosophila	NEURON			English	Review							CENTRAL-NERVOUS-SYSTEM; SURVIVAL	Trophic survival mechanisms are crucial for the determination of cell numbers in the developing vertebrate nervous system, but important neurotrophic factor families such as the neurotrophins have not yet been found in either Drosophila or C. elegans. Two independent studies on distinct glial populations in Drosophila have now shown that their survival is regulated by EGF family members secreted by adjacent neurons. Fly genetics thus promises new insights on trophic signaling mechanisms and confirms that trophic regulation of cell survival is an evolutionarily ancient mechanism for building the nervous system.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Fainzilber, M (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.			Fainzilber, Mike/0000-0001-8173-8557				Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Boillee S, 2001, J NEUROSCI, V21, P7079, DOI 10.1523/JNEUROSCI.21-18-07079.2001; Booth GE, 2000, DEVELOPMENT, V127, P237; Hermann PM, 2000, J NEUROSCI, V20, P6355, DOI 10.1523/JNEUROSCI.20-17-06355.2000; Hidalgo A, 2001, DEV CELL, V1, P679, DOI 10.1016/S1534-5807(01)00074-0; Jaaro H, 2001, TRENDS NEUROSCI, V24, P79, DOI 10.1016/S0166-2236(00)01690-8; Jones BW, 2001, BIOESSAYS, V23, P877, DOI 10.1002/bies.1129; Junier MP, 2000, PROG NEUROBIOL, V62, P443, DOI 10.1016/S0301-0082(00)00017-4; Khursigara G, 2001, J NEUROSCI, V21, P5854, DOI 10.1523/JNEUROSCI.21-16-05854.2001; Kinrade EFV, 2001, DEVELOPMENT, V128, P207; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lemke G, 2001, ANNU REV NEUROSCI, V24, P87, DOI 10.1146/annurev.neuro.24.1.87; Parkinson DB, 2001, J NEUROSCI, V21, P8572, DOI 10.1523/JNEUROSCI.21-21-08572.2001; RAZ E, 1992, DEVELOPMENT, V114, P113; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SUGAYA R, 1994, MECH DEVELOP, V45, P139, DOI 10.1016/0925-4773(94)90027-2; Tsui-Pierchala B, 2002, NEURON, V33, P261, DOI 10.1016/S0896-6273(01)00585-2	21	9	9	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					673	675		10.1016/S0896-6273(02)00619-0	http://dx.doi.org/10.1016/S0896-6273(02)00619-0			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879645	Bronze			2022-12-28	WOS:000174286200004
J	Chen, CF; Blitz, DM; Regehr, WG				Chen, CF; Blitz, DM; Regehr, WG			Contributions of receptor desensitization and saturation to plasticity at the retinogeniculate synapse	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; PAIRED-PULSE DEPRESSION; PURKINJE-CELL SYNAPSES; MULTIPLE RELEASE SITES; NON-NMDA RECEPTORS; CLIMBING FIBER; RETINAL INPUTS; SIGNAL TRANSMISSION; COCHLEAR NUCLEUS; VISUAL RESPONSES	The retinogeniculate synapse conveys visual information from the retina to thalamic relay neurons. Here, we examine the mechanisms of short-term plasticity that can influence transmission at this connection in mouse brain slices. Our studies show that synaptic strength is modified by physiological activity patterns due to marked depression at high frequencies. Postsynaptic mechanisms of plasticity make prominent contributions to this synaptic depression. During trains of retinal input stimulation, receptor desensitization attenuates the AMPA EPSC while the NMDA EPSC saturates. This differential plasticity may help explain the distinct roles of these receptors in shaping the relay neuron response to visual stimulation with the AMPA component being important for transient responses, while sustained high frequency responses rely more on the NMDA component.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Chen, CF (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.				NINDS NIH HHS [KO8-NS02056, 5 T32 NS07484, P01-NS38312, R01-NS32405] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038312, R01NS032405, K08NS002056, T32NS007484] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; Brenowitz S, 2001, J NEUROSCI, V21, P1857, DOI 10.1523/JNEUROSCI.21-06-01857.2001; CANT NB, 1979, NEUROSCIENCE, V4, P1925, DOI 10.1016/0306-4522(79)90066-6; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen CY, 1999, AM J PHYSIOL-HEART C, V277, pH1350, DOI 10.1152/ajpheart.1999.277.4.H1350; CLELAND BG, 1985, J PHYSIOL-LONDON, V369, P249, DOI 10.1113/jphysiol.1985.sp015899; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dittman JS, 2000, J NEUROSCI, V20, P1374; Dzubay JA, 1999, J NEUROSCI, V19, P5265; FAMIGLIETTI EV, 1972, J COMP NEUROL, V144, P285, DOI 10.1002/cne.901440304; Guido W, 1995, Int J Neurosci, V80, P41, DOI 10.3109/00207459508986093; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; HEGGELUND P, 1990, J NEUROPHYSIOL, V63, P1347, DOI 10.1152/jn.1990.63.6.1347; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; Hjelmstad GO, 1999, J NEUROPHYSIOL, V81, P3096, DOI 10.1152/jn.1999.81.6.3096; Kinney GA, 1997, J NEUROPHYSIOL, V78, P1320, DOI 10.1152/jn.1997.78.3.1320; KWON YH, 1991, J NEUROPHYSIOL, V66, P414, DOI 10.1152/jn.1991.66.2.414; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; MASTRONARDE DN, 1987, J NEUROPHYSIOL, V57, P381, DOI 10.1152/jn.1987.57.2.381; MASTRONARDE DN, 1992, VISUAL NEUROSCI, V8, P407, DOI 10.1017/S0952523800004934; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; McCormick David A., 1994, Current Opinion in Neurobiology, V4, P550, DOI 10.1016/0959-4388(94)90056-6; Oleskevich S, 2000, J PHYSIOL-LONDON, V524, P513, DOI 10.1111/j.1469-7793.2000.00513.x; OLVERMAN HJ, 1988, NEUROSCIENCE, V26, P1, DOI 10.1016/0306-4522(88)90123-6; Otis T, 1996, J NEUROSCI, V16, P7496; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PARKS TN, 1981, J COMP NEUROL, V203, P425, DOI 10.1002/cne.902030307; Peters A., 1991, FINE STRUCTURE NERVO; RAMAN IM, 1994, J NEUROSCI, V14, P4998; RAMOA AS, 1994, J NEUROSCI, V14, P2098; Rowe MH, 2001, VISUAL NEUROSCI, V18, P219, DOI 10.1017/S0952523801182076; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SILLITO AM, 1990, J NEUROPHYSIOL, V63, P347, DOI 10.1152/jn.1990.63.2.347; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Steriade M., 1997, THALAMUS; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; TURNER JP, 1994, J PHYSIOL-LONDON, V480, P281, DOI 10.1113/jphysiol.1994.sp020359; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Urwyler S, 1996, NEUROPHARMACOLOGY, V35, P643, DOI 10.1016/S0028-3908(96)00049-4; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Wang XK, 2000, J CEREBR BLOOD F MET, V20, P15, DOI 10.1097/00004647-200001000-00004; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	61	120	121	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					779	788		10.1016/S0896-6273(02)00611-6	http://dx.doi.org/10.1016/S0896-6273(02)00611-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879654	Bronze			2022-12-28	WOS:000174286200013
J	O'Doherty, JP; Deichmann, R; Critchley, HD; Dolan, RJ				O'Doherty, JP; Deichmann, R; Critchley, HD; Dolan, RJ			Neural responses during anticipation of a primary taste reward	NEURON			English	Article							BRAIN-STIMULATION REWARD; ORBITOFRONTAL CORTEX; DOPAMINE NEURONS; BASOLATERAL AMYGDALA; INCENTIVE SALIENCE; PREFRONTAL CORTEX; MACAQUE MONKEY; FMRI; ACTIVATION; AMPHETAMINE	The aim of this study was to determine the brain regions involved in anticipation of a primary taste reward and to compare these regions to those responding to the receipt of a taste reward. Using fMRI, we scanned human subjects who were presented with visual cues that signaled subsequent reinforcement with a pleasant sweet taste (1 M glucose), a moderately unpleasant salt taste (0.2 M saline), or a neutral taste. Expectation of a pleasant taste produced activation in dopaminergic midbrain, posterior dorsal amygdala, striatum, and orbitofrontal cortex (OFC). Apart from OFC, these regions were not activated by reward receipt. The findings indicate that when rewards are predictable, brain regions recruited during expectation are, in part, dissociable from areas responding to reward receipt.	Inst Neurol, WEllcome Dept Imaging Neurosci, London WC1 3BG, England; Royal Free Hosp, Sch Med, London NW3 2PF, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	O'Doherty, JP (corresponding author), Inst Neurol, WEllcome Dept Imaging Neurosci, 12 Queen Sq, London WC1 3BG, England.		critchley, hugo d/G-9267-2011; O'Doherty, John P/F-1204-2013	critchley, hugo d/0000-0002-2445-9284; Dolan, Ray/0000-0001-9356-761X				ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Baxter MG, 2000, J NEUROSCI, V20, P4311; BAYLIS LL, 1991, EXP BRAIN RES, V86, P617; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BERRIDGE KC, 1989, BEHAV NEUROSCI, V103, P36, DOI 10.1037/0735-7044.103.1.36; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Constable RT, 1999, MAGNET RESON MED, V42, P110, DOI 10.1002/(SICI)1522-2594(199907)42:1<110::AID-MRM15>3.0.CO;2-3; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Deichmann R, 2000, NEUROIMAGE, V12, P112, DOI 10.1006/nimg.2000.0601; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Duvernoy HM, 1995, HUMAN BRAIN STEM CER; DUVEROY HM, 1999, HUMAN BRAIN; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; FRAHM J, 1988, MAGNET RESON MED, V6, P474, DOI 10.1002/mrm.1910060412; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; GALLISTEL CR, 1984, PHARMACOL BIOCHEM BE, V20, P73, DOI 10.1016/0091-3057(84)90104-7; Glover GH, 1999, MAGNET RESON MED, V42, P290, DOI 10.1002/(SICI)1522-2594(199908)42:2<290::AID-MRM11>3.0.CO;2-N; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Malkova L, 1997, J NEUROSCI, V17, P6011; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; OLDS ME, 1963, J COMP NEUROL, V120, P259, DOI 10.1002/cne.901200206; ONO T, 2000, NEW COGNITIVE NEUROS; ORDIDGE RJ, 1994, MAGNET RESON MED, V32, P335, DOI 10.1002/mrm.1910320309; Parkinson JA, 2000, EUR J NEUROSCI, V12, P405, DOI 10.1046/j.1460-9568.2000.00960.x; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; POSSE S, 1992, MAGNET RESON MED, V25, P12, DOI 10.1002/mrm.1910250103; Ramnani N, 2000, J NEUROPHYSIOL, V84, P3026, DOI 10.1152/jn.2000.84.6.3026; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rolls ET, 1997, CRIT REV NEUROBIOL, V11, P263, DOI 10.1615/CritRevNeurobiol.v11.i4.20; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; SANGHERA MK, 1979, EXP NEUROL, V63, P610, DOI 10.1016/0014-4886(79)90175-4; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; SCOTT TR, 1993, J NEUROPHYSIOL, V69, P1810, DOI 10.1152/jn.1993.69.6.1810; Sell LA, 1999, EUR J NEUROSCI, V11, P1042, DOI 10.1046/j.1460-9568.1999.00522.x; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wilkinson LS, 1998, EUR J NEUROSCI, V10, P1019, DOI 10.1046/j.1460-9568.1998.00119.x; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; WISE RA, 1985, BEHAV BRAIN SCI, V8, P178, DOI 10.1017/S0140525X00020306; WISE RA, 1993, BEHAV BRAIN RES, V55, P195, DOI 10.1016/0166-4328(93)90115-7; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143	73	795	803	4	56	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					815	826		10.1016/S0896-6273(02)00603-7	http://dx.doi.org/10.1016/S0896-6273(02)00603-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879657	Bronze, Green Published			2022-12-28	WOS:000174286200016
J	Lanjuin, A; Sengupta, P				Lanjuin, A; Sengupta, P			Regulation of chemosensory receptor expression and sensory signaling by the KIN-29 Ser/Thr kinase	NEURON			English	Review							CONTROLLING DAUER FORMATION; ACTIVATED PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; CHEMORECEPTOR GENES; LARVAL DEVELOPMENT; NERVOUS-SYSTEM; NEURON FATES; YEAST SNF1; BODY-SIZE	Sensory signals regulate multiple developmental and behavioral circuits in C. elegans, providing a genetically tractable system in which to investigate the mechanisms underlying the acquisition and integration of sensory information. kin-29 mutants are defective in the expression of a set of chemoreceptor genes, and exhibit characteristics associated with altered sensory signaling, including increased lifespan, decreased body size, and deregulated entry into the dauer developmental stage. kin-29 encodes a Ser/Thr kinase with similarity to the MARK and AMPK/SNF1 family of kinases. We show that KIN-29 acts cell-autonomously and non-cell-autonomously in sensory neurons to regulate chemoreceptor expression, body size, and the dauer decision, suggesting that kin-29 function is essential for the correct acquisition and transduction of sensory information.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Sengupta, P (corresponding author), Brandeis Univ, Dept Biol, MS 008,415 South St, Waltham, MA 02454 USA.	sengupta@brandeis.edu						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ailion M, 2000, GENETICS, V156, P1047; Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Ashrafi K, 2000, GENE DEV, V14, P1872; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Avery Leon, 1993, Genetics, V134, P455; Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bessone S, 1999, DEV BIOL, V214, P87, DOI 10.1006/dbio.1999.9379; BRENNER S, 1974, GENETICS, V77, P71; Britton JS, 1998, DEVELOPMENT, V125, P2149; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Collet J, 1998, GENETICS, V148, P187; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Daniels SA, 2000, GENETICS, V156, P123; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dettman RW, 2001, GENETICS, V158, P253; DORMAN JB, 1995, GENETICS, V141, P1399; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fukushige T, 1999, J CELL SCI, V112, P395; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Gottesmann B., 1994, HALLESCHES JB GEOWIS, V16, P23; GOTTLIEB S, 1994, GENETICS, V137, P107; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; LARSEN PL, 1995, GENETICS, V139, P1567; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LIU DWC, 1994, J NEUROSCI, V14, P1953; LIVINGSTONE D, 1991, THESIS U CAMBRIDGE C; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; NGUYEN M, 1995, GENETICS, V140, P527; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; Ostling J, 1998, EUR J BIOCHEM, V252, P162, DOI 10.1046/j.1432-1327.1998.2520162.x; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; POPHAM JD, 1979, CAN J ZOOL, V57, P794, DOI 10.1139/z79-098; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riddle DL, 1997, C ELEGANS, P739; ROBERTSON FW, 1963, GENET RES, V4, P74, DOI 10.1017/S001667230000344X; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; Sarafi-Reinach TR, 2001, DEVELOPMENT, V128, P3269; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shen P, 2001, J NEUROBIOL, V47, P16, DOI 10.1002/neu.1012; Stern DL, 1999, DEVELOPMENT, V126, P1091; STONE J, 1982, TRENDS NEUROSCI, V5, P441, DOI 10.1016/0166-2236(82)90237-5; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; THOMAS JH, 1993, GENETICS, V134, P1105; THOMAS JH, 1990, GENETICS, V124, P855; THOMPSONJAEGER S, 1991, GENETICS, V129, P697; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TRENT C, 1983, GENETICS, V104, P619; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TROEMEL ER, 1999, THESIS U CALIFORNIA; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; VOWELS JJ, 1994, GENETICS, V138, P303; VOWELS JJ, 1992, GENETICS, V130, P105; Waggoner LF, 2000, GENETICS, V154, P1181; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; WOODS A, 1994, J BIOL CHEM, V269, P19509	101	45	50	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					369	381		10.1016/S0896-6273(02)00572-X	http://dx.doi.org/10.1016/S0896-6273(02)00572-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832225	Bronze			2022-12-28	WOS:000173643200008
J	Perrier, AL; Massoulie, J; Krejci, E				Perrier, AL; Massoulie, J; Krejci, E			PRiMA: The membrane anchor of acetylcholinesterase in the brain	NEURON			English	Article							COLLAGEN-TAILED FORMS; C-TERMINAL DOMAINS; MOLECULAR-FORMS; HUMAN BUTYRYLCHOLINESTERASE; RAT ACETYLCHOLINESTERASE; QUATERNARY ASSOCIATIONS; NEUROMUSCULAR-JUNCTION; ATTACHMENT DOMAIN; CAUDATE-NUCLEUS; SUBUNIT	As a tetramer, acetylcholinesterase (AChE) is anchored to the basal lamina of the neuromuscular junction and to the membrane of neuronal synapses. We have previously shown that collagen Q (CoIQ) anchors AChE at the neuromuscular junction. We have now cloned the gene PRiMA (proline-rich membrane anchor) encoding the AChE anchor in mammalian brain. We show that PRiMA is able to organize AChE into tetramers and to anchor them at the surface of transfected cells. Furthermore, we demonstrate that AChE is actually anchored in neural cell membranes through its interaction with PRiMA. Finally, we propose that only PRiMA anchors AChE in mammalian brain and muscle cell membranes.	Ecole Normale Super, CNRS, UMR 8544, Neurobiol Cellulaire & Mol Lab, F-75230 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Krejci, E (corresponding author), Ecole Normale Super, CNRS, UMR 8544, Neurobiol Cellulaire & Mol Lab, 46 Rue Ulm, F-75230 Paris 05, France.	krejci@wotan.ens.fr	Perrier, Anselme L/B-2272-2019; Perrier, Anselme/E-3764-2010	Perrier, Anselme L/0000-0001-7915-1968; 				Blong RM, 1997, BIOCHEM J, V327, P747, DOI 10.1042/bj3270747; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; Boschetti N, 1996, FEBS LETT, V380, P133, DOI 10.1016/0014-5793(96)00041-5; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Bourne Y, 1999, J BIOL CHEM, V274, P30370, DOI 10.1074/jbc.274.43.30370; DUVAL N, 1992, EMBO J, V11, P3255, DOI 10.1002/j.1460-2075.1992.tb05403.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; FUENTES ME, 1988, BIOCHEM J, V256, P1047, DOI 10.1042/bj2561047; GENNARI K, 1987, J NEUROCHEM, V49, P12, DOI 10.1111/j.1471-4159.1987.tb03386.x; Giacobini E., 2000, CHOLINESTERASES CHOL, V3rd ed.; Gupta R, 1999, NUCLEIC ACIDS RES, V27, P370, DOI 10.1093/nar/27.1.370; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; KARLSSON E, 1984, J PHYSIOLOGY PARIS, V79, P232; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; Krejci E, 1999, J NEUROSCI, V19, P10672, DOI 10.1523/JNEUROSCI.19-24-10672.1999; Kronman C, 2000, J BIOL CHEM, V275, P29488, DOI 10.1074/jbc.M004298200; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAZAR M, 1980, J NEUROCHEM, V35, P1067, DOI 10.1111/j.1471-4159.1980.tb07860.x; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; LI Y, 1991, J BIOL CHEM, V266, P23083; LIAO J, 1993, EUR J BIOCHEM, V215, P333, DOI 10.1111/j.1432-1033.1993.tb18039.x; LIAO J, 1993, J NEUROCHEM, V61, P1127, DOI 10.1111/j.1471-4159.1993.tb03629.x; MARSH D, 1984, J NEUROCHEM, V43, P204, DOI 10.1111/j.1471-4159.1984.tb06698.x; MASSON P, 1993, J BIOL CHEM, V268, P14329; Massoulie J, 1998, J PHYSIOLOGY-PARIS, V92, P183, DOI 10.1016/S0928-4257(98)80007-7; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MESULAM M, 2000, CHOLINESTERASES CHOL, P121; Navaratnam DS, 2000, J NEUROCHEM, V74, P2146, DOI 10.1046/j.1471-4159.2000.0742146.x; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; ROBERTS WL, 1991, J BIOL CHEM, V266, P7481; Simon S, 1998, EMBO J, V17, P6178, DOI 10.1093/emboj/17.21.6178; Tsigelny I, 2000, PROTEIN SCI, V9, P180	42	207	218	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					275	285		10.1016/S0896-6273(01)00584-0	http://dx.doi.org/10.1016/S0896-6273(01)00584-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804574	Bronze			2022-12-28	WOS:000173387700014
J	Callaway, EM				Callaway, EM			Neural mechanisms for the generation of visual complex cells	NEURON			English	Editorial Material							ORIENTATION SELECTIVITY; CORTEX; CAT; INPUT		Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267				Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; MALPELI JG, 1983, J NEUROPHYSIOL, V49, P595, DOI 10.1152/jn.1983.49.3.595; MALPELI JG, 1986, J NEUROPHYSIOL, V56, P1062, DOI 10.1152/jn.1986.56.4.1062; Martinez LM, 2001, NEURON, V32, P515, DOI 10.1016/S0896-6273(01)00489-5; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; STONE J, 1979, BRAIN RES REV, V1, P345, DOI 10.1016/0165-0173(79)90010-9; Zemelman BV, 2001, CURR OPIN NEUROBIOL, V11, P409, DOI 10.1016/S0959-4388(00)00227-0	11	7	8	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					378	380		10.1016/S0896-6273(01)00497-4	http://dx.doi.org/10.1016/S0896-6273(01)00497-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709148	Bronze			2022-12-28	WOS:000172119100003
J	Okubo, Y; Kakizawa, S; Hirose, K; Iino, M				Okubo, Y; Kakizawa, S; Hirose, K; Iino, M			Visualization of IP3 dynamics reveals a novel AMPA receptor-triggered IP3 production pathway mediated by voltage-dependent Ca2+ influx in Purkinje cells	NEURON			English	Article							LONG-TERM DEPRESSION; INOSITOL 1,4,5-TRISPHOSPHATE 5-PHOSPHATASE; PHOSPHOLIPASE-C ISOZYMES; MGLUR1 MUTANT MICE; IMMUNOHISTOCHEMICAL LOCALIZATION; POLYMORPHONUCLEAR NEUTROPHILS; PHOSPHOINOSITIDE HYDROLYSIS; SYNAPTIC DEPRESSION; GLUTAMATE RECEPTORS; DENDRITIC SPINES	IP3 signaling in Purkinje cells is involved in the regulation of cell functions including LTD. We have used a GFP-tagged pleckstrin homology domain to visualize IP3 dynamics in Purkinje cells. Surprisingly, IP3 production was observed in response not only to mGIuR activation, but also to AMPA receptor activation in Purkinje cells in culture. AMPA-induced IP3 production was mediated by depolarization-induced Call influx because it was mimicked by depolarization and was blocked by inhibition of the P-type Ca2+ channel. Furthermore, trains of complex spikes, elicited by climbing fiber stimulation (1 Hz), induced IP3 production in Purkinje cells in cerebellar slices. These results revealed a novel IP3 signaling pathway in Purkinje cells that can be elicited by synaptic inputs from climbing fibers.	Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo 1130033, Japan; Japan Sci & Technol Corp, CREST, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Iino, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo 1130033, Japan.	iino@m.u-tokyo.ac.jp						AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; BANNO Y, 1994, J BIOL CHEM, V269, P15846; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BIDEN TJ, 1987, J BIOL CHEM, V262, P3567; BLANK JL, 1992, J BIOL CHEM, V267, P23069; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Capozzi I, 1999, BIOCHEM J, V344, P545, DOI 10.1042/0264-6021:3440545; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHOI WC, 1989, BRAIN RES, V499, P193, DOI 10.1016/0006-8993(89)91153-0; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Communi D, 1996, J BIOL CHEM, V271, P11676, DOI 10.1074/jbc.271.20.11676; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; DeSmedt F, 1996, J BIOL CHEM, V271, P10419, DOI 10.1074/jbc.271.17.10419; DESMEDT F, 1994, FEBS LETT, V347, P69, DOI 10.1016/0014-5793(94)00509-5; DOMINO SE, 1988, J BIOL CHEM, V263, P690; EBERHARD DA, 1987, J NEUROCHEM, V49, P1634, DOI 10.1111/j.1471-4159.1987.tb01037.x; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Ehrengruber MU, 1999, P NATL ACAD SCI USA, V96, P7041, DOI 10.1073/pnas.96.12.7041; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Gruol DL, 1996, J NEUROPHYSIOL, V76, P3325, DOI 10.1152/jn.1996.76.5.3325; Gwag BJ, 1998, MOL BRAIN RES, V63, P53, DOI 10.1016/S0169-328X(98)00251-4; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 1984, CEREBELLUM NEURAL CO; KASONO K, 1995, NEUROREPORT, V6, P569, DOI 10.1097/00001756-199502000-00040; KENDALL DA, 1984, J NEUROCHEM, V42, P1388, DOI 10.1111/j.1471-4159.1984.tb02799.x; KHODAKHAH K, 1995, J PHYSIOL-LONDON, V487, P343, DOI 10.1113/jphysiol.1995.sp020884; KHODAKHAH K, 1993, P NATL ACAD SCI USA, V90, P4976, DOI 10.1073/pnas.90.11.4976; Khodakhah K, 1997, P NATL ACAD SCI USA, V94, P14009, DOI 10.1073/pnas.94.25.14009; Kim YH, 1999, J BIOL CHEM, V274, P26127, DOI 10.1074/jbc.274.37.26127; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LAXMINARAYAN KM, 1994, J BIOL CHEM, V269, P17305; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; Lu YM, 1997, J NEUROSCI, V17, P5196; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martelli AM, 1996, ACTA HISTOCHEM, V98, P131, DOI 10.1016/S0065-1281(96)80031-6; MELDRUM E, 1991, EUR J BIOCHEM, V196, P159, DOI 10.1111/j.1432-1033.1991.tb15799.x; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MIZUGUCHI M, 1991, BRAIN RES, V548, P35, DOI 10.1016/0006-8993(91)91103-8; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reyes M, 1996, J NEUROSCI, V16, P5951; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SHARP AH, 1993, J NEUROSCI, V13, P3051; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SIMPSON PB, 1995, TRENDS NEUROSCI, V18, P299, DOI 10.1016/0166-2236(95)93919-O; SMART D, 1995, BIOCHEM J, V305, P577, DOI 10.1042/bj3050577; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Tempia F, 1996, J NEUROSCI, V16, P456; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang Y, 1997, J NEUROPHYSIOL, V77, P812, DOI 10.1152/jn.1997.77.2.812; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; Watanabe M, 1998, EUR J NEUROSCI, V10, P2016, DOI 10.1046/j.1460-9568.1998.00213.x; Wilsch VW, 1998, J NEUROSCI, V18, P6071; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180	76	88	92	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					113	122		10.1016/S0896-6273(01)00464-0	http://dx.doi.org/10.1016/S0896-6273(01)00464-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604143	Bronze			2022-12-28	WOS:000171525200013
J	Rees, G				Rees, G			Attention, adaptation, and the motion aftereffect	NEURON			English	Editorial Material							PERCEPTION	Activation of the human visual motion area V5/MT was previously thought to be the basis of the motion aftereffect. New findings suggest that previous observations were confounded by attention and arousal, providing evidence that adaptation of directionally selective neurons in area V5/MT represents the fundamental substrate for the motion aftereffect.	UCL, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Rees, G (corresponding author), UCL, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.		Rees, Geraint/C-1493-2008	Rees, Geraint/0000-0002-9623-7007	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CHAUDHURI A, 1990, NATURE, V344, P60, DOI 10.1038/344060a0; Culham JC, 1999, J NEUROPHYSIOL, V81, P388, DOI 10.1152/jn.1999.81.1.388; Culham JC, 2000, NEURON, V28, P607, DOI 10.1016/S0896-6273(00)00137-9; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Hautzel H, 2001, BRAIN RES, V892, P281, DOI 10.1016/S0006-8993(00)03224-8; He S, 1998, CURR BIOL, V8, P1215, DOI 10.1016/S0960-9822(07)00512-X; MASLAND RH, 1969, SCIENCE, V165, P819, DOI 10.1126/science.165.3895.819; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Taylor JG, 2000, NEUROIMAGE, V11, P257, DOI 10.1006/nimg.1999.0529; TOOTELL RB, 1996, NATURE, V375, P139; WOLGEMUTH A, 1911, BRIT J PSYCHOL, V1, P1	11	4	4	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					6	8		10.1016/S0896-6273(01)00457-3	http://dx.doi.org/10.1016/S0896-6273(01)00457-3			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604133	Bronze			2022-12-28	WOS:000171525200003
J	Ji, RR; Samad, TA; Jin, SX; Schmoll, R; Woolf, CJ				Ji, RR; Samad, TA; Jin, SX; Schmoll, R; Woolf, CJ			p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia	NEURON			English	Article							NERVE GROWTH-FACTOR; ROOT GANGLION NEURONS; SIGNAL-REGULATED KINASE; PROTEIN-KINASE; CAPSAICIN RECEPTOR; PAIN HYPERSENSITIVITY; VANILLOID RECEPTOR-1; MESSENGER-RNA; IMMUNOCYTOCHEMICAL LOCALIZATION; PERIPHERAL INFLAMMATION	Peripheral inflammation induces p38 MAPK activation in the soma of C fiber nociceptors in the dorsal root ganglion [DRG) after 24 hr. Inflammation also increases protein, but not mRNA levels, of the heat-gated ion channel TRPV1 (VR1) in these cells, which is then transported to peripheral but not central C fiber terminals. Inhibiting p38 activation in the DRG reduces the increase in TRPV1 in the DRG and inflamed skin and diminishes inflammation-induced heat hypersensitivity without affecting inflammatory swelling or basal pain sensitivity. p38 activation in the DRG is secondary to peripheral production of NGF during inflammation and is required for NGF-induced increases in TRPV1. The activation of p38 in the DRG following retrograde NGF transport, by increasing TRPV1 levels in nociceptor peripheral terminals in a transcription-independent fashion, contributes to the maintenance of inflammatory heat hypersensitivity.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ji, RR (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Boston, MA 02129 USA.	ji@helix.mgh.harvard.edu	Ji, Ru-Rong/L-7070-2017; Woolf, Clifford/A-9784-2010	Ji, Ru-Rong/0000-0002-9355-3688; 	NINDS NIH HHS [R01 NS40698, R 01 NS39518, R01 NS040698] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039518, R01NS040698] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aley KO, 2001, J NEUROSCI, V21, P6933, DOI 10.1523/JNEUROSCI.21-17-06933.2001; Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Carlton SM, 2001, NEUROSCI LETT, V310, P53, DOI 10.1016/S0304-3940(01)02093-6; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Faour WH, 2001, J BIOL CHEM, V276, P31720, DOI 10.1074/jbc.M104036200; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Ji RR, 1996, REGUL PEPTIDES, V66, P179, DOI 10.1016/S0167-0115(96)00101-2; Ji RR, 1995, J NEUROSCI, V15, P8156; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LESLIE TA, 1995, NEUROSCIENCE, V67, P753, DOI 10.1016/0306-4522(95)00101-N; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Michael GJ, 1997, J NEUROSCI, V17, P8476; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Nicholas RS, 1999, NEUROSCIENCE, V91, P1425, DOI 10.1016/S0306-4522(98)00706-4; NOGUCHI K, 1988, MOL BRAIN RES, V4, P31, DOI 10.1016/0169-328X(88)90015-0; Novakovic SD, 1998, J NEUROSCI, V18, P2174; Paul A, 1999, CELL SIGNAL, V11, P491, DOI 10.1016/S0898-6568(99)00018-2; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Sammons MJ, 2000, BRAIN RES, V876, P48, DOI 10.1016/S0006-8993(00)02596-8; Sanchez JF, 2001, NEUROSCIENCE, V107, P373, DOI 10.1016/S0306-4522(01)00373-6; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stanisz AM, 2000, ANN NY ACAD SCI, V917, P268; STEIN C, 1988, PHARMACOL BIOCHEM BE, V31, P445, DOI 10.1016/0091-3057(88)90372-3; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tanaka M, 1998, NEUROREPORT, V9, P967, DOI 10.1097/00001756-199804200-00003; Tohda C, 2001, J NEUROCHEM, V76, P1628, DOI 10.1046/j.1471-4159.2001.00193.x; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Winston J, 2001, PAIN, V89, P181, DOI 10.1016/S0304-3959(00)00370-5; WINTER J, 1988, NEURON, V1, P973, DOI 10.1016/0896-6273(88)90154-7; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yiangou Y, 2001, LANCET, V357, P1338, DOI 10.1016/S0140-6736(00)04503-7; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	64	949	997	5	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					57	68		10.1016/S0896-6273(02)00908-X	http://dx.doi.org/10.1016/S0896-6273(02)00908-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367506	Bronze			2022-12-28	WOS:000178295100007
J	Vassalli, A; Rothman, A; Feinstein, P; Zapotocky, M; Mombaerts, P				Vassalli, A; Rothman, A; Feinstein, P; Zapotocky, M; Mombaerts, P			Minigenes impart odorant receptor-specific axon guidance in the olfactory bulb	NEURON			English	Article							GENE-EXPRESSION; GENOMIC STRUCTURE; SENSORY NEURONS; MOUSE; PROJECTIONS; CLUSTER; FAMILY; MAP; TRANSCRIPTION; ORGANIZATION	An olfactory sensory neuron (OSN) expresses selectively one member from a repertoire of similar to1000 odorant receptor (OR) genes and projects its axon to a specific glomerulus in the olfactory bulb. Both processes are here recapitulated by MOR23 and M71 OR minigenes, introduced into mice. Minigenes of 9 kb and as short as 2.2 kb are selectively expressed by neurons that do not coexpress the endogenous gene but coproject their axons to the same glomeruli. Deletion of a 395 bp upstream region in the MOR23 minigene abolishes expression. In this region we recognize sequence motifs conserved in many OR genes. Transgenic lines expressing the OR in ectopic epithelial zones form ectopic glomeruli, which also receive input from OSNs expressing the cognate endogenous receptor. This suggests a recruitment through homotypic interactions between OSNs expressing the same OR.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Vassalli, A (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Zapotocky, Martin/B-8225-2008; Vassalli, Anne/M-7866-2016	Zapotocky, Martin/0000-0002-0437-2528; Vassalli, Anne/0000-0002-5314-5620				Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Bulger M, 2000, P NATL ACAD SCI USA, V97, P14560, DOI 10.1073/pnas.97.26.14560; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Dugas JC, 2001, GENOMICS, V71, P53, DOI 10.1006/geno.2000.6415; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Hoppe R, 2000, GENOMICS, V66, P284, DOI 10.1006/geno.2000.6205; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Mohler WA, 1996, P NATL ACAD SCI USA, V93, P12423, DOI 10.1073/pnas.93.22.12423; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Mombaerts P, 2001, ANNU REV GENOM HUM G, V2, P493, DOI 10.1146/annurev.genom.2.1.493; Mori T, 2000, BIOL PHARM BULL, V23, P165; Nagao H, 2000, NEUROREPORT, V11, P3023, DOI 10.1097/00001756-200009110-00039; Pyrski M, 2001, J NEUROSCI, V21, P4637, DOI 10.1523/JNEUROSCI.21-13-04637.2001; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Tsuboi A, 1999, J NEUROSCI, V19, P8409; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang SS, 1997, J NEUROSCI, V17, P4149; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	40	196	199	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					681	696		10.1016/S0896-6273(02)00793-6	http://dx.doi.org/10.1016/S0896-6273(02)00793-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194868	Bronze			2022-12-28	WOS:000177521000009
J	Frisen, J				Frisen, J			Stem cell plasticity?	NEURON			English	Review							BONE-MARROW; IN-VIVO; BRAIN; TRANSDIFFERENTIATION; HEPATOCYTES; MUSCLE; BLOOD	Cells differentiate according to stereotype pedigrees, or at least so we thought. Several studies have challenged this dogma and suggested that stem cells in several tissues may be plastic and switch lineages, but many of the results are open to other interpretations. Is there solid evidence for stem cell plasticity and should we rewrite the textbooks just yet?	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.							Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Maves L, 1999, CURR TOP DEV BIOL, V43, P115; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; PATAPOUTIAN A, 1995, SCIENCE, V270, P1818, DOI 10.1126/science.270.5243.1818; Slack JMW, 2001, CURR OPIN GENET DEV, V11, P581, DOI 10.1016/S0959-437X(00)00236-7; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	19	45	46	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					415	418		10.1016/S0896-6273(02)00798-5	http://dx.doi.org/10.1016/S0896-6273(02)00798-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165465	Bronze			2022-12-28	WOS:000177331200004
J	Honma, Y; Araki, T; Gianino, S; Bruce, A; Heuckeroth, RO; Johnson, EM; Milbrandt, J				Honma, Y; Araki, T; Gianino, S; Bruce, A; Heuckeroth, RO; Johnson, EM; Milbrandt, J			Artemin is a vascular-derived neurotropic factor for developing sympathetic neurons	NEURON			English	Article							MICE LACKING GDNF; SUPERIOR CERVICAL-GANGLION; PERIPHERAL NERVOUS-SYSTEM; NEURAL CREST; IN-VIVO; AUTONOMIC GANGLIA; ENTERIC NEURONS; RENAL AGENESIS; SURVIVAL; MIGRATION	Artemin (ARTN) is a member of the GDNF family of ligands and signals through the Ret/GFRalpha3 receptor complex. Characterization of ARTN- and GFRalpha3-deficient mice revealed similar abnormalities in the migration and axonal projection pattern of the entire sympathetic nervous system. This resulted in abnormal innervation of target tissues and consequent cell death due to deficiencies of target-derived neurotrophic support. ARTN is expressed along blood vessels and in cells nearby to sympathetic axonal projections. In the developing vasculature, ARTN is expressed in smooth muscle cells of the vessels, and it acts as a guidance factor that encourages sympathetic fibers to follow blood vessels as they project toward their final target tissues. The chemoattractive properties of ARTN were confirmed by the demonstration that sympathetic neuroblasts migrate and project axons toward ARTN-soaked beads implanted into mouse embryos.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, 660 S Euclid Ave,POB 8118, St Louis, MO 63110 USA.		Araki, Toshiyuki/H-4289-2019	Araki, Toshiyuki/0000-0003-3625-2042; Milbrandt, Jeffrey/0000-0002-5477-7689; Heuckeroth, Robert/0000-0002-3282-1765	NIA NIH HHS [AG13730, AG 13729] Funding Source: Medline; NICHD NIH HHS [HD01487] Funding Source: Medline; NINDS NIH HHS [NS39358] Funding Source: Medline; PHS HHS [K57038-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730, R01AG013729] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Andres R, 2001, DEVELOPMENT, V128, P3685; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Baudet C, 2000, DEVELOPMENT, V127, P4335; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Chalazonitis A, 1998, DEV BIOL, V204, P385, DOI 10.1006/dbio.1998.9090; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; COSTA M, 1984, NEUROSCIENCE, V13, P911, DOI 10.1016/0306-4522(84)90105-2; Damon DH, 2001, AM J PHYSIOL-HEART C, V280, pH1722, DOI 10.1152/ajpheart.2001.280.4.H1722; Durbec PL, 1996, DEVELOPMENT, V122, P349; Elshamy WM, 1996, DEVELOPMENT, V122, P491; Enomoto H, 2000, DEVELOPMENT, V127, P4877; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Fagan AM, 1996, J NEUROSCI, V16, P6208; FERNHOLM M, 1971, Z ANAT ENTWICKLUNGS, V133, P305, DOI 10.1007/BF00519305; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Garcia-Castro M, 1999, CURR OPIN CELL BIOL, V11, P695, DOI 10.1016/S0955-0674(99)00038-1; GOLDSTEIN RS, 1991, DEVELOPMENT, V112, P327; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hearn CJ, 1998, DEV BIOL, V197, P93, DOI 10.1006/dbio.1998.8876; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Hirsch MR, 1998, DEVELOPMENT, V125, P599; HOYLE GW, 1993, NEURON, V10, P1019, DOI 10.1016/0896-6273(93)90051-R; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kandel E., 2000, PRINCIPLES NEURAL SC; KISHIMOTO S, 1982, J INVEST DERMATOL, V79, P141, DOI 10.1111/1523-1747.ep12500043; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Krull CE, 2001, MECH DEVELOP, V105, P37, DOI 10.1016/S0925-4773(01)00395-1; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Martin P, 1999, METH MOL B, V97, P7, DOI 10.1385/1-59259-270-8:7; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; RUBIN E, 1985, J NEUROSCI, V5, P673; Saarma M, 1999, MICROSC RES TECHNIQ, V45, P292, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Schmidt RE, 1998, J NEUROPATH EXP NEUR, V57, P158, DOI 10.1097/00005072-199802000-00007; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Smith PG, 1998, J COMP NEUROL, V400, P529, DOI 10.1002/(SICI)1096-9861(19981102)400:4<529::AID-CNE7>3.0.CO;2-C; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Tang MJ, 1998, J CELL BIOL, V142, P1337, DOI 10.1083/jcb.142.5.1337; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Widenfalk J, 1998, EUR J NEUROSCI, V10, P1508, DOI 10.1046/j.1460-9568.1998.00192.x; Young HM, 2001, ANAT REC, V262, P1; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	64	244	260	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					267	282		10.1016/S0896-6273(02)00774-2	http://dx.doi.org/10.1016/S0896-6273(02)00774-2			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160745	Bronze			2022-12-28	WOS:000177034200007
J	Cossart, R; Epsztein, J; Tyzio, R; Becq, H; Hirsch, J; Ben-Ari, Y; Crepel, V				Cossart, R; Epsztein, J; Tyzio, R; Becq, H; Hirsch, J; Ben-Ari, Y; Crepel, V			Quantal release of glutamate generates pure kainate and mixed AMPA/kainate EPSCs in hippocampal neurons	NEURON			English	Article							EXCITATORY POSTSYNAPTIC CURRENTS; RECEPTOR-MEDIATED RESPONSES; SYNAPTIC TRANSMISSION; GLUR6-DEFICIENT MICE; PYRAMIDAL NEURONS; AMPA RECEPTORS; MOSSY FIBERS; IN-VITRO; INTERNEURONS; ACTIVATION	The relative contribution of kainate receptors to ongoing glutamatergic activity is at present unknown. We report the presence of spontaneous, miniature, and minimal stimulation-evoked excitatory postsynaptic currents (EPSCs) that are mediated solely by kainate receptors (EPSCkainate) or by both AMPA and kainate receptors (EPSCAMPA/kanate). EPSCkainate and EPSCAMPA/kainate are selectively enriched in CA1 interneurons and mossy fibers synapses of CA3 pyramidal neurons, respectively. In CA1 interneurons, the decay time constant of EPSCkainate (circa 10 ms) is comparable to values obtained in heterologous expression systems. In both hippocampal neurons, the quantal release of glutamate generates kainate receptor-mediated EPSCs that provide as much as half of the total glutamatergic current. Kainate receptors are, therefore, key players of the ongoing glutamatergic transmission in the hippocampus.	INMED INSERM U29, F-13273 Marseille 9, France; Univ Mediterranee, F-13273 Marseille 9, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Ben-Ari, Y (corresponding author), INMED INSERM U29, Parc Sci Luminy,BP 13, F-13273 Marseille 9, France.	ben-ari@inmed.univ-mrs.fr	Cossart, Rosa/E-7674-2014; Epsztein, Jerome/O-7922-2016; Crépel, Valérie/E-1870-2016; Cossart, Rosa/AAT-7934-2020	Cossart, Rosa/0000-0003-2111-6638; Epsztein, Jerome/0000-0002-5344-3986; Crépel, Valérie/0000-0003-0408-3766; Cossart, Rosa/0000-0003-2111-6638; Ben-Ari, Yehezkel/0000-0001-6208-8480				ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Bureau I, 1999, J NEUROSCI, V19, P653; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Cui CH, 1999, J NEUROSCI, V19, P8281; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Henze DA, 1997, J NEUROPHYSIOL, V77, P1075, DOI 10.1152/jn.1997.77.3.1075; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; LIVSEY CT, 1992, NEURON, V8, P745, DOI 10.1016/0896-6273(92)90095-U; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PETRALIA RS, 1994, J COMP NEUROL, V349, P85, DOI 10.1002/cne.903490107; Qin LX, 2001, J COMP NEUROL, V440, P284, DOI 10.1002/cne.1386; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Swanson GT, 1998, J PHYSIOL-LONDON, V513, P639, DOI 10.1111/j.1469-7793.1998.639ba.x; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; WILDING TJ, 1995, MOL PHARMACOL, V47, P582	37	115	118	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					147	159		10.1016/S0896-6273(02)00753-5	http://dx.doi.org/10.1016/S0896-6273(02)00753-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123615	Bronze			2022-12-28	WOS:000176601800017
J	Sack, AT; Sperling, JM; Prvulovic, D; Formisano, E; Goebel, R; Di Salle, F; Dierks, T; Linden, DEJ				Sack, AT; Sperling, JM; Prvulovic, D; Formisano, E; Goebel, R; Di Salle, F; Dierks, T; Linden, DEJ			Tracking the mind's image in the brain II: Transcranial magnetic stimulation reveals parietal asymmetry in visuospatial imagery	NEURON			English	Article							MENTAL-IMAGERY; FUNCTIONAL-ANATOMY; VISUAL-IMAGERY; ATTENTION; CORTEX; ACTIVATION; SYSTEM; SAFETY; SPACE; TASK	The functional relevance of brain activity during visuospatial tasks was investigated by combining functional magnetic resonance imaging with unilateral repetitive transcranial magnetic stimulation (rTMS). The cognitive tasks involved visuospatial operations on visually presented and mentally imagined material ("mental clock task"). While visuospatial operations were associated with activation of the intraparietal sulcus region bilaterally, only the group which received rTMS to the right parietal lobe showed an impairment of performance during and immediately after rTMS. This functional parietal asymmetry might indicate a capacity of the right parietal lobe to compensate for a temporary suppression of the left. This is compatible with current theories of spatial hemineglect and constitutes a constraint for models of distributed information processing in the parietal lobes.	Goethe Univ Frankfurt, Dept Psychiat, Lab Neurophysiol & Neuroimaging, DE-60590 Frankfurt, Germany; Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; Univ Naples Federico II, Dept Neuroradiol, I-80131 Naples, Italy; Univ Hosp Clin Psychiat, Dept Psychiat Neurophysiol, CH-3000 Bern 60, Switzerland; Max Planck Inst Hirnforsch, DE-60528 Frankfurt, Germany	Goethe University Frankfurt; Maastricht University; University of Naples Federico II; University of Bern; University Hospital of Bern; Max Planck Society	Linden, DEJ (corresponding author), Goethe Univ Frankfurt, Dept Psychiat, Lab Neurophysiol & Neuroimaging, Theodor Stern Kai 7, DE-60590 Frankfurt, Germany.	linden@mpih-frankfurt.mpg.de	Dierks, Thomas/B-7092-2012; Linden, David E J/C-7355-2013; Linden, David/S-9948-2019	Dierks, Thomas/0000-0002-4173-5308; Linden, David E J/0000-0002-5638-9292; Linden, David/0000-0002-5638-9292; Di Salle, Francesco/0000-0002-0226-8460; Formisano, Elia/0000-0001-5008-2460; Sack, Alexander/0000-0002-1471-0885; Goebel, Rainer/0000-0003-1780-2467				Bohning DE, 1999, BIOL PSYCHIAT, V45, P385, DOI 10.1016/S0006-3223(98)00368-0; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Chen R, 1997, ELECTROMYOGR MOTOR C, V105, P415, DOI 10.1016/S0924-980X(97)00036-2; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; Diwadkar VA, 2000, NEUROIMAGE, V12, P85, DOI 10.1006/nimg.2000.0586; Draper NR., 1998, WILEY SERIES PROBABI, V3rd ed.; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; FARAH MJ, 1989, TRENDS NEUROSCI, V12, P395, DOI 10.1016/0166-2236(89)90079-9; FARAH MJ, 1985, NEUROPSYCHOLOGIA, V23, P115, DOI 10.1016/0028-3932(85)90049-1; Formisano E, 2002, NEURON, V35, P185, DOI 10.1016/S0896-6273(02)00747-X; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Goebel R, 1998, NEUROREPORT, V9, P713, DOI 10.1097/00001756-199803090-00028; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; JENKINS WM, 1990, NEUROPSYCHOLOGIA, V28, P573, DOI 10.1016/0028-3932(90)90035-M; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Klein I, 2000, J COGNITIVE NEUROSCI, V12, P15, DOI 10.1162/089892900564037; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; KOSSLYN SM, 1994, TRENDS NEUROSCI, V17, P290, DOI 10.1016/0166-2236(94)90059-0; Lamm C, 2001, NEUROIMAGE, V14, P268, DOI 10.1006/nimg.2001.0850; Landis T, 2000, SPATIAL VISION, V13, P179, DOI 10.1163/156856800741199; Leonards U, 2000, J COGNITIVE NEUROSCI, V12, P61, DOI 10.1162/089892900564073; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; MARSHALL JC, 2001, NEUROIMAGE, V14, P2; Mellet E, 1996, J NEUROSCI, V16, P6504; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; Mellet E, 2000, J COGNITIVE NEUROSCI, V12, P98, DOI 10.1162/08989290051137620; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; PASCUALLEONE A, 1994, NEUROREPORT, V5, P2517, DOI 10.1097/00001756-199412000-00028; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P281, DOI 10.1016/0166-2236(94)90057-4; Sack AT, 2002, COGNITIVE BRAIN RES, V13, P85, DOI 10.1016/S0926-6410(01)00087-8; Seitz RJ, 1999, STROKE, V30, P1844, DOI 10.1161/01.STR.30.9.1844; TROJANO L, 1994, BRAIN COGNITION, V24, P213, DOI 10.1006/brcg.1994.1012; Trojano L, 2000, CEREB CORTEX, V10, P473, DOI 10.1093/cercor/10.5.473; TROJANO L, 2002, IN PRESS NEUROPSYCHO; Vallar G, 1996, J Int Neuropsychol Soc, V2, P452; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125; Wang H, 1996, NEUROREPORT, V7, P521, DOI 10.1097/00001756-199601310-00035; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734	46	115	117	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					195	204		10.1016/S0896-6273(02)00745-6	http://dx.doi.org/10.1016/S0896-6273(02)00745-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	569KP	12123619	Bronze, Green Published			2022-12-28	WOS:000176601800021
J	Jorntell, H; Ekerot, CF				Jorntell, H; Ekerot, CF			Reciprocal bidirectional plasticity of parallel fiber receptive fields in cerebellar Purkinje cells and their afferent interneurons	NEURON			English	Article							LONG-TERM DEPRESSION; NUCLEUS INTERPOSITUS ANTERIOR; CLIMBING FIBERS; TOPOGRAPHICAL ORGANIZATION; COMPLEX SPIKES; CAT CEREBELLUM; GLUTAMATE; RAT; CORTEX; POTENTIATION	The highly specific relationships between parallel fiber (PF) and climbing fiber (CF) receptive fields in Purkinje cells and interneurons suggest that normal PF receptive fields are established by CF-specific plasticity. To test this idea, we used PF stimulation that was either paired or unpaired with CF activity. Conspicuously, unpaired PF stimulation that induced long-lasting, very large increases in the receptive field sizes of Purkinje cells induced long-lasting decreases in receptive field sizes of their afferent interneurons. In contrast, PF stimulation paired with CIF activity that induced long-lasting decreases in the receptive fields of Purkinje cells induced long-lasting, large increases in the receptive fields of interneurons. These properties, and the fact the mossy fiber receptive fields were unchanged, suggest that the receptive field changes were due to bidirectional PF synaptic plasticity in Purkinje cells and interneurons.	Lund Univ, Biomed Ctr F10, Dept Physiol Sci, Sect Neurophysiol, SE-22184 Lund, Sweden	Lund University	Jorntell, H (corresponding author), Lund Univ, Biomed Ctr F10, Dept Physiol Sci, Sect Neurophysiol, Tornavagen 10, SE-22184 Lund, Sweden.							ANDERSSON G, 1987, J PHYSIOL-LONDON, V385, P107, DOI 10.1113/jphysiol.1987.sp016487; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BISHOP GA, 1982, J COMP NEUROL, V210, P1, DOI 10.1002/cne.902100102; DECAMILLI P, 1984, NEUROSCIENCE, V11, P761, DOI 10.1016/0306-4522(84)90193-3; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; EKEROT CF, 1991, J PHYSIOL-LONDON, V441, P257, DOI 10.1113/jphysiol.1991.sp018750; EKEROT CF, 1995, EXP BRAIN RES, V106, P365; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Garwicz M, 1998, J PHYSIOL-LONDON, V512, P277, DOI 10.1111/j.1469-7793.1998.277bf.x; GARWICZ M, 1994, J PHYSIOL-LONDON, V474, P245, DOI 10.1113/jphysiol.1994.sp020017; GELLMAN R, 1985, J NEUROPHYSIOL, V54, P40, DOI 10.1152/jn.1985.54.1.40; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; HAWKES R, 1989, BRAIN RES, V476, P279, DOI 10.1016/0006-8993(89)91248-1; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 1984, CEREBELLUM NEURAL CO; Jorntell H, 1999, J PHYSIOL-LONDON, V514, P551, DOI 10.1111/j.1469-7793.1999.551ae.x; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Linden DJ, 1999, J NEUROSCI, V19, P10221; Palay S.L., 1974, CEREBELLAR CORTEX; PITCHITPORNCHAI C, 1994, J COMP NEUROL, V342, P206; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Sugihara I, 1999, J COMP NEUROL, V414, P131; Sultan F, 2001, EUR J NEUROSCI, V13, P2123, DOI 10.1046/j.0953-816x.2001.01593.x; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1	34	215	215	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					797	806		10.1016/S0896-6273(02)00713-4	http://dx.doi.org/10.1016/S0896-6273(02)00713-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062025	Bronze			2022-12-28	WOS:000175951800013
J	Kreitzer, AC; Carter, AG; Regehr, WG				Kreitzer, AC; Carter, AG; Regehr, WG			Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum	NEURON			English	Article							RECTIFYING POTASSIUM CHANNELS; ACID AMIDE HYDROLASE; CB1 RECEPTOR; CANNABINOID CB1; PURKINJE-CELLS; ENDOGENOUS CANNABINOIDS; RETROGRADE INHIBITION; LOCALIZATION; CURRENTS; NEURONS	Endocannabinoids serve as retrograde messengers in many brain regions. These diffusible lipophilic molecules are released by postsynaptic cells and regulate presynaptic neurotransmitter release. Here we describe an additional mechanism that mediates the spread of endocannabinoid signaling to distant inhibitory synapses. Depolarization of cerebellar Purkinje cells reduced the firing rate of nearby interneurons, and this reduction in firing was blocked by the cannabinoid receptor antagonist AM251. The cannabinoid receptor agonist WIN55,212-2 also reduced firing rates in interneurons, and this inhibition arose from the activation of a small potassium conductance. Thus, endocannabinoids released from the dendrites of depolarized neurons can lead to inhibition of firing in nearby cells. Because interneurons can project over several hundred micrometers, this inhibition of firing allows cells to regulate synaptic inputs at distances well beyond the limits of endocannabinoid diffusion.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032405] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS32405-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cajal S. R., 1911, HISTOLOGIE SYSTEME N, V2; COMPTON DR, 1992, J PHARMACOL EXP THER, V263, P1118; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DAMBRA TE, 1992, J MED CHEM, V35, P124, DOI 10.1021/jm00079a016; DEADWYLER SA, 1995, J PHARMACOL EXP THER, V273, P734; DEADWYLER SA, 1993, RECEPTOR CHANNEL, V1, P121; DeSanty KP, 2001, PHARMACOL BIOCHEM BE, V69, P251, DOI 10.1016/S0091-3057(01)00539-1; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; HENRY DJ, 1995, NEUROSCI LETT, V186, P91, DOI 10.1016/0304-3940(95)11289-9; HERRINGTON J, 1995, PULSE CONTROL V4 5 I; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Karschin C, 1996, J NEUROSCI, V16, P3559; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Lee MY, 2000, BRAIN RES, V864, P52, DOI 10.1016/S0006-8993(00)02134-X; Liao YJ, 1996, J NEUROSCI, V16, P7137; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MACKIE K, 1995, J NEUROSCI, V15, P6552; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; McAllister SD, 1999, J PHARMACOL EXP THER, V291, P618; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P329, DOI 10.1113/jphysiol.1992.sp019381; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palay S.L., 1974, CEREBELLAR CORTEX; Patel S, 2001, J PHARMACOL EXP THER, V297, P629; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Sanudo-Pena MC, 1999, LIFE SCI, V65, P703, DOI 10.1016/S0024-3205(99)00293-3; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Sodickson DL, 1996, J NEUROSCI, V16, P6374; STANDEN NB, 1978, J PHYSIOL-LONDON, V280, P169, DOI 10.1113/jphysiol.1978.sp012379; Sullivan JM, 2000, LEARN MEMORY, V7, P132, DOI 10.1101/lm.7.3.132; Sultan F, 1998, J COMP NEUROL, V393, P353; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	42	117	121	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					787	796		10.1016/S0896-6273(02)00695-5	http://dx.doi.org/10.1016/S0896-6273(02)00695-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062024	Bronze			2022-12-28	WOS:000175951800012
J	Swanson, GT; Green, T; Sakai, R; Contractor, A; Che, W; Kamiya, H; Heinemann, SF				Swanson, GT; Green, T; Sakai, R; Contractor, A; Che, W; Kamiya, H; Heinemann, SF			Differential activation of individual subunits in heteromeric kainate receptors	NEURON			English	Article							LIGAND-BINDING CORE; GLUTAMATE-RECEPTOR; HIGH-AFFINITY; ION CHANNELS; AMPA; AGONIST; GLUR5; BEHAVIOR; CLONING	Neuronal kainate receptors are assembled from subunits with dissimilar specificities for agonists and antagonists. The composite biophysical behavior of heteromeric kainate receptors is determined by intersubunit interactions whose nature is unclear. Here we use dysiherbaine, a selective kainate receptor agonist, to show that GluR5 subunits assembled in heteromeric GluR5/KA-2 kainate receptor complexes can gate current without concomitant activation of their partner KA-2 subunits. A long-lasting interaction between dysiherbaine and GluR5 subunits elicits a tonic current from GluR5/KA-2 receptors; subsequent cooperative gating of KA-2 subunits can be elicited by both agonists, such as glutamate, and some classically defined antagonists, such as CNQX. This study demonstrates that each type of subunit within a heteromeric kainate receptor contributes a distinct conductance upon activation by agonist binding, and therefore provides insight into the biophysical function of ionotropic glutamate receptors.	Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England; Kitasato Univ, Sch Fisheries Sci, Sanriku, Iwate 0220101, Japan; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Liverpool; Kitasato University; Salk Institute	Swanson, GT (corresponding author), Univ Texas, Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.			Contractor, Anis/0000-0002-5131-2536				Abele R, 1999, BIOCHEMISTRY-US, V38, P10949, DOI 10.1021/bi982928y; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Cui CH, 1999, J NEUROSCI, V19, P8281; Dingledine R, 1999, PHARMACOL REV, V51, P7; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Sakai R, 2001, J PHARMACOL EXP THER, V296, P650; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; STEMBACH Y, 1994, NEURON, V13, P1345; Swanson GT, 1998, MOL PHARMACOL, V53, P942; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0	20	80	82	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					589	598		10.1016/S0896-6273(02)00676-1	http://dx.doi.org/10.1016/S0896-6273(02)00676-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062042	Bronze			2022-12-28	WOS:000175665700012
J	Hasson, U; Levy, I; Behrmann, M; Hendler, T; Malach, R				Hasson, U; Levy, I; Behrmann, M; Hendler, T; Malach, R			Eccentricity bias as an organizing principle for human high-order object areas	NEURON			English	Article							HUMAN VISUAL-CORTEX; FUSIFORM FACE AREA; PROCESSING STAGES; WORD RECOGNITION; REPRESENTATION; PERCEPTION; ACTIVATION; FMRI; IDENTIFICATION; PASS	We have recently proposed a center-periphery organization based on resolution needs, in which objects engaging in recognition processes requiring central-vision (e.g., face-related) are associated with center-biased representations, while objects requiring large-scale feature integration (e.g., buildings) are associated with periphery-biased representations. Here we tested this hypothesis by comparing the center-periphery organization with activations to five object categories: faces, buildings, tools, letter strings, and words. We found that faces, letter strings, and words were mapped preferentially within the center-biased representation. Faces showed a hemispheric lateralization opposite to that of letter strings and words. In contrast, buildings were mapped mainly to the periphery-biased representation, while tools activated both central and peripheral representations. The results are compatible with the notion that center-periphery organization allows the optimal allocation of cortical magnification to the specific requirements of various recognition processes.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Dept Imaging, IL-64239 Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Carnegie Mellon University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Malach, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	rafi.malach@weizmann.ac.il	hendler, talma/C-7677-2012	Levy, Ifat/0000-0001-7851-9070; Hasson, Uri/0000-0002-3599-7168; Behrmann, Marlene/0000-0002-3814-1015				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Beauregard M, 1997, J COGNITIVE NEUROSCI, V9, P441, DOI 10.1162/jocn.1997.9.4.441; Behrmann M, 1998, NEUROPSYCHOLOGIA, V36, P1115, DOI 10.1016/S0028-3932(98)00005-0; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; COSTEN NP, 1994, PERCEPTION, V23, P129, DOI 10.1068/p230129; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Edelman S, 1998, BEHAV BRAIN SCI, V21, P449, DOI 10.1017/S0140525X98001253; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gold J, 1999, VISION RES, V39, P3537, DOI 10.1016/S0042-6989(99)00080-2; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; HASSON U, 2001, J COGNITIVE NEUROSCI, V13, P1; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HAYES T, 1986, PERCEPTION, V15, P595, DOI 10.1068/p150595; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Ivry R.B., 1998, 2 SIDES PERCEPTION; Jacobs RA, 1999, TRENDS COGN SCI, V3, P31, DOI 10.1016/S1364-6613(98)01260-1; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Leff AP, 2001, BRAIN, V124, P510, DOI 10.1093/brain/124.3.510; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Makela P, 2001, VISION RES, V41, P599, DOI 10.1016/S0042-6989(00)00259-5; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Mechelli A, 2000, J COGNITIVE NEUROSCI, V12, P145, DOI 10.1162/089892900564000; Melmoth DR, 2000, INVEST OPHTH VIS SCI, V41, P2811; Moore CJ, 1999, NEUROIMAGE, V10, P181, DOI 10.1006/nimg.1999.0450; NAZIR TA, 1992, PERCEPT PSYCHOPHYS, V52, P315, DOI 10.3758/BF03209148; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Puce A, 1996, J NEUROSCI, V16, P5205; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Springer SP, 1997, LEFT BRAIN RIGHT BRA; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; Talairach J., 1988, COPLANAR STEREOTAXIC; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Uchida I, 1999, NEUROIMAGE, V9, P208, DOI 10.1006/nimg.1999.0400	56	363	364	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					479	490		10.1016/S0896-6273(02)00662-1	http://dx.doi.org/10.1016/S0896-6273(02)00662-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	545JW	11988177	Bronze			2022-12-28	WOS:000175214700017
J	Deisseroth, K; Tsien, RW				Deisseroth, K; Tsien, RW			Dynamic multiphosphorylation passwords for activity-dependent gene expression	NEURON			English	Review							CREB PHOSPHORYLATION; ACTIVATION; TRANSCRIPTION; NUCLEUS; LIGHT; IV	Synapse-to-nucleus signaling leading to CREB-mediated transcription is important for neuronal plasticity. Nuclear CREB phosphorylation at Ser133 allows convergence of multiple kinase pathways driven by neuronal activity and links them to transcriptional activation. But, can various pathways share a common effector mechanism (phosphorylating Ser133) while generating distinct patterns of gene expression? We review three Neuron articles that highlight novel ways Ca2+ signals can trigger multiple phosphorylation events working in combination to control CREB and its interaction with coactivator molecules.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.							Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mermelstein PG, 2001, P NATL ACAD SCI USA, V98, P15342, DOI 10.1073/pnas.211563998; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198	19	98	98	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					179	182		10.1016/S0896-6273(02)00664-5	http://dx.doi.org/10.1016/S0896-6273(02)00664-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970860	Bronze			2022-12-28	WOS:000174976200004
J	Graybiel, AM; Saka, E				Graybiel, AM; Saka, E			A genetic basis for obsessive grooming	NEURON			English	Editorial Material							RATS	Excessive grooming behaviors, cleansing rituals, and self-mutilation are important features of a range of neuropsychiatric diseases including obsessive compulsive (OC)-spectrum disorders. In this issue of Neuron, Greer and Capecchi (2002) report that Hoxb8 mutant mice exhibit this behavioral phenotype. These Hoxb8 mutants will be valuable in exploring the genetics and pathophysiology of OC-spectrum disorders as well as strategies for their treatment.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Graybiel, AM (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Graybiel, Ann/0000-0002-4326-7720				BERRIDGE KC, 1987, BEHAV BRAIN RES, V23, P59, DOI 10.1016/0166-4328(87)90242-7; CRISWELL HE, 1992, NEUROPSYCHOPHARMACOL, V7, P95; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; MCGINNIS W, 1992, CELL, V68, P282; Pato M T, 2001, Curr Psychiatry Rep, V3, P163, DOI 10.1007/s11920-001-0015-0; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; van den Akker E, 1999, MECH DEVELOP, V89, P103, DOI 10.1016/S0925-4773(99)00212-9	8	25	26	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					1	2		10.1016/S0896-6273(01)00575-X	http://dx.doi.org/10.1016/S0896-6273(01)00575-X			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779470	Bronze			2022-12-28	WOS:000173106200001
J	Druzgal, TJ; D'Esposito, M				Druzgal, TJ; D'Esposito, M			A neural network reflecting decisions about human faces	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; HUMAN EXTRASTRIATE CORTEX; INFERIOR TEMPORAL CORTEX; HUMAN FUSIFORM GYRUS; FRONTAL EYE FIELD; WORKING-MEMORY; VISUAL-SEARCH; OCCIPITOTEMPORAL CORTEX; PREFRONTAL CORTEX; MECHANISMS	Anatomic structures have been linked to the mnemonic component of working memory, but the neural network underlying associated decision processes remains elusive. Here we present an event-related functional magnetic resonance imaging study that measured activity during the decision period of a delayed face recognition task. A double dissociation of activity between anterior cingulate cortex (ACC), and a network including left fusiform face area (FFA) and left dorsolateral prefrontal cortex (DLPFC), reflected whether a probe face matched the remembered face at the time of decision. Greater activity in the left FFA and left DLPFC correlated with probe faces that matched the remembered face; in contrast, activity in ACC was greater when the probe face did not match the remembered face. These results support a model where frontal regions act in concert with stimulus-specific temporal structures to make recognition decisions about visual stimuli.	Univ Calif Berkeley, Dept Psychol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University of California System; University of California Berkeley; University of Pennsylvania	Druzgal, TJ (corresponding author), Univ Calif Berkeley, Dept Psychol, Helen Wills Neurosci Inst, 3210 Tolman Hall, Berkeley, CA 94720 USA.	druzgal@mail.med.upenn.edu		Druzgal, Jason/0000-0001-7240-9487	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015793, R01AG013483] Funding Source: NIH RePORTER; NIA NIH HHS [AG15793, AG13483] Funding Source: Medline; NIGMS NIH HHS [T32-GM07517] Funding Source: Medline; NINDS NIH HHS [NS01762] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Aguirre GK, 1998, NEUROIMAGE, V8, P302, DOI 10.1006/nimg.1998.0367; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; BENTON A, 1990, CORTEX, V26, P491, DOI 10.1016/S0010-9452(13)80299-7; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; de Gelder B, 2001, ACTA PSYCHOL, V107, P183, DOI 10.1016/S0001-6918(01)00024-5; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Druzgal TJ, 2001, COGNITIVE BRAIN RES, V10, P355, DOI 10.1016/S0926-6410(00)00056-2; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Fuster JM, 1995, MEMORY CEREBRAL CORT; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; HILLGER LA, 1991, J COGNITIVE NEUROSCI, V3, P42, DOI 10.1162/jocn.1991.3.1.42; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KIMBERG DY, 1993, J EXP PSYCHOL GEN, V122, P411, DOI 10.1037/0096-3445.122.4.411; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Miller EK, 1996, J NEUROSCI, V16, P5154; Postle BR, 2000, BRAIN RES PROTOC, V5, P57, DOI 10.1016/S1385-299X(99)00053-7; PROCTOR RW, 1986, PSYCHOL REV, V93, P473, DOI 10.1037/0033-295X.93.4.473; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; RATCLIFF R, 1985, PSYCHOL REV, V92, P212, DOI 10.1037/0033-295X.92.2.212; RHODES G, 1993, BRAIN COGNITION, V22, P19, DOI 10.1006/brcg.1993.1022; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; STJAMES JD, 1991, PERCEPTION OF STRUCTURE, P157, DOI 10.1037/10101-009; Talairach I., 1988, COPLANAR STEREOTACTI; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	54	59	60	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2001	32	5					947	955		10.1016/S0896-6273(01)00519-0	http://dx.doi.org/10.1016/S0896-6273(01)00519-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	501RW	11738037	Bronze			2022-12-28	WOS:000172700700018
J	Krichevsky, AM; Kosik, KS				Krichevsky, AM; Kosik, KS			Neuronal RNA granules: A link between RNA localization and stimulation-dependent translation	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LOCAL PROTEIN-SYNTHESIS; LONG-TERM FACILITATION; HEAT-SHOCK RESPONSE; MESSENGER-RNA; TARGETING ELEMENT; STRESS GRANULES; LIVING NEURONS; KINASE-II; BC1 RNA	RNA granules are a macromolecular structure observed in neurons, where they serve as motile units that translocate mRNAs. Isolated RNA granules are highly enriched in Staufen protein and ultrastructurally contain densely packed clusters of ribosomes. With depolarization, many mRNAs, including those involved in plasticity, rapidly shift from the RNA granule fraction to polysomes. Depolarization reorganizes granules and induces a less compact organization of their ribosomes. RNA granules are not translationally competent, as indicated by the failure to incorporate radioactive amino acids and the absence of eIF4E, 4G, and tRNAs. We concluded that RNA granules are a local storage compartment for mRNAs under translational arrest but are poised for release to actively translated pools. Local release of mRNAs and ribosomes from granules may serve as a macromolecular mechanism linking RNA localization to translation and synaptic plasticity.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kosik, KS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.			Krichevsky, Anna/0000-0002-5080-5507	NIA NIH HHS [AG06601] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG006601] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; BARBARESE E, 1995, J CELL SCI, V108, P2781; Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; ESCOBAR MI, 1986, NEUROSCIENCE, V17, P975, DOI 10.1016/0306-4522(86)90074-6; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FORRISTALL C, 1995, DEVELOPMENT, V121, P201; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kashikawa M, 1999, DEV GROWTH DIFFER, V41, P495; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; KLOC M, 1995, DEVELOPMENT, V121, P287; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kobayashi S, 1998, BIOCHEM BIOPH RES CO, V253, P448, DOI 10.1006/bbrc.1998.9704; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lipshitz HD, 2000, CURR OPIN GENET DEV, V10, P476, DOI 10.1016/S0959-437X(00)00116-7; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Muslimov IA, 1997, J NEUROSCI, V17, P4722; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; NOVER L, 1991, NEW BIOL, V3, P855; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; Racca C, 1997, J NEUROSCI, V17, P1691; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Scharf KD, 1998, MOL CELL BIOL, V18, P2240, DOI 10.1128/MCB.18.4.2240; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; SIERRA JM, 1994, MOL BIOL REP, V19, P211, DOI 10.1007/BF00986963; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; SUNDELL CL, 1990, J CELL BIOL, V111, P2397, DOI 10.1083/jcb.111.6.2397; Tiedge H, 1996, J NEUROSCI, V16, P7171; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Tujebajeva RM, 2000, J BIOL CHEM, V275, P6288, DOI 10.1074/jbc.275.9.6288; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Wallace CS, 1998, J NEUROSCI, V18, P26; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wanner I, 1997, HISTOCHEM CELL BIOL, V108, P345, DOI 10.1007/s004180050175; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; ZIMMERMAN JL, 1989, PLANT CELL, V1, P1137, DOI 10.1105/tpc.1.12.1137	52	397	408	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					683	696		10.1016/S0896-6273(01)00508-6	http://dx.doi.org/10.1016/S0896-6273(01)00508-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719208	Bronze			2022-12-28	WOS:000172363900014
J	Liu, DX; Greene, LA				Liu, DX; Greene, LA			Regulation of neuronal survival and death by E2F-dependent gene repression and derepression	NEURON			English	Article							CYCLIN-DEPENDENT KINASES; TRANSCRIPTION FACTOR E2F-1; DIFFERENTIATED PC12 CELLS; NERVE GROWTH-FACTOR; S-PHASE ENTRY; SYMPATHETIC NEURONS; RETINOBLASTOMA PROTEIN; APOPTOTIC RESPONSE; PROMOTE SURVIVAL; JNK ACTIVATION	Neuronal death induced by a variety of means requires participation of the E2F family of transcription factors. Here, we show that E2F acts as a gene silencer in neurons and that repression of E2F-responsive genes is required for neuronal survival. Moreover, neuronal death evoked by DNA damaging agents or trophic factor withdrawal is characterized by derepression of E2F-responsive genes. Such derepression, rather than direct E2F-promoted gene activation, is required for death. Among the genes that are derepressed in neurons subjected to DNA damage or trophic factor withdrawal are the transcription factors B- and C-myb. Overexpression of B- and C-myb is sufficient to evoke neuronal death. These findings support a model in which E2F-dependent gene repression and derepression play pivotal roles in neuronal survival and death, respectively.	Columbia Univ Coll Phys & Surg, Dept Pathol, Taub Ctr Alzheimers Dis Res, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University	Liu, DX (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, Taub Ctr Alzheimers Dis Res, 630 W 168th St, New York, NY 10032 USA.				NIA NIH HHS [AG00189-12] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Athanasiou M, 1996, ONCOGENE, V12, P337; Athanasiou MC, 1998, MOL CELL NEUROSCI, V12, P16, DOI 10.1006/mcne.1998.0699; BIES J, 1995, CANCER RES, V55, P501; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Cheng HK, 1999, DECIS SUPPORT SYST, V25, P19, DOI 10.1016/S0167-9236(98)00089-X; Chow KNB, 1996, MOL CELL BIOL, V16, P4862; Courtney MJ, 1999, EUR J NEUROSCI, V11, P1073, DOI 10.1046/j.1460-9568.1999.00520.x; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Farinelli SE, 1996, J NEUROSCI, V16, P1150, DOI 10.1523/jneurosci.16-03-01150.1996; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Giovanni A, 1999, J BIOL CHEM, V274, P19011, DOI 10.1074/jbc.274.27.19011; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guegan C, 1997, NEUROREPORT, V8, P1003, DOI 10.1097/00001756-199703030-00037; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; He S, 2000, MOL CELL BIOL, V20, P363, DOI 10.1128/MCB.20.1.363-371.2000; Hou ST, 2000, J NEUROCHEM, V75, P91, DOI 10.1046/j.1471-4159.2000.0750091.x; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; JOHNSON AF, 1993, ECOSYSTEMS WORLD, V2, P365; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; McShea A, 1997, AM J PATHOL, V150, P1933; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Morris EJ, 2001, J NEUROSCI, V21, P5017, DOI 10.1523/JNEUROSCI.21-14-05017.2001; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Park DS, 1996, J BIOL CHEM, V271, P21898, DOI 10.1074/jbc.271.36.21898; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Raina A K, 2000, Prog Cell Cycle Res, V4, P235; Sala A, 1996, CANCER RES, V56, P1991; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; Shin DH, 2001, BRAIN RES, V892, P203, DOI 10.1016/S0006-8993(00)03300-X; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Troy CM, 2001, J NEUROSCI, V21, P5007, DOI 10.1523/JNEUROSCI.21-14-05007.2001; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhu XW, 1999, AM J PATHOL, V155, P327, DOI 10.1016/S0002-9440(10)65127-9	56	107	112	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					425	438		10.1016/S0896-6273(01)00495-0	http://dx.doi.org/10.1016/S0896-6273(01)00495-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709154	Bronze			2022-12-28	WOS:000172119100009
J	Schuett, S; Bonhoeffer, T; Hubener, M				Schuett, S; Bonhoeffer, T; Hubener, M			Pairing-induced changes of orientation maps in cat visual cortex	NEURON			English	Article							LONG-TERM DEPRESSION; STRIATE CORTEX; MONOCULAR DEPRIVATION; SYNAPTIC PLASTICITY; OCULAR DOMINANCE; RECEPTIVE-FIELD; INTRACORTICAL INHIBITION; CORTICAL-NEURONS; RAT HIPPOCAMPUS; PYRAMIDAL CELLS	We have studied the precise temporal requirements for plasticity of orientation preference maps in kitten visual cortex. Pairing a brief visual stimulus with electrical stimulation in the cortex, we found that the relative timing determines the direction of plasticity: a shift in orientation preference toward the paired orientation occurs if the cortex is activated first visually and then electrically; the cortical response to the paired orientation is diminished if the sequence of visual and electrical activation is reversed. We furthermore show that pinwheel centers are less affected by the pairing than the pinwheel surround. Thus, plasticity is not uniformly distributed across the cortex, and, most importantly, the same spike time-dependent learning rules that have been found in single-cell in vitro studies are also valid on the level of cortical maps.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Hubener, M (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.		Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634				ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BERMAN N, 1982, J NEUROPHYSIOL, V48, P1362, DOI 10.1152/jn.1982.48.6.1362; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 2000, J NEUROSCI, V20, P1922; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; FERRER JMR, 1988, PROC R SOC SER B-BIO, V233, P77, DOI 10.1098/rspb.1988.0013; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FREEMAN RD, 1973, NATURE, V246, P359, DOI 10.1038/246359a0; Fregnac Y, 1999, J NEUROBIOL, V41, P69; FREGNAC Y, 1992, J NEUROSCI, V12, P1280; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Godecke I, 1996, NATURE, V379, P251, DOI 10.1038/379251a0; Grinvald A., 1999, IN VIVO OPTICAL IMAG, P893; Hetherington PA, 1999, VISUAL NEUROSCI, V16, P637, DOI 10.1017/S0952523899164046; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; Hubener M, 1997, J NEUROSCI, V17, P9270; IKEDA H, 1975, J PHYSL, V245, P114; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kojic L, 2000, P NATL ACAD SCI USA, V97, P1841, DOI 10.1073/pnas.97.4.1841; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; KOSSUT M, 1983, ACTA NEUROBIOL EXP, V43, P273; KOSSUT M, 1991, EXP BRAIN RES, V85, P519; MAFFEI L, 1976, SCIENCE, V191, P579, DOI 10.1126/science.1251195; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; Miller KD, 1999, J NEUROBIOL, V41, P44, DOI 10.1002/(SICI)1097-4695(199910)41:1<44::AID-NEU7>3.0.CO;2-V; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; MURPHY PC, 1986, J PHYSIOL-LONDON, V381, P95, DOI 10.1113/jphysiol.1986.sp016315; MUSTARI M, 1981, BRAIN RES, V211, P165, DOI 10.1016/0006-8993(81)90077-9; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Schuett S, 2000, EUR J NEUROSCI, V12, P74; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Sermasi E, 1999, DEV BRAIN RES, V113, P61, DOI 10.1016/S0165-3806(98)00190-4; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Shevelev IA, 1998, NEUROSCIENCE, V84, P11, DOI 10.1016/S0306-4522(97)00363-1; Shouval HZ, 2000, J NEUROSCI, V20, P1119, DOI 10.1523/JNEUROSCI.20-03-01119.2000; Shulz DE, 2000, NATURE, V403, P549, DOI 10.1038/35000586; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trepel C, 1998, J NEUROSCI, V18, P3404; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; Yousef T, 2001, NEUROREPORT, V12, P1693, DOI 10.1097/00001756-200106130-00035; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	65	110	113	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					325	337		10.1016/S0896-6273(01)00472-X	http://dx.doi.org/10.1016/S0896-6273(01)00472-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11684001	Bronze			2022-12-28	WOS:000171893700016
J	Erickson, MG; Alseikhan, BA; Peterson, BZ; Yue, DT				Erickson, MG; Alseikhan, BA; Peterson, BZ; Yue, DT			Preassociation of calmodulin with voltage-gated Ca2+ channels revealed by FRET in single living cells	NEURON			English	Article							RESONANCE ENERGY-TRANSFER; GREEN FLUORESCENT PROTEIN; CALCIUM CHANNELS; CA2+-SENSITIVE INACTIVATION; CA2+-DEPENDENT INACTIVATION; ALPHA(1C) SUBUNIT; BETA-SUBUNIT; INHIBITION; DEPENDS; MOTIF	Among the most intriguing forms of Ca2+ channel modulation is the regulation of L-type and P/Q-type channels by intracellular Ca2+, acting via unconventional channel-calmodulin (CaM) interactions. In particular, overexpressing Ca2+-insensitive mutant CaM abolishes Ca2+-dependent modulation, hinting that Ca2+-free CaM may "preassociate" with these channels to enhance detection of local Ca2+. Despite the far-reaching consequences of this proposal, in vitro experiments testing for preassociation provide conflicting results. Here, we develop a three filter-cube fluorescence resonance energy transfer method (three-cube FRET) to directly probe for constitutive associations between channel subunits and CaM in single living cells. This FRET assay detects Ca2+-independent associations between CaM and the pore-forming a, subunit of L-type, P/Q-type, and, surprisingly, R-type channels. These results now definitively demonstrate channel-CaM preassociation in resting cells and underscore the potential of three-cube FRET for probing protein-protein interactions.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Calcium Signals Lab, Baltimore, MD 21205 USA; Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.							Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; EPE B, 1983, P NATL ACAD SCI-BIOL, V80, P2579, DOI 10.1073/pnas.80.9.2579; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Harpur AG, 2001, NAT BIOTECHNOL, V19, P167, DOI 10.1038/84443; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Moon DL, 2001, BIOPHYS J, V80, p362A; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Patterson G, 2001, J CELL SCI, V114, P837; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRON L, 1984, BIOPHYS J, V45, P939, DOI 10.1016/S0006-3495(84)84240-X; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	46	367	371	2	29	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					973	985		10.1016/S0896-6273(01)00438-X	http://dx.doi.org/10.1016/S0896-6273(01)00438-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580897	Bronze			2022-12-28	WOS:000171281300012
J	Suga, N; Xiao, ZJ; Ma, XF; Ji, WQ				Suga, N; Xiao, ZJ; Ma, XF; Ji, WQ			Plasticity and corticofugal modulation for hearing in adult animals	NEURON			English	Review							RECEPTIVE-FIELD PLASTICITY; PRIMARY AUDITORY-CORTEX; MIDBRAIN FREQUENCY MAP; PHYSIOLOGICAL MEMORY; GUINEA-PIG; NUCLEUS; NEURONS; BAT; DISCRIMINATION; REORGANIZATION	The descending (corticofugal) auditory system adjusts and improves auditory signal processing in the subcortical auditory nuclei. The auditory cortex and corticofugal system evoke small, short-term changes of the subcortical auditory nuclei in response to a sound repetitively delivered to an animal. These changes are specific to the parameters characterizing the sound. When the sound becomes significant to the animal through conditioning (associative learning), the changes are augmented and the cortical changes become long-term. There are two types of reorganizations: expanded reorganization resulting from centripetal shifts in tuning curves of neurons toward the values of the parameters characterizing a sound and compressed reorganization resulting from centrifugal shifts in tuning curves of neurons away from these values. The two types of reorganizations are based on a single mechanism consisting of two components: facilitation and inhibition.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Suga, N (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	suga@biology.wustl.edu			NIDCD NIH HHS [DC00175] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000175] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bakin JS, 1996, BEHAV NEUROSCI, V110, P905, DOI 10.1037/0735-7044.110.5.905; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BARTUS RT, 1985, PHARMACOL BIOCHEM BE, V23, P125, DOI 10.1016/0091-3057(85)90139-X; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bjordahl TS, 1998, BEHAV NEUROSCI, V112, P467, DOI 10.1037/0735-7044.112.3.467; Buonomano DV, 1998, J NEUROPHYSIOL, V80, P1765, DOI 10.1152/jn.1998.80.4.1765; Chowdhury SA, 2000, J NEUROPHYSIOL, V83, P1856, DOI 10.1152/jn.2000.83.4.1856; Covey E, 1999, ANNU REV PHYSIOL, V61, P457, DOI 10.1146/annurev.physiol.61.1.457; DIAMOND DM, 1989, BEHAV NEUROSCI, V103, P471, DOI 10.1037/0735-7044.103.3.471; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P82, DOI 10.1037/0735-7044.107.1.82; Ergenzinger ER, 1998, NAT NEUROSCI, V1, P226, DOI 10.1038/673; GAIONI SJ, 1990, J NEUROPHYSIOL, V64, P1801, DOI 10.1152/jn.1990.64.6.1801; Gao E, 1998, P NATL ACAD SCI USA, V95, P12663, DOI 10.1073/pnas.95.21.12663; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; Goldberg RL, 1998, HEARING RES, V122, P71, DOI 10.1016/S0378-5955(98)00078-1; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; Ji WQ, 2001, J NEUROPHYSIOL, V86, P211, DOI 10.1152/jn.2001.86.1.211; JOHNSTON MV, 1979, P NATL ACAD SCI USA, V76, P5392, DOI 10.1073/pnas.76.10.5392; Krupa DJ, 1999, P NATL ACAD SCI USA, V96, P8200, DOI 10.1073/pnas.96.14.8200; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Ma XF, 2001, P NATL ACAD SCI USA, V98, P14060, DOI 10.1073/pnas.241517098; Maldonado PE, 1996, EXP BRAIN RES, V112, P420; POLLAK G, 1972, SCIENCE, V176, P66, DOI 10.1126/science.176.4030.66; Poremba A, 2001, J NEUROSCI, V21, P270, DOI 10.1523/JNEUROSCI.21-01-00270.2001; PRICE JL, 1981, J NEUROSCI, V1, P1242; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RIGDON GC, 1986, J NEUROSCI, V6, P2535; Sakai M, 2001, P NATL ACAD SCI USA, V98, P3507, DOI 10.1073/pnas.061021698; Sakai M, 2002, P NATL ACAD SCI USA, V99, P7108, DOI 10.1073/pnas.102165399; Schnitzler H., 1980, ANIMAL SONAR SYSTEMS, V28, P109, DOI [10.10007/978-1-4684-7254-7_6, DOI 10.1007/978-1-4684-7254-7_6]; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; SUGA N, 1977, J EXP BIOL, V69, P207; Suga N, 1984, DYNAMIC ASPECTS NEOC, P315; Suga Nobuo, 1995, P295; Weinberger NM, 1998, NEUROBIOL LEARN MEM, V70, P226, DOI 10.1006/nlme.1998.3850; WEINBERGER NM, 1993, P NATL ACAD SCI USA, V90, P2394, DOI 10.1073/pnas.90.6.2394; WEINBERGER NM, 1990, CONCEPTS NEUROSCIENC, V1, P91; WOZNIAK DF, 1989, NEUROBIOL AGING, V10, P173, DOI 10.1016/0197-4580(89)90027-4; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Yan J, 2001, NEUROREPORT, V12, P3313, DOI 10.1097/00001756-200110290-00033; Yan J, 2002, EUR J NEUROSCI, V16, P119, DOI 10.1046/j.1460-9568.2002.02046.x; Yan J, 1996, SCIENCE, V273, P1100, DOI 10.1126/science.273.5278.1100; Yan W, 1998, NAT NEUROSCI, V1, P54, DOI 10.1038/255; Zhang YF, 1997, NATURE, V387, P900, DOI 10.1038/43180; Zhang YF, 2000, J NEUROPHYSIOL, V84, P325, DOI 10.1152/jn.2000.84.1.325; Zhou XM, 2000, J NEUROPHYSIOL, V84, P3083, DOI 10.1152/jn.2000.84.6.3083	48	156	163	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					9	18		10.1016/S0896-6273(02)00933-9	http://dx.doi.org/10.1016/S0896-6273(02)00933-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367501	Bronze			2022-12-28	WOS:000178295100004
J	Kotecha, SA; Oak, JN; Jackson, MF; Perez, Y; Orser, BA; Van Tol, HHM; MacDonald, JF				Kotecha, SA; Oak, JN; Jackson, MF; Perez, Y; Orser, BA; Van Tol, HHM; MacDonald, JF			A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission	NEURON			English	Article							LONG-TERM POTENTIATION; GROWTH-FACTOR RECEPTOR; PROTEIN-COUPLED RECEPTORS; CALCIUM-DEPENDENT INACTIVATION; SIGNAL-REGULATED KINASE; SYNAPTIC-TRANSMISSION; PREFRONTAL CORTEX; HIPPOCAMPAL-FORMATION; EGF RECEPTOR; RAT	Receptor tyrosine kinases (RTKs) are membrane spanning proteins with intrinsic kinase activity. Although these receptors are known to be involved in proliferation and differentiation of cells, their roles in regulating central synaptic transmission are largely unknown. In CA1 pyramidal neurons, activation of D2 class dopamine receptors depressed excitatory transmission mediated by the NMDA subtype of glutamate receptor. This depression resulted from the quinpirole-induced release of intracellular Ca2+ and enhanced Ca2+-dependent inactivation of NMDA receptors. The dopamine receptor-mediated depression was dependent on the "transactivation" of PDGFRbeta. Therefore, RTK transactivation provides a novel mechanism of communication between dopaminergic and glutamatergic systems and might help to explain how,reciprocal changes in these systems could be linked to the deficits in cognition, memory, and attention observed in schizophrenia and attention deficit hyperactivity disorder.	Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Fac Med, Dept Pharmacol, Toronto, ON, Canada; Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada; Univ Toronto, Fac Med, Dept Anesthesiol, Toronto, ON, Canada; Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; Univ Toronto, Fac Med, Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	MacDonald, JF (corresponding author), Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada.	j.macdonald@utoronto.ca	Jackson, Mike/H-5573-2012	Jackson, Mike/0000-0002-4730-201X	NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABE K, 1992, BRAIN RES, V587, P102, DOI 10.1016/0006-8993(92)91433-F; AMSTEN AF, 2000, NEUROPSYCHOPHARMACOL, V23, P405; Barkley RA, 1998, SCI AM, V279, P66, DOI 10.1038/scientificamerican0998-66; Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Calabresi P, 1997, J NEUROSCI, V17, P4536; Castro NG, 1999, BRIT J PHARMACOL, V126, P1847, DOI 10.1038/sj.bjp.0702479; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Defagot MC, 2000, J NEUROSCI RES, V59, P202, DOI 10.1002/(SICI)1097-4547(20000115)59:2<202::AID-JNR6>3.3.CO;2-X; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; DESCARRIES L, 1987, NEUROSCIENCE, V21, P807, DOI 10.1016/0306-4522(87)90038-8; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GASBARRI A, 1994, BRAIN RES, V668, P71, DOI 10.1016/0006-8993(94)90512-6; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; HARVEY J, 1993, NEUROSCI LETT, V162, P165, DOI 10.1016/0304-3940(93)90586-A; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Hsu KS, 1996, J NEUROPHYSIOL, V76, P1887, DOI 10.1152/jn.1996.76.3.1887; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; INGLESE J, 1994, P NATL ACAD SCI USA, V91, P3637, DOI 10.1073/pnas.91.9.3637; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kotecha SA, 1997, J COMP NEUROL, V386, P277; Krupp JJ, 1999, J NEUROSCI, V19, P1165; LAWTHO D, 1994, NEUROSCI RES, V21, P151, DOI 10.1016/0168-0102(94)90157-0; Lei SB, 1999, J BIOL CHEM, V274, P30617, DOI 10.1074/jbc.274.43.30617; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Lu WY, 2000, J NEUROSCI, V20, P4452, DOI 10.1523/JNEUROSCI.20-12-04452.2000; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lu WY, 1998, J PHYSIOL-LONDON, V512, P29, DOI 10.1111/j.1469-7793.1998.029bf.x; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MEADORWOODRUFF JH, 1994, NEUROPSYCHOPHARMACOL, V10, P239, DOI 10.1038/npp.1994.27; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Peavy RD, 2001, J NEUROSCI, V21, P9619, DOI 10.1523/JNEUROSCI.21-24-09619.2001; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; POPOV N, 1988, J HIRNFORSCH, V29, P473; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sawutz DG, 1996, BIOCHEM PHARMACOL, V51, P1631, DOI 10.1016/0006-2952(96)00112-8; Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; Snyder GL, 1998, J NEUROSCI, V18, P10297; Swanson J, 1998, CURR OPIN NEUROBIOL, V8, P263, DOI 10.1016/S0959-4388(98)80150-5; Todd RD, 2001, TRENDS PHARMACOL SCI, V22, P55, DOI 10.1016/S0165-6147(00)01612-6; Uchida S, 2000, NEUROPHARMACOLOGY, V39, P191, DOI 10.1016/S0028-3908(99)00111-2; Umemiya M, 1997, J NEUROPHYSIOL, V78, P1248, DOI 10.1152/jn.1997.78.3.1248; Valenzuela CF, 1997, BRAIN RES REV, V24, P77; Valenzuela CF, 1996, J BIOL CHEM, V271, P16151, DOI 10.1074/jbc.271.27.16151; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907; Weinberger DR, 1999, BIOL PSYCHIAT, V45, P395, DOI 10.1016/S0006-3223(98)00331-X; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zheng P, 1999, NEUROSCIENCE, V91, P527, DOI 10.1016/S0306-4522(98)00604-6	67	178	184	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1111	1122		10.1016/S0896-6273(02)00859-0	http://dx.doi.org/10.1016/S0896-6273(02)00859-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354400	Bronze			2022-12-28	WOS:000178040000011
J	Kim, AH; Yano, H; Cho, H; Meyer, D; Monks, B; Margolis, B; Birnbaum, MJ; Chao, MV				Kim, AH; Yano, H; Cho, H; Meyer, D; Monks, B; Margolis, B; Birnbaum, MJ; Chao, MV			Akt1 regulates a JNK scaffold during excitotoxic apoptosis	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; PROMOTES CELL-SURVIVAL; SIGNAL-TRANSDUCTION; FUNCTIONAL DOMAINS; GLUTAMATE; GROWTH; DEATH; PHOSPHORYLATION; TRANSCRIPTION	Cell survival is determined by a balance among signaling cascades, including those that recruit the Akt and JNK pathways. Here we describe a novel interaction between Akt1 and JNK interacting protein 1 (JIP1), a JNK pathway scaffold. Direct association between Akt1 and JIP1 was observed in primary neurons. Neuronal exposure to an excitotoxic stimulus decreased the Akt1 -JIP1 interaction and concomitantly increased association between JIP1 and JNK. Akt1 interaction with JIP1 inhibited JIP1-mediated potentiation of JNK activity by decreasing JIP1 binding to specific JNK pathway kinases. Consistent with this view, neurons from Akt1-deficient mice exhibited higher susceptibility to kainate than wild-type littermates. Overexpression of Akt1 mutants that bind JIP1 reduced excitotoxic apoptosis. These results suggest that Akt1 binding to JIP1 acts as a regulatory gate preventing JNK activation, which is released under conditions of excitotoxic injury.	NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Internal Med, Philadelphia, PA 19104 USA	New York University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Pennsylvania	Chao, MV (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA.	chao@saturn.med.nyu.edu	Kim, Albert H./HGF-0057-2022	Chao, Moses/0000-0002-6969-3744; Birnbaum, Morris/0000-0001-9972-8680	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA056490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072] Funding Source: NIH RePORTER; NCI NIH HHS [CA56490] Funding Source: Medline; NICHD NIH HHS [HD23315] Funding Source: Medline; NINDS NIH HHS [NS21072] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bock BC, 2000, J BIOL CHEM, V275, P14231, DOI 10.1074/jbc.275.19.14231; Bonny C, 1998, J BIOL CHEM, V273, P1843, DOI 10.1074/jbc.273.4.1843; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cerezo A, 1998, MOL BIOL CELL, V9, P3107, DOI 10.1091/mbc.9.11.3107; Cheng JK, 2000, MOL CELL BIOL, V20, P2334, DOI 10.1128/MCB.20.7.2334-2342.2000; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DeCoster MA, 1998, J NEUROSCI RES, V53, P297, DOI 10.1002/(SICI)1097-4547(19980801)53:3<297::AID-JNR3>3.0.CO;2-5; DEL PL, 1997, SCIENCE, V278, P687; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eilers A, 2001, J NEUROCHEM, V76, P1439, DOI 10.1046/j.1471-4159.2001.00150.x; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; FERKANY JW, 1984, NATURE, V308, P561, DOI 10.1038/308561a0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Harding TC, 2001, J BIOL CHEM, V276, P4531, DOI 10.1074/jbc.C000815200; Hetman M, 2000, J NEUROSCI, V20, P2567; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kerchner GA, 1999, HANDB EXP PHARM, V141, P443; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim AH, 2000, BRAIN RES, V886, P99, DOI 10.1016/S0006-8993(00)02944-9; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KOH JY, 1990, J NEUROSCI, V10, P693; Lawlor MA, 2001, J CELL SCI, V114, P2903; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; Negri S, 2000, GENOMICS, V64, P324, DOI 10.1006/geno.2000.6129; Nihalani D, 2000, J BIOL CHEM, V275, P7273, DOI 10.1074/jbc.275.10.7273; Okubo Y, 1998, J BIOL CHEM, V273, P25961, DOI 10.1074/jbc.273.40.25961; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Pellet JB, 2000, EUR J NEUROSCI, V12, P621, DOI 10.1046/j.1460-9568.2000.00945.x; POLLARD H, 1994, NEUROREPORT, V5, P1053, DOI 10.1097/00001756-199405000-00009; Rameau GA, 2000, NEUROPHARMACOLOGY, V39, P2255, DOI 10.1016/S0028-3908(00)00066-6; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Sarmiere PD, 2001, MOL CELL NEUROSCI, V18, P320, DOI 10.1006/mcne.2001.1021; Savinainen A, 2001, J BIOL CHEM, V276, P11382, DOI 10.1074/jbc.M100190200; SCHREIBER SS, 1993, J MOL NEUROSCI, V4, P149, DOI 10.1007/BF02782498; Schwarzschild MA, 1997, J NEUROSCI, V17, P3455; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	61	175	180	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					697	709		10.1016/S0896-6273(02)00821-8	http://dx.doi.org/10.1016/S0896-6273(02)00821-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194869	Bronze			2022-12-28	WOS:000177521000010
J	DiGregorio, DA; Nusser, Z; Silver, RA				DiGregorio, DA; Nusser, Z; Silver, RA			Spillover of glutamate onto synaptic AMPA receptors enhances fast transmission at a cerebellar synapse	NEURON			English	Article							BETA-HYDROXYASPARTATE DERIVATIVES; PURKINJE-CELL SYNAPSES; MULTIPLE RELEASE SITES; TIME-COURSE; GRANULE CELLS; NMDA RECEPTORS; CLIMBING FIBER; PARALLEL FIBER; RAT; CURRENTS	Diffusion of glutamate from the synaptic cleft can activate high-affinity receptors, but is not thought to contribute to fast AMPA receptor-mediated transmission. Here, we show that single AMPA receptor EPSCs at the cerebellar mossy fiber-granule cell connection are mediated by both direct release of glutamate and rapid diffusion of glutamate from neighboring synapses. Immunogold localization revealed that AMPA receptors are located exclusively in postsynaptic densities, indicating that spillover of glutamate occurs between synaptic contacts. Spillover currents contributed half the synaptic charge and exhibited little trial-to-trial variability. We propose that spillover of glutamate improves transmission efficacy by both increasing the amplitude and duration of the EPSP and reducing fluctuations arising from the probabilistic nature of transmitter release.	UCL, Dept Physiol, London WC1E 6BT, England; Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, H-1083 Budapest, Hungary	University of London; University College London; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk	Nusser, Zoltan/K-8587-2014	Silver, Robin/0000-0002-5480-6638; Nusser, Zoltan/0000-0001-7004-4111				Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Diamond JS, 1997, J NEUROSCI, V17, P4672; Eccles J.C., 1967, CEREBELLUM COMPUTATI; FABER DS, 1988, P NATL ACAD SCI USA, V85, P8708, DOI 10.1073/pnas.85.22.8708; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; Hausser M, 1997, J NEUROSCI, V17, P7606; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Matsubara A, 1996, J NEUROSCI, V16, P4457; MENNERICK S, 1995, J NEUROSCI, V15, P3178; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; NUSSER Z, 1995, EUR J NEUROSCI, V7, P630, DOI 10.1111/j.1460-9568.1995.tb00667.x; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Overstreet LS, 1999, J NEUROSCI, V19, P9663; Palay SL, 1974, CEREBELLAR CORTEX CO; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Rusakov DA, 2001, BIOPHYS J, V81, P1947, DOI 10.1016/S0006-3495(01)75846-8; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SHEPPARD GM, 1998, SYNAPTIC ORG BRAIN; Shigeri Y, 2001, J NEUROCHEM, V79, P297, DOI 10.1046/j.1471-4159.2001.00588.x; Shimamoto K, 2000, BIOORG MED CHEM LETT, V10, P2407, DOI 10.1016/S0960-894X(00)00487-X; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Smith TC, 1999, J PHYSIOL-LONDON, V517, P51, DOI 10.1111/j.1469-7793.1999.0051z.x; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; TYRRELL T, 1992, PHILOS T ROY SOC B, V336, P239, DOI 10.1098/rstb.1992.0059; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wahl LM, 1996, J NEUROPHYSIOL, V75, P597, DOI 10.1152/jn.1996.75.2.597; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; WILDING TJ, 1995, MOL PHARMACOL, V47, P582	56	177	178	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					521	533		10.1016/S0896-6273(02)00787-0	http://dx.doi.org/10.1016/S0896-6273(02)00787-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165473	Bronze			2022-12-28	WOS:000177331200012
J	Meng, YH; Zhang, Y; Tregoubov, V; Janus, C; Cruz, L; Jackson, M; Lu, WY; MacDonald, JF; Wang, JY; Falls, DL; Jial, ZP				Meng, YH; Zhang, Y; Tregoubov, V; Janus, C; Cruz, L; Jackson, M; Lu, WY; MacDonald, JF; Wang, JY; Falls, DL; Jial, ZP			Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice	NEURON			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE; SYNAPTIC-TRANSMISSION; COFILIN PHOSPHORYLATION; ZINC-FINGER; ACTIN CYTOSKELETON; DENDRITIC SPINES; CELL MOTILITY; ALPHA-ACTININ; PLASTICITY	In vitro studies indicate a role for the LIM kinase family in the regulation of cofilin phosphorylation and actin dynamics. In addition, abnormal expression of LIMK-1 is associated with Williams syndrome, a mental disorder with profound deficits in visuospatial cognition. However, the in vivo function of this family of kinases remains elusive. Using LIMK-1 knockout mice, we demonstrate a significant role for LIMK-1 in vivo in regulating cofilin and the actin cytoskeleton. Furthermore, we show that the knockout mice exhibited significant abnormalities in spine morphology and in synaptic function, including enhanced hippocampal long-term potentiation. The knockout mice also showed altered fear responses and spatial learning. These results indicate that LIMK-1 plays a critical role in dendritic spine morphogenesis and brain function.	Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Emory University	Jial, ZP (corresponding author), Hosp Sick Children, Program Brain & Behav, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jia@sickkids.ca	Lu, Wei-Yang/K-4404-2013; Jackson, Mike/H-5573-2012; Jia, zhengping/AAZ-4190-2021	Jackson, Mike/0000-0002-4730-201X; 				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Ehlers MD, 2002, TRENDS NEUROSCI, V25, P64, DOI 10.1016/S0166-2236(02)02061-1; FINCH DM, 1990, BRAIN RES, V518, P269, DOI 10.1016/0006-8993(90)90979-L; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; JANUS C, 1995, BEHAV PROCESS, V34, P129, DOI 10.1016/0376-6357(94)00060-T; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kim CH, 1999, J NEUROSCI, V19, P4314; Kirov SA, 1999, J NEUROSCI, V19, P2876; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Lian JP, 2000, J BIOL CHEM, V275, P2869, DOI 10.1074/jbc.275.4.2869; Lu YM, 1997, J NEUROSCI, V17, P5196; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MIZUNO K, 1994, ONCOGENE, V9, P1605; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Mori T, 1997, MOL BRAIN RES, V45, P247, DOI 10.1016/S0169-328X(96)00257-4; MORRIS R, 1996, HIPPOCAMPUS FUNCTION, P55; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PROSCHEL C, 1995, ONCOGENE, V11, P1271; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Smart FM, 2000, HIPPOCAMPUS, V10, P542, DOI 10.1002/1098-1063(2000)10:5<542::AID-HIPO4>3.3.CO;2-Z; Smolich B, 1997, J BIOCHEM-TOKYO, V121, P382; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Sumida J, 1998, VICTORIAN STUD, V42, P147, DOI 10.2979/VIC.1998.42.1.147; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Wang JY, 1998, J BIOL CHEM, V273, P20525, DOI 10.1074/jbc.273.32.20525; Wang JY, 2000, J COMP NEUROL, V416, P319, DOI 10.1002/(SICI)1096-9861(20000117)416:3<319::AID-CNE4>3.0.CO;2-Q; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	60	509	527	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					121	133		10.1016/S0896-6273(02)00758-4	http://dx.doi.org/10.1016/S0896-6273(02)00758-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123613	Bronze			2022-12-28	WOS:000176601800015
J	Muchowskil, PJ				Muchowskil, PJ			Protein misfolding, amyloid formation, and neurodegeneration: A critical role for molecular chaperones?	NEURON			English	Review							ALPHA-SYNUCLEIN; HUNTINGTONS-DISEASE; SUPPRESSION; DROSOPHILA; THERAPY; HSP70; NEUROPATHOLOGY; GENES; MODEL	The most conspicuous feature of many neurodegenerative disorders, including Alzheimer's, Parkinson's, and Huntington's disease, is the occurrence of protein aggregates in ordered fibrillar structures known as amyloid found inside and outside of brain cells. The appearance of aggregates in diseased brains implies an underlying incapacity in the cellular machinery of molecular chaperones that normally functions to prevent the accumulation of misfolded proteins. Here we review recent studies that have revealed a critical role for molecular chaperones in several neurodegenerative disorders.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Muchowskil, PJ (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.							Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bagatell R, 2001, CLIN CANCER RES, V7, P2076; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	23	235	244	1	29	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					9	12		10.1016/S0896-6273(02)00761-4	http://dx.doi.org/10.1016/S0896-6273(02)00761-4			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123602	Bronze			2022-12-28	WOS:000176601800004
J	Matise, M				Matise, M			A dorsal elaboration in the spinal cord	NEURON			English	Editorial Material							NERVOUS-SYSTEM; SPECIFICATION; FATES		UMDNJ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Program Physiol & Neurobiol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Matise, M (corresponding author), UMDNJ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Program Physiol & Neurobiol, 675 Hoes Lane, Piscataway, NJ 08854 USA.							ALTMAN J, 1984, ADV ANATOMY EMBRYOLO; ANDERSON DJ, 2001, CELL, V30, P19; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Sharma K, 2001, NEURON, V29, P321, DOI 10.1016/S0896-6273(01)00208-2	11	18	19	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					491	493		10.1016/S0896-6273(02)00710-9	http://dx.doi.org/10.1016/S0896-6273(02)00710-9			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062030	Bronze			2022-12-28	WOS:000175665700001
J	Garlow, SJ				Garlow, SJ			And now, transcriptomics	NEURON			English	Editorial Material							PRE-MESSENGER-RNA; 5-HT2C RECEPTOR; SUICIDE	In this issue of Neuron, Gurevich et al. (2002) report different patterns of 5-HT2C pre-mRNA editing in suicide victims, as compared to controls. Treatment of mice with fluoxetine alters the pattern of 5-HT2C transcript editing in the direction opposite that observed for suicide victims. The authors speculate on a possible serotonergic mechanism controlling 5-HT2C pre-mRNA editing.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	Emory University	Garlow, SJ (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 1639 Pierce Dr,Suite 4000, Atlanta, GA 30322 USA.							Berg KA, 2001, BRIT J PHARMACOL, V134, P386, DOI 10.1038/sj.bjp.0704255; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Herrick-Davis K, 1999, J NEUROCHEM, V73, P1711, DOI 10.1046/j.1471-4159.1999.731711.x; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Niswender CM, 1998, ANN NY ACAD SCI, V861, P38, DOI 10.1111/j.1749-6632.1998.tb10171.x; Niswender CM, 2001, NEUROPSYCHOPHARMACOL, V24, P478, DOI 10.1016/S0893-133X(00)00223-2; Price RD, 2000, MOL PHARMACOL, V58, P859, DOI 10.1124/mol.58.4.859; Reenan RA, 2001, TRENDS GENET, V17, P53, DOI 10.1016/S0168-9525(00)02169-7; Sodhi MS, 2001, MOL PSYCHIATR, V6, P373, DOI 10.1038/sj.mp.4000920; Wang QD, 2000, J NEUROCHEM, V74, P1290	11	6	6	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					327	328		10.1016/S0896-6273(02)00680-3	http://dx.doi.org/10.1016/S0896-6273(02)00680-3			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988161	Bronze			2022-12-28	WOS:000175214700001
J	Wemmie, JA; Chen, JG; Askwith, CC; Hruska-Hageman, AM; Price, MP; Nolan, BC; Yoder, PG; Lamani, E; Hoshi, T; Freeman, JH; Welsh, MJ				Wemmie, JA; Chen, JG; Askwith, CC; Hruska-Hageman, AM; Price, MP; Nolan, BC; Yoder, PG; Lamani, E; Hoshi, T; Freeman, JH; Welsh, MJ			The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory	NEURON			English	Article							MAMMALIAN DEGENERIN MDEG; LONG-TERM POTENTIATION; GATED NA+ CHANNEL; NEUROPEPTIDE-FF; PURKINJE-CELLS; CEREBELLAR LTD; NMDA; RECEPTOR; PH; BRAIN	Many central neurons possess large acid-activated currents, yet their molecular identity is unknown. We found that eliminating the acid sensing ion channel (ASIC) abolished H+-gated currents in hippocampal neurons. Neuronal H+-gated currents and transient acidification are proposed to play a role in synaptic transmission. Investigating this possibility, we found ASIC in hippocampus, in synaptosomes, and in dendrites localized at synapses. Moreover, loss of ASIC impaired hippocampal long-term potentiation. ASIC null mice had reduced excitatory postsynaptic potentials and NMDA receptor activation during high-frequency stimulation. Consistent with these findings, null mice displayed defective spatial learning and eye-blink conditioning. These results identify ASIC as a key component of acid-activated currents and implicate these currents in processes underlying synaptic plasticity, learning, and memory.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Peoples R China; Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Huazhong University of Science & Technology; University of Pennsylvania	Welsh, MJ (corresponding author), Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	mjwelsh@blue.weeg.uiowa.edu	Telch, Michael J/E-7027-2010	Welsh, Michael/0000-0002-1646-6206; Wemmie, John/0000-0001-7531-9065	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038890] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 14338, HL 64645] Funding Source: Medline; NIDDK NIH HHS [DK 25295] Funding Source: Medline; NIGMS NIH HHS [GM 57654] Funding Source: Medline; NINDS NIH HHS [NS 38890] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen L, 1996, J NEUROSCI, V16, P2829; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOI DW, 1987, J NEUROSCI, V7, P369; COTTRELL GA, 1992, EXP PHYSIOL, V77, P881, DOI 10.1113/expphysiol.1992.sp003655; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; During MJ, 2000, SCIENCE, V287, P1453, DOI 10.1126/science.287.5457.1453; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Freeman JH, 2000, J NEUROSCI, V20, P813, DOI 10.1523/JNEUROSCI.20-02-00813.2000; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; GOTTFRIED JA, 1994, J PHYSIOL-LONDON, V478, P373, DOI 10.1113/jphysiol.1994.sp020258; GRUOL DL, 1980, BRAIN RES, V183, P247, DOI 10.1016/0006-8993(80)90138-9; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; HUANG YY, 1987, NEUROSCIENCE, V22, P9, DOI 10.1016/0306-4522(87)90193-X; KAVALIERS M, 1993, NEUROSCI LETT, V157, P75, DOI 10.1016/0304-3940(93)90646-3; Kleschevnikov AM, 2001, HIPPOCAMPUS, V11, P168, DOI 10.1002/hipo.1034; KRISHTAL OA, 1981, NEUROSCI LETT, V24, P243, DOI 10.1016/0304-3940(81)90164-6; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MULLER WE, 1994, LIFE SCI, V55, P2147, DOI 10.1016/0024-3205(94)00395-5; OBRENOVITCH TP, 1988, J CEREBR BLOOD F MET, V8, P866, DOI 10.1038/jcbfm.1988.144; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Saybasili H, 1998, BRAIN RES, V786, P128, DOI 10.1016/S0006-8993(97)01461-3; Schehr RS, 1996, NAT BIOTECHNOL, V14, P1549, DOI 10.1038/nbt1196-1549; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Thompson RF, 1996, P NATL ACAD SCI USA, V93, P13438, DOI 10.1073/pnas.93.24.13438; Traynelis SF, 2001, NEURON, V32, P960, DOI 10.1016/S0896-6273(01)00549-9; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Varming T, 1999, NEUROPHARMACOLOGY, V38, P1875, DOI 10.1016/S0028-3908(99)00079-9; VYKLICKY L, 1990, J PHYSIOL-LONDON, V430, P497, DOI 10.1113/jphysiol.1990.sp018304; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877	65	522	551	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					463	477		10.1016/S0896-6273(02)00661-X	http://dx.doi.org/10.1016/S0896-6273(02)00661-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988176	Bronze			2022-12-28	WOS:000175214700016
J	Doi, M; Iwasaki, K				Doi, M; Iwasaki, K			Regulation of retrograde signaling at neuromuscular junctions by the novel C2 domain protein AEX-1	NEURON			English	Article							ELEGANS NERVOUS-SYSTEM; CAENORHABDITIS-ELEGANS; SYNAPTIC TRANSMISSION; TRANSMITTER RELEASE; GENETIC-ANALYSIS; MUTANTS; G(Q)ALPHA; RECEPTOR; ENCODES; IDENTIFICATION	Retrograde signaling from postsynaptic cells to presynaptic neurons Is essential for regulation of synaptic development, maintenance, and plasticity. Here we report that the novel protein AEX-1 controls retrograde signaling at neuromuscular junctions in C. elegans. aex-1 mutants show neural defects including reduced presynaptic activity and abnormal localization of the synaptic vesicle fusion protein UNC-13. Muscle-specific AEX-1 expression rescues these defects but neuron-specific expression does not. AEX-1 has an UNC-13 homologous domain and appears to regulate exocytosis in muscles. This retrograde signaling requires prohormone-convertase function in muscles, suggesting that a peptide is the retrograde signal. This signal regulates synaptic vesicle release via the EGL-30 Gqalpha protein at presynaptic terminals.	AIST, Neurosci Res Inst, Mol Neurobiol Lab, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Iwasaki, K (corresponding author), AIST, Neurosci Res Inst, Mol Neurobiol Lab, Tsukuba, Ibaraki 3058566, Japan.		Doi, Motomichi/L-7438-2018	Doi, Motomichi/0000-0002-7837-3056				Bamber BA, 1999, J NEUROSCI, V19, P5348; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; CULLCANDY SG, 1978, NATURE, V271, P74, DOI 10.1038/271074a0; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; Epstein HF, 1995, METHODS CELL BIOL, V48; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Fleming JT, 1997, J NEUROSCI, V17, P5843; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; ITO Y, 1976, PROC R SOC SER B-BIO, V192, P475, DOI 10.1098/rspb.1976.0025; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; Iwasaki K, 2000, EMBO J, V19, P4806, DOI 10.1093/emboj/19.17.4806; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; LIU DWC, 1994, J NEUROSCI, V14, P1953; MADURO M, 1995, GENETICS, V141, P977; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mendel J, 1999, NEURON, V24, P287, DOI 10.1016/S0896-6273(00)80840-5; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; MOLENAAR PC, 1981, J NEUROCHEM, V37, P1081, DOI 10.1111/j.1471-4159.1981.tb04657.x; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; NGUYEN M, 1995, GENETICS, V140, P527; Nick TA, 2000, NAT NEUROSCI, V3, P142, DOI 10.1038/72082; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; OKKEMA PG, 1993, GENETICS, V135, P385; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Richards D, 1999, BRIT DENT J, V1, P3; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shiratsuchi T, 1998, BIOCHEM BIOPH RES CO, V251, P158, DOI 10.1006/bbrc.1998.9408; Thacker C, 2000, BIOESSAYS, V22, P545, DOI 10.1002/(SICI)1521-1878(200006)22:6&lt;545::AID-BIES7&gt;3.0.CO;2-F; THOMAS JH, 1990, GENETICS, V124, P855; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Zhao HJ, 2000, DEVELOPMENT, V127, P1253; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	42	66	76	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					249	259		10.1016/S0896-6273(01)00587-6	http://dx.doi.org/10.1016/S0896-6273(01)00587-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804572	Bronze			2022-12-28	WOS:000173387700012
J	Chao, MV; Bothwell, M				Chao, MV; Bothwell, M			Neurotrophins: To cleave or not to cleave	NEURON			English	Review							NERVE GROWTH-FACTOR; FACTOR PRECURSOR; HIGH-AFFINITY; RECEPTOR P75; DEATH; TRK; EXPRESSION; NEURONS; CELLS	The family of neurotrophic factors known as neurotrophins has yielded a series of surprises, both with regard to the broad extent of their functional roles and the remarkable complexity of their signaling mechanisms. The recent discovery that a neurotrophin precursor protein and its proteolytically processed products may differentially activate pro- and antiapoptotic cellular responses, through preferential activation of Trk or p75 receptors, promises to unveil yet another level of regulatory complexity.	NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med,Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med,Dept Physiol, New York, NY 10016 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med,Dept Neurosci, New York, NY 10016 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	New York University; New York University; New York University; University of Washington; University of Washington Seattle	Chao, MV (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med,Dept Cell Biol, New York, NY 10016 USA.			Bothwell, Mark/0000-0001-5423-2702; Chao, Moses/0000-0002-6969-3744				Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Dechant G, 1997, J NEUROSCI, V17, P5281; Dicou E, 1997, J CELL BIOL, V136, P389, DOI 10.1083/jcb.136.2.389; DONOVAN MJ, 1995, AM J PATHOL, V147, P309; EDWARDS RH, 1988, J BIOL CHEM, V263, P6810; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Frade JM, 1999, DEVELOPMENT, V126, P683; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; LEDESMA MD, 2000, EMBO REPORTS, V1, P477; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Majdan M, 1999, INT J DEV NEUROSCI, V17, P153, DOI 10.1016/S0736-5748(99)00016-7; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Reinshagen M, 2000, J NEUROCHEM, V74, P2127, DOI 10.1046/j.1471-4159.2000.0742127.x; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; SUTER U, 1991, EMBO J, V10, P2394; Yoon SO, 1998, J NEUROSCI, V18, P3273	22	225	233	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					9	12		10.1016/S0896-6273(01)00573-6	http://dx.doi.org/10.1016/S0896-6273(01)00573-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779474	Bronze			2022-12-28	WOS:000173106200005
J	Battelli, L; Cavanagh, P; Intriligator, J; Tramo, MJ; Henaff, MA; Michel, F; Barton, JJS				Battelli, L; Cavanagh, P; Intriligator, J; Tramo, MJ; Henaff, MA; Michel, F; Barton, JJS			Unilateral right parietal damage leads to bilateral deficit for high-level motion	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; FIRST-ORDER MOTION; BRAIN-DAMAGE; APPARENT MOTION; VISUAL EXTINCTION; SELECTIVE IMPAIRMENT; ATTENTIVE TRACKING; 2ND-ORDER MOTION; NEGLECT PATIENTS; SPATIAL NEGLECT	Patients with right parietal damage demonstrate a variety of attentional deficits in their left visual field contralateral to their lesion. We now report that patients with right lesions also show a severe loss in the perception of apparent motion in their "good" right visual field ipsilateral to their lesion. Three tests of attention were conducted, and losses were found only in the contralesional fields for a selective attention and a multiple object tracking task. Losses in apparent motion, however, were bilateral in all cases. The deficit in apparent motion in the parietal patients supports previous claims that this relatively effortless percept is mediated by attention. However, the bilateral deficit suggests that the disruption is due to a bilateral loss in the temporal resolution of attention to transient events that drive the apparent motion percept.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Beth Israel Deaconess Med Ctr, Dept Neurol & Opthalmol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; INSERM, U280, F-69008 Lyon, France	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm)	Battelli, L (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.		Barton, Jason JS/A-6362-2012		NEI NIH HHS [EY09258] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009258] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANSTIS SM, 1980, PHILOS T ROY SOC B, V290, P153, DOI 10.1098/rstb.1980.0088; ARGUIN M, 1994, BRAIN COGNITION, V24, P44, DOI 10.1006/brcg.1994.1003; Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Bellmann A, 2001, BRAIN, V124, P676, DOI 10.1093/brain/124.4.676; BLACK SE, 1990, J CLIN EXPT NEUROPSY, V12, P102; BOULTON JC, 1993, VISION RES, V33, P2013, DOI 10.1016/0042-6989(93)90024-Q; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; CAVANAGH P, 1990, J EXP PSYCHOL HUMAN, V16, P479, DOI 10.1037/0096-1523.16.3.479; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Cusack R, 2000, J COGNITIVE NEUROSCI, V12, P1056, DOI 10.1162/089892900563867; DAMASIO H, 1995, HUMAN BRAIN ANATOMY; DICK M, 1991, VISION RES, V31, P2025, DOI 10.1016/0042-6989(91)90197-D; Duncan J, 1999, J EXP PSYCHOL GEN, V128, P450, DOI 10.1037/0096-3445.128.4.450; Dupont P, 1997, CEREB CORTEX, V7, P283, DOI 10.1093/cercor/7.3.283; GREENLEE MW, 1995, J NEUROSCI, V15, P2287, DOI 10.1523/JNEUROSCI.15-03-02287.1995; Greenlee MW, 1997, J NEUROSCI, V17, P804; Harrington DL, 1998, J NEUROSCI, V18, P1085; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Husain M, 1997, NATURE, V385, P154, DOI 10.1038/385154a0; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; James W, 1890, PRINCIPLES PSYCHOL, V1; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Lu ZL, 1996, CURR DIR PSYCHOL SCI, V5, P44, DOI 10.1111/1467-8721.ep10772720; MATHER G, 1994, VISUAL DETECTION MOT; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; PASCUALLEONE A, 1994, NEUROLOGY, V44, P494, DOI 10.1212/WNL.44.3_Part_1.494; PLANT GT, 1993, BRAIN, V116, P1337, DOI 10.1093/brain/116.6.1337; POSNER MI, 1984, J NEUROSCI, V4, P1863; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; RAMACHANDRAN VS, 1983, VISION RES, V23, P1719, DOI 10.1016/0042-6989(83)90188-8; Reppas JB, 1997, NATURE, V388, P175, DOI 10.1038/40633; RIZZO M, 1995, BRAIN, V118, P1105, DOI 10.1093/brain/118.5.1105; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; ROBERTSON IH, 1999, ATTENTION SPACE ACTI, P297; Robertson L, 1997, J COGNITIVE NEUROSCI, V9, P295, DOI 10.1162/jocn.1997.9.3.295; Rorden C, 1997, NEUROPSYCHOLOGIA, V35, P421, DOI 10.1016/S0028-3932(96)00093-0; Seiffert AE, 1998, VISION RES, V38, P3569, DOI 10.1016/S0042-6989(98)00035-2; Seiffert AE, 1999, VISION RES, V39, P4172, DOI 10.1016/S0042-6989(99)00129-7; Shulman GL, 1999, J NEUROSCI, V19, P9480; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; SPINELLI D, 1992, NEUROPSYCHOLOGIA, V30, P393, DOI 10.1016/0028-3932(92)90112-Y; TERNUS J, 1938, SOURCE BOOK GESTALT; ULLMAN S, 1978, PERCEPTION, V7, P683, DOI 10.1068/p070683; Vaina LM, 1996, P ROY SOC B-BIOL SCI, V263, P1225, DOI 10.1098/rspb.1996.0180; Vaina LM, 1998, VISUAL NEUROSCI, V15, P333, DOI 10.1017/S0952523898152082; VAINA LM, 1990, VISUAL NEUROSCI, V5, P353, DOI 10.1017/S0952523800000444; VALLAR G, 1994, J NEUROL NEUROSUR PS, V57, P464, DOI 10.1136/jnnp.57.4.464; Vallar G, 1993, UNILATERAL NEGLECT C, P27; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; Vuilleumier PO, 2000, BRAIN, V123, P1263, DOI 10.1093/brain/123.6.1263; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; YANTIS S, 1993, J EXP PSYCHOL HUMAN, V19, P676, DOI 10.1037/0096-1523.19.3.676; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	62	137	140	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					985	995		10.1016/S0896-6273(01)00536-0	http://dx.doi.org/10.1016/S0896-6273(01)00536-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	504ZT	11754832	Bronze			2022-12-28	WOS:000172886800007
J	Keleman, K; Dickson, BJ				Keleman, K; Dickson, BJ			Short- and long-range repulsion by the Drosophila Unc5 netrin receptor	NEURON			English	Article							CONTROLLING TARGET SELECTION; PIONEER AXON MIGRATIONS; GROWTH CONE GUIDANCE; C-ELEGANS; COLORECTAL-CANCER; GENETIC-ANALYSIS; CNS MIDLINE; COMMISSURAL AXONS; TNF RECEPTOR; MOTOR AXONS	Netrins are bifunctional guidance molecules, attracting some axons and repelling others. They act through receptors of the DCC and UNCS families. DCC receptors have been implicated in both attraction and repulsion by Netrins. UNC5 receptors are required only for repulsion. In Drosophila, Netrins are expressed by midline cells of the CNS and by specific muscles in the periphery. They attract commissural and motor axons expressing the DCC family receptor Frazzled. Here we report the identification of the Drosophila Unc5 receptor, and show that it is a repulsive Netrin receptor likely to contribute to motor axon guidance. Ectopic expression of Unc5 on CNS axons can elicit either short- or long-range repulsion from the midline. Both short- and long-range repulsion require Netrin function, but only long-range repulsion requires Frazzled.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Gong QZ, 1999, DEVELOPMENT, V126, P1451; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; HOFMANN K, 1995, FEBS LETT, V371, P321, DOI 10.1016/0014-5793(95)00931-X; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; SONNENFELD MJ, 1994, MECH DEVELOP, V46, P3, DOI 10.1016/0925-4773(94)90033-7; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3	48	228	244	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					605	617		10.1016/S0896-6273(01)00505-0	http://dx.doi.org/10.1016/S0896-6273(01)00505-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719202	Bronze			2022-12-28	WOS:000172363900008
J	Harel, M; Kasher, R; Nicolas, A; Guss, JM; Balass, M; Fridkin, M; Smit, AB; Brejc, K; Sixma, TK; Katchalski-Katzir, E; Sussman, JL; Fuchs, S				Harel, M; Kasher, R; Nicolas, A; Guss, JM; Balass, M; Fridkin, M; Smit, AB; Brejc, K; Sixma, TK; Katchalski-Katzir, E; Sussman, JL; Fuchs, S			The binding site of acetylcholine receptor as visualized in the X-ray structure of a complex between alpha-bungarotoxin and a mimotope peptide	NEURON			English	Article							SYNTHETIC PEPTIDES; GAMMA-SUBUNIT; DELTA-SUBUNIT; MOLECULAR REPLACEMENT; NICOTINIC RECEPTOR; TORPEDO-MARMORATA; CRYSTAL-STRUCTURE; RESIDUES 173-204; EPSILON-SUBUNIT; SNAKE	We have determined the crystal structure at 1.8 Angstrom resolution of a complex of alpha -bungarotoxin with a high affinity 13-residue peptide that is homologous to the binding region of the alpha subunit of acetylcholine receptor. The peptide fits snugly to the toxin and adopts a beta hairpin conformation. The structures of the bound peptide and the homologous loop of acetylcholine binding protein, a soluble analog of the extracellular domain of acetylcholine receptor, are remarkably similar. Their superposition indicates that the toxin wraps around the receptor binding site loop, and in addition, binds tightly at the interface of two of the receptor subunits where it inserts a finger into the ligand binding site, thus blocking access to the acetylcholine binding site and explaining its strong antagonistic activity.	Weizmann Inst Sci, Dept Struct Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Vrije Universiteit Amsterdam; Netherlands Cancer Institute	Fuchs, S (corresponding author), Weizmann Inst Sci, Dept Struct Chem, IL-76100 Rehovot, Israel.	sara.fuchs@weizmann.ac.il	Guss, Jules Mitchell/N-1387-2019; Smit, August B/E-8410-2011; Guss, Jules M/B-1283-2009	Guss, Jules Mitchell/0000-0003-4259-6079; Brejc, Katjusa/0000-0002-4562-6109; Sussman, Joel/0000-0003-0306-3878; Sixma, Titia K/0000-0001-6180-0632				Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; ARONHEIM A, 1988, J BIOL CHEM, V263, P9933; Atherton E., 1990, SOLID PHASE PEPTIDE; Balass M, 1997, P NATL ACAD SCI USA, V94, P6054, DOI 10.1073/pnas.94.12.6054; BARCHAN D, 1995, BIOCHEMISTRY-US, V34, P9172, DOI 10.1021/bi00028a029; BARCHAN D, 1992, P NATL ACAD SCI USA, V89, P7717, DOI 10.1073/pnas.89.16.7717; BASUS VJ, 1993, BIOCHEMISTRY-US, V32, P12290, DOI 10.1021/bi00097a004; BETZEL C, 1991, J BIOL CHEM, V266, P21530; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; CONTITRONCONI BM, 1990, BIOCHEMISTRY-US, V29, P6221, DOI 10.1021/bi00478a016; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KACHALSKY SG, 1995, P NATL ACAD SCI USA, V92, P10801, DOI 10.1073/pnas.92.23.10801; KAO PN, 1984, J BIOL CHEM, V259, P1662; Karlin A, 1979, Adv Cytopharmacol, V3, P183; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kasher R, 2001, CHEM BIOL, V8, P147, DOI 10.1016/S1074-5521(00)90063-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee C Y, 1966, Mem Inst Butantan, V33, P555; LENTZ TL, 1995, BIOCHEMISTRY-US, V34, P1316, DOI 10.1021/bi00004a026; LOVE RA, 1986, PROTEIN ENG, V1, P37, DOI 10.1093/protein/1.1.37; Malany S, 2000, BIOCHEMISTRY-US, V39, P15388, DOI 10.1021/bi001825o; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; Michalet S, 2000, J BIOL CHEM, V275, P25608, DOI 10.1074/jbc.M002362200; MIKHAILOV AM, 1990, FEBS LETT, V269, P255, DOI 10.1016/0014-5793(90)81167-M; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEUMANN D, 1985, P NATL ACAD SCI USA, V82, P3490, DOI 10.1073/pnas.82.10.3490; NEUMANN D, 1986, P NATL ACAD SCI USA, V83, P3008, DOI 10.1073/pnas.83.9.3008; NEUMANN D, 1986, P NATL ACAD SCI USA, V83, P9250, DOI 10.1073/pnas.83.23.9250; NEUMANN D, 1989, P NATL ACAD SCI USA, V86, P7255, DOI 10.1073/pnas.86.18.7255; Osaka H, 2000, J BIOL CHEM, V275, P5478, DOI 10.1074/jbc.275.8.5478; Osaka H, 1999, J BIOL CHEM, V274, P9581, DOI 10.1074/jbc.274.14.9581; OSWALD RE, 1982, FEBS LETT, V139, P225, DOI 10.1016/0014-5793(82)80857-0; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; RALSTON S, 1987, BIOCHEMISTRY-US, V26, P3261, DOI 10.1021/bi00386a004; Samson AO, 2001, BIOCHEMISTRY-US, V40, P5464, DOI 10.1021/bi0022689; Scherf T, 1997, P NATL ACAD SCI USA, V94, P6059, DOI 10.1073/pnas.94.12.6059; Scherf T, 2001, P NATL ACAD SCI USA, V98, P6629, DOI 10.1073/pnas.111164298; Sine SM, 1997, J BIOL CHEM, V272, P23521, DOI 10.1074/jbc.272.38.23521; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; TZARTOS SJ, 1984, J BIOL CHEM, V259, P1512; UNGER R, 1989, PROTEINS, V5, P355, DOI 10.1002/prot.340050410; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WILSON PT, 1988, BIOCHEMISTRY-US, V27, P6667, DOI 10.1021/bi00418a004; WILSON PT, 1988, MOL PHARMACOL, V34, P643; WILSON PT, 1985, P NATL ACAD SCI USA, V82, P8790, DOI 10.1073/pnas.82.24.8790; Zeng HY, 2001, J BIOL CHEM, V276, P22930, DOI 10.1074/jbc.M102300200	53	111	113	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					265	275		10.1016/S0896-6273(01)00461-5	http://dx.doi.org/10.1016/S0896-6273(01)00461-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683996	Bronze			2022-12-28	WOS:000171893700011
J	Nairn, AC; Greengard, P				Nairn, AC; Greengard, P			A novel cyclin provides a link between dopamine and RNA processing	NEURON			English	Editorial Material							NUCLEAR	Regulation of gene expression by dopamine may play an, Important role in learning, reward, and addiction. Hyman and colleagues now report the characterization of, ania-6, a novel cyclin that associates with RNA polymerase II and is induced by dopamine or cocaine in the neostriatum. Ania-6 may thus provide a link between dopamine and gene expression at the level of mRNA processing.	Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10021 USA; Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	Rockefeller University; Yale University	Nairn, AC (corresponding author), Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10021 USA.			Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA010044] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ANDO K, 2000, IN PRESS J BIOL CHEM; Berke JD, 2001, NEURON, V32, P277, DOI 10.1016/S0896-6273(01)00465-2; Berke JD, 1998, J NEUROSCI, V18, P5301, DOI 10.1523/JNEUROSCI.18-14-05301.1998; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Chun HS, 2001, J NEUROCHEM, V76, P1010, DOI 10.1046/j.1471-4159.2001.00096.x; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hirose Y, 2000, GENE DEV, V14, P1415; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Misteli T, 2000, J CELL SCI, V113, P1841; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277	14	7	7	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					174	176		10.1016/S0896-6273(01)00469-X	http://dx.doi.org/10.1016/S0896-6273(01)00469-X			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683987	Bronze			2022-12-28	WOS:000171893700002
J	Nystuen, A; Legare, ME; Shultz, LD; Frankel, WN				Nystuen, A; Legare, ME; Shultz, LD; Frankel, WN			A null mutation in inositol polyphosphate 4-phosphatase type I causes selective neuronal loss in weeble mutant mice	NEURON			English	Article							1,4,5-TRISPHOSPHATE RECEPTOR; SIGNALING REACTIONS; PROTEIN; METABOLISM; EXPRESSION; ANTIGEN; CELLS; MOUSE; GENE; AKT	Weeble mutant mice have severe locomotor instability and significant neuronal loss in the cerebellum and in the hippocampal CA1 field. Genetic mapping was used to localize the mutation to the gene encoding inositol polyphosphate 4-phosphatase type I (Inpp4a), where a single nucleotide deletion results in a likely null allele. The substrates of INPP4A are intermediates in a pathway affecting intracellular Ca2+ release but are also involved in cell cycle regulation through binding the Akt protooncogene; dysfunction in either may account for the neuronal loss of weeble mice. Although other mutations in phosphoinositide enzymes are associated with synaptic defects without neuronal loss, weeble shows that Inpp4a is critical for the survival of a subset of neurons during postnatal development in mice.	Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Frankel, WN (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	wnf@jax.org			NATIONAL CANCER INSTITUTE [R01CA020408, P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031348, R01NS031348] Funding Source: NIH RePORTER; NCI NIH HHS [CA34196, CA20408] Funding Source: Medline; NINDS NIH HHS [NS31348] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acharya JK, 1998, NEURON, V20, P1219, DOI 10.1016/S0896-6273(00)80502-4; Altman J., 1996, RELATION ITS EVOLUTI; ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BANSAL VS, 1987, J BIOL CHEM, V262, P9444; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chi HB, 2000, MOL CELL BIOL, V20, P6496, DOI 10.1128/MCB.20.17.6496-6507.2000; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Feddersen RM, 1997, MOL CELL NEUROSCI, V9, P42, DOI 10.1006/mcne.1997.0601; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; KAUSHIK N, 1994, MAMM GENOME, V5, P688, DOI 10.1007/BF00426074; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; Majerus PW, 1996, GENE DEV, V10, P1051, DOI 10.1101/gad.10.9.1051; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Norris FA, 1997, J BIOL CHEM, V272, P23859, DOI 10.1074/jbc.272.38.23859; SCHWARTZKROIN PA, 1981, DEV BRAIN RES, V2, P469, DOI 10.1016/0165-3806(81)90017-1; SERESS L, 1988, DEV BRAIN RES, V44, P197, DOI 10.1016/0165-3806(88)90218-0; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Street VA, 1997, J NEUROSCI, V17, P635; Vyas P, 2000, P NATL ACAD SCI USA, V97, P13696, DOI 10.1073/pnas.250476397; Zhang XL, 1998, SEMIN CELL DEV BIOL, V9, P153, DOI 10.1006/scdb.1997.0220	31	70	73	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					203	212		10.1016/S0896-6273(01)00468-8	http://dx.doi.org/10.1016/S0896-6273(01)00468-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683991	Bronze			2022-12-28	WOS:000171893700006
J	Arshavsky, VY				Arshavsky, VY			Like night and day: Rods and cones have different pigment regeneration pathways	NEURON			English	Editorial Material							ADAPTATION; VERTEBRATE; RETINA; PHOTORECEPTORS; CELLS	Sustained vision requires continuous regeneration of visual pigments in rod and cone photoreceptors by the 11-cis-retinal chromophore. In this issue of Neuron, Mata et al. report a novel enzymatic pathway uniquely designed to keep up with the high demand for cone pigment regeneration in bright light and to preclude rods from utilizing chromophore produced in daylight, when rods are not very useful for vision.	Harvard Univ, Sch Med, Howe Labs Ophthalmol, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Arshavsky, VY (corresponding author), Harvard Univ, Sch Med, Howe Labs Ophthalmol, Boston, MA 02114 USA.							Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; GOLDSTEIN EB, 1973, VISION RES, V13, P527, DOI 10.1016/0042-6989(73)90022-9; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Osterberg G., 1935, ACTA OPHTHALMOL    S, V6, P1; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337	11	16	19	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					1	3		10.1016/S0896-6273(02)00937-6	http://dx.doi.org/10.1016/S0896-6273(02)00937-6			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367498	Bronze			2022-12-28	WOS:000178295100001
J	Song, W; Ranjan, R; Dawson-Scully, K; Bronk, P; Marin, L; Seroude, L; Lin, YJ; Nie, ZP; Atwood, HL; Benzer, S; Zinsmaier, KE				Song, W; Ranjan, R; Dawson-Scully, K; Bronk, P; Marin, L; Seroude, L; Lin, YJ; Nie, ZP; Atwood, HL; Benzer, S; Zinsmaier, KE			Presynaptic regulation of neurotransmission in Drosophila by the G protein-coupled receptor Methuselah	NEURON			English	Article							CYSTEINE-STRING PROTEIN; TRANSMITTER RELEASE; KINASE-C; CALCIUM SENSITIVITY; SYNAPTIC VESICLES; ALPHA-LATROTOXIN; LIFE-SPAN; EXOCYTOSIS; INHIBITION; MEMBRANE	Regulation of synaptic strength is essential for neuronal information processing, but the molecular mechanisms that control changes in neuroexocytosis are only partially known. Here we show that the putative G protein-coupled receptor Methuselah (Mth) is required in the presynaptic motor neuron to acutely upregulate neurotransmitter exocytosis at larval Drosophila NMJs. Mutations in the mth gene reduce evoked neurotransmitter release by similar to50%, and decrease synaptic area and the density of docked and clustered vesicles. Prebut not postsynaptic expression of normal Mth restored normal release in mth mutants. Conditional expression of Mth restored normal release and normal vesicle docking and clustering but not the reduced size of synaptic sites, suggesting that Mth acutely adjusts vesicle trafficking to synaptic sites.	Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Arizona; University of Pennsylvania; California Institute of Technology; University of Toronto	Zinsmaier, KE (corresponding author), Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA.	kez@neurobio.arizona.edu	Dawson-Scully, Ken/B-6438-2008; Gimenez, Luis E Diaz/D-9291-2011	Seroude, Laurent/0000-0002-4785-3890; Song, Wei/0000-0001-6531-8317	NEI NIH HHS [EY09278] Funding Source: Medline; NIA NIH HHS [AG16630] Funding Source: Medline; NINDS NIH HHS [R01NS38274] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016630] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Atwood H. L., 1997, Invertebrate Neuroscience, V3, P81, DOI 10.1007/BF02480362; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bahner M, 2000, J BIOL CHEM, V275, P2901, DOI 10.1074/jbc.275.4.2901; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bittner MA, 1998, J NEUROSCI, V18, P2914; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1993, J NEUROSCI, V13, P167; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; CHANG HG, 1994, J PHYSIOL-LONDON, V476, P1; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davletov BA, 1998, EMBO J, V17, P3909, DOI 10.1093/emboj/17.14.3909; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; FINKELSTEIN A, 1976, SCIENCE, V193, P1009, DOI 10.1126/science.948756; Gems D, 2000, GENETICS, V154, P1597; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gu GG, 1997, J NEUROBIOL, V33, P265, DOI 10.1002/(SICI)1097-4695(199709)33:3<265::AID-NEU5>3.0.CO;2-#; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KOENIG JH, 1993, J NEUROSCI, V13, P2313, DOI 10.1523/JNEUROSCI.13-06-02313.1993; KOENIG JH, 1989, J NEUROSCI, V9, P1937; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Koenig JH, 1998, P NATL ACAD SCI USA, V95, P12677, DOI 10.1073/pnas.95.21.12677; KURDYAK P, 1994, J COMP NEUROL, V350, P463, DOI 10.1002/cne.903500310; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; LITTLETON JT, 1994, GENETICS, V138, P111; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MILLER CA, 1983, P NATL ACAD SCI-BIOL, V80, P7641, DOI 10.1073/pnas.80.24.7641; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Ranjan R, 1998, J NEUROSCI, V18, P956; Renger JJ, 2000, J NEUROSCI, V20, P3980; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Stimson DT, 2001, J NEUROSCI, V21, P3034, DOI 10.1523/JNEUROSCI.21-09-03034.2001; Takahashi T, 2000, SCIENCE, V289, P460, DOI 10.1126/science.289.5478.460; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Wong K, 1999, J NEUROPHYSIOL, V82, P1497, DOI 10.1152/jn.1999.82.3.1497; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yuan LL, 1999, SCIENCE, V283, P1343, DOI 10.1126/science.283.5406.1343; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	70	52	57	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					105	119		10.1016/S0896-6273(02)00932-7	http://dx.doi.org/10.1016/S0896-6273(02)00932-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367510	Green Published, Bronze			2022-12-28	WOS:000178295100011
J	Zenisek, D; Steyer, JA; Feldman, ME; Almers, W				Zenisek, D; Steyer, JA; Feldman, ME; Almers, W			A membrane marker leaves synaptic vesicles in milliseconds after exocytosis in retinal bipolar cells	NEURON			English	Article							NEUROTRANSMITTER RELEASE; CAPACITANCE MEASUREMENTS; TRANSMITTER RELEASE; FAST ENDOCYTOSIS; FUSION PORE; KINETICS; RIBBON; KISS; FLUORESCENCE; TRANSPORT	Perhaps synaptic vesicles can recycle so rapidly because they avoid complete exocytosis, and release transmitter through a fusion pore that opens transiently. This view emerges from imaging whole terminals where the fluorescent lipid FM1-43 seems unable to leave vesicles during transmitter release. Here we imaged single, FM1-43-stained synaptic vesicles by evanescent field fluorescence microscopy, and tracked the escape of dye from single vesicles by watching the increase in fluorescence after exocytosis. Dye left rapidly and completely during most or all exocytic events. We conclude that vesicles at this terminal allow lipid exchange soon after exocytosis, and lose their dye even if they connected with the plasma membrane only briefly. At the level of single vesicles, therefore, observations with FM1-43 provide no evidence that exocytosis of synaptic vesicles is incomplete.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Calif Berkeley, Dept Biol, Berkeley, CA 94720 USA; Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Oregon Health & Science University; University of California System; University of California Berkeley; Cornell University; Yale University	Almers, W (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA.	almersw@ohsu.edu	Zenisek, David/C-6555-2011; 李, 应辉/A-7739-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060600] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60600] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Axelrod D, 2001, J BIOMED OPT, V6, P6, DOI 10.1117/1.1335689; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BLOOM JA, 1983, BIOPHYS J, V42, P295, DOI 10.1016/S0006-3495(83)84397-5; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Crank J., 1970, MATH DIFFUSION; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; GINGELL D, 1979, BIOPHYS J, V26, P507, DOI 10.1016/S0006-3495(79)85268-6; Gomis A, 1999, J NEUROSCI, V19, P6309; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEIDELBERGER R, 1992, J PHYSL, V207, P623; HELLEN EH, 1988, SPECTROSCOPIC MEMBRA, P47; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; Henkel AW, 1995, J NEUROSCI, V15, P8246; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JACOBSON K, 1981, BIOCHEMISTRY-US, V20, P5268, DOI 10.1021/bi00521a027; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kavalali ET, 1999, PHILOS T ROY SOC B, V354, P337, DOI 10.1098/rstb.1999.0385; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; MELDOLESI J, 1981, PHILOS T ROY SOC B, V296, P55, DOI 10.1098/rstb.1981.0171; Mennerick S, 1997, J NEUROPHYSIOL, V78, P51, DOI 10.1152/jn.1997.78.1.51; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rouze NC, 1998, J NEUROSCI, V18, P8614; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Sund SE, 1999, BIOPHYS J, V77, P2266, DOI 10.1016/S0006-3495(99)77066-9; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; TORRITARELLI F, 1985, J CELL BIOL, V101, P1386, DOI 10.1083/jcb.101.4.1386; TSE FW, 1993, J CELL BIOL, V121, P543, DOI 10.1083/jcb.121.3.543; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; VALTORTA F, 1990, NEUROSCIENCE, V35, P477, DOI 10.1016/0306-4522(90)90323-V; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	59	148	151	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1085	1097		10.1016/S0896-6273(02)00896-6	http://dx.doi.org/10.1016/S0896-6273(02)00896-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354398	Bronze			2022-12-28	WOS:000178040000009
J	Dockendorff, TC; Su, HS; McBride, SMJ; Yang, ZH; Choi, CH; Siwicki, KK; Sehgal, A; Jongens, TA				Dockendorff, TC; Su, HS; McBride, SMJ; Yang, ZH; Choi, CH; Siwicki, KK; Sehgal, A; Jongens, TA			Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest	NEURON			English	Article							LONG-TERM-MEMORY; MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; BEHAVIORAL RHYTHMS; LOCOMOTOR-ACTIVITY; MUSHROOM BODIES; NERVOUS-SYSTEM; RNA-BINDING; KINASE-A; GENE	Fragile X mental retardation is a prominent genetic disorder caused by the lack of the FMR1 gene product, a known RNA binding protein. Specific physiologic pathways regulated by FMR1 function have yet to be identified. Adult dfmr1 (also called dfxr) mutant flies display arrhythmic circadian activity and have erratic patterns of locomotor activity, whereas overexpression of dFMR1 leads to a lengthened period. dfmr1 mutant males also display reduced courtship activity which appears to result from their inability to maintain courtship interest. Molecular analysis fails to reveal any defects in the expression of clock components; however, the CREB output is affected. Morphological analysis of neurons required for normal circadian behavior reveals subtle abnormalities, suggesting that defects in axonal pathfinding or synapse formation may cause the observed behavioral defects.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; Swarthmore College	Jongens, TA (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	jongens@mail.med.upenn.edu						ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Backes M, 2000, AM J MED GENET, V95, P150; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; BAKKER CE, 1994, CELL, V78, P23; BALLINGER DG, 1988, P NATL ACAD SCI USA, V85, P3960, DOI 10.1073/pnas.85.11.3960; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; de Vries BBA, 1998, J MED GENET, V35, P579, DOI 10.1136/jmg.35.7.579; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Faulkner DL, 1998, DEV GENET, V23, P264, DOI 10.1002/(SICI)1520-6408(1998)23:4<264::AID-DVG2>3.0.CO;2-6; Feng Y, 1997, J NEUROSCI, V17, P1539; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Gould EL, 2000, AM J MED GENET, V95, P307; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; HAGERMAN RJ, 1996, FRAGILE X SYNDROME D, P3; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Majercak J, 1997, MOL CELL BIOL, V17, P5915, DOI 10.1128/MCB.17.10.5915; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; Martin JR, 1998, LEARN MEMORY, V5, P179; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Orgad S, 2000, GENETICS, V155, P1267; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; REISCHMANN T, 1995, S AFR J GEOL, V1, P1; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	56	228	235	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					973	984		10.1016/S0896-6273(02)00724-9	http://dx.doi.org/10.1016/S0896-6273(02)00724-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086644	Bronze			2022-12-28	WOS:000176249700014
J	Del Negro, CA; Morgado-Valle, C; Feldman, JL				Del Negro, CA; Morgado-Valle, C; Feldman, JL			Respiratory rhythm: An emergent network property?	NEURON			English	Article							PRE-BOTZINGER COMPLEX; NEUROPROTECTIVE AGENT RILUZOLE; STEM IN-VITRO; PATCH-CLAMP RECORDINGS; CHICK SENSORY NEURONS; PREBOTZINGER COMPLEX; PACEMAKER NEURONS; NEONATAL-RAT; NEWBORN RATS; SYNAPTIC TRANSMISSION	We tested the hypothesis that pacemaker neurons generate breathing rhythm in mammals. We monitored respiratory-related motor nerve rhythm in neonatal rodent slice preparations. Blockade of the persistent sodium current (I(NaP)), which was postulated to underlie voltage-dependent bursting in respiratory pacemaker neurons, with riluzole (less than or equal to200 muM) did not alter the frequency of respiratory-related motor output. Yet, in every pacemaker neuron recorded (50/50), bursting was abolished at much lower concentrations of riluzole (less than or equal to520 muM). Thus, eliminating the pacemaker population (our statistics confirm that this population is reduced at least 94%, p < 0.05) does not affect respiratory rhythm. These results suggest that voltage-dependent bursting in pacemaker neurons is not essential for respiratory rhythmogenesis, which may instead be an emergent network property.	Univ Calif Los Angeles, Dept Neurobiol, Syst Neurobiol Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Del Negro, CA (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Syst Neurobiol Lab, Box 95-1763, Los Angeles, CA 90095 USA.	delnegro@ucla.edu	Del Negro, Christopher A./AAB-4565-2020; Del Negro, Ciro/K-3451-2013; feldman, jack/AAO-7505-2021; Morgado-Valle, Consuelo/G-6109-2019	Del Negro, Christopher A./0000-0002-7848-8224; feldman, jack/0000-0003-3692-9412; Morgado-Valle, Consuelo/0000-0003-0158-7096	NHLBI NIH HHS [HL-40959, R01 HL040959] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040959] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baker RE, 1995, INT J DEV NEUROSCI, V13, P799, DOI 10.1016/0736-5748(95)00081-X; Ballanyi K, 1999, PROG NEUROBIOL, V59, P583, DOI 10.1016/S0301-0082(99)00009-X; Brockhaus J, 1998, EUR J NEUROSCI, V10, P3823, DOI 10.1046/j.1460-9568.1998.00396.x; Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; Butera RJ, 1999, J NEUROPHYSIOL, V82, P382, DOI 10.1152/jn.1999.82.1.382; CHERAMY A, 1992, NEUROSCI LETT, V147, P209, DOI 10.1016/0304-3940(92)90597-Z; DEBONO MW, 1993, EUR J PHARMACOL, V235, P283, DOI 10.1016/0014-2999(93)90147-A; Del Negro CA, 2001, J NEUROPHYSIOL, V86, P59, DOI 10.1152/jn.2001.86.1.59; Duprat F, 2000, MOL PHARMACOL, V57, P906; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FELDMAN JL, 1989, ANN NY ACAD SCI, V563, P114, DOI 10.1111/j.1749-6632.1989.tb42194.x; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; Ge Q, 1998, J PHYSIOL-LONDON, V509, P255, DOI 10.1111/j.1469-7793.1998.255bo.x; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Huang CS, 1997, J PHARMACOL EXP THER, V282, P1280; Inoue S., 1997, VIDEO MICROSCOPY FUN; Jehle T, 2000, BRIT J PHARMACOL, V130, P1227, DOI 10.1038/sj.bjp.0703424; JOHNSON SM, 1994, J NEUROPHYSIOL, V72, P2598, DOI 10.1152/jn.1994.72.6.2598; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; MARTIN D, 1993, EUR J PHARMACOL, V250, P473, DOI 10.1016/0014-2999(93)90037-I; MIZOULE J, 1985, NEUROPHARMACOLOGY, V24, P767, DOI 10.1016/0028-3908(85)90011-5; ONIMARU H, 1990, PFLUG ARCH EUR J PHY, V417, P425, DOI 10.1007/BF00370663; Onimaru H, 1997, JPN J PHYSIOL, V47, P385, DOI 10.2170/jjphysiol.47.385; ONIMARU H, 1989, EXP BRAIN RES, V76, P530, DOI 10.1007/BF00248909; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Rekling JC, 1997, J NEUROPHYSIOL, V78, P2483, DOI 10.1152/jn.1997.78.5.2483; Rekling JC, 1996, J NEUROPHYSIOL, V75, P795, DOI 10.1152/jn.1996.75.2.795; Rekling JC, 1997, J NEUROPHYSIOL, V78, P3508, DOI 10.1152/jn.1997.78.6.3508; Rekling JC, 2000, J NEUROSCI, V20, part. no.; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Ritter B, 2000, EUR J NEUROSCI, V12, P2975, DOI 10.1046/j.1460-9568.2000.00152.x; Rybak IA, 2001, ADV EXP MED BIOL, V499, P159; Shao XM, 1997, J NEUROPHYSIOL, V77, P1853, DOI 10.1152/jn.1997.77.4.1853; Siniscalchi A, 1997, BRIT J PHARMACOL, V120, P225, DOI 10.1038/sj.bjp.0700905; Smith JC, 2000, RESP PHYSIOL, V122, P131, DOI 10.1016/S0034-5687(00)00155-9; SMITH JC, 1992, NEUROSCI LETT, V134, P153, DOI 10.1016/0304-3940(92)90504-Z; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SMITH JC, 1997, NEURONS NETWORKS MOT, P97; Song JH, 1997, J PHARMACOL EXP THER, V282, P707; Stefani A, 1997, EXP NEUROL, V147, P115, DOI 10.1006/exnr.1997.6554; Thoby-Brisson M, 2001, J NEUROPHYSIOL, V86, P104, DOI 10.1152/jn.2001.86.1.104; Umemiya M, 1995, BRIT J PHARMACOL, V116, P3227, DOI 10.1111/j.1476-5381.1995.tb15128.x; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169; Xu L, 2001, J PHARMACOL EXP THER, V299, P227	49	187	187	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					821	830		10.1016/S0896-6273(02)00712-2	http://dx.doi.org/10.1016/S0896-6273(02)00712-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062027	Bronze			2022-12-28	WOS:000175951800015
J	Gau, D; Lemberger, T; von Gall, C; Kretz, O; Minh, NL; Gass, P; Schmid, W; Schibler, U; Korf, HW; Schutz, G				Gau, D; Lemberger, T; von Gall, C; Kretz, O; Minh, NL; Gass, P; Schmid, W; Schibler, U; Korf, HW; Schutz, G			Phosphorylation of CREB Ser142 regulates light-induced phase shifts of the circadian clock	NEURON			English	Article								Biological rhythms are driven in mammals by a central circadian clock located in the suprachiasmatic nucleus (SCN). Light-induced phase shifting of this clock is correlated with phosphorylation of CREB at Ser133 in the SCN. Here, we characterize phosphorylation of CREB at Ser142 and describe its contribution to the entrainment of the clock. In the SCN, light and glutamate strongly induce CREB Ser142 phosphorylation. To determine the physiological relevance of phosphorylation at Ser142, we generated a mouse mutant, CREBS142A, lacking this phosphorylation site. Light-induced phase shifts of locomotion and expression of c-Fos and mPer1 in the SCN are significantly attenuated in CREBS142A mutants. Our findings provide genetic evidence that CREB Ser142 phosphorylation is involved in the entrainment of the mammalian clock and reveal a novel phosphorylation-dependent regulation of CREB activity.	German Canc Res Ctr, Div Mol Biol Cell 1, D-69120 Heidelberg, Germany; Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Zent Inst Seel Gesundheit, D-68159 Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Geneva; Central Institute of Mental Health	Schutz, G (corresponding author), German Canc Res Ctr, Div Mol Biol Cell 1, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Lemberger, Thomas/A-7301-2008; Von+Gall, Charlotte/AAJ-2160-2021; Korf, Horst/ACX-9860-2022	Lemberger, Thomas/0000-0002-2499-4025; Von+Gall, Charlotte/0000-0002-5088-3118; Korf, Horst/0000-0002-5051-0303; Kretz, Oliver/0000-0003-1152-5956					0	203	208	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					245	252		10.1016/S0896-6273(02)00656-6	http://dx.doi.org/10.1016/S0896-6273(02)00656-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970866	Bronze			2022-12-28	WOS:000174976200010
J	Hanley, JG; Khatri, L; Hanson, PI; Ziff, EB				Hanley, JG; Khatri, L; Hanson, PI; Ziff, EB			NSF ATPase and alpha-/beta-SNAPs disassemble the AMPA receptor-PICK1 complex	NEURON			English	Article							SENSITIVE FUSION PROTEIN; DOMAIN-CONTAINING PROTEIN; PDZ DOMAIN; SYNAPTIC TRANSMISSION; MEMBRANE-FUSION; CRYSTAL-STRUCTURE; C-TERMINUS; IN-VITRO; GLUR2; BINDING	AMPA receptor (AMPAR) trafficking is crucial for synaptic plasticity that may be important for learning and memory. NSF and PICK1 bind the AMPAR GluR2 subunit and are involved in trafficking of AMPARs. Here, we show that GluR2, PICK1, NSF, and alpha-/beta-SNAPs form a complex in the presence of ATPgammaS. Similar to SNARE complex disassembly, NSF ATPase activity disrupts PICK1-GluR2 interactions in this complex. alpha-and beta-SNAP have differential effects on this reaction. SNAP overexpression in hippocampal neurons leads to corresponding changes in AMPAR trafficking by acting on GluR2-PICK1 complexes. This demonstrates that the previously reported synaptic stabilization of AMPARs by NSF involves disruption of GluR2-PICK1 interactions. Furthermore, we are reporting a non-SNARE substrate for NSF disassembly activity.	NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; New York University; Washington University (WUSTL)	Ziff, EB (corresponding author), NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA.		Hanson, Phyllis/E-9420-2012	Ziff, Edward/0000-0001-7389-8649; Hanley, Jonathan/0000-0003-1704-4707	NATIONAL INSTITUTE ON AGING [R01AG013620, R37AG013620] Funding Source: NIH RePORTER; NIA NIH HHS [AG 13620] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chung HJ, 2000, J NEUROSCI, V20, P7258; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; May AP, 1999, NAT CELL BIOL, V1, P175, DOI 10.1038/11097; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Sudlow AW, 1996, FEBS LETT, V393, P185, DOI 10.1016/0014-5793(96)00880-0; Takeya R, 2000, BIOCHEM BIOPH RES CO, V267, P149, DOI 10.1006/bbrc.1999.1932; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	46	150	163	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					53	67		10.1016/S0896-6273(02)00638-4	http://dx.doi.org/10.1016/S0896-6273(02)00638-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931741	Bronze			2022-12-28	WOS:000174695100009
J	Mansvelder, HD; Keath, JR; McGehee, DS				Mansvelder, HD; Keath, JR; McGehee, DS			Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas	NEURON			English	Article							VENTRAL TEGMENTAL AREA; INDUCED DOPAMINE RELEASE; RAT HIPPOCAMPAL INTERNEURONS; FREELY MOVING RATS; ACETYLCHOLINE-RECEPTORS; NUCLEUS-ACCUMBENS; SUBSTANTIA-NIGRA; GABAERGIC NEURONS; CA1 INTERNEURONS; GABA RELEASE	A single nicotine exposure increases dopamine levels in the mesolimbic reward system for hours, but nicotine concentrations experienced by smokers desensitize nAChRs on dopamine neurons in seconds to minutes. Here, we show that persistent modulation of both GABAergic and glutamatergic synaptic transmission by nicotine can contribute to the sustained increase in dopamine neuron excitability. Nicotine enhances GABAergic transmission transiently, which is followed by a persistent depression of these inhibitory inputs due to nAChR desensitization. Simultaneously, nicotine enhances glutamatergic transmission through nAChRs that desensitize less than those on GABA neurons. The net effect is a shift toward excitation of the dopamine reward system. These results suggest that spatial and temporal differences in nicotinic receptor activity on both excitatory and inhibitory neurons in reward areas coordinate to reinforce nicotine self-administration.	Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	McGehee, DS (corresponding author), Univ Chicago, Dept Anesthesia & Crit Care, 5841 S Maryland Ave,MC 4028, Chicago, IL 60637 USA.		Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340	NIDA NIH HHS [DA07255] Funding Source: Medline; NINDS NIH HHS [NS35090] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007255] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alkondon M, 2000, NEUROPHARMACOLOGY, V39, P2726, DOI 10.1016/S0028-3908(00)00156-8; Alkondon M, 2000, J NEUROSCI, V20, P66, DOI 10.1523/JNEUROSCI.20-01-00066.2000; Alkondon M, 1999, J NEUROSCI, V19, P2693; Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396; ALKONDON M, 1992, MOL PHARMACOL, V41, P802; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; Blaha CD, 1996, J NEUROSCI, V16, P714; Bonci A, 1999, J NEUROSCI, V19, P3723; Camara AL, 1997, NEUROTOXICOLOGY, V18, P589; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Charpantier E, 1998, NEUROREPORT, V9, P3097, DOI 10.1097/00001756-199809140-00033; CORRIGALL WA, 1994, BRAIN RES, V653, P278, DOI 10.1016/0006-8993(94)90401-4; Corringer PJ, 1998, J NEUROSCI, V18, P648; Court JA, 1998, NEUROSCIENCE, V87, P63, DOI 10.1016/S0306-4522(98)00088-8; Dani JA, 2000, EUR J PHARMACOL, V393, P31, DOI 10.1016/S0014-2999(00)00003-0; David V, 1997, PSYCHOPHARMACOLOGY, V130, P85, DOI 10.1007/s002130050214; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DiFranza JR, 2000, TOB CONTROL, V9, P313, DOI 10.1136/tc.9.3.313; FELDBERG W, 1945, PHYSIOL REV, V25, P596, DOI 10.1152/physrev.1945.25.4.596; Fenster CP, 1997, J NEUROSCI, V17, P5747; Fiorillo CD, 2000, J NEUROSCI, V20, P7855; Fisher JL, 1998, J PHYSIOLOGY-PARIS, V92, P209, DOI 10.1016/S0928-4257(98)80012-0; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Garzon M, 1999, J COMP NEUROL, V410, P197, DOI 10.1002/(SICI)1096-9861(19990726)410:2<197::AID-CNE3>3.0.CO;2-D; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Grottick AJ, 2000, J PHARMACOL EXP THER, V294, P1112; Hamid S, 1997, NEUROSCI RES, V29, P81, DOI 10.1016/S0168-0102(97)00074-6; Hefft S, 1999, J PHYSIOL-LONDON, V515, P769, DOI 10.1111/j.1469-7793.1999.769ab.x; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Ikemoto S, 1997, BEHAV NEUROSCI, V111, P369, DOI 10.1037/0735-7044.111.2.369; Ikemoto S, 1997, J NEUROCHEM, V69, P137, DOI 10.1046/j.1471-4159.1997.69010137.x; IMPERATO A, 1986, EUR J PHARMACOL, V132, P337, DOI 10.1016/0014-2999(86)90629-1; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; KALIVAS PW, 1993, NEUROSCIENCE, V57, P1047, DOI 10.1016/0306-4522(93)90048-K; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Lena C, 1997, J NEUROSCI, V17, P576; LENA C, 1993, J NEUROSCI, V13, P2680, DOI 10.1523/JNEUROSCI.13-06-02680.1993; Lu Y, 1999, J PHARMACOL EXP THER, V291, P1127; LUETJE CW, 1990, FASEB J, V4, P2753, DOI 10.1096/fasebj.4.10.2197155; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; McQuiston AR, 1999, J NEUROSCI, V19, P2887; MERCURI NB, 1995, EUR J NEUROSCI, V7, P462, DOI 10.1111/j.1460-9568.1995.tb00342.x; NISELL M, 1994, SYNAPSE, V16, P36, DOI 10.1002/syn.890160105; OAKMAN SA, 1995, J NEUROSCI, V15, P5859; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Schilstrom B, 1998, NEUROSCIENCE, V85, P1005, DOI 10.1016/S0306-4522(98)00114-6; Schilstrom B, 1998, NEUROSCIENCE, V82, P781; SEGUELA P, 1993, J NEUROSCI, V13, P596; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; WALAAS I, 1980, NEUROSCIENCE, V5, P63, DOI 10.1016/0306-4522(80)90071-8; Westerink BHC, 1996, J NEUROSCI, V16, P2605; World Health Organisation, 1999, COMB TOB EP; Yin RY, 2000, BRAIN RES BULL, V51, P507, DOI 10.1016/S0361-9230(00)00237-9	68	536	552	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					905	919		10.1016/S0896-6273(02)00625-6	http://dx.doi.org/10.1016/S0896-6273(02)00625-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906697	Bronze			2022-12-28	WOS:000174389600008
J	Rosenbaum, T; Gordon, SE				Rosenbaum, T; Gordon, SE			Dissecting intersubunit contacts in cyclic nucleotide-gated ion channels	NEURON			English	Article							ACTIVATION; MODULATION; MOVEMENT; RESIDUE; DOMAINS; SITE	In cyclic nucleotide-gated (CNG) ion channels, binding of cGMP or cAMP drives a conformational change that leads to opening of an ion-conducting pore. One region implicated in the coupling of ligand binding to opening of the pore is the C linker region. Here, we used crosslinking of endogenous cysteines to study interregion proximity. We demonstrate that an individual amino acid-C481-in the C linker region of each of two neighboring subunits can form a disulfide bond. Further, using tandem dimers, we show that a disulfide bond between C35 in the N-terminal region and C481 in the C linker region can form either within a subunit or between subunits. From our data on proximity between individual amino acids and previous studies, a picture emerges of the C linker as a potential dimerization interface.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gordon, SE (corresponding author), Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.	seg@u.washington.edu		Rosenbaum, Tamara/0000-0002-4791-3195	NATIONAL EYE INSTITUTE [R01EY013007, P30EY001730] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY13007, EY01730] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Armstrong N, 1999, PROTEIN SCI, V8, P1475, DOI 10.1110/ps.8.7.1475; Bonigk W, 1999, J NEUROSCI, V19, P5332; Broillet MC, 2000, J BIOL CHEM, V275, P15135, DOI 10.1074/jbc.275.20.15135; Brown RL, 2000, BIOCHEMISTRY-US, V39, P432, DOI 10.1021/bi9920735; Brown RL, 1998, BIOPHYS J, V75, P825, DOI 10.1016/S0006-3495(98)77571-X; GORDON SE, 1992, NEURON, V9, P739, DOI 10.1016/0896-6273(92)90036-D; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GORDON SE, 1995, NEURON, V14, P177; Hilgemann DW, 1998, METHOD ENZYMOL, V293, P267; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Matulef K, 1999, BIOPHYS J, V76, pA337; Molokanova E, 1997, J NEUROSCI, V17, P9068; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Richards MJ, 2000, BIOCHEMISTRY-US, V39, P14003, DOI 10.1021/bi001639i; Ruiz M, 1999, J GEN PHYSIOL, V113, P873, DOI 10.1085/jgp.113.6.873; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3	26	35	36	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					703	713		10.1016/S0896-6273(02)00599-8	http://dx.doi.org/10.1016/S0896-6273(02)00599-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879648	Bronze			2022-12-28	WOS:000174286200007
J	Huguenard, JR				Huguenard, JR			Sodium channels: Grit, determination, and persistence	NEURON			English	Editorial Material							HIPPOCAMPAL-NEURONS; PHENYTOIN; INHIBITION; INVITRO	Persistent sodium channel activity modulates neuronal gain in a neurotransmitter-dependent fashion. Previous studies have suggested that persistent and spike-related sodium channel activities are mediated by separate species. In this issue of Neuron, Taddese and Bean (2002) show that a single channel population is sufficient to explain both gating behaviors. A simple allosteric model is provided that can explain the results.	Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA	Stanford University	Huguenard, JR (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.		Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191				Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.ph.58.030196.002025; Hammarstrom AKM, 1998, J PHYSIOL-LONDON, V510, P735, DOI 10.1111/j.1469-7793.1998.735bj.x; HOTSON JR, 1979, J NEUROPHYSIOL, V42, P889, DOI 10.1152/jn.1979.42.3.889; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; KUO CC, 1994, MOL PHARMACOL, V46, P716; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; Mittmann T, 1998, J NEUROPHYSIOL, V79, P1579, DOI 10.1152/jn.1998.79.3.1579; Pierson P, 2001, EUR J NEUROSCI, V14, P957, DOI 10.1046/j.0953-816x.2001.01718.x; QUANDT FN, 1988, MOL PHARMACOL, V34, P557; Segal MM, 1997, J NEUROPHYSIOL, V77, P3021, DOI 10.1152/jn.1997.77.6.3021; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3	12	6	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					492	494		10.1016/S0896-6273(02)00592-5	http://dx.doi.org/10.1016/S0896-6273(02)00592-5			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856523	Bronze			2022-12-28	WOS:000173911100003
J	Chang, KT; Berg, DK				Chang, KT; Berg, DK			Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons	NEURON			English	Article							ACETYLCHOLINE-RECEPTORS; TYROSINE-HYDROXYLASE; ALPHA-BUNGAROTOXIN; CALCIUM CHANNELS; OKADAIC ACID; C-FOS; PROTEIN; CA2+; TRANSCRIPTION; CIRCUITS	Synaptic activation of the transcription factor CREB and downstream gene expression usually depend on calcium influx aided by voltage-gated calcium channels. We find that nicotinic signaling, in contrast, activates CREB and gene expression in ciliary ganglion neurons both in culture and in situ only if voltage-gated channels are silent. The nicotinic response requires calcium influx and release from internal stores and acts through CaMK and MAPK pathways to sustain activated CREB. Voltage-gated channels mobilize CaMK to activate CREB initially, but they also enable calcineurin and PP1 to terminate the activation before transcription is affected. L-type voltage-gated channels dominate the outcome and block the effects of nicotinic signaling on transcription. This demonstrates a novel aspect of activity-dependent gene regulation.	Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Berg, DK (corresponding author), Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012601, R01NS035469] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35469, NS12601] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberini CM, 1999, J EXP BIOL, V202, P2887; ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Bansal A, 2000, J NEUROSCI, V20, P7672; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Blumenthal EM, 1999, J NEUROPHYSIOL, V81, P111, DOI 10.1152/jn.1999.81.1.111; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; CHALAZONITIS A, 1980, J PHYSIOL-LONDON, V300, P525, DOI 10.1113/jphysiol.1980.sp013177; Chang KT, 1999, J NEUROSCI, V19, P3701; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; CORRIVEAU RA, 1993, J NEUROSCI, V13, P2662, DOI 10.1523/JNEUROSCI.13-06-02662.1993; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; FAUCONBIGUET N, 1989, NEUROSCI LETT, V104, P189; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Greenberg ME, 2001, SYNAPSES, P357; Gueorguiev VD, 2000, J NEUROCHEM, V75, P1997, DOI 10.1046/j.1471-4159.2000.0751997.x; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Lein ES, 2000, J NEUROSCI, V20, P1470; Lena C, 1997, CURR OPIN NEUROBIOL, V7, P674, DOI 10.1016/S0959-4388(97)80088-8; Levin ED, 1999, BEHAV PHARMACOL, V10, P675, DOI 10.1097/00008877-199911000-00014; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu YW, 1999, J GASTROINTEST SURG, V3, P82, DOI 10.1016/S1091-255X(99)80013-4; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Milner LD, 1999, J NEUROSCI, V19, P3007; Nagao M, 1995, MUTAT RES-FUND MOL M, V333, P173, DOI 10.1016/0027-5107(95)00143-3; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; PELTOHUIKKO M, 1995, J NEUROSCI, V15, P1854, DOI 10.1523/JNEUROSCI.15-03-01854.1995; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Salminen O, 1999, J NEUROSCI, V19, P8145; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; Shoop RD, 2001, J NEUROSCI, V21, P771, DOI 10.1523/JNEUROSCI.21-03-00771.2001; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Svoboda K, 1999, NEURON, V22, P427, DOI 10.1016/S0896-6273(00)80698-4; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Zhang ZW, 1996, NEURON, V17, P1231, DOI 10.1016/S0896-6273(00)80253-6	51	134	136	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					855	865		10.1016/S0896-6273(01)00516-5	http://dx.doi.org/10.1016/S0896-6273(01)00516-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738031	Bronze			2022-12-28	WOS:000172700700012
J	MacDermott, AB				MacDermott, AB			Glutamate and GABA: A painful combination	NEURON			English	Editorial Material							SPINAL DORSAL HORN; RAT; NEURONS; RECEPTORS; GLYCINE; CORD		Columbia Univ, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	MacDermott, AB (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.							Chery N, 2000, J NEUROPHYSIOL, V84, P1006, DOI 10.1152/jn.2000.84.2.1006; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Iyadomi M, 2000, PAIN, V85, P385, DOI 10.1016/S0304-3959(99)00285-7; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Robertson SJ, 2001, CURR OPIN NEUROBIOL, V11, P378, DOI 10.1016/S0959-4388(00)00222-1; SCHNEIDER SP, 1988, J NEUROSCI, V8, P2062; SPIKE RC, 1992, J COMP NEUROL, V323, P359, DOI 10.1002/cne.903230305; Todd AJ, 1996, EUR J NEUROSCI, V8, P2492, DOI 10.1111/j.1460-9568.1996.tb01543.x; TODD AJ, 1993, PROG NEUROBIOL, V41, P609, DOI 10.1016/0301-0082(93)90045-T; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312	12	6	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					376	378		10.1016/S0896-6273(01)00494-9	http://dx.doi.org/10.1016/S0896-6273(01)00494-9			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709147	Bronze			2022-12-28	WOS:000172119100002
J	Macaluso, E; Frith, CD; Driver, J				Macaluso, E; Frith, CD; Driver, J			Crossmodal spatial influences of touch on extrastriate visual areas take current gaze direction into account	NEURON			English	Article							POSITRON-EMISSION-TOMOGRAPHY; POSTERIOR PARIETAL CORTEX; MODAL LINKS; MINDS EYE; ATTENTION; VISION; NEURONS; SPACE; MOVEMENTS; BRAIN	Recent results indicate that crossmodal interactions can affect activity in cortical regions traditionally regarded as "unimodal." Previously we found that combining touch on one hand with visual stimulation in the anatomically corresponding hemifield could boost responses in contralateral visual cortex. Here we manipulated which visual hemifield corresponded to the location of the stimulated hand, by changing gaze direction such that right-hand touch could now arise in either the left or right visual field. Crossmodal effects on visual cortex switched from one hemisphere to the other, depending on gaze direction, regardless of whether the hand was seen. This indicates that crossmodal influences of touch upon visual cortex depend on spatial alignment for the multimodal stimuli, with gaze posture taken into account.	UCL, Inst Cognit Neurosci, London, England; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Macaluso, E (corresponding author), UCL, Inst Cognit Neurosci, London, England.	e.macaluso@fil.ion.ucl.ac.uk	Frith, Chris D/A-2171-2009; Driver, Jon/A-4779-2010; Macaluso, Emiliano/H-3139-2017; Macaluso, Emiliano/AAE-9185-2019	Frith, Chris D/0000-0002-8665-0690; Macaluso, Emiliano/0000-0002-1919-5288; Macaluso, Emiliano/0000-0002-1919-5288				Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Bertelson P, 2000, PERCEPT PSYCHOPHYS, V62, P321, DOI 10.3758/BF03205552; Bremmer F, 2001, NEUROIMAGE, V14, pS46, DOI 10.1006/nimg.2001.0817; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BURTON H, 1993, SOMATOSENS MOT RES, V10, P297, DOI 10.3109/08990229309028839; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Driver J, 1998, CURR OPIN NEUROBIOL, V8, P245, DOI 10.1016/S0959-4388(98)80147-5; Driver J, 1998, TRENDS COGN SCI, V2, P254, DOI 10.1016/S1364-6613(98)01188-7; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Eimer M, 2000, PSYCHOPHYSIOLOGY, V37, P697, DOI 10.1111/1469-8986.3750697; Francis ST, 2000, NEUROIMAGE, V11, P188, DOI 10.1006/nimg.2000.0541; GALLETTI C, 1989, J NEUROSCI, V9, P1112; Graziano Michael S. A., 1995, P1021; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Henson R.N.A., 1999, NEUROIMAGE, V9, P125, DOI DOI 10.1016/J.NEUROIMAGE.2011.06.078; KAWASHIMA R, 1995, P NATL ACAD SCI USA, V92, P5969, DOI 10.1073/pnas.92.13.5969; Kennett S, 2001, J COGNITIVE NEUROSCI, V13, P462, DOI 10.1162/08989290152001899; Kinsbourne M, 1970, Trans Am Neurol Assoc, V95, P143; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Macaluso E, 2001, SCIENCE, V292; Macaluso E, 2001, NEUROPSYCHOLOGIA, V39, P1304, DOI 10.1016/S0028-3932(01)00119-1; Macaluso E, 2000, J NEUROPHYSIOL, V83, P3062, DOI 10.1152/jn.2000.83.5.3062; Massaro DW, 1999, TRENDS COGN SCI, V3, P310, DOI 10.1016/S1364-6613(99)01360-1; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; McDonald JJ, 2001, SCIENCE, V292; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P544, DOI 10.3758/BF03206045; Spence C, 2000, J EXP PSYCHOL HUMAN, V26, P1298, DOI 10.1037//0096-1523.26.4.1298; Stein BE., 1993, MERGING SENSES; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	43	73	75	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 16	2002	34	4					647	658		10.1016/S0896-6273(02)00678-5	http://dx.doi.org/10.1016/S0896-6273(02)00678-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062047	Bronze			2022-12-28	WOS:000175665700017
J	Aydar, E; Palmer, CP; Klyachko, VA; Jackson, MB				Aydar, E; Palmer, CP; Klyachko, VA; Jackson, MB			The sigma receptor as a ligand-regulated auxiliary potassium channel subunit	NEURON			English	Article							PITUITARY MELANOTROPE CELLS; GATED K+ CHANNELS; BETA-SUBUNIT; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; NERVE-TERMINALS; MODULATION; COEXPRESSION; SENSITIVITY; HALOPERIDOL	The sigma receptor is a novel protein that mediates the modulation of ion channels by psychotropic drugs through a unique transduction mechanism depending neither on G proteins nor protein phosphorylation. The present study investigated sigma receptor signal transduction by reconstituting responses in Xenopus oocytes. Sigma receptors modulated voltage-gated K+ channels (Kv1.4 or Kv1.5) in different ways in the presence and absence of ligands. Association between Kv1.4 channels and sigma receptors was demonstrated by coimmunoprecipitation. These results indicate a novel mechanism of signal transduction dependent on protein-protein interactions. Domain accessibility experiments suggested a structure for the sigma receptor with two cytoplasmic termini and two membrane-spanning segments. The ligand-independent effects on channels suggest that sigma receptors serve as auxiliary subunits to voltage-gated K+ channels with distinct functional interactions, depending on the presence or absence of ligand.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Bock Labs, Dept Mol Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jackson, MB (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.		Klyachko, Vitaly/E-9431-2012		NINDS NIH HHS [NS 30016] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030016, R37NS030016] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADELMAN JP, 1995, CURR OPIN NEUROBIOL, V5, P286, DOI 10.1016/0959-4388(95)80040-9; BIELEFELDT K, 1992, J PHYSIOL-LONDON, V458, P41, DOI 10.1113/jphysiol.1992.sp019405; Connor JX, 1998, J BIOL CHEM, V273, P28906, DOI 10.1074/jbc.273.44.28906; De Costa B.R., 1994, SIGMA RECEPTORS, P45; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Ishiguro H, 1998, NEUROSCI LETT, V257, P45, DOI 10.1016/S0304-3940(98)00797-6; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; KAHOUN JR, 1992, P NATL ACAD SCI USA, V89, P1393, DOI 10.1073/pnas.89.4.1393; Kekuda R, 1996, BIOCHEM BIOPH RES CO, V229, P553, DOI 10.1006/bbrc.1996.1842; KNAUS HG, 1994, J BIOL CHEM, V269, P23336; Leff P, 1997, TRENDS PHARMACOL SCI, V18, P355, DOI 10.1016/S0165-6147(97)90664-7; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Morin-Surun MP, 1999, P NATL ACAD SCI USA, V96, P8196, DOI 10.1073/pnas.96.14.8196; MORIO Y, 1994, BRAIN RES, V637, P190, DOI 10.1016/0006-8993(94)91232-7; PAJOR AM, 1992, AM J PHYSIOL, V263, pR489, DOI 10.1152/ajpregu.1992.263.3.R489; Perez-Garcia MT, 1999, J GEN PHYSIOL, V113, P897, DOI 10.1085/jgp.113.6.897; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; PRAGNELL M, 1990, NEURON, V4, P807, DOI 10.1016/0896-6273(90)90207-V; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Seth P, 1997, BIOCHEM BIOPH RES CO, V241, P535, DOI 10.1006/bbrc.1997.7840; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; Soriani O, 1998, J PHARMACOL EXP THER, V286, P163; Soriani O, 1999, J PHARMACOL EXP THER, V289, P321; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; SU TP, 1993, CRIT REV NEUROBIOL, V7, P187; Suessbrich H, 1997, BRIT J PHARMACOL, V120, P968, DOI 10.1038/sj.bjp.0700989; TSENGCRANK JCL, 1990, FEBS LETT, V268, P63, DOI 10.1016/0014-5793(90)80973-M; WALKER JM, 1993, ASPECTS SYNAPTIC TRA, P91; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Wilke RA, 1999, J BIOL CHEM, V274, P18387, DOI 10.1074/jbc.274.26.18387; Wilke RA, 1999, J PHYSIOL-LONDON, V517, P391, DOI 10.1111/j.1469-7793.1999.00391.x; Yamamoto H, 1999, FEBS LETT, V445, P19, DOI 10.1016/S0014-5793(99)00084-8; ZUKIN SR, 1979, P NATL ACAD SCI USA, V76, P5372, DOI 10.1073/pnas.76.10.5372; [No title captured]	42	323	337	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					399	410		10.1016/S0896-6273(02)00677-3	http://dx.doi.org/10.1016/S0896-6273(02)00677-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988171	Bronze			2022-12-28	WOS:000175214700011
J	Chung, S; Li, XR; Nelson, SB				Chung, S; Li, XR; Nelson, SB			Short-term depression at thalamocortical synapses contributes to rapid adaptation of cortical sensory responses in vivo	NEURON			English	Article							CAT VISUAL-CORTEX; UNDERLYING CONTRAST ADAPTATION; MEDIAL NUCLEUS VPM; RAT BARREL CORTEX; SOMATOSENSORY CORTEX; SYNAPTIC DEPRESSION; PYRAMIDAL NEURONS; SIMPLE CELLS; ORIENTATION SELECTIVITY; TEMPORAL INTERACTIONS	In vivo whole-cell recordings revealed that during repeated stimulation, synaptic responses to deflection of facial whiskers rapidly adapt. Extracellular recordings in the somatosensory thalamus revealed that part of the adaptation occurs subcortically, but because cortical adaptation is stronger and recovers more slowly, cortical mechanisms must also contribute. Trains of sensory stimuli that produce profound sensory adaptation did not alter intrinsic membrane properties, including resting membrane potential, input resistance, and current-evoked firing. Synaptic input evoked via intracortical stimulation was also unchanged; however, synaptic input from the somatosensory thalamus was depressed by sensory stimulation, and this depression recovered with a time course matching that of the recovery of sensory responsiveness. These data strongly suggest that synaptic depression of thalamic input to the cortex contributes to the dynamic regulation of neuronal sensitivity during rapid changes in sensory input.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Nelson, SB (corresponding author), Brandeis Univ, Dept Biol, Mailstop 008,415 South St, Waltham, MA 02454 USA.	nelson@brandeis.edu		Nelson, Sacha/0000-0002-0108-8599	NEI NIH HHS [EY 11116] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adorjan P, 1999, REV NEUROSCIENCE, V10, P181; Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2001, J NEUROPHYSIOL, V86, P354, DOI 10.1152/jn.2001.86.1.354; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Angulo MC, 1999, J NEUROSCI, V19, P1566; ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; ARMSTRONGJAMES M, 1991, J COMP NEUROL, V303, P211, DOI 10.1002/cne.903030204; BARLOW H, 1989, COMP NEUR S, P54; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brumberg JC, 1999, J NEUROPHYSIOL, V82, P1808, DOI 10.1152/jn.1999.82.4.1808; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CastroAlamancos MA, 1997, REV NEUROSCIENCE, V8, P95; CastroAlamancos MA, 1996, J NEUROSCI, V16, P2767; CastroAlamancos MA, 1996, SCIENCE, V272, P274, DOI 10.1126/science.272.5259.274; Chance FS, 1998, J NEUROSCI, V18, P4785; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; DEALY RS, 1974, J PHYSIOL-LONDON, V241, P261, DOI 10.1113/jphysiol.1974.sp010652; DEBRUYN EJ, 1986, BRAIN RES, V383, P339, DOI 10.1016/0006-8993(86)90036-3; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P233, DOI 10.1113/jphysiol.1985.sp015822; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FERSTER D, 1992, J NEUROSCI, V12, P1262; FINLAYSON PG, 1995, EXP BRAIN RES, V106, P145; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; GREENLEE MW, 1991, VISION RES, V31, P223, DOI 10.1016/0042-6989(91)90113-J; Hartings JA, 1998, J NEUROPHYSIOL, V80, P1016, DOI 10.1152/jn.1998.80.2.1016; HELLWEG FC, 1977, J NEUROPHYSIOL, V40, P463, DOI 10.1152/jn.1977.40.3.463; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUMPHREY GK, 1995, CURR BIOL, V5, P545, DOI 10.1016/S0960-9822(95)00107-2; MADDESS T, 1988, BIOL CYBERN, V59, P229, DOI 10.1007/BF00332911; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MORIN D, 1981, BRAIN RES, V205, P49, DOI 10.1016/0006-8993(81)90719-8; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NATHAN T, 1990, NEUROSCI LETT, V110, P309, DOI 10.1016/0304-3940(90)90865-7; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; NELSON SB, 1991, J NEUROSCI, V11, P344; NELSON SB, 1991, J NEUROSCI, V11, P369; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Reyes A, 1999, J NEUROSCI, V19, P3827; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Sheth BR, 1998, J NEUROPHYSIOL, V79, P464, DOI 10.1152/jn.1998.79.1.464; SHIPLEY MT, 1974, J NEUROPHYSIOL, V37, P73, DOI 10.1152/jn.1974.37.1.73; SHU ZJ, 1993, NATURE, V364, P721, DOI 10.1038/364721a0; SIMONS DJ, 1983, BRAIN RES, V276, P178, DOI 10.1016/0006-8993(83)90561-9; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Todorov EV, 1997, COMPUTATIONAL NEUROSCIENCE: TRENDS IN RESEARCH, 1997, P525; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varela JA, 1997, J NEUROSCI, V17, P7926; WAITE PME, 1973, J PHYSIOL-LONDON, V228, P541, DOI 10.1113/jphysiol.1973.sp010099; WELKER E, 1993, EUR J NEUROSCI, V5, P691, DOI 10.1111/j.1460-9568.1993.tb00534.x; Wilson DA, 1998, J NEUROPHYSIOL, V80, P998, DOI 10.1152/jn.1998.80.2.998; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	71	377	391	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					437	446		10.1016/S0896-6273(02)00659-1	http://dx.doi.org/10.1016/S0896-6273(02)00659-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988174	Bronze			2022-12-28	WOS:000175214700014
J	Culham, J				Culham, J			Dissociations within association cortex	NEURON			English	Editorial Material							ATTENTION; FMRI	The parietal lobes of nonhuman primates have been well characterized by single neuron recordings, yet clear partitioning of the human parietal lobes has not been clearly demonstrated. An elegant new fMRI study by Simon and colleagues (this issue of Neuron) suggests that parietal cortex does indeed contain dissociable subregions, each specialized for a particular visuomotor or cognitive function.	Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada	Western University (University of Western Ontario)	Culham, J (corresponding author), Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada.		Culham, Jody C./A-9863-2013	Culham, Jody C./0000-0003-0754-2999				Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; KRUBITZER L, 1995, TRENDS NEUROSCI, V18, P408, DOI 10.1016/0166-2236(95)93938-T; MINER AD, 1995, VISUAL BRAIN ACTRION; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7	12	4	4	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					318	320		10.1016/S0896-6273(02)00584-6	http://dx.doi.org/10.1016/S0896-6273(02)00584-6			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832220	Bronze			2022-12-28	WOS:000173643200003
J	Holthoff, K; Tsay, D; Yuste, R				Holthoff, K; Tsay, D; Yuste, R			Calcium dynamics of spines depend on their dendritic location	NEURON			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; PROPAGATING ACTION-POTENTIALS; POSTSYNAPTIC DENSITY; HIPPOCAMPAL SPINES; SINGLE SPINES; CA2+; RELEASE; KINASE; COMPARTMENTALIZATION; COINCIDENCE	Dendritic spines are morphologically and functionally heterogeneous. To understand this diversity, we use two-photon imaging of layer 5 neocortical pyramidal cells and measure action potential-evoked [Ca2+](i) transients in spines. Spine calcium kinetics are controlled by (i) the diameter of the parent dendrite, (ii) the length of the spine neck, and (iii) the strength of spine calcium pumps. These factors produce different calcium dynamics in spines from basal, proximal apical, and distal apical dendrites, differences that are more pronounced without exogenous buffers. In proximal and distal apical dendrites, different calcium dynamics correlate with different susceptibility to synaptic depression, and modifying calcium kinetics in spines changes the expression of long-term depression. Thus, the spine location apparently determines its calcium dynamics and synaptic plasticity. Our results highlight the precision in design of neocortical neurons.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Holthoff, K (corresponding author), Univ Munich, Inst Phys, Biedersteiner Str 29, D-80802 Munich, Germany.				NATIONAL EYE INSTITUTE [R01EY011787, R01EY013237] Funding Source: NIH RePORTER; NEI NIH HHS [EY11787, EY13237] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Berg H. C., 1982, RANDOM WALKS BIOL; CAJAL R, 1891, REV CIENC MED BARCL, V22, P1; CAJAL R, 1888, REV TRIM HISTOL NORM, V1, P1; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Conchello JA, 1998, J OPT SOC AM A, V15, P2609, DOI 10.1364/JOSAA.15.002609; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hille B., 1992, IONIC CHANNELS EXCIT; JONES EG, 1969, J CELL SCI, V5, P509; KOCH C, 1993, J NEUROSCI, V13, P413; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Korkotian E, 1998, EUR J NEUROSCI, V10, P2076, DOI 10.1046/j.1460-9568.1998.00219.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Majewska A, 2000, J NEUROSCI, V20, P1722; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Murthy VN, 2000, P NATL ACAD SCI USA, V97, P901, DOI 10.1073/pnas.97.2.901; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Shepherd GM, 1996, J NEUROPHYSIOL, V75, P2197, DOI 10.1152/jn.1996.75.6.2197; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tank DW, 1995, J NEUROSCI, V15, P7940; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Yuste R, 1999, J NEUROSCI, V19, P1976	49	94	94	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					425	437		10.1016/S0896-6273(02)00576-7	http://dx.doi.org/10.1016/S0896-6273(02)00576-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832229	Bronze			2022-12-28	WOS:000173643200012
J	Platt, ML				Platt, ML			Caudate clues to rewarding cues	NEURON			English	Editorial Material							DORSOLATERAL PREFRONTAL CORTEX; MACAQUE; NEURONS	Behavioral studies indicate that prior experience can influence discrimination of subsequent stimuli. The mechanisms responsible for highlighting a particular aspect of the stimulus, such as motion or color, as most relevant and thus deserving further scrutiny, however, remain poorly understood. In the current issue of Neuron, Lauwereyns et al. (2002) demonstrate that neurons in the caudate nucleus of the basal ganglia signal which dimension of a visual cue, either color or location, is associated with reward in an eye movement task. These findings raise the possibility that this structure participates in the reward-based control of visual attention.	Duke Univ, Med Ctr, Ctr Cognit Neurosci, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biol Anthropol & Anat, Durham, NC 27710 USA	Duke University; Duke University	Platt, ML (corresponding author), Duke Univ, Med Ctr, Ctr Cognit Neurosci, Dept Neurobiol, Durham, NC 27710 USA.							Ciaramitaro VM, 2001, VISION RES, V41, P57, DOI 10.1016/S0042-6989(00)00203-0; Dorris MC, 1998, J NEUROSCI, V18, P7015; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0	7	6	6	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					316	318		10.1016/S0896-6273(02)00579-2	http://dx.doi.org/10.1016/S0896-6273(02)00579-2			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832219	Bronze			2022-12-28	WOS:000173643200002
J	Stellwagen, D; Shatz, CJ				Stellwagen, D; Shatz, CJ			An instructive role for retinal waves in the development of retinogeniculate connectivity	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; DEVELOPING MAMMALIAN RETINA; NEURONAL-ACTIVITY; OCULAR DOMINANCE; GANGLION-CELLS; RETINOTECTAL PROJECTION; PRENATAL DEVELOPMENT; BURSTING ACTIVITY; VISUAL-CORTEX; FERRET	A central hypothesis of neural development is that patterned activity drives the refinement of initially imprecise connections. We have examined this hypothesis directly by altering the frequency of spontaneous waves of activity that sweep across the mammalian retina prior to vision. Activity levels were increased in vivo using agents that elevate cAMP. When one eye is made more active, its layer within the LGN is larger despite the other eye having normal levels of activity. Remarkably, when the frequency of retinal waves is Increased in both eyes, normally sized layers form. Because relative, rather than absolute, levels of activity between the eyes regulate the amount of LGN territory devoted to each eye, we conclude that activity acts instructively to guide binocular segregation during development.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	carla_shatz@hms.harvard.edu			NIGMS NIH HHS [GM0748] Funding Source: Medline; NIMH NIH HHS [MH48108] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Cramer KS, 1997, DEV BRAIN RES, V98, P287, DOI 10.1016/S0165-3806(96)00188-5; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; DUBIN MW, 1986, J NEUROSCI, V6, P1021; EISELE LE, 1988, J NEUROBIOL, V19, P395, DOI 10.1002/neu.480190502; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Hahm JO, 1999, J COMP NEUROL, V411, P327, DOI 10.1002/(SICI)1096-9861(19990823)411:2<327::AID-CNE12>3.0.CO;2-#; HENDERSON Z, 1988, J NEUROSCI, V8, P1194; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LAM K, 1982, DEV BRAIN RES, V3, P487, DOI 10.1016/0165-3806(82)90014-1; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MESULAM MM, 1978, J HISTOCHEM CYTOCHEM, V26, P106, DOI 10.1177/26.2.24068; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; POTTS RA, 1982, DEV BRAIN RES, V3, P481, DOI 10.1016/0165-3806(82)90013-X; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; SCHMIDT JT, 1993, J NEUROBIOL, V24, P384, DOI 10.1002/neu.480240310; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; Sernagor E, 1996, CURR BIOL, V6, P1503, DOI 10.1016/S0960-9822(96)00755-5; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Shen SL, 1999, NEURON, V23, P285, DOI 10.1016/S0896-6273(00)80780-1; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; STRYKER MP, 1983, J NEUROSCI, V3, P1943; TSAI SC, 1987, P NATL ACAD SCI USA, V84, P5139, DOI 10.1073/pnas.84.15.5139; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	43	256	259	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					357	367		10.1016/S0896-6273(02)00577-9	http://dx.doi.org/10.1016/S0896-6273(02)00577-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832224	Bronze			2022-12-28	WOS:000173643200007
J	Kalidas, S; Smith, DP				Kalidas, S; Smith, DP			Novel genomic cDNA hybrids produce effective RNA interference in adult Drosophila	NEURON			English	Article							GENETIC INTERFERENCE; EXPRESSION; POTENT	Drosophila melanogaster has been a premier genetic model system for nearly 100 years, yet lacks a simple method to disrupt gene expression. Here, we show genomic cDNA fusions predicted to form double-stranded RNA (dsRNA) following splicing, effectively silencing expression of target genes in adult transgenic animals. We targeted three Drosophila genes: lush, white, and dGqalpha. In each case, target gene expression is dramatically reduced, and the white RNAi phenotype is indistinguishable from a deletion mutant. This technique efficiently targets genes expressed in neurons, a tissue refractory to RNAi in C. elegans. These results demonstrate a simple strategy to knock out gene function in specific cells in living adult Drosophila that can be applied to define the biological function of hundreds of orphan genes and open reading frames.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Smith, DP (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dean.smith@utsouthwestern.edu			NIDCD NIH HHS [DC02539] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002539] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRAND AH, 1993, DEVELOPMENT, V118, P401; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furner IJ, 1998, GENETICS, V149, P651; Galindo K, 2001, GENETICS, V159, P1059; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; HAY BA, 1994, DEVELOPMENT, V120, P2121; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kim MS, 1998, GENETICS, V150, P711; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; Mackenzie SM, 2000, GENETICA, V108, P239, DOI 10.1023/A:1004115718597; Martinek S, 2000, GENETICS, V156, P1717; Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Pirrotta V, 1988, Biotechnology, V10, P437; Rong YS, 2001, GENETICS, V157, P1307; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; TALLURI S, 1995, P NATL ACAD SCI USA, V92, P11475, DOI 10.1073/pnas.92.25.11475; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	35	170	177	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					177	184		10.1016/S0896-6273(02)00560-3	http://dx.doi.org/10.1016/S0896-6273(02)00560-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804566	Bronze			2022-12-28	WOS:000173387700006
J	Whitford, KL; Marillat, V; Stein, E; Goodman, CS; Tessier-Lavigne, M; Chedotal, A; Ghosh, A				Whitford, KL; Marillat, V; Stein, E; Goodman, CS; Tessier-Lavigne, M; Chedotal, A; Ghosh, A			Regulation of cortical dendrite development by Slit-Robo interactions	NEURON			English	Article							REPULSIVE AXON GUIDANCE; EXTRACELLULAR PROTEIN; ADAPTER PROTEIN; OPPOSING ROLES; NERVOUS-SYSTEM; KINASE PAK1; GROWTH; ROUNDABOUT; DROSOPHILA; REPELLENT	Slit proteins have previously been shown to regulate axon guidance, branching, and neural migration. Here we report that, in addition to acting as a chemorepellant for cortical axons, Slit1 regulates dendritic development. Slit1 is expressed in the developing cortex, and exposure to Slit1 leads to increased dendritic growth and branching. Conversely, inhibition of Slit-Robo interactions by Robo-Fc fusion proteins or by a dominant-negative Robo attenuates dendritic branching. Stimulation of neurons transfected with a Met-Robo chimeric receptor with Hepatocyte growth factor leads to a robust induction of dendritic growth and branching, suggesting that Robo-mediated signaling is sufficient to induce dendritic remodeling. These experiments indicate that Slit-Robo interactions may exert a significant influence over the specification of cortical neuron morphology by regulating both axon guidance and dendritic patterning.	Johns Hopkins Univ, Dept Neurosci, Sch Med, Baltimore, MD 21205 USA; Hop La Pitie Salpetriere, INSERM, U106, F-75013 Paris, France; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Johns Hopkins University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Ghosh, A (corresponding author), Johns Hopkins Univ, Dept Neurosci, Sch Med, 725 N Wolfe St, Baltimore, MD 21205 USA.	aghosh@jhmi.edu	Stein, Elke/E-8107-2013; Chedotal, Alain/F-2750-2017	Stein, Elke/0000-0001-8965-5692; Chedotal, Alain/0000-0001-7577-3794	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039993] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39993] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Erskine L, 2000, J NEUROSCI, V20, P4975; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Metin C, 1997, DEVELOPMENT, V124, P5063; Niclou SP, 2000, J NEUROSCI, V20, P4962; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Richards LJ, 1997, J NEUROSCI, V17, P2445; Ringstedt T, 2000, J NEUROSCI, V20, P4983; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	39	215	223	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 3	2002	33	1					47	61		10.1016/S0896-6273(01)00566-9	http://dx.doi.org/10.1016/S0896-6273(01)00566-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779479	Bronze			2022-12-28	WOS:000173106200009
J	Pugh, EN				Pugh, EN			Rods are rods and cones cones, and (never) the twain shall meet	NEURON			English	Editorial Material							RETINAL ROD; DARK NOISE; PHOTORECEPTORS; PROTEIN		Univ Penn, Sch Med, FM Kirby Ctr, Dept Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania	Pugh, EN (corresponding author), Univ Penn, Sch Med, FM Kirby Ctr, Dept Ophthalmol, Philadelphia, PA 19104 USA.							BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; MEARS AJ, 2001, IN PRESS NAT GENET; MILLER JL, 1994, J GEN PHYSIOL, V104, P909, DOI 10.1085/jgp.104.5.909; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Rebrik TI, 1998, J GEN PHYSIOL, V112, P537, DOI 10.1085/jgp.112.5.537; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; YOKOYAMA R, 2000, HDB BIOL PHYSICS, V3, P257	12	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					375	376		10.1016/S0896-6273(01)00492-5	http://dx.doi.org/10.1016/S0896-6273(01)00492-5			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709146	Bronze			2022-12-28	WOS:000172119100001
J	Harris, KD; Hirase, H; Leinekugel, X; Henze, DA; Buzsaki, G				Harris, KD; Hirase, H; Leinekugel, X; Henze, DA; Buzsaki, G			Temporal interaction between single spikes and complex spike bursts in hippocampal pyramidal cells	NEURON			English	Article							SODIUM-CHANNEL INACTIVATION; RAT HIPPOCAMPUS; SYNAPTIC PLASTICITY; NEURONS INVITRO; CA1; SYNAPSES; POTENTIATION; GENERATION; INDUCTION; PATTERNS	Cortical pyramidal cells fire single spikes and complex spike bursts, However, neither the conditions necessary for triggering complex spikes, nor their computational function are well understood, CA1 pyramidal cell burst activity was examined in behaving rats. The fraction of bursts was not reliably higher in place field centers, but rather in places where discharge frequency was 6-7 Hz. Burst probability was lower and bursts were shorter after recent spiking activity than after prolonged periods of silence (100 ms-1 s). Burst initiation probability and burst length were correlated with extracellular spike amplitude and with intracellular action potential rising slope. We suggest that bursts may function as "conditional synchrony detectors," signaling strong afferent synchrony after neuronal silence, and that single spikes triggered by a weak input may suppress bursts evoked by a subsequent strong input.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Leinekugel, Xavier/F-4034-2014; Harris, Kenneth/B-3469-2009; Leinekugel, Xavier/ABD-8347-2021; Hirase, Hajime/A-3709-2012	Leinekugel, Xavier/0000-0003-2878-3791; Hirase, Hajime/0000-0003-3806-6905; Buzsaki, Gyorgy/0000-0002-3100-4800; Harris, Kenneth/0000-0002-5930-6456	NIMH NIH HHS [MH12403, MH54671] Funding Source: Medline; NINDS NIH HHS [NS34994] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREASEN M, 1995, J PHYSIOL-LONDON, V483, P421, DOI 10.1113/jphysiol.1995.sp020595; Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; BAIR W, 1994, J NEUROSCI, V14, P2870; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BUZSAKI G, 1981, EXP BRAIN RES, V43, P429; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; HENZE DA, 2001, IN PRESS NEUROSCIENC; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Jung HY, 1997, J NEUROSCI, V17, P6639; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Metzner W, 1998, J NEUROSCI, V18, P2283; Mickus T, 1999, ANN NY ACAD SCI, V868, P97, DOI 10.1111/j.1749-6632.1999.tb11280.x; MILES R, 1987, J PHYSIOL-LONDON, V388, P611, DOI 10.1113/jphysiol.1987.sp016634; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Su HL, 2001, J NEUROSCI, V21, P4173, DOI 10.1523/JNEUROSCI.21-12-04173.2001; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86	46	276	283	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					141	149		10.1016/S0896-6273(01)00447-0	http://dx.doi.org/10.1016/S0896-6273(01)00447-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604145	Bronze			2022-12-28	WOS:000171525200015
J	Phillips, GR; Huang, JK; Wang, Y; Tanaka, H; Shapiro, L; Zhang, WD; Shan, WS; Arndt, K; Frank, M; Gordon, RE; Gawinowicz, MA; Zhao, YM; Colman, DR				Phillips, GR; Huang, JK; Wang, Y; Tanaka, H; Shapiro, L; Zhang, WD; Shan, WS; Arndt, K; Frank, M; Gordon, RE; Gawinowicz, MA; Zhao, YM; Colman, DR			The presynaptic particle web: Ultrastructure, composition, dissolution, and reconstitution	NEURON			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; ACTIVE ZONES; NEUROTRANSMITTER RELEASE; POSTSYNAPTIC DENSITY; PROTEIN INTERACTIONS; HIPPOCAMPAL-NEURONS; CENTRAL SYNAPSES; N-CADHERIN; MEMBRANE; TRANSPORT	We report the purification of a presynaptic "particle web" consisting of similar to 50 nm pyramidally shaped particles interconnected by similar to 100 nm spaced fibrils. This is the "presynaptic grid" described in early EM studies. It is completely soluble above pH 8, but reconstitutes after dialysis against pH 6. Interestingly, reconstituted particles orient and bind PSDs asymmetrically. Mass spectrometry of purified web components reveals major proteins involved in the exocytosis of synaptic vesicles and in membrane retrieval. Our data support the idea that the CNS synaptic junction is organized by transmembrane adhesion molecules interlinked in the synaptic cleft, connected via their intracytoplasmic domains to the presynaptic web on one side and to the postsynaptic density on the other. The CNS synaptic junction may therefore be conceptualized as a complicated macromolecular scaffold that isostatically bridges two closely aligned plasma membranes.	CUNY Mt Sinai Sch Med, Dept Neurol, Corinne Goldsmith Dickinson Ctr Mutiple Sclerosis, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Program Struct Biol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; Columbia Univ, Howard Hughes Med Inst, Prot Chem Core Facil, New York, NY 10032 USA; Kratos Analyt Inc, Chestnut Ridge, NY 10977 USA; Osaka Univ, Sch Med, Dept Pharmacol, Suita, Osaka 565, Japan; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Columbia University; Howard Hughes Medical Institute; Osaka University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Colman, DR (corresponding author), CUNY Mt Sinai Sch Med, Dept Neurol, Corinne Goldsmith Dickinson Ctr Mutiple Sclerosis, 1 Gustave L Levy Pl, New York, NY 10029 USA.	david.colman@mssm.edu	Huang, Jeffrey K./AAH-2418-2021; Huang, Jeffrey/J-5248-2017	Huang, Jeffrey K./0000-0003-0996-9451; Huang, Jeffrey/0000-0003-0996-9451	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037731, R01NS041687, R01NS020147] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37731, NS20147, NS10836, NS041687] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Adam JC, 2000, MOL BIOL CELL, V11, P3123, DOI 10.1091/mbc.11.9.3123; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Benson DL, 1998, J NEUROSCI, V18, P6892; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; BLOOM FE, 1968, J ULTRA MOL STRUCT R, V22, P361, DOI 10.1016/S0022-5320(68)90027-0; BURRY RW, 1980, BRAIN RES, V184, P85, DOI 10.1016/0006-8993(80)90588-0; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; COHEN RS, 1977, J CELL BIOL, V74, P181, DOI 10.1083/jcb.74.1.181; COLMAN DR, 1997, NEURITES CADHERINS S; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fenyo D, 1998, ELECTROPHORESIS, V19, P998, DOI 10.1002/elps.1150190615; Forgac M, 2000, J EXP BIOL, V203, P71; Foster M., 1897, TXB PHYSL 3; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Garner JA, 1996, J NEUROCHEM, V67, P845; HAINFELD JF, 1977, J SUPRAMOL STR CELL, V6, P301, DOI 10.1002/jss.400060303; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; HULL BE, 1979, J CELL BIOL, V81, P67, DOI 10.1083/jcb.81.1.67; Huntley GW, 1999, J COMP NEUROL, V407, P453; ICHIMURA T, 1988, J NEUROCYTOL, V17, P3, DOI 10.1007/BF01735373; Kennedy MB, 1998, BRAIN RES REV, V26, P243, DOI 10.1016/S0165-0173(97)00043-X; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Peters A., 1991, FINE STRUCTURE NERVO; PFENNINGER K, 1972, J NEUROCYTOL, V1, P129, DOI 10.1007/BF01099180; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; Rao A, 2000, NAT NEUROSCI, V3, P747, DOI 10.1038/77636; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHELLER RH, 1995, NEURON, V14, P893; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Soltys BJ, 1999, TRENDS BIOCHEM SCI, V24, P174, DOI 10.1016/S0968-0004(99)01390-0; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; TRILLER A, 1985, J NEUROCYTOL, V14, P177, DOI 10.1007/BF01258446; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Vincent V, 1997, J BIOL CHEM, V272, P7062, DOI 10.1074/jbc.272.11.7062; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zinsmaier KE, 2001, BIOCHEM PHARMACOL, V62, P1, DOI 10.1016/S0006-2952(01)00648-7	62	360	368	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					63	77		10.1016/S0896-6273(01)00450-0	http://dx.doi.org/10.1016/S0896-6273(01)00450-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604139	Bronze			2022-12-28	WOS:000171525200009
J	Parnavelas, JG; Nadarajah, B				Parnavelas, JG; Nadarajah, B			Radial glial cells: Are they really glia?	NEURON			English	Review							NEURAL STEM-CELLS; VENTRICULAR ZONE; FETAL MONKEY; MIGRATION; NEURONS; NEUROGENESIS; NEOCORTEX; LINEAGE	During the development of the cerebral cortex, radial glia serve as a scaffold to support and direct neurons during their migration. This view is now changing in the light of emerging evidence showing that these cells have a much more dynamic and diverse role. A recent series of studies has provided strong support for their role as precursor cells in the ventricular zone that generate cortical neurons and glia, in addition to providing migration guidance.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London	Parnavelas, JG (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.	j.parnavelas@ucl.ac.uk						Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; GRAY GE, 1992, DEVELOPMENT, V114, P271; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HIS W, 1887, ABH KGL SACHS GES MP, V13, P479; LEVITT P, 1981, J NEUROSCI, V1, P27, DOI 10.1523/JNEUROSCI.01-01-00027.1981; MISSON JP, 1988, DEV BRAIN RES, V38, P183, DOI 10.1016/0165-3806(88)90043-0; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; NYE JS, 1994, DEVELOPMENT, V120, P2421; Pamavelas J. G., 2000, TRENDS NEUROSCI, V23, P126; PAMAVELAS JG, 1999, EXP NEUROL, V156, P418; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic Pasko, 1995, P746; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Zhong WM, 1997, DEVELOPMENT, V124, P1887	21	80	83	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					881	884		10.1016/S0896-6273(01)00437-8	http://dx.doi.org/10.1016/S0896-6273(01)00437-8			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580889	Bronze			2022-12-28	WOS:000171281300004
J	Tobaben, S; Thakur, P; Fernandez-Chacon, R; Sudhof, TC; Rettig, J; Stahl, B				Tobaben, S; Thakur, P; Fernandez-Chacon, R; Sudhof, TC; Rettig, J; Stahl, B			A trimeric protein complex functions as a synaptic chaperone machine	NEURON			English	Article							CYSTEINE-STRING PROTEIN; TETRATRICOPEPTIDE REPEAT; ESCHERICHIA-COLI; VESICLE CYCLE; PURIFICATION; INTERACTS; DNAJ; OVEREXPRESSION; MODULATION; EXOCYTOSIS	We identify a chaperone complex composed of (1) the synaptic vesicle cysteine string protein (CSP), thought to function in neurotransmitter release, (2) the ubiquitous heat-shock protein cognate Hsc70, and (3) the SGT protein containing three tandem tetratricopeptide repeats. These three proteins interact with each other to form a stable trimeric complex that is located on the synaptic vesicle surface, and is disrupted in CSP knockout mice. The CSP/SGT/Hsc70 complex functions as an ATP-dependent chaperone that reactivates a denatured substrate. SGT overexpression in cultured neurons inhibits neurotransmitter release, suggesting that the CSP/SGT/Hsc70 complex is important for maintenance of a normal synapse. Taken together, our results identify a novel trimeric complex that functions as a synapse-specific chaperone machine.	Max Planck Inst Expt Med, D-37075 Gottingen, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Univ Saarland, Inst Physiol, D-66421 Homburg, Germany; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Ctr Bas Neurosci, Howard Hughes Med Inst, Dallas, TX 75235 USA	Max Planck Society; Max Planck Society; Saarland University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Stahl, B (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	stahl@em.mpg.de	Rettig, Jens/K-5103-2013; IBIS, FISIOLOGIA/O-9485-2015; Fernandez-Chacon, Rafael/E-6303-2010	Rettig, Jens/0000-0001-6160-3954; Fernandez-Chacon, Rafael/0000-0002-9845-9885				Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Buchner E, 1997, TRENDS NEUROSCI, V20, P223, DOI 10.1016/S0166-2236(96)10082-5; Callahan MA, 1998, J VIROL, V72, P5189, DOI 10.1128/JVI.72.6.5189-5197.1998; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chamberlain LH, 1996, J BIOL CHEM, V271, P19514, DOI 10.1074/jbc.271.32.19514; Cziepluch C, 1998, J VIROL, V72, P4149, DOI 10.1128/JVI.72.5.4149-4156.1998; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Graham ME, 2000, J NEUROSCI, V20, P1281; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; Hendrick JP, 1995, FASEB J, V9, P1559, DOI 10.1096/fasebj.9.15.8529835; HOHFELD J, 1995, CELL, V83, P589; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Nie ZP, 1999, J NEUROSCI, V19, P10270; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ranjan R, 1998, J NEUROSCI, V18, P956; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Scales SJ, 1999, NATURE, V401, P123, DOI 10.1038/43582; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stahl B, 1999, EUR J CELL BIOL, V78, P375, DOI 10.1016/S0171-9335(99)80079-X; Stahl B, 1996, EMBO J, V15, P1799, DOI 10.1002/j.1460-2075.1996.tb00529.x; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	50	167	174	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2001	31	6					987	999		10.1016/S0896-6273(01)00427-5	http://dx.doi.org/10.1016/S0896-6273(01)00427-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580898	Green Published, Bronze			2022-12-28	WOS:000171281300013
J	Takeyama, K; Ito, S; Yamamoto, A; Tanimoto, H; Furutani, T; Kanuka, H; Miura, M; Tabata, T; Kato, S				Takeyama, K; Ito, S; Yamamoto, A; Tanimoto, H; Furutani, T; Kanuka, H; Miura, M; Tabata, T; Kato, S			Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila	NEURON			English	Article							NUCLEAR RECEPTOR; BINDING DOMAIN; INTRANUCLEAR INCLUSIONS; AGGREGATE FORMATION; ESTROGEN-RECEPTOR; CELL-DEATH; PROTEIN; COACTIVATOR; ACTIVATION; GENE	Spinal and bulbar muscular atrophy (SBMA) is an X-linked, adult-onset, neurodegenerative disorder affecting only males and is caused by expanded polyglutamine (polyQ) stretches in the N-terminal A/B domain of human androgen receptor (hAR). Although no overt phenotype was detected in adult fly eye photoreceptor neurons expressing mutant hAR (polyQ 52), ingestion of androgen or its known antagonists caused marked neurodegeneration with nuclear localization and structural alteration of the hAR mutant. Ligand-independent toxicity was detected with a truncated polyQ-expanded A/B domain alone, which was attenuated with cytosolic trapping by coexpression of the unliganded hAR E/F ligand binding domain. Thus, our findings suggest that the full binding of androgen to the polyQ-expanded hAR mutants leads to structural alteration with nuclear translocation that eventually results in the onset of SBMA in male patients.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; RIKEN, Brain Sci Inst, Lab Cell Recovery Mech, Wako, Saitama 3510198, Japan; Japan Sci & Technol, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Astellas Pharmaceuticals; RIKEN; Japan Science & Technology Agency (JST)	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.		Tanimoto, Hiromu/J-6810-2016					Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Becker M, 2000, J CELL BIOL, V149, P255, DOI 10.1083/jcb.149.2.255; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN TR, 1988, P NATL ACAD SCI USA, V85, P8151, DOI 10.1073/pnas.85.21.8151; Choong CS, 1998, J MOL ENDOCRINOL, V21, P235, DOI 10.1677/jme.0.0210235; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Glass CK, 2000, GENE DEV, V14, P121; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kim TW, 1998, NEURON, V21, P657, DOI 10.1016/S0896-6273(00)80581-4; Kitagawa H, 2002, MOL CELL BIOL, V22, P3698, DOI 10.1128/MCB.22.11.3698-3706.2002; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; LA SA, 1991, NATURE, V352, P77; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Merry DE, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P101; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; PINSKY L, 1992, CLIN INVEST MED, V15, P456; Poujol N, 2000, J BIOL CHEM, V275, P24022, DOI 10.1074/jbc.M001999200; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Ruijter E, 1999, ENDOCR REV, V20, P22, DOI 10.1210/er.20.1.22; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tomura A, 2001, J BIOL CHEM, V276, P28395, DOI 10.1074/jbc.M101755200; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Yamamoto A, 2000, J CELL BIOL, V150, P873, DOI 10.1083/jcb.150.4.873; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1; YONG EL, 1994, LANCET, V344, P826, DOI 10.1016/S0140-6736(94)92385-X; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	49	230	236	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					855	864		10.1016/S0896-6273(02)00875-9	http://dx.doi.org/10.1016/S0896-6273(02)00875-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372281	Bronze			2022-12-28	WOS:000177779800009
J	Luo, ZG; Wang, Q; Zhou, JZ; Wang, JB; Luo, ZJ; Liu, MY; He, X; Wynshaw-Boris, A; Xiong, WC; Lu, B; Mei, L				Luo, ZG; Wang, Q; Zhou, JZ; Wang, JB; Luo, ZJ; Liu, MY; He, X; Wynshaw-Boris, A; Xiong, WC; Lu, B; Mei, L			Regulation of AChR clustering by dishevelled interacting with MuSK and PAK1	NEURON			English	Article							RECEPTOR TYROSINE KINASE; ACETYLCHOLINE-RECEPTOR; POSTSYNAPTIC DIFFERENTIATION; NEUROMUSCULAR-JUNCTION; SIGNALING PATHWAY; GENE-EXPRESSION; CELL POLARITY; CRD DOMAIN; AGRIN; PROTEIN	An important aspect of synapse development is the clustering of neurotransmitter receptors in the postsynaptic membrane. Although MuSK is required for acetylcholine receptor (AChR) clustering at the neuromuscular junction (NMJ), the underlying molecular mechanisms remain unclear. We report here that in muscle cells, MuSK interacts with Dishevelled (Dvl), a signaling molecule important for planar cell polarity. Disruption of the MuSK-Dvl interaction inhibits Agrin- and neuron-induced AChR clustering. Expression of dominant-negative Dvl1 in postsynaptic muscle cells reduces the amplitude of spontaneous synaptic currents at the NMJ. Moreover, Dvl1 interacts with downstream kinase PAK1. Agrin activates PAK, and this activation requires Dvl. Inhibition of PAK1 activity attenuates AChR clustering. These results demonstrate important roles of DO and PAK in Agrin/MuSK-induced AChR clustering and reveal a novel function of Dvl in synapse development.	Univ Alabama Birmingham, Civitan Int Res Ctr, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Civitan Int Res Ctr, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Civitan Int Res Ctr, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; NICHD, Unit Synapse Dev & Plast, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Sch Med, Dept Pediat & Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; Boston Univ, Sch Med, Evans Dept Med, Endocrinol Sect,Diabet & Metab Res Unit, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Texas A&M Univ Syst, Hlth Sci Ctr, Dept Med Biochem & Genet, Inst Biosci & Technol, Houston, TX 77030 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Diego; University of California System; University of California San Diego; Boston University; Boston University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Boston Children's Hospital; Harvard Medical School	Mei, L (corresponding author), Univ Alabama Birmingham, Civitan Int Res Ctr, Dept Neurobiol, 1530 3rd Ave S, Birmingham, AL 35294 USA.	lmei@nrc.uab.edu	Mei, Lin/G-8755-2012; Lu, Bai/A-4018-2012; Luo, Zhen-Ge/GNM-7635-2022; Luo, Zhijun/AAE-9302-2019	Luo, Zhijun/0000-0001-8105-5289; Lu, Bai/0000-0001-5418-9759; Luo, Zhen-Ge/0000-0001-5037-0542; Liu, Mingyao/0000-0001-7339-5048	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Borges LS, 2001, J CELL BIOL, V153, P1, DOI 10.1083/jcb.153.1.1; Borges LS, 2002, J NEUROBIOL, V50, P69, DOI 10.1002/neu.10020; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; Colledge M, 1998, P NATL ACAD SCI USA, V95, P3341, DOI 10.1073/pnas.95.7.3341; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; Dale TC, 1998, BIOCHEM J, V329, P209; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; Ferns M, 2001, NEURON, V30, P311, DOI 10.1016/S0896-6273(01)00311-7; Fuhrer C, 1996, J BIOL CHEM, V271, P32474, DOI 10.1074/jbc.271.50.32474; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; GANJU P, 1995, ONCOGENE, V11, P281; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Gillespie SKH, 1996, NEURON, V16, P953, DOI 10.1016/S0896-6273(00)80118-X; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1997, P NATL ACAD SCI USA, V94, P8848, DOI 10.1073/pnas.94.16.8848; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; HOCH W, 1994, J CELL BIOL, V126, P1, DOI 10.1083/jcb.126.1.1; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; Kim HW, 2001, MOL CELL, V7, P1095, DOI 10.1016/S1097-2765(01)00248-9; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Klingensmith J, 1996, MECH DEVELOP, V58, P15, DOI 10.1016/S0925-4773(96)00549-7; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Malbon CC, 2001, BIOCHEM BIOPH RES CO, V287, P589, DOI 10.1006/bbrc.2001.5630; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; Megeath LJ, 1998, J NEUROSCI, V18, P672; Mohamed AS, 2001, J NEUROSCI, V21, P3806, DOI 10.1523/JNEUROSCI.21-11-03806.2001; Nguyen QT, 2000, J NEUROSCI, V20, P6077, DOI 10.1523/JNEUROSCI.20-16-06077.2000; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; QU Z, 1994, J NEUROSCI, V14, P6834; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; Si JT, 1999, J NEUROSCI, V19, P8498; Smith CL, 2001, J NEUROSCI, V21, P3151, DOI 10.1523/JNEUROSCI.21-09-03151.2001; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; Tanowitz M, 1996, BRAIN RES, V712, P299, DOI 10.1016/0006-8993(95)01475-6; THEISEN H, 1994, DEVELOPMENT, V120, P347; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tsang M, 1996, DEV DYNAM, V207, P253, DOI 10.1002/(SICI)1097-0177(199611)207:3<253::AID-AJA2>3.0.CO;2-G; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; Wang CY, 2001, NEURON, V32, P99, DOI 10.1016/S0896-6273(01)00434-2; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Won S, 1999, J NEUROCHEM, V73, P2358, DOI 10.1046/j.1471-4159.1999.0732358.x; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xia CZ, 2001, P NATL ACAD SCI USA, V98, P6174, DOI 10.1073/pnas.101137298; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	83	196	205	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					489	505		10.1016/S0896-6273(02)00783-3	http://dx.doi.org/10.1016/S0896-6273(02)00783-3			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165471	Bronze			2022-12-28	WOS:000177331200010
J	Grefkes, C; Weiss, PH; Zilles, K; Fink, GR				Grefkes, C; Weiss, PH; Zilles, K; Fink, GR			Crossmodal processing of object features in human anterior intraparietal cortex: an fMRI study implies equivalencies between humans and monkeys	NEURON			English	Article							PARIETAL CORTEX; POSTERIOR PARIETAL; NEURAL MECHANISMS; SPATIAL ATTENTION; MENTAL ROTATION; VISUAL GUIDANCE; INFERIOR AREA-6; MACAQUE MONKEY; TACTILE SHAPE; HAND ACTION	The organization of macaque posterior parietal cortex (PPC) reflects its functional specialization in integrating polymodal sensory information for object recognition and manipulation. Neuropsychological and recent human imaging studies imply equivalencies between human and macaque PPC, and in particular, the cortex buried in the intraparietal sulcus (IPS). Using functional MRI, we tested the hypothesis that an area in human anterior intraparietal cortex is activated when healthy subjects perform a crossmodal visuo-tactile delayed matching-to-sample task with objects. Tactile or visual object presentation (encoding and recognition) both significantly activated anterior intraparietal cortex. As hypothesized, neural activity in this area was further enhanced when subjects transferred object information between modalities (crossmodal matching). Based on both the observed functional properties and the anatomical location, we suggest that this area in anterior IPS is the human equivalent of macaque area AIP.	Forschungszentrum Julich, Inst Med, D-52425 Julich, Germany; Univ Dusseldorf, C&O Vogt Brain Res Inst, D-40001 Dusseldorf, Germany; Rhein Westfal TH Aachen Klinikum, Dept Neurol, D-52074 Aachen, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; RWTH Aachen University; RWTH Aachen University Hospital	Fink, GR (corresponding author), Forschungszentrum Julich, Inst Med, Postfach 1913, D-52425 Julich, Germany.	g.fink@fz-juelich.de	Zilles, Karl/Y-3784-2019; Grefkes, Christian/H-3972-2013; Weiss, Peter H./H-8983-2013; Fink, Gereon R./E-1616-2012; Zilles, Karl/J-9704-2013; Fink, Gereon R./AFW-9377-2022	Zilles, Karl/0000-0002-4705-4175; Grefkes, Christian/0000-0002-1656-720X; Weiss, Peter H./0000-0002-5230-9080; Fink, Gereon R./0000-0002-8230-1856; Zilles, Karl/0000-0001-9296-9959; Fink, Gereon R./0000-0002-8230-1856				Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Banati RB, 2000, NEUROPSYCHOLOGIA, V38, P115, DOI 10.1016/S0028-3932(99)00074-3; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Bremmer F, 2001, NEUROIMAGE, V14, pS46, DOI 10.1006/nimg.2001.0817; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Bremmer F, 1997, PARIETAL LOBE CONTRI, P619; Brodmann K, 1909, VERGLEICHENDE LOKALI; Butters N, 1970, Cortex, V6, P174; BUTTERS N, 1968, CORTEX, P328; Caselli R. J., 1997, BEHAV NEUROLOGY NEUR, P277; CASELLI RJ, 1993, NEUROLOGY, V43, P762, DOI 10.1212/WNL.43.4.762; CASELLI RJ, 1991, MAYO CLIN PROC, V66, P129, DOI 10.1016/S0025-6196(12)60484-4; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Colby CL, 1996, COGNITIVE BRAIN RES, V5, P105, DOI 10.1016/S0926-6410(96)00046-8; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; DiGirolamo GJ, 2001, NEUROREPORT, V12, P2065, DOI 10.1097/00001756-200107030-00054; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Fink GR, 1997, BRAIN, V120, P1779, DOI 10.1093/brain/120.10.1779; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Gurd JM, 2002, BRAIN, V125, P1024, DOI 10.1093/brain/awf093; Hadjikhani N, 1998, J NEUROSCI, V18, P1072; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; Jancke L, 2001, CEREB CORTEX, V11, P114, DOI 10.1093/cercor/11.2.114; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jordan K, 2001, NEUROIMAGE, V13, P143, DOI 10.1006/nimg.2000.0677; Lepage M, 2001, NEUROIMAGE, V14, P572, DOI 10.1006/nimg.2001.0866; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Macaluso E, 2002, CEREB CORTEX, V12, P357, DOI 10.1093/cercor/12.4.357; Macaluso E, 2001, NEUROPSYCHOLOGIA, V39, P1304, DOI 10.1016/S0028-3932(01)00119-1; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; MCNALLY C, 1982, CORTEX, V18, P91, DOI 10.1016/S0010-9452(82)80021-X; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ono M, 1990, ATLAS CEREBRAL SULCI; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; REED CL, 1994, NEUROPSYCHOLOGIA, V32, P527, DOI 10.1016/0028-3932(94)90142-2; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Roland PE, 1996, CURR OPIN NEUROBIOL, V6, P773, DOI 10.1016/S0959-4388(96)80027-4; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Rushworth MFS, 2001, J COGNITIVE NEUROSCI, V13, P698, DOI 10.1162/089892901750363244; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Sakata H, 1999, EXP BRAIN RES, V128, P160, DOI 10.1007/s002210050831; Sakata Hideo, 1994, Current Opinion in Neurobiology, V4, P847, DOI 10.1016/0959-4388(94)90133-3; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Talairach J., 1988, COPLANAR STEREOTAXIC; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Valenza N, 2001, BRAIN, V124, P2287, DOI 10.1093/brain/124.11.2287; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; VONECONOMO K, 1925, CYTOARCHITEKTONIK; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zilles K, 2001, NEUROIMAGE, V14, pS8, DOI 10.1006/nimg.2001.0823	76	238	240	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					173	184		10.1016/S0896-6273(02)00741-9	http://dx.doi.org/10.1016/S0896-6273(02)00741-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123617	Bronze			2022-12-28	WOS:000176601800019
J	Walker, MP; Brakefield, T; Morgan, A; Hobson, JA; Stickgold, R				Walker, MP; Brakefield, T; Morgan, A; Hobson, JA; Stickgold, R			Practice with sleep makes perfect: Sleep-dependent motor skill learning	NEURON			English	Article							PRIMARY SOMATOSENSORY CORTEX; OWL MONKEYS; DISCRIMINATION; MEMORY; ACQUISITION; REORGANIZATION; REPRESENTATION; IMPROVEMENT; PLASTICITY	Improvement in motor skill performance is known to continue for at least 24 hr following training, yet the relative contributions of time spent awake and asleep are unknown. Here we provide evidence that a night of sleep results in a 20% increase in motor speed without loss of accuracy, while an equivalent period of time during wake provides no significant benefit. Furthermore, a significant correlation exists between the improved performance overnight and the amount of stage 2 NREM sleep, particularly late in the night. This finding of sleep-dependent motor skill improvement may have important implications for the efficient learning of all skilled actions in humans.	Harvard Univ, Sch Med, Dept Psychiat, Neurophysiol Lab, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walker, MP (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Neurophysiol Lab, 74 Fenwood Rd, Boston, MA 02115 USA.	mwalker@hms.harvard.edu			NIDA NIH HHS [DA11744-01A1] Funding Source: Medline; NIMH NIH HHS [MH-48832] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011744] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; De Gennaro L, 2000, J SLEEP RES, V9, P155, DOI 10.1046/j.1365-2869.2000.00193.x; FOGEL S, 2001, ACTAS FISIOLOGIA URU; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Liu J, 1997, RES Q EXERCISE SPORT, V68, P145, DOI 10.1080/02701367.1997.10607990; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Miller RGJ, 1991, SIMULTANEOUS STAT IN; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; RECANZONE GH, 1992, CEREB CORTEX, V2, P181, DOI 10.1093/cercor/2.3.181; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; SALZARULO P, 1995, BEHAV BRAIN RES, V69, P23, DOI 10.1016/0166-4328(95)00022-L; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; SMITH C, 1994, J SLEEP RES, V3, P206, DOI 10.1111/j.1365-2869.1994.tb00133.x; SMITH C, 1982, PHYSIOL BEHAV, V29, P469, DOI 10.1016/0031-9384(82)90268-2; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; TWEED S, 1999, SLEEP S1, V22; WILLIAMS RL, 1978, SLEEP DISORDERS DIAG	30	835	851	4	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					205	211		10.1016/S0896-6273(02)00746-8	http://dx.doi.org/10.1016/S0896-6273(02)00746-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	569KP	12123620	Bronze			2022-12-28	WOS:000176601800022
J	Eaton, BA; Fetter, RD; Davis, GW				Eaton, BA; Fetter, RD; Davis, GW			Dynactin is necessary for synapse stabilization	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; DYNEIN HEAVY-CHAIN; CYTOPLASMIC DYNEIN; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL COMPONENTS; AXONAL-TRANSPORT; STRUCTURAL PLASTICITY; ACTIN CYTOSKELETON; MITOTIC SPINDLE; CELL CORTEX	We present evidence that synapse retraction occurs during normal synaptic growth at the Drosophila neuromuscular junction (NMJ). An RNAi-based screen to identify the molecular mechanisms that regulate synapse retraction identified Arp-1/centractin, a subunit of the dynactin complex. Arp-1 dsRNA enhances synapse retraction, and this effect is phenocopied by a mutation in P150/Glued, also a dynactin component. The Glued protein is enriched within the presynaptic nerve terminal, and presynaptic expression of a dominant-negative Glued transgene enhances retraction. Retraction is associated with a local disruption of the synaptic microtubule cytoskeleton. Electrophysiological, ultrastructural, and immunohistochemical data support a model in which presynaptic retraction precedes disassembly of the postsynaptic apparatus. Our data suggests that dynactin functions locally within the presynaptic arbor to promote synapse stability.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 513 Parnassus Ave, San Francisco, CA 94143 USA.	gdavis@biochem.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS042533] Funding Source: NIH RePORTER; NINDS NIH HHS [F32 NS42533] Funding Source: Medline; PHS HHS [44908-32374] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Allen MJ, 1999, J NEUROSCI, V19, P9374; Amberg DC, 1997, MOL BIOL CELL, V8, P729, DOI 10.1091/mbc.8.4.729; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; CLARK SW, 1994, J CELL BIOL, V127, P129, DOI 10.1083/jcb.127.1.129; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DESAI CJ, 1994, J NEUROSCI, V14, P7272; Dillman JF, 1996, P NATL ACAD SCI USA, V93, P141, DOI 10.1073/pnas.93.1.141; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; ENGELFRIET J, 1997, HDB GRAPH GRAMMARS C, V1, P1, DOI [10.1142/9789812384720_0001, DOI 10.1142/9789812384720_0001, DOI 10.1142/9789812384720_]; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Featherstone DE, 2002, NAT NEUROSCI, V5, P141, DOI 10.1038/nn789; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garces JA, 1999, CURR BIOL, V9, P1497, DOI 10.1016/S0960-9822(00)80122-0; Guan B, 1996, CURR BIOL, V6, P695, DOI 10.1016/S0960-9822(09)00451-5; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KURDYAK P, 1994, J COMP NEUROL, V350, P463, DOI 10.1002/cne.903500310; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LETINSKY MS, 1976, J NEUROCYTOL, V5, P691, DOI 10.1007/BF01181582; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MCGRAIL M, 1995, J CELL BIOL, V131, P411, DOI 10.1083/jcb.131.2.411; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Morrison EE, 2002, MOL BRAIN RES, V98, P145, DOI 10.1016/S0169-328X(01)00290-X; Murphey RK, 1999, DEV BIOL, V209, P86, DOI 10.1006/dbio.1999.9217; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Phillis R, 1996, DEVELOPMENT, V122, P2955; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Reddy S, 1997, J NEUROBIOL, V33, P711, DOI 10.1002/(SICI)1097-4695(19971120)33:6<711::AID-NEU1>3.0.CO;2-C; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schafer DA, 1999, ANNU REV CELL DEV BI, V15, P341, DOI 10.1146/annurev.cellbio.15.1.341; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Schuyler SC, 2001, J CELL SCI, V114, P247; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; SWAROOP A, 1985, P NATL ACAD SCI USA, V82, P1751, DOI 10.1073/pnas.82.6.1751; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Vallee RB, 2000, BBA-MOL CELL RES, V1496, P89, DOI 10.1016/S0167-4889(00)00011-2; Valtz N, 1996, J CELL BIOL, V135, P725, DOI 10.1083/jcb.135.3.725; WatermanStorer CM, 1996, J BIOL CHEM, V271, P1153, DOI 10.1074/jbc.271.2.1153; WERNIG A, 1980, J NEUROCYTOL, V9, P277, DOI 10.1007/BF01181538; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Zahner JE, 1996, MOL CELL BIOL, V16, P1857; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	72	196	201	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					729	741		10.1016/S0896-6273(02)00721-3	http://dx.doi.org/10.1016/S0896-6273(02)00721-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062020	Bronze			2022-12-28	WOS:000175951800008
J	Krauzlis, RJ				Krauzlis, RJ			Reaching for answers	NEURON			English	Editorial Material							PRIMARY MOTOR CORTEX; PARIETAL CORTEX; MOVEMENTS; REPRESENTATION; DIRECTION; FORCE	The exact function of motor cortex continues to be an enigma. In this issue of Neuron, Graziano et al. (2002) present provocative data showing that microstimulation of the precentral cortex evokes complex movements, and conclude that the motor and premotor cortex together may form a single map of complex postures.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Krauzlis, RJ (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Richard, Krauzlis/0000-0002-1826-0447				Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Sergio LE, 1998, J NEUROPHYSIOL, V80, P1577, DOI 10.1152/jn.1998.80.3.1577; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	12	2	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					673	674		10.1016/S0896-6273(02)00723-7	http://dx.doi.org/10.1016/S0896-6273(02)00723-7			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062014	Bronze			2022-12-28	WOS:000175951800003
J	Kidd, FL; Coumis, U; Collingridge, GL; Crabtree, JW; Isaac, JTR				Kidd, FL; Coumis, U; Collingridge, GL; Crabtree, JW; Isaac, JTR			A presynaptic kainate receptor is involved in regulating the dynamic properties of thalamocortical synapses during development	NEURON			English	Article							MOSSY FIBER SYNAPSES; EXCITATORY SYNAPTIC TRANSMISSION; LONG-TERM POTENTIATION; RAT HIPPOCAMPUS; NEOCORTICAL SYNAPSES; CRITICAL PERIOD; RELEASE; CORTEX; CA1; INTERNEURONS	Previous studies have shown that pharmacological activation of presynaptic kainate receptors at glutamatergic synapses facilitates or depresses transmission in a dose-dependent manner. However, the only synaptically activated kainate autoreceptor described to date is facilitatory. Here, we describe a kainate autoreceptor that depresses synaptic transmission. This autoreceptor is present at developing thalamocortical synapses in the barrel cortex, specifically regulates transmission at frequencies corresponding to those observed in vivo during whisker activation, and is developmentally down regulated during the first postnatal week. This receptor may, therefore, limit the transfer of high-frequency activity to the developing cortex, the loss of which mechanism may be important for the maturation of sensory processing.	Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Isaac, JTR (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.		collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015	Collingridge, Graham L/0000-0002-9572-5359				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; BAHN S, 1994, J NEUROSCI, V14, P5525; Bleisch TJ, 1997, BIOORG MED CHEM LETT, V7, P1161, DOI 10.1016/S0960-894X(97)00185-6; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; DAVIES CH, 1993, NEUROPHARMACOLOGY, V32, P1071, DOI 10.1016/0028-3908(93)90073-C; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Finnerty GT, 2000, P NATL ACAD SCI USA, V97, P12864, DOI 10.1073/pnas.230175697; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kidd FL, 2001, J NEUROPHYSIOL, V86, P1139, DOI 10.1152/jn.2001.86.3.1139; Kullmann DM, 2001, NEURON, V32, P561, DOI 10.1016/S0896-6273(01)00507-4; Lauri SE, 2001, NEUROPHARMACOLOGY, V41, P907, DOI 10.1016/S0028-3908(01)00152-6; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Markram H, 1998, NEUROPHARMACOLOGY, V37, P489, DOI 10.1016/S0028-3908(98)00049-5; NICOLELIS MAL, 1994, J NEUROSCI, V14, P3511; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, P NATL ACAD SCI USA, V98, P11003, DOI 10.1073/pnas.191351498; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Semyanov A, 2001, NAT NEUROSCI, V4, P718, DOI 10.1038/89506; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Thomas NK, 1998, NEUROPHARMACOLOGY, V37, P1223, DOI 10.1016/S0028-3908(98)00124-5; THOMSON AM, 1994, TRENDS NEUROSCI, V17, P119, DOI 10.1016/0166-2236(94)90121-X; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8	49	63	66	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					635	646		10.1016/S0896-6273(02)00699-2	http://dx.doi.org/10.1016/S0896-6273(02)00699-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062046	Bronze			2022-12-28	WOS:000175665700016
J	Martin, TFJ				Martin, TFJ			Prime movers of synaptic vesicle exocytosis	NEURON			English	Review							MEMBRANE-FUSION; C-ELEGANS; UNC-13	Chemical synapses contain specialized pre- and postsynaptic structures that underlie rapid synaptic transmission and its modulation. Studies of postsynaptic organization have revealed a network of interacting proteins that enable rapid synaptic responses and their modulation. Recent genetic and electrophysiological studies on two active zone proteins-RIM and Munc13-reveal important roles in priming vesicles for Ca2+-triggered fusion and in mediating the regulation of this process. This work sheds new light on how presynaptic structure provides speed and plasticity to synaptic transmission.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.							Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	21	55	57	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					9	12		10.1016/S0896-6273(02)00651-7	http://dx.doi.org/10.1016/S0896-6273(02)00651-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931737	Bronze			2022-12-28	WOS:000174695100005
J	Warren, JD; Zielinski, BA; Green, GGR; Rauschecker, JP; Griffiths, TD				Warren, JD; Zielinski, BA; Green, GGR; Rauschecker, JP; Griffiths, TD			Perception of sound-source motion by the human brain	NEURON			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PRIMARY AUDITORY-CORTEX; HUMAN CEREBRAL-CORTEX; VOLUME MEASUREMENT; MACAQUE MONKEY; HUMAN FMRI; MOVEMENT; PARIETAL; AREAS; LOCALIZATION	We assessed the human brain network for sound-motion processing using the same virtual stimulus in three independent functional imaging experiments. All experiments show a bilateral posterior network of activation, including planum temporale (PT) and parieto-temporal operculum (PTO). This was demonstrated in contrasts between sound movement and two control conditions: externalized stationary stimuli (in the midline or to the side of the head) and midline sounds within the head with similar spectro-temporal structure. We suggest specific computational mechanisms in PT for disambiguation of the intrinsic spectro-temporal features of a sound and the spectro-temporal effect of sound movement. The results support the existence of a posteriorly directed temporo-parietal pathway for obligatory perceptual processing of sound-source motion.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Univ Newcastle Upon Tyne, Sch Med, Auditory Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Georgetown Univ, Med Ctr, Georgetown Inst Cognit & Computat Sci, Washington, DC 20007 USA	University of London; University College London; Newcastle University - UK; Georgetown University	Griffiths, TD (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	t.d.griffiths@ncl.ac.uk	Green, Gary GR/D-3543-2009; Rauschecker, Josef P/A-4120-2013	Green, Gary GR/0000-0003-1977-7509; Rauschecker, Josef P./0000-0003-4353-9084; Warren, Jason/0000-0002-5405-0826; Griffiths, Timothy/0000-0001-8066-4381	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH012598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003489] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC 03489] Funding Source: Medline; NIMH NIH HHS [F31 MH 12598, F31 MH012598] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AHISSAR M, 1992, J NEUROPHYSIOL, V67, P203, DOI 10.1152/jn.1992.67.1.203; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Attias H, 1998, NEURAL COMPUT, V10, P1373, DOI 10.1162/neco.1998.10.6.1373; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Binder JR, 1996, BRAIN, V119, P1239, DOI 10.1093/brain/119.4.1239; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Coull JT, 1998, J NEUROSCI, V18, P7426; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Griffiths TD, 1999, NEUROREPORT, V10, P3825, DOI 10.1097/00001756-199912160-00019; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; GRIFFITHS TD, 1994, CURR BIOL, V4, P892, DOI 10.1016/S0960-9822(00)00198-6; Griffiths TD, 1996, NATURE, V383, P425, DOI 10.1038/383425a0; Griffiths TD, 1999, NEUROIMAGE, V10, P84, DOI 10.1006/nimg.1999.0464; Griffiths TD, 2000, HUM BRAIN MAPP, V9, P72, DOI 10.1002/(SICI)1097-0193(200002)9:2<72::AID-HBM2>3.0.CO;2-9; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Mummery CJ, 1999, J ACOUST SOC AM, V106, P449, DOI 10.1121/1.427068; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Talairach P., 1988, STEREOTACTIC COPLANA; Thivard L, 2000, NEUROREPORT, V11, P2969, DOI 10.1097/00001756-200009110-00028; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; TORONCHUK JM, 1992, EXP BRAIN RES, V88, P169, DOI 10.1007/BF02259138; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; ZAKARAUSKAS P, 1991, HEARING RES, V52, P233, DOI 10.1016/0378-5955(91)90203-L; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	45	209	219	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					139	148		10.1016/S0896-6273(02)00637-2	http://dx.doi.org/10.1016/S0896-6273(02)00637-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931748	Bronze			2022-12-28	WOS:000174695100016
J	Small, DM				Small, DM			Toward an understanding of the brain substrates of reward in humans	NEURON			English	Editorial Material							STIMULATION; ACTIVATION; EMOTION; CORTEX	A network of brain regions has been implicated in food-reward processing. O'Doherty et al. (2002) now provide evidence that this network is differentially modulated by anticipation versus receipt of a food reward and suggest an additional effect of valence of the stimulus.	Northwestern Univ, Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA	Northwestern University	Small, DM (corresponding author), Northwestern Univ, Sch Med, Cognit Neurol & Alzheimers Dis Ctr, 320 E Super,Searle 11-465, Chicago, IL 60611 USA.			Small, Dana/0000-0001-7363-1100				Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; CABANAC M, 1979, Q REV BIOL, V54, P1, DOI 10.1086/410981; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; O'Doherty J, 2000, NEUROREPORT, V11, P399, DOI 10.1097/00001756-200002070-00035; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143	12	23	24	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					668	671		10.1016/S0896-6273(02)00620-7	http://dx.doi.org/10.1016/S0896-6273(02)00620-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879644	Bronze			2022-12-28	WOS:000174286200003
J	Parekh-Olmedo, H; Krainc, D; Kmiec, EB				Parekh-Olmedo, H; Krainc, D; Kmiec, EB			Targeted gene repair and its application to neurodegenerative disorders	NEURON			English	Review							CHIMERIC RNA/DNA OLIGONUCLEOTIDES; RNA-DNA OLIGONUCLEOTIDE; MAMMALIAN-CELLS; MUTATION; STRAND	Synthetic DNA oligonucleotides can direct the exchange of single nucleotides within coding regions of mammalian genes by hybridizing to their complementary sequence in the chromosome and creating a recombination joint structure with a single mismatched base pair. Inherent DNA repair processes recognize the mismatch and resolve it using the DNA sequence of the oligonucleotide vector as the template. This gene surgery approach can be used to repair mutations or to disrupt tri-nucleotide repeats in dysfunctional genes responsible for neurological disorders.	Univ Delaware, Dept Biol Sci, Delaware Biotechnol Inst, Newark, DE 19716 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02114 USA	University of Delaware; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kmiec, EB (corresponding author), Univ Delaware, Dept Biol Sci, Delaware Biotechnol Inst, Newark, DE 19716 USA.							Alexeev V, 2000, NAT BIOTECHNOL, V18, P43, DOI 10.1038/71901; Bartlett RJ, 2000, NAT BIOTECHNOL, V18, P615, DOI 10.1038/76448; Chan PP, 1999, J BIOL CHEM, V274, P11541, DOI 10.1074/jbc.274.17.11541; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; Costantini LC, 2000, GENE THER, V7, P93, DOI 10.1038/sj.gt.3301119; Culver KW, 1999, NAT BIOTECHNOL, V17, P989, DOI 10.1038/13684; Gamper HB, 2000, NUCLEIC ACIDS RES, V28, P4332, DOI 10.1093/nar/28.21.4332; Gamper HB, 2000, BIOCHEMISTRY-US, V39, P5808, DOI 10.1021/bi9921891; Kren BT, 1997, HEPATOLOGY, V25, P1462, DOI 10.1002/hep.510250626; Kren BT, 1998, NAT MED, V4, P285, DOI 10.1038/nm0398-285; Kren BT, 1999, P NATL ACAD SCI USA, V96, P10349, DOI 10.1073/pnas.96.18.10349; Luo ZJ, 2000, P NATL ACAD SCI USA, V97, P9003, DOI 10.1073/pnas.160004997; PAREKHOLMEDO H, 2001, SCI STKE, V73, P1; Rice MC, 2001, NAT BIOTECHNOL, V19, P321, DOI 10.1038/86701; SENUT MC, 1998, GENE THERAPY NEUROLO, P3345; Tagalakis AD, 2001, J BIOL CHEM, V276, P13226, DOI 10.1074/jbc.C000883200; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; YAMAMOTO T, 1992, GENETICS, V131, P811; Yoon K, 1996, P NATL ACAD SCI USA, V93, P2071, DOI 10.1073/pnas.93.5.2071	19	9	10	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					495	498		10.1016/S0896-6273(02)00594-9	http://dx.doi.org/10.1016/S0896-6273(02)00594-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856524	Bronze			2022-12-28	WOS:000173911100004
J	Mansour, M; Nagarajan, N; Nehring, RB; Clements, JD; Rosenmund, C				Mansour, M; Nagarajan, N; Nehring, RB; Clements, JD; Rosenmund, C			Heteromeric AMPA receptors assemble with a preferred subunit stoichiometry and spatial arrangement	NEURON			English	Article							GLUTAMATE BINDING-SITE; INWARD RECTIFICATION; CALCIUM PERMEABILITY; HIPPOCAMPAL-NEURONS; KAINATE RECEPTORS; CA2+ PERMEABILITY; CHANNELS; DESENSITIZATION; CONDUCTANCE; MECHANISMS	AMPA receptors are thought to be a tetrameric assembly of the subunits GluR1-4. We have examined whether two coexpressed subunits (GluR1/2) combine at random to form channels, or preferentially assemble with a specific stoichiometry and spatial configuration. The subunits carried markers controlling ion permeation and desensitization, and these properties were monitored as a function of relative expression level and subunit composition. Homomeric receptors assembled stochastically while heteromeric receptors preferentially formed with a stoichiometry of two GluR1 and two GluR2 subunits, and with identical subunits positioned on opposite sides of the channel pore. This structure will predominate if GluR1 binds to GluR2 more rapidly during receptor assembly than other subunit combinations. The practical outcome of selective heteromeric assembly is a more homogenous receptor population in vivo.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37070 Gottingen, Germany; Australian Natl Univ, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia	Max Planck Society; Australian National University	Rosenmund, C (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37070 Gottingen, Germany.		Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444				Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Dingledine R, 1999, PHARMACOL REV, V51, P7; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hall RA, 1997, J NEUROCHEM, V68, P625; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IINO M, 1994, NEUROSCI LETT, V173, P14, DOI 10.1016/0304-3940(94)90139-2; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Mano I, 1998, NEUROREPORT, V9, P327, DOI 10.1097/00001756-199801260-00027; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; RAMAN IM, 1994, J NEUROSCI, V14, P4998; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Smith TC, 2000, J NEUROSCI, V20, P2073; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Thalhammer A, 1999, NEUROSCI LETT, V277, P161, DOI 10.1016/S0304-3940(99)00885-X; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Washburn MS, 1997, J NEUROSCI, V17, P9393; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; YAMADA KA, 1993, J NEUROSCI, V13, P3904	39	172	179	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					841	853		10.1016/S0896-6273(01)00520-7	http://dx.doi.org/10.1016/S0896-6273(01)00520-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738030	Green Published, Bronze			2022-12-28	WOS:000172700700011
J	McGuire, SE; Davis, RL				McGuire, SE; Davis, RL			Presenilin-1 and memories of the forebrain	NEURON			English	Editorial Material							MICE	In this issue of Neuron, Feng and colleagues (2001) report that forebrain-specific Presenilin-1 conditional knockout mice show defects in enrich ment-induced neurogenesis in the dentate gyrus. This defect in neurogenesis is associated with enhanced fear memory of contextual cues when animals are subjected to enrichment between training and testing. The authors suggest that neurogenesis in the adult dentate gyrus may serve to clear out old memory traces from the hippocampus, thus leaving the hippocampus available for new memory processing.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	McGuire, SE (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608				Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Handler M, 2000, DEVELOPMENT, V127, P2593; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2	10	4	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					763	765		10.1016/S0896-6273(01)00525-6	http://dx.doi.org/10.1016/S0896-6273(01)00525-6			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738022	Bronze			2022-12-28	WOS:000172700700003
J	Rattner, A; Smallwood, PM; Williams, J; Cooke, C; Savchenko, A; Lyubarsky, A; Pugh, EN; Nathans, J				Rattner, A; Smallwood, PM; Williams, J; Cooke, C; Savchenko, A; Lyubarsky, A; Pugh, EN; Nathans, J			A photoreceptor-specific cadherin is essential for the structural integrity of the outer segment and for photoreceptor survival	NEURON			English	Article							DISK MEMBRANE MORPHOGENESIS; FIBRILLARY ACIDIC PROTEIN; RETINAL DEGENERATION; ACTIVATION STEPS; MULLER CELLS; MYOSIN VIIA; KINESIN-II; MOUSE; ROD; LOCALIZATION	A cadherin family member, prCAD, was identified in retina cDNA by subtractive hybridization and high throughput sequencing. prCAD is expressed only in retinal photoreceptors, and the prCAD protein is localized to the base of the outer segment of both rods and cones. In prCAD(-/-) mice, outer segments are disorganized and fragmented, and there is progressive death of photoreceptor cells. prCAD is unlikely to be involved in protein trafficking between inner and outer segments, since phototransduction proteins appear to be correctly localized and the light responses of both rods and cones are only modestly compromised in prCAD(-/-) mice. These experiments imply a highly specialized cell biological function for prCAD and suggest that localized adhesion activity is essential for outer segment integrity.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Microscope Facil, Baltimore, MD 21205 USA; Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Rattner, Amir/0000-0001-9542-6212; Nathans, Jeremy/0000-0001-8106-5460	NATIONAL EYE INSTITUTE [R01EY002660] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Angst BD, 2001, J CELL SCI, V114, P629; ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Beech PL, 1996, J CELL SCI, V109, P889; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; deRaad S, 1996, OPHTHALMIC RES, V28, P99, DOI 10.1159/000267881; Goodyear R, 1999, J NEUROSCI, V19, P3761; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; HARLOW E, 1988, ANTIBODIES PRACTICAL; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; Honjo M, 2000, INVEST OPHTH VIS SCI, V41, P546; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1997, CELL MOTIL CYTOSKEL, V37, P240, DOI 10.1002/(SICI)1097-0169(1997)37:3<240::AID-CM6>3.3.CO;2-2; LOLLEY RN, 1994, INVEST OPHTH VIS SCI, V35, P358; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; MURESAN V, 1993, J CELL SCI, V104, P1229; Muresan V, 1997, EXP EYE RES, V64, P895, DOI 10.1006/exer.1996.0261; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Pennesi ME, 1998, INVEST OPHTH VIS SCI, V39, P2148; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Pugh EN, 1998, PHOTOSTASIS AND RELATED PHENOMENA, P93, DOI 10.1007/978-1-4899-1549-8_7; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SEMPLEROWLAND SL, 1991, J COMP NEUROL, V305, P582, DOI 10.1002/cne.903050405; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Smith NP, 1997, VISION RES, V37, P2943, DOI 10.1016/S0042-6989(97)00094-1; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRAVIS GH, 1992, NEURON, V9, P113, DOI 10.1016/0896-6273(92)90226-4; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Whitehead JL, 1999, EXP EYE RES, V69, P491, DOI 10.1006/exer.1999.0724; Wilkinson DG, 1992, SITU HYBRIDIZATION P; WILLIAMS DS, 1988, J COMP NEUROL, V272, P161, DOI 10.1002/cne.902720202; Wohrn JCP, 1998, J COMP NEUROL, V396, P20; Wyszecki G., 1982, COLOR SCI, V8; Yagi T, 2000, GENE DEV, V14, P1169; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303	53	99	107	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2001	32	5					775	786		10.1016/S0896-6273(01)00531-1	http://dx.doi.org/10.1016/S0896-6273(01)00531-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738025	Bronze			2022-12-28	WOS:000172700700006
J	Zilberberg, N; Ilan, N; Goldstein, SAN				Zilberberg, N; Ilan, N; Goldstein, SAN			KCNKO: Opening and closing the 2-P-domain potassium leak channel entails "C-type" gating of the outer pore	NEURON			English	Article							PIG VENTRICULAR MYOCYTES; RECTIFIER K+ CHANNEL; SLOW INACTIVATION; MYELINATED NERVE; EXTRACELLULAR K+; MODULATION; REGION; TASK-1; ION; SELECTIVITY	Essential to nerve and muscle function, little is known about how potassium leak channels operate. KCNKO opens and closes in a kinase-dependent fashion. Here, the transition is shown to correspond to changes in the outer aspect of the ion conduction pore. Voltage-gated potassium (VGK) channels open and close via an internal gate; however, they also have an outer pore gate that produces "C-type" inactivation. While KCNKO does not inactivate, KCNKO and VGK channels respond in like manner to outer pore blockers, potassium, mutations, and chemical modifiers. Structural relatedness is confirmed: VGK residues that come close during C-type gating predict KCNKO sites that crosslink (after mutation to cysteine) to yield channels controlled by reduction and oxidization. We conclude that similar outer pore gates mediate KCNKO opening and closing and VGK channel C-type inactivation despite their divergent structures and physiological roles.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA	Yale University; Yale University	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, 333 Cedar St, New Haven, CT 06536 USA.		Zilberberg, Noam/F-2005-2012; Goldstein, Steven A./E-9817-2015	Zilberberg, Noam/0000-0002-7848-2391; Goldstein, Steven A./0000-0001-5207-5061				Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; BACKX PH, 1993, CIRC RES, V72, P890, DOI 10.1161/01.RES.72.4.890; BAKER M, 1987, J PHYSIOL-LONDON, V383, P45; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; Bockenhauer D, 2001, NAT NEUROSCI, V4, P486, DOI 10.1038/87434; Bowlby MR, 1997, J GEN PHYSIOL, V110, P601, DOI 10.1085/jgp.110.5.601; BOYLE WA, 1992, J GEN PHYSIOL, V100, P1041, DOI 10.1085/jgp.100.6.1041; Buckler KJ, 2000, J PHYSIOL-LONDON, V525, P135, DOI 10.1111/j.1469-7793.2000.00135.x; CHOL KL, 1991, P NATL ACAD SCI USA, V88, P5092; Colquhoun David, 1995, P483; Craven KB, 2001, BIOPHYS J, V80, p631A; Czirjak G, 2000, MOL ENDOCRINOL, V14, P863, DOI 10.1210/me.14.6.863; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fadool DA, 1997, J NEUROPHYSIOL, V78, P1563, DOI 10.1152/jn.1997.78.3.1563; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Goldstein SAN, 1999, P NATL ACAD SCI USA, V96, P318; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; GRISSMER S, 1989, BIOPHYS J, V55, P203, DOI 10.1016/S0006-3495(89)82793-6; Heath BM, 2000, J PHYSIOL-LONDON, V522, P391, DOI 10.1111/j.1469-7793.2000.t01-2-00391.x; Hille B, 1975, Membranes, V3, P255; HILLE B, 1973, J GEN PHYSIOL, V61, P669, DOI 10.1085/jgp.61.6.669; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Ilan N, 2001, BIOPHYS J, V80, P241, DOI 10.1016/S0006-3495(01)76010-9; JONES SW, 1989, NEURON, V3, P153, DOI 10.1016/0896-6273(89)90028-7; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; KOH DS, 1992, J MEMBRANE BIOL, V130, P149; Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Loots E, 2000, J GEN PHYSIOL, V116, P623, DOI 10.1085/jgp.116.5.623; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Miller AG, 1996, NEURON, V16, P853, DOI 10.1016/S0896-6273(00)80105-1; Ogielska EM, 1999, J GEN PHYSIOL, V113, P347, DOI 10.1085/jgp.113.2.347; Ortega-Saenz P, 2000, J GEN PHYSIOL, V116, P181, DOI 10.1085/jgp.116.2.181; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; SCHMIDT H, 1966, PFLUG ARCH GES PHYS, V287, P311, DOI 10.1007/BF00363245; Sesti F, 2001, BIOPHYS J, V80, p446A; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Vergani P, 1998, EMBO J, V17, P7190, DOI 10.1093/emboj/17.24.7190; Wang KW, 1996, NEURON, V16, P571, DOI 10.1016/S0896-6273(00)80076-8; WU JV, 1993, J NEUROSCI, V13, P5153, DOI 10.1523/JNEUROSCI.13-12-05153.1993; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; YUE DT, 1988, PFLUG ARCH EUR J PHY, V413, P127, DOI 10.1007/BF00582522; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zilberberg N, 2000, J GEN PHYSIOL, V116, P721, DOI 10.1085/jgp.116.5.721	64	66	66	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					635	648		10.1016/S0896-6273(01)00503-7	http://dx.doi.org/10.1016/S0896-6273(01)00503-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719204	Bronze			2022-12-28	WOS:000172363900010
J	Wadiche, JI; Jahr, CE				Wadiche, JI; Jahr, CE			Multivesicular release at climbing fiber-Purkinje cell synapses	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; GLUTAMATE-RECEPTOR CHANNELS; RAT CEREBELLAR SLICES; BERGMANN GLIAL-CELLS; TRANSMITTER RELEASE; TIME-COURSE; SYNAPTIC CURRENTS; EXTRASYNAPTIC GLUTAMATE; HIPPOCAMPAL SYNAPSES; EXCITATORY SYNAPSES	Synapses driven by action potentials are thought to release transmitter in an all-or-none fashion; either one synaptic vesicle undergoes exocytosis, or there is no release. We have estimated the glutamate concentration transient at climbing fiber synapses on Purkinje cells by measuring the inhibition of excitatory postsynaptic currents (EPSCs) produced by a low-affinity competitive antagonist of AMPA receptors, gamma -DGG. The results, together with simulations using a kinetic model of the AMPA receptor, suggest that the peak glutamate concentration at this synapse is dependent on release probability but is not affected by pooling of transmitter released from neighboring synapses. We propose that the mechanism responsible for the elevated glutamate concentration at this synapse is the simultaneous release of multiple vesicles per site.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Jahr, CE (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.			Wadiche, Jacques/0000-0001-8180-2061	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS040056, R01NS040056, F32NS011095] Funding Source: NIH RePORTER; NINDS NIH HHS [NS40056, NS11095] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; ALVAREZLEEFMANS FJ, 1979, J PHYSIOL-LONDON, V294, P387, DOI 10.1113/jphysiol.1979.sp012936; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Auger C, 1998, J NEUROSCI, V18, P4532; Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DATYNER NB, 1980, J PHYSIOL-LONDON, V303, P299, DOI 10.1113/jphysiol.1980.sp013286; Dehnes Y, 1998, J NEUROSCI, V18, P3606; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hanse E, 2001, J PHYSIOL-LONDON, V531, P481, DOI 10.1111/j.1469-7793.2001.0481i.x; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KORN H, 1994, ADV SEC MESS PHOSPH, V29, P301; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LIVSEY CT, 1993, J NEUROSCI, V13, P5324, DOI 10.1523/JNEUROSCI.13-12-05324.1993; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Palay S. L., 1974, CEREBELLAR CORTEX CY; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Prange O, 1999, J NEUROPHYSIOL, V81, P1810, DOI 10.1152/jn.1999.81.4.1810; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rusakov DA, 1998, TRENDS NEUROSCI, V21, P469, DOI 10.1016/S0166-2236(98)01309-5; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SORRA KE, 1993, J NEUROSCI, V13, P3736; SPACEK J, 1985, ANAT EMBRYOL, V171, P235, DOI 10.1007/BF00341418; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; WATKINS JC, 1991, CAN J PHYSIOL PHARM, V69, P1064, DOI 10.1139/y91-158; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	63	289	292	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					301	313		10.1016/S0896-6273(01)00488-3	http://dx.doi.org/10.1016/S0896-6273(01)00488-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683999	Bronze			2022-12-28	WOS:000171893700014
J	Patterson, SL; Pittenger, C; Morozov, A; Martin, KC; Scanlin, H; Drake, C; Kandel, ER				Patterson, SL; Pittenger, C; Morozov, A; Martin, KC; Scanlin, H; Drake, C; Kandel, ER			Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; NERVE GROWTH-FACTOR; INDUCED SYNAPTIC POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; ACTIVITY-DEPENDENT RELEASE; TERM POTENTIATION; NEUROTROPHIC FACTOR; LATE-PHASE; RAT HIPPOCAMPUS; MEMORY STORAGE	Long-lasting forms of synaptic plasticity like the late phase of LTP (L-LTP) typically require an elevation of cAMP, the recruitment of the cAMP-dependent protein kinase (PKA), and ultimately the activation of transcription and translation; some forms also require brain-derived neurotrophic factor (BDNF). Both cAMP and BDNF can activate mitogen-activated protein kinase (MAPK/ERK), which also plays a role in LTP. However, little is known about the mechanisms whereby cAMP, BDNF, and MAPK interact. We find that increases in cAMP can rapidly activate the BDNF receptor TrkB and induce BDNF-dependent long-lasting potentiation at the Schaffer collateral-CA1 synapse in hippocampus. Surprisingly, in these BDNF-dependent forms of potentiation, which are also MAPK dependent, TrkB activation is not critical for the activation of MAPK but instead appears to modulate the subcellular distribution and nuclear translocation of the activated MAPK.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Cornell Univ, Weill Med Coll, Dept Neurol, Div Neurobiol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Neurosci, New York, NY 10021 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cornell University; Cornell University	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA.		Pittenger, Christopher/G-8402-2012	Pittenger, Christopher/0000-0003-2117-9321	NIGMS NIH HHS [GM08464-05/06] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Aloyz R, 1999, LEARN MEMORY, V6, P216; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; Binder DK, 1999, J NEUROSCI, V19, P4616; BIOCHI A, 1995, EUR J NEUROSCI, V7, P1220; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blochl A, 1996, MOL CELL NEUROSCI, V7, P173, DOI 10.1006/mcne.1996.0014; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982; BRAMHAM CR, 1990, NEUROSCIENCE, V39, P405, DOI 10.1016/0306-4522(90)90277-B; Cavus I, 1996, J NEUROPHYSIOL, V76, P3038, DOI 10.1152/jn.1996.76.5.3038; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; Chen GQ, 1999, J NEUROSCI, V19, P7983; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Drake CT, 1999, J NEUROSCI, V19, P8009; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Friedman WJ, 1998, NEUROSCIENCE, V84, P101, DOI 10.1016/S0306-4522(97)00526-5; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Gottschalk W, 1998, J NEUROSCI, V18, P6830; GROVER LM, 1995, SYNAPSE, V19, P121, DOI 10.1002/syn.890190208; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; GUITON M, 1994, J BIOL CHEM, V269, P30370; GUNNING PW, 1981, J CELL BIOL, V89, P240, DOI 10.1083/jcb.89.2.240; HEIDEMANN SR, 1985, J CELL BIOL, V100, P916, DOI 10.1083/jcb.100.3.916; HRKENHAM M, 1988, NIDA RES MONOGR, V82, P33; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Jankowsky JL, 1999, MOL CELL NEUROSCI, V14, P273, DOI 10.1006/mcne.1999.0792; Jarvis CR, 1997, J NEUROPHYSIOL, V78, P2363, DOI 10.1152/jn.1997.78.5.2363; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KANG HJ, 1995, J PHYSIOLOGY-PARIS, V89, P11, DOI 10.1016/0928-4257(96)80547-X; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; LENORMAND P, 1993, ADV SEC MESS PHOSPH, V28, P237; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; LESSMANN V, 1994, NEUROREPORT, V6, P21; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Peters A., 1991, FINE STRUCTURE NERVO; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Roberson ED, 1999, J NEUROSCI, V19, P4337; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Suen PC, 1997, P NATL ACAD SCI USA, V94, P8191, DOI 10.1073/pnas.94.15.8191; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; TIMMUSK T, 1993, EUR J NEUROSCI, V5, P605, DOI 10.1111/j.1460-9568.1993.tb00526.x; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang SJ, 1999, J NEUROSCI, V19, P570; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; YAO H, 1995, J BIOL CHEM, V270, P20748, DOI 10.1074/jbc.270.35.20748	73	261	267	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					123	140		10.1016/S0896-6273(01)00443-3	http://dx.doi.org/10.1016/S0896-6273(01)00443-3			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604144	Bronze			2022-12-28	WOS:000171525200014
J	Wenk, MR; Pellegrini, L; Klenchin, VA; Di Paolo, G; Chang, SH; Daniell, L; Arioka, M; Martin, TF; De Camilli, P				Wenk, MR; Pellegrini, L; Klenchin, VA; Di Paolo, G; Chang, SH; Daniell, L; Arioka, M; Martin, TF; De Camilli, P			PIP kinase 1 gamma is the major PI(4,5)P-2 synthesizing enzyme at the synapse	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; I PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASES; STIMULATION-DEPENDENT DEPHOSPHORYLATION; TERMINAL-SPECIFIC PHOSPHOPROTEIN; PLECKSTRIN HOMOLOGY DOMAIN; NERVE-TERMINALS; PLASMA-MEMBRANE; NEUROTRANSMITTER RELEASE; VESICLE EXOCYTOSIS; COATED VESICLES	Disruption of the presynaptically enriched polyphosphoinositide phosphatase synaptojanin 1 leads to an increase of clathrin-coated intermediates and of polymerized actin at endocytic zones of nerve terminals. These changes correlate with elevated levels of PI(4,5)P-2 in neurons. We report that phosphatidylinositol phosphate kinase type I gamma (PIPKI gamma), a major brain PI(4)P 5-kinase, is concentrated at synapses. Synaptojanin 1 and PIPKI gamma antagonize each other in the recruitment of clathrin coats to lipid membranes. Like synaptojanin 1 and other proteins involved in endocytosis, PIPKI gamma undergoes stimulation-dependent dephosphorylation. These results implicate PIPKI gamma in the synthesis of a PI(4,5)P-2 pool that acts as a positive regulator of clathrin coat recruitment and actin function at the synapse.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06511 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06511 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Howard Hughes Medical Institute; Yale University; Yale University; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06511 USA.		Wenk, Markus Rene/D-1441-2014; Chang, Sunghoe/J-2784-2012	chang, sunghoe/0000-0002-3446-7288				Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BERNSTEIN BW, 1989, NEURON, V3, P257, DOI 10.1016/0896-6273(89)90039-1; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; BRODIN L, 1999, BIOCHIMIE, V81, P49; Chen H, 1999, J BIOL CHEM, V274, P3257, DOI 10.1074/jbc.274.6.3257; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cremona O, 2001, J CELL SCI, V114, P1041; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Dunaevsky A, 2000, J NEUROSCI, V20, P6007, DOI 10.1523/JNEUROSCI.20-16-06007.2000; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; GELL MI, 1996, SCIENCE, V272, P533; Haffner C, 1997, FEBS LETT, V419, P175, DOI 10.1016/S0014-5793(97)01451-8; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Hawthorne J N, 1977, Adv Exp Med Biol, V83, P419; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HOKIN LE, 1985, ANNU REV BIOCHEM, V54, P205, DOI 10.1146/annurev.biochem.54.1.205; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 2000, J BIOL CHEM, V275, P19389, DOI 10.1074/jbc.M000426200; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Kirk CJ., 1990, PEPTIDE HORMONE ACTI, P151; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; LOLJENS JC, 1996, J BIOL CHEM, V271, P32937; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Martin TFJ, 1997, CURR OPIN NEUROBIOL, V7, P331, DOI 10.1016/S0959-4388(97)80060-8; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Mikoshiba K, 1999, CHEM PHYS LIPIDS, V98, P59, DOI 10.1016/S0009-3084(99)00018-3; MINOGUE S, 2001, J BIOL CHEM, V13, P13; Munn AL, 2001, BBA-MOL BASIS DIS, V1535, P236, DOI 10.1016/S0925-4439(01)00028-X; Nemoto Y, 2000, J BIOL CHEM, V275, P34293, DOI 10.1074/jbc.M003923200; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Park SJ, 2001, J BIOL CHEM, V276, P4781, DOI 10.1074/jbc.M010177200; Prior I A, 1999, Mol Cell Biol Res Commun, V1, P162, DOI 10.1006/mcbr.1999.0126; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Sechi AS, 2000, J CELL SCI, V113, P3685; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; SUHOF TC, 2000, SYNAPSE, P177; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; TAKEI K, 1992, J NEUROSCI, V12, P489; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Tolias KF, 1999, CHEM PHYS LIPIDS, V98, P69, DOI 10.1016/S0009-3084(99)00019-5; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wiedemann C, 1998, J NEUROSCI, V18, P5594; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Woscholski R, 1997, J BIOL CHEM, V272, P9625; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002	78	184	187	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					79	88		10.1016/S0896-6273(01)00456-1	http://dx.doi.org/10.1016/S0896-6273(01)00456-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604140	Bronze			2022-12-28	WOS:000171525200010
J	Zito, K; Svoboda, K				Zito, K; Svoboda, K			Activity-dependent synaptogenesis in the adult mammalian cortex	NEURON			English	Review							DENDRITIC SPINES; BARREL CORTEX; UP-REGULATION; PLASTICITY; EXPRESSION; BDNF; SYNAPSES; DYNAMICS; RAT	Recent electron microscopic studies provide evidence that the adult cortex generates new synapses in response to sensory activity and that these structural changes can occur rapidly, within 24 hr of sensory stimulation. Together with progress imaging synapses in vivo, the stage appears set for advances in understanding the dynamics and mechanisms of experience-dependent synaptogenesis.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.			Zito, Karen/0000-0002-0799-0460				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Barth AL, 2000, J NEUROSCI, V20, P4206; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Dailey ME, 1996, J NEUROSCI, V16, P2983; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kleim JA, 1996, J NEUROSCI, V16, P4529; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Rocamora N, 1996, J NEUROSCI, V16, P4411; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716	14	97	98	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1015	1017		10.1016/S0896-6273(02)00903-0	http://dx.doi.org/10.1016/S0896-6273(02)00903-0			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354392	Bronze			2022-12-28	WOS:000178040000003
J	Cai, DM; Deng, KW; Mellado, W; Lee, J; Ratan, RR; Filbin, MT				Cai, DM; Deng, KW; Mellado, W; Lee, J; Ratan, RR; Filbin, MT			Arginase I and Polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro	NEURON			English	Article							RAT HIPPOCAMPAL-NEURONS; D-ASPARTATE RECEPTORS; NITRIC-OXIDE; ORNITHINE DECARBOXYLASE; NEURITE GROWTH; SCIATIC-NERVE; NR2 SUBUNITS; SPINAL-CORD; L-ARGININE; REGENERATION	Elevation of cAMP can overcome myelin inhibitors to encourage regeneration of the CNS. We show that a consequence of elevated cAMP is the synthesis of polyamines, resulting from an up-regulation of Arginase I, a key enzyme in their synthesis. Inhibiting polyamine synthesis blocks the cAMP effect on regeneration. Either over-expression of Arginase I or exogenous polyamines can overcome inhibition by MAG and by myelin in general. While MAG/myelin support the growth of young DRG neurons, they become inhibitory as DRGs mature. Endogenous Arginase I levels are high in young DRGs but drop spontaneously at an age that coincides with the switch from promotion to inhibition by MAG/myelin. Over-expressing Arginase I in maturing DRGs blocks that switch. Arginase I and polyamines are more specific targets than cAMP for intervention to encourage regeneration after CNS injury.	CUNY Hunter Coll, Dept Biol, New York, NY 10024 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	City University of New York (CUNY) System; Hunter College (CUNY); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol, 695 Pk Ave, New York, NY 10024 USA.	filbin@genectr.hunter.cuny.edu		Cai, Dongming/0000-0002-0601-6826	NINDS NIH HHS [NS41073, NS 37060, NS40591] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041073, R01NS040591, R37NS037060, R01NS037060] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abe K, 1997, BRAIN RES, V766, P281, DOI 10.1016/S0006-8993(97)00750-6; Banan A, 1998, AM J PHYSIOL-GASTR L, V274, pG879, DOI 10.1152/ajpgi.1998.274.5.G879; BATES CA, 1993, EXP NEUROL, V123, P106, DOI 10.1006/exnr.1993.1144; BOUCHER JL, 1994, BIOCHEM BIOPH RES CO, V203, P1614, DOI 10.1006/bbrc.1994.2371; Bregman B S, 1983, Brain Res, V285, P137; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CARBONETTO S, 1987, J NEUROSCI, V7, P610; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chao J, 1997, MOL PHARMACOL, V51, P861, DOI 10.1124/mol.51.5.861; Cheng K, 2000, PSYCHOL SCI, V11, P403, DOI 10.1111/1467-9280.00278; CHU PJ, 1995, BRAIN RES, V673, P233, DOI 10.1016/0006-8993(94)01419-I; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; De Bellard M, 1999, J NEUROSCI RES, V56, P213, DOI 10.1002/(SICI)1097-4547(19990415)56:2<213::AID-JNR11>3.3.CO;2-L; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; DORNAY M, 1986, EXP NEUROL, V92, P665, DOI 10.1016/0014-4886(86)90307-9; Esch F, 1998, J NEUROSCI, V18, P4083; GILAD GM, 1988, DEV BRAIN RES, V38, P175, DOI 10.1016/0165-3806(88)90042-9; Gilad VH, 1996, BRAIN RES, V724, P141, DOI 10.1016/0006-8993(96)00287-9; Gnegy ME, 2000, CRIT REV NEUROBIOL, V14, P91; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hanson MG, 1998, J NEUROSCI, V18, P7361; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; INGOGLIA NA, 1982, J NEUROSCI, V2, P1412; KAMINSKA B, 1992, FEBS LETT, V304, P198, DOI 10.1016/0014-5793(92)80618-Q; Kashiwagi K, 1997, MOL PHARMACOL, V52, P701, DOI 10.1124/mol.52.4.701; KAUPPILA T, 1992, BRAIN RES, V575, P299, DOI 10.1016/0006-8993(92)90093-O; Kepka-Lenhart D, 2000, AM J PHYSIOL-REG I, V279, pR2237; LI H, 2001, AM J PHYSIOL-REG I, V353, pR245; LINDQUIST TD, 1985, J NEUROCHEM, V44, P1913, DOI 10.1111/j.1471-4159.1985.tb07187.x; LIU BP, 2002, IN PRESS SCIENCE; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; NAKAMURA H, 1990, BRAIN RES, V530, P108, DOI 10.1016/0006-8993(90)90664-W; NEBES VL, 1988, MOL ENDOCRINOL, V2, P444, DOI 10.1210/mend-2-5-444; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shen YJ, 1998, MOL CELL NEUROSCI, V12, P79, DOI 10.1006/mcne.1998.0700; SLOTKIN TA, 1986, BRAIN RES BULL, V17, P307, DOI 10.1016/0361-9230(86)90236-4; SLOTKIN TA, 1982, J PHARMACOL EXP THER, V222, P741; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; WILLIAMS K, 1994, MOL PHARMACOL, V45, P803; Wolff J, 1998, BIOCHEMISTRY-US, V37, P10722, DOI 10.1021/bi980400n	55	252	260	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					711	719		10.1016/S0896-6273(02)00826-7	http://dx.doi.org/10.1016/S0896-6273(02)00826-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194870	Bronze			2022-12-28	WOS:000177521000011
J	Snider, WD; Zhou, FQ; Zhong, J; Markus, A				Snider, WD; Zhou, FQ; Zhong, J; Markus, A			Signaling the pathway to regeneration	NEURON			English	Review							SENSORY AXONS; NEURONS	Robust axon regeneration occurs after peripheral nerve injury through coordinated activation of a genetic program and local intracellular signaling cascades. Although regeneration-associated genes are being identified with increasing frequency, most aspects of regeneration-associated intracellular signaling remain poorly understood. Two independent studies now report that upregulation of cAMP is a component of the PNS regeneration program that can be exploited to enhance axon regeneration through the normally inhibitory CNS environment.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Snider, WD (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.	wsnider@med.unc.edu						Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Condic ML, 2001, J NEUROSCI, V21, P4782, DOI 10.1523/JNEUROSCI.21-13-04782.2001; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; Smith DS, 1997, J NEUROSCI, V17, P646; Werner A, 2000, J NEUROSCI, V20, P1822; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Zhong J, 1999, J NEUROSCI, V19, P4305; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	24	118	121	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					13	16		10.1016/S0896-6273(02)00762-6	http://dx.doi.org/10.1016/S0896-6273(02)00762-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123603	Bronze			2022-12-28	WOS:000176601800005
J	Lossin, C; Wang, DW; Rhodes, TH; Vanoye, CG; George, AL				Lossin, C; Wang, DW; Rhodes, TH; Vanoye, CG; George, AL			Molecular basis of an inherited epilepsy	NEURON			English	Article							FEBRILE SEIZURES PLUS; NEURONAL SODIUM-CHANNEL; GENERALIZED EPILEPSY; MUTATIONS; GENE; INACTIVATION; CURRENTS; SCN1A; GAMMA-2-SUBUNIT; MICROCULTURES	Epilepsy is a common neurological condition that reflects neuronal hyperxcitability arising from largely unknown cellular and molecular mechanisms. In generalized epilepsy with febrile seizures plus, an autosomal dominant epilepsy syndrome, mutations in three genes coding for voltage-gated sodium channel a or beta1 subunits (SCN1A, SCN2A, SCN1B) and one GABA receptor subunit gene (GABRG2) have been identified. Here, we characterize the functional effects of three mutations in the human neuronal sodium channel a subunit SCN1A by heterologous expression with its known accessory subunits, beta1 and beta2, in cultured mammalian cells. SCN1A mutations alter channel inactivation, resulting in persistent inward sodium current. This gain-of-function abnormality will likely enhance excitability of neuronal membranes by causing prolonged membrane depolarization, a plausible underlying biophysical mechanism responsible for this inherited human epilepsy.	Vanderbilt Univ, Div Med Genet, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	George, AL (corresponding author), Vanderbilt Univ, Div Med Genet, 221 Kirkland Hall, Nashville, TN 37232 USA.			Lossin, Christoph/0000-0001-8101-2924	NINDS NIH HHS [NS3287] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abou-Khalil B, 2001, NEUROLOGY, V57, P2265, DOI 10.1212/WNL.57.12.2265; Alekov AK, 2001, EUR J NEUROSCI, V13, P2171, DOI 10.1046/j.0953-816x.2001.01590.x; Alekov AK, 2000, J PHYSIOL-LONDON, V529, P533, DOI 10.1111/j.1469-7793.2000.00533.x; AYALA GF, 1970, J NEUROPHYSIOL, V33, P73, DOI 10.1152/jn.1970.33.1.73; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Berkovic SF, 2001, CHANNELOPATHIES OF THE NERVOUS SYSTEM, P239; Browne TR, 2001, NEW ENGL J MED, V344, P1145, DOI 10.1056/NEJM200104123441507; CANNON SC, 1993, BIOPHYS J, V65, P270, DOI 10.1016/S0006-3495(93)81045-2; Cannon SC, 2000, KIDNEY INT, V57, P772, DOI 10.1046/j.1523-1755.2000.00914.x; Catterall W A, 1999, Adv Neurol, V79, P441; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Dudek FE, 1998, CELL BIOL INT, V22, P793, DOI 10.1006/cbir.1999.0397; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; KRAFTE DS, 1990, J GEN PHYSIOL, V96, P689, DOI 10.1085/jgp.96.4.689; MATSUMOTO H, 1964, EXP NEUROL, V9, P305, DOI 10.1016/0014-4886(64)90026-3; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Meisler MH, 2001, ANNU REV GENET, V35, P567, DOI 10.1146/annurev.genet.35.102401.091142; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; Reckziegel G, 1998, J PHYSIOL-LONDON, V509, P139, DOI 10.1111/j.1469-7793.1998.139bo.x; SAH DWY, 1995, J NEUROPHYSIOL, V74, P1889, DOI 10.1152/jn.1995.74.5.1889; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Segal MM, 2002, NOVART FDN SYMP, V241, P173; SEGAL MM, 1994, J NEUROPHYSIOL, V72, P1874, DOI 10.1152/jn.1994.72.4.1874; SEGAL MM, 1991, J NEUROPHYSIOL, V65, P761, DOI 10.1152/jn.1991.65.4.761; SHIN C, 1994, ANNU REV MED, V45, P379; Singh R, 1999, ANN NEUROL, V45, P75, DOI 10.1002/1531-8249(199901)45:1<75::AID-ART13>3.0.CO;2-W; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; Sugawara T, 2001, NEUROLOGY, V57, P703, DOI 10.1212/WNL.57.4.703; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	39	266	297	0	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					877	884		10.1016/S0896-6273(02)00714-6	http://dx.doi.org/10.1016/S0896-6273(02)00714-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086636	Bronze			2022-12-28	WOS:000176249700006
J	Redmond, L; Kashani, AH; Ghosh, A				Redmond, L; Kashani, AH; Ghosh, A			Calcium regulation of dendritic growth via CaM kinase IV and CREB-mediated transcription	NEURON			English	Article							BINDING PROTEIN; VISUAL-CORTEX; NEURONS; PHOSPHORYLATION; ACTIVATION; NUCLEUS; CELLS; GENE; CBP; MATURATION	We report that CaM kinase IV and CREB play a critical role in mediating calcium-induced dendritic growth in cortical neurons. Calcium-dependent dendritic growth is suppressed by CaM kinase inhibitors, a constitutively active form of CaM kinase IV induces dendritic growth in the absence of extracellular stimulation, and a kinase-dead form of CaM kinase IV suppresses dendritic growth induced by calcium influx. CaM kinase IV activates the transcription factor CREB, and expression of a dominant negative form of CREB blocks calcium- and CaM kinase IV-induced dendritic growth. In cortical slice cultures, dendritic growth is attenuated by inhibitors of voltage-sensitive calcium channels and by dominant negative CREB. These experiments indicate that calcium-induced dendritic growth is regulated by activation of a transcriptional program that involves CaM kinase IV and CREB-mediated signaling to the nucleus.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ghosh, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolf St, Baltimore, MD 21205 USA.	aghosh@jhmi.edu			NIMH NIH HHS [MH60598] Funding Source: Medline; NINDS NIH HHS [NS39993] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039993] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENES FM, 1977, BRAIN RES, V122, P1, DOI 10.1016/0006-8993(77)90658-8; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Chawla S, 2001, J NEUROCHEM, V79, P849, DOI 10.1046/j.1471-4159.2001.00645.x; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; COLEMAN PD, 1968, J ANAT, V102, P363; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DEITCH JS, 1984, J COMP NEUROL, V229, P66, DOI 10.1002/cne.902290106; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Ho N, 1996, J EXP MED, V184, P101, DOI 10.1084/jem.184.1.101; HOLLOWAY RALPH L., 1966, BRAIN RES, V2, P393, DOI 10.1016/0006-8993(66)90009-6; Horch HW, 1999, NEURON, V23, P353; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; JURASKA JM, 1982, J COMP NEUROL, V212, P208, DOI 10.1002/cne.902120210; KALB RG, 1994, DEVELOPMENT, V120, P3063; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; LOHMANN C, 2002, IN PRESS NATURE; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mason CA, 1997, PERSPECT DEV NEUROBI, V5, P69; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; PURVES D, 1981, J NEUROSCI, V1, P441; Rajan I, 1998, J NEUROSCI, V18, P7836; RAKIC P, 1973, J COMP NEUROL, V152, P133, DOI 10.1002/cne.901520203; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SOTELO C, 1975, BRAIN RES, V94, P19, DOI 10.1016/0006-8993(75)90874-4; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976	51	359	373	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					999	1010		10.1016/S0896-6273(02)00737-7	http://dx.doi.org/10.1016/S0896-6273(02)00737-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086646	Bronze			2022-12-28	WOS:000176249700016
J	Impey, S; Fong, AL; Wang, YH; Cardinaux, JR; Fass, DM; Obrietan, K; Wayman, GA; Storm, DR; Soderling, TR; Goodman, RH				Impey, S; Fong, AL; Wang, YH; Cardinaux, JR; Fass, DM; Obrietan, K; Wayman, GA; Storm, DR; Soderling, TR; Goodman, RH			Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV	NEURON			English	Article							LONG-TERM-MEMORY; RUBINSTEIN-TAYBI SYNDROME; ELEMENT-BINDING PROTEIN; GENE-EXPRESSION; CREB PHOSPHORYLATION; DEPENDENT TRANSCRIPTION; SYNAPTIC PLASTICITY; COACTIVATOR CBP; NUCLEAR; CALCIUM	Activity-regulated transcription has been implicated in adaptive plasticity in the CNS. In many instances, this plasticity depends upon the transcription factor CREB. Precisely how neuronal activity regulates CREB remains unclear. To address this issue, we examined the phosphorylation state of components of the CREB transcriptional pathway. We show that NMDA activates transcription of CREB-responsive genes in hippocampal neurons, with ERK responsible for persistent CREB phosphorylation and CaM kinase IV (CaMKIV) responsible for phosphorylating the CREB coactivator, CBP. Ser301 of CBP was identified as a major target of CaMKIV phosphorylation in vitro and in vivo. CaM kinase inhibitors attenuated phosphorylation at Ser301 and blocked CBP-dependent transcription. Additionally, mutation of Ser301 impaired NMDA- and CaMKIV-stimulated transcription. These findings demonstrate that activity-induced CaMKIV signaling contributes to CREB/CBP-dependent transcription by phosphorylating CBP at Ser301.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	Oregon Health & Science University; University System of Ohio; Ohio State University; University of Washington; University of Washington Seattle	Impey, S (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd,L474, Portland, OR 97201 USA.	impeys@ohsu.edu	Cardinaux, Jean-René/G-5391-2012	Cardinaux, Jean-René/0000-0001-6423-0014				Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Ahn S, 2000, ANNU REV PHYSIOL, V62, P803, DOI 10.1146/annurev.physiol.62.1.803; Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Cruzalegui FH, 1999, EMBO J, V18, P1335, DOI 10.1093/emboj/18.5.1335; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dudai Y, 1997, NEURON, V18, P179, DOI 10.1016/S0896-6273(00)80257-3; ENSLEN H, 1995, BIOCHEM BIOPH RES CO, V207, P1038, DOI 10.1006/bbrc.1995.1289; Fields RD, 1997, J NEUROSCI, V17, P7252; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Kandel ER, 1999, PHILOS T R SOC B, V354, P2027, DOI 10.1098/rstb.1999.0542; Kane CD, 2000, EMBO J, V19, P691, DOI 10.1093/emboj/19.4.691; Kasahara J, 2000, J NEUROSCI RES, V59, P594, DOI 10.1002/(SICI)1097-4547(20000301)59:5<594::AID-JNR2>3.3.CO;2-H; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kung AL, 2000, GENE DEV, V14, P272; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu YZ, 1998, J BIOL CHEM, V273, P32400, DOI 10.1074/jbc.273.49.32400; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; SEGER R, 1994, J BIOL CHEM, V269, P25699; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Soutoglou E, 2000, J BIOL CHEM, V275, P12515, DOI 10.1074/jbc.275.17.12515; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Suzuki T, 1999, BRAIN RES, V840, P36, DOI 10.1016/S0006-8993(99)01762-X; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930; Zanger K, 2001, MOL CELL, V7, P551, DOI 10.1016/S1097-2765(01)00202-7	64	280	285	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 11	2002	34	2					235	244		10.1016/S0896-6273(02)00654-2	http://dx.doi.org/10.1016/S0896-6273(02)00654-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970865	Bronze			2022-12-28	WOS:000174976200009
J	Trudeau, MC; Zagotta, WN				Trudeau, MC; Zagotta, WN			An intersubunit interaction regulates trafficking of rod cyclic nucleotide-gated channels and is disrupted in an inherited form of blindness	NEURON			English	Article							SUBUNIT STOICHIOMETRY; RETINITIS-PIGMENTOSA; PLASMA-MEMBRANE; CATION CHANNEL; ION CHANNELS; PROTEIN; PHOTORECEPTOR; CONDUCTANCE; ARRANGEMENT; RESOLUTION	A mutation in a cyclic nucleotide-gated channel (CNGA1) is associated with retinitis pigmentosa (RP), a common, inherited eye disease. Expression of mutant (CNGA1-RP) homomeric channels in Xenopus oocytes revealed no measurable differences compared to wild-type CNGA1 homomers. As native retinal rod CNG channels comprise CNGA1 and CNGB1 subunits, we coexpressed CNGA1-RP and CNGB1. Surprisingly, this subunit combination did not produce detectable channels at the membrane surface. We show that the mechanism underlying this defect involves an inter-subunit interaction between CNGA1 and CNGB1 that was not formed between CNGA1-RP and CNGB1 sub-units. In the absence of this interaction, a short N-terminal region in CNGB1 prevented membrane expression. Thus, disruption of a regulatory interaction by mutation in CNGA1 exposed a region of CNGB1 that disrupted surface expression of heteromeric CNGA1-RP/CNGB1 channels, accounting for this instance of RP.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA.				NATIONAL EYE INSTITUTE [T32EY007031, R01EY010329] Funding Source: NIH RePORTER; NEI NIH HHS [T32 EY07031, R01 EY010329-09, R01 EY010329] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bareil C, 2001, HUM GENET, V108, P328, DOI 10.1007/s004390100496; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GORDON SE, 1995, NEURON, V14, P177; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; He YJ, 2000, P NATL ACAD SCI USA, V97, P895, DOI 10.1073/pnas.97.2.895; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Misaka T, 1997, J BIOL CHEM, V272, P22623, DOI 10.1074/jbc.272.36.22623; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Phelan JK, 2000, MOL VIS, V6, P116; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Richards MJ, 2000, BIOCHEMISTRY-US, V39, P14003, DOI 10.1021/bi001639i; Savchenko A, 1997, NATURE, V390, P694, DOI 10.1038/37803; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	28	53	57	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					197	207		10.1016/S0896-6273(02)00647-5	http://dx.doi.org/10.1016/S0896-6273(02)00647-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970862	Bronze			2022-12-28	WOS:000174976200006
J	Ellerby, LM				Ellerby, LM			Hunting for excitement: NMDA receptors in Huntington's disease	NEURON			English	Editorial Material							STRIATAL NEURONS; MUTANT HUNTINGTIN; QUINOLINIC ACID; MODEL	Excitotoxic cell death stimulated by quinolinic acid injection into the striatum has a long history of "mimicking" many aspects of motor, behavioral, and neurochemical changes observed in Huntington's disease patients. In this issue of Neuron, Zeron et al. (2002) provide insight into the role of NMDA receptors in the cell-specific excitotoxic death observed in Huntington's disease (HD) using a HD mouse model expressing full-length mutant huntingtin (htt).	Buck Inst Age Res, Novato, CA 94945 USA	Buck Institute for Research on Aging	Ellerby, LM (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.							BEAL MF, 1985, BRAIN RES, V361, P135; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Chen NS, 1999, J NEUROCHEM, V72, P1890, DOI 10.1046/j.1471-4159.1999.0721890.x; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; HUANG Q, 1995, NEUROSCIENCE, V65, P397, DOI 10.1016/0306-4522(94)00494-P; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zeron MM, 2001, MOL CELL NEUROSCI, V17, P41, DOI 10.1006/mcne.2000.0909; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	12	9	9	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					841	842		10.1016/S0896-6273(02)00631-1	http://dx.doi.org/10.1016/S0896-6273(02)00631-1			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906690	Bronze			2022-12-28	WOS:000174389600001
J	Magdaleno, S; Keshvara, L; Curran, T				Magdaleno, S; Keshvara, L; Curran, T			Rescue of ataxia and preplate splitting by ectopic expression of reelin in reeler mice	NEURON			English	Article							MOUSE-BRAIN DEVELOPMENT; APOE RECEPTOR 2; CORTICAL DEVELOPMENT; CEREBRAL-CORTEX; EXTRACELLULAR-MATRIX; NEURONAL MIGRATION; MUTANT MICE; TYROSINE PHOSPHORYLATION; LAMINAR ORGANIZATION; SIGNALING PATHWAY	The gene mutated in reeler (reelin) encodes a protein secreted by neurons in the developing brain that controls laminar positioning of migrating cells in the CNS by an unknown mechanism. To investigate Reelin function, we used the nestin promoter to express Reelin ectopically in the ventricular zone and other brain regions in transgenic mice. In the presence of the endogenous protein, ectopic Reelin did not alter cell migration in the neocortex or the cerebellum. However, in the reeler background, ectopic Reelin induced tyrosine phosphorylation of Dab-1 in the ventricular zone and rescued some, but not all, of the neuroanatomic and behavioral abnormalities characteristic of reeler. These results indicate that Reelin does not function simply as a positional signal. Rather, it appears to participate in multiple events critical for neuronal migration and cell positioning.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Curran, T (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	fos1@aol.com	Curran, Tom/D-7515-2011; Curran, Thomas/AAE-7631-2019; Curran, Tom/F-5234-2018; Curran, Tom/C-1164-2008	Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551	NINDS NIH HHS [R01 NS36558] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036558] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Caviness V S Jr, 1982, Brain Res, V256, P293; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DArcangelo G, 1996, MOL BRAIN RES, V39, P234, DOI 10.1016/0169-328X(96)00046-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; DERER P, 1979, NEUROSCI LETT, V13, P195, DOI 10.1016/0304-3940(79)90041-7; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Frotscher M, 1997, CELL TISSUE RES, V290, P315, DOI 10.1007/s004410050936; Gilmore EC, 2000, CURR BIOL, V10, pR162, DOI 10.1016/S0960-9822(00)00332-8; Gilmore EC, 1998, J NEUROSCI, V18, P6370; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howe S, 1999, STAND MAG, V1, P19; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Kwon YT, 1998, J COMP NEUROL, V395, P510, DOI 10.1002/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MIKOSHIBA K, 1984, DEV NEUROSCI-BASEL, V6, P101; Miyata T, 1997, J NEUROSCI, V17, P3599; Miyata T, 1996, J COMP NEUROL, V372, P215; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; PEARLMAN AL, 1986, PROG BRAIN RES, V108, P117; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; Rice DS, 1998, DEVELOPMENT, V125, P3719; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Searle S.R., 1987, LINEAR MODELS UNBALA; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; TERASHIMA T, 1986, J COMP NEUROL, V252, P264, DOI 10.1002/cne.902520209; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; WASSEF M, 1985, DEV BIOL, V111, P129, DOI 10.1016/0012-1606(85)90441-5; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	48	139	145	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 14	2002	33	4					573	586		10.1016/S0896-6273(02)00582-2	http://dx.doi.org/10.1016/S0896-6273(02)00582-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856531	Bronze			2022-12-28	WOS:000173911100010
J	Murai, KK; Pasquale, EB				Murai, KK; Pasquale, EB			Can Eph receptors stimulate the mind?	NEURON			English	Review							TYROSINE KINASES; PROTEINS; MEMBRANE; LIGANDS	The Eph receptors are multitalented tyrosine kinases capable of performing many tasks. The receptors together with their ligands-the ephrins-are well known to play a critical role in the initial assembly of neuronal circuits in the embryo. However, the recently discovered function of these receptors in the adult brain is now receiving significant acclaim. Three new articles show that the Eph receptors continue to be important in modifying the strength of existing neuronal connections (synapses). They do so in close association with at least one family of ion channels, the NMDA receptors.	Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Pasquale, EB (corresponding author), Burnham Inst, Neurobiol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Gerlai R, 1999, J NEUROSCI, V19, P9538; Gerlai R, 2000, BEHAV BRAIN RES, V108, P133, DOI 10.1016/S0166-4328(99)00139-4; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; Moreno-Flores MT, 1999, NEUROSCIENCE, V91, P193, DOI 10.1016/S0306-4522(98)00568-5; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; TAKASU MA, 2001, IN PRESS SCIENCE; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Yu HH, 2001, ONCOGENE, V20, P3995, DOI 10.1038/sj.onc.1204524	22	52	55	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					159	162		10.1016/S0896-6273(02)00565-2	http://dx.doi.org/10.1016/S0896-6273(02)00565-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804564	Bronze			2022-12-28	WOS:000173387700004
J	Luo, M; Katz, LC				Luo, M; Katz, LC			Response correlation maps of neurons in the mammalian olfactory bulb	NEURON			English	Article							MITRAL TUFTED CELLS; CAT STRIATE CORTEX; ODOR STIMULATION; MITRAL/TUFTED CELLS; RECEPTIVE-FIELDS; GLOMERULAR LAYER; ORGANIZATION; SALAMANDER; REPRESENTATIONS; COMBINATORIAL	To define the relationship between glomerular activation patterns and neuronal olfactory responses in the main olfactory bulb, intracellular recordings were combined with optical imaging of intrinsic signals. Response correlation maps (RCMs) were constructed by correlating the fluctuations in membrane potential and firing rate during odorant presentations with patterns of glomerular activation. The RCMs indicated that mitral/tufted cells were excited by activation of a focal region surrounding their principal glomerulus and generally inhibited by activation of more distant regions. However, the structure of the RCMs and the relative contribution of excitatory and inhibitory glomerular input evolved and even changed sign during and after odorant application. These data suggest a dynamic center-surround organization of mitral/tufted cell receptive fields.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Luo, M (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.			Luo, Minmin/0000-0003-3535-6624				BAIER H, 1994, J NEUROSCI, V14, P219; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; BUONVISO N, 1991, J COMP NEUROL, V307, P57, DOI 10.1002/cne.903070106; Buonviso N, 1996, J NEUROPHYSIOL, V76, P2393, DOI 10.1152/jn.1996.76.4.2393; BUONVISO N, 1992, J NEUROPHYSIOL, V68, P417, DOI 10.1152/jn.1992.68.2.417; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chalansonnet M, 1998, CHEM SENSES, V23, P1; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; DAWIS S, 1984, VISION RES, V24, P549, DOI 10.1016/0042-6989(84)90109-3; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; Delaney K, 2001, EUR J NEUROSCI, V13, P1658, DOI 10.1046/j.1460-9568.2001.01545.x; DEMONASTERIO FM, 1979, BRAIN RES, V166, P39, DOI 10.1016/0006-8993(79)90647-4; DOVING KB, 1966, J PHYSIOL-LONDON, V186, P97; EZEH PI, 1993, J NEUROPHYSIOL, V70, P263, DOI 10.1152/jn.1993.70.1.263; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HAMILTON KA, 1989, J NEUROPHYSIOL, V62, P609, DOI 10.1152/jn.1989.62.3.609; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Jenison RL, 2001, J NEUROSCI, V21, P4408, DOI 10.1523/JNEUROSCI.21-12-04408.2001; JIANG T, 1992, J NEUROPHYSIOL, V68, P726, DOI 10.1152/jn.1992.68.3.726; Johnson BA, 2000, J COMP NEUROL, V426, P330, DOI 10.1002/1096-9861(20001016)426:2<330::AID-CNE12>3.0.CO;2-5; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P717, DOI 10.1113/jphysiol.1974.sp010773; King JR, 2000, J NEUROSCI, V20, P2391; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Laurent G, 1997, CURR OPIN NEUROBIOL, V7, P547, DOI 10.1016/S0959-4388(97)80035-9; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MCLEAN J, 1994, VISUAL NEUROSCI, V11, P271, DOI 10.1017/S0952523800001632; Meister M, 2001, J NEUROSCI, V21, P1351; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1982, J NEUROSCI, V2, P497; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mori Kensaku, 1994, Seminars in Cell Biology, V5, P65, DOI 10.1006/scel.1994.1009; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; WILSON DA, 1987, BRAIN RES, V417, P175, DOI 10.1016/0006-8993(87)90196-X; Wilson DA, 2001, CHEM SENSES, V26, P577, DOI 10.1093/chemse/26.5.577; Wilson DA, 2000, J NEUROPHYSIOL, V84, P3036, DOI 10.1152/jn.2000.84.6.3036; Xu FQ, 2000, J COMP NEUROL, V422, P489, DOI 10.1002/1096-9861(20000710)422:4<489::AID-CNE1>3.0.CO;2-#; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yoshihara Y, 2001, SCIENCE, V291, P835, DOI 10.1126/science.1058773	68	139	142	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1165	1179		10.1016/S0896-6273(01)00537-2	http://dx.doi.org/10.1016/S0896-6273(01)00537-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754845	Bronze			2022-12-28	WOS:000172886800020
J	Beaumont, V; Zhong, N; Fletcher, R; Froemke, RC; Zucker, RS				Beaumont, V; Zhong, N; Fletcher, R; Froemke, RC; Zucker, RS			Phosphorylation and local presynaptic protein synthesis in calcium- and calcineurin-dependent induction of crayfish long-term facilitation	NEURON			English	Article							LATE-PHASE LTP; NEUROMUSCULAR-JUNCTION; NERVE-TERMINALS; SYNAPTIC TRANSMISSION; TRANSMITTER RELEASE; GLUTAMATE RECEPTORS; HIPPOCAMPAL SLICES; MOTOR SYNAPSES; REQUIRING CAMP; VISUAL-CORTEX	Long-term facilitation at the crayfish opener muscle is elicited by prolonged high frequency stimulation, and arises from an increase in functional active zones, resulting in increased transmitter release. LTF induction depends critically upon presynaptic calcium accumulation and calcineurin (PP2B) activity. The protein synthesis dependence of this synaptic strengthening was investigated. LTF occurred without transcription, but the translation inhibitors cycloheximide and anisomycin, or local presynaptic injection of mRNA cap analog m(7)GpppG, impaired LTF expression. Both MAP kinase and phosphatidylinositol 3-OH kinase (PI3K) activation are implicated in this rapamycin-sensitive synaptic potentiation. This study defines an important role for protein synthesis in the expression of activity-dependent plasticity, and provides mechanistic insight for the induction of this process at presynaptic sites.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Beaumont, V (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Hills Rd, Cambridge CB2 2QH, England.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343; Beaumont, Vahri/0000-0002-6488-2175; Zhong, Ning/0000-0002-3696-5301; Froemke, Robert/0000-0002-1230-6811				Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Amaldi F, 1997, Prog Mol Subcell Biol, V18, P1; ATWOOD HL, 1975, BRAIN RES, V100, P198, DOI 10.1016/0006-8993(75)90260-7; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Bradley J, 1999, BRAIN RES, V815, P140, DOI 10.1016/S0006-8993(98)01112-3; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Crispino M, 1997, J NEUROSCI, V17, P7694; Crow T, 1999, J NEUROPHYSIOL, V82, P495, DOI 10.1152/jn.1999.82.1.495; DELANEY K, 1991, J NEUROSCI, V11, P2631; DELANEY KR, 1989, J NEUROSCI, V9, P3558; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hodgkiss JP, 1995, BRAIN RES, V705, P241, DOI 10.1016/0006-8993(95)01168-4; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Khan A, 2001, J NEUROSCI, V21, P382, DOI 10.1523/JNEUROSCI.21-02-00382.2001; Lazarovici P, 1996, ADV EXP MED BIOL, V391, P367; LNENICKA GA, 1985, J NEUROBIOL, V16, P97, DOI 10.1002/neu.480160203; Lu YF, 1999, J NEUROSCI, V19, P10250; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin R, 1998, J CELL SCI, V111, P3157; Merlin LR, 1998, J NEUROPHYSIOL, V80, P989, DOI 10.1152/jn.1998.80.2.989; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; MULKEY RM, 1991, NATURE, V350, P153, DOI 10.1038/350153a0; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MULLER D, 1995, NEURON, V14, P599, DOI 10.1016/0896-6273(95)90316-X; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Parnas I, 1996, EUR J NEUROSCI, V8, P116, DOI 10.1111/j.1460-9568.1996.tb01172.x; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Roberts LA, 1998, MOL BRAIN RES, V56, P38, DOI 10.1016/S0169-328X(98)00026-6; Schilhab TSS, 1996, NEUROSCIENCE, V73, P999, DOI 10.1016/0306-4522(96)00068-1; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sotelo JR, 1999, NEUROSCIENCE, V90, P705, DOI 10.1016/S0306-4522(98)00587-9; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Sutton MA, 2000, NEURON, V26, P219, DOI 10.1016/S0896-6273(00)81152-6; TORII N, 1995, NEUROSCI LETT, V185, P1, DOI 10.1016/0304-3940(94)11210-A; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; WOJTOWICZ JM, 1994, J NEUROSCI, V14, P3688; WOJTOWICZ JM, 1988, J NEUROSCI, V8, P4667; WOJTOWICZ JM, 1988, NEUROSCI LETT, V90, P152, DOI 10.1016/0304-3940(88)90803-8; WOJTOWICZ JM, 1986, J NEUROPHYSIOL, V55, P484, DOI 10.1152/jn.1986.55.3.484; WOJTOWICZ JM, 1985, J NEUROPHYSIOL, V54, P220, DOI 10.1152/jn.1985.54.2.220; Xie KW, 1997, J NEUROSCI, V17, P2947; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	59	75	76	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					489	501		10.1016/S0896-6273(01)00483-4	http://dx.doi.org/10.1016/S0896-6273(01)00483-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709159	Bronze			2022-12-28	WOS:000172119100014
J	Hao, JC; Yu, TW; Fujisawa, K; Culotti, JG; Gengyo-Ando, K; Mitani, S; Moulder, G; Barstead, R; Tessier-Lavigne, M; Bargmann, CI				Hao, JC; Yu, TW; Fujisawa, K; Culotti, JG; Gengyo-Ando, K; Mitani, S; Moulder, G; Barstead, R; Tessier-Lavigne, M; Bargmann, CI			C-elegans slit acts in midline, dorsal-ventral, and anterior-posterior guidance via the SAX-3/Robo receptor	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; AXON GUIDANCE; TRANSMEMBRANE PROTEIN; NEURONAL MIGRATION; VERTEBRATE SLIT; SEMAPHORIN-III; CELL LINEAGE; NETRIN CUES; GENES; MORPHOGENESIS	Robo receptors interact with ligands of the Slit family. The nematode C. elegans has one Robo receptor (SAX-3) and one Slit protein (SLT-1), which direct ventral axon guidance and guidance at the midline. In larvae, slt-1 expression in dorsal muscles repels axons to promote ventral guidance. SLT-1 acts through the SAX-3 receptor, in parallel with the ventral attractant UNC-6 (Netrin). Removing both UNC-6 and SLT-1 eliminates all ventral guidance information for some axons, revealing an underlying longitudinal guidance pathway. In the embryo, slt-1 is expressed at high levels in anterior epidermis. Embryonic expression of SLT-1 provides anterior-posterior guidance information to migrating CAN neurons. Surprisingly, slt-1 mutants do not exhibit the nerve ring and epithelial defects of sax-3 mutants, suggesting that SAX-3 has both Slit-dependent and Slit-independent functions in development.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Neurosci, San Francisco, CA 94143 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; Japan Sci & Technol Corp, PRESTO, Tokyo 1628666, Japan; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Tokyo Women's Medical University; Japan Science & Technology Agency (JST); Oklahoma Medical Research Foundation	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu	Gengyo-Ando, Keiko/AAC-4504-2019; Yu, Timothy W./AAF-5738-2019; Gengyo-Ando, Keiko/B-2753-2012; Culotti, Joseph/G-6467-2013	Yu, Timothy W./0000-0003-2988-7701; Bargmann, Cornelia/0000-0002-8484-0618; Culotti, Joseph/0000-0001-6325-4612				Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Battye R, 2001, J NEUROSCI, V21, P4290, DOI 10.1523/JNEUROSCI.21-12-04290.2001; BRENNER S, 1974, GENETICS, V77, P71; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Erskine L, 2000, J NEUROSCI, V20, P4975; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Forrester WC, 1998, GENETICS, V148, P151; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Graham PL, 1997, J CELL BIOL, V137, P1171, DOI 10.1083/jcb.137.5.1171; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sym M, 1999, CELL, V98, P25, DOI 10.1016/S0092-8674(00)80603-0; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WilliamsMasson EM, 1997, DEVELOPMENT, V124, P2889; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; [No title captured]	50	180	194	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					25	38		10.1016/S0896-6273(01)00448-2	http://dx.doi.org/10.1016/S0896-6273(01)00448-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604136	Bronze			2022-12-28	WOS:000171525200006
J	Klyachko, VA; Ahern, GP; Jackson, MB				Klyachko, VA; Ahern, GP; Jackson, MB			CGMP-mediated facilitation in nerve terminals by enhancement of the spike afterhyperpolarization	NEURON			English	Article							LONG-TERM POTENTIATION; NITRIC-OXIDE; INTRACELLULAR CALCIUM; TRANSMITTER RELEASE; POTASSIUM CHANNELS; CYCLIC-GMP; INDUCTION; DEPOLARIZATION; ARBORIZATION; VASOPRESSIN	cGMP has long been suspected to play a role in synaptic plasticity, but the inaccessibility of nerve terminals to electrical recording has impeded tests of this hypothesis. In posterior pituitary nerve terminals, nitric oxide enhanced Ca2+-activated K+ channel activity by activating guanylate cyclase and PKG. This enhancement occured only at depolarized potentials, so the spike threshold remained unaltered but the afterhyperpolarization became larger. During spike trains, the enhanced afterhyperpolarization promoted Na+ channel recovery from inactivation, thus reducing action potential failures and allowing more Ca2+ to enter. Activating guanylate cyclase, either with applied nitric oxide, or with physiological stimulation to activate nitric oxide synthase, increased action potential firing. Thus, the cGMP/nitric oxide cascade generates a shortterm, use-dependent enhancement of release.	Univ Wisconsin, Dept Physiol & Biophys, PhD Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Jackson, MB (corresponding author), Univ Wisconsin, Dept Physiol & Biophys, PhD Program, 1300 Univ Ave, Madison, WI 53706 USA.	mjackson@physiology.wisc.edu	Klyachko, Vitaly/E-9431-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030016, R01NS030016] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 30016] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern GP, 1999, J PHYSIOL-LONDON, V520, P165, DOI 10.1111/j.1469-7793.1999.00165.x; Ahern GP, 2000, J BIOL CHEM, V275, P28810, DOI 10.1074/jbc.M003090200; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BIELEFELDT K, 1993, J NEUROPHYSIOL, V70, P284, DOI 10.1152/jn.1993.70.1.284; BIELEFELDT K, 1994, J PHYSIOL-LONDON, V475, P241, DOI 10.1113/jphysiol.1994.sp020065; BIELEFELDT K, 1992, J PHYSIOL-LONDON, V458, P41, DOI 10.1113/jphysiol.1992.sp019405; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BOURQUE CW, 1990, J PHYSIOL-LONDON, V421, P247, DOI 10.1113/jphysiol.1990.sp017943; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BRETHES D, 1987, P NATL ACAD SCI USA, V84, P1439, DOI 10.1073/pnas.84.5.1439; Broillet MC, 1997, NEURON, V18, P951, DOI 10.1016/S0896-6273(00)80334-7; Calabresi P, 1999, J NEUROSCI, V19, P2489; CHARLTON MP, 1978, J GEN PHYSIOL, V72, P487, DOI 10.1085/jgp.72.4.487; Chen CH, 1998, NEUROSCI LETT, V248, P127, DOI 10.1016/S0304-3940(98)00316-4; DERRICK BE, 1991, BRAIN RES BULL, V27, P219, DOI 10.1016/0361-9230(91)90071-Q; DEVENTE J, 1992, ACTA HISTOCHEM, V92, P13, DOI 10.1016/S0065-1281(11)80138-8; GAINER H, 1986, NEUROENDOCRINOLOGY, V43, P557, DOI 10.1159/000124582; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; GRAHAM B, 1994, J NEUROPHYSIOL, V71, P538, DOI 10.1152/jn.1994.71.2.538; Hindley S, 1997, J NEUROSCI RES, V47, P427; Holscher C, 1997, TRENDS NEUROSCI, V20, P298, DOI 10.1016/S0166-2236(97)01065-5; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; Hsu SF, 1999, J NEUROSCI METH, V90, P67, DOI 10.1016/S0165-0270(99)00071-0; JACKSON MB, 1993, J NEUROPHYSIOL, V69, P692, DOI 10.1152/jn.1993.69.3.692; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; JACKSON MB, 1995, J PHYSIOL-LONDON, V483, P597, DOI 10.1113/jphysiol.1995.sp020609; KHARITONOV VG, 1995, J BIOL CHEM, V270, P28158; Lei SB, 2000, NAT NEUROSCI, V3, P559, DOI 10.1038/75729; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; MURPHY KPSJ, 1994, NEUROPHARMACOLOGY, V33, P1375, DOI 10.1016/0028-3908(94)90039-6; Muschol M, 2000, J NEUROSCI, V20, P6773, DOI 10.1523/JNEUROSCI.20-18-06773.2000; Obaid AL, 1996, J GEN PHYSIOL, V107, P353, DOI 10.1085/jgp.107.3.353; OGILVIE P, 1995, FASEB J, V9, P799, DOI 10.1096/fasebj.9.9.7541381; PACKER L, 1996, NITRIC OXIDE, V268; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; RENAUD LP, 1991, PROG NEUROBIOL, V36, P131, DOI 10.1016/0301-0082(91)90020-2; Rudy B, 1999, ANN NY ACAD SCI, V868, P304, DOI 10.1111/j.1749-6632.1999.tb11295.x; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SCHUMAN EM, 1994, P NATL ACAD SCI USA, V91, P11958, DOI 10.1073/pnas.91.25.11958; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; Son H, 1996, CELL, V87, P1015, DOI 10.1016/S0092-8674(00)81796-1; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STUENKEL EL, 1990, BRAIN RES, V529, P96, DOI 10.1016/0006-8993(90)90815-S; STUENKEL EL, 1994, J PHYSIOL-LONDON, V481, P251, DOI 10.1113/jphysiol.1994.sp020436; Swayze RD, 2001, J BIOL CHEM, V276, P19729, DOI 10.1074/jbc.M005711200; VALE MR, 1982, J NEUROCHEM, V39, P569, DOI 10.1111/j.1471-4159.1982.tb03983.x; WANG G, 1992, J PHYSIOL-LONDON, V457, P47, DOI 10.1113/jphysiol.1992.sp019364; White RE, 1999, ADV SEC MESS PHOSPH, V33, P251; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; ZHANG SLJ, 1993, SCIENCE, V259, P531, DOI 10.1126/science.8380942; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; ZUCKER RS, 1974, J PHYSIOL-LONDON, V241, P111, DOI 10.1113/jphysiol.1974.sp010643	57	62	67	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2001	31	6					1015	1025		10.1016/S0896-6273(01)00449-4	http://dx.doi.org/10.1016/S0896-6273(01)00449-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580900	Bronze			2022-12-28	WOS:000171281300015
J	Burgess, N; Maguire, EA; O'Keefe, J				Burgess, N; Maguire, EA; O'Keefe, J			The human hippocampus and spatial and episodic memory	NEURON			English	Review							UNILATERAL TEMPORAL-LOBE; IMPAIRED RECOGNITION MEMORY; HEAD-DIRECTION CELLS; RETROGRADE-AMNESIA; WORKING-MEMORY; FRONTAL-LOBE; PLACE CELLS; DEVELOPMENTAL AMNESIA; OBJECT-RECOGNITION; HUMAN NAVIGATION	Finding one's way around an environment and remembering the events that occur within it are crucial cognitive abilities that have been linked to the hippocampus and medial temporal lobes. Our review of neuropsychological, behavioral, and neuroimaging studies of human hippocampal involvement in spatial memory concentrates on three important concepts in this field: spatial frameworks, dimensionality, and orientation and self-motion. We also compare variation in hippocampal structure and function across and within species. We discuss how its spatial role relates to its accepted role in episodic memory. Five related studies use virtual reality to examine these two types of memory in ecologically valid situations. While processing of spatial scenes involves the parahippocampus, the right hippocampus appears particularly involved in memory for locations within an environment, with the left hippocampus more involved in context-dependent episodic or autobiographical memory.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Anat & Dev Biol, London WC1N 3AR, England; UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	Burgess, N (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	n.burgess@ucl.ac.uk	Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584	MRC [G117/433] Funding Source: UKRI; Medical Research Council [G117/433] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; Abrahams S, 1999, BRAIN COGNITION, V41, P39, DOI 10.1006/brcg.1999.1095; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aguirre GK, 1997, J NEUROSCI, V17, P2512; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; [Anonymous], 1983, CANADIAN PSYCHOL; Arthur EJ, 1997, ERGONOMICS, V40, P69, DOI 10.1080/001401397188387; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; Bachevalier J, 1996, HIPPOCAMPUS, V6, P553, DOI 10.1002/(SICI)1098-1063(1996)6:5<553::AID-HIPO8>3.0.CO;2-J; Baddeley A.D., 1980, ATTENTION PERFORM, VVIII, P521, DOI DOI 10.4324/9781315793252; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; BARR WB, 1990, NEUROPSYCHOLOGIA, V28, P243, DOI 10.1016/0028-3932(90)90018-J; Baxendale SA, 1998, EPILEPSIA, V39, P158, DOI 10.1111/j.1528-1157.1998.tb01353.x; Baxendale SA, 1998, NEUROPSYCHOLOGIA, V36, P591, DOI 10.1016/S0028-3932(97)00163-2; Becker S, 2001, ADV NEUR IN, V13, P96; BISIACH E, 1978, CORTEX, V14, P129, DOI 10.1016/S0010-9452(78)80016-1; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Brooks BM, 1999, NEUROPSYCHOL REHABIL, V9, P63, DOI 10.1080/713755589; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Burgess N, 2001, PHILOS T R SOC B, V356, P1493, DOI 10.1098/rstb.2001.0948; Burgess N, 2001, NEUROIMAGE, V14, P439, DOI 10.1006/nimg.2001.0806; Burgess N, 2002, Q J EXP PSYCHOL-A, V55, P1057, DOI 10.1080/02724980244000224; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Burgess N, 1999, HIPPOCAMPAL PARIETAL, P3; BURGESS N, 2001, INT ENCY SOCIAL BEHA, P10417; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; Chan D, 2001, ANN NEUROL, V49, P433, DOI 10.1002/ana.92.abs; Chance SS, 1998, PRESENCE-TELEOP VIRT, V7, P168, DOI 10.1162/105474698565659; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; CHRISTOU CG, 1999, 75 MPI, P1; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cressant A, 1997, J NEUROSCI, V17, P2531; DEJONG BM, 1994, BRAIN, V117, P1039; DELLAROCCHETTA AI, 1993, NEUROPSYCHOLOGIA, V31, P503; Diwadkar VA, 1997, PSYCHOL SCI, V8, P302, DOI 10.1111/j.1467-9280.1997.tb00442.x; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; EASTON RD, 1995, J EXP PSYCHOL LEARN, V21, P483, DOI 10.1037/0278-7393.21.2.483; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Eichenbaum H, 1999, BEHAV BRAIN RES, V103, P123, DOI 10.1016/S0166-4328(99)00044-3; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Emery NJ, 2001, NATURE, V414, P443, DOI 10.1038/35106560; Epstein R, 2001, COGNITIVE NEUROPSYCH, V18, P481, DOI 10.1080/02643290125929; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Etienne AS, 1996, J EXP BIOL, V199, P201; Feigenbaum JD, 1996, NEUROPSYCHOLOGIA, V34, P163, DOI 10.1016/0028-3932(95)00107-7; Fink GR, 1996, J NEUROSCI, V16, P4275; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P349, DOI 10.1016/0028-3932(90)90061-R; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; GARDINER JM, 1991, MEM COGNITION, V19, P617, DOI 10.3758/BF03197157; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Ghaem O, 1997, NEUROREPORT, V8, P739, DOI 10.1097/00001756-199702100-00032; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; GUARIGLIA C, 1993, NATURE, V364, P235, DOI 10.1038/364235a0; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Hermer-Vazquez L, 1999, COGNITIVE PSYCHOL, V39, P3, DOI 10.1006/cogp.1998.0713; HOKKANEN L, 1995, PSYCHOL MED, V25, P203, DOI 10.1017/S0033291700028245; Holdstock JS, 2002, NEUROPSYCHOLOGIA, V40, P748, DOI 10.1016/S0028-3932(01)00192-0; Holdstock JS, 2000, NEUROPSYCHOLOGIA, V38, P410, DOI 10.1016/S0028-3932(99)00099-8; Holdstock JS, 2000, CORTEX, V36, P301, DOI 10.1016/S0010-9452(08)70843-8; HYVARINEN J, 1974, BRAIN, V97, P673, DOI 10.1093/brain/97.1.673; Jacobs WJ, 1998, LEARN MOTIV, V29, P288, DOI 10.1006/lmot.1998.1008; Jacobs WJ, 1997, LEARN MOTIV, V28, P521, DOI 10.1006/lmot.1997.0977; Johnsrude IS, 1999, NEUROPSYCHOLOGIA, V37, P829, DOI 10.1016/S0028-3932(98)00136-5; Kapur N, 1997, BRAIN COGNITION, V35, P58, DOI 10.1006/brcg.1997.0927; KING JA, 2002, IN PRESS HIPPOCAMPUS; Klatzky RL, 1998, PSYCHOL SCI, V9, P293, DOI 10.1111/1467-9280.00058; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; KNOWLTON BJ, 1995, J EXP PSYCHOL LEARN, V21, P699, DOI 10.1037/0278-7393.21.3.699; Kolb B, 1996, FUNDAMENTALS HUMAN N; Kopelman MD, 1998, NEUROPSYCHOLOGIA, V36, P785, DOI 10.1016/S0028-3932(97)00167-X; Kosslyn S.M., 1994, IMAGE BRAIN RESOLUTI; KREBS JR, 1989, P NATL ACAD SCI USA, V86, P1388, DOI 10.1073/pnas.86.4.1388; Lavenex P, 2000, EUR J NEUROSCI, V12, P643, DOI 10.1046/j.1460-9568.2000.00949.x; Learmonth AE, 2001, J EXP CHILD PSYCHOL, V80, P225, DOI 10.1006/jecp.2001.2635; Lee DW, 1998, NEUROREPORT, V9, pR15; Maguire EA, 1999, CURR OPIN NEUROBIOL, V9, P171, DOI 10.1016/S0959-4388(99)80023-3; Maguire EA, 1998, J NEUROL NEUROSUR PS, V65, P903, DOI 10.1136/jnnp.65.6.903; Maguire EA, 2001, BRAIN, V124, P1156, DOI 10.1093/brain/124.6.1156; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 1996, P ROY SOC B-BIOL SCI, V263, P1745, DOI 10.1098/rspb.1996.0255; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Maguire EA, 1996, NEUROPSYCHOLOGIA, V34, P993, DOI 10.1016/0028-3932(96)00022-X; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 1997, J NEUROSCI, V17, P7103; Maguire EA, 1999, HIPPOCAMPUS, V9, P54, DOI 10.1002/(SICI)1098-1063(1999)9:1<54::AID-HIPO6>3.0.CO;2-O; Maguire EA, 2001, NEUROREPORT, V12, P441, DOI 10.1097/00001756-200103050-00004; Maguire EA, 2000, HIPPOCAMPUS, V10, P475; Manns JR, 1999, HIPPOCAMPUS, V9, P495, DOI 10.1002/(SICI)1098-1063(1999)9:5<495::AID-HIPO2>3.0.CO;2-O; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Matsumura N, 1999, J NEUROSCI, V19, P2381; Mayes AR, 2001, COGNITIVE NEUROPSYCH, V18, P97, DOI 10.1080/02643290125897; McCarthy RA, 1996, J NEUROL NEUROSUR PS, V60, P318, DOI 10.1136/jnnp.60.3.318; Milner A. D., 1999, HIPPOCAMPAL PARIETAL, P443; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Moffat SD, 1998, EVOL HUM BEHAV, V19, P73, DOI 10.1016/S1090-5138(97)00104-9; Morris R, 2000, J COMP NEUROL, V421, P14, DOI 10.1002/(SICI)1096-9861(20000522)421:1<14::AID-CNE2>3.0.CO;2-S; MORRIS RG, 1999, HIPPOCAMPAL PARIETAL, P259; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Mou WM, 2002, J EXP PSYCHOL LEARN, V28, P162, DOI 10.1037//0278-7393.28.1.162; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1994, J NEUROSCI, V14, P7235; Mumby DG, 1996, BEHAV NEUROSCI, V110, P266, DOI 10.1037/0735-7044.110.2.266; MURRAY EA, 1989, EXP BRAIN RES, V74, P173; Murray EA, 1998, J NEUROSCI, V18, P6568; Nunn JA, 1998, NEUROPSYCHOLOGIA, V36, P837, DOI 10.1016/S0028-3932(98)00030-X; Nunn JA, 1999, BRAIN, V122, P47, DOI 10.1093/brain/122.1.47; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; O'Keefe J, 1999, HIPPOCAMPUS, V9, P352, DOI 10.1002/(SICI)1098-1063(1999)9:4<352::AID-HIPO3>3.0.CO;2-1; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Keefe J., 1996, LANGUAGE SPACE, P277; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1979, BEHAV BRAIN SCI, V2, P487, DOI 10.1017/S0140525X00063949; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Owen AM, 1996, BRAIN, V119, P1597, DOI 10.1093/brain/119.5.1597; Patel SN, 1997, BEHAV BRAIN RES, V89, P115, DOI 10.1016/S0166-4328(97)00051-X; PIGOTT S, 1993, NEUROPSYCHOLOGIA, V31, P1, DOI 10.1016/0028-3932(93)90076-C; REGIAN JW, 1994, J ENVIRON PSYCHOL, V14, P211; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rolls ET, 1997, EUR J NEUROSCI, V9, P1789, DOI 10.1111/j.1460-9568.1997.tb01538.x; Ruddle RA, 1997, J EXP PSYCHOL-APPL, V3, P143, DOI 10.1037/1076-898X.3.2.143; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SEIDENBERG M, 1993, BRAIN LANG, V44, P191, DOI 10.1006/brln.1993.1013; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; SHERRY DF, 1992, TRENDS NEUROSCI, V15, P298, DOI 10.1016/0166-2236(92)90080-R; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Silverman I, 1992, ADAPTED MIND EVOLUTI, P487; Simons DJ, 1998, PSYCHOL SCI, V9, P315, DOI 10.1111/1467-9280.00062; SMITH ML, 1995, NEUROPSYCHOLOGIA, V33, P275; SMITH ML, 1989, NEUROPSYCHOLOGIA, V27, P71, DOI 10.1016/0028-3932(89)90091-2; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; SMULDERS TV, 1995, J NEUROBIOL, V27, P15, DOI 10.1002/neu.480270103; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Spiers HJ, 2001, HIPPOCAMPUS, V11, P715, DOI 10.1002/hipo.1087; Spiers HJ, 2001, BRAIN, V124, P2476, DOI 10.1093/brain/124.12.2476; Spiers HJ, 2001, NEUROCASE, V7, P357, DOI 10.1076/neur.7.5.357.16245; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Tanaka Y, 1999, NEUROLOGY, V53, P344, DOI 10.1212/WNL.53.2.344; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; TAUBE JS, 1990, J NEUROSCI, V10, P420; Tulving E, 2001, PHILOS T R SOC B, V356, P1505, DOI 10.1098/rstb.2001.0937; Tulving E., 1993, CURRENT DIRECTIONS P, V2, P67, DOI [10.1111/1467-8721.ep10770899, DOI 10.1111/1467-8721.EP10770899]; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Viskontas IV, 2000, J NEUROSCI, V20, P5853, DOI 10.1523/JNEUROSCI.20-15-05853.2000; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wang RXF, 2000, COGNITION, V77, P215, DOI 10.1016/S0010-0277(00)00105-0; Wang RXF, 1999, COGNITION, V70, P191; Wang RXF, 1999, BEHAV NEUROSCI, V113, P475, DOI 10.1037/0735-7044.113.3.475; Warrington E., 1996, CAMDEN MEMORY TESTS; WHITELEY AM, 1978, J NEUROL NEUROSUR PS, V41, P575, DOI 10.1136/jnnp.41.6.575; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wilson PN, 1996, DISABIL REHABIL, V18, P633, DOI 10.3109/09638289609166328; Witmer B. G., 1994, 1014 US ARM RES I BE; Witmer BG, 1996, INT J HUM-COMPUT ST, V45, P413, DOI 10.1006/ijhc.1996.0060; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P144, DOI 10.1162/105474698565640; Wood F., 1975, SHORT TERM MEMORY, P257; Worsley CL, 2001, NEUROPSYCHOLOGIA, V39, P452, DOI 10.1016/S0028-3932(00)00140-8; Wraga M, 2000, J EXP PSYCHOL LEARN, V26, P151, DOI 10.1037/0278-7393.26.1.151; Zhu XO, 1996, NEUROREPORT, V7, P1871, DOI 10.1097/00001756-199607290-00037; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	178	1532	1561	15	444	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					625	641		10.1016/S0896-6273(02)00830-9	http://dx.doi.org/10.1016/S0896-6273(02)00830-9			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	585JE	12194864	Bronze			2022-12-28	WOS:000177521000005
J	Freeman, TCB; Durand, S; Kiper, DC; Carandini, M				Freeman, TCB; Durand, S; Kiper, DC; Carandini, M			Suppression without inhibition in visual cortex	NEURON			English	Article							CAT STRIATE CORTEX; LATERAL GENICULATE-NUCLEUS; CROSS-ORIENTATION INHIBITION; NEUROTRANSMITTER RELEASE PROBABILITY; UNDERLYING CONTRAST ADAPTATION; RETINAL GANGLION-CELLS; CORTICAL-NEURONS; TEMPORAL INTERACTIONS; GAIN-CONTROL; AREA 17	Neurons in primary visual cortex (V1) are thought to receive inhibition from other V1 neurons selective for a variety of orientations. Evidence for this inhibition is commonly found in cross-orientation suppression: responses of a V1 neuron to optimally oriented bars are suppressed by superimposed mask bars of different orientation. We show, however, that suppression is unlikely to result from intracortical inhibition. First, suppression can be obtained with masks drifting too rapidly to elicit much of a response in cortex. Second, suppression is immune to hyperpolarization (through visual adaptation) of cortical neurons responding to the mask. Signals mediating suppression might originate in thalamus, rather than in cortex. Thalamic neurons exhibit some suppression; additional suppression might arise from depression at thalamocortical synapses. The mechanisms of suppression are subcortical and possibly include the very first synapse into cortex.	Univ Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Carandini, M (corresponding author), Univ Zurich, Inst Neuroinformat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		freeman, tobe/GZN-0356-2022; Carandini, Matteo/C-1922-2008; Carandini, Matteo/ABD-8296-2021	freeman, tobe/0000-0002-1883-958X; Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Allison JD, 2001, VISUAL NEUROSCI, V18, P941, DOI 10.1017/S0952523801186116; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2001, J NEUROSCI, V21, P2104, DOI 10.1523/JNEUROSCI.21-06-02104.2001; BAUMAN LA, 1991, VISION RES, V31, P933, DOI 10.1016/0042-6989(91)90201-F; BENEVENTO LA, 1972, NATURE-NEW BIOL, V238, P124, DOI 10.1038/newbio238124a0; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Boynton GM, 1999, VISION RES, V39, P1641, DOI 10.1016/S0042-6989(98)00199-0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Chance FS, 1998, J NEUROSCI, V18, P4785; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; Crook JM, 1998, EUR J NEUROSCI, V10, P2056, DOI 10.1046/j.1460-9568.1998.00218.x; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DOUGLAS RJ, 1988, NATURE, V332, P642, DOI 10.1038/332642a0; EYSEL UT, 1990, EXP BRAIN RES, V80, P626; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P217, DOI 10.1113/jphysiol.1985.sp015821; FERSTER D, 1988, J NEUROSCI, V8, P1172; Foley John M., 1997, Vision Research, V37, P2779, DOI 10.1016/S0042-6989(97)00081-3; GILBERT CD, 1975, J COMP NEUROL, V163, P81, DOI 10.1002/cne.901630106; GRIEVE KL, 1991, EXP BRAIN RES, V87, P521; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; IKEDA H, 1975, EXP BRAIN RES, V22, P363; Kayser A, 2001, J NEUROPHYSIOL, V85, P2130, DOI 10.1152/jn.2001.85.5.2130; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Lauritzen TZ, 2001, J NEUROPHYSIOL, V86, P1803, DOI 10.1152/jn.2001.86.4.1803; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MEIER L, 2002, J VISION; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MORRONE MC, 1987, EXP BRAIN RES, V67, P635; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Muller JR, 2001, J NEUROSCI, V21, P6978, DOI 10.1523/JNEUROSCI.21-17-06978.2001; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; Murphy PC, 1999, SCIENCE, V286, P1552, DOI 10.1126/science.286.5444.1552; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; NELSON SB, 1991, J NEUROSCI, V11, P344; NELSON SB, 1991, J NEUROSCI, V11, P357; NELSON SB, 1991, J NEUROSCI, V11, P369; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; Payne BR, 2002, CAT PRIMARY VISUAL C, P1, DOI [10.1016/b978-012552104-8/50002-x, DOI 10.1016/B978-012552104-8/50002-X]; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; ROBINSON DA, 1968, PR INST ELECTR ELECT, V56, P1065, DOI 10.1109/PROC.1968.6458; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; SAUL AB, 1992, VISUAL NEUROSCI, V8, P365, DOI 10.1017/S0952523800005101; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Sengpiel F, 1998, VISION RES, V38, P2067, DOI 10.1016/S0042-6989(97)00413-6; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; SENGPIEL F, 1994, NATURE, V368, P847, DOI 10.1038/368847a0; Senn W, 2001, NEURAL COMPUT, V13, P35, DOI 10.1162/089976601300014628; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P304; SMITH MA, 2001, J VISION; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; TOLHURST DJ, 1980, EXP BRAIN RES, V38, P431; TOLHURST DJ, 1987, EXP BRAIN RES, V66, P607, DOI 10.1007/BF00270694; Troyer TW, 1998, J NEUROSCI, V18, P5908; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varela JA, 1997, J NEUROSCI, V17, P7926; Vidyasagar TR, 1996, TRENDS NEUROSCI, V19, P272, DOI 10.1016/S0166-2236(96)20027-X; Walker GA, 1998, J NEUROPHYSIOL, V79, P227, DOI 10.1152/jn.1998.79.1.227	91	162	162	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					759	771		10.1016/S0896-6273(02)00819-X	http://dx.doi.org/10.1016/S0896-6273(02)00819-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194874	Bronze			2022-12-28	WOS:000177521000015
J	Otis, TS				Otis, TS			Helping thy neighbors: Spillover at the mossy fiber glomerulus	NEURON			English	Editorial Material							SYNAPTICALLY RELEASED GLUTAMATE; TRANSPORTERS; TRANSMISSION; ACTIVATION; CURRENTS; SYNAPSE	Neurotransmitter "spillover" between neighboring synapses challenges the principle of synapse specificity. In this issue of Neuron, DiGregorio et al. (2002) show that release from neighboring presynaptic sites contributes significantly to AMPA receptor-mediated postsynaptic currents at cerebellar mossy fiber synapses. Unexpectedly, spillover is predicted to improve the reliability and reduce the variability of transmission at this glomerular synapse.	Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Otis, TS (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.							Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Diamond JS, 1997, J NEUROSCI, V17, P4672; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Overstreet LS, 1999, J NEUROSCI, V19, P9663; Wall MJ, 1998, NAT NEUROSCI, V1, P675, DOI 10.1038/3677	10	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					412	414		10.1016/S0896-6273(02)00796-1	http://dx.doi.org/10.1016/S0896-6273(02)00796-1			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165464	Bronze			2022-12-28	WOS:000177331200003
J	Pittman, AJ; Chien, CB				Pittman, AJ; Chien, CB			Understanding dorsoventral topography: Backwards and forwards	NEURON			English	Editorial Material							RETINAL AXONS	Retinal axons project to their central targets along two orthogonal topographic axes, anterior-posterior (A-P) and dorsal-ventral (D-V). While ephrin-A/EphA signaling determines A-P topography, little has been known about the molecular mechanisms guiding axons along the D-V axis. Two papers by Mann et al. and Hindges et al. in this issue of Neuron provide evidence for both forward and reverse ephrin-B/EphB signaling in regulating D-V topography.	Univ Utah, Med Ctr, Program Neurosci, Salt Lake City, UT 84132 USA; Univ Utah, Med Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Pittman, AJ (corresponding author), Univ Utah, Med Ctr, Program Neurosci, 20 North 1900 East, Salt Lake City, UT 84132 USA.							Birgbauer E, 2001, DEVELOPMENT, V128, P3041; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Mui SH, 2002, DEVELOPMENT, V129, P797; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Trowe T, 1996, DEVELOPMENT, V123, P439; WALTER J, 1987, DEVELOPMENT, V101, P909; Wilkinson DG, 2000, CURR BIOL, V10, pR447, DOI 10.1016/S0960-9822(00)00530-3	11	11	11	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					409	411		10.1016/S0896-6273(02)00797-3	http://dx.doi.org/10.1016/S0896-6273(02)00797-3			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165462	Bronze			2022-12-28	WOS:000177331200001
J	Yao, HS; Li, CY				Yao, HS; Li, CY			Clustered organization of neurons with similar extra-receptive field properties in the primary visual cortex	NEURON			English	Article							MACAQUE MONKEY; FUNCTIONAL ARCHITECTURE; INTRINSIC CONNECTIONS; CORTICAL DYNAMICS; SPATIAL SUMMATION; CAT; INTEGRATION; INHIBITION; DIRECTION; AREA-17	The primary visual cortex is organized into clusters of cells having similar classical receptive field (CRF) properties. Nonclassical, extra-receptive fields (ERFs) can either inhibit or facilitate the response elicited by stimulation within the CRF. Here, we report that in the primary visual cortex of cat, neurons with similar inhibitory or facilitatory ERF properties are also grouped into clusters. These clusters are randomly distributed in all cortical layers, with no detectable relationship with orientation and ocular dominance columns. This functional organization of neurons with respect to ERF properties may allow an efficient processing of global visual information.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, CY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.							ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; AMIR Y, 1993, J COMP NEUROL, V334, P19, DOI 10.1002/cne.903340103; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GULYAS B, 1987, J NEUROPHYSIOL, V57, P1767, DOI 10.1152/jn.1987.57.6.1767; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LI CY, 1995, J NEUROSCI METH, V57, P217, DOI 10.1016/0165-0270(94)00151-6; Li CY, 1996, NEWS PHYSIOL SCI, V11, P181; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Li CY, 1999, P NATL ACAD SCI USA, V96, P4052, DOI 10.1073/pnas.96.7.4052; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; MAFFEI L, 1976, NATURE, V264, P754, DOI 10.1038/264754a0; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; PAYNE BR, 1981, BRAIN RES, V211, P445, DOI 10.1016/0006-8993(81)90971-9; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; Shmuel A, 1996, J NEUROSCI, V16, P6945; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; TOLHURST DJ, 1981, PROC R SOC SER B-BIO, V213, P183, DOI 10.1098/rspb.1981.0061; TOOTELL RB, 1981, SCIENCE, V214, P813, DOI 10.1126/science.7292014; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0	38	44	50	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					547	553		10.1016/S0896-6273(02)00782-1	http://dx.doi.org/10.1016/S0896-6273(02)00782-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165475	Bronze			2022-12-28	WOS:000177331200014
J	Tobin, DM; Madsen, DM; Kahn-Kirby, A; Peckol, EL; Moulder, G; Barstead, R; Maricq, AV; Bargmann, CI				Tobin, DM; Madsen, DM; Kahn-Kirby, A; Peckol, EL; Moulder, G; Barstead, R; Maricq, AV; Bargmann, CI			Combinatorial expression of TRPV channel proteins defines their sensory functions and subcellular localization in C-elegans neurons	NEURON			English	Article							NUCLEOTIDE-GATED CHANNEL; PDZ-DOMAIN PROTEIN; CAENORHABDITIS-ELEGANS; CATION CHANNEL; CA2+ CHANNEL; SIGNALING COMPLEXES; GLUTAMATE; INAD; ADAPTATION; OLFACTION	C. elegans OSM-9 is a TRPV channel protein involved in sensory transduction and adaptation. Here, we show that distinct sensory functions arise from different combinations of OSM-9 and related OCR TRPV proteins. Both OSM-9 and OCR-2 are essential for several forms of sensory transduction, including olfaction, osmosensation, mechanosensation, and chemosensation. In neurons that express both OSM-9 and OCR-2, tagged OCR-2 and OSM-9 proteins reside in sensory cilia and promote each other's localization to cilia. In neurons that express only OSM-9, tagged OSM-9 protein resides in the cell body and acts in sensory adaptation rather than sensory transduction. Thus, alternative combinations of TRPV proteins may direct different functions in distinct subcellular locations. Animals expressing the mammalian TRPV1 (VR1) channel in ASH nociceptor neurons avoid the TRPV1 ligand capsaicin, allowing selective, drug-inducible activation of a specific behavior.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Oklahoma Medical Research Foundation	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu		Tobin, David/0000-0003-3465-5518; Bargmann, Cornelia/0000-0002-8484-0618				Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CLARK SG, 1994, GENETICS, V137, P987; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart AC, 1999, J NEUROSCI, V19, P1952; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; YANDELL MD, 1994, P NATL ACAD SCI USA, V91, P1381, DOI 10.1073/pnas.91.4.1381; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	64	316	353	5	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					307	318		10.1016/S0896-6273(02)00757-2	http://dx.doi.org/10.1016/S0896-6273(02)00757-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160748	Bronze			2022-12-28	WOS:000177034200010
J	Broihier, HT; Skeath, JB				Broihier, HT; Skeath, JB			Drosophila homeodomain protein dHb9 directs neuronal fate via crossrepressive and cell-nonautonomous mechanisms	NEURON			English	Article							VENTRAL NEURAL-TUBE; MOTOR AXON GUIDANCE; SPINAL-CORD; EMBRYONIC NEUROBLASTS; GENE-EXPRESSION; NERVOUS-SYSTEM; IDENTITY; SPECIFICATION; CNS; TRANSPOSITION	Here we present the identification and characterization of dHb9, the Drosophila homolog of vertebrate Hb9, which encodes a factor central to motorneuron (MN) development. We show that dHb9 regulates neuronal fate by restricting expression of Lim3 and Even-skipped (Eve), two homeodomain (HD) proteins required for development of distinct neuronal classes. Also, dHb9 and Lim3 are activated independently of each other in a virtually identical population of ventrally and laterally projecting MNs. Surprisingly, dHb9 represses Lim3 cell nonautonomously in a subset of dorsally projecting MNs, revealing a novel role for intercellular signaling in the establishment of neuronal fate in Drosophila. Lastly, we provide evidence that dHb9 and Eve regulate each other's expression through Groucho-dependent crossrepression. This mutually antagonistic relationship bears similarity to the crossrepressive relationships between pairs of HD proteins that pattern the vertebrate neural tube.	Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Skeath, JB (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.			Broihier, Heather/0000-0003-1363-3088	NINDS NIH HHS [R01-NS-36570] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036570] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BRAND AH, 1993, DEVELOPMENT, V118, P401; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Goodman Corey S., 1993, P1131; HUFF R, 1989, DEV BIOL, V134, P146, DOI 10.1016/0012-1606(89)90085-7; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Kobayashi M, 2001, DEVELOPMENT, V128, P1805; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Landgraf M, 1997, J NEUROSCI, V17, P9642; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Saha MS, 1997, DEV BIOL, V187, P209, DOI 10.1006/dbio.1997.8625; Schmid A, 1999, DEVELOPMENT, V126, P4653; Sepp KJ, 1999, GENETICS, V151, P1093; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Skeath JB, 1998, DEVELOPMENT, V125, P1857; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; ZHANG P, 1993, GENETICS, V133, P361	35	108	109	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					39	50		10.1016/S0896-6273(02)00743-2	http://dx.doi.org/10.1016/S0896-6273(02)00743-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123607	Bronze			2022-12-28	WOS:000176601800009
J	Swiercz, JM; Kuner, R; Behrens, J; Offermanns, S				Swiercz, JM; Kuner, R; Behrens, J; Offermanns, S			Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology	NEURON			English	Article							NUCLEOTIDE EXCHANGE FACTOR; AXONAL GUIDANCE; ACTIVE RAC; DBL FAMILY; SEMAPHORIN RECEPTORS; NEURITE RETRACTION; G-PROTEINS; GTPASES; ACTIVATION; CELLS	Plexins are widely expressed transmembrane proteins that, in the nervous system, mediate repulsive signals of semaphorins.However, the molecular nature of plexin-mediated signal transduction remains poorly understood. Here, we demonstrate that plexin-B family members associate through their C termini with the Rho guanine nucleotide exchange factors PDZ-RhoGEF and LARG. Activation of plexin-B1 by semaphorin 4D regulates PDZ-RhoGEF/LARG activity leading to RhoA activation. In addition, a dominant-negative form of PDZ-RhoGEF blocks semaphorin 4D-induced growth cone collapse in primary hippocampal neurons. Our study indicates that the interaction of mammalian plexin-B family members with the multidomain proteins PDZ-RhoGEF and LARG represents an essential molecular link between plexin-B and localized, Rho-mediated downstream signaling events which underly various plexin-mediated cellular phenomena including axonal growth cone collapse.	Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany	Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Offermanns, S (corresponding author), Heidelberg Univ, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	stefan.offermanns@urz.uni-heidelberg.de	Kuner, Rohini/AGU-0204-2022; Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805				Bateman J, 2001, J CELL SCI, V114, P1973; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; ISHIKAWA K, 1997, DNA RES, V31, P307; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jin Z, 1997, J NEUROSCI, V17, P6256; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mack TGA, 2000, MOL CELL NEUROSCI, V15, P51, DOI 10.1006/mcne.1999.0802; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Togashi H, 2000, J BIOL CHEM, V275, P29570, DOI 10.1074/jbc.M003726200; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Vojtek AB, 1997, ADV MOLEC BIOL, P29; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Whitehead IP, 1996, J BIOL CHEM, V271, P18643, DOI 10.1074/jbc.271.31.18643; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	56	296	307	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					51	63		10.1016/S0896-6273(02)00750-X	http://dx.doi.org/10.1016/S0896-6273(02)00750-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123608	Bronze			2022-12-28	WOS:000176601800010
J	Vaillant, AR; Zanassi, P; Walsh, GS; Aumont, A; Alonso, A; Miller, FD				Vaillant, AR; Zanassi, P; Walsh, GS; Aumont, A; Alonso, A; Miller, FD			Signaling mechanisms underlying reversible, activity-dependent dendrite formation	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; SUPERIOR CERVICAL-GANGLION; NERVE GROWTH-FACTOR; SYMPATHETIC NEURONS; STRUCTURAL-CHANGES; CELL MORPHOLOGY; KINASE-II; IN-VITRO; PHOSPHORYLATION; MAP2	Neuronal activity and neurotrophins play a central role in the formation, maintenance, and plasticity of dendritic arbors. Here, we show that neuronal activity, mediated by electrical stimulation, KCl depolarization, or cholinergic receptor activation, promotes reversible dendrite formation in sympathetic neurons and that this effect is enhanced by NGF. Activity-dependent dendrite formation is accompanied by increased association of HMW MAP2 with microtubules and increased microtubule stability. Inhibition of either CaMKII or the MEK-ERK pathway, both of which phosphorylate MAP2, inhibits dendrite formation, but inhibition of both pathways simultaneously is required for dendrites to retract. These data indicate that neuronal activity signals via CamKII and the ERKs to regulate MAP2:microtubule interactions and hence reversible dendrite stability, and to provide a mechanism whereby activity and neurotrophins converge intracellularly to dynamically regulate dendritic morphology.	McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Brain Tumor Res Ctr, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, Grp Cell Biol Excitable Tissues, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Miller, FD (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Brain Tumor Res Ctr, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	freda.miller@mcgill.ca		VAILLANT, Andrew/0000-0002-1433-0700				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; [Anonymous], [No title captured]; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; COLLINS CA, 1987, J CELL BIOL, V105, P2847, DOI 10.1083/jcb.105.6.2847; DIAZNIDO J, 1993, EUR J NEUROSCI, V5, P818, DOI 10.1111/j.1460-9568.1993.tb00933.x; FRANKLIN JL, 1995, J NEUROSCI, V15, P643; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; JAMESON L, 1981, P NATL ACAD SCI-BIOL, V78, P3413, DOI 10.1073/pnas.78.6.3413; JOSHI HC, 1989, J CELL BIOL, V109, P663, DOI 10.1083/jcb.109.2.663; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KATZ LC, 1989, J NEUROSCI, V9, P1389; LECLERC N, 1993, P NATL ACAD SCI USA, V90, P6223, DOI 10.1073/pnas.90.13.6223; LEE JC, 1978, BIOCHEMISTRY-US, V17, P2783, DOI 10.1021/bi00607a013; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; MADERDRUT JL, 1988, BRAIN RES, V444, P189, DOI 10.1016/0006-8993(88)90928-6; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Niblock MM, 2000, J NEUROSCI, V20, P4165; OBAR RA, 1989, NEURON, V3, P639, DOI 10.1016/0896-6273(89)90274-2; PURVES D, 1986, J NEUROSCI, V6, P1051; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; Quinlan EM, 1996, NEURON, V16, P357, DOI 10.1016/S0896-6273(00)80053-7; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RUBIN E, 1985, J NEUROSCI, V5, P673; RUBIN E, 1985, J NEUROSCI, V5, P697; RUBINO HM, 1989, NEURON, V3, P631, DOI 10.1016/0896-6273(89)90273-0; RUIT KG, 1990, J NEUROSCI, V10, P2412; RUIT KG, 1991, J COMP NEUROL, V314, P106, DOI 10.1002/cne.903140110; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SNIDER WD, 1988, J NEUROSCI, V8, P2628; THROWER D, 1991, J IMMUNOL METHODS, V136, P45, DOI 10.1016/0022-1759(91)90248-E; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Vaillant AR, 1998, J BIOL CHEM, V273, P13973, DOI 10.1074/jbc.273.22.13973; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; VOYVODIC JT, 1989, J NEUROSCI, V9, P1997; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; YAWO H, 1987, J NEUROSCI, V7, P3703	54	194	198	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					985	998		10.1016/S0896-6273(02)00717-1	http://dx.doi.org/10.1016/S0896-6273(02)00717-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086645	Bronze			2022-12-28	WOS:000176249700015
J	Aizenman, CD; Munoz-Elias, G; Cline, HT				Aizenman, CD; Munoz-Elias, G; Cline, HT			Visually driven modulation of glutamatergic synaptic transmission is mediated by the regulation of intracellular polyamines	NEURON			English	Article							CALCIUM-PERMEABLE AMPA; LONG-TERM POTENTIATION; DEVELOPING RETINOTECTAL SYNAPSES; RECEPTOR CHANNELS; RAT-BRAIN; IN-VIVO; ORNITHINE DECARBOXYLASE; SUBUNIT COMPOSITION; KAINATE RECEPTORS; CA2+ PERMEABILITY	Ca2+-permeable AMPARs are inwardly rectifying due to block by intracellular polyamines. Neuronal activity regulates polyamine synthesis, yet whether this affects Ca2+-AMPAR-mediated synaptic transmission is unknown. We test whether 4 hr of increased visual stimulation regulates glutamatergic retino-tectal synapses in Xenopus tadpoles. Tectal neurons containing Ca2+-AMPARs form a gradient along the rostro-caudal developmental axis. These neurons had inwardly rectifying AMPAR-mediated EPSCs. Four hours of visual stimulation or addition of intracellular spermine increased rectification in immature neurons. Polyamine synthesis inhibitors blocked the effect of visual stimulation, suggesting that visual activity regulates AMPARs via the polyamine synthesis pathway. This modulation resulted in changes in the integrative properties of tectal neurons. Regulation of polyamine synthesis by physiological stimuli is a novel form of modulation of synaptic transmission important for understanding the short-term effects of enhanced sensory experience during development.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Cline, HT (corresponding author), Cold Spring Harbor Lab, Beckman Bldg,1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.							Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BAUDRY M, 1994, NEUROSCI LETT, V171, P151, DOI 10.1016/0304-3940(94)90627-0; BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8; Bollmann JH, 1998, J NEUROSCI, V18, P10409; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bowie D, 1998, J NEUROSCI, V18, P8175; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Carvalho AL, 2000, NEUROCHEM RES, V25, P1245, DOI 10.1023/A:1007644128886; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Estabel J, 1999, LIFE SCI, V64, P607, DOI 10.1016/S0024-3205(98)00603-1; Fox K, 2000, CURR OPIN NEUROBIOL, V10, P494, DOI 10.1016/S0959-4388(00)00112-4; FOX K, 1992, J NEUROSCI, V12, P1826; Furuta A, 1999, J NEUROBIOL, V39, P67, DOI 10.1002/(SICI)1097-4695(199904)39:1<67::AID-NEU6>3.0.CO;2-7; Gimenez-Llort L, 1998, NEUROREPORT, V9, P937, DOI 10.1097/00001756-199803300-00032; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; HAYASHI Y, 1993, NEUROSCI LETT, V149, P63, DOI 10.1016/0304-3940(93)90348-O; HAYASHI Y, 1992, J NEUROCHEM, V58, P562, DOI 10.1111/j.1471-4159.1992.tb09756.x; HERBERG LJ, 1992, EPILEPSY RES, V11, P3, DOI 10.1016/0920-1211(92)90015-L; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Knudsen EI, 1999, J COMP PHYSIOL A, V185, P305, DOI 10.1007/s003590050391; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Lawrence JJ, 2000, J NEUROSCI, V20, P4864; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; NAJM I, 1992, DEV BRAIN RES, V69, P11, DOI 10.1016/0165-3806(92)90117-F; OTIS TS, 1995, J PHYSIOL-LONDON, V482, P309, DOI 10.1113/jphysiol.1995.sp020519; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PELLEGRINIGIAMPIETRO DE, 1992, NEUROSCI LETT, V144, P65, DOI 10.1016/0304-3940(92)90717-L; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Pickard L, 2000, J NEUROSCI, V20, P7922; PRUSS RM, 1991, NEURON, V7, P509, DOI 10.1016/0896-6273(91)90302-G; Rajan I, 1998, J NEUROSCI, V18, P7836; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Standley S, 1998, DEV BRAIN RES, V107, P277, DOI 10.1016/S0165-3806(98)00036-4; STRAZNICKY K, 1972, J EMBRYOL EXP MORPH, V28, P87; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Washburn MS, 1997, J NEUROSCI, V17, P9393; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; ZAWIA NH, 1990, MOL BRAIN RES, V7, P243, DOI 10.1016/0169-328X(90)90034-B; ZAWIA NH, 1993, DEV BRAIN RES, V71, P53, DOI 10.1016/0165-3806(93)90104-I; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	61	81	81	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					623	634		10.1016/S0896-6273(02)00674-8	http://dx.doi.org/10.1016/S0896-6273(02)00674-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062045	Bronze			2022-12-28	WOS:000175665700015
J	Tanemoto, M; Fujita, A; Higashi, K; Kurachi, Y				Tanemoto, M; Fujita, A; Higashi, K; Kurachi, Y			PSD-95 mediates formation of a functional homomeric Kir5.1 channel in the brain	NEURON			English	Article							RECTIFIER K+-CHANNEL; PROTEIN-KINASE; SULFONYLUREA RECEPTOR; POTASSIUM CHANNELS; PDZ PROTEINS; FAMILY; PHOSPHORYLATION; EXPRESSION; DOMAIN; LOCALIZATION	Homomeric assembly of Kir5.1, an inward-rectifying K+ channel subunit, is believed to be nonfunctional, although the subunit exists abundantly in the brain. We show that HEK293T cells cotransfected with Kir5.1 and PSD-95 exhibit a Ball-sensitive inward-rectifying K+ current. Kir5.1 coexpressed with PSD-95 located on the plasma membrane in a clustered manner, while the Kir5.1 subunit expressed alone distributed mostly in cytoplasm, probably due to rapid internalization. The binding of Kir5.1 with PSD-95 was prevented by protein kinase A (PKA)-mediated phosphorylation of its carboxyl terminus. The currents flowing through Kir5.1/PSD-95 were suppressed promptly and reversibly by PKA activation. Because the Kir5.1/PSD-95 complex was detected in the brain, this functional brain K+ channel is potentially a novel physiological target of PKA-mediated signaling.	Osaka Univ, Grad Sch Med A7, Dept Pharmacol 2, Suita, Osaka 5650871, Japan	Osaka University	Kurachi, Y (corresponding author), Osaka Univ, Grad Sch Med A7, Dept Pharmacol 2, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.							BOND CT, 1994, RECEPTOR CHANNEL, V2, P183; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Hibino H, 2000, EMBO J, V19, P78, DOI 10.1093/emboj/19.1.78; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inanobe A, 1999, J NEUROSCI, V19, P1006; Isomoto S, 1997, JPN J PHYSIOL, V47, P11, DOI 10.2170/jjphysiol.47.11; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Pearson WL, 1999, J PHYSIOL-LONDON, V514, P639, DOI 10.1111/j.1469-7793.1999.639ad.x; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Salvatore L, 1999, FEBS LETT, V449, P146, DOI 10.1016/S0014-5793(99)00420-2; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Tanemoto M, 2000, J PHYSIOL-LONDON, V525, P587, DOI 10.1111/j.1469-7793.2000.00587.x; Tucker SJ, 2000, J BIOL CHEM, V275, P16404, DOI 10.1074/jbc.C000127200; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Wischmeyer E, 1996, P NATL ACAD SCI USA, V93, P5819, DOI 10.1073/pnas.93.12.5819; Xu HX, 2000, J PHYSIOL-LONDON, V524, P725, DOI 10.1111/j.1469-7793.2000.00725.x; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	29	56	59	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					387	397		10.1016/S0896-6273(02)00675-X	http://dx.doi.org/10.1016/S0896-6273(02)00675-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988170	Bronze			2022-12-28	WOS:000175214700010
J	Weeber, EJ; Sweatt, JD				Weeber, EJ; Sweatt, JD			Molecular neurobiology of human cognition	NEURON			English	Review							MICE; PKA	Recent studies into human mental retardation syndromes have given new insights into the molecular underpinnings of human cognitive processing, in particular into mechanisms likely to contribute to learning and memory. In this minireview, we present an overview of one signal transduction cascade that has garnered attention of late in this context, the ras/ERK/CREB pathway. We focus on this cascade because of recent exciting discoveries concerning the basis of neurofibromatosis type 1 (NF1) mental retardation, which link cognitive defects in this syndrome to disruptions of ras and its intracellular targets.	Baylor Coll Med, Div Neurosci, Dept Physiol & Mol Biophys, Mental Retardat Res Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Weeber, EJ (corresponding author), Baylor Coll Med, Div Neurosci, Dept Physiol & Mol Biophys, Mental Retardat Res Ctr, Houston, TX 77030 USA.		Weeber, Edwin J/A-5396-2012	Sweatt, J. David/0000-0003-3567-485X				ANDERSEN LB, 1993, MOL CELL BIOL, V13, P487, DOI 10.1128/MCB.13.1.487; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; Dufresne SD, 2001, MOL CELL BIOL, V21, P81, DOI 10.1128/MCB.21.1.81-87.2001; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Harum KH, 2001, NEUROLOGY, V56, P207, DOI 10.1212/WNL.56.2.207; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Ozonoff S, 1999, AM J MED GENET, V89, P45, DOI 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Roberson ED, 1999, J NEUROSCI, V19, P4337; Sweatt JD, 2001, NEURON, V31, P671, DOI 10.1016/S0896-6273(01)00419-6; Tong JY, 2002, NAT NEUROSCI, V5, P95, DOI 10.1038/nn792	15	109	114	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					845	848		10.1016/S0896-6273(02)00634-7	http://dx.doi.org/10.1016/S0896-6273(02)00634-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906692	Bronze			2022-12-28	WOS:000174389600003
J	Wessely, O; De Robertis, EM				Wessely, O; De Robertis, EM			Neural plate patterning by secreted signals	NEURON			English	Editorial Material							SPECIFICATION	The patterning of the CNS relies on the interaction of multiple signaling molecules such as Sonic Hedgehog, Wnts, and BMPs and their antagonists Chordin and Noggin. The identification of the secreted molecule Tiarin (Tsuda et al., 2002, this issue of Neuron), produced by the nonneural ectoderm at border of the anterior and lateral neural plate, now introduces a novel signaling pathway participating in CNS development.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Wessely, O (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD021502-16, R37 HD021502] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baker JC, 1999, GENE DEV, V13, P3149, DOI 10.1101/gad.13.23.3149; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Moreno TA, 2001, DEV BIOL, V240, P340, DOI 10.1006/dbio.2001.0472; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Tashiro K, 1999, METHOD ENZYMOL, V303, P479; Tsuda H, 2002, NEURON, V33, P515, DOI 10.1016/S0896-6273(02)00590-1; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747	12	20	20	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					489	491		10.1016/S0896-6273(02)00596-2	http://dx.doi.org/10.1016/S0896-6273(02)00596-2			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856521	Green Accepted, Bronze			2022-12-28	WOS:000173911100001
J	Bagri, A; Marin, O; Plump, AS; Mak, J; Pleasure, SJ; Rubenstein, JLR; Tessier-Lavigne, M				Bagri, A; Marin, O; Plump, AS; Mak, J; Pleasure, SJ; Rubenstein, JLR; Tessier-Lavigne, M			Slit proteins prevent midline crossing and determine the dorsoventral position of major axonal pathways in the mammalian forebrain	NEURON			English	Article							THALAMOCORTICAL AXONS; CEREBRAL-CORTEX; CORTICOTHALAMIC PROJECTIONS; INTERMEDIATE TARGET; NEURONAL MIGRATION; NERVOUS-SYSTEM; GUIDANCE; GROWTH; RAT; ROUNDABOUT	We report that Slit proteins, a family of secreted chemorepellents, are crucial for the proper development of several major forebrain tracts. Mice deficient in Slit2 and, even more so, mice deficient in both Slit1 and Slit2 show significant axon guidance errors in a variety of pathways, including corticofugal, callosal, and thalamocortical tracts. Analysis of multiple pathways suggests several generalizations regarding the functions of Slit proteins in the brain, which appear to contribute to (1) the maintenance of dorsal position by prevention of axonal growth into ventral regions, (2) the prevention of axonal extension toward and across the midline, and (3) the channeling of axons toward particular regions.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Langley Porter Psychiat Inst, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Med Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Stanford Univ, Dept Biol Sci, 371 Serra Mall, Stanford, CA 94305 USA.	marctl@stanford.edu	Marin, Oscar/F-3856-2012	Marin, Oscar/0000-0001-6264-7027	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001046, R01MH049428, R01MH051561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012462] Funding Source: NIH RePORTER; NIDA NIH HHS [R01DA12462] Funding Source: Medline; NIMH NIH HHS [K02MH01046-01, R01MH51561-01A1, R01MH49428-01] Funding Source: Medline; NINDS NIH HHS [NS02208] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams NC, 1997, EUR J NEUROSCI, V9, P204, DOI 10.1111/j.1460-9568.1997.tb01391.x; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; DECARLOS JA, 1992, J NEUROSCI, V12, P1194; Erskine L, 2000, J NEUROSCI, V20, P4975; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; JONES EG, 1996, CEREBRAL CORTEX, V5; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KIM GJ, 1991, J NEUROBIOL, V22, P629, DOI 10.1002/neu.480220608; LEE VMY, 1987, J NEUROSCI, V7, P3474; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Marin O, 2000, J NEUROSCI, V20, P6063; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; Metin C, 1996, J NEUROSCI, V16, P3219; Metin C, 1997, DEVELOPMENT, V124, P5063; MILLER B, 1993, J COMP NEUROL, V335, P16, DOI 10.1002/cne.903350103; MITROFANIS J, 1993, J COMP NEUROL, V338, P575, DOI 10.1002/cne.903380407; Molnar Z, 1999, J COMP NEUROL, V413, P1, DOI 10.1002/(SICI)1096-9861(19991011)413:1<1::AID-CNE1>3.0.CO;2-5; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Murray MJ, 1999, J NEUROSCI, V19, P7901; Nieuwenhuys R., 1985, CHEMOARCHITECTURE BR, VVolume 33; Parent JM, 1997, J NEUROSCI, V17, P3727; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Richards LJ, 1997, J NEUROSCI, V17, P2445; Ringstedt T, 2000, J NEUROSCI, V20, P4983; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Skaliora I, 2000, J NEUROSCI, V20, P3650, DOI 10.1523/JNEUROSCI.20-10-03650.2000; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	50	333	340	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					233	248		10.1016/S0896-6273(02)00561-5	http://dx.doi.org/10.1016/S0896-6273(02)00561-5			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804571	Bronze			2022-12-28	WOS:000173387700011
J	Dechant, G				Dechant, G			Chat in the trophic web: NGF activates Ret by inter-RTK signaling	NEURON			English	Editorial Material							NERVE GROWTH-FACTOR; SURVIVAL	In this issue of Neuron, Tsui-Pierchala et al. (2002) show that in rodent SCG neurons NGF activates Ret, the signaling component of the multisubunit GDNF receptor, in vitro and in vivo by a mechanism, which is independent of GFL ligands and GFRalpha coreceptors. NGF-dependent Ret phosphorylation regulates soma size and metabolism but not survival of maturing postnatal sympathetic neurons.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Dechant, G (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Martinsried, Germany.							Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; ANGELETTI PU, 1971, BRAIN RES, V27, P343, DOI 10.1016/0006-8993(71)90259-9; Enomoto H, 2001, DEVELOPMENT, V128, P3963; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; Linnarsson S, 2001, P NATL ACAD SCI USA, V98, P14681, DOI 10.1073/pnas.251548898; McAllister AK, 2001, CELL MOL LIFE SCI, V58, P1054, DOI 10.1007/PL00000920; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; RUIT KG, 1990, J NEUROSCI, V10, P2412; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Tsui-Pierchala B, 2002, NEURON, V33, P261, DOI 10.1016/S0896-6273(01)00585-2; Weiss FU, 1997, CURR OPIN GENET DEV, V7, P80, DOI 10.1016/S0959-437X(97)80113-X	12	10	10	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					156	158		10.1016/S0896-6273(02)00564-0	http://dx.doi.org/10.1016/S0896-6273(02)00564-0			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804563	Bronze			2022-12-28	WOS:000173387700003
J	Matynia, A; Anagnostaras, SG; Silva, AJ				Matynia, A; Anagnostaras, SG; Silva, AJ			Weaving the molecular and cognitive strands of memory	NEURON			English	Review							LONG-TERM POTENTIATION; PROTEIN-SYNTHESIS; CONSOLIDATION; STORAGE; CREB; MICE	Several recent studies seamlessly blend cognitive, systems, and molecular neuroscience to unravel the temporal organization of memory.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Silva, AJ (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Anagnostaras, Stephan/0000-0002-6906-1181				Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Cho YH, 1998, SCIENCE, V279, P867, DOI 10.1126/science.279.5352.867; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Graham KS, 1997, NEUROPSYCHOLOGY, V11, P77, DOI 10.1037/0894-4105.11.1.77; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Lisman J, 2001, NATURE, V411, P248, DOI 10.1038/35077185; Nadel L, 2001, HIPPOCAMPUS, V11, P56, DOI 10.1002/1098-1063(2001)11:1<56::AID-HIPO1020>3.0.CO;2-O; Rotenberg A, 2000, J NEUROSCI, V20, P8096; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SILVA AJ, 1992, COLD SPRING HARB SYM, V57, P527, DOI 10.1101/SQB.1992.057.01.058; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520	19	6	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					557	559		10.1016/S0896-6273(01)00510-4	http://dx.doi.org/10.1016/S0896-6273(01)00510-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	495WT	11719197	Bronze			2022-12-28	WOS:000172363900003
J	Pan, ZH; Hu, HJ; Perring, P; Andrade, R				Pan, ZH; Hu, HJ; Perring, P; Andrade, R			T-type Ca2+ channels mediate neurotransmitter release in retinal bipolar cells	NEURON			English	Article							TIGER SALAMANDER RETINA; ADRENAL CHROMAFFIN CELLS; CALCIUM CHANNELS; TRANSMITTER RELEASE; SYNAPTIC TERMINALS; GOLDFISH RETINA; GANGLION-CELLS; AMACRINE CELLS; GENE FAMILY; RAT RETINA	Transmitter release in neurons is thought to be mediated exclusively by high-voltage-activated (HVA) Ca2+ channels. However, we now report that, in retinal bipolar cells, low-voltage-activated (LVA) Ca2+ channels also mediate neurotransmitter release. Bipolar cells are specialized neurons that release neurotransmitter in response to graded depolarizations. Here we show that these cells express T-type Ca2+ channel subunits and functional LVA Call currents sensitive to mibefradil. Activation of these currents results in Call influx into presynaptic terminals and exocytosis, which we detected as a capacitance increase in isolated terminals and the appearance of reciprocal currents in retinal slices. The involvement of T-type Call channels in bipolar cell transmitter release may contribute to retinal information processing.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Pan, ZH (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.			Hu, Huijuan/0000-0003-2306-2514	NATIONAL EYE INSTITUTE [R01EY012180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043985, R29MH043985, R01MH049355] Funding Source: NIH RePORTER; NEI NIH HHS [EY12180] Funding Source: Medline; NIMH NIH HHS [MH 49355, MH 43985] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ASHMORE JF, 1983, J PHYSIOL-LONDON, V340, P569, DOI 10.1113/jphysiol.1983.sp014781; ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P115, DOI 10.1113/jphysiol.1980.sp013155; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Bieda MC, 2000, VISUAL NEUROSCI, V17, P243, DOI 10.1017/S0952523800172062; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; COHEN CJ, 1987, J PHYSIOL-LONDON, V387, P195, DOI 10.1113/jphysiol.1987.sp016570; COHEN CJ, 1988, P NATL ACAD SCI USA, V85, P2412, DOI 10.1073/pnas.85.7.2412; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; de la Villa P, 1998, EUR J NEUROSCI, V10, P317, DOI 10.1046/j.1460-9568.1998.00051.x; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DIXON DB, 1992, J PHYSIOL-LONDON, V449, P589, DOI 10.1113/jphysiol.1992.sp019103; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Gillis Kevin D., 1995, P155; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Ivanov AI, 2000, J NEUROSCI, V20, P4930; KANEKO A, 1989, J PHYSIOL-LONDON, V410, P613, DOI 10.1113/jphysiol.1989.sp017551; Lambert RC, 1998, J NEUROSCI, V18, P8605; LASATER EM, 1988, J NEUROPHYSIOL, V60, P1460, DOI 10.1152/jn.1988.60.4.1460; Lee JH, 1999, J NEUROSCI, V19, P1912; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; MAGUIRE G, 1989, P NATL ACAD SCI USA, V86, P10144, DOI 10.1073/pnas.86.24.10144; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MISHRA SK, 1994, CIRC RES, V75, P144, DOI 10.1161/01.RES.75.1.144; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Pan ZH, 2000, J NEUROPHYSIOL, V83, P513, DOI 10.1152/jn.2000.83.1.513; PAN ZH, 1995, J NEUROSCI, V15, P2668; Pan ZH, 2001, VISUAL NEUROSCI, V18, P279, DOI 10.1017/S095252380118212X; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Plant TD, 1998, J NEUROSCI, V18, P9573; Protti DA, 1998, J NEUROSCI, V18, P3715; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; RICHARD S, 1991, NEUROSCI LETT, V132, P229, DOI 10.1016/0304-3940(91)90308-G; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; SAITO T, 1983, J GEN PHYSIOL, V81, P589, DOI 10.1085/jgp.81.4.589; SIMON EJ, 1975, NATURE, V256, P661, DOI 10.1038/256661a0; TACHIBANA M, 1991, J NEUROSCI, V11, P2199; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; Talley EM, 1999, J NEUROSCI, V19, P1895; TSIEN RW, 1995, TRENDS NEUROSCI, V18, P52; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TURNER TJ, 1995, MOL PHARMACOL, V47, P348; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; WERBLIN FS, 1978, J PHYSIOL-LONDON, V280, P449, DOI 10.1113/jphysiol.1978.sp012394; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Zhuang H, 2000, DIABETES, V49, P59, DOI 10.2337/diabetes.49.1.59	63	95	97	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					89	98		10.1016/S0896-6273(01)00454-8	http://dx.doi.org/10.1016/S0896-6273(01)00454-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604141	Bronze			2022-12-28	WOS:000171525200011
J	Winberg, ML; Tamagnone, L; Bai, JW; Comoglio, PM; Montell, D; Goodman, CS				Winberg, ML; Tamagnone, L; Bai, JW; Comoglio, PM; Montell, D; Goodman, CS			The transmembrane protein off-track associates with plexins and functions downstream of semaphorin signaling during axon guidance	NEURON			English	Article							TYROSINE KINASE FAMILY; ACTIVE RAC; EPH RECEPTORS; CELL-ADHESION; DROSOPHILA; SLIT; IMMUNOGLOBULIN; REPELLENT; MOLECULE; ENCODES	The Plexin family of transmembrane proteins appears to function as repulsive receptors for most if not all Semaphorins. Here, we use genetic and biochemical analysis in Drosophila to show that the transmembrane protein Off-track (OTK) associates with Plexin A, the receptor for Sema 1a, and that OTK is a component of the repulsive signaling response to Semaphorin ligands. In vitro, OTK associates with Plexins. In vivo, mutations in the otk gene lead to phenotypes resembling those of loss-of-function mutations of either Sema1a or PlexA. The otk gene displays strong genetic interactions with Sema1a and PlexA, suggesting that OTK and Plexin A function downstream of Sema 1a.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Turin, Sch Med, Canc Res Inst, Dept Mol Oncol, I-10060 Turin, Italy; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Turin; Johns Hopkins University	Goodman, CS (corresponding author), Renovis Inc, 270 Littlefield Ave, San Francisco, CA 94080 USA.	goodman@uclink4.berkeley.edu	Tamagnone, Luca/J-8948-2018; Comoglio, Paolo/G-6323-2011	Tamagnone, Luca/0000-0002-2884-7946; Comoglio, Paolo/0000-0002-7056-5328	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021294, R37HD021294] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline; Telethon [E.1129] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CHOU YH, 1991, P NATL ACAD SCI USA, V88, P4897, DOI 10.1073/pnas.88.11.4897; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Katso RM, 1999, MOL CELL BIOL, V19, P6427; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; MOSSIE K, 1995, ONCOGENE, V11, P2179; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Park SK, 1996, J BIOCHEM, V119, P235; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Suga H, 1997, FEBS LETT, V412, P540, DOI 10.1016/S0014-5793(97)00639-X; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; van Kesteren RE, 1998, EMBO J, V17, P2534, DOI 10.1093/emboj/17.9.2534; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; VOELKER RA, 1984, GENETICS, V107, P279; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	40	127	131	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					53	62		10.1016/S0896-6273(01)00446-9	http://dx.doi.org/10.1016/S0896-6273(01)00446-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604138	Bronze			2022-12-28	WOS:000171525200008
J	Minichiello, L; Calella, AM; Medina, DL; Bonhoeffer, T; Klein, R; Korte, M				Minichiello, L; Calella, AM; Medina, DL; Bonhoeffer, T; Klein, R; Korte, M			Mechanism of TrkB-mediated hippocampal long-term potentiation	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; NEUROTROPHIC FACTOR; SYNAPTIC-TRANSMISSION; TRANSCRIPTION FACTOR; UP-REGULATION; MICE LACKING; LATE-PHASE; BDNF; CREB; EXPRESSION	The TrkB receptor tyrosine kinase and its ligand, BDNF, have an essential role in certain forms of synaptic plasticity. However, the downstream pathways required to mediate these functions are unknown. We have studied mice with a targeted mutation in either the Shc or the phospholipase Cgamma (PLCgamma) docking sites of TrkB (trkB(SHC/SHC) and trkB(PLC/PLC) mice). We found that hippocampal long-term potentiation was impaired in trkB(PLC/PLC) mice, but not trkB(SHC/SHC) mice. BDNF stimulation of primary neurons derived from trkB(PLC/PLC) mice fully retained their ability to activate MAP kinases, whereas induction of CREB and CaMKIV phosphorylation was strongly impaired. The opposite effect was observed in trkB(SHC/SHC) neurons, suggesting that MAPKs and CREB act in parallel pathways. Our results provide genetic evidence that TrkB mediates hippocampal plasticity via recruitment of PLCgamma, and by subsequent phosphorylation of CaMKIV and CREB.	European Mol Biol Lab, I-00016 Monterotondo, Italy; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Minichiello, L (corresponding author), European Mol Biol Lab, Via Ramarini 32, I-00016 Monterotondo, Italy.	mini@embl-monterotondo.it; rklein@neuro.mpg.de	Medina, Diego/AAC-9622-2020; Bonhoeffer, Tobias/B-9481-2009; Minichiello, Liliana/AAA-7190-2022; Klein, Ruediger/C-6147-2008	Medina, Diego/0000-0002-7347-2645; Bonhoeffer, Tobias/0000-0001-7897-6634; Klein, Ruediger/0000-0002-3109-0163				Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Canossa M, 2001, EMBO J, V20, P1640, DOI 10.1093/emboj/20.7.1640; Cash S, 1996, NEURON, V16, P745, DOI 10.1016/S0896-6273(00)80095-1; DOTTI CG, 1987, NEUROSCIENCE, V23, P121, DOI 10.1016/0306-4522(87)90276-4; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gass P, 1998, LEARN MEMORY, V5, P274; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; JANSSENTIMMEN U, 1989, GENE, V80, P325, DOI 10.1016/0378-1119(89)90296-5; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 2000, NEUROPHARMACOLOGY, V39, P717, DOI 10.1016/S0028-3908(99)00273-7; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; LESSMANN V, 1994, NEUROREPORT, V6, P21; Li YX, 1998, J NEUROSCI, V18, P10231; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Yoo J, 2002, J BIOL CHEM, V277, P11904, DOI 10.1074/jbc.M111788200; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	59	330	348	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					121	137		10.1016/S0896-6273(02)00942-X	http://dx.doi.org/10.1016/S0896-6273(02)00942-X			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367511	Bronze			2022-12-28	WOS:000178295100012
J	Lee, CJ; Bardoni, R; Tong, CK; Engelman, HS; Joseph, DJ; Magherini, PC; MacDermott, AB				Lee, CJ; Bardoni, R; Tong, CK; Engelman, HS; Joseph, DJ; Magherini, PC; MacDermott, AB			Functional expression of AMPA receptors on central terminals of rat dorsal root ganglion neurons and presynaptic inhibition of glutamate release	NEURON			English	Article							NON-NMDA RECEPTORS; SPINAL-CORD; KAINATE RECEPTORS; DRG NEURONS; IMMUNOCYTOCHEMICAL LOCALIZATION; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; PRIMARY AFFERENTS; ACTION-POTENTIALS; HORN NEURONS	No direct evidence has been found for expression of functional AMPA receptors by dorsal root ganglion neurons despite immunocytochemical evidence suggesting they are present. Here we report evidence for expression of functional AMPA receptors by a subpopulation of dorsal root ganglion neurons. The AMPA receptors are most prominently located near central terminals of primary afferent fibers. AMPA and kainate receptors were detected by recording receptor-mediated depolarization of the central terminals under selective pharmacological conditions. We demonstrate that activation of presynaptic AMPA receptors by exogenous agonists causes inhibition of glutamate release from the terminals, possibly via primary afferent depolarization (PAD). These results challenge the traditional view that GABA and GABA(A) receptors exclusively mediate PAD, and indicate that PAD is also mediated by glutamate acting on presynaptically localized AMPA and kainate receptors.	Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41100 Modena, Italy	Columbia University; Columbia University; Universita di Modena e Reggio Emilia	MacDermott, AB (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.		Bardoni, Rita/AAE-2255-2020; Bardoni, Rita/C-1109-2016	Bardoni, Rita/0000-0002-0959-9983; Lee, C Justin/0000-0002-3555-0980	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029797] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 29797] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGRAWAL SG, 1986, BRIT J PHARMACOL, V87, P345, DOI 10.1111/j.1476-5381.1986.tb10823.x; AULT B, 1993, J PHARMACOL EXP THER, V265, P927; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; Cochilla AJ, 1997, J PHYSIOL-LONDON, V499, P443, DOI 10.1113/jphysiol.1997.sp021940; Coggeshall RE, 1998, J COMP NEUROL, V391, P78; DESARMENIEN M, 1984, BRIT J PHARMACOL, V81, P327, DOI 10.1111/j.1476-5381.1984.tb10082.x; DODD J, 1985, J NEUROSCI, V5, P3278; Donevan SD, 1998, J PHARMACOL EXP THER, V285, P539; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; EVANS RH, 1989, NEUROSCI LETT, V100, P231, DOI 10.1016/0304-3940(89)90690-3; FITZGERALD M, 1994, J COMP NEUROL, V348, P225, DOI 10.1002/cne.903480205; FITZGERALD M, 1981, J PHYSIOL-LONDON, V318, P25; Goldstein ME, 1996, NEUROSCIENCE, V71, P243, DOI 10.1016/0306-4522(95)00404-1; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; GRAHAM B, 1994, J NEUROPHYSIOL, V71, P538, DOI 10.1152/jn.1994.71.2.538; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; Hackman JC, 1997, NEUROSCIENCE, V81, P1079, DOI 10.1016/S0306-4522(97)00234-0; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Huettner JE, 1998, NEUROPHARMACOLOGY, V37, P1239, DOI 10.1016/S0028-3908(98)00082-3; Hwang SJ, 2001, J COMP NEUROL, V436, P275; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Kerchner GA, 2001, J NEUROSCI, V21, P59, DOI 10.1523/JNEUROSCI.21-01-00059.2001; KYROZIS A, 1995, J PHYSIOL-LONDON, V485, P373, DOI 10.1113/jphysiol.1995.sp020736; Lee CJ, 2001, J NEUROSCI, V21, P4572, DOI 10.1523/JNEUROSCI.21-13-04572.2001; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; LIU H, 1994, P NATL ACAD SCI USA, V91, P8383, DOI 10.1073/pnas.91.18.8383; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; MIRNICS K, 1995, J COMP NEUROL, V355, P601, DOI 10.1002/cne.903550409; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Pelkey KA, 1998, CAN J PHYSIOL PHARM, V76, P900, DOI 10.1139/cjpp-76-9-900; PIGNATELLI D, 1989, BRAIN RES, V491, P33, DOI 10.1016/0006-8993(89)90085-1; POOK P, 1993, BRIT J PHARMACOL, V108, P179, DOI 10.1111/j.1476-5381.1993.tb13459.x; REICHLING DB, 1991, J PHYSIOL-LONDON, V441, P199, DOI 10.1113/jphysiol.1991.sp018746; RIBEIRODASILVA A, 1985, J NEUROCYTOL, V14, P203, DOI 10.1007/BF01258448; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Russo RE, 2000, J PHYSIOL-LONDON, V528, P115, DOI 10.1111/j.1469-7793.2000.00115.x; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; SATO K, 1993, NEUROREPORT, V4, P1263, DOI 10.1097/00001756-199309000-00013; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; Stucky CL, 1999, J NEUROSCI, V19, P6497; SUR C, 1995, NEUROSCIENCE, V66, P697, DOI 10.1016/0306-4522(94)00579-T; TACHIBANA M, 1994, J COMP NEUROL, V344, P431, DOI 10.1002/cne.903440307; Uchida I, 1996, EUR J PHARMACOL, V307, P89, DOI 10.1016/0014-2999(96)00156-2; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; WONG LA, 1993, MOL PHARMACOL, V44, P504; Zhou LM, 1997, J PHARMACOL EXP THER, V280, P422	51	88	91	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					135	146		10.1016/S0896-6273(02)00729-8	http://dx.doi.org/10.1016/S0896-6273(02)00729-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123614	Bronze			2022-12-28	WOS:000176601800016
J	Gross, MK; Dottori, M; Goulding, M				Gross, MK; Dottori, M; Goulding, M			Lbx1 specifies somatosensory association Interneurons in the dorsal spinal cord	NEURON			English	Article							COMMISSURAL INTERNEURONS; NEURONS; IDENTITY; PATHWAY; MATH1; MOUSE; FATE; RAT; SPECIFICATION; EXPRESSION	Association and relay neurons that are generated in the dorsal spinal cord play essential roles in transducing somatosensory information. During development, these two major neuronal classes are delineated by the expression of the homeodomain transcription factor Lbx1. Lbx1 is expressed in and required for the correct specification of three early dorsal interneuron populations and late-born neurons that form the substantia gelatinosa. In mice lacking Lbx1, cells types that arise in the ventral alar plate acquire more dorsal identities. This results in the loss of dorsal horn association interneurons, excess production of commissural neurons, and disrupted sensory afferent innervation of the dorsal horn. Lbx1, therefore, plays a critical role in the development of sensory pathways in the spinal cord that relay pain and touch.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Goulding, M (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Dottori, Mirella/0000-0003-0598-4195				ANTAL M, 1991, J COMP NEUROL, V314, P114, DOI 10.1002/cne.903140111; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brown AG, 1981, ORG SPINAL CORD; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Dottori M, 2001, DEVELOPMENT, V128, P4127; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Gross MK, 2000, DEVELOPMENT, V127, P413; Helms AW, 1998, DEVELOPMENT, V125, P919; HOLLEY JA, 1982, J COMP NEUROL, V205, P371, DOI 10.1002/cne.902050406; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Li YQ, 1999, BRAIN RES, V840, P179, DOI 10.1016/S0006-8993(99)01794-1; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; PITUELLO F, 1995, P NATL ACAD SCI USA, V92, P6952, DOI 10.1073/pnas.92.15.6952; Polgar E, 1999, J NEUROSCI, V19, P2637; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; SAITO T, 1995, MOL CELL NEUROSCI, V6, P280, DOI 10.1006/mcne.1995.1022; Schubert FR, 2001, MECH DEVELOP, V101, P181, DOI 10.1016/S0925-4773(00)00537-2; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; SZENTAGOTHAI J, 1964, J COMP NEUROL, V122, P219, DOI 10.1002/cne.901220207; Tracey D, 1985, RAT NERVOUS SYSTEM, P129; Wang SS, 1997, J NEUROSCI, V17, P4149; Willis Jr W. D., 1991, SENSORY MECH SPINAL	36	291	294	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					535	549		10.1016/S0896-6273(02)00690-6	http://dx.doi.org/10.1016/S0896-6273(02)00690-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062038	Bronze			2022-12-28	WOS:000175665700008
J	Hughes, SW; Cope, DW; Blethyn, KL; Crunelli, V				Hughes, SW; Cope, DW; Blethyn, KL; Crunelli, V			Cellular mechanisms of the slow (< 1 Hz) oscillation in thalamocortical neurons in vitro	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; LOW-FREQUENCY RHYTHMS; IN-VITRO; CORTICOTHALAMIC NETWORKS; SYNCHRONIZED OSCILLATIONS; DELTA-WAVES; SLEEP; RAT; CAT; ACTIVATION	The slow (<1 Hz) rhythm is a defining feature of the electroencephalogram during sleep. Since cortical circuits can generate this rhythm in isolation, it is assumed that the accompanying slow oscillation in thalamocortical (TC) neurons is largely a passive reflection of neocortical activity. Here we show, however, that by activating the metabotropic glutamate receptor (mGluR), mGluR1a, cortical inputs can recruit intricate cellular mechanisms that enable the generation of an intrinsic slow oscillation in TC neurons in vitro with identical properties to those observed in vivo. These mechanisms rely on the "window" component of the T-type Ca2+ current and a Ca2+-activated, nonselective cation current. These results suggest an active role for the thalamus in shaping the slow (<1 Hz) sleep rhythm.	Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales	Cardiff University	Crunelli, V (corresponding author), Cardiff Univ, Sch Biosci, Museum Ave, Cardiff CF10 3US, S Glam, Wales.		Crunelli, Vincenzo/A-7258-2010	Crunelli, Vincenzo/0000-0001-7154-9752; Hughes, Stuart/0000-0003-0423-777X				Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; AMZICA F, 1995, J NEUROSCI, V15, P4658; Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794; Chuang SC, 2000, J NEUROPHYSIOL, V83, P2844, DOI 10.1152/jn.2000.83.5.2844; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Contreras D, 1997, NEUROSCIENCE, V76, P25; Contreras D, 1997, NEUROSCIENCE, V76, P11; CONTRERAS D, 1995, J NEUROSCI, V15, P604; CRUNELLI V, 1989, J PHYSIOL-LONDON, V413, P543, DOI 10.1113/jphysiol.1989.sp017668; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; Godwin DW, 1996, J NEUROSCI, V16, P8181; Gutierrez C, 2001, J NEUROSCI, V21, P1022, DOI 10.1523/JNEUROSCI.21-03-01022.2001; Hughes SW, 1999, J PHYSIOL-LONDON, V517, P805, DOI 10.1111/j.1469-7793.1999.0805s.x; Lee KH, 1997, NEUROSCIENCE, V77, P335, DOI 10.1016/S0306-4522(96)00481-2; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Pakhotin PI, 1997, NEUROREPORT, V8, P1755, DOI 10.1097/00001756-199705060-00037; PARTRIDGE LD, 1988, TRENDS NEUROSCI, V11, P69, DOI 10.1016/0166-2236(88)90167-1; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Simon NR, 2000, BRAIN RES, V860, P64, DOI 10.1016/S0006-8993(00)01974-0; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1991, J NEUROSCI, V11, P3200; Steriade M, 1996, J NEUROSCI, V16, P2788; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3253; Tennigkeit F, 1999, J NEUROPHYSIOL, V82, P718, DOI 10.1152/jn.1999.82.2.718; Timofeev I, 1996, J NEUROPHYSIOL, V76, P4152, DOI 10.1152/jn.1996.76.6.4152; TOKIMASA T, 1985, BRAIN RES, V337, P386, DOI 10.1016/0006-8993(85)90081-2; Toth TI, 1998, NEUROSCIENCE, V87, P519, DOI 10.1016/S0306-4522(98)00118-3; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Turner JP, 2000, NEUROSCIENCE, V100, P493, DOI 10.1016/S0306-4522(00)00280-3; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Zhan XJ, 2000, J NEUROSCI, V20, P3909, DOI 10.1523/JNEUROSCI.20-10-03909.2000; Zhu JJ, 1999, NEUROSCIENCE, V91, P1445, DOI 10.1016/S0306-4522(98)00665-4	42	177	181	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					947	958		10.1016/S0896-6273(02)00623-2	http://dx.doi.org/10.1016/S0896-6273(02)00623-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906700	Bronze			2022-12-28	WOS:000174389600011
J	Medina, AE; Liao, DS; Mower, AF; Ramoa, AS				Medina, AE; Liao, DS; Mower, AF; Ramoa, AS			Do NMDA receptor kinetics regulate the end of critical periods of plasticity?	NEURON			English	Editorial Material							OCULAR DOMINANCE PLASTICITY; NR2A SUBUNIT EXPRESSION; VISUAL-CORTEX; DISRUPTION	Increasing NR2A subunit expression and the associated shortening of the NMDA-EPSC are thought to underlie the loss of diverse types of sensory cortical plasticity. Lu and colleagues (Lu et al., 2001 [this issue of Neuron]) now report that mice lacking the NR2A subunit display normal duration of critical periods of barrel cortex plasticity. Shortening of the NMDA-EPSC is therefore not responsible for the end of these critical periods.	Virginia Commonwealth Univ, Sch Med, Dept Anat, Richmond, VA 23298 USA	Virginia Commonwealth University	Medina, AE (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Anat, Med Coll Virginia Campus, Richmond, VA 23298 USA.			Medina, Alexandre/0000-0003-0517-7756				Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; BEAR MF, 1990, J NEUROSCI, V10, P909; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen L, 2000, MOL BRAIN RES, V78, P196, DOI 10.1016/S0169-328X(00)00076-0; Flint AC, 1997, J NEUROSCI, V17, P2469; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Ramoa AS, 1997, DEV BRAIN RES, V101, P165, DOI 10.1016/S0165-3806(97)00061-8; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2	14	13	13	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					553	555		10.1016/S0896-6273(01)00514-1	http://dx.doi.org/10.1016/S0896-6273(01)00514-1			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719195	Bronze			2022-12-28	WOS:000172363900001
J	Cheng, K; Waggoner, RA; Tanaka, K				Cheng, K; Waggoner, RA; Tanaka, K			Human ocular dominance columns as revealed by high-field functional magnetic resonance imaging	NEURON			English	Article							CYTOCHROME-OXIDASE PATCHES; PRIMARY VISUAL-CORTEX; HUMAN STRIATE CORTEX; CEREBRAL-BLOOD-FLOW; OXYGEN-CONSUMPTION; RECEPTIVE-FIELDS; BOLD CONTRAST; MONKEY; MACAQUE; MRI	We mapped ocular dominance columns (ODCs) in normal human subjects using high-field (4 T) functional magnetic resonance imaging (fMRI) with a segmented echo planar imaging technique and an in-plane resolution of 0.47 x 0.47 mm(2). The differential responses to left or right eye stimulation could be reliably resolved in anatomically well-defined sections of V1. The orientation and width (similar to1 mm) of mapped ODC stripes conformed to those previously revealed in postmortem brains stained with cytochrome oxidase. In addition, we showed that mapped ODC patterns could be largely reproduced in different experiments conducted within the same experimental session or over different sessions. Our results demonstrate that high-field fMRI can be used for studying the functions of human brains at columnar spatial resolution.	RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, Wako, Saitama 3510198, Japan; Japan Sci & Technol Corp, CREST, Wako, Saitama 3510198, Japan	RIKEN; Japan Science & Technology Agency (JST)	Cheng, K (corresponding author), RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kcheng@mailman.riken.go.jp	Waggoner, Allen/F-2654-2010; Cheng, Kang/A-6448-2016; Tanaka, Keiji/N-5917-2015	Waggoner, Allen/0000-0002-4921-7521; Tanaka, Keiji/0000-0002-1910-3427				BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Dechent P, 2000, NEUROREPORT, V11, P3247, DOI 10.1097/00001756-200009280-00039; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; ERNST T, 1994, MAGN RESON MED, V32, P146, DOI 10.1002/mrm.1910320122; FLORENCE SL, 1992, VISUAL NEUROSCI, V8, P449, DOI 10.1017/S0952523800004958; Fransson P, 1998, MAGNET RESON MED, V39, P912, DOI 10.1002/mrm.1910390608; Gati JS, 1997, MAGNET RESON MED, V38, P296, DOI 10.1002/mrm.1910380220; Grinvald A, 2000, NAT NEUROSCI, V3, P105, DOI 10.1038/72045; HITCHCOCK PF, 1980, BRAIN RES, V182, P176; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P255, DOI 10.1098/rstb.1984.0022; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HORTON JC, 1990, ARCH OPHTHALMOL-CHIC, V108, P1025, DOI 10.1001/archopht.1990.01070090127054; HU XP, 1994, MAGN RESON MED, V31, P495, DOI 10.1002/mrm.1910310505; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1972, J COMP NEUROL, V146, P421, DOI 10.1002/cne.901460402; Jones M, 2001, NEUROIMAGE, V13, P1002, DOI 10.1006/nimg.2001.0808; KENNEDY C, 1976, P NATL ACAD SCI USA, V73, P4230, DOI 10.1073/pnas.73.11.4230; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Kim SG, 1996, MAGNET RESON MED, V35, P895, DOI 10.1002/mrm.1910350618; Kim SG, 1999, MAGN RESON MED, V41, P1152, DOI 10.1002/(SICI)1522-2594(199906)41:6<1152::AID-MRM11>3.0.CO;2-T; LEUBA G, 1994, ANAT EMBRYOL, V190, P351; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Luh WM, 2000, MAGNET RESON MED, V44, P137, DOI 10.1002/1522-2594(200007)44:1<137::AID-MRM20>3.0.CO;2-R; Maas LC, 1997, MAGNET RESON MED, V37, P131, DOI 10.1002/mrm.1910370119; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Menon RS, 1997, J NEUROPHYSIOL, V77, P2780, DOI 10.1152/jn.1997.77.5.2780; MENON RS, 1993, MAGNET RESON MED, V30, P380, DOI 10.1002/mrm.1910300317; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; Menon RS, 1999, MAGNET RESON MED, V41, P230, DOI 10.1002/(SICI)1522-2594(199902)41:2<230::AID-MRM3>3.0.CO;2-O; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ogawa S, 1998, ANNU REV BIOPH BIOM, V27, P447, DOI 10.1146/annurev.biophys.27.1.447; Ono M, 1990, ATLAS CEREBRAL SULCI; PONCELET BP, 1992, RADIOLOGY, V185, P645, DOI 10.1148/radiology.185.3.1438740; Schwarzbauer C, 1999, MAGNET RESON MED, V41, P537, DOI 10.1002/(SICI)1522-2594(199903)41:3<537::AID-MRM16>3.0.CO;2-V; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; TOOTELL RBH, 1988, J NEUROSCI, V8, P1500; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; TURNER R, 1991, MAGNET RESON MED, V22, P159, DOI 10.1002/mrm.1910220117; WIESEL TN, 1974, BRAIN RES, V79, P273, DOI 10.1016/0006-8993(74)90416-8; Wiser AK, 1997, VISUAL NEUROSCI, V14, P241, DOI 10.1017/S095252380001138X; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yacoub E, 1999, MAGNET RESON MED, V41, P1088, DOI 10.1002/(SICI)1522-2594(199906)41:6<1088::AID-MRM3>3.0.CO;2-Q; Yoshioka T, 1996, CEREB CORTEX, V6, P297, DOI 10.1093/cercor/6.2.297	58	274	279	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					359	374		10.1016/S0896-6273(01)00477-9	http://dx.doi.org/10.1016/S0896-6273(01)00477-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11684004	Bronze			2022-12-28	WOS:000171893700019
J	Selkoe, DJ				Selkoe, DJ			Clearing the brain's amyloid cobwebs	NEURON			English	Review							INSULIN-DEGRADING ENZYME; BETA-PROTEIN; ALZHEIMER-DISEASE; EXTRACELLULAR LEVELS; DEGRADATION; PROTEOLYSIS; PATHOLOGY; NEURONS; SYSTEM	Elevated cerebral levels of amyloid beta -protein occur universally in Alzheimer's disease, yet only a few patients show evidence of increased A beta production. Therefore, defects in proteases that degrade A beta could underlie some or many cases of familial and sporadic AD. This previously neglected topic has begun receiving serious attention. Understanding how proteolysis regulates A beta levels in the cerebral cortex has implications for both the pathogenesis and the treatment of this protean disorder.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.							Backstrom JR, 1996, J NEUROSCI, V16, P7910; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; DEMATTOS RB, 2001, BIOL CHEM, V276, P24540; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; McDermott JR, 1996, NEUROREPORT, V7, P2163, DOI 10.1097/00001756-199609020-00021; Mucke L, 2000, AM J PATHOL, V157, P2003, DOI 10.1016/S0002-9440(10)64839-0; Mukherjee A, 2000, J NEUROSCI, V20, P8745; Nilsson LNG, 2001, J NEUROSCI, V21, P1444, DOI 10.1523/JNEUROSCI.21-05-01444.2001; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Savage MJ, 1998, J NEUROSCI, V18, P1743; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Tucker HM, 2000, J NEUROSCI, V20, P3937; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Yamin R, 1999, J BIOL CHEM, V274, P18777, DOI 10.1074/jbc.274.26.18777	23	453	494	2	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					177	180		10.1016/S0896-6273(01)00475-5	http://dx.doi.org/10.1016/S0896-6273(01)00475-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683988	Bronze			2022-12-28	WOS:000171893700003
J	Helmchen, F; Fee, MS; Tank, DW; Denk, W				Helmchen, F; Fee, MS; Tank, DW; Denk, W			A miniature head-mounted two-photon microscope: High-resolution brain imaging in freely moving animals	NEURON			English	Article							DENDRITIC CALCIUM DYNAMICS; NEOCORTICAL PYRAMIDAL NEURONS; GREEN FLUORESCENT PROTEINS; CORTEX IN-VIVO; ACTION-POTENTIALS; BEHAVING ANIMALS; RAT; INTEGRATION; HIPPOCAMPAL; INDICATOR	Two-photon microscopy has enabled anatomical and functional fluorescence imaging in the intact brain of rats. Here, we extend two-photon imaging from anesthetized, head-stabilized to awake, freely moving animals by using a miniaturized head-mounted microscope. Excitation light is conducted to the microscope in a single-mode optical fiber, and images are scanned using vibrations of the fiber tip. Microscope performance was first characterized in the neocortex of anesthetized rats. We readily obtained images of vasculature filled with fluorescently labeled blood and of layer 2/3 pyramidal neurons filled with a calcium indicator. Capillary blood flow and dendritic calcium transients were measured with high time resolution using line scans. In awake, freely moving rats, stable imaging was possible except during sudden head movements.	Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA; Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany	Alcatel-Lucent; Lucent Technologies; AT&T; Max Planck Society	Denk, W (corresponding author), Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA.		denk, winfried/I-6627-2012; Helmchen, Fritjof/A-6255-2008	Helmchen, Fritjof/0000-0002-8867-9569; Fee, Michale/0000-0001-7539-1745				Agrawal G.P., 2006, NONLINEAR FIBER OPTI, V4th; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BIRGE RR, 1986, ACCOUNTS CHEM RES, V19, P138, DOI 10.1021/ar00125a003; BORST A, 1992, P NATL ACAD SCI USA, V89, P4139, DOI 10.1073/pnas.89.9.4139; Bussau LJ, 1998, J ANAT, V192, P187, DOI 10.1046/j.1469-7580.1998.19220187.x; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; Davis MD, 2000, J NEUROSCI METH, V99, P9, DOI 10.1016/S0165-0270(00)00209-0; deCharms RC, 1999, J NEUROSCI METH, V93, P27, DOI 10.1016/S0165-0270(99)00087-4; Delaney P. M., 1995, P515; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; Denk Winfried, 1995, P445; Dickensheets DL, 1996, OPT LETT, V21, P764, DOI 10.1364/OL.21.000764; DIRNAGL U, 1992, J MICROSC-OXFORD, V165, P147, DOI 10.1111/j.1365-2818.1992.tb04312.x; Eilers J, 1997, CURR OPIN NEUROBIOL, V7, P385, DOI 10.1016/S0959-4388(97)80067-0; Fee MS, 2000, NEURON, V27, P461, DOI 10.1016/S0896-6273(00)00057-X; FORK RL, 1984, OPT LETT, V9, P150, DOI 10.1364/OL.9.000150; GOSNELL TR, 1991, SELECTED PAPERS ULTR; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hofmann U, 1999, P SOC PHOTO-OPT INS, V3878, P29, DOI 10.1117/12.361269; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LISSAJOUS JA, 1855, CR HEBD ACAD SCI, V41, P814; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Papworth GD, 1998, J ANAT, V192, P489, DOI 10.1046/j.1469-7580.1998.19240489.x; Pare D, 1998, NEUROSCIENCE, V84, P377, DOI 10.1016/S0306-4522(97)00530-7; Rector DM, 1997, J NEUROSCI METH, V78, P85, DOI 10.1016/S0165-0270(97)00137-4; RECTOR DM, 1993, NEUROSCIENCE, V54, P633, DOI 10.1016/0306-4522(93)90234-7; Regehr Wade G., 1994, Current Opinion in Neurobiology, V4, P373, DOI 10.1016/0959-4388(94)90099-X; Sabharwal YS, 1999, APPL OPTICS, V38, P7133, DOI 10.1364/AO.38.007133; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TREACY EB, 1969, IEEE J QUANTUM ELECT, VQE 5, P454, DOI 10.1109/JQE.1969.1076303; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; YUSTE R, 1999, IMAGING NEURONS LAB	42	455	487	6	67	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					903	912		10.1016/S0896-6273(01)00421-4	http://dx.doi.org/10.1016/S0896-6273(01)00421-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580892	Bronze			2022-12-28	WOS:000171281300007
J	Benn, SC; Perrelet, D; Kato, AC; Scholz, J; Decosterd, I; Mannion, RJ; Bakowska, JC; Woolf, CJ				Benn, SC; Perrelet, D; Kato, AC; Scholz, J; Decosterd, I; Mannion, RJ; Bakowska, JC; Woolf, CJ			Hsp27 upregulation and phosphorylation is required for injured sensory and motor neuron survival	NEURON			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; PERIPHERAL-NERVE INJURY; C-DEPENDENT ACTIVATION; PROGRAMMED CELL-DEATH; HEAT-SHOCK PROTEINS; IAP FAMILY PROTEINS; CYTOCHROME-C; DEVELOPING MOTONEURONS; SCIATIC-NERVE; IN-VIVO	Peripheral nerve transection results in the rapid death by apoptosis of neonatal but not adult sensory and motor neurons. We show that this is due to induction and phosphorylation in all adult axotomized neurons of the small heat shock protein Hsp27 and the failure of such induction in most neonatal neurons. In vivo delivery of human Hsp27 but not a nonphosphorylatable mutant prevents neonatal rat motor neurons from nerve injury-induced death, while knockdown in vitro and in vivo of Hsp27 in adult injured sensory neurons results in apoptosis. Hsp27's neuroprotective action is downstream of cytochrome c release from mitochondria and upstream of caspase-3 activation. Transcriptional and posttranslational regulation of Hsp27 is necessary for sensory and motor neuron survival following peripheral nerve injury.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Neurol, Mol Neurogenet Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; CHU Vaudois, Dept Anesthesiol, CH-1011 Lausanne, Switzerland; CHU Vaudois, Dept Expt Surg, CH-1011 Lausanne, Switzerland; Ctr Med Univ Geneva, Fac Med, Dept Anesthesiol Pharmacol & Surg Intens Care, CH-1211 Geneva 4, Switzerland	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA.	woolf.clifford@mgh.harvard.edu	Woolf, Clifford/A-9784-2010		NICHD NIH HHS [HD38533] Funding Source: Medline; NINDS NIH HHS [NS38253] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARRIGO AP, 1994, BIOL HEAT SHOCK PROT; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Benn SC, 2001, J NEUROSCI, V21, P6077, DOI 10.1523/JNEUROSCI.21-16-06077.2001; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carper SW, 1997, J CELL BIOCHEM, V66, P153, DOI 10.1002/(SICI)1097-4644(19970801)66:2<153::AID-JCB3>3.3.CO;2-N; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; CLARKE PGH, 1995, METHOD CELL BIOL, V46, P277; Concannon CG, 2001, GENE EXPRESSION, V9, P195, DOI 10.3727/000000001783992605; Costigan M, 1998, J NEUROSCI, V18, P5891; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; Garces A, 2000, J NEUROSCI, V20, P4992; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Guay J, 1997, J CELL SCI, V110, P357; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Henderson CE, 1996, NEURON, V17, P579, DOI 10.1016/S0896-6273(00)80191-9; Houenou LJ, 1996, J NEUROPATH EXP NEUR, V55, P698, DOI 10.1097/00005072-199606000-00003; Huot J, 1996, CANCER RES, V56, P273; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kalmar B, 2002, EXP NEUROL, V176, P87, DOI 10.1006/exnr.2002.7945; Kato K, 2001, CELL STRESS CHAPERON, V6, P16, DOI 10.1379/1466-1268(2001)006<0016:PKICSS>2.0.CO;2; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; Krueger-Naug AMR, 2002, NEUROSCIENCE, V110, P653, DOI 10.1016/S0306-4522(01)00453-5; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; Landry J, 1999, BIOCHEM SOC SYMP, P79; Lewis SE, 1999, J NEUROSCI, V19, P8945, DOI 10.1523/JNEUROSCI.19-20-08945.1999; Li L, 2001, J NEUROBIOL, V46, P249, DOI 10.1002/1097-4695(200103)46:4<249::AID-NEU1006>3.0.CO;2-G; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu X, 2000, DEV DYNAM, V218, P94, DOI 10.1002/(SICI)1097-0177(200005)218:1<94::AID-DVDY8>3.0.CO;2-Z; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Ma JJ, 2001, EXP BRAIN RES, V139, P216, DOI 10.1007/s002210100769; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Mehlen P, 1997, J BIOL CHEM, V272, P31657, DOI 10.1074/jbc.272.50.31657; Murashov AK, 2001, MOL BRAIN RES, V93, P199, DOI 10.1016/S0169-328X(01)00212-1; Namikawa K, 2000, J NEUROSCI, V20, P2875; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Oliveira ALR, 1997, NEUROREPORT, V8, P2837; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Perrelet D, 2000, EUR J NEUROSCI, V12, P2059, DOI 10.1046/j.1460-9568.2000.00098.x; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Pieri I, 2001, J NEUROSCI RES, V65, P247, DOI 10.1002/jnr.1148; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Saeki Y, 1998, HUM GENE THER, V9, P2787, DOI 10.1089/hum.1998.9.18-2787; Saeki Y, 2001, MOL THER, V3, P591, DOI 10.1006/mthe.2001.0294; Sendtner M, 2000, CELL TISSUE RES, V301, P71, DOI 10.1007/s004410000217; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Valentine B, 2001, J ACAD LIBR, V27, P107, DOI 10.1016/S0099-1333(00)00182-8; VEJSADA R, 1995, EUR J NEUROSCI, V7, P108, DOI 10.1111/j.1460-9568.1995.tb01025.x; Wagstaff MJD, 1999, J BIOL CHEM, V274, P5061, DOI 10.1074/jbc.274.8.5061; Wiese S, 1999, EUR J NEUROSCI, V11, P1668, DOI 10.1046/j.1460-9568.1999.00585.x; Yamada M, 2001, EXP NEUROL, V168, P225, DOI 10.1006/exnr.2000.7597; Yokoyama A, 2001, INVEST OPHTH VIS SCI, V42, P3283	62	209	218	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					45	56		10.1016/S0896-6273(02)00941-8	http://dx.doi.org/10.1016/S0896-6273(02)00941-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367505	Bronze			2022-12-28	WOS:000178295100006
J	Clandinin, TR; Zipursky, SL				Clandinin, TR; Zipursky, SL			Making connections in the fly visual system	NEURON			English	Review							PROTEIN-TYROSINE-PHOSPHATASE; PHOTORECEPTOR AXON GUIDANCE; CELL-ADHESION; N-CADHERIN; RETINAL AXONS; DROSOPHILA-MELANOGASTER; TARGET SPECIFICITY; SYNAPTIC ACTIVITY; GLIAL-CELLS; OPTIC LOBE	Understanding the molecular mechanisms that regulate formation of precise patterns of neuronal connections within the central nervous system remains a challenging problem in neurobiology. Genetic studies in worms and files and molecular studies in vertebrate systems have led to an increasingly sophisticated understanding of how growth cones navigate toward their targets and form topographic maps. Considerably less is known about how growth cones recognize their cellular targets and form synapses with them. Here, we review connection formation in the fly visual system, the methodological approaches used to study it, and recent progress in uncovering the molecular basis of connection specificity.	Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, 5-748 MRL,675 Charles E Young Dr S, Los Angeles, CA 90095 USA.			Zipursky, Stephen/0000-0001-5630-7181				Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Barth M, 1997, J NEUROSCI, V17, P1493; BASLER K, 1990, GENE DEV, V4, P728, DOI 10.1101/gad.4.5.728; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; CAJAL SRY, 1915, TRAB LAB INV BIOL, V13; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; Giurfa M, 1997, CURR OPIN NEUROBIOL, V7, P505, DOI 10.1016/S0959-4388(97)80030-X; Heisenberg M, 1980, Basic Life Sci, V16, P373; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hummel T, 2002, NEURON, V33, P193, DOI 10.1016/S0896-6273(01)00581-5; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jin YS, 2002, CURR OPIN NEUROBIOL, V12, P71, DOI 10.1016/S0959-4388(02)00292-1; KAMINKER J, 2002, IN PRESS NAT NEUROSC; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KELLY RB, 1988, NEURON, V1, P431, DOI 10.1016/0896-6273(88)90174-2; KIRSHFELD K, 1967, EXP BRAIN RES, V3; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Meinertzhagen Ian A., 1993, P1363; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Newsome TP, 2000, DEVELOPMENT, V127, P851; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; OLEARY DDM, 1986, J NEUROSCI, V6, P3692; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Ramon y Cajal S, 1937, RECOLLECTIONS MY LIF; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; Salecker I, 1998, CELL, V95, P587, DOI 10.1016/S0092-8674(00)81627-X; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Senti KA, 2000, DEVELOPMENT, V127, P2291; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1991, J COMP NEUROL, V307, P393, DOI 10.1002/cne.903070305; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stowers RS, 1999, GENETICS, V152, P1631; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THANOS S, 1984, P NATL ACAD SCI-BIOL, V81, P1906, DOI 10.1073/pnas.81.6.1906; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Trujille-Cenoz O., 1966, P339; TRUJILLO.O, 1965, J ULTRA MOL STRUCT R, V13, P1, DOI 10.1016/S0022-5320(65)80086-7; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; Vigier P, 1909, CR HEBD ACAD SCI, V148, P1221; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	84	138	139	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					827	841		10.1016/S0896-6273(02)00876-0	http://dx.doi.org/10.1016/S0896-6273(02)00876-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372279	Bronze			2022-12-28	WOS:000177779800007
J	Waddell, S				Waddell, S			Forgetting those painful moments	NEURON			English	Editorial Material							EXTINCTION; DROSOPHILA; MEMORY; ACQUISITION		Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01655 USA.			Waddell, Scott/0000-0003-4503-6229				Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Rescorla RA, 2001, HANDBOOK OF CONTEMPORARY LEARNING THEORIES, P119; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2001, TRENDS GENET, V17, P719, DOI 10.1016/S0168-9525(01)02526-4; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	13	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 29	2002	35	5					815	817		10.1016/S0896-6273(02)00865-6	http://dx.doi.org/10.1016/S0896-6273(02)00865-6			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372275	Bronze			2022-12-28	WOS:000177779800003
J	Shahbazian, MD; Young, JI; Yuva-Paylor, LA; Spencer, CM; Antalffy, BA; Noebels, JL; Armstrong, DL; Paylor, R; Zoghbi, HY				Shahbazian, MD; Young, JI; Yuva-Paylor, LA; Spencer, CM; Antalffy, BA; Noebels, JL; Armstrong, DL; Paylor, R; Zoghbi, HY			Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3	NEURON			English	Article							CPG-BINDING PROTEIN-2; LINKED MENTAL-RETARDATION; TRANSCRIPTIONAL REPRESSION; CHROMOSOMAL PROTEIN; DNA METHYLATION; MUTATIONS; LOCALIZATION; GENE; DEACETYLATION; PHENOTYPES	Mutations in the methyl-CpG binding protein 2 (MECP2) gene cause Rett syndrome (RTT), a neurodevelopmental disorder characterized by the loss of language and motor skills during early childhood. We generated mice with a truncating mutation similar to those found in RTT patients. These mice appeared normal and exhibited normal motor function for about 6 weeks, but then developed a progressive neurological disease that includes many features of RTT: tremors, motor impairments, hypoactivity, increased anxiety-related behavior, seizures, kyphosis, and stereotypic forelimb motions. Additionally, we show that although the truncated MeCP2 protein in these mice localizes normally to heterochromatic domains in vivo, histone H3 is hyperacetylated, providing evidence that the chromatin architecture is abnormal and that gene expression may be misregulated in this model of Rett syndrome.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.			Zoghbi, Huda/0000-0002-0700-3349; Noebels, Jeffrey/0000-0002-2887-0839	NICHD NIH HHS [P01 HD40301, HD24064] Funding Source: Medline; NIMH NIH HHS [MH12555-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040301] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Bourdon V, 2001, HUM GENET, V108, P43, DOI 10.1007/s004390000422; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cohen D, 2002, AM J PSYCHIAT, V159, P148, DOI 10.1176/appi.ajp.159.1.148-a; Glaze DG, 1998, ELECTROEN CLIN NEURO, V106, P79, DOI 10.1016/S0013-4694(97)00084-9; Gregory RI, 2001, MOL CELL BIOL, V21, P5426, DOI 10.1128/MCB.21.16.5426-5436.2001; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG BA, 1994, PEDIATR NEUROL, V11, P5, DOI 10.1016/0887-8994(94)90082-5; Hoffbuhr K, 2001, NEUROLOGY, V56, P1486, DOI 10.1212/WNL.56.11.1486; Imessaoudene B, 2001, J MED GENET, V38, P171, DOI 10.1136/jmg.38.3.171; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; LaSalle JM, 2001, HUM MOL GENET, V10, P1729, DOI 10.1093/hmg/10.17.1729; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; Lorincz MC, 2001, MOL CELL BIOL, V21, P7913, DOI 10.1128/MCB.21.23.7913-7922.2001; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; MICZEK KA, 1979, PSYCHOPHARMACOLOGY, V60, P253, DOI 10.1007/BF00426664; Nan XS, 1996, MOL CELL BIOL, V16, P414; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Paylor R, 1998, LEARN MEMORY, V5, P302; Schanen C, 1998, AM J HUM GENET, V63, P267, DOI 10.1086/301932; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Shahbazian MD, 2001, CURR OPIN NEUROL, V14, P171, DOI 10.1097/00019052-200104000-00006; Steffenburg U, 2001, ACTA PAEDIATR, V90, P34; TREVATHAN E, 1988, ANN NEUROL, V23, P425; Vacca M, 2001, J MOL MED, V78, P648, DOI 10.1007/s001090000155; Van den Veyver IB, 2001, BRAIN DEV-JPN, V23, pS147, DOI 10.1016/S0387-7604(01)00376-X; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Wan MM, 2001, HUM MOL GENET, V10, P1085, DOI 10.1093/hmg/10.10.1085; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Zappella M, 2001, AM J MED GENET, V104, P14, DOI 10.1002/ajmg.10005	40	585	597	2	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					243	254		10.1016/S0896-6273(02)00768-7	http://dx.doi.org/10.1016/S0896-6273(02)00768-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160743	Bronze			2022-12-28	WOS:000177034200005
J	Chen, SG; Gambetti, P				Chen, SG; Gambetti, P			A journey through the species barrier	NEURON			English	Editorial Material							CREUTZFELDT-JAKOB-DISEASE; MOLECULAR-BASIS; PRION STRAINS; SCRAPIE	The species barrier in prion infectivity is believed to reside in the degree of amino acid sequence heterology between the infectious prion protein, PrPSc, of the donor and the normal PrP of the host. Peretz et al. (2002) bring new evidence that distinct PrPSc species or prion strains may have different conformations even when they have identical amino acid sequence and that the conformation of the exogenous prion strain is a determinant of the species barrier in hosts that have identical PrP genotype.	Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA	Case Western Reserve University	Chen, SG (corresponding author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.		Chen, Shu G./O-4750-2014; Chen, Shu G./AAK-7301-2021	Chen, Shu G./0000-0001-7180-3001; Chen, Shu G./0000-0001-7180-3001				BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Gambetti P, 2001, J ALZHEIMERS DIS, V3, P87, DOI 10.3233/JAD-2001-3113; MONARI L, 1994, P NATL ACAD SCI USA, V91, P2839, DOI 10.1073/pnas.91.7.2839; Pan T, 2001, J BIOL CHEM, V276, P37284, DOI 10.1074/jbc.M107358200; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; PATTISON IH, 1966, RES VET SCI, V7, P207; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; PRUSINER SB, 1999, DEV PRION CONCEPTS, P67; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654	13	10	11	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					854	856		10.1016/S0896-6273(02)00736-5	http://dx.doi.org/10.1016/S0896-6273(02)00736-5			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086631	Bronze			2022-12-28	WOS:000176249700002
J	Fraser, C; Power, M; Hamdy, S; Rothwell, J; Hobday, D; Hollander, I; Tyrell, P; Hobson, A; Williams, S; Thompson, D				Fraser, C; Power, M; Hamdy, S; Rothwell, J; Hobday, D; Hollander, I; Tyrell, P; Hobson, A; Williams, S; Thompson, D			Driving plasticity in human adult motor cortex is associated with improved motor function after brain injury	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; ACUTE STROKE; REORGANIZATION; RECOVERY; FMRI; EXCITABILITY; ACTIVATION; ASPIRATION; DYSPHAGIA; MRI	Changes in somatosensory input can remodel human cortical motor organization, yet the input characteristics that promote reorganization and their functional significance have not been explored. Here we show with transcranial magnetic stimulation that sensory-driven reorganization of human motor cortex is highly dependent upon the frequency, intensity, and duration of stimulus applied. Those patterns of input associated with enhanced excitability (5 Hz, 75% maximal tolerated intensity for 10 min) induce stronger cortical activation to fMRI. When applied to acutely dysphagic stroke patients, swallowing corticobulbar excitability is increased mainly in the undamaged hemisphere, being strongly correlated with an improvement in swallowing function. Thus, input to the human adult brain can be programmed to promote beneficial changes in neuroplasticity and function after cerebral injury.	Hope Hosp, Univ Dept Gastroenterol, Salford M6 8HD, Lancs, England; Hope Hosp, Univ Dept Stroke Med, Salford M6 8HD, Lancs, England; Inst Neurol, Sobell Dept Neurophysiol, London WC1N 3BG, England; Univ Manchester, Dept Imaging Sci & Biomed Engn, Manchester M13 9PL, Lancs, England	University of London; University College London; University of Manchester	Hamdy, S (corresponding author), Hope Hosp, Univ Dept Gastroenterol, Salford M6 8HD, Lancs, England.		Williams, Steve R/C-8945-2011; Williams, Steve C/D-6979-2011; Hamdy, Shaheen/O-5039-2014	Williams, Steve R/0000-0001-5940-1675; Williams, Steve C/0000-0003-4299-1941; Hamdy, Shaheen/0000-0001-9640-7427; Rothwell, John/0000-0003-1367-6467				BENECKE R, 1991, EXP BRAIN RES, V83, P419; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Cohen LG, 1998, J CLIN NEUROPHYSIOL, V15, P305, DOI 10.1097/00004691-199807000-00003; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Cook IJ, 1999, GASTROENTEROLOGY, V116, P455, DOI 10.1016/S0016-5085(99)70144-7; DONOGHUE JP, 1996, SUBSTRATES MECH LEAR; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; GORDON C, 1987, BRIT MED J, V295, P411, DOI 10.1136/bmj.295.6595.411; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hamdy S, 1999, AM J PHYSIOL-GASTR L, V277, pG219, DOI 10.1152/ajpgi.1999.277.1.G219; Hamdy S, 1996, NAT MED, V2, P1217, DOI 10.1038/nm1196-1217; Hamdy S, 1997, AM J PHYSIOL-GASTR L, V272, pG802, DOI 10.1152/ajpgi.1997.272.4.G802; Hamdy S, 1998, GASTROENTEROLOGY, V115, P1104, DOI 10.1016/S0016-5085(98)70081-2; Hamdy S, 1998, NAT NEUROSCI, V1, P64, DOI 10.1038/264; Hobday DI, 2001, BRAIN, V124, P361, DOI 10.1093/brain/124.2.361; KIDD D, 1995, QJM-MON J ASSOC PHYS, V88, P409; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; MAHONEY F I, 1965, Md State Med J, V14, P61; Medical research council of the United Kingdom, 1976, AIDS EX PER NERV SYS; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Thacker NA, 1999, JMRI-J MAGN RESON IM, V10, P582, DOI 10.1002/(SICI)1522-2586(199910)10:4<582::AID-JMRI12>3.0.CO;2-X; Thacker NA, 1999, PHYSIOL MEAS, V20, P251, DOI 10.1088/0967-3334/20/3/303; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; Vokurka EA, 1999, JMRI-J MAGN RESON IM, V10, P550, DOI 10.1002/(SICI)1522-2586(199910)10:4<550::AID-JMRI8>3.0.CO;2-Q; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605	32	263	294	2	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					831	840		10.1016/S0896-6273(02)00705-5	http://dx.doi.org/10.1016/S0896-6273(02)00705-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062028	Bronze			2022-12-28	WOS:000175951800016
J	Mazzucchelli, C; Vantaggiato, C; Ciamei, A; Fasano, S; Pakhotin, P; Krezel, W; Welzl, H; Wolfer, DP; Pages, G; Valverde, O; Marowsky, A; Porrazzo, A; Orban, PC; Maldonado, R; Ehrengruber, MU; Cestari, V; Lipp, HP; Chapman, PF; Pouyssegur, J; Brambilla, R				Mazzucchelli, C; Vantaggiato, C; Ciamei, A; Fasano, S; Pakhotin, P; Krezel, W; Welzl, H; Wolfer, DP; Pages, G; Valverde, O; Marowsky, A; Porrazzo, A; Orban, PC; Maldonado, R; Ehrengruber, MU; Cestari, V; Lipp, HP; Chapman, PF; Pouyssegur, J; Brambilla, R			Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; RECEPTOR MUTANT MICE; NUCLEUS-ACCUMBENS; MOLECULAR MECHANISMS; SIGNALING PATHWAY; DOPAMINE; COCAINE; RAS; EXPRESSION	Extracellular signal-regulated kinases (ERK1 and 2) are synaptic signaling components necessary for several forms of learning. In mice lacking ERK1, we observe a dramatic enhancement of striatum-dependent long-term memory, which correlates with a facilitation of long-term potentiation in the nucleus accumbens. At the cellular level, we find that ablation of ERK1 results in a stimulus-dependent increase of ERK2 signaling, likely due to its enhanced interaction with the upstream kinase MEK. Consistently, such activity change is responsible for the hypersensitivity of ERK1 mutant mice to the rewarding properties of morphine. Our results reveal an unexpected complexity of ERK-dependent signaling in the brain and a critical regulatory role for ERK1 in the long-term adaptive changes underlying striatum-dependent behavioral plasticity and drug addiction.	San Raffaele Res Inst, I-20132 Milan, Italy; Univ Milan, I-20132 Milan, Italy; Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales; Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; CNR, Ist Neurosci, Sez Psicobiol & Psicofarmacol, I-00137 Rome, Italy; Ctr Antoine Lacassagne, Inst Signaling Dev Biol & Canc Res, CNRS, UMR 6543, F-06189 Nice, France; Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Barcelona 08003, Spain; Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland	University of Milan; Cardiff University; University of Zurich; Consiglio Nazionale delle Ricerche (CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Pompeu Fabra University; University of Zurich	Brambilla, R (corresponding author), San Raffaele Res Inst, Via Olgettina 58, I-20132 Milan, Italy.		Vantaggiato, Chiara/AAH-5702-2019; KREZEL, Wojciech/S-8331-2019; Valverde, Olga/D-8654-2012; Brambilla, Riccardo/A-6082-2010; Maldonado, Rafael/F-5657-2014; Krezel, Wojciech/I-7886-2016; Krezel, Wojciech/H-9080-2017; Wolfer, David P/B-3293-2016	Vantaggiato, Chiara/0000-0002-3910-6836; Valverde, Olga/0000-0003-2264-7852; Maldonado, Rafael/0000-0002-4359-8773; Krezel, Wojciech/0000-0003-1605-3185; Krezel, Wojciech/0000-0003-1605-3185; Wolfer, David P/0000-0002-5957-1401; Brambilla, Riccardo/0000-0003-3569-5706; Cestari, Vincenzo/0000-0002-9623-157X; Fasano, Stefania/0000-0002-3696-7139				Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; CLINCKE GHC, 1993, BEHAV NEUROSCIENCE, V1; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Izquierdo I, 1997, EUR J NEUROSCI, V9, P786, DOI 10.1111/j.1460-9568.1997.tb01427.x; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Krezel W, 2001, P NATL ACAD SCI USA, V98, P12278, DOI 10.1073/pnas.221451898; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lundstrom K, 2001, HISTOCHEM CELL BIOL, V115, P83, DOI 10.1007/s004180000223; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Martin M, 2000, EUR J NEUROSCI, V12, P4038, DOI 10.1046/j.1460-9568.2000.00287.x; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; OLANOW CW, 2000, TRENDS NEUROSCI S, V23; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; ROOZENDAAL B, 1993, BEHAV NEURAL BIOL, V59, P143, DOI 10.1016/0163-1047(93)90873-G; SAHGAL A, 1993, BEHAV NEUROSCIENCE, V1; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; SCHMUED LC, 1990, J HISTOCHEM CYTOCHEM, V38, P721, DOI 10.1177/38.5.2332627; SCHUTZ RA, 1979, PHYSIOL BEHAV, V23, P97, DOI 10.1016/0031-9384(79)90128-8; Schwarzschild MA, 1999, J NEUROCHEM, V72, P2248, DOI 10.1046/j.1471-4159.1999.0722248.x; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Sweatt JD, 1999, LEARN MEMORY, V6, P399, DOI 10.1101/lm.6.5.399; TAGHZOUTI K, 1985, BRAIN RES, V344, P9, DOI 10.1016/0006-8993(85)91184-9; Valjent E, 2000, J NEUROSCI, V20, P8701; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	41	375	387	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					807	820		10.1016/S0896-6273(02)00716-X	http://dx.doi.org/10.1016/S0896-6273(02)00716-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062026	Bronze			2022-12-28	WOS:000175951800014
J	Ebinu, JO; Yankner, BA				Ebinu, JO; Yankner, BA			A RIP tide in neuronal signal transduction	NEURON			English	Review							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE CLEAVAGE; INTRAMEMBRANE CLEAVAGE; MECHANISMS; INHIBITORS; APP	The generation of nuclear signaling proteins by regulated intramembrane proteolysis (RIP) is a new paradigm of signal transduction. Mammalian proteins that are processed by RIP include SREBP-1, Notch-1, amyloid precursor protein (APP), and ErbB-4. Intramembranous gamma-secretase cleavage of APP plays a central role in Alzheimer's disease by generating the amyloid P protein. An intriguing possibility is that the cognate C-terminal fragment generated by T-secretase cleavage could also play a role through the regulation of nuclear signaling events. Thus, RIP may contribute to both brain development and degeneration and may provide unexpected diversity to the signaling repertoire of a cell.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Yankner, BA (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Enders 260,300 Longwood Ave, Boston, MA 02115 USA.	bruce.yankner@tch.harvard.edu						Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	21	139	145	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 16	2002	34	4					499	502		10.1016/S0896-6273(02)00704-3	http://dx.doi.org/10.1016/S0896-6273(02)00704-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062033	Bronze			2022-12-28	WOS:000175665700004
J	Nicolelis, MAL				Nicolelis, MAL			Depression at thalamocortical synapses: The key for cortical neuronal adaptation?	NEURON			English	Editorial Material								Neuronal adaptation to repetitive sensory stimuli is ubiquitous in the mammalian cortex. Despite its prevalence, the cellular mechanisms underlying this basic physiological property remain a matter of dispute. In this issue of Neuron, Chung et al. provide conclusive evidence that depression of thalamocortical synapses may play a significant role in the expression of neuronal adaptation in the rat somatosensory cortex.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Nicolelis, MAL (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.							Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; NICOLELIS MAL, 2002, IN PRESS NAT NEUROSC	4	6	6	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					331	332		10.1016/S0896-6273(02)00691-8	http://dx.doi.org/10.1016/S0896-6273(02)00691-8			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988163	Bronze			2022-12-28	WOS:000175214700003
J	Pittenger, C; Huang, YY; Paletzki, RF; Bourtchouladze, R; Scanlin, H; Vronskaya, S; Kandel, ER				Pittenger, C; Huang, YY; Paletzki, RF; Bourtchouladze, R; Scanlin, H; Vronskaya, S; Kandel, ER			Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory	NEURON			English	Article							LONG-TERM-MEMORY; ELEMENT-BINDING PROTEIN; MEDIATED GENE-EXPRESSION; LATE-PHASE; SYNAPTIC PLASTICITY; NUCLEAR TRANSLOCATION; TARGETED MUTATION; UP-REGULATION; MAP KINASE; POTENTIATION	CREB is critical for long-lasting synaptic and behavioral plasticity in invertebrates. Its role in the mammalian hippocampus is less clear. We have interfered with CREB family transcription factors in region CA1 of the dorsal hippocampus. This impairs learning in the Morris water maze, which specifically requires the dorsal hippocampus, but not context conditioning, which does not. The deficit is specific to long-term memory, as shown in an object recognition task. Several forms of late-phase LTP are normal, but forskolin-induced and dopamine-regulated potentiation are disrupted. These experiments represent the first targeting of the dorsal hippocampus in genetically modified mice and confirm a role for CREB in hippocampus-dependent learning. Nevertheless, they suggest that some experimental forms of plasticity bypass the requirement for CREB.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; NINCDS, Mol Plast Sect, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.		Pittenger, Christopher/G-8402-2012	Pittenger, Christopher/0000-0003-2117-9321	NIMH NIH HHS [MH 12956-01] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Amaral D.G., 1995, RAT NERVOUS SYSTEM; ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Barth AL, 2000, J NEUROSCI, V20, P4206; Bartsch D, 2000, CELL, V103, P595, DOI 10.1016/S0092-8674(00)00163-X; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; CRAIG JC, 2000, J BIOL CHEM, V27, P27; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gass P, 1998, LEARN MEMORY, V5, P274; GERFEN CR, 1991, J NEUROSCI, V11, P1016; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; HUANG JY, 1995, LASER SPECTROSCOPY P, V1, P5; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kandel ER, 1999, PHILOS T R SOC B, V354, P2027, DOI 10.1098/rstb.1999.0542; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KIDA S, 2002, IN PRESS NAT NEUROSC; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; KONRADI C, 1993, P NATL ACAD SCI USA, V90, P7005, DOI 10.1073/pnas.90.15.7005; KONRADI C, 1995, J NEUROCHEM, V65, P1007; LORIAUX MM, 1993, P NATL ACAD SCI USA, V90, P9046, DOI 10.1073/pnas.90.19.9046; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pittenger C, 1998, CR ACAD SCI III-VIE, V321, P91, DOI 10.1016/S0764-4469(97)89807-1; PITTENGER C, 2002, THESIS COLUMBIA U NE; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sgambato V, 1998, J NEUROSCI, V18, P8814; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Steckler T, 1998, PROG NEUROBIOL, V54, P313, DOI 10.1016/S0301-0082(97)00061-0; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Zha XM, 2001, HEARING RES, V156, P53, DOI 10.1016/S0378-5955(01)00267-2	65	390	417	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					447	462		10.1016/S0896-6273(02)00684-0	http://dx.doi.org/10.1016/S0896-6273(02)00684-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988175	Bronze			2022-12-28	WOS:000175214700015
J	Knott, GW; Quairiaux, C; Genoud, C; Welker, E				Knott, GW; Quairiaux, C; Genoud, C; Welker, E			Formation of dendritic spines with GABAergic synapses by whisker stimulation in induced adult mice	NEURON			English	Article							RAT BARREL CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; MONKEY STRIATE CORTEX; CAT VISUAL-CORTEX; SYNAPTIC PLASTICITY; SENSORY STIMULATION; CLUTCH CELLS; FIELD CORTEX; LAYER-IV; MOUSE	During development, alterations in sensory experience modify the structure of cortical neurons, particularly at the level of the dendritic spine. Are similar adaptations involved in plasticity of the adult cortex? Here we show that a 24 hr period of single whisker stimulation in freely moving adult mice increases, by 36%, the total synaptic density in the corresponding cortical barrel. This is due to an increase in both excitatory and inhibitory synapses found on spines. Four days after stimulation, the inhibitory inputs to the spines remain despite total synaptic density returning to pre-stimulation levels. Functional analysis of layer IV cells demonstrated altered response properties, immediately after stimulation, as well as four days later. These results indicate activity-dependent alterations in synaptic circuitry in adulthood, modifying the flow of sensory information into the cerebral cortex.	Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland	University of Lausanne	Welker, E (corresponding author), Univ Lausanne, Inst Biol Cellulaire & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.			Knott, Graham W/0000-0002-2956-9052; Quairiaux, Charles/0000-0003-3770-8232				ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; CAJAL SRY, 1891, CAJAL CEREBRAL CORTE, P23; CHANG FLF, 1982, BRAIN RES, V232, P283, DOI 10.1016/0006-8993(82)90274-8; DEAN JB, 1989, NEUROSCI RES, V6, P487, DOI 10.1016/0168-0102(89)90012-6; DEHAY C, 1991, J PHYSIOL-LONDON, V440, P723, DOI 10.1113/jphysiol.1991.sp018732; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fan YP, 2000, J NEUROPHYSIOL, V84, P2896, DOI 10.1152/jn.2000.84.6.2896; GREENOUGH WT, 1985, P NATL ACAD SCI USA, V82, P4549, DOI 10.1073/pnas.82.13.4549; Grenier F, 1998, P NATL ACAD SCI USA, V95, P13929, DOI 10.1073/pnas.95.23.13929; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; JONES EG, 1969, J CELL SCI, V5, P509; Jones TA, 1996, BRAIN RES, V733, P142, DOI 10.1016/0006-8993(96)00792-5; Kirov SA, 1999, J NEUROSCI, V19, P2876; KISVARDAY ZF, 1986, NEUROSCIENCE, V19, P741, DOI 10.1016/0306-4522(86)90296-4; KISVARDAY ZF, 1985, J COMP NEUROL, V241, P111, DOI 10.1002/cne.902410202; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P274, DOI 10.1006/nlme.1998.3827; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MELZER P, 1985, BRAIN RES, V348, P229, DOI 10.1016/0006-8993(85)90441-X; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Peters A, 1997, J NEUROCYTOL, V26, P779, DOI 10.1023/A:1018518515982; Rocamora N, 1996, J NEUROSCI, V16, P4411; SOMOGYI P, 1986, NEUROSCIENCE, V19, P1051, DOI 10.1016/0306-4522(86)90122-3; STAFSTROM CE, 1984, J NEUROPHYSIOL, V52, P244, DOI 10.1152/jn.1984.52.2.244; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; Steriade M, 1997, J NEUROSCI, V17, P3778; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; VANDERLOOS H, 1986, J HERED, V77, P66, DOI 10.1093/oxfordjournals.jhered.a110201; Vees AM, 1998, J COMP NEUROL, V400, P110; WELKER E, 1993, EUR J NEUROSCI, V5, P691, DOI 10.1111/j.1460-9568.1993.tb00534.x; WELKER E, 1989, EXP BRAIN RES, V78, P659, DOI 10.1007/BF00230256; WELKER E, 1992, J NEUROSCI, V12, P153; WHITE EL, 1993, J COMP NEUROL, V334, P86, DOI 10.1002/cne.903340107; WOOLSEY TA, 1975, P NATL ACAD SCI USA, V72, P2165, DOI 10.1073/pnas.72.6.2165; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	38	339	348	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					265	273		10.1016/S0896-6273(02)00663-3	http://dx.doi.org/10.1016/S0896-6273(02)00663-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970868	Bronze			2022-12-28	WOS:000174976200012
J	Kornhauser, JM; Cowan, CW; Shaywitz, AJ; Dolmetsch, RE; Griffith, EC; Hu, LS; Haddad, C; Xia, ZG; Greenberg, ME				Kornhauser, JM; Cowan, CW; Shaywitz, AJ; Dolmetsch, RE; Griffith, EC; Hu, LS; Haddad, C; Xia, ZG; Greenberg, ME			CREB transcriptional activity in neurons is regulated by multiple, calcium-specific phosphorylation events	NEURON			English	Article							BINDING PROTEIN CREB; GLYCOGEN-SYNTHASE KINASE-3; FACTOR-DEPENDENT MECHANISM; GENE-EXPRESSION; MEMBRANE DEPOLARIZATION; SIGNALING PATHWAY; COMPLEX-FORMATION; CELL-SURVIVAL; CBP; ACTIVATION	The transcription factor CREB mediates diverse responses in the nervous system. It is not known how CREB induces specific patterns of gene expression in response to different extracellular stimuli. We find that Ca2+ influx into neurons induces CREB phosphorylation at Ser133 and two additional sites, Ser142 and Ser143. While CREB Ser133 phosphorylation is induced by many stimuli, phosphorylation at Ser142 and Ser143 is selectively activated by Ca2+ influx. The triple phosphorylation of CREB is required for effective Ca2+ stimulation of CREB-dependent transcription, but the phosphorylation of Ser142 and Ser143, in addition to Ser133, disrupts the interaction of CREB with its cofactor CBP. These results suggest that Ca2+ influx triggers a specific program of gene expression in neurons by selectively regulating CREB phosphorylation.	Harvard Univ, Sch Med, Div Neurosci, Childrens Hosp, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Neurobiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Div Neurosci, Childrens Hosp, Cambridge, MA 02138 USA.	michael.greenberg@tch.harvard.edu	Cowan, Christopher W/I-2497-2014	Griffith, Eric/0000-0003-0428-3215	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829, F32NS009933, R01NS028829] Funding Source: NIH RePORTER; NICHD NIH HHS [P30 HD18655] Funding Source: Medline; NINDS NIH HHS [F32 NS09933, NS28829] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Goldman PS, 1997, RECENT PROG HORM RES, V52, P103; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Moore AN, 1996, J BIOL CHEM, V271, P14214, DOI 10.1074/jbc.271.24.14214; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Parker D, 1996, MOL CELL BIOL, V16, P694; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; PLANASSILVA MD, 1992, EMBO J, V11, P507, DOI 10.1002/j.1460-2075.1992.tb05081.x; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Sasaki M, 2000, P NATL ACAD SCI USA, V97, P8617, DOI 10.1073/pnas.97.15.8617; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; SUN PQ, 1995, J BIOL CHEM, V270, P7041, DOI 10.1074/jbc.270.13.7041; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Walton M, 1999, J NEUROCHEM, V73, P1836; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	45	227	232	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 11	2002	34	2					221	233		10.1016/S0896-6273(02)00655-4	http://dx.doi.org/10.1016/S0896-6273(02)00655-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970864	Bronze			2022-12-28	WOS:000174976200008
J	Beauchamp, MS; Lee, KE; Haxby, JV; Martin, A				Beauchamp, MS; Lee, KE; Haxby, JV; Martin, A			Parallel visual motion processing streams for manipulable objects and human movements	NEURON			English	Article							EVENT-RELATED FMRI; BIOLOGICAL MOTION; TEMPORAL CORTEX; FACE PERCEPTION; AREAS; STIMULI; SYSTEMS; PSYCHOPHYSICS; ACTIVATION; KNOWLEDGE	We tested the hypothesis that different regions of lateral temporal cortex are specialized for processing different types of visual motion by studying the cortical responses to moving gratings and to humans and manipulable objects (tools and utensils) that were either stationary or moving with natural or artificially generated motions. Segregated responses to human and tool stimuli were observed in both ventral and lateral regions of posterior temporal cortex. Relative to ventral cortex, lateral temporal cortex showed a larger response for moving compared with static humans and tools. Superior temporal cortex preferred human motion, and middle temporal gyrus preferred tool motion. A greater response was observed in STS to articulated compared with unarticulated human motion. Specificity for different types of complex motion (in combination with visual form) may be an organizing principle in lateral temporal cortex.	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Beauchamp, MS (corresponding author), NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA.		martin, alex/B-6176-2009; Beauchamp, Michael/AAK-9813-2020	Beauchamp, Michael/0000-0002-7599-9934				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Bonda E, 1996, J NEUROSCI, V16, P3737; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox R, 2001, NEUROIMAGE, V13, pS101; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2000, TRENDS COGN SCI, V4, P3, DOI 10.1016/S1364-6613(99)01423-0; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MARTIN A, 2000, NEW COGNITIVE NEUROS, P1023; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; OCRAVEN KM, 1997, NEURON, V21, P1988; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Puce A, 1998, J NEUROSCI, V18, P2188; Rao RPN, 1999, VISION RES, V39, P1963, DOI 10.1016/S0042-6989(98)00279-X; Senior C, 2000, CURR BIOL, V10, P16, DOI 10.1016/S0960-9822(99)00259-6; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Snowden RJ, 1999, TRENDS COGN SCI, V3, P369, DOI 10.1016/S1364-6613(99)01381-9; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Vaina LM, 1998, CURR OPIN NEUROBIOL, V8, P494, DOI 10.1016/S0959-4388(98)80037-8; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79	45	398	403	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					149	159		10.1016/S0896-6273(02)00642-6	http://dx.doi.org/10.1016/S0896-6273(02)00642-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931749	Bronze			2022-12-28	WOS:000174695100017
J	Melyan, Z; Wheal, HV; Lancaster, B				Melyan, Z; Wheal, HV; Lancaster, B			Metabotropic-mediated kainate receptor regulation of I(sAHP) and excitability in pyramidal cells	NEURON			English	Article							HIPPOCAMPAL-NEURONS INVITRO; GLUTAMATE RECEPTORS; SYNAPTIC ACTIVATION; K+ CURRENT; POTASSIUM CONDUCTANCES; EPILEPTIFORM ACTIVITY; SYMPATHETIC NEURONS; CALCIUM CHANNELS; G-PROTEINS; RAT	Kainate receptors (KARs) on CA1 pyramidal cells make no detectable contribution to EPSCs. We report that these receptors have a metabotropic function, as shown previously for CA1 interneurons. Brief kainate exposure caused long-lasting inhibition of a postspike potassium current (1(sAHP)) in CA1 pyramidal cells. The pharmacological profile was independent of AMPA receptors or the GluR5 subunit, indicating a possible role for the GluR6 subunit. KAR inhibition of I(sAHP) did not require ionotropic action or network activity, but was blocked by the inhibitor of pertussis toxin-sensitive G proteins, N-ethylmaleimide (NEM), or the PKC inhibitor calphostin C. These data suggest how KARs, putatively containing GluR6, directly increase excitability of CA1 pyramidal cells and help explain the propensity for seizure activity following KAR activation.	Univ Southampton, Ctr Neurosci, Southampton SO16 7PX, Hants, England; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of Southampton; University of London; University College London	Wheal, HV (corresponding author), Univ Southampton, Ctr Neurosci, Bassett Crescent E, Southampton SO16 7PX, Hants, England.	h.v.wheal@soton.ac.uk			Wellcome Trust [WT069189] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AbdulGhani MA, 1996, J NEUROPHYSIOL, V76, P2691, DOI 10.1152/jn.1996.76.4.2691; ASHWOOD TJ, 1986, EXP BRAIN RES, V62, P189; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Bleakman D, 1996, NEUROPHARMACOLOGY, V35, P1689, DOI 10.1016/S0028-3908(96)00156-6; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; Bureau I, 1999, J NEUROSCI, V19, P653; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CHARPAK S, 1990, NATURE, V347, P765, DOI 10.1038/347765a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; COLE AE, 1984, J PHYSIOL-LONDON, V352, P173, DOI 10.1113/jphysiol.1984.sp015285; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; DEBONNEL G, 1989, CAN J PHYSIOL PHARM, V67, P29, DOI 10.1139/y89-005; Delmas P, 1997, J PHYSIOL-LONDON, V498, P627, DOI 10.1113/jphysiol.1997.sp021888; Engisch KL, 1996, HIPPOCAMPUS, V6, P183, DOI 10.1002/(SICI)1098-1063(1996)6:2<183::AID-HIPO8>3.0.CO;2-Q; FISHER RS, 1984, J NEUROSCI, V4, P1312; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; GHO M, 1986, BRAIN RES, V385, P411, DOI 10.1016/0006-8993(86)91093-0; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; Heuss C, 1999, NAT NEUROSCI, V2, P1070, DOI 10.1038/15996; Jane DE, 1997, J MED CHEM, V40, P3645, DOI 10.1021/jm9702387; KNOPFEL T, 1990, P NATL ACAD SCI USA, V87, P4083, DOI 10.1073/pnas.87.11.4083; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; LANCASTER B, 2000, J PHYSL, V495, P449; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MALENKA RC, 1986, J NEUROSCI, V6, P475; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; MULLER W, 1992, J NEUROPHYSIOL, V68, P2264, DOI 10.1152/jn.1992.68.6.2264; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NISTRI A, 1991, J PHYSIOL-LONDON, V435, P465, DOI 10.1113/jphysiol.1991.sp018519; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Pedarzani P, 1996, PFLUG ARCH EUR J PHY, V431, P723, DOI 10.1007/s004240050057; PEDARZANI P, 1993, NEURON, V11, P1023, DOI 10.1016/0896-6273(93)90216-E; Robinson I. K., 1991, HDB SYNCHROTRON RAD, V3, P221; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Semyanov A, 2001, NAT NEUROSCI, V4, P718, DOI 10.1038/89506; SHAPIRO MS, 1994, J NEUROSCI, V14, P7109; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; TRAUB RD, 1993, J PHYSIOL-LONDON, V461, P525, DOI 10.1113/jphysiol.1993.sp019527; Viana F, 1996, J NEUROSCI, V16, P6000; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; WONG LA, 1994, J NEUROSCI, V14, P3881; ZHANG L, 1994, PFLUG ARCH EUR J PHY, V426, P247, DOI 10.1007/BF00374778	50	159	164	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					107	114		10.1016/S0896-6273(02)00624-4	http://dx.doi.org/10.1016/S0896-6273(02)00624-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931745	Bronze			2022-12-28	WOS:000174695100013
J	Xiong, WH; Chen, WR				Xiong, WH; Chen, WR			Dynamic gating of spike propagation in the mitral cell lateral dendrites	NEURON			English	Article							RAT OLFACTORY-BULB; ACTION-POTENTIALS; TUFTED CELLS; DENDRODENDRITIC INHIBITION; FUNCTIONAL EXPRESSION; RECIPROCAL SYNAPSES; NEURAL ASSEMBLIES; PYRAMIDAL NEURONS; NMDA RECEPTORS; ODOR	A unique feature of the olfactory bulb circuit is the long projection of the mitral cell lateral dendrites. Through dendrodendritic reciprocal synapses, these dendrites connect one olfactory glomerular module to hundreds of others; but the functional principles governing these extensive lateral interactions remain largely unknown. Here we report that the spatial extent of action potential propagation in these dendrites is dynamically regulated by inhibitory synapses distributed along the dendrites. The extent of propagation determines the spatial pattern of Ca2+ influx and thus the range and number of dendrodendritic synapses to be activated. Accordingly, network control of spike traffic in the mitral cell lateral dendrites can mediate dynamic interaction with different combinations of glomerular modules in response to different odorants.	Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA	Yale University	Chen, WR (corresponding author), Yale Univ, Dept Neurobiol, 333 Cedar St,C303 SHM, New Haven, CT 06520 USA.				NIDCD NIH HHS [R01 DC 03918] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003918] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BUONVISO N, 1990, J NEUROPHYSIOL, V63, P447, DOI 10.1152/jn.1990.63.3.447; BUONVISO N, 1992, J NEUROPHYSIOL, V68, P417, DOI 10.1152/jn.1992.68.2.417; Carlson GC, 2000, J NEUROSCI, V20, P2011; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; EZEH PI, 1993, J NEUROPHYSIOL, V70, P263, DOI 10.1152/jn.1993.70.1.263; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; HAMILTON KA, 1989, J NEUROPHYSIOL, V62, P609, DOI 10.1152/jn.1989.62.3.609; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Larkum ME, 1996, J NEUROPHYSIOL, V75, P154, DOI 10.1152/jn.1996.75.1.154; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; LEVETEAU J, 1966, SCIENCE, V153, P175, DOI 10.1126/science.153.3732.175; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Meister M, 2001, J NEUROSCI, V21, P1351; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Nickell WT, 1996, BRAIN RES BULL, V39, P57, DOI 10.1016/0361-9230(95)02042-X; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; Pare D, 1998, NEUROSCIENCE, V84, P377, DOI 10.1016/S0306-4522(97)00530-7; PRICE JL, 1970, J CELL SCI, V7, P631; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Williams SR, 2000, J NEUROSCI, V20, P1307; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	55	112	113	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					115	126		10.1016/S0896-6273(02)00628-1	http://dx.doi.org/10.1016/S0896-6273(02)00628-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931746	Bronze			2022-12-28	WOS:000174695100014
J	Hernandez, A; Zainos, A; Romo, R				Hernandez, A; Zainos, A; Romo, R			Temporal evolution of a decision-making process in medial premotor cortex	NEURON			English	Article							CONTRASTING NEURONAL-ACTIVITY; PRESUPPLEMENTARY MOTOR AREAS; WORKING-MEMORY; PSYCHOPHYSICAL MEASUREMENTS; SENSORY DISCRIMINATION; CORTICOCORTICAL CONNECTIONS; CUTANEOUS REPRESENTATIONS; PERCEPTUAL DECISION; PARIETAL CORTEX; LATERAL SULCUS	The events linking sensory discrimination to motor action remain unclear. It is not known, for example, whether the motor areas of the frontal lobe receive the result of the discrimination process from other areas or whether they actively participate in it. To investigate this, we trained monkeys to discriminate between two mechanical vibrations applied sequentially to the fingertips; here subjects had to recall the first vibration, compare it to the second one, and indicate with a hand/arm movement which of the two vibrations had the higher frequency. We recorded the activity of single neurons in medial premotor cortex (MPC) and found that their responses correlate with the diverse stages of the discrimination process. Thus, activity in MPC reflects the temporal evolution of the decision-making process leading to action selection during this perceptual task.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	rromo@ifisiol.unam.mx		romo, ranulfo/0000-0003-3529-3635; zainos, antonio/0000-0001-6137-1794				BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BURTON H, 1995, J COMP NEUROL, V355, P539, DOI 10.1002/cne.903550405; BURTON H, 1995, J COMP NEUROL, V355, P508, DOI 10.1002/cne.903550404; CHEN YC, 1995, EXP BRAIN RES, V102, P461; Cipolloni PB, 1999, J COMP NEUROL, V403, P431; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; FALZETT M, 1985, BRAIN RES, V347, P127, DOI 10.1016/0006-8993(85)90898-4; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1771, DOI 10.1152/jn.1980.43.6.1771; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1793, DOI 10.1152/jn.1980.43.6.1793; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; JONES EG, 1969, BRAIN, V92, P477, DOI 10.1093/brain/92.3.477; JURGENS U, 1984, BRAIN RES, V300, P63, DOI 10.1016/0006-8993(84)91341-6; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KRUBITZER L, 1995, J NEUROSCI, V15, P3821; KURATA K, 1985, J NEUROPHYSIOL, V53, P142, DOI 10.1152/jn.1985.53.1.142; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Merchant H, 1997, J NEUROPHYSIOL, V77, P1132, DOI 10.1152/jn.1997.77.3.1132; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; MOUNTCASTLE VB, 1992, CEREB CORTEX, V2, P277, DOI 10.1093/cercor/2.4.277; MOUNTCASTLE VB, 1991, J NEUROSCI METH, V36, P77, DOI 10.1016/0165-0270(91)90140-U; PANDYA DN, 1969, BRAIN RES, V13, P13, DOI 10.1016/0006-8993(69)90141-3; Petit L, 1998, J NEUROSCI, V18, P9429; Pollmann S, 2000, EXP BRAIN RES, V133, P12, DOI 10.1007/s002210000396; PONS TP, 1987, SCIENCE, V237, P417, DOI 10.1126/science.3603028; PONS TP, 1992, J NEUROPHYSIOL, V68, P518, DOI 10.1152/jn.1992.68.2.518; ROMO R, 1993, J NEUROPHYSIOL, V70, P2690, DOI 10.1152/jn.1993.70.6.2690; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; ROMO R, 1992, EXP BRAIN RES, V91, P396, DOI 10.1007/BF00227836; Romo R, 1997, CEREB CORTEX, V7, P317, DOI 10.1093/cercor/7.4.317; ROMO R, 1987, EXP BRAIN RES, V67, P656; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Salinas E, 1998, J NEUROSCI, V18, P499; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Tanji J, 1996, CURR OPIN NEUROBIOL, V6, P782, DOI 10.1016/S0959-4388(96)80028-6; TANJI J, 1985, J NEUROPHYSIOL, V53, P129, DOI 10.1152/jn.1985.53.1.129; THALER D, 1995, EXP BRAIN RES, V102, P445; Zhang J, 1997, J NEUROSCI, V17, P2227; Zhang J, 1997, J MATH PSYCHOL, V41, P219, DOI 10.1006/jmps.1997.1168; [No title captured]	56	190	190	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 14	2002	33	6					959	972		10.1016/S0896-6273(02)00613-X	http://dx.doi.org/10.1016/S0896-6273(02)00613-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906701	Bronze, Green Submitted			2022-12-28	WOS:000174389600012
J	Buzsaki, G				Buzsaki, G			Theta oscillations in the hippocampus	NEURON			English	Review							RHYTHMICAL SLOW ACTIVITY; LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; SOURCE DENSITY ANALYSIS; SEPTUM DIAGONAL BAND; FREELY-MOVING RATS; GUINEA-PIG BRAIN; IN-VIVO; PHASE-PRECESSION; BEHAVING RAT	Theta oscillations represent the "on-line" state of the hippocampus. The extracellular currents underlying theta waves are generated mainly by the entorhinal Input, CA3 (Schaffer) collaterals, and voltage-dependent Ca2+ currents in pyramidal cell dendrites. The rhythm is believed to be critical for temporal coding/ decoding of active neuronal ensembles and the modification of synaptic weights. Nevertheless, numerous critical issues regarding both the generation of theta oscillations and their functional significance remain challenges for future research.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Neurol Inst New Jersey, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu		Buzsaki, Gyorgy/0000-0002-3100-4800	NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS34994] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adey W R, 1967, Prog Brain Res, V27, P228; ALONSO A, 1982, NEUROSCI LETT, V31, P209, DOI 10.1016/0304-3940(82)90021-0; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1987, EXP BRAIN RES, V67, P493, DOI 10.1007/BF00247282; Alonso A, 1996, EUR J NEUROSCI, V8, P169, DOI 10.1111/j.1460-9568.1996.tb01178.x; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ARNOLDS DEAT, 1980, ELECTROEN CLIN NEURO, V50, P324, DOI 10.1016/0013-4694(80)90160-1; ARTEMENKO D P, 1972, Neurophysiology, V4, P409; Banks MI, 2000, NEURON, V25, P449, DOI 10.1016/S0896-6273(00)80907-1; BARNES CA, 1990, PROG BRAIN RES, V83, P287; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BLAND BH, 1975, BRAIN RES, V94, P199, DOI 10.1016/0006-8993(75)90057-8; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; Bodizs R, 2001, HIPPOCAMPUS, V11, P747, DOI 10.1002/hipo.1090; Borhegyi Z, 1998, BRAIN RES BULL, V46, P453, DOI 10.1016/S0361-9230(98)00038-0; Borisyuk R, 1999, BIOL CYBERN, V81, P359, DOI 10.1007/s004220050568; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; Brazhnik ES, 1999, EXP BRAIN RES, V127, P244, DOI 10.1007/s002210050794; Broca P., 1878, REV ANTHR, V1, P385; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BULLOCK TH, 1990, NEUROSCIENCE, V38, P609, DOI 10.1016/0306-4522(90)90055-9; BUNO W, 1977, PHYSIOL BEHAV, V19, P615, DOI 10.1016/0031-9384(77)90035-X; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; BUZSAKI G, 1989, EXP BRAIN RES, V78, P268; BUZSAKI G, 1987, BRAIN RES, V400, P334, DOI 10.1016/0006-8993(87)90632-9; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; BUZSAKI G, 1979, ELECTROEN CLIN NEURO, V47, P64, DOI 10.1016/0013-4694(79)90033-6; Buzsaki G., 1994, TEMPORAL CODING BRAI, P145; Chapman CA, 1999, J NEUROSCI, V19, P8637; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; COLE AE, 1983, SCIENCE, V221, P1299, DOI 10.1126/science.6612345; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; DASILVA FHL, 1990, PHYSIOL REV, V70, P453, DOI 10.1152/physrev.1990.70.2.453; Denham MJ, 2000, HIPPOCAMPUS, V10, P698, DOI 10.1002/1098-1063(2000)10:6<698::AID-HIPO1008>3.0.CO;2-Z; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V82, P3213, DOI 10.1152/jn.1999.82.6.3213; Eichenbaum H, 2000, CURR BIOL, V10, pR785, DOI 10.1016/S0960-9822(00)00763-6; Fellous JM, 2000, HIPPOCAMPUS, V10, P187, DOI 10.1002/(SICI)1098-1063(2000)10:2<187::AID-HIPO8>3.3.CO;2-D; Fischer Y, 1999, J PHYSIOL-LONDON, V519, P405, DOI 10.1111/j.1469-7793.1999.0405m.x; FOX SE, 1989, EXP BRAIN RES, V77, P283, DOI 10.1007/BF00274985; FOX SE, 1986, EXP BRAIN RES, V62, P495; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Givens B, 1996, NEUROREPORT, V8, P159, DOI 10.1097/00001756-199612200-00032; GRASTYAN E, 1959, ELECTROEN CLIN NEURO, V11, P409, DOI 10.1016/0013-4694(59)90040-9; GREENSTEIN YJ, 1988, BRAIN RES, V438, P331, DOI 10.1016/0006-8993(88)91358-3; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hajos N, 1998, NEUROSCIENCE, V82, P355; HALASY K, 1993, EUR J NEUROSCI, V5, P411, DOI 10.1111/j.1460-9568.1993.tb00508.x; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hasselmo ME, 2001, J NEUROPHYSIOL, V86, P1792, DOI 10.1152/jn.2001.86.4.1792; HASSELMO ME, 2002, IN PRESS NEURAL COMP; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HOLSHEIMER J, 1982, BRAIN RES, V235, P31, DOI 10.1016/0006-8993(82)90194-9; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Horvath Z, 1988, SYNAPTIC PLASTICITY, P45; HOSCHLER C, 1997, J NEUROSCI, V17, P6470; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; JOUVET M, 1969, SCIENCE, V163, P32, DOI 10.1126/science.163.3862.32; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kandel ER, 2000, SCIENCE, V290, P1113, DOI 10.1126/science.290.5494.1113; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; King C, 1998, EUR J NEUROSCI, V10, P464, DOI 10.1046/j.1460-9568.1998.00026.x; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; KONOPACKI J, 1987, BRAIN RES BULL, V18, P25, DOI 10.1016/0361-9230(87)90029-3; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LEANZA G, 1993, BRAIN RES, V618, P47, DOI 10.1016/0006-8993(93)90427-O; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; Leranth C, 1999, NEUROSCIENCE, V88, P701, DOI 10.1016/S0306-4522(98)00245-0; LEUNG LWS, 1987, BRAIN RES, V407, P68, DOI 10.1016/0006-8993(87)91220-0; LEUNG LWS, 1991, BRAIN RES, V553, P261, DOI 10.1016/0006-8993(91)90834-I; LEUNG LWS, 1984, J NEUROPHYSIOL, V52, P1051, DOI 10.1152/jn.1984.52.6.1051; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; MACVICAR BA, 1989, J PHYSIOL-LONDON, V417, P197, DOI 10.1113/jphysiol.1989.sp017797; MADISON DV, 1987, J NEUROSCI, V7, P733; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; McMahon LL, 1998, J NEUROSCI, V18, P5640; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; MILLER R, 1989, PSYCHOBIOLOGY, V17, P115; MITCHELL SJ, 1980, BRAIN RES, V189, P49, DOI 10.1016/0006-8993(80)90006-2; MIZUMORI SJY, 1990, EXP BRAIN RES, V80, P365; MONMAUR P, 1986, BRAIN RES, V378, P262, DOI 10.1016/0006-8993(86)90929-7; MORONI F, 1981, N-S ARCH PHARMACOL, V316, P235, DOI 10.1007/BF00505655; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Otmakhova NA, 2000, ANN NY ACAD SCI, V911, P462; Pare D, 2000, J NEUROSCI, V20, P2701; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; PEET MJ, 1987, NEUROSCIENCE, V22, P563, DOI 10.1016/0306-4522(87)90353-8; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; Pyapali GK, 1998, J COMP NEUROL, V391, P335, DOI 10.1002/(SICI)1096-9861(19980216)391:3<335::AID-CNE4>3.0.CO;2-2; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; ROSE GM, 1986, NEUROSCI LETT, V69, P244, DOI 10.1016/0304-3940(86)90487-8; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; SEGAL M, 1985, BRAIN RES, V336, P302, DOI 10.1016/0006-8993(85)90656-0; SEMBA K, 1978, ELECTROEN CLIN NEURO, V44, P61, DOI 10.1016/0013-4694(78)90105-0; Serafin M, 1996, NEUROSCIENCE, V75, P671, DOI 10.1016/0306-4522(96)00349-1; SHERRINGTON CS, 1897, TXB PHYSL 3; SIK A, 1994, SCIENCE, V265, P1722, DOI 10.1126/science.8085161; SIK A, 1995, J NEUROSCI, V15, P6651; Sik A, 1997, EUR J NEUROSCI, V9, P573, DOI 10.1111/j.1460-9568.1997.tb01634.x; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; Strata F, 1998, HIPPOCAMPUS, V8, P666, DOI 10.1002/(SICI)1098-1063(1998)8:6<666::AID-HIPO9>3.0.CO;2-A; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; TOTH K, 1993, J NEUROSCI, V13, P3712; Toth K, 1997, J PHYSIOL-LONDON, V500, P463, DOI 10.1113/jphysiol.1997.sp022033; TRAUB RD, 1992, J PHYSIOL-LONDON, V451, P653, DOI 10.1113/jphysiol.1992.sp019184; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; TURNER DA, 1995, J COMP NEUROL, V356, P580, DOI 10.1002/cne.903560408; Van der Linden S, 1999, J NEUROPHYSIOL, V82, P2441, DOI 10.1152/jn.1999.82.5.2441; Vanderwolf C.H., 1983, NEUROBIOLOGY HIPPOCA, P275; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vertes RP, 1997, NEUROSCIENCE, V81, P893; VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I; Vizi ES, 1998, HIPPOCAMPUS, V8, P566, DOI 10.1002/(SICI)1098-1063(1998)8:6<566::AID-HIPO2>3.0.CO;2-W; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WHISHAW IQ, 1978, BRAIN RES, V146, P249, DOI 10.1016/0006-8993(78)90972-1; WHISHAW IQ, 1976, BRAIN RES BULL, V1, P573, DOI 10.1016/0361-9230(76)90084-8; Williams JH, 1997, J NEUROPHYSIOL, V78, P2631, DOI 10.1152/jn.1997.78.5.2631; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; WINSON J, 1974, ELECTROEN CLIN NEURO, V36, P291, DOI 10.1016/0013-4694(74)90171-0; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110	160	2106	2150	5	196	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					325	340		10.1016/S0896-6273(02)00586-X	http://dx.doi.org/10.1016/S0896-6273(02)00586-X			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832222	Bronze			2022-12-28	WOS:000173643200005
J	Tsui-Pierchala, B; Milbrandt, J; Johnson, EM				Tsui-Pierchala, B; Milbrandt, J; Johnson, EM			NGF utilizes c-Ret via a novel GFL-independent, inter-RTK signaling mechanism to maintain the trophic status of mature sympathetic neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; PROTEIN-COUPLED RECEPTORS; NEUROTROPHIC FACTOR; GDNF-FAMILY; CELL-LINE; TYROSINE KINASE; EGF RECEPTOR; PHOSPHORYLATION; NEURTURIN; SURVIVAL	During postnatal development, sympathetic neurons lose their dependence upon NGF for survival but continue to require NGF for soma and process growth and for development of a mature neurotransmitter phenotype. Although c-Ret is expressed in sympathetic neurons during this period, its function in these transitional processes is unclear. The level of Ret phosphorylation markedly increased with postnatal age in SCG neurons in vitro and in vivo. Postnatal Ret phosphorylation did not require either GFLs or GFRalpha coreceptors. Instead, NGF promoted age-dependent Ret phosphorylation with delayed kinetics both in vitro and in vivo. Functionally, maximal NGF-dependent trophism of mature sympathetic neurons required Ret, but not GFRalpha coreceptors. Therefore, NGF promotes phosphorylation of the heterologous RTK Ret resulting in augmented growth, metabolism, and gene expression.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Johnson, EM (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.			Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007129, R01NS038651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012947] Funding Source: NIH RePORTER; NIA NIH HHS [AG12947] Funding Source: Medline; NINDS NIH HHS [5T32-NS07129, NS38651-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2000, ANNU REV PHYSIOL, V62, P803, DOI 10.1146/annurev.physiol.62.1.803; Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; ANGELETTI PU, 1971, BRAIN RES, V27, P343, DOI 10.1016/0006-8993(71)90259-9; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERG MM, 1992, J BIOL CHEM, V267, P13; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; Easton RM, 1997, J NEUROSCI, V17, P9656; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Francis NJ, 1999, ANNU REV NEUROSCI, V22, P541, DOI 10.1146/annurev.neuro.22.1.541; GOEDERT M, 1978, BRAIN RES, V148, P264, DOI 10.1016/0006-8993(78)90401-8; GORIN PD, 1980, BRAIN RES, V198, P27, DOI 10.1016/0006-8993(80)90341-8; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kato M, 2000, MOL BIOL CELL, V11, P93, DOI 10.1091/mbc.11.1.93; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kobayashi M, 2000, NEUROREPORT, V11, P2541, DOI 10.1097/00001756-200008030-00039; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LAZARUS KJ, 1976, BRAIN RES, V113, P159, DOI 10.1016/0006-8993(76)90013-5; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liu PS, 1999, BIOCHEM BIOPH RES CO, V261, P695, DOI 10.1006/bbrc.1999.1082; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Masure S, 1999, EUR J BIOCHEM, V266, P892, DOI 10.1046/j.1432-1327.1999.00925.x; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; NAKAMURA T, 1994, J PATHOL, V172, P255, DOI 10.1002/path.1711720305; OHMICHI M, 1992, BIOCHEMISTRY-US, V31, P4034, DOI 10.1021/bi00131a019; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; REICHARDT LF, 1987, MOL CELLULAR APPROAC, P220; Rosenblad C, 2000, MOL CELL NEUROSCI, V15, P199, DOI 10.1006/mcne.1999.0817; RUIT KG, 1990, J NEUROSCI, V10, P2412; SANTORO M, 1990, ONCOGENE, V5, P1595; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHOTZINGER RJ, 1988, NATURE, V335, P637, DOI 10.1038/335637a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; TAHIRA T, 1990, ONCOGENE, V5, P97; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; TAPLEY P, 1992, ONCOGENE, V7, P371; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369	53	95	97	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					261	273		10.1016/S0896-6273(01)00585-2	http://dx.doi.org/10.1016/S0896-6273(01)00585-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804573	Bronze			2022-12-28	WOS:000173387700013
J	Coyle, JE; Qamar, S; Rajashankar, KR; Nikolov, DB				Coyle, JE; Qamar, S; Rajashankar, KR; Nikolov, DB			Structure of GABARAP in two conformations: Implications for GABA(A) receptor localization and tubulin binding	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; MICROTUBULE-ASSOCIATED PROTEINS; MEMBRANE-TRANSPORT MODULATOR; GEPHYRIN; NSF; STOICHIOMETRY; SUBUNIT; IDENTIFICATION; AUTOPHAGY; DOMAINS	GABARAP recognizes and binds the gamma2 subunit of the GABA(A) receptor, interacts with microtubules and the N-ethyl maleimide sensitive factor, and is proposed to function in GABA(A) receptor trafficking and postsynaptic localization. We have determined the crystal structure of human GABARAP at 1.6 Angstrom resolution. The structure comprises an N-terminal helical subdomain and a ubiquitin-like C-terminal domain. Structure-based mutational analysis demonstrates that the N-terminal subdomain is responsible for tubulin binding while the C-terminal domain contains the binding site for the GABA(A). A second GABARAP crystal form was determined at 1.9 Angstrom resolution and documents that GABARAP can self-associate in a head-to-tail manner. The structural details of this oligomerization reveal how GABARAP can both promote tubulin polymerization and facilitate GABA(A) receptor clustering.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Brookhaven Natl Lab, Upton, NY 11973 USA	Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Brookhaven National Laboratory	Nikolov, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	dimitar@ximpact3.ski.mskcc.org						Amos LA, 2000, CURR OPIN STRUC BIOL, V10, P236, DOI 10.1016/S0959-440X(00)00070-1; BACKUS KH, 1993, NEUROREPORT, V5, P285, DOI 10.1097/00001756-199312000-00026; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; BRANDT R, 1993, J BIOL CHEM, V268, P3414; BRUNNETT B, 1993, SURVEYS MATH IND, V3, P1; Chang YC, 1996, J NEUROSCI, V16, P5415; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; Colledge M, 1998, P NATL ACAD SCI USA, V95, P3341, DOI 10.1073/pnas.95.7.3341; Deka J, 1998, EUR J BIOCHEM, V253, P591, DOI 10.1046/j.1432-1327.1998.2530591.x; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Hanley JG, 1999, NATURE, V397, P66, DOI 10.1038/16258; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; JANIN J, 1990, J BIOL CHEM, V265, P16027; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KHAN ZU, 1994, J NEUROCHEM, V63, P1466; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; KISHIDA T, 1995, CANCER RES, V55, P4544; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Legesse-Miller A, 1998, J BIOL CHEM, V273, P3105, DOI 10.1074/jbc.273.5.3105; LITTAUER UZ, 1986, P NATL ACAD SCI USA, V83, P7162, DOI 10.1073/pnas.83.19.7162; Maimone MM, 1999, MOL CELL NEUROSCI, V14, P340, DOI 10.1006/mcne.1999.0779; MANN SS, 1994, J BIOL CHEM, V269, P11492; MARYA PK, 1994, J CELL SCI, V107, P339; McDonald PH, 1999, J BIOL CHEM, V274, P10677, DOI 10.1074/jbc.274.16.10677; MELKI R, 1991, BIOCHEMISTRY-US, V30, P11536, DOI 10.1021/bi00113a008; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; QUIRK K, 1994, MOL PHARMACOL, V45, P1061; Ramarao MK, 2001, J BIOL CHEM, V276, P7475, DOI 10.1074/jbc.M009888200; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tretter V, 1997, J NEUROSCI, V17, P2728; Unwin N, 1998, J STRUCT BIOL, V121, P181, DOI 10.1006/jsbi.1997.3949; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; YOON Y, 1995, BIOCHEMISTRY-US, V34, P6373, DOI 10.1021/bi00019a016; YOUNG L, 1994, PROTEIN SCI, V3, P717; Zhou B, 1997, J CLIN INVEST, V100, P3070, DOI 10.1172/JCI119862	67	117	121	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 3	2002	33	1					63	74		10.1016/S0896-6273(01)00558-X	http://dx.doi.org/10.1016/S0896-6273(01)00558-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779480	Bronze			2022-12-28	WOS:000173106200010
J	Tang, SJ; Meulemans, D; Vazquez, L; Colaco, N; Schuman, E				Tang, SJ; Meulemans, D; Vazquez, L; Colaco, N; Schuman, E			A role for a rat homolog of staufen in the transport of RNA to neuronal dendrites	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; MENTAL-RETARDATION PROTEIN; LONG-TERM POTENTIATION; MESSENGER-RNA; HIPPOCAMPAL-NEURONS; ASYMMETRIC PROTEIN; MAMMALIAN STAUFEN; BINDING PROTEIN; LOCALIZATION; MICROTUBULES	RNAs are present in dendrites and may be used for local protein synthesis in response to synaptic activity. To begin to understand dendritic RNA targeting, we cloned a rat homolog of staufen, a Drosophila gene that participates in mRNA targeting during development. In hippocampal neurons, rat staufen protein displays a microtubule-dependent somatodendritic distribution pattern that overlaps with dendritic RNAs. To determine whether r-staufen is required for dendritic RNA targeting, we constructed a mutant version containing the RNA binding domains (stau-RBD) but lacking the C-terminal portion potentially involved in dendritic targeting. Stau-RBD expression was restricted to the cell bodies and proximal dendrites. Expression of stau-RBD significantly decreased, while overexpression of wild-type r-staufen increased, the amount of dendritic mRNA. Taken together, these results suggest that the rat staufen protein plays an important role in the delivery of RNA to dendrites.	CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, E (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 216-76, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Schuman, Erin M/D-6204-2011	MEDEIROS, DANIEL/0000-0002-8182-6028				ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BASSELL GJ, 1994, NEURON, V12, P571, DOI 10.1016/0896-6273(94)90213-5; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Cohen AS, 1998, HIPPOCAMPUS, V8, P160, DOI 10.1002/(SICI)1098-1063(1998)8:2<160::AID-HIPO8>3.3.CO;2-J; Cohen AS, 1996, J NEUROPHYSIOL, V76, P953, DOI 10.1152/jn.1996.76.2.953; DESGROSEILLERS L, 2001, J NEUROCHEM, V76, P155; Duchaine T, 2000, MOL CELL BIOL, V20, P5592, DOI 10.1128/MCB.20.15.5592-5601.2000; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Feng Y, 1997, J NEUROSCI, V17, P1539; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Goslin K., 1990, CULTURING NERVE CELL; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; KLEIMAN R, 1993, MOL BRAIN RES, V20, P305, DOI 10.1016/0169-328X(93)90057-V; Knowles RB, 1997, P NATL ACAD SCI USA, V94, P14804, DOI 10.1073/pnas.94.26.14804; Knowles RB, 1996, J NEUROSCI, V16, P7812; KOHMANN M, 1999, MOL BIOL CELL, V10, P2945; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Ouyang Y, 1999, J NEUROSCI, V19, P7823; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Righi M, 2000, J NEUROSCI, V20, P3165, DOI 10.1523/JNEUROSCI.20-09-03165.2000; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; VERKERK AJMH, 1993, HUM MOL GENET, V2, P1348, DOI 10.1093/hmg/2.8.1348; Weiler IJ, 1999, AM J MED GENET, V83, P248, DOI 10.1002/(SICI)1096-8628(19990402)83:4<248::AID-AJMG3>3.0.CO;2-1; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wickham L, 1999, MOL CELL BIOL, V19, P2220; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; YISRAELI JK, 1990, DEVELOPMENT, V108, P289	49	182	187	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2001	32	3					463	475		10.1016/S0896-6273(01)00493-7	http://dx.doi.org/10.1016/S0896-6273(01)00493-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709157	Bronze			2022-12-28	WOS:000172119100012
J	Noesselt, T; Hillyard, SA; Woldorff, MG; Schoenfeld, A; Hagner, T; Jancke, L; Tempelmann, C; Hinrichs, H; Heinze, HJ				Noesselt, T; Hillyard, SA; Woldorff, MG; Schoenfeld, A; Hagner, T; Jancke, L; Tempelmann, C; Hinrichs, H; Heinze, HJ			Delayed striate cortical activation during spatial attention	NEURON			English	Article							PRIMARY VISUAL-CORTEX; BILATERAL STIMULUS ARRAYS; INDEX FOCUSED ATTENTION; SELECTIVE ATTENTION; RETINOTOPIC ORGANIZATION; EXPERIMENTAL-DESIGNS; BRAIN ACTIVITY; AREAS V1; EXTRASTRIATE; POTENTIALS	Recordings of event-related potentials (ERPs) and event-related magnetic fields (ERMFs) were combined with functional magnetic resonance imaging (fMRI) to study visual cortical activity in humans during spatial attention. While subjects attended selectively to stimulus arrays in one visual field, fMRI revealed stimulus-related activations in the contralateral primary visual cortex and in multiple extrastriate areas. ERP and ERMF recordings showed that attention did not affect the initial evoked response at 60-90 ms poststimulus that was localized to primary cortex, but a similarly localized late response at 140-250 ms was enhanced to attended stimuli. These findings provide evidence that the primary visual cortex participates in the selective processing of attended stimuli by means of delayed feedback from higher visual-cortical areas.	Otto von Guericke Univ, Dept Neurol 2, D-39120 Magdeburg, Germany; Otto von Guericke Univ, Inst Gen Psychol, D-39120 Magdeburg, Germany; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; Duke Univ, Dept Psychol & Brain Sci, Durham, NC 27708 USA	Otto von Guericke University; Otto von Guericke University; University of California System; University of California San Diego; Duke University; Duke University	Noesselt, T (corresponding author), Otto von Guericke Univ, Dept Neurol 2, D-39120 Magdeburg, Germany.	toemme@neuro2.med.uni-magdeburg.de	Jäncke, Lutz/C-3792-2009; Jancke, Lutz/D-2910-2013	Jäncke, Lutz/0000-0002-8115-4890; Schoenfeld, Mircea Ariel/0000-0001-9003-4092; Tempelmann, Claus/0000-0001-8570-4960; Jancke, Lutz/0000-0003-2110-9067; Noesselt, Toemme/0000-0002-9611-9713; Woldorff, Marty/0000-0002-2683-4551	NIMH NIH HHS [MH-25594] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH025594, R01MH025594] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aine C J, 1995, Int J Neurosci, V80, P79, DOI 10.3109/00207459508986095; Aine CJ, 1996, CEREB CORTEX, V6, P354, DOI 10.1093/cercor/6.3.354; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.3.CO;2-X; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gratton G, 1997, NEUROREPORT, V8, P1749, DOI 10.1097/00001756-199705060-00036; HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hinrichs H, 2000, J COGNITIVE NEUROSCI, V12, P76, DOI 10.1162/089892900564082; Ilmoniemi R J, 1993, Brain Topogr, V5, P331, DOI 10.1007/BF01128686; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; LAMME VAF, 2000, NEW COGNITIVE NEUROS, P279; Lange JJ, 1998, BIOL PSYCHOL, V48, P153, DOI 10.1016/S0301-0511(98)00011-8; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; Maunsell J., 2000, NEW COGNITIVE NEUROS, P315; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Robinson SE, 1989, ADV BIOMAGNETISM, P721, DOI [10.1007/978-1-4613-0581-1_162, DOI 10.1007/978-1-4613-0581-1_162]; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sengpiel F, 1999, CURR BIOL, V9, pR318, DOI 10.1016/S0960-9822(99)80202-4; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; Vidyasagar TR, 1999, BRAIN RES REV, V30, P66, DOI 10.1016/S0165-0173(99)00005-3; Wijers AA, 1997, PSYCHOPHYSIOLOGY, V34, P553, DOI 10.1111/j.1469-8986.1997.tb01742.x; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x	49	214	224	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					575	587		10.1016/S0896-6273(02)00781-X	http://dx.doi.org/10.1016/S0896-6273(02)00781-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165478	Bronze			2022-12-28	WOS:000177331200017
J	Formisano, E; Linden, DEJ; Di Salle, F; Trojano, L; Esposito, F; Sack, AT; Grossi, D; Zanella, FE; Goebel, R				Formisano, E; Linden, DEJ; Di Salle, F; Trojano, L; Esposito, F; Sack, AT; Grossi, D; Zanella, FE; Goebel, R			Tracking the mind's image in the brain I: Time-resolved fMRI during visuospatila mental imagery	NEURON			English	Article							CORTICAL ACTIVATION; FUNCTIONAL-ANATOMY; TARGET DETECTION; VISUAL-IMAGERY; ATTENTION; NEUROPSYCHOLOGY; GENERATION; NETWORKS; ROTATION	Mental imagery, the generation and manipulation of mental representations in the absence of sensory stimulation, is a core element of numerous cognitive processes. We investigate the cortical mechanisms underlying imagery and spatial analysis in the visual domain using event-related functional magnetic resonance imaging during the mental clock task. The time-resolved analysis of cortical activation from auditory perception to motor response reveals a sequential activation of the left and right posterior parietal cortex, suggesting that these regions perform distinct functions in this imagery task. This is confirmed by a trial-by-trial analysis of correlations between reaction time and onset, width, and amplitude of the hemodynamic response. These findings pose neurophysiological constraints on cognitive models of mental imagery.	Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; Max Planck Inst Hirnforsch, D-60528 Frankfurt, Germany; Univ Frankfurt Klinikum, Dept Psychiat, Lab Neuroimaging & Neurophysiol, D-60590 Frankfurt, Germany; Univ Frankfurt Klinikum, Dept Neuroradiol, D-60590 Frankfurt, Germany; Salvatore Maugeri Fdn, IRCCS, Ctr Telese, Loc S Stefano Lanterria, I-82037 Telese Terme, BN, Italy; Univ Naples 2, Inst Neurol Sci, I-80138 Naples, Italy; Univ Naples 2, Dept Psychol, Caserta, Italy; Univ Naples Federico II, Nuovo Policlin, Dept Neuroradiol, I-80131 Naples, Italy	Maastricht University; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Istituti Clinici Scientifici Maugeri IRCCS; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Naples Federico II	Goebel, R (corresponding author), Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, Postbus 616, NL-6200 MD Maastricht, Netherlands.	r.goebel@psychology.unimaas.nl	Trojano, Luigi/F-2396-2016; Esposito, Fabrizio/M-8555-2015; Linden, David E J/C-7355-2013; Linden, David/S-9948-2019	Trojano, Luigi/0000-0002-0328-9642; Esposito, Fabrizio/0000-0002-5099-9786; Linden, David E J/0000-0002-5638-9292; Linden, David/0000-0002-5638-9292; Goebel, Rainer/0000-0003-1780-2467; Sack, Alexander/0000-0002-1471-0885; Di Salle, Francesco/0000-0002-0226-8460; Formisano, Elia/0000-0001-5008-2460				Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Chee MWL, 1999, HUM BRAIN MAPP, V7, P15, DOI 10.1002/(SICI)1097-0193(1999)7:1<15::AID-HBM2>3.3.CO;2-Y; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; FARAH MJ, 1988, BRAIN COGNITION, V8, P147, DOI 10.1016/0278-2626(88)90046-2; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P1455, DOI 10.1016/0028-3932(95)00075-E; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Goebel R, 1998, NEUROREPORT, V9, P713, DOI 10.1097/00001756-199803090-00028; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; GROSSI D, 1989, BRAIN COGNITION, V10, P18, DOI 10.1016/0278-2626(89)90072-9; HILLYARD SA, 1993, CURR OPIN NEUROBIOL, V3, P217, DOI 10.1016/0959-4388(93)90213-I; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Knauff M, 2000, NEUROREPORT, V11, P3957, DOI 10.1097/00001756-200012180-00011; Kosslyn S.M., 1994, IMAGE BRAIN RESOLUTI; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1485, DOI 10.1016/0028-3932(95)00077-G; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Mellet E, 2000, J COGNITIVE NEUROSCI, V12, P98, DOI 10.1162/08989290051137620; Menon RS, 1998, P NATL ACAD SCI USA, V95, P10902, DOI 10.1073/pnas.95.18.10902; Menon RS, 1999, TRENDS COGN SCI, V3, P207, DOI 10.1016/S1364-6613(99)01329-7; MUNK MHJ, 2002, IN PRESS CEREB CORTE; PAIVIO A, 1978, J EXP PSYCHOL HUMAN, V4, P61, DOI 10.1037/0096-1523.4.1.61; Posner M.I., 1978, CHRONOMETRIC EXPLORA; Raij T, 1999, J COGNITIVE NEUROSCI, V11, P282, DOI 10.1162/089892999563391; RENAULT B, 1982, SCIENCE, V215, P1413, DOI 10.1126/science.7063853; Richter W, 2000, J COGNITIVE NEUROSCI, V12, P310, DOI 10.1162/089892900562129; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Sack AT, 2002, NEURON, V35, P195, DOI 10.1016/S0896-6273(02)00745-6; SERGENT J, 1990, BRAIN COGNITION, V13, P98, DOI 10.1016/0278-2626(90)90043-N; Shepard RN., 1982, J HIST BEHAV SCI, V19, P301, DOI 10.2307/1422825; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; STANGALINO C, 1995, NEUROPSYCHOLOGIA, V33, P1473, DOI 10.1016/0028-3932(95)00076-F; Talairach J., 1988, COPLANAR STEREOTAXIC; TROJANO L, 1994, BRAIN COGNITION, V24, P213, DOI 10.1006/brcg.1994.1012; Trojano L, 2000, CEREB CORTEX, V10, P473, DOI 10.1093/cercor/10.5.473; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7	42	186	188	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					185	194		10.1016/S0896-6273(02)00747-X	http://dx.doi.org/10.1016/S0896-6273(02)00747-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	569KP	12123618	Green Published, Bronze			2022-12-28	WOS:000176601800020
J	Sarmiere, PD; Bamburg, JR				Sarmiere, PD; Bamburg, JR			Head, neck, and spines: A role for LIMK-1 in the hippocampus	NEURON			English	Editorial Material									Colorado State Univ, Dept Biochem & Mol Biol, Program Mol Cellular & Integrat Neurosci, Ft Collins, CO 80523 USA	Colorado State University	Sarmiere, PD (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Program Mol Cellular & Integrat Neurosci, Ft Collins, CO 80523 USA.							Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Takahashi H, 2002, DEV BIOL, V241, P259, DOI 10.1006/dbio.2001.0512; Toshima J, 2001, BIOCHEM BIOPH RES CO, V286, P566, DOI 10.1006/bbrc.2001.5404	11	22	23	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					3	5		10.1016/S0896-6273(02)00759-6	http://dx.doi.org/10.1016/S0896-6273(02)00759-6			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123600	Bronze			2022-12-28	WOS:000176601800002
J	Lee, TS				Lee, TS			The nature of illusory contour computation	NEURON			English	Editorial Material							DYNAMICS; CORTEX	Neural correlates of illusory contour perception have been found in both the early and the higher visual areas. But the locus and the mechanism for its computation remain elusive. Psychophysical evidence provided in this issue of Neuron shows that perceptual contour completion is likely done in the early visual cortex in a cascade manner using horizontal connections.	Carnegie Mellon Univ, Ctr Neural Basis Cognit, Dept Comp Sci, Mellon Inst, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, TS (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, Dept Comp Sci, Mellon Inst, Rm 115,4400 5th Ave, Pittsburgh, PA 15213 USA.							Geiger D, 1996, PROC CVPR IEEE, P155, DOI 10.1109/CVPR.1996.517068; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GROSOF DH, 1993, NATURE, V365, P550, DOI 10.1038/365550a0; GROSSBERG S, 1985, PERCEPT PSYCHOPHYS, V38, P141, DOI 10.3758/BF03198851; HEITGER F, 1993, P 4 INT C COMP VIS, P32; Huxlin KR, 2000, CEREB CORTEX, V10, P671, DOI 10.1093/cercor/10.7.671; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Mendola JD, 1999, J NEUROSCI, V19, P8560; Pillow J, 2002, NEURON, V33, P805, DOI 10.1016/S0896-6273(02)00605-0; Ramsden BM, 2001, CEREB CORTEX, V11, P648, DOI 10.1093/cercor/11.7.648; Sheth BR, 1996, SCIENCE, V274, P2110, DOI 10.1126/science.274.5295.2110; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501	12	10	10	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					667	668		10.1016/S0896-6273(02)00616-5	http://dx.doi.org/10.1016/S0896-6273(02)00616-5			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879643	Bronze			2022-12-28	WOS:000174286200002
J	Li, Z; Aizenman, CD; Cline, HT				Li, Z; Aizenman, CD; Cline, HT			Regulation of rho GTPases by crosstalk and neuronal activity in vivo	NEURON			English	Article							WISKOTT-ALDRICH SYNDROME; BINDING PROTEIN-RHO; IN-VIVO; SERINE/THREONINE KINASE; DENDRITIC SPINES; AXON OUTGROWTH; FAMILY GTPASES; RAC; CDC42; GROWTH	Proper development of neurons depends on synaptic activity, but the mechanisms of activity-dependent neuronal growth are not well understood. The small GTPases, RhoA, Rac, and Cdc42, regulate neuronal morphogenesis by controlling the assembly and stability of the actin cytoskeleton. We report an in situ method to determine endogenous Rho GTPase activity In intact Xenopus brain. We use this method to provide evidence for crosstalk between Rho GTPases in optic tectal cells. Moreover, crosstalk between the Rho GTPases appears to affect dendritic arbor development in vivo. Finally, we demonstrate that optic nerve stimulation regulates Rho GTPase activity in a glutamate receptor-dependent manner. These data suggest a link between glutamate receptor function, Rho GTPase activity, and dendritic arbor growth in the intact animal.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Cline, HT (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Li, Zheng/I-8016-2014	Li, Zheng/0000-0002-2978-2531				Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CLINE HT, 1999, IMAGING LAB MANUAL; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Foa L, 2001, NAT NEUROSCI, V4, P499, DOI 10.1038/87447; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1996, PERSPECT DEV NEUROBI, V4, P199; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Moore K D, 1999, Health Forum J, V42, P22; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Rajan I, 1998, J NEUROSCI, V18, P7836; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; VAN AL, 1997, GENE DEV, V11, P2295; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wong WT, 2000, J NEUROSCI, V20, P5024; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9	50	179	182	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					741	750		10.1016/S0896-6273(02)00621-9	http://dx.doi.org/10.1016/S0896-6273(02)00621-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879651	Bronze			2022-12-28	WOS:000174286200010
J	Spehr, M; Wetzel, CH; Hatt, H; Ache, BW				Spehr, M; Wetzel, CH; Hatt, H; Ache, BW			3-Phosphoinositides modulate cyclic nucleotide signaling in olfactory receptor neurons	NEURON			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PLASMA-MEMBRANE; PHOSPHOINOSITIDE 3-KINASE; RESPONSE PROPERTIES; RAT; TRANSDUCTION; CHANNELS; EXPRESSION; ODORANTS; BETA	Phosphatidylinositol 3-kinase (PI3K)-dependent phosphoinositide signaling has been implicated in diverse cellular systems coupled to receptors for many different ligands, but the extent to which it functions in sensory transduction is yet to be determined. We now report that blocking PI3K activity increases odorant-evoked, cyclic nucleotide-dependent elevation of [Ca2+](i) in acutely dissociated rat olfactory receptor neurons and does so in an odorant-specific manner. These findings imply that 3-phosphoinositide signaling acts in vertebrate olfactory transduction to inhibit cyclic nucleotide-dependent excitation of the cells and that the interaction of the two signaling pathways is important in odorant coding, indicating that 3-phosphoinositide signaling can play a role in sensory transduction.	Univ Florida, Ctr Smell & Taste, Dept Zool, Whitney Lab, Gainesville, FL 32610 USA; Univ Florida, Ctr Smell & Taste, Dept Neurosci, Whitney Lab, Gainesville, FL 32610 USA; Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA; Ruhr Univ Bochum, Dept Cell Physiol, D-44780 Bochum, Germany	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Ruhr University Bochum	Ache, BW (corresponding author), Univ Florida, Ctr Smell & Taste, Dept Zool, Whitney Lab, Gainesville, FL 32610 USA.	bwa@whitney.ufl.edu	Wetzel, Christian/F-1366-2018; Spehr, Marc/AAK-3162-2021; Spehr, Marc/B-3140-2011; Wetzel, Christian H/N-9880-2017; Wetzel, Christian/C-2501-2009	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; Wetzel, Christian H/0000-0002-5762-0003; Wetzel, Christian/0000-0002-5762-0003	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001655] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC01655] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ACHE BW, 1995, CURR OPIN NEUROBIOL, V5, P461, DOI 10.1016/0959-4388(95)80006-9; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bozza TC, 1998, J NEUROSCI, V18, P4560; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Chen S, 2000, J NEUROPHYSIOL, V84, P575, DOI 10.1152/jn.2000.84.1.575; CUNNINGHAM AM, 1993, NEUROSCIENCE, V57, P339, DOI 10.1016/0306-4522(93)90067-P; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; Gold GH, 1999, ANNU REV PHYSIOL, V61, P857, DOI 10.1146/annurev.physiol.61.1.857; Gomez G, 2000, NEUROSCIENCE, V98, P181, DOI 10.1016/S0306-4522(00)00112-3; GUELLAEN G, 1977, BIOCHIM BIOPHYS ACTA, V484, P465, DOI 10.1016/0005-2744(77)90102-4; HAWKINS PT, 1992, NATURE, V358, P157, DOI 10.1038/358157a0; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; KURAHASHI T, 1994, SCIENCE, V265, P118, DOI 10.1126/science.8016645; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; Lischka FW, 1999, BIOPHYS J, V76, P1410, DOI 10.1016/S0006-3495(99)77302-9; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MORALES B, 2000, BIOL RES, V29, P333; Munger SD, 2000, J BIOL CHEM, V275, P20450, DOI 10.1074/jbc.M001989200; Noe J, 1998, J NEUROCHEM, V71, P2286; OKADA Y, 1994, J NEUROPHYSIOL, V71, P595, DOI 10.1152/jn.1994.71.2.595; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; SANHUEZA M, 2000, AM J PHYSIOL, V279, P31; Schandar M, 1998, J BIOL CHEM, V273, P16669, DOI 10.1074/jbc.273.27.16669; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Tang XW, 1997, J BIOL CHEM, V272, P14193, DOI 10.1074/jbc.272.22.14193; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vargas G, 1999, CHEM SENSES, V24, P211, DOI 10.1093/chemse/24.2.211; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vogl A, 2000, EUR J BIOCHEM, V267, P4529, DOI 10.1046/j.1432-1327.2000.01503.x; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858; YULE DI, 1992, J BIOL CHEM, V267, P13830; Zhainazarov AB, 2001, J NEUROPHYSIOL, V85, P2537, DOI 10.1152/jn.2001.85.6.2537; Zhang XL, 1998, SEMIN CELL DEV BIOL, V9, P153, DOI 10.1006/scdb.1997.0220; Zhao H, 2001, CHEM SENSES, V26, P1110; Zufall F, 2000, J NEUROPHYSIOL, V83, P501, DOI 10.1152/jn.2000.83.1.501	44	93	95	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					731	739		10.1016/S0896-6273(02)00610-4	http://dx.doi.org/10.1016/S0896-6273(02)00610-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879650	Bronze			2022-12-28	WOS:000174286200009
J	Rosenmund, C; Sigler, A; Augustin, I; Reim, K; Brose, N; Rhee, JS				Rosenmund, C; Sigler, A; Augustin, I; Reim, K; Brose, N; Rhee, JS			Differential control of vesicle priming and short-term plasticity by Munc13 isoforms	NEURON			English	Article							READILY RELEASABLE POOL; PROTEIN-KINASE-C; SYNAPTIC PLASTICITY; TRANSMITTER RELEASE; CHROMAFFIN CELLS; HIPPOCAMPAL SYNAPSES; PYRAMIDAL NEURONS; TRANSMISSION; PROBABILITY; MODULATION	Presynaptic short-term plasticity is an important adaptive mechanism regulating synaptic transmitter release at varying action potential frequencies. However, the underlying molecular mechanisms are unknown. We examined genetically defined and functionally unique axonal subpopulations of synapses in excitatory hippocampal neurons that utilize either Munc13-1 or Munc13-2 as synaptic vesicle priming factor. In contrast to Munc13-1-dependent synapses, Munc-13-2-driven synapses show pronounced and transient augmentation of synaptic amplitudes following high-frequency stimulation. This augmentation is caused by a Ca2+-dependent increase in release probability and releasable vesicle pool size, and requires phospholipase C activity. Thus, differential expression of Munc13 isoforms at individual synapses represents a general mechanism that controls short-term plasticity and contributes to the heterogeneity of synaptic Information coding.	Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Max Planck Inst Expt Med, AG Mol Neurobiol, Abt Neurogenet, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society	Rosenmund, C (corresponding author), Max Planck Inst Biophys Chem, Abt Membranbiophys, Fassberg 11, D-37077 Gottingen, Germany.		Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444				Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Asztely F, 2000, EUR J NEUROSCI, V12, P662, DOI 10.1046/j.1460-9568.2000.00956.x; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; DAVIS GW, 1994, TRENDS NEUROSCI, V17, P9, DOI 10.1016/0166-2236(94)90028-0; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Malgaroli A, 1999, NAT NEUROSCI, V2, P3, DOI 10.1038/4503; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Pouzat C, 1997, J NEUROSCI, V17, P9104; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Schikorski T, 1997, J NEUROSCI, V17, P5858; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	37	243	246	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					411	424		10.1016/S0896-6273(02)00568-8	http://dx.doi.org/10.1016/S0896-6273(02)00568-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832228	Green Published, Bronze			2022-12-28	WOS:000173643200011
J	Hummel, T; Attix, S; Gunning, D; Zipursky, SL				Hummel, T; Attix, S; Gunning, D; Zipursky, SL			Temporal control of glial cell migration in the Drosophila eye requires gilgamesh, hedgehog, and eye specification genes	NEURON			English	Article							GROWTH CONE GUIDANCE; CASEIN-KINASE-I; OLIGODENDROCYTE PRECURSORS ORIGINATE; CENTRAL-NERVOUS-SYSTEM; AXON GUIDANCE; EMBRYONIC CNS; OPTIC-NERVE; TRACT FORMATION; MIDLINE GLIA; SPINAL-CORD	In the Drosophila visual system, photoreceptor neurons (R cells) extend axons towards glial cells located at the posterior edge of the eye disc. In gilgamesh (gish) mutants, glial cells invade anterior regions of the eye disc prior to R cell differentiation and R cell axons extend anteriorly along these cells. gish encodes casein kinase Igamma. gish, sine oculis, eyeless, and hedgehog (hh) act in the posterior region of the eye disc to prevent precocious glial cell migration. Targeted expression of Hh in this region rescues the gish phenotype, though the glial cells do not require the canonical Hh signaling pathway to respond. We propose that the spatiotemporal control of glial cell migration plays a critical role in determining the directionality of R cell axon outgrowth.	Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, 5-748 MRL,675 Charles Young Dr S, Los Angeles, CA 90095 USA.			Zipursky, Stephen/0000-0001-5630-7181				Auld V, 1999, CELL MOL LIFE SCI, V55, P1377, DOI 10.1007/s000180050378; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bertuzzi S, 1999, GENE DEV, V13, P3092, DOI 10.1101/gad.13.23.3092; Booth GE, 2000, DEVELOPMENT, V127, P237; CameronCurry P, 1995, NEURON, V15, P1299, DOI 10.1016/0896-6273(95)90009-8; CHOI KW, 1994, NEURON, V12, P423, DOI 10.1016/0896-6273(94)90282-8; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; FFRENCHCONSTANT C, 1988, J NEUROCYTOL, V17, P13, DOI 10.1007/BF01735374; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Giesen K, 1997, DEVELOPMENT, V124, P2307; Goodman C. S., 1993, DEV DROSOPHILA MELAN; Granderath S, 1999, CURR OPIN NEUROBIOL, V9, P531, DOI 10.1016/S0959-4388(99)00008-2; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; HALTER DA, 1995, DEVELOPMENT, V121, P317; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Hidalgo A, 2000, DEVELOPMENT, V127, P393; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Jacobs JR, 2000, PROG NEUROBIOL, V62, P475, DOI 10.1016/S0301-0082(00)00016-2; JACOBS JR, 1989, J NEUROSCI, V9, P2402; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kinrade EFV, 2001, DEVELOPMENT, V128, P207; Klambt C, 1996, DEV GENET, V18, P40, DOI 10.1002/(SICI)1520-6408(1996)18:1&lt;40::AID-DVG5&gt;3.0.CO;2-1; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Newsome TP, 2000, DEVELOPMENT, V127, P851; NOLL E, 1993, DEVELOPMENT, V118, P563; Ono K, 1997, NEURON, V19, P283, DOI 10.1016/S0896-6273(00)80939-3; Ono K, 1997, J NEUROSCI RES, V48, P212; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pignoni F, 1997, DEVELOPMENT, V124, P271; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Powell EM, 1997, CELL TISSUE RES, V290, P385, DOI 10.1007/s004410050945; Powell EM, 1999, GLIA, V26, P73, DOI 10.1002/(SICI)1098-1136(199903)26:1<73::AID-GLIA8>3.0.CO;2-S; Rangarajan R, 1999, DEVELOPMENT, V126, P3285; READY DF, 1989, TRENDS NEUROSCI, V12, P102, DOI 10.1016/0166-2236(89)90166-5; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Rogister B, 1999, MOL CELL NEUROSCI, V14, P287, DOI 10.1006/mcne.1999.0790; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Sela-Donenfeld D, 1999, DEVELOPMENT, V126, P4749; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stowers RS, 1999, GENETICS, V152, P1631; Stuermer CAO, 2000, PROG NEUROBIOL, V62, P197, DOI 10.1016/S0301-0082(00)00012-5; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Testaz S, 2001, P NATL ACAD SCI USA, V98, P12521, DOI 10.1073/pnas.221108698; Tix S, 1997, CELL TISSUE RES, V289, P397, DOI 10.1007/s004410050886; TOWER J, 1993, GENETICS, V133, P347; WANG PC, 1992, MOL BIOL CELL, V3, P275, DOI 10.1091/mbc.3.3.275; WINBERG ML, 1992, DEVELOPMENT, V115, P903; WOLFF T, 1991, DEVELOPMENT, V113, P841; Zhang JR, 1996, BIOCHEMISTRY-US, V35, P16319, DOI 10.1021/bi9614444; ZHANG P, 1993, GENETICS, V133, P361	56	85	86	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					193	203		10.1016/S0896-6273(01)00581-5	http://dx.doi.org/10.1016/S0896-6273(01)00581-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804568	Bronze			2022-12-28	WOS:000173387700008
J	Finn, AK; Whistler, JL				Finn, AK; Whistler, JL			Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal	NEURON			English	Article							RAT-BRAIN; GABA RELEASE; MORPHINE; KINASE; DESENSITIZATION; INTERNALIZATION; DISSOCIATION; DEPENDENCE; ACTIVATION; CELLS	Morphine is unusual in its failure to promote robust desensitization and endocytosis of the mu opioid receptor (MOR), processes that for many receptors contribute directly to tolerance. This apparent paradox has led us to revise the idea that receptor desensitization and endocytosis are solely responsible for tolerance and withdrawal to morphine, and instead test the hypothesis that these side effects occur due to abnormally prolonged MOR signaling. We report here that MOR mutations that facilitate endocytosis reduce the development of cellular tolerance and cAMP superactivation, a cellular hallmark of withdrawal. Moreover, mutant receptors with reduced endocytosis produce exacerbated superactivation. These data demonstrate a critical role for receptor endocytosis in the development of adverse side effects associated with prolonged opiate use.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California Berkeley	Whistler, JL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA.							Abbadie C, 2000, J COMP NEUROL, V419, P244, DOI 10.1002/(SICI)1096-9861(20000403)419:2<244::AID-CNE8>3.0.CO;2-R; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; AvidorReiss T, 1996, J BIOL CHEM, V271, P21309, DOI 10.1074/jbc.271.35.21309; AVIDORREISS T, 1995, J BIOL CHEM, V270, P29732; Blake AD, 1997, J BIOL CHEM, V272, P782, DOI 10.1074/jbc.272.2.782; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bonci A, 1997, J NEUROSCI, V17, P796; BURROUGHS WS, 1956, B J ADDICT, V53; Chieng B, 1998, J NEUROSCI, V18, P7033; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; De Quincey Thomas., 1976, CONFESSIONS ENGLISH; Evans CJ, 1993, BIOL BASIS SUBSTANCE, P31; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Liu JG, 2001, MOL PHARMACOL, V60, P53, DOI 10.1124/mol.60.1.53; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 1996, NEURON, V16, P897, DOI 10.1016/S0896-6273(00)80110-5; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; Sim LJ, 1996, J NEUROSCI, V16, P2684; Sim-Selley LJ, 2000, J NEUROSCI, V20, P4555, DOI 10.1523/JNEUROSCI.20-12-04555.2000; SNYDER SH, 1996, DRUGS BRAIN; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Trapaidze N, 2000, MOL BRAIN RES, V76, P220, DOI 10.1016/S0169-328X(00)00002-4; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Whistler JL, 1999, J BIOL CHEM, V274, P24575, DOI 10.1074/jbc.274.35.24575; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	33	223	237	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					829	839		10.1016/S0896-6273(01)00517-7	http://dx.doi.org/10.1016/S0896-6273(01)00517-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738029	Bronze			2022-12-28	WOS:000172700700010
J	Howe, CL; Valletta, JS; Rusnak, AS; Mobley, WC				Howe, CL; Valletta, JS; Rusnak, AS; Mobley, WC			NGF signaling from clathrin-coated vesicles: Evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway	NEURON			English	Article							NERVE GROWTH-FACTOR; RECEPTOR-MEDIATED ENDOCYTOSIS; SYMPATHETIC NEURONS; RETROGRADE TRANSPORT; TRKA; INSULIN; KINASE; INTERNALIZATION; PHOSPHORYLATION; CULTURES	The target-derived neurotrophic factor "nerve growth factor" (NGF) signals through TrkA to promote the survival, differentiation, and maintenance of neurons. How the NGF signal in axon terminals is conveyed to the cell body is unknown. The "signaling endosome hypothesis" envisions that NGF-TrkA complexes are internalized at the axon terminal and retrogradely transported to the cell body. Following NGF treatment, we found that clathrin-coated vesicles contained NGF bound to TrkA together with activated signaling proteins of the Ras-MAP kinase pathway. Evidence that these vesicles could signal was their ability in vitro to activate Elk, a downstream target of Erk1/2. Our results point to the existence of a population of signaling endosomes derived from clathrin-coated membranes in NGF-treated cells.	Stanford Univ, Med Ctr, Dept Neurol, Stanford, CA 94305 USA	Stanford University	Howe, CL (corresponding author), Mayo Clin & Mayo Fdn, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.		Howe, Charles/B-4945-2009	Howe, Charles/0000-0002-3889-8739	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024054] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24054] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beattie EC, 2000, J NEUROSCI, V20, P7325; Beattie EC, 1996, COLD SPRING HARB SYM, V61, P389; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; Casaccia-Bonnefil P, 1999, ADV EXP MED BIOL, V468, P275; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Chan JR, 1998, P NATL ACAD SCI USA, V95, P10459, DOI 10.1073/pnas.95.18.10459; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; DAVIES PJA, 1984, DIABETES CARE, V7, P35; EHLERS MD, 1995, J CELL BIOL, V130, P149, DOI 10.1083/jcb.130.1.149; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; GILAD GM, 1986, INT J DEV NEUROSCI, V4, P401, DOI 10.1016/0736-5748(86)90022-5; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Grimes ML, 1996, J NEUROSCI, V16, P7950; HENDRY IA, 1993, NEUROTROPHIC FACTORS, P51; JOHANSON SO, 1995, BRAIN RES, V690, P55, DOI 10.1016/0006-8993(95)00587-G; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Leof EB, 2000, TRENDS CELL BIOL, V10, P343, DOI 10.1016/S0962-8924(00)01795-5; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MOBLEY WC, 1985, SCIENCE, V229, P284, DOI 10.1126/science.2861660; PEELER JS, 1993, J CELL BIOL, V120, P47, DOI 10.1083/jcb.120.1.47; Reynolds AJ, 2001, NEUROSCIENCE, V105, P761, DOI 10.1016/S0306-4522(01)00235-4; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; SOFER A, 1995, J BIOL CHEM, V270, P12117, DOI 10.1074/jbc.270.20.12117; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; WEI L, 1990, J NEUROCHEM, V54, P1661, DOI 10.1111/j.1471-4159.1990.tb01219.x; Wood TL, 2000, J MAMMARY GLAND BIOL, V5, P1, DOI 10.1023/A:1009580913795; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	37	271	280	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					801	814		10.1016/S0896-6273(01)00526-8	http://dx.doi.org/10.1016/S0896-6273(01)00526-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738027	Bronze			2022-12-28	WOS:000172700700008
J	Lauri, SE; Bortolotto, ZA; Bleakman, D; Ornstein, PL; Lodge, D; Isaac, JTR; Collingridge, GL				Lauri, SE; Bortolotto, ZA; Bleakman, D; Ornstein, PL; Lodge, D; Isaac, JTR; Collingridge, GL			A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP	NEURON			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL CA3 NEURONS; SYNAPTIC ACTIVATION; RAT HIPPOCAMPUS; BINDING-SITES; GLUR5 SUBTYPE; 2 FORMS; PLASTICITY; SYNAPSES; INDUCTION	The mechanisms involved in mossy fiber LTP in the hippocampus are not well established. In the present study, we show that the kainate receptor antagonist LY382884 (10 muM) is selective for presynaptic kainate receptors in the CA3 region of the hippocampus. At a concentration at which it blocks mossy fiber LTP, LY382884 selectively blocks the synaptic activation of a presynaptic kainate receptor that facilitates AMPA receptor-mediated synaptic transmission. Following the induction of mossy fiber LTP, there is a complete loss of the presynaptic kainate receptor-mediated facilitation of synaptic transmission. These results identify a central role for the presynaptic kainate receptor in the induction of mossy fiber LTP. In addition, these results suggest that the pathway by which kainate receptors facilitate glutamate release is utilized for the expression of mossy fiber LTP.	Univ Bristol, Sch Med, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA	University of Bristol; Eli Lilly	Collingridge, GL (corresponding author), Univ Bristol, Sch Med, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.		Ornstein, Paul/E-4212-2016; Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020; Lauri, Sari/AAD-6417-2021	Ornstein, Paul/0000-0002-4335-1877; Collingridge, Graham L/0000-0002-9572-5359; Lauri, Sari/0000-0002-5895-1357				Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Bleisch TJ, 1997, BIOORG MED CHEM LETT, V7, P1161, DOI 10.1016/S0960-894X(97)00185-6; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bortolotto ZA, 2000, NATURE, V406, P957, DOI 10.1038/35023077; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; DAVIES CH, 1993, NEUROPHARMACOLOGY, V32, P1071, DOI 10.1016/0028-3908(93)90073-C; FREKING M, 2001, J NEUROSCI, V21, P2958; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948, DOI 10.1152/jn.1990.64.3.948; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; KEHL SJ, 1984, NEUROSCIENCE, V11, P111, DOI 10.1016/0306-4522(84)90217-3; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kidd FL, 2001, J NEUROPHYSIOL, V86, P1139, DOI 10.1152/jn.2001.86.3.1139; LAURI SE, 2001, IN PRESS NEUROPHARMA, V47; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nicoll RA, 2000, NATURE, V406, P957, DOI 10.1038/35023075; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; Robinson I. K., 1991, HDB SYNCHROTRON RAD, V3, P221; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Urban NN, 1996, J NEUROSCI, V16, P4293; Vignes M, 1997, NEUROPHARMACOLOGY, V36, P1477, DOI 10.1016/S0028-3908(97)00158-5; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	42	156	161	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					697	709		10.1016/S0896-6273(01)00511-6	http://dx.doi.org/10.1016/S0896-6273(01)00511-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719209	Bronze			2022-12-28	WOS:000172363900015
J	Ahissar, E; Arieli, A				Ahissar, E; Arieli, A			Figuring space by time	NEURON			English	Review							RAT BARREL CORTEX; POSTERIOR MEDIAL NUCLEUS; SOMATIC SENSORY RESPONSES; RETINAL GANGLION-CELLS; PRIMARY VISUAL-CORTEX; STRIATE CORTEX; SOMATOSENSORY CORTEX; EYE-MOVEMENTS; SPATIOTEMPORAL INTERPOLATION; FUNCTIONAL ARCHITECTURE	Sensory information is encoded both in space and in time. Spatial encoding is based on the identity of activated receptors, while temporal encoding is based on the timing of activation. In order to generate accurate internal representations of the external world, the brain must decode both types of encoded information, even when processing stationary stimuli. We review here evidence in support of a parallel processing scheme for spatially and temporally encoded information in the tactile system and discuss the advantages and limitations of sensory-derived temporal coding in both the tactile and visual systems. Based on a large body of data, we propose a dynamic theory for vision, which avoids the impediments of previous dynamic theories.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ahissar, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.							Adler FH, 1934, ARCH OPHTHALMOL-CHIC, V12, P475; Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; AHISSAR E, 1990, P NATL ACAD SCI USA, V87, P8935, DOI 10.1073/pnas.87.22.8935; Ahissar E, 2001, Prog Brain Res, V130, P75; Ahissar E, 2001, J NEUROPHYSIOL, V86, P354, DOI 10.1152/jn.2001.86.1.354; Ahissar E, 1998, NEURAL COMPUT, V10, P597, DOI 10.1162/089976698300017683; Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; AHISSAR E, 1995, GCEA954 WEIZM I SCI; ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; [Anonymous], 1988, EYE BRAIN VISION; AREND LE, 1973, PSYCHOL REV, V80, P374, DOI 10.1037/h0020072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; BARLOW HB, 1952, J PHYSIOL-LONDON, V116, P290, DOI 10.1113/jphysiol.1952.sp004706; BARLOW HB, 1979, NATURE, V279, P189, DOI 10.1038/279189a0; BENGI H, 1968, MED BIOL ENG, V6, P171, DOI 10.1007/BF02474271; Bengi H., 1972, PERSPECTIVES BIOMEDI, P281; BERNARDO KL, 1990, J COMP NEUROL, V291, P231, DOI 10.1002/cne.902910207; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Brumberg JC, 1999, J NEUROPHYSIOL, V82, P1808, DOI 10.1152/jn.1999.82.4.1808; Bryngdahl O, 1961, OPT ACTA, V8, P1; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; BURR D, 1986, TRENDS NEUROSCI, V9, P304, DOI 10.1016/0166-2236(86)90088-3; BURR DC, 1986, PROC R SOC SER B-BIO, V227, P249, DOI 10.1098/rspb.1986.0022; BYFORD GH, 1961, J PHYSIOL-LONDON, V159, pP2; Carpenter RHS, 1988, MOVEMENTS EYES; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; COAKLEY D, 1983, MINUTE EYE MOVEMENT; Coppola D, 1996, P NATL ACAD SCI USA, V93, P8001, DOI 10.1073/pnas.93.15.8001; Crick FHC, 1981, ORG CEREBRAL CORTEX, P505; DARIANSMITH I, 1980, J PHYSIOL-LONDON, V309, P117, DOI 10.1113/jphysiol.1980.sp013498; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; Diamond ME, 1995, CEREBR CORT, V11, P189; Ditchburn R.W., 1973, EYE MOVEMENTS VISUAL; DOW BM, 1981, EXP BRAIN RES, V44, P213; Dudai Y., 1989, NEUROBIOLOGY MEMORY; ECKHORN R, 1994, PROG BRAIN RES, V102, P405; ECKHORN R, 1993, NEUROREPORT, V4, P243, DOI 10.1097/00001756-199303000-00004; EIZENMAN M, 1985, VISION RES, V25, P1635, DOI 10.1016/0042-6989(85)90134-8; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FAHLE M, 1981, PROC R SOC SER B-BIO, V213, P451, DOI 10.1098/rspb.1981.0075; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fetz E E, 1993, Curr Opin Neurobiol, V3, P932, DOI 10.1016/0959-4388(93)90165-U; FINDLAY JM, 1971, KYBERNETIK, V8, P207, DOI 10.1007/BF00288749; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Gardner F.M., 1979, PHASELOCK TECHNIQUES; GEORGOPOULOS AP, 1986, ANNU REV NEUROSCI, V9, P147, DOI 10.1146/annurev.ne.09.030186.001051; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; Ghazanfar AA, 1997, J NEUROPHYSIOL, V78, P506, DOI 10.1152/jn.1997.78.1.506; Goodale M A, 1993, Curr Opin Neurobiol, V3, P578, DOI 10.1016/0959-4388(93)90059-8; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Gray CM, 1997, J NEUROSCI, V17, P3239; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; GUR M, 1987, VISION RES, V27, P2081, DOI 10.1016/0042-6989(87)90122-2; Gur M, 1997, VISION RES, V37, P257, DOI 10.1016/S0042-6989(96)00182-4; GUSTAFSON JW, 1977, PSYCHOL BULL, V84, P477, DOI 10.1037/0033-2909.84.3.477; HADANI I, 1984, VISION RES, V34, P871; Haidarliu S, 1997, J COMP NEUROL, V385, P515, DOI 10.1002/(SICI)1096-9861(19970908)385:4<515::AID-CNE3>3.0.CO;2-6; Haidarliu S, 1999, J NEUROSCI METH, V94, P27, DOI 10.1016/S0165-0270(99)00123-5; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; HIRSCH JA, 1995, NATURE, V378, P612, DOI 10.1038/378612a0; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; HOOGLAND PV, 1988, CELLULAR THALAMIC ME, P152; Hubel D, 1996, NATURE, V380, P197, DOI 10.1038/380197a0; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Kaas J, 1998, NAT NEUROSCI, V1, P341, DOI 10.1038/1546; KEESEY UT, 1960, J OPT SOC AM, V50, P769, DOI 10.1364/JOSA.50.000769; KELLER A, 1995, CEREBR CORT, V11, P221; Kim U, 1999, J COMP NEUROL, V408, P489; KLEIN SA, 1985, J OPT SOC AM A, V2, P1170, DOI 10.1364/JOSAA.2.001170; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Lebedev MA, 1995, J COMPUT NEUROSCI, V2, P313, DOI 10.1007/BF00961443; Levi DM, 1999, PERCEPTION, V28, P1443, DOI 10.1068/p2819; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Lotze Hermann, 1885, MICROCOSMOS; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Marshall W. H., 1942, BIOL S VISUAL MECHAN, V7, P117; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; MATIN L, 1981, VISION RES, V21, P647, DOI 10.1016/0042-6989(81)90072-9; MATIN L, 1964, BIOMEDICAL SCIENCES, P79; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; MCKEE SP, 1987, J OPT SOC AM A, V4, P1104, DOI 10.1364/JOSAA.4.001104; MCKEE SP, 1990, VISION RES, V30, P879, DOI 10.1016/0042-6989(90)90056-Q; MORGAN MJ, 1990, J OPT SOC AM A, V7, P297, DOI 10.1364/JOSAA.7.000297; MORGAN MJ, 1983, VISION RES, V23, P997, DOI 10.1016/0042-6989(83)90010-X; MORGAN MJ, 1983, VISION RES, V23, P541, DOI 10.1016/0042-6989(83)90129-3; Murakami I, 1998, NATURE, V395, P798, DOI 10.1038/27435; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; NICOLELIS MAL, 1994, J NEUROSCI, V14, P3511; Nijhawan R, 1997, NATURE, V386, P66, DOI 10.1038/386066a0; Perkel D.H., 1968, NEUROSCI RES PROGRAM, V6, P221; PRITCHARD R, 1961, SCI AM, V204, P72, DOI 10.1038/scientificamerican0661-72; PRITCHARD RM, 1960, CAN J PSYCHOLOGY, V14, P131, DOI 10.1037/h0083176; Purves D, 1996, P NATL ACAD SCI USA, V93, P3693, DOI 10.1073/pnas.93.8.3693; RATLIFF F, 1950, J EXP PSYCHOL, V40, P687, DOI 10.1037/h0057754; RIGGS LA, 1953, J OPT SOC AM, V43, P495, DOI 10.1364/JOSA.43.000495; RIGGS LA, 1954, J OPT SOC AM, V44, P315, DOI 10.1364/JOSA.44.000315; SAKURANAGA M, 1987, J GEN PHYSIOL, V90, P229, DOI 10.1085/jgp.90.2.229; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shakhnovich A. R., 1977, BRAIN REGULATION EYE; SHAPLEY R, 1986, SCIENCE, V231, P999, DOI 10.1126/science.3945816; SHECHTER S, 1988, VISION RES, V28, P1013, DOI 10.1016/0042-6989(88)90078-8; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SHIPLEY MT, 1974, J NEUROPHYSIOL, V37, P73, DOI 10.1152/jn.1974.37.1.73; Shulz DE, 2000, NATURE, V403, P549, DOI 10.1038/35000586; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SIMONS DJ, 1995, CEREBR CORT, V11, P263; SNODDERLY DM, 2001, IN PRESS VIS NEUROSC; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; Spauschus A, 1999, EXP BRAIN RES, V126, P556, DOI 10.1007/s002210050764; Staiger JF, 2000, NEUROSCI RES, V37, P49, DOI 10.1016/S0168-0102(00)00094-8; Steinman R M, 1990, Rev Oculomot Res, V4, P115; SWINDALE NV, 1986, NATURE, V319, P591, DOI 10.1038/319591a0; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; VANOPSTAL AJ, 1989, VISION RES, V29, P1183, DOI 10.1016/0042-6989(89)90064-3; Verheijen F., 1961, J OPTICA ACTA, V8, P309, DOI [10.1080/713826390, DOI 10.1080/713826390]; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WESTHEIMER G, 1990, COLD SH Q B, V55, P759; WESTHEIMER G, 1976, AM J OPTOM PHYS OPT, V53, P362; WHITE JM, 1992, VISION RES, V32, P513, DOI 10.1016/0042-6989(92)90243-C; Wiener N., 1949, CYBERNETICS; Wilson H. R., 1991, COMPUTATIONAL MODELS, P153; WILSON HR, 1986, VISION RES, V26, P453, DOI 10.1016/0042-6989(86)90188-4; WINESKI LE, 1983, J ZOOL, V200, P261; WISE SP, 1993, TRENDS NEUROSCI, V16, P46, DOI 10.1016/0166-2236(93)90014-D; WOOLSEY TA, 1997, ENCY NEUROSCIENCE, P195; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Zhang MS, 2000, NATURE, V408, P971, DOI 10.1038/35050097; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	146	162	165	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					185	201		10.1016/S0896-6273(01)00466-4	http://dx.doi.org/10.1016/S0896-6273(01)00466-4			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683990	Bronze			2022-12-28	WOS:000171893700005
J	Miller, LM; Escabi, MA; Read, HL; Schreiner, CE				Miller, LM; Escabi, MA; Read, HL; Schreiner, CE			Functional convergence of response properties in the auditory thalamocortical system	NEURON			English	Article							CROSS-CORRELATION ANALYSIS; RECEPTIVE-FIELDS; MEDIAL GENICULATE; ORIENTATION SELECTIVITY; SOMATOSENSORY CORTEX; SYNAPTIC INTEGRATION; SIMPLE CELLS; CAT; ORGANIZATION; PLASTICITY	One of the brain's fundamental tasks is to construct and transform representations of an animal's environment, yet few studies describe how individual neurons accomplish this. Our results from correlated pairs in the auditory thalamocortical system show that cortical excitatory receptive field regions can be directly inherited from thalamus, constructed from smaller inputs, and assembled by the cooperative activity of neuronal ensembles. The prevalence of functional thalamocortical connectivity is strictly governed by tonotopy, but connection strength is not. Finally, spectral and temporal modulation preferences in cortex may differ dramatically from the thalamic input. Our observations reveal a radical reconstruction of response properties from auditory thalamus to cortex, and illustrate how some properties are propagated with great fidelity while others are significantly transformed or generated intracortically.	Univ Calif San Francisco, Med Ctr, UCSF UCB Bioengn Grp, San Francisco, CA 94143 USA; Univ Connecticut, Storrs, CT 06269 USA	University of California System; University of California San Francisco; University of Connecticut	Miller, LM (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall 1650, Berkeley, CA 94720 USA.	lmiller@socrates.berkeley.edu		Schreiner, Christoph/0000-0002-4571-4328; Escabi, Monty/0000-0001-7271-1061	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-02260, R01 DC002260, R01 DC002260-06] Funding Source: Medline; NINDS NIH HHS [NS34835] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adrian ED, 1941, J PHYSIOL-LONDON, V100, P159, DOI 10.1113/jphysiol.1941.sp003932; AERTSEN AMHJ, 1980, BIOL CYBERN, V38, P223, DOI 10.1007/BF00337015; Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; ANDERSEN RA, 1980, J COMP NEUROL, V194, P663, DOI 10.1002/cne.901940312; Arai T, 1998, INT CONF ACOUST SPEE, P933, DOI 10.1109/ICASSP.1998.675419; BRANDNER S, 1990, J NEUROSCI, V10, P50; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Cetas JS, 1999, BRAIN RES, V830, P203, DOI 10.1016/S0006-8993(99)01355-4; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; CLAREY JC, 1994, MAMMALIAN AUDITORY P, P232; Cotillon N, 2000, HEARING RES, V142, P113, DOI 10.1016/S0378-5955(00)00016-2; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DEVENECIA RK, 1994, DEV BRAIN RES, V81, P135, DOI 10.1016/0165-3806(94)90077-9; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; EGGERMONT JJ, 1992, HEARING RES, V61, P1, DOI 10.1016/0378-5955(92)90029-M; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1988, J NEUROSCI, V8, P1172; Fishman YI, 1998, BRAIN RES, V786, P18, DOI 10.1016/S0006-8993(97)01423-6; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Johnson MJ, 1996, J NEUROPHYSIOL, V75, P1444, DOI 10.1152/jn.1996.75.4.1444; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; KYRIAZI HT, 1993, J NEUROSCI, V13, P1601; Langner G, 1997, J COMP PHYSIOL A, V181, P665, DOI 10.1007/s003590050148; LEVICK WR, 1972, INVEST OPHTH VISUAL, V11, P302; LEWICKI MS, 1994, NEURAL COMPUT, V6, P1005, DOI 10.1162/neco.1994.6.5.1005; MIDDLEBROOKS JC, 1983, J NEUROSCI, V3, P203; Miller LM, 2000, J NEUROSCI, V20, P7011, DOI 10.1523/JNEUROSCI.20-18-07011.2000; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Nicolelis MAL, 1998, REV NEUROSCIENCE, V9, P213; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Rajan R, 1998, AUDIOL NEURO-OTOL, V3, P123, DOI 10.1159/000013786; RECANZONE GH, 1993, J NEUROSCI, V13, P87; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Scharf B., 1970, F MODERN AUDITORY TH, V1, P159; Schreiner C.E., 1994, AUDIT NEUROSCI, V1, P39; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Schreiner CE, 1997, NATURE, V388, P383, DOI 10.1038/41106; SCHROEDER CE, 1995, J NEUROPHYSIOL, V74, P722, DOI 10.1152/jn.1995.74.2.722; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; Worgotter F, 2000, TRENDS NEUROSCI, V23, P497, DOI 10.1016/S0166-2236(00)01632-5; Zhang YF, 1997, J NEUROPHYSIOL, V78, P3489, DOI 10.1152/jn.1997.78.6.3489	56	169	172	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					151	160		10.1016/S0896-6273(01)00445-7	http://dx.doi.org/10.1016/S0896-6273(01)00445-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604146	Bronze			2022-12-28	WOS:000171525200016
J	La Spada, AR; Fu, YH; Sopher, BL; Libby, RT; Wang, XJ; Li, LY; Einum, DD; Huang, J; Possin, DE; Smith, AC; Martinez, RA; Koszdin, KL; Treuting, PM; Ware, CB; Hurley, JB; Ptacek, LJ; Chen, SM				La Spada, AR; Fu, YH; Sopher, BL; Libby, RT; Wang, XJ; Li, LY; Einum, DD; Huang, J; Possin, DE; Smith, AC; Martinez, RA; Koszdin, KL; Treuting, PM; Ware, CB; Hurley, JB; Ptacek, LJ; Chen, SM			Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7	NEURON			English	Article							DOMINANT CEREBELLAR-ATAXIA; TRANSCRIPTION FACTOR NRL; NUCLEAR-LOCALIZATION; TRANSGENIC MICE; HOMEOBOX GENE; RETINAL DEGENERATION; HUNTINGTONS-DISEASE; LEUCINE-ZIPPER; PROTEIN; PHOTORECEPTOR	Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant disorder caused by a CAG repeat expansion. To determine the mechanism of neurotoxicity, we produced transgenic mice and observed a cone-rod dystrophy. Nuclear inclusions were present, suggesting that the disease pathway involves the nucleus. When yeast two-hybrid assays indicated that cone-rod homeobox protein (CRX) interacts with ataxin-7, we performed further studies to assess this interaction. We found that ataxin-7 and CRX colocalize and coimmunoprecipitate. We observed that polyglutamine-expanded ataxin-7 can dramatically suppress CRX transactivation. In SCA7 transgenic mice, electrophoretic mobility shift assays indicated reduced CRX binding activity, while RT-PCR analysis detected reductions in CRX-regulated genes. Our results suggest that CRX transcription interference accounts for the retinal degeneration in SCA7 and thus may provide an explanation for how cell-type specificity is achieved in this polyglutamine repeat disease.	Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Comparat Med, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Utah, Dept Anat & Neurobiol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Washington, Med Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	La Spada, AR (corresponding author), Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA.		Alcaraz, Raul/L-7592-2014; La Spada, Albert/AAG-8809-2020; Treuting, Piper M./AAB-2721-2019	Alcaraz, Raul/0000-0002-0942-3638; Treuting, Piper M./0000-0002-1812-1519	NATIONAL EYE INSTITUTE [P30EY002687, R01EY012543, P30EY001730] Funding Source: NIH RePORTER; NEI NIH HHS [EY06641, EY12543, R01 EY012543, EY01730, EY02687] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Chen SM, 1996, J BIOL CHEM, V271, P28549, DOI 10.1074/jbc.271.45.28549; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Ferrigno P, 2000, NEURON, V26, P9, DOI 10.1016/S0896-6273(00)81132-0; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Kaytor MD, 1999, HUM MOL GENET, V8, P1657, DOI 10.1093/hmg/8.9.1657; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Lindenberg KS, 2000, BRAIN PATHOL, V10, P385; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; Mauger C, 1999, MOL BRAIN RES, V74, P35, DOI 10.1016/S0169-328X(99)00256-9; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Moore D.D., 1987, CURRENT PROTOCOLS MO; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; SIEBERT PD, 1992, NATURE, V359, P557, DOI 10.1038/359557a0; SOPHER BL, 1992, J BIOL CHEM, V267, P6178; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; TO KW, 1993, OPHTHALMOLOGY, V100, P15; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Yvert G, 2000, HUM MOL GENET, V9, P2491, DOI 10.1093/hmg/9.17.2491; Zack DJ, 2000, NEURON, V26, P285, DOI 10.1016/S0896-6273(00)81160-5; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	46	175	179	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					913	927		10.1016/S0896-6273(01)00422-6	http://dx.doi.org/10.1016/S0896-6273(01)00422-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580893	Bronze			2022-12-28	WOS:000171281300008
J	Li, JYH; Lao, ZM; Joyner, AL				Li, JYH; Lao, ZM; Joyner, AL			Changing requirements for gbx2 in development of the cerebellum and maintenance of the mid/hindbrain organizer	NEURON			English	Article							MOUSE OTX2; ANTERIOR NEUROECTODERM; EXPRESSION; FGF8; GENE; SPECIFICATION; HINDBRAIN; MIDBRAIN; REGIONS; MESODERM	We examined whether Gbx2 is required after embryonic day 9 (E9) to repress Otx2 in the cerebellar anlage and position the midbrain/hindbrain organizer. In contrast to Gbx2 null mutants, mice lacking Gbx2 in rhombomere 1 (r1) after E9 (Gbx2-CKO) are viable and develop a cerebellum. A Gbx2-independent pathway can repress Otx2 in r1 after E9. Mid/hindbrain organizer gene expression, however, continues to be dependent on Gbx2. We found that Fgf8 expression normally correlates with the isthmus where cells undergo low proliferation and that in Gbx2-CKO mutants this domain is expanded. We propose that Fgf8 permits lateral cerebellar development through repression of Otx2 and also suppresses medial cerebellar growth in Gbx2-CKO embryos. Our work has uncovered distinct requirements for Gbx2 during cerebellum formation and provided a model for how a transcription factor can play multiple roles during development.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University	Joyner, AL (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 540 1st Ave, New York, NY 10016 USA.	joyner@saturn.med.nyu.edu; joyner@saturn.med.nyu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS041702] Funding Source: NIH RePORTER; NINDS NIH HHS [F32 NS041702-02, F32 NS041702] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; ALTMAN J, 1997, DEV CERBELLAR SYSTEM; ANG SL, 1994, DEVELOPMENT, V120, P2979; Ang SL, 1996, DEVELOPMENT, V122, P243; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; BOUILLET P, 1995, DEV DYNAM, V204, P372, DOI 10.1002/aja.1002040404; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Castanon I, 2001, DEVELOPMENT, V128, P3145; Chapman G, 1997, GENOMICS, V46, P223, DOI 10.1006/geno.1997.4969; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Donoghue MJ, 1996, MOL CELL NEUROSCI, V8, P185, DOI 10.1006/mcne.1996.0056; Flenniken AM, 1996, DEV BIOL, V179, P382, DOI 10.1006/dbio.1996.0269; Garda AL, 2001, MECH DEVELOP, V101, P111, DOI 10.1016/S0925-4773(00)00567-0; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hogan B, 1994, MANIPULATING MOUSE E; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; Katahira T, 2000, MECH DEVELOP, V91, P43, DOI 10.1016/S0925-4773(99)00262-2; Kimmel RA, 2000, GENE DEV, V14, P1377; Li JYH, 2001, DEVELOPMENT, V128, P4979; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Liu AM, 1999, DEVELOPMENT, V126, P4827; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; Martinez S, 1999, DEVELOPMENT, V126, P1189; Martinez-Barbera JP, 2001, DEVELOPMENT, V128, P4789; Matise MP, 2000, PRACT APPROACH SER, V212, P101; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; Millett S, 1999, NATURE, V401, P161, DOI 10.1038/43664; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; PARR BA, 1993, DEVELOPMENT, V119, P247; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sato T, 2001, DEVELOPMENT, V128, P2461; Shamim H, 1999, DEVELOPMENT, V126, P945; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sugiyama S, 2000, DEV BIOL, V221, P168, DOI 10.1006/dbio.2000.9643; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761	41	101	101	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					31	43		10.1016/S0896-6273(02)00935-2	http://dx.doi.org/10.1016/S0896-6273(02)00935-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367504	Bronze			2022-12-28	WOS:000178295100005
J	Hebert, JM; Mishina, Y; McConnell, SK				Hebert, JM; Mishina, Y; McConnell, SK			BMP signaling is required locally to pattern the dorsal telencephalic midline	NEURON			English	Article							BONE MORPHOGENETIC PROTEINS; CEREBRAL-CORTEX; MOUSE EMBRYOGENESIS; VENTRICULAR ZONE; EXPRESSION; MICE; RECEPTORS; FOREBRAIN; EYE; CRE	BMPs have been proposed to pattern the medial-lateral axis of the telencephalon in a concentration-dependent manner, thus helping to subdivide the embryonic telencephalon into distinct forebrain regions. Using a CRE/1oxP genetic approach, we tested this hypothesis by disrupting the Bmpr1a gene in the telencephalon. In mutants, BMP signaling was compromised throughout the dorsal telencephalon, but only the most dorsalmedial derivative, the choroid plexus, failed to be specified or differentiate. Choroid plexus precursors remained proliferative and did not adopt the fate of their lateral telencephalic neighbors. These results demonstrate that BMP signaling is required for the formation of the most dorsal telencephalic derivative, the choroid plexus, and that BMP signaling plays an essential role in locally patterning the dorsal midline. Our data fall to support a more global, concentration-dependent role in specifying telencephalic cell fates.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; NIEHS, NIH, Res Triangle Pk, NC 27709 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	McConnell, SK (corresponding author), Stanford Univ, Dept Biol Sci, 385 Serra Mall, Stanford, CA 94305 USA.				NIMH NIH HHS [MH51864] Funding Source: Medline; NINDS NIH HHS [NS12151] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051864, R01MH051864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS012151, P01NS012151] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Li WW, 1998, J NEUROSCI, V18, P8853; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; ORourke NA, 1997, DEVELOPMENT, V124, P997; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; Porter FD, 1997, DEVELOPMENT, V124, P2935; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; STURROCK RR, 1979, J ANAT, V129, P777; THOMAS T, 1988, DEV BIOL, V128, P415, DOI 10.1016/0012-1606(88)90303-X; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yi SE, 2000, DEVELOPMENT, V127, P621; ZAKI W, 1981, Z MIKROSK ANAT FORSC, V95, P919; Zhang HB, 1996, DEVELOPMENT, V122, P2977	37	195	202	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1029	1041		10.1016/S0896-6273(02)00900-5	http://dx.doi.org/10.1016/S0896-6273(02)00900-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354394	Bronze			2022-12-28	WOS:000178040000005
J	Ranganathan, R; Buck, LB				Ranganathan, R; Buck, LB			Olfactory axon pathfinding: Who is the pied piper?	NEURON			English	Editorial Material							ZONAL ORGANIZATION; SENSORY MAP; EXPRESSION; TRANSGENE	Mammalian olfactory sensory neurons that express a particular odorant receptor (OR) project axons to the same few glomeruli in the olfactory bulb. In this issue of Neuron, Vassalli et al. (2002) use OR minigenes that coexpress histochemical markers and show that the determinants in the sensory neurons required to generate the stereotyped olfactory bulb map are the same as those needed for appropriate expression of the OR.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Ranganathan, R (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.							Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Ebrahimi FAW, 2000, DEV DYNAM, V217, P225, DOI 10.1002/(SICI)1097-0177(200002)217:2<225::AID-DVDY9>3.0.CO;2-3; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2000, PHILOS T R SOC B, V355, P1801, DOI 10.1098/rstb.2000.0736; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang SS, 1997, J NEUROSCI, V17, P4149; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	12	4	4	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					599	600		10.1016/S0896-6273(02)00831-0	http://dx.doi.org/10.1016/S0896-6273(02)00831-0			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194860	Bronze			2022-12-28	WOS:000177521000001
J	Ostroff, LE; Fiala, JC; Allwardt, B; Harris, KM				Ostroff, LE; Fiala, JC; Allwardt, B; Harris, KM			Polyribosomes redistribute from dendritic shafts into spines with enlarged synapses during LTP in developing rat hippocampal slices	NEURON			English	Article							LONG-TERM POTENTIATION; LOCAL PROTEIN-SYNTHESIS; SYNAPTIC ACTIVATION CAUSES; MESSENGER-RNA; DENTATE GYRUS; AREA CA1; POSTSYNAPTIC SITES; GRANULE CELLS; LATE-PHASE; KINASE-II	The presence of polyribosomes in dendritic spines suggests a potential involvement of local protein synthesis in the modification of synapses. Dendritic spine and synapse ultrastructure were compared after low-frequency control or tetanic stimulation in hippocampal slices from postnatal day (P)15 rats. The percentage of spines containing polyribosomes increased from 12% +/- 4% after control stimulation to 39% +/- 4% after tetanic stimulation, with a commensurate loss of polyribosomes from dendritic shafts at 2 hr posttetanus. Postsynaptic densities on spines containing polyribosomes were larger after tetanic stimulation. Local protein synthesis might therefore serve to stabilize stimulation-induced growth of the postsynaptic density. Furthermore, coincident polyribosomes and synapse enlargement might indicate spines that are expressing long-term potentiation induced by tetanic stimulation.	Boston Univ, Dept Biol, Program Neurosci, Boston, MA 02215 USA	Boston University	Harris, KM (corresponding author), Boston Univ, Dept Biol, Program Neurosci, 5 Cummington St, Boston, MA 02215 USA.			Ostroff, Linnaea/0000-0002-3348-342X; Harris, Kristen/0000-0002-1943-4744	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033574] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 57351] Funding Source: Medline; NINDS NIH HHS [NS 33574] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DESMOND NL, 1990, SYNAPSE, V5, P139, DOI 10.1002/syn.890050208; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, NAT NEUROSCI, V5, P297, DOI 10.1038/nn830; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; Fiala JC, 2001, J AM MED INFORM ASSN, V8, P1; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1982, J NEUROCYTOL, V11, P183, DOI 10.1007/BF01258243; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Greenberg ME, 2001, SYNAPSES, P357; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; JACKSON PS, 1993, J NEUROPHYSIOL, V70, P1412, DOI 10.1152/jn.1993.70.4.1412; JENSEN FE, 1989, J NEUROSCI METH, V29, P217, DOI 10.1016/0165-0270(89)90146-5; Job C, 2001, P NATL ACAD SCI USA, V98, P13037, DOI 10.1073/pnas.231485698; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kirov SA, 1999, J NEUROSCI, V19, P2876; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; LEE KS, 1980, J NEUROPHYSIOL, V44, P247, DOI 10.1152/jn.1980.44.2.247; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Luscher C, 2001, TRENDS NEUROSCI, V24, P665, DOI 10.1016/S0166-2236(00)01959-7; MACKLER SA, 1992, NEURON, V9, P539, DOI 10.1016/0896-6273(92)90191-F; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Ouyang Y, 1999, J NEUROSCI, V19, P7823; RAO A, 1991, J NEUROSCI, V11, P2881; Roberts LA, 1998, MOL BRAIN RES, V56, P38, DOI 10.1016/S0169-328X(98)00026-6; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sorra KE, 1998, J NEUROSCI, V18, P658; STEWARD O, 1988, J NEUROSCI, V8, P176; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1999, J NEUROSCI, V19, P7834; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1983, COLD SPRING HARB SYM, V48, P745, DOI 10.1101/SQB.1983.048.01.077; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; TEYLER TJ, 1985, NEUROSCI BIOBEHAV RE, V9, P337; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; TORRE ER, 1992, J NEUROSCI, V12, P762; VANHARREVELD A, 1975, EXP NEUROL, V49, P736, DOI 10.1016/0014-4886(75)90055-2; WEILER I J, 1991, Molecular and Cellular Neuroscience, V2, P305, DOI 10.1016/1044-7431(91)90060-2; Wells DG, 2000, CURR OPIN NEUROBIOL, V10, P132, DOI 10.1016/S0959-4388(99)00050-1; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	66	323	329	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					535	545		10.1016/S0896-6273(02)00785-7	http://dx.doi.org/10.1016/S0896-6273(02)00785-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165474	Bronze			2022-12-28	WOS:000177331200013
J	Carey, MR; Lisberger, SG				Carey, MR; Lisberger, SG			Embarrassed, but not depressed: Eye opening lessons for cerebellar learning	NEURON			English	Review							VESTIBULOOCULAR REFLEX; PLASTICITY		Univ Calif San Francisco, Grad Program Neurosci, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Carey, MR (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA.			Carey, Megan/0000-0002-4499-1657				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Bao SW, 2002, P NATL ACAD SCI USA, V99, P1592, DOI 10.1073/pnas.032655399; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Kim JJ, 1998, SCIENCE, V279, P570, DOI 10.1126/science.279.5350.570; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; Raymond JL, 1998, J NEUROSCI, V18, P9112; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	18	39	40	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					223	226		10.1016/S0896-6273(02)00771-7	http://dx.doi.org/10.1016/S0896-6273(02)00771-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160741	Bronze			2022-12-28	WOS:000177034200003
J	Markus, A; Zhong, J; Snider, WD				Markus, A; Zhong, J; Snider, WD			Raf and akt mediate distinct aspects of sensory axon growth	NEURON			English	Article							BAX-DEFICIENT MICE; PROTEIN-KINASE-B; NERVE GROWTH; PC12 CELLS; SYMPATHETIC NEURONS; NEURITE OUTGROWTH; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; SURVIVAL SIGNALS	Nerve growth factor (NGF) induces dramatic axon growth from responsive embryonic peripheral neurons. However, the roles of the various NGF-triggered signaling cascades in determining specific axon morphological features remain unknown. Here, we transfected activated and inhibitory mutants of Trk effectors into sensory neurons lacking the proapoptotic protein Bax. This allowed axon growth to be studied in the absence of NGF, enabling us to observe the contributions of individual signaling mediators. While Ras was both necessary and sufficient for NGF-stimulated axon growth, the Ras effectors Raf and Akt induced distinct morphologies. Activated Raf-1 caused axon lengthening comparable to NGF, while active Akt increased axon caliber and branching. Our results suggest that the different Trk effector pathways mediate distinct morphological aspects of developing neurons.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Snider, WD (corresponding author), Univ N Carolina, Ctr Neurosci, 103 Mason Farm Rd, Chapel Hill, NC 27599 USA.	wsnider@med.unc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031768] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS31768] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bang OS, 2001, J CELL SCI, V114, P81; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; BORASIO GD, 1989, NEURON, V2, P1087; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; CLEVELAND DW, 1991, CELL, V67, P453, DOI 10.1016/0092-8674(91)90518-4; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Edsjo A, 2001, CELL GROWTH DIFFER, V12, P39; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; GOLD BG, 1991, J NEUROSCI, V11, P943; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hilton M, 1997, CURR BIOL, V7, P798, DOI 10.1016/S0960-9822(06)00339-3; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jackson TR, 1996, J CELL SCI, V109, P289; Jaiswal RK, 1996, J BIOL CHEM, V271, P23626, DOI 10.1074/jbc.271.39.23626; JAISWAL RK, 1994, MOL CELL BIOL, V14, P6944, DOI 10.1128/MCB.14.10.6944; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Klesse LJ, 1998, J NEUROSCI, V18, P10420; Klinz FJ, 1996, J NEUROSCI RES, V46, P720, DOI 10.1002/(SICI)1097-4547(19961215)46:6<720::AID-JNR8>3.0.CO;2-H; Klippel A, 1996, MOL CELL BIOL, V16, P4117; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Korhonen JM, 1999, J BIOL CHEM, V274, P37307, DOI 10.1074/jbc.274.52.37307; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Lentz SI, 1999, J NEUROSCI, V19, P1038; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Markus A, 1997, DEV BIOL, V191, P306, DOI 10.1006/dbio.1997.8771; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Munson JB, 1997, J NEUROSCI, V17, P470, DOI 10.1523/JNEUROSCI.17-01-00470.1997; Munson JB, 1997, EUR J NEUROSCI, V9, P1126, DOI 10.1111/j.1460-9568.1997.tb01465.x; Namikawa K, 2000, J NEUROSCI, V20, P2875; NOBES CD, 1995, EUR J NEUROSCI, V7, P344, DOI 10.1111/j.1460-9568.1995.tb01069.x; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Pearson G, 2000, J BIOL CHEM, V275, P37303, DOI 10.1074/jbc.C000570200; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; Tsui-Pierchala BA, 2000, J NEUROSCI, V20, P7228; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Ulupinar E, 2000, J COMP NEUROL, V425, P202, DOI 10.1002/1096-9861(20000918)425:2<202::AID-CNE4>3.0.CO;2-T; White FA, 1998, J NEUROSCI, V18, P1428; Wiese S, 2001, NAT NEUROSCI, V4, P137, DOI 10.1038/83960; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	80	266	277	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					65	76		10.1016/S0896-6273(02)00752-3	http://dx.doi.org/10.1016/S0896-6273(02)00752-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123609	Bronze, Green Published			2022-12-28	WOS:000176601800011
J	Walker, HC; Lawrence, JJ; McBain, CJ				Walker, HC; Lawrence, JJ; McBain, CJ			Activation of kinetically distinct synaptic conductances on inhibitory interneurons by electrotonically overlapping afferents	NEURON			English	Article							TARGET-SPECIFIC EXPRESSION; PYRAMIDAL CELLS; GLUTAMATE RECEPTORS; SUBUNIT COMPOSITION; NMDA RECEPTORS; AMPA RECEPTORS; MOSSY FIBERS; TIME-COURSE; TRANSMISSION; NEURONS	Mossy fiber (MF) and CA3 collateral (CL) axons activate common interneurons via synapses comprised of different AMPA receptors to provide feedforward and feedback inhibitory control of the CA3 hippocampal network. Because synapses potentially occur over variable electrotonic distances that distort somatically recorded synaptic currents, it is not known whether the underlying afferent-specific synaptic conductances are associated with different time courses. Using a somatic voltage jump technique to alter the driving force at the site of the synapse, we demonstrate that MF and CL synapses overlap in electrotonic location yet differ in conductance time course. Thus, afferent-specific conductance time courses allow single interneurons to differentially integrate feedforward and feedback information without the need to segregate distinct AMPA receptor subunits to different electrotonic domains.	NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	McBain, CJ (corresponding author), NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA.	mcbainc@mail.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Banks MI, 2000, J NEUROSCI, V20, P937, DOI 10.1523/JNEUROSCI.20-03-00937.2000; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; Brenowitz S, 2001, J NEUROSCI, V21, P1857, DOI 10.1523/JNEUROSCI.21-06-01857.2001; CLAIBORNE BJ, 1993, HIPPOCAMPUS, V3, P115, DOI 10.1002/hipo.450030202; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Dingledine R, 1999, PHARMACOL REV, V51, P7; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Fuchs EC, 2001, P NATL ACAD SCI USA, V98, P3571, DOI 10.1073/pnas.051631898; Gardner SM, 2001, J NEUROSCI, V21, P7428, DOI 10.1523/JNEUROSCI.21-18-07428.2001; Geiger JRP, 1999, HANDB EXP PHARM, V141, P363; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; Hausser M, 1997, J NEUROSCI, V17, P7606; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; HERLITZE S, 1993, NEURON, V10, P1131, DOI 10.1016/0896-6273(93)90061-U; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kapur A, 1998, J NEUROPHYSIOL, V79, P2181, DOI 10.1152/jn.1998.79.4.2181; Kumar SS, 2001, J NEUROPHYSIOL, V86, P2973, DOI 10.1152/jn.2001.86.6.2973; Lawrence JJ, 2000, J NEUROSCI, V20, P4864; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; MANZONI OJ, 1995, NEUROPHARMACOLOGY, V34, P965, DOI 10.1016/0028-3908(95)00060-J; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Monyer H, 1999, HANDB EXP PHARM, V141, P309; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Silver R. A., 1999, DENDRITES, P114; Spruston N, 1997, J COMP NEUROL, V385, P427; STUART G, 1995, CURR OPIN NEUROBIOL, V5, P389, DOI 10.1016/0959-4388(95)80053-0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Tovar KR, 1999, J NEUROSCI, V19, P4180; Trussell L, 1998, PROG BRAIN RES, V116, P59, DOI 10.1016/S0079-6123(08)60430-6; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346	50	34	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					161	171		10.1016/S0896-6273(02)00734-1	http://dx.doi.org/10.1016/S0896-6273(02)00734-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123616	Bronze			2022-12-28	WOS:000176601800018
J	Attwell, PJE; Cooke, SF; Yeo, CH				Attwell, PJE; Cooke, SF; Yeo, CH			Cerebellar function in consolidation of a motor memory	NEURON			English	Article							NICTITATING-MEMBRANE RESPONSE; CONDITIONED EYELID RESPONSES; CLIMBING FIBER ACTIVATION; INFERIOR OLIVE; PURKINJE-CELLS; MOSSY FIBER; REVERSIBLE INACTIVATIONS; LOBULE HVI; RABBIT; ACQUISITION	Several forms of motor learning, including classical conditioning of the eyeblink and nictitating membrane response (NMR), are dependent upon the cerebellum, but it is not known how motor memories are stored within the cerebellar circuitry. Localized infusions of the GABA(A) agonist muscimol were used to target putative consolidation processes by producing reversible inactivations after NMR conditioning sessions. Post-training inactivations of eyeblink control regions in cerebellar cortical lobule HVI completely prevented conditioning from developing over four sessions. In contrast, similar inactivations of eyeblink control regions in the cerebellar nuclei allowed conditioning to develop normally. These findings provide evidence that there are critical posttraining memory consolidation processes for eyeblink conditioning mediated by the cerebellar cortex.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London	Yeo, CH (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	c.yeo@ucl.ac.uk		cooke, samuel/0000-0002-4876-6502				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ANDERSSON G, 1987, EXP BRAIN RES, V67, P533; ANDERSSON G, 1988, EXP BRAIN RES, V72, P450; ANDERSSON G, 1987, EXP BRAIN RES, V67, P523; Attwell PJE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0003.1999; Attwell PJE, 2001, J NEUROSCI, V21, P5715, DOI 10.1523/JNEUROSCI.21-15-05715.2001; Bao SW, 2002, P NATL ACAD SCI USA, V99, P1592, DOI 10.1073/pnas.032655399; BENEDETTI F, 1983, J PHYSIOL-LONDON, V340, P195, DOI 10.1113/jphysiol.1983.sp014758; Bracha V, 1998, BRAIN RES, V788, P169, DOI 10.1016/S0006-8993(97)01535-7; BRIONI JD, 1989, BRAIN RES, V487, P105, DOI 10.1016/0006-8993(89)90945-1; COLIN F, 1980, BRAIN RES, V187, P3, DOI 10.1016/0006-8993(80)90491-6; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; Garcia KS, 1998, NEUROPHARMACOLOGY, V37, P471, DOI 10.1016/S0028-3908(98)00055-0; GILBERT P, 1975, NATURE, V254, P688, DOI 10.1038/254688a0; GORMEZANO I, 1962, SCIENCE, V138, P33, DOI 10.1126/science.138.3536.33; GRUART A, 1995, EXP BRAIN RES, V104, P431; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hardiman MJ, 1996, EXP BRAIN RES, V110, P235; HARDIMAN MJ, 1992, EUR J NEUROSCI, V4, P966, DOI 10.1111/j.1460-9568.1992.tb00123.x; HERNANDEZ LL, 1983, BEHAV NEUROSCI, V97, P478, DOI 10.1037/0735-7044.97.3.478; Hesslow G, 1999, NEURON, V24, P179, DOI 10.1016/S0896-6273(00)80831-4; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; IZQUIERDO I, 1990, BEHAV NEURAL BIOL, V54, P105, DOI 10.1016/0163-1047(90)91282-G; JOMTELL H, 2002, NEURON, V34, P797; KEHOE EJ, 1974, B PSYCHONOMIC SOC, V4, P434, DOI 10.3758/BF03336746; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; KRUPA DJ, 1995, P NATL ACAD SCI USA, V92, P5097, DOI 10.1073/pnas.92.11.5097; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; Lisberger SG, 1998, CELL, V92, P701, DOI 10.1016/S0092-8674(00)81397-5; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MATTHIES H, 1989, PROG NEUROBIOL, V32, P277, DOI 10.1016/0301-0082(89)90024-5; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MCCORMICK DA, 1985, BRAIN RES, V359, P120, DOI 10.1016/0006-8993(85)91419-2; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 1999, J NEUROSCI, V19, P7140, DOI 10.1523/JNEUROSCI.19-16-07140.1999; MONTAROLO PG, 1982, J PHYSIOL-LONDON, V332, P187, DOI 10.1113/jphysiol.1982.sp014409; PERRETT SP, 1995, J NEUROSCI, V15, P2074, DOI 10.1523/JNEUROSCI.15-03-02074.1995; Ramnani N, 1996, J PHYSIOL-LONDON, V495, P159, DOI 10.1113/jphysiol.1996.sp021581; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; SCAVIO MJ, 1992, BEHAV NEUROSCI, V106, P900, DOI 10.1037/0735-7044.106.6.900; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Vazdarjanova A, 1999, J NEUROSCI, V19, P6615; Welsh JP, 1998, EUR J NEUROSCI, V10, P3321, DOI 10.1046/j.1460-9568.1998.00400.x; YEO CH, 1985, EXP BRAIN RES, V60, P114, DOI 10.1007/BF00237024; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4; YEO CH, 1992, EXP BRAIN RES, V88, P623; YEO CH, 1985, EXP BRAIN RES, V60, P87, DOI 10.1007/BF00237022; YEO CH, 1985, EXP BRAIN RES, V60, P99, DOI 10.1007/BF00237023; Yeo CH, 1997, LEARN MEMORY, V3, P557, DOI 10.1101/lm.3.6.557; YEO CH, 1986, EXP BRAIN RES, V63, P81	54	115	117	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					1011	1020		10.1016/S0896-6273(02)00719-5	http://dx.doi.org/10.1016/S0896-6273(02)00719-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086647	Bronze			2022-12-28	WOS:000176249700017
J	Gao, FB				Gao, FB			Understanding fragile X syndrome: Insights from retarded flies	NEURON			English	Review							MENTAL-RETARDATION PROTEIN; MESSENGER-RNAS; DROSOPHILA; BINDING; HOMOLOG; FUTSCH; BRAIN; FMR1; GENE	Fragile X syndrome, the most common form of inherited mental retardation, is caused by loss-of-function mutations in the fragile X mental retardation 1 (fmr1) gene. FMR1 is an RNA binding protein that is highly expressed in neurons of the central nervous system. Recent studies in Drosophila indicate that FMR1 plays an important role in synaptogenesis and axonal arborization, which may underlie the observed deficits in flight ability and circadian behavior of fmr1 mutant flies. The relevance of these studies to our understanding of fragile X syndrome is discussed.	Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gao, FB (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA.							ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; HAGERMAN RJ, 1996, FRAGILE X SYNDROME D, P3; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SWEENEY NT, 2002, IN PRESS DEV BIOL; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; 1994, DUTCH BELGIAN FRAGIL, V78, P23	20	33	36	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					859	862		10.1016/S0896-6273(02)00740-7	http://dx.doi.org/10.1016/S0896-6273(02)00740-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086633	Bronze			2022-12-28	WOS:000176249700004
J	Delmas, P; Wanaverbecq, N; Abogadie, FC; Mistry, M; Brown, DA				Delmas, P; Wanaverbecq, N; Abogadie, FC; Mistry, M; Brown, DA			Signaling microdomains define the specificity of receptor-mediated InsP(3) pathways in neurons	NEURON			English	Article							RAT SYMPATHETIC NEURONS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; INTRACELLULAR CA2+ STORES; M-CURRENT INHIBITION; PROTEIN-KINASE-C; MUSCARINIC INHIBITION; PHOSPHOLIPASE-C; POTENTIAL TRP; CALCIUM-ENTRY; CHANNELS	M-1 muscarinic (M(1)AChRs) and B-2 bradykinin (B(2)Rs) receptors are two PLCbeta-coupled receptors that mobilize Ca2+ in nonexcitable cells. In many neurons, however, B(2)Rs but not M(1)AChRs mobilize intracellular Ca2+. We have studied the membrane organization and dynamics underlying this coupling specificity by using Trp channels as biosensors for real-time detection of PLCbeta products. We found that, in sympathetic neurons, although both receptors rapidly produced DAG and InsP(3) as messengers, only InsP(3) formed by B(2)Rs has the ability to activate IP(3)Rs. This exclusive coupling results from spatially restricted complexes linking B(2)Rs to IP(3)Rs, a missing partnership for M(1)AChRs. These complexes allow fast and localized rises of InsP(3), necessary to activate the low-affinity neuronal IP3R. Thus, these signaling microdomains are of critical importance for the induction of selective responses, discriminating proinflammatory information associated with B(2)Rs from cholinergic neurotransmission.	UCL, Dept Pharmacol, Wellcome Lab Mol Pharmacol, London WC1E 6BT, England; CNRS, F-13402 Marseille, France	University of London; University College London; Centre National de la Recherche Scientifique (CNRS)	Delmas, P (corresponding author), UCL, Dept Pharmacol, Wellcome Lab Mol Pharmacol, Gower St, London WC1E 6BT, England.	delmas@irlnb.cnrs-mrs.fr	Brown, David A/J-9019-2012	Wanaverbecq, Nicolas/0000-0001-5486-2771				BERHNEIM L, 1992, P NATL ACAD SCI USA, V89, P9544; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; BOURGUIGNON LYW, 1993, CELL BIOL INT, V17, P751, DOI 10.1006/cbir.1993.1136; Brown DA, 1997, LIFE SCI, V60, P1137, DOI 10.1016/S0024-3205(97)00058-1; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Delmas P, 1999, J PHYSIOL-LONDON, V518, P23, DOI 10.1111/j.1469-7793.1999.0023r.x; Delmas P, 2000, NAT NEUROSCI, V3, P670, DOI 10.1038/76621; Delmas P, 1998, EUR J NEUROSCI, V10, P1654, DOI 10.1046/j.1460-9568.1998.00170.x; Delmas P, 1998, J PHYSIOL-LONDON, V506, P319, DOI 10.1111/j.1469-7793.1998.319bw.x; Dray A, 1997, CAN J PHYSIOL PHARM, V75, P704, DOI 10.1139/cjpp-75-6-704; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Fink CC, 2000, BIOPHYS J, V79, P163, DOI 10.1016/S0006-3495(00)76281-3; FUKUDA K, 1988, NATURE, V335, P355, DOI 10.1038/335355a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haley JE, 2000, J NEUROSCI, V20, P3973; Haley JE, 1998, J NEUROSCI, V18, P4521; HALEY JE, 2000, J NEUROSCI, V20, P1; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; JONES S, 1995, NEURON, V14, P399, DOI 10.1016/0896-6273(95)90295-3; KHODAKHAH K, 1993, P NATL ACAD SCI USA, V90, P4976, DOI 10.1073/pnas.90.11.4976; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; MARRION NV, 1989, BRIT J PHARMACOL, V98, P557, DOI 10.1111/j.1476-5381.1989.tb12630.x; MARSH SJ, 1995, NEURON, V15, P729, DOI 10.1016/0896-6273(95)90160-4; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Putney JW, 1999, P NATL ACAD SCI USA, V96, P14669, DOI 10.1073/pnas.96.26.14669; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; ROBBINS J, 1993, J PHYSIOL-LONDON, V469, P153, DOI 10.1113/jphysiol.1993.sp019809; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; ROSSIER MF, 1991, BIOCHEM J, V274, P643, DOI 10.1042/bj2740643; Sakmann B., 1995, SINGLE CHANNEL RECOR; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	52	222	228	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					209	220		10.1016/S0896-6273(02)00641-4	http://dx.doi.org/10.1016/S0896-6273(02)00641-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970863	Bronze			2022-12-28	WOS:000174976200007
J	Veruki, ML; Hartveit, E				Veruki, ML; Hartveit, E			All (rod) amacrine cells form a network of electrically coupled Interneurons in the mammalian retina	NEURON			English	Article							SLICE PREPARATION; NEURONS; CURRENTS; PATHWAYS; SYNAPSES; AII	All (rod) amacrine cells in the mammalian retina are reciprocally connected via gap junctions, but there is no physiological evidence that demonstrates a proposed function as electrical synapses. In whole-cell recordings from pairs of All amacrine cells in a slice preparation of the rat retina, bidirectional, nonrectifying electrical coupling was observed in all pairs with overlapping dendritic trees (average conductance similar to700 pS). Coupling displayed characteristics of a low-pass filter, with no evidence for amplification of spike-evoked electrical postsynaptic potentials by active conductances. Coincidence detection, as well as precise temporal synchronization of subthreshold membrane potential oscillations and TTX-sensitive spiking, was commonly observed. These results indicate a unique mode of operation and integrative capability of the network of All amacrine cells.	Univ Bergen, Dept Anat & Cell Biol, N-5009 Bergen, Norway	University of Bergen	Hartveit, E (corresponding author), Univ Bergen, Dept Anat & Cell Biol, Arstadveien 19, N-5009 Bergen, Norway.			Hartveit, Espen/0000-0003-1798-1901; Veruki, Margaret/0000-0002-0532-144X				Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; BOOS R, 1993, J NEUROSCI, V13, P2874; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Feigenspan A, 2001, J NEUROSCI, V21, P230, DOI 10.1523/JNEUROSCI.21-01-00230.2001; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hartveit E, 1996, J NEUROPHYSIOL, V76, P401, DOI 10.1152/jn.1996.76.1.401; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Loewenstein Y, 2001, P NATL ACAD SCI USA, V98, P8095, DOI 10.1073/pnas.131116898; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mills SL, 2001, J COMP NEUROL, V436, P336; Nolan MF, 1999, J PHYSIOL-LONDON, V519, P753, DOI 10.1111/j.1469-7793.1999.0753n.x; SMITH RG, 1995, VISUAL NEUROSCI, V12, P851, DOI 10.1017/S095252380000941X; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Van Rijen HVM, 1998, PFLUG ARCH EUR J PHY, V436, P141, DOI 10.1007/s004240050615; Vaney DI, 1997, INVEST OPHTH VIS SCI, V38, P267	22	125	127	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					935	946		10.1016/S0896-6273(02)00609-8	http://dx.doi.org/10.1016/S0896-6273(02)00609-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906699	Bronze			2022-12-28	WOS:000174389600010
J	Pillow, J; Rubin, N				Pillow, J; Rubin, N			Perceptual completion across the vertical meridian and the role of early visual cortex	NEURON			English	Article							ILLUSORY CONTOURS; CALLOSAL CONNECTIONS; AREAS V1; DYNAMICS; MONKEY; REPRESENTATION; ORGANIZATION; MECHANISMS; SALIENT; FIELDS	Perceptual completion can link widely separated contour fragments and interpolate illusory contours (ICs) between them. The mechanisms underlying such long-range linking are not well understood. Here we report that completion is much poorer when ICs cross the vertical meridian than when they reside entirely within the left or right visual hemifield. This deficit reflects limitations in cross-hemispheric integration. We also show that the sensitivity to the interhemispheric divide is unique to perceptual completion: a comparable task which did not require completion showed no across-meridian impairment. We propose that these findings support the existence of specialized completion mechanisms in early visual cortical areas (V1/V2), since those areas are likely to be more sensitive to the interhemispheric divide.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Rubin, N (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	nava@cns.nyu.edu	Rubin, Nava/J-5189-2012	Pillow, Jonathan/0000-0002-3638-8831				ANDERSON BL, 1994, NATURE, V367, P365, DOI 10.1038/367365a0; Bakin JS, 2000, J NEUROSCI, V20, P8188; BIEDERMAN I, 1974, J EXP PSYCHOL, V103, P597, DOI 10.1037/h0037158; Blake Randolph, 1995, P17; CLARKE S, 1990, J COMP NEUROL, V298, P188, DOI 10.1002/cne.902980205; Ellis A, 1988, HUMAN COGNITIVE NEUR; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fodor J. A, 1983, MODULARITY MIND; Geiger D, 1998, PROC CVPR IEEE, P118, DOI 10.1109/CVPR.1998.698597; GILBERT CD, 1985, VISION RES, V25, P365, DOI 10.1016/0042-6989(85)90061-6; Gillam B, 1987, PERCEPTION ILLUSORY, P268; Gold JM, 2000, CURR BIOL, V10, P663, DOI 10.1016/S0960-9822(00)00523-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; GROSOF DH, 1993, NATURE, V365, P550, DOI 10.1038/365550a0; GROSS CG, 1977, BRAIN RES, V131, P227, DOI 10.1016/0006-8993(77)90517-0; Grossberg S, 1997, PSYCHOL REV, V104, P618, DOI 10.1037/0033-295X.104.3.618; HEITGER F, 1992, VISION RES, V32, P963, DOI 10.1016/0042-6989(92)90039-L; Innocenti GM., 1986, CEREBRAL CORTEX VOL, P291, DOI [10.1007/978-1-4613-2149-1_9, DOI 10.1007/978-1-4613-2149-1_9]; KANIZSA G, 1976, SCI AM, V234, P48, DOI 10.1038/scientificamerican0476-48; Kanizsa G., 1955, RIV PSICOL, V49, P7; Kellman PJ, 1998, J EXP PSYCHOL HUMAN, V24, P859, DOI 10.1037/0096-1523.24.3.859; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; KENNEDY H, 1986, J COMP NEUROL, V247, P398, DOI 10.1002/cne.902470309; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Mendola JD, 1999, J NEUROSCI, V19, P8560; MINGUZZI GF, 1987, PERCEPTION ILLUSORY, P71; MUMFORD D, 1994, LARGE SCALE NEURONAL, P125; MURRAY MM, 2002, IN PRESS J NEUROSCI; Murray RF, 2001, INVEST OPHTH VIS SCI, V42, pS723; NAKAYAMA K, 1990, VISION RES, V30, P1811, DOI 10.1016/0042-6989(90)90161-D; NEWSOME WT, 1980, J COMP NEUROL, V194, P209, DOI 10.1002/cne.901940111; PETERHANS E, 1989, J NEUROSCI, V9, P1749; PETERSON MA, 1994, CURR DIR PSYCHOL SCI, V3, P105, DOI 10.1111/1467-8721.ep10770552; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; RINGO JL, 1994, CEREB CORTEX, V4, P331, DOI 10.1093/cercor/4.4.331; Rock I., 1987, PERCEPTION ILLUSORY, P62, DOI [10.1007/978-1-4612-4760-9_6, DOI 10.1007/978-1-4612-4760-9_6]; Rubin N, 1996, SCIENCE, V271, P651, DOI 10.1126/science.271.5249.651; Rubin N, 2001, PERCEPTION, V30, P339, DOI 10.1068/p3173; Rubin N, 1997, CURR BIOL, V7, P461, DOI 10.1016/S0960-9822(06)00217-X; Saron CD, 2002, IS CL CO NE, P171; Seghier M, 2000, CEREB CORTEX, V10, P663, DOI 10.1093/cercor/10.7.663; Sugita Y, 1999, NATURE, V401, P269, DOI 10.1038/45785; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; ULLMAN S, 1976, BIOL CYBERN, V25, P1; Ullman S., 1988, P 2 INT C COMP VIS, P321, DOI DOI 10.1109/CCV.1988.590008; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WALLACH H, 1988, PERCEPT PSYCHOPHYS, V43, P101, DOI 10.3758/BF03214186; Williams LR, 1997, NEURAL COMPUT, V9, P837, DOI 10.1162/neco.1997.9.4.837; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; Yen SC, 1998, VISION RES, V38, P719, DOI 10.1016/S0042-6989(97)00197-1	53	73	74	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					805	813		10.1016/S0896-6273(02)00605-0	http://dx.doi.org/10.1016/S0896-6273(02)00605-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	529EC	11879656	Bronze, Green Submitted			2022-12-28	WOS:000174286200015
J	Christensen, M; Estevez, A; Yin, XY; Fox, R; Morrison, R; McDonnell, M; Gleason, C; Miller, DM; Strange, K				Christensen, M; Estevez, A; Yin, XY; Fox, R; Morrison, R; McDonnell, M; Gleason, C; Miller, DM; Strange, K			A primary culture system for functional analysis of C-elegans neurons and muscle cells	NEURON			English	Article							HEAVY-CHAIN ISOFORMS; DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; HOMEODOMAIN PROTEIN; CALCIUM TRANSIENTS; DROSOPHILA; EXPRESSION; UNC-4; MYOSIN	C. elegans has provided important insights into neuromuscular system function and development. However, the animal's small size limits access to individual neurons and muscle cells for physiological, biochemical, and molecular study. We describe here primary culture methods that allow C. elegans embryonic cells to differentiate into neurons and muscle cells in vitro. Morphological, electrophysiological, and GFP reporter studies demonstrate that the differentiation and functional properties of cultured cells are similar to those observed in vivo. Enriched populations of cells expressing specific GFP reporters can be generated by fluorescence-activated cell sorting. Addition of double-stranded RNA to the culture medium induces dramatic knockdown of targeted gene expression. Primary nematode cell culture provides a new foundation for a wide variety of experimental opportunities heretofore unavailable in the field.	Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Strange, K (corresponding author), Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA.	kevin.strange@mcmail.vanderbilt.edu			NCI NIH HHS [CA68485] Funding Source: Medline; NCRR NIH HHS [S10 RR15682] Funding Source: Medline; NICHD NIH HHS [T32 HD007502] Funding Source: Medline; NIDDK NIH HHS [P01 DK58212, R01 DK51610, R21 DK60829, DK20593] Funding Source: Medline; NINDS NIH HHS [R01 NS26511] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P01DK058212, P30DK020593, R21DK060829, R01DK051610] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bloom L., 1993, THESIS MIT CAMBRIDGE; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; BRENNER S, 1974, GENETICS, V77, P71; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; CAMARDO J, 1983, J NEUROSCI, V3, P2614; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Christensen M, 2001, J BIOL CHEM, V276, P45024, DOI 10.1074/jbc.M107652200; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; EPSTEIN HF, 1974, J MOL BIOL, V90, P291, DOI 10.1016/0022-2836(74)90374-X; Fei YJ, 2000, J BIOL CHEM, V275, P9563, DOI 10.1074/jbc.275.13.9563; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GOSSETT LA, 1982, CELL, V30, P193, DOI 10.1016/0092-8674(82)90025-3; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Khatchatouriants A, 2000, BIOPHYS J, V79, P2345, DOI 10.1016/S0006-3495(00)76480-0; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Lockery SR, 1998, METHOD ENZYMOL, V293, P201; MADURO M, 1995, GENETICS, V141, P977; Maduro MF, 2000, J NEUROGENET, V13, P191, DOI 10.3109/01677060009084494; Mellmann A, 2000, J HOSP INFECT, V44, P281, DOI 10.1053/jhin.1999.0704; Mello C, 1995, METHOD CELL BIOL, V48, P451; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; MILLER DM, 1995, DEVELOPMENT, V121, P2877; MILLER DM, 1983, CELL, V34, P477, DOI 10.1016/0092-8674(83)90381-1; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Pflugrad A, 1997, DEVELOPMENT, V124, P1699; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; PRIESS JR, 1987, CELL, V48, P241, DOI 10.1016/0092-8674(87)90427-2; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Schmidt H, 2000, J NEUROBIOL, V44, P392, DOI 10.1002/1097-4695(20000915)44:4<392::AID-NEU3>3.0.CO;2-M; Schnabel R., 1997, C ELEGANS, P361; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Ui-Tei K, 2000, FEBS LETT, V479, P79, DOI 10.1016/S0014-5793(00)01883-4; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winnier AR, 1999, GENE DEV, V13, P2774, DOI 10.1101/gad.13.21.2774; YAMAMOTO N, 1992, NEURON, V9, P217, DOI 10.1016/0896-6273(92)90161-6; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zamore PD, 2001, NAT STRUCT BIOL, V8, P746, DOI 10.1038/nsb0901-746	55	167	174	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 14	2002	33	4					503	514		10.1016/S0896-6273(02)00591-3	http://dx.doi.org/10.1016/S0896-6273(02)00591-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856526	Bronze			2022-12-28	WOS:000173911100005
J	Tao, X; West, AE; Chen, WG; Corfas, G; Greenberg, ME				Tao, X; West, AE; Chen, WG; Corfas, G; Greenberg, ME			A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF	NEURON			English	Article							NEUROTROPHIC FACTOR; DENDRITIC GROWTH; MESSENGER-RNAS; CREB; RECEPTORS; IDENTIFICATION; STIMULATION; REQUIREMENT; PROMOTERS; SURVIVAL	Transcription of the brain-derived neurotrophic factor (BDNF) gene is regulated in a calcium- and neuron-selective manner; however, the mechanisms that underlie this selectivity are not known. We have characterized a new calcium-response element, CaRE1, that is required for activity-de pendent transcription of BDNF exon III and have cloned a transcription factor, CaRF, that activates transcription from BDNF promoter III in a CaRE1-dependent manner. The transcriptional activity of CaRF is regulated in a calcium- and neuron-selective manner, suggesting that CaRF may confer selectivity upon the activity-dependent induction of BDNF exon III expression.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	michael.greenberg@tch.harvard.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473; Chen, Wen/0000-0003-0853-7526	NICHD NIH HHS [HD18655] Funding Source: Medline; NINDS NIH HHS [NS28829-07] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829, R01NS028829] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Cruzalegui FH, 2000, CELL MOL LIFE SCI, V57, P402, DOI 10.1007/PL00000702; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Liang FQ, 1998, NEUROSCI LETT, V242, P89, DOI 10.1016/S0304-3940(98)00062-7; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Ringstedt T, 1998, NEURON, V21, P305, DOI 10.1016/S0896-6273(00)80540-1; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1995, J CELL BIOL, V128, P185, DOI 10.1083/jcb.128.1.185; TIMMUSK T, 1994, NEUROSCIENCE, V60, P287, DOI 10.1016/0306-4522(94)90242-9; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; WANG T, 1995, J NEUROSCI, V15, P4796; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Xia ZG, 1996, J NEUROSCI, V16, P5425; YOUN HD, 1999, SCIENCE, V268, P709; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	39	257	268	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					383	395		10.1016/S0896-6273(01)00561-X	http://dx.doi.org/10.1016/S0896-6273(01)00561-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832226	Bronze			2022-12-28	WOS:000173643200009
J	Morishita, W; Connor, JH; Xia, H; Quinlan, EM; Shenolikar, S; Malenka, RC				Morishita, W; Connor, JH; Xia, H; Quinlan, EM; Shenolikar, S; Malenka, RC			Regulation of synaptic strength by protein phosphatase 1	NEURON			English	Article							LONG-TERM DEPRESSION; VOLTAGE-DEPENDENT POTENTIATION; GLYCOGEN-TARGETING SUBUNIT; D-ASPARTATE RECEPTOR; GLUTAMATE RECEPTORS; CATALYTIC SUBUNIT; SKELETAL-MUSCLE; KINASE-II; DENDRITIC SPINES; AMPA RECEPTORS	We investigated the role of postsynaptic protein phosphatase 1 (PP1) in regulating synaptic strength by loading CA1 pyramidal cells either with peptides that disrupt PP1 binding to synaptic targeting proteins or with active PP1. The peptides blocked synaptically evoked LTD but had no effect on basal synaptic currents mediated by either AMPA or NMDA receptors. They did, however, cause an increase in synaptic strength following the induction of LTD. Similarly, PP1 had no effect on basal synaptic strength but enhanced LTD. In cultured neurons, synaptic activation of NMDA receptors increased the proportion of PP1 localized to synapses. These results suggest that PP1 does not significantly regulate basal synaptic strength. Appropriate NMDA receptor activation, however, allows PP1 to gain access to synaptic substrates and be recruited to synapses where its activity is necessary for sustaining LTD.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Univ Maryland, Dept Biol Neurobiol & Cognit Sci, College Pk, MD 20742 USA	Stanford University; Duke University; University System of Maryland; University of Maryland College Park	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.			Connor, John/0000-0002-8867-7256	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052054] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52054] Funding Source: Medline; NIMH NIH HHS [MH00942] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bear MF, 2001, SYNAPSES, P455; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chung HJ, 2000, J NEUROSCI, V20, P7258; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Connor JH, 2000, J BIOL CHEM, V275, P18670, DOI 10.1074/jbc.M909312199; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; DEGUZMAN A, 1988, METHOD ENZYMOL, V159, P356; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JOHNSON BD, 1994, P NATL ACAD SCI USA, V91, P11492, DOI 10.1073/pnas.91.24.11492; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Liu J, 2000, J BIOL CHEM, V275, P26074, DOI 10.1074/jbc.M003843200; Liu J, 2000, BIOCHEM J, V346, P77, DOI 10.1042/0264-6021:3460077; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; McAvoy T, 1999, BIOCHEMISTRY-US, V38, P12943, DOI 10.1021/bi991227d; Moorhead G, 1998, FEBS LETT, V438, P141, DOI 10.1016/S0014-5793(98)01276-9; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; O'Dell T J, 1994, Learn Mem, V1, P129; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Price NE, 1999, CURR OPIN NEUROBIOL, V9, P336, DOI 10.1016/S0959-4388(99)80049-X; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Terry-Lorenzo RT, 2000, J BIOL CHEM, V275, P2439, DOI 10.1074/jbc.275.4.2439; Thiels E, 1998, NEUROSCIENCE, V86, P1023, DOI 10.1016/S0306-4522(98)00135-3; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516	65	183	189	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1133	1148		10.1016/S0896-6273(01)00554-2	http://dx.doi.org/10.1016/S0896-6273(01)00554-2			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754843	Bronze			2022-12-28	WOS:000172886800018
J	Byrd, DT; Kawasaki, M; Walcoff, M; Hisamoto, N; Matsumoto, K; Jin, YS				Byrd, DT; Kawasaki, M; Walcoff, M; Hisamoto, N; Matsumoto, K; Jin, YS			UNC-16, a JNK-signaling scaffold protein, regulates vesicle transport in C-elegans	NEURON			English	Article							N-TERMINAL KINASE; NEMATODE CAENORHABDITIS-ELEGANS; GLUTAMIC-ACID DECARBOXYLASE; DYNEIN SUPERFAMILY PROTEINS; KINESIN HEAVY-CHAIN; SYNAPTIC TRANSMISSION; AXONAL-TRANSPORT; HOMEODOMAIN PROTEIN; ORGANELLE TRANSPORT; NERVOUS-SYSTEM	Transport of synaptic components is a regulated process. Loss-of-function mutations in the C. elegans unc-16 gene result in the mislocalization of synaptic vesicle and glutamate receptor markers. unc-16 encodes a homolog of mouse JSAP1/JIP3 and Drosophila Sunday Driver. Like JSAP1/JIP3, UNC-16 physically interacts with JNK. and JNK kinases. Deletion mutations in Caenorhabditis elegans JNK and JNK kinases result in similar mislocalization of synaptic vesicle markers and enhance weak unc-16 mutant phenotypes. unc-116 kinesin heavy chain mutants also mislocalize synaptic vesicle markers, as well as a functional UNC16::GFP. Intriguingly, unc-16 mutations partially suppress the vesicle retention defect in unc-104 KIF1A kinesin mutants. Cur results suggest that UNC-16 may regulate the localization of vesicular cargo by integrating JNK signaling and kinesin-1 transport.	Univ Calif Santa Cruz, Sinsheimer Labs, Dept MCD Biol, Santa Cruz, CA 95064 USA; Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan; Univ Calif Santa Cruz, Howard Hughes Med Inst, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Japan Science & Technology Agency (JST); Nagoya University; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Jin, YS (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept MCD Biol, Santa Cruz, CA 95064 USA.			Jin, Yishi/0000-0002-9371-9860	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32GM0864602] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akechi M, 2001, NEUROSCI RES, V39, P391, DOI 10.1016/S0168-0102(01)00194-8; Bamber BA, 1999, J NEUROSCI, V19, P5348; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; BRENNER S, 1974, GENETICS, V77, P71; Brownlees J, 2000, J CELL SCI, V113, P401; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Eastman C, 1999, J NEUROSCI, V19, P6225; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; HALL D H, 1991, Journal of Cell Biology, V115, p389A; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hobert O, 1998, J NEUROSCI, V18, P2084; Ito M, 1999, MOL CELL BIOL, V19, P7539; Ito M, 2000, GENE, V255, P229, DOI 10.1016/S0378-1119(00)00335-8; IWASAKI K, 1995, P NATL ACAD SCI USA, V92, P10317, DOI 10.1073/pnas.92.22.10317; Jin YS, 1999, J NEUROSCI, V19, P539; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Koushika SP, 2000, CURR OPIN CELL BIOL, V12, P517, DOI 10.1016/S0955-0674(00)00125-3; LEE KD, 1995, J BIOL CHEM, V270, P5600, DOI 10.1074/jbc.270.10.5600; LEOPOLD PL, 1992, CELL MOTIL CYTOSKEL, V23, P19, DOI 10.1002/cm.970230104; Lindesmith L, 1997, J BIOL CHEM, V272, P22929, DOI 10.1074/jbc.272.36.22929; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; McDonald D, 2000, US FOR SERV RMRS-P, V2, P290; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; PATEL N, 1993, P NATL ACAD SCI USA, V90, P9181, DOI 10.1073/pnas.90.19.9181; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sambrook J., 2002, MOL CLONING LAB MANU; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Schaefer AM, 2001, CURR OPIN NEUROBIOL, V11, P127, DOI 10.1016/S0959-4388(00)00183-5; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; THOMAS JH, 1990, GENETICS, V124, P855; TRENT C, 1983, GENETICS, V104, P619; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang Y, 1998, P NATL ACAD SCI USA, V95, P2586, DOI 10.1073/pnas.95.5.2586; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	61	173	186	2	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					787	+		10.1016/S0896-6273(01)00532-3	http://dx.doi.org/10.1016/S0896-6273(01)00532-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738026	Bronze			2022-12-28	WOS:000172700700007
J	Yao, HS; Dan, Y				Yao, HS; Dan, Y			Stimulus timing-dependent plasticity in cortical processing of orientation	NEURON			English	Article							LONG-TERM POTENTIATION; UNDERLYING CONTRAST ADAPTATION; PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; SYNAPTIC DEPRESSION; RESPONSE AMPLITUDE; PYRAMIDAL CELLS; SELECTIVITY; NEURONS; HIPPOCAMPUS	The relative timing of presynaptic and postsynaptic spikes plays a critical role in activity-induced synaptic modification. Here we examined whether plasticity of orientation selectivity in the visual cortex depends on stimulus timing. Repetitive pairing of visual stimuli at two orientations induced a shift in orientation tuning of cat cortical neurons, with the direction of the shift depending on the temporal order of the pair. Induction of a significant shift required that the interval between the pair fall within +/-40 ms, reminiscent of the temporal window for spike timing-dependent synaptic plasticity. Mirroring the plasticity found in cat visual cortex, similar conditioning also induced a shift in perceived orientation by human subjects, further suggesting functional relevance of this phenomenon. Thus, relative timing of visual stimuli can play a critical role in dynamic modulation of adult cortical function, perhaps through spike timing-dependent synaptic plasticity.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Dan, Yang/0000-0002-3818-877X				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chance FS, 1998, J NEUROSCI, V18, P4785; DEAN AF, 1981, J PHYSIOL-LONDON, V318, P413; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FREGNAC Y, 1992, J NEUROSCI, V12, P1280; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McLean J, 1998, VISUAL NEUROSCI, V15, P177, DOI 10.1017/S0952523898151143; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; RAO RPN, 2000, ADV NEURAL INFORMATI; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SCHUETT S, 2000, SOC NEUR ABSTR, V26; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	42	172	175	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					315	323		10.1016/S0896-6273(01)00460-3	http://dx.doi.org/10.1016/S0896-6273(01)00460-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11684000	Bronze			2022-12-28	WOS:000171893700015
J	Suh, BC; Hille, B				Suh, BC; Hille, B			Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis	NEURON			English	Article							LIGHT-CHAIN KINASE; RAT SYMPATHETIC NEURONS; POTASSIUM CURRENT; PHOSPHOINOSITIDE TURNOVER; PHOSPHOLIPASE-C; SENSITIVE POOLS; CA2+ CHANNELS; SMOOTH-MUSCLE; G-PROTEINS; INHIBITION	Suppression of M current channels by muscarinic receptors enhances neuronal excitability. Little is known about the molecular mechanism of this inhibition except the requirement for a specific G protein and the involvement of an unidentified diffusible second messenger. We demonstrate here that intracellular ATP is required for recovery of KCNQ2/KCNQ3 current from muscarinic suppression, with an EC50 of similar to0.5 mM. Substitution of nonhydrolyzable ATP analogs for ATP slowed or prevented recovery. ADPbetaS but not ADP also prevented the recovery. Receptor-mediated inhibition was irreversible when recycling of agonist-sensitive pools of phosphatidylinositol-4,5-bisphosphate (PIP2) was blocked by lipid kinase inhibitors. Lipid phosphorylation by PI4-kinase is required for recovery from muscarinic modulation of M current.	Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hille, B (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA.	hille@u.washington.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 00286] Funding Source: Medline; NINDS NIH HHS [NS 08174] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKASU T, 1993, NEURON, V11, P1133, DOI 10.1016/0896-6273(93)90226-H; Aromolaran AS, 2000, J PHYSIOL-LONDON, V524, P853, DOI 10.1111/j.1469-7793.2000.00853.x; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; CAULFIELD MP, 1994, J PHYSIOL-LONDON, V477, P415, DOI 10.1113/jphysiol.1994.sp020203; CHEN HY, 1992, BRIT J PHARMACOL, V105, P329, DOI 10.1111/j.1476-5381.1992.tb14254.x; Choi S, 1996, J NEUROSCI, V16, P36; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; ECKSTEIN F, 1976, BIOCHEMISTRY-US, V15, P1685, DOI 10.1021/bi00653a015; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Haley JE, 1998, J NEUROSCI, V18, P4521; Haley JE, 2000, J NEUROSCI, V20; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; JENKINSON S, 1994, MOL PHARMACOL, V46, P1138; JONES S, 1995, NEURON, V14, P399, DOI 10.1016/0896-6273(95)90295-3; Lamas JA, 1997, EUR J NEUROSCI, V9, P605, DOI 10.1111/j.1460-9568.1997.tb01637.x; Linseman DA, 1999, J NEUROCHEM, V73, P1933; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; MARRION NV, 1993, NEURON, V11, P77, DOI 10.1016/0896-6273(93)90272-S; Meyers R, 1997, J BIOL CHEM, V272, P4384, DOI 10.1074/jbc.272.7.4384; NAKANISHI S, 1988, J BIOL CHEM, V263, P6215; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; OKADA T, 1994, J BIOL CHEM, V269, P3563; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Samizo K, 1999, BIOCHEM BIOPH RES CO, V261, P95, DOI 10.1006/bbrc.1999.0956; SCHAEFER T, 1994, ANN NY ACAD SCI, V710, P356, DOI 10.1111/j.1749-6632.1994.tb26642.x; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; Shapiro MS, 2000, J NEUROSCI, V20, P1710; SHAPIRO MS, 1994, NEURON, V12, P1319, DOI 10.1016/0896-6273(94)90447-2; SHAPIRO MS, 1994, J NEUROSCI, V14, P7109; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; SIMMONS MA, 1994, J PHARMACOL EXP THER, V271, P581; Simmons MA, 1998, J NEUROSCI, V18, P6254; SIMMONS MA, 1990, NEURON, V4, P557, DOI 10.1016/0896-6273(90)90113-T; Sorensen SD, 1998, MOL PHARMACOL, V53, P827; SUH BC, 1995, J NEUROCHEM, V65, P2124; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TOKIMASA T, 1995, BRIT J PHARMACOL, V114, P489, DOI 10.1111/j.1476-5381.1995.tb13253.x; TOKIMASA T, 1990, J PHYSIOL-LONDON, V426, P241, DOI 10.1113/jphysiol.1990.sp018136; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WANG HS, 1995, J PHYSIOL-LONDON, V485, P319, DOI 10.1113/jphysiol.1995.sp020732; Watanabe H, 1998, FASEB J, V12, P341, DOI 10.1096/fasebj.12.3.341; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Yue JC, 2001, J BIOL CHEM, V276, P49093, DOI 10.1074/jbc.M101328200	57	370	380	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					507	520		10.1016/S0896-6273(02)00790-0	http://dx.doi.org/10.1016/S0896-6273(02)00790-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165472	Bronze			2022-12-28	WOS:000177331200011
J	Wyss-Coray, T; Mucke, L				Wyss-Coray, T; Mucke, L			Inflammation in neurodegenerative disease - A double-edged sword	NEURON			English	Review							CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA-PEPTIDE; MHC CLASS-I; AMYOTROPHIC-LATERAL-SCLEROSIS; TUMOR-NECROSIS-FACTOR; INGESTED APOPTOTIC CELLS; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; COMPLEMENT ACTIVATION	Inflammation is a defense reaction against diverse insults, designed to remove noxious agents and to inhibit their detrimental effects. It consists of a dazzling array of molecular and cellular mechanisms and an intricate network of controls to keep them in check. In neurodegenerative diseases, inflammation may be triggered by the accumulation of proteins with abnormal conformations or by signals emanating from injured neurons. Given the multiple functions of many inflammatory factors, it has been difficult to pinpoint their roles in specific (patho)physiological situations. Studies of genetically modified mice and of molecular pathways in activated glia are beginning to shed light on this issue. Altered expression of different inflammatory factors can either promote or counteract neurodegenerative processes. Since many inflammatory responses are beneficial, directing and instructing the inflammatory machinery may be a better therapeutic objective than suppressing it.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Wyss-Coray, T (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA.	twysscoray@gladstone.ucsf.edu; lmucke@gladstone.ucsf.edu	Wyss-Coray, Tony/AAF-3380-2019	Wyss-Coray, Tony/0000-0001-5893-0831; Mucke, Lennart/0000-0001-6256-9559	NINDS NIH HHS [NS 43945] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aisen PS, 2000, ACTA NEUROL SCAND, V102, P85, DOI 10.1034/j.1600-0404.2000.00312.x; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Akwa Y, 1998, J IMMUNOL, V161, P5016; Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Andreasson KI, 2001, J NEUROSCI, V21, P8198; Archelos JJ, 2000, TRENDS NEUROSCI, V23, P317, DOI 10.1016/S0166-2236(00)01575-7; Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bas J, 2001, J NEUROIMMUNOL, V113, P146, DOI 10.1016/S0165-5728(00)00422-7; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Benveniste EN, 2001, NEUROCHEM INT, V39, P381, DOI 10.1016/S0197-0186(01)00045-6; Bien CG, 2002, ANN NEUROL, V51, P311, DOI 10.1002/ana.10100; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; Bradt BM, 1998, J EXP MED, V188, P431, DOI 10.1084/jem.188.3.431; Brazil MI, 2000, J BIOL CHEM, V275, P16941, DOI 10.1074/jbc.M000937200; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Buttini M, 1998, NAT MED, V4, P441, DOI 10.1038/nm0498-441; Calida DM, 2001, J IMMUNOL, V166, P723, DOI 10.4049/jimmunol.166.2.723; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; COTMAN CW, 1999, ALZHEIMER DIS, P347; Cowan WM, 2001, JAMA-J AM MED ASSOC, V285, P594, DOI 10.1001/jama.285.5.594; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Dandoy-Dron F, 1998, J BIOL CHEM, V273, P7691, DOI 10.1074/jbc.273.13.7691; Davoust N, 1999, J IMMUNOL, V163, P6551; DEFAZIO G, 1994, BRAIN RES, V633, P206, DOI 10.1016/0006-8993(94)91541-5; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; DeWitt DA, 1998, EXP NEUROL, V149, P329, DOI 10.1006/exnr.1997.6738; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Donnadieu E, 2001, IMMUNOLOGY, V103, P417, DOI 10.1046/j.1365-2567.2001.01268.x; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; EHRHARD PB, 1993, P NATL ACAD SCI USA, V90, P10984, DOI 10.1073/pnas.90.23.10984; ElKhoury J, 1996, NATURE, V382, P716; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FINCH CE, 1993, J CELL BIOCHEM, V53, P314, DOI 10.1002/jcb.240530408; Finch CE, 1996, NEUROBIOL AGING, V17, P809; Fishelson Z, 2001, MOL IMMUNOL, V38, P207, DOI 10.1016/S0161-5890(01)00055-4; FISZER U, 1994, ACTA NEUROL SCAND, V90, P160; FLARIS NA, 1993, GLIA, V7, P34, DOI 10.1002/glia.440070108; FRACKOWIAK J, 1992, ACTA NEUROPATHOL, V84, P225; FRAUTSCHY SA, 1992, AM J PATHOL, V140, P1389; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Giles KM, 2000, BRIT J HAEMATOL, V109, P1, DOI 10.1046/j.1365-2141.2000.01805.x; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Green DR, 2001, NATURE, V412, P133, DOI 10.1038/35084313; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hauss-Wegrzyniak B, 1999, NEUROBIOL AGING, V20, P305, DOI 10.1016/S0197-4580(99)00028-7; Head E, 2001, NEUROBIOL DIS, V8, P252, DOI 10.1006/nbdi.2000.0380; Hengartner MO, 2001, CELL, V104, P325, DOI 10.1016/S0092-8674(01)00219-7; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Hohlfeld R, 2000, J NEUROIMMUNOL, V107, P161, DOI 10.1016/S0165-5728(00)00233-2; Holers VM, 1996, CLIN IMMUNOLOGY PRIN, P363; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hyman BT, 2001, ANN NEUROL, V49, P808, DOI 10.1002/ana.1061; Jackson GS, 2001, NATURE, V414, P269, DOI 10.1038/35104694; Jantzen PT, 2002, J NEUROSCI, V22, P2246, DOI 10.1523/JNEUROSCI.22-06-02246.2002; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jucker M, 1997, BEHAV BRAIN RES, V85, P1, DOI 10.1016/S0166-4328(96)02243-7; Katchar K, 2001, SCAND J IMMUNOL, V54, P220, DOI 10.1046/j.1365-3083.2001.00923.x; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Knopf PM, 1998, J IMMUNOL, V161, P692; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Leblhuber F, 1998, CLIN CHEM LAB MED, V36, P747, DOI 10.1515/CCLM.1998.132; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Leyton L, 2001, CURR BIOL, V11, P1028, DOI 10.1016/S0960-9822(01)00262-7; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Linda H, 1999, J NEUROIMMUNOL, V101, P76, DOI 10.1016/S0165-5728(99)00135-6; Linda H, 1998, EXP NEUROL, V150, P282, DOI 10.1006/exnr.1997.6768; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McDonald PP, 1999, J IMMUNOL, V163, P6164; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; McGeer PL, 2001, ARCH NEUROL-CHICAGO, V58, P1790, DOI 10.1001/archneur.58.11.1790; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; McGeer PL, 1999, J LEUKOCYTE BIOL, V65, P409, DOI 10.1002/jlb.65.4.409; Medana I, 2001, AM J PATHOL, V159, P809, DOI 10.1016/S0002-9440(10)61755-5; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; METCHNIKOFF E, 1884, ALLG WIENER MED ZTG, V29, P307; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Monsonego A, 2001, P NATL ACAD SCI USA, V98, P10273, DOI 10.1073/pnas.191118298; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morgan TE, 1999, NEUROSCIENCE, V89, P687, DOI 10.1016/S0306-4522(98)00334-0; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mukherjee P, 2001, J NEUROCHEM, V77, P43, DOI 10.1046/j.1471-4159.2001.00167.x; Myagkova MA, 2001, B EXP BIOL MED+, V131, P127, DOI 10.1023/A:1017527508878; Nataf S, 1999, TRENDS NEUROSCI, V22, P397, DOI 10.1016/S0166-2236(98)01390-3; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Orr HT, 2000, CELL, V101, P1, DOI 10.1016/S0092-8674(00)80617-0; Osaka H, 1999, J CELL BIOCHEM, V73, P303, DOI 10.1002/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.0.CO;2-2; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Pasinetti GM, 1996, NEUROBIOL DIS, V3, P197, DOI 10.1006/nbdi.1996.0020; Pasinetti GM, 1998, J NEUROSCI RES, V54, P1; Prolla TA, 2001, TRENDS NEUROSCI, V24, pS21, DOI 10.1016/S0166-2236(00)01957-3; Raina AK, 2001, ACTA NEUROPATHOL, V101, P305; Raivich G, 1998, J NEUROSCI, V18, P5804; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Rockwell P, 2000, ARCH BIOCHEM BIOPHYS, V374, P325, DOI 10.1006/abbi.1999.1646; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Sastry PS, 2000, J NEUROCHEM, V74, P1, DOI 10.1046/j.1471-4159.2000.0740001.x; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schwartz M, 1999, J MOL MED, V77, P713, DOI 10.1007/s001099900047; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Senior K, 2002, LANCET NEUROL, V1, P3, DOI 10.1016/S1474-4422(02)00023-6; SHAFFER LM, 1995, NEUROBIOL AGING, V16, P737, DOI 10.1016/0197-4580(95)00055-J; Shen Y, 2001, NEUROSCI LETT, V305, P165, DOI 10.1016/S0304-3940(01)01842-0; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Song WC, 2000, IMMUNOPHARMACOLOGY, V49, P187, DOI 10.1016/S0162-3109(00)80303-3; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Stalder AK, 1998, AM J PATHOL, V153, P767, DOI 10.1016/S0002-9440(10)65620-9; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Stoltzner SE, 2000, AM J PATHOL, V156, P489, DOI 10.1016/S0002-9440(10)64753-0; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; TAUBER AI, 1992, CELL IMMUNOL, V139, P505, DOI 10.1016/0008-8749(92)90089-8; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Tenner AJ, 1998, IMMUNOBIOLOGY, V199, P250, DOI 10.1016/S0171-2985(98)80031-4; Tenner AJ, 1999, CURR OPIN IMMUNOL, V11, P34, DOI 10.1016/S0952-7915(99)80007-7; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; TOH BH, 1985, P NATL ACAD SCI USA, V82, P3485, DOI 10.1073/pnas.82.10.3485; Trieb K, 1996, NEUROBIOL AGING, V17, P541; TROOST D, 1989, CLIN NEUROPATHOL, V8, P289; Van Gool WA, 2001, LANCET, V358, P455, DOI 10.1016/S0140-6736(01)05623-9; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Walker LC, 2000, MOL NEUROBIOL, V21, P83, DOI 10.1385/MN:21:1-2:083; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Webster S, 1997, NEUROBIOL AGING, V18, P415, DOI 10.1016/S0197-4580(97)00042-0; Webster S, 1997, J NEUROCHEM, V69, P388; Webster SD, 2001, J IMMUNOL, V166, P7496, DOI 10.4049/jimmunol.166.12.7496; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; WEGIEL J, 1990, ACTA NEUROPATHOL, V81, P116, DOI 10.1007/BF00334499; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Whitney KD, 1999, ANNU REV NEUROSCI, V22, P175, DOI 10.1146/annurev.neuro.22.1.175; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321; WYSSCORAY T, 2002, IN PRESS P NATL ACAD; YAMADA T, 1992, ACTA NEUROPATHOL, V84, P100, DOI 10.1007/BF00427222; Yan SD, 1999, AM J PATHOL, V155, P1403, DOI 10.1016/S0002-9440(10)65452-1; Yi FH, 2000, J NEUROIMMUNOL, V109, P211, DOI 10.1016/S0165-5728(00)00288-5; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zandi PP, 2001, NEUROBIOL AGING, V22, P811, DOI 10.1016/S0197-4580(01)00297-4; Zarkadis IK, 2001, DEV COMP IMMUNOL, V25, P745, DOI 10.1016/S0145-305X(01)00034-9	176	922	957	2	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					419	432		10.1016/S0896-6273(02)00794-8	http://dx.doi.org/10.1016/S0896-6273(02)00794-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165466	Bronze			2022-12-28	WOS:000177331200005
J	Samson, AO; Scherf, T; Eisenstein, M; Chill, JH; Anglister, J				Samson, AO; Scherf, T; Eisenstein, M; Chill, JH; Anglister, J			The mechanism for acetylcholine receptor inhibition by alpha-neurotoxins and species-specific resistance to alpha-bungarotoxin revealed by NMR	NEURON			English	Article							BINDING-SITE; NICOTINIC RECEPTORS; LIGAND-BINDING; HIGH-AFFINITY; SUBUNIT; RESIDUES; PEPTIDE; COMPLEX; SENSITIVITY; PROTEIN	The structure of a peptide corresponding to residues 182-202 of the acetylcholine receptor alpha1 subunit in complex with alpha-bungarotoxin was solved using NMR spectroscopy. The peptide contains the complete sequence of the major determinant of AChR involved in alpha-bungarotoxin binding. One face of the long beta hairpin formed by the AChR peptide consists of exposed nonconserved residues, which interact extensively with the toxin. Mutations of these receptor residues confer resistance to the toxin. Conserved AChR residues form the opposite face of the beta hairpin, which creates the inner and partially hidden pocket for acetylcholine. An NMR-derived model for the receptor complex with two alpha-bungarotoxin molecules shows that this pocket is occupied by the conserved alpha-neurotoxin residue R36, which forms cation-pi interactions with both (alpha)W149 and (gamma)W55/(delta)W57 of the receptor and mimics acetylcholine.	Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Chem Serv, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Anglister, J (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	jacob.anglister@weizmann.ac.il	Chill, Jordan/W-5048-2018	Chill, Jordan/0000-0002-9518-824X				Ariel S, 1998, ANN NY ACAD SCI, V841, P93, DOI 10.1111/j.1749-6632.1998.tb10912.x; ARONHEIM A, 1988, J BIOL CHEM, V263, P9933; BARCHAN D, 1995, BIOCHEMISTRY-US, V34, P9172, DOI 10.1021/bi00028a029; BARCHAN D, 1992, P NATL ACAD SCI USA, V89, P7717, DOI 10.1073/pnas.89.16.7717; BASU AK, 1988, CHEM RES TOXICOL, V1, P1, DOI 10.1021/tx00001a001; BASUS VJ, 1993, BIOCHEMISTRY-US, V32, P12290, DOI 10.1021/bi00097a004; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHATURVEDI V, 1993, BIOCHEMISTRY-US, V32, P9570, DOI 10.1021/bi00088a008; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; HAGGERTY JG, 1981, J BIOL CHEM, V256, P8294; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; KAO PN, 1986, J BIOL CHEM, V261, P8085; Karlin A, 1993, Curr Opin Neurobiol, V3, P299, DOI 10.1016/0959-4388(93)90121-E; Kasher R, 2001, CHEM BIOL, V8, P147, DOI 10.1016/S1074-5521(00)90063-2; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Levandoski MM, 1999, J BIOL CHEM, V274, P26113, DOI 10.1074/jbc.274.37.26113; Malany S, 2000, BIOCHEMISTRY-US, V39, P15388, DOI 10.1021/bi001825o; Moise L, 2002, J BIOL CHEM, V277, P12406, DOI 10.1074/jbc.M110320200; NEIDIG KP, 1995, J BIOMOL NMR, V6, P255, DOI 10.1007/BF00197807; OHANA B, 1990, BIOCHEMISTRY-US, V29, P6409, DOI 10.1021/bi00479a011; Osaka H, 2000, J BIOL CHEM, V275, P5478, DOI 10.1074/jbc.275.8.5478; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Roberts G.C.K., 1993, NMR MACROMOLECULES; Samson AO, 2001, BIOCHEMISTRY-US, V40, P5464, DOI 10.1021/bi0022689; Scarselli M, 2002, BIOCHEMISTRY-US, V41, P1457, DOI 10.1021/bi011012f; Scherf T, 1997, P NATL ACAD SCI USA, V94, P6059, DOI 10.1073/pnas.94.12.6059; Scherf T, 2001, P NATL ACAD SCI USA, V98, P6629, DOI 10.1073/pnas.111164298; Servent D, 1998, TOXICOL LETT, V103, P199, DOI 10.1016/S0378-4274(98)00307-5; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Spura A, 1999, BIOCHEMISTRY-US, V38, P4912, DOI 10.1021/bi982656z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRONCONI BMC, 1991, BIOCHEMISTRY-US, V30, P2575; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; WILSON PT, 1988, MOL PHARMACOL, V34, P643; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zeng HY, 2001, J BIOL CHEM, V276, P22930, DOI 10.1074/jbc.M102300200; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	42	60	65	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					319	332		10.1016/S0896-6273(02)00773-0	http://dx.doi.org/10.1016/S0896-6273(02)00773-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160749	Bronze			2022-12-28	WOS:000177034200011
J	Cannon, SC				Cannon, SC			Sodium channel gating: No margin for error	NEURON			English	Editorial Material							GENERALIZED EPILEPSY; FEBRILE SEIZURES; MUTATION; SCN1A	Voltage-gated Na+ channels are the workhorses of spike generation and propagation in excitable cells. Mutations in Na+ channel genes have been identified in disorders causing episodic dysfunction of heart, skeletal muscle, and brain. Lossin and colleagues from Al George's lab report in this issue of Neuron that three missense mutations of SCN1A found in a dominant epilepsy syndrome disrupt inactivation, thereby producing small persistent inward Na+ currents that may result in hyperexcitability and seizures.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Dept Neurobiol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Cannon, SC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Dept Neurobiol, Wellman 423, Boston, MA 02114 USA.		Cannon, Stephen/V-5343-2019	Cannon, Stephen/0000-0001-8428-3690				BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Cannon SC, 2000, KIDNEY INT, V57, P772, DOI 10.1046/j.1523-1755.2000.00914.x; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Kearney JA, 2001, NEUROSCIENCE, V102, P307, DOI 10.1016/S0306-4522(00)00479-6; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252	10	7	11	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					853	854		10.1016/S0896-6273(02)00735-3	http://dx.doi.org/10.1016/S0896-6273(02)00735-3			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086630	Bronze			2022-12-28	WOS:000176249700001
J	Okazawa, H; Rich, T; Chang, A; Lin, X; Waragai, M; Kajikawa, M; Enokido, Y; Komuro, A; Kato, S; Shibata, M; Hatanaka, H; Mouradian, MM; Sudol, M; Kanazawa, I				Okazawa, H; Rich, T; Chang, A; Lin, X; Waragai, M; Kajikawa, M; Enokido, Y; Komuro, A; Kato, S; Shibata, M; Hatanaka, H; Mouradian, MM; Sudol, M; Kanazawa, I			Interaction between mutant ataxin-1 and POBP-1 affects transcription and cell death	NEURON			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED POLYGLUTAMINE PROTEIN; CREB-BINDING PROTEIN; RNA-POLYMERASE-II; NUCLEAR INCLUSIONS; TRACT-BINDING; WW DOMAIN; DISEASE; AGGREGATION; IDENTIFICATION	PQBP-1 was isolated on the basis of its interaction with polyglutamine tracts. In this study, using in vitro and in vivo assays, we show that the association between ataxin-1 and PQBP-1 is positively influenced by expanded polyglutamine sequences. In cell lines, interaction between the two molecules induces apoptotic cell death. As a possible mechanism underlying this phenomenon, we found that mutant ataxin-1 enhances binding of PQBP-1 to the C-terminal domain of RNA polymerase II large subunit (Pol II). This reduces the level of phosphorylated Pol II and transcription. Our results suggest the involvement of PQBP-1 in the pathology of spinocerebellar ataxia type 1 (SCA1) and support the idea that modified transcription underlies polyglutamine-mediated pathology.	Univ Tokyo, Grad Sch med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; MBL Co Ltd, Dept Pharmaceut Dev, Nagano 3960002, Japan; Osaka Univ, Inst Prot Res, Div Prot Biosynth, Suita, Osaka 5650871, Japan; JST, ERATO, Sagami Chem Res Ctr, Kanagawa 2290012, Japan; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Pediat Neurol Neurosci & Mol Genet, Houston, TX 77030 USA; NINCDS, Expt Therapeut Branch, NIH, Bethesda, MD 20892 USA	University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); University of Cambridge; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Okazawa, H (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Mol Therapeut, 2-6 Musashidai, Tokyo 1838526, Japan.	okazawa@tmin.ac.jp		Enokido, Yasushi/0000-0003-3252-504X; Mouradian, M. Maral/0000-0002-9937-412X; Chang, Alex/0000-0001-8584-2984	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002826] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Berry LD, 1997, J CELL BIOL, V137, P1337, DOI 10.1083/jcb.137.6.1337; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chang A, 2000, J BIOL CHEM, V275, P20562, DOI 10.1074/jbc.M002479200; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gall JG, 1999, MOL BIOL CELL, V10, P4385, DOI 10.1091/mbc.10.12.4385; Gilman S, 1996, ANN NEUROL, V39, P241, DOI 10.1002/ana.410390214; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Hirose Y, 2000, GENE DEV, V14, P1415; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Iwamoto K, 2000, GENE, V259, P69, DOI 10.1016/S0378-1119(00)00437-6; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kobayashi Y, 1998, BIOCHEM BIOPH RES CO, V252, P145, DOI 10.1006/bbrc.1998.9624; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Komuro A, 1999, NUCLEIC ACIDS RES, V27, P1957, DOI 10.1093/nar/27.9.1957; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Lunkes A, 1997, NAT MED, V3, P1201, DOI 10.1038/nm1197-1201; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okazawa H, 1996, P NATL ACAD SCI USA, V93, P11933, DOI 10.1073/pnas.93.21.11933; Okazawa H, 2001, BRAIN RES BULL, V56, P273, DOI 10.1016/S0361-9230(01)00579-2; Okazawa H, 1996, J CELL BIOL, V132, P955, DOI 10.1083/jcb.132.5.955; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Rich T, 1999, HUM MOL GENET, V8, P2451, DOI 10.1093/hmg/8.13.2451; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Wanker EE, 2000, MOL MED TODAY, V6, P387, DOI 10.1016/S1357-4310(00)01761-5; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yanagisawa H, 2000, HUM MOL GENET, V9, P1433, DOI 10.1093/hmg/9.9.1433; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zhang JW, 2000, THIN WALL STRUCT, V38, P1, DOI 10.1016/S0263-8231(00)00027-6	56	149	156	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					701	713		10.1016/S0896-6273(02)00697-9	http://dx.doi.org/10.1016/S0896-6273(02)00697-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062018	Bronze			2022-12-28	WOS:000175951800006
J	Ahmari, SE; Smith, SJ				Ahmari, SE; Smith, SJ			Knowing a nascent synapse when you see it	NEURON			English	Review							HIPPOCAMPAL-NEURONS; SYNAPTOGENESIS; CULTURE; VESICLE	To understand brain development, we must learn how synapse formation shapes functional neural circuits. At the heart of this process lies the nascent synapse-an enigmatic structure spanning the developmental gap between initial cell-cell contact and the mature synapse. New experimental techniques are beginning to illuminate the processes involved in synaptogenesis, but much remains to be learned, including simply how to recognize the synapse in its nascent form.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Beckman Ctr, Stanford, CA 94305 USA	Stanford University	Ahmari, SE (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Beckman Ctr, Room B100,279 Campus Dr, Stanford, CA 94305 USA.		Ahmari, Susanne E./J-5812-2013	Ahmari, Susanne E./0000-0003-4576-076X				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Fiala JC, 1998, J NEUROSCI, V18, P8900; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Kannenberg K, 1999, EUR J NEUROSCI, V11, P1256, DOI 10.1046/j.1460-9568.1999.00533.x; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	20	48	51	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					333	336		10.1016/S0896-6273(02)00685-2	http://dx.doi.org/10.1016/S0896-6273(02)00685-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988164	Bronze			2022-12-28	WOS:000175214700004
J	Lonze, BE; Riccio, A; Cohen, S; Ginty, DD				Lonze, BE; Riccio, A; Cohen, S; Ginty, DD			Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB	NEURON			English	Article							ELEMENT-BINDING PROTEIN; FAMILY TRANSCRIPTION FACTOR; BAX-DEFICIENT MICE; SYMPATHETIC NEURONS; CELL-DEATH; SIGNAL-TRANSDUCTION; NEURITE OUTGROWTH; BCL-2 EXPRESSION; GENE-EXPRESSION; PRECURSOR CELLS	CRE-binding protein (CREB) belongs to a family of transcription factors that mediates stimulus-dependent gene expression in neuronal and non-neuronal cells. Here we show that CREB is phosphorylated on its transcriptional regulatory site, Ser-133, in vivo in a neurotrophin-dependent manner. In mice harboring a null mutation in the Creb gene, sensory neurons exhibit excess apoptosis and degeneration, and display impaired axonal growth and projections. Interestingly, excess apoptosis is not observed in the central nervous system. CREB is required within sensory and sympathetic neurons for survival and axon extension since both of these neurotrophin-dependent processes are compromised in cultured neurons from CREB null mice. Thus, during their period of neurotrophin dependency, peripheral neurons require CREB-mediated gene expression for both survival and growth in vivo.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Lonze, Bonnie/0000-0002-0973-1657	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034814, R01NS034814, R37NS034814] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 34814] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelastro JM, 2000, P NATL ACAD SCI USA, V97, P10424, DOI 10.1073/pnas.97.19.10424; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BURSTEIN DE, 1978, P NATL ACAD SCI USA, V75, P6059, DOI 10.1073/pnas.75.12.6059; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cowan WM, 2001, ANNU REV NEUROSCI, V24, P551, DOI 10.1146/annurev.neuro.24.1.551; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; ElShamy WM, 1998, NEURON, V21, P1003, DOI 10.1016/S0896-6273(00)80619-4; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; ElShamy WM, 1996, DEVELOPMENT, V122, P2405; Elshamy WM, 1996, DEVELOPMENT, V122, P491; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Fagan AM, 1996, J NEUROSCI, V16, P6208; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fitzli D, 2000, J CELL BIOL, V149, P951, DOI 10.1083/jcb.149.4.951; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GOPALAKRISHNAN L, 1994, J BIOL CHEM, V269, P105; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; LEVIMONTALCINI R, 1956, P NATL ACAD SCI USA, V42, P695, DOI 10.1073/pnas.42.9.695; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Liu YZ, 1999, NUCLEIC ACIDS RES, V27, P2086, DOI 10.1093/nar/27.10.2086; Long FX, 2001, DEVELOPMENT, V128, P541; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Pugazhenthi S, 1999, J BIOL CHEM, V274, P27529, DOI 10.1074/jbc.274.39.27529; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Sakai R, 2000, NEURON, V28, P819, DOI 10.1016/S0896-6273(00)00156-2; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; White FA, 1996, J NEUROSCI, V16, P4662; White FA, 1998, J NEUROSCI, V18, P1428; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277	66	265	273	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					371	385		10.1016/S0896-6273(02)00686-4	http://dx.doi.org/10.1016/S0896-6273(02)00686-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988169	Bronze			2022-12-28	WOS:000175214700009
J	Goldberg, JL; Espinosa, JS; Xu, YF; Davidson, N; Kovacs, GTA; Barres, BA				Goldberg, JL; Espinosa, JS; Xu, YF; Davidson, N; Kovacs, GTA; Barres, BA			Retinal ganglion cells do not extend axons by default: Promotion by neurotrophic signaling and electrical activity	NEURON			English	Article							ADULT SENSORY NEURONS; BCL-2 TRANSGENIC MICE; GROWTH CONE MOTILITY; NEURITE OUTGROWTH; MICROELECTRODE ARRAYS; TROPHIC FACTORS; SEVERED AXONS; MAMMALIAN CNS; SPINAL-CORD; IN-VIVO	We investigate the signaling mechanisms that induce retinal ganglion cell (RGC) axon elongation by asking whether surviving neurons extend axons by default. We show that bcl-2 overexpression is sufficient to keep purified RGCs alive in the absence of any glial or trophic support. The bcl-2-expressing RGCs do not extend axons or dendrites unless signaled to do so by single peptide trophic factors. Axon growth stimulated by peptide trophic factors is remarkably slow but is profoundly potentiated by physiological levels of electrical activity spontaneously generated within embryonic explants or mimicked on a multielectrode silicon chip. These findings demonstrate that these surviving neurons do not constitutively extend axons and provide insight into the signals that may be necessary to promote CNS regeneration.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; Stanford Univ, CIS 202X, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; California Institute of Technology; Stanford University	Goldberg, JL (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Sherman Fairchild Sci Bldg D231,299 Campus Dr, Stanford, CA 94305 USA.	jlgoldbe@stanford.edu		Goldberg, Jeffrey/0000-0002-1390-7360	NATIONAL EYE INSTITUTE [U10EY011030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY11030] Funding Source: Medline; NIGMS NIH HHS [2T32GM07365] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BAHR M, 1988, EXP BRAIN RES, V73, P393; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1993, DEVELOPMENT, V118, P283; BernsteinGoral H, 1997, EXP NEUROL, V148, P13, DOI 10.1006/exnr.1997.6640; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; Bonfanti L, 1996, J NEUROSCI, V16, P4186; Borkholder DA, 1997, J NEUROSCI METH, V77, P61, DOI 10.1016/S0165-0270(97)00112-X; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; CALOF AL, 1994, NEURON, V13, P117, DOI 10.1016/0896-6273(94)90463-4; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Cenni MC, 1996, EUR J NEUROSCI, V8, P1735, DOI 10.1111/j.1460-9568.1996.tb01317.x; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chierzi S, 1999, J NEUROSCI, V19, P8367; COHAN CS, 1986, SCIENCE, V232, P1638, DOI 10.1126/science.3715470; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; Cui Q, 1999, INVEST OPHTH VIS SCI, V40, P760; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; DUSART I, 1994, J COMP NEUROL, V347, P211, DOI 10.1002/cne.903470206; EDGAR D, 1985, J CELL SCI, P107; Ehrengruber MU, 1998, METHOD ENZYMOL, V293, P483; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FIELDS RD, 1990, J NEUROSCI, V10, P2950; FROMHERZ P, 1995, PHYS REV LETT, V75, P1670, DOI 10.1103/PhysRevLett.75.1670; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Gramowski A, 2000, NEUROTOXICOLOGY, V21, P331; GROSS GW, 1993, J NEUROSCI METH, V50, P131, DOI 10.1016/0165-0270(93)90001-8; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; HARRIS WA, 1980, J COMP NEUROL, V194, P303, DOI 10.1002/cne.901940203; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jenkner M, 2001, BIOL CYBERN, V84, P239, DOI 10.1007/s004220000218; Jo SA, 1999, NEUROSCIENCE, V89, P579, DOI 10.1016/S0306-4522(98)00546-6; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; LANDER AD, 1985, P NATL ACAD SCI USA, V82, P2183, DOI 10.1073/pnas.82.7.2183; LANDER AD, 1985, J CELL BIOL, V101, P898, DOI 10.1083/jcb.101.3.898; LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; LIPTON SA, 1988, P NATL ACAD SCI USA, V85, P2388, DOI 10.1073/pnas.85.7.2388; LOCHTER A, 1993, J NEUROSCI, V13, P3986; Lodovichi C, 2001, EUR J NEUROSCI, V13, P833, DOI 10.1046/j.1460-9568.2001.01440.x; Maher MP, 1999, J NEUROSCI METH, V87, P45, DOI 10.1016/S0165-0270(98)00156-3; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mi HY, 1999, J NEUROSCI, V19, P1049; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NEUGEBAUER KM, 1991, NATURE, V350, P68, DOI 10.1038/350068a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RASHID NA, 1992, DEV BRAIN RES, V67, P301, DOI 10.1016/0165-3806(92)90231-K; Scholl M, 2000, J NEUROSCI METH, V104, P65, DOI 10.1016/S0165-0270(00)00325-3; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Service RFS, 1999, SCIENCE, V284, P578, DOI 10.1126/science.284.5414.578; Shen SL, 1999, NEURON, V23, P285, DOI 10.1016/S0896-6273(00)80780-1; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Watson FL, 1999, J NEUROSCI, V19, P7889; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8	79	353	360	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					689	702		10.1016/S0896-6273(02)00602-5	http://dx.doi.org/10.1016/S0896-6273(02)00602-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879647	Bronze			2022-12-28	WOS:000174286200006
J	Kovoor, A; Lester, HA				Kovoor, A; Lester, HA			Gi Irks GIRKs	NEURON			English	Editorial Material							BETA-GAMMA-SUBUNITS; POTASSIUM CHANNEL; K+ CHANNELS; G-PROTEINS; ACTIVATION; RECEPTORS; BINDING; RGS	G protein-activated potassium channels (GIRKs), monitored with the temporal and molecular resolution of electrophysiology, play a key role in the study of signal transduction. GIRKs are activated primarily by the Gbetagamma subunits, but a paper by Peleg et al. (2002 [this issue of Neuron]) demonstrates a role for Galpha subunits in suppressing basal activity and supports the idea of a macromolecular complex of G protein, GIRK, and perhaps RGS protein.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Kovoor, A (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.							Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; MIRSHAHI T, 2001, IN PRESS J BIOL CHEM; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Petit-Jacques J, 1999, J GEN PHYSIOL, V114, P673, DOI 10.1085/jgp.114.5.673; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saitoh O, 1999, J BIOL CHEM, V274, P9899, DOI 10.1074/jbc.274.14.9899; Sodickson DL, 1996, J NEUROSCI, V16, P6374; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0	14	18	18	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					6	8		10.1016/S0896-6273(01)00572-4	http://dx.doi.org/10.1016/S0896-6273(01)00572-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779473	Bronze			2022-12-28	WOS:000173106200004
J	Suh, GSB; Poeck, B; Chouard, T; Oron, E; Segal, D; Chamovitz, DA; Zipursky, SL				Suh, GSB; Poeck, B; Chouard, T; Oron, E; Segal, D; Chamovitz, DA; Zipursky, SL			Drosophila JAB1/CSN5 acts in photoreceptor cells to induce glial cells	NEURON			English	Article							POLARITY GENE HEDGEHOG; COP9 SIGNALOSOME; AXON GUIDANCE; BITHORAX COMPLEX; NERVOUS-SYSTEM; VISUAL-SYSTEM; MELANOGASTER; PROTEIN; LIGHT; ARABIDOPSIS	Different classes of photoreceptor neurons (R cells) in the Drosophila compound eye form connections in different optic ganglia, The R1-R6 subclass connects to the first optic ganglion, the lamina, and relies upon glial cells as intermediate targets. Conversely, R cells promote glial cell development including migration of glial cells into the target region. Here, we show that the JAB1/CSN5 subunit of the COP9 signalosome complex is expressed in R cells, accumulates in the developing optic lobe neuropil, and through the analysis of a unique set of missense mutations, is required in R cells to induce lamina glial cell migration. In these CSN5 alleles, R1-R6 targeting is disrupted. Genetic analysis of protein null alleles further revealed that the COP9 signalosome is required at an earlier stage of development for R cell differentiation.	Univ Calif Los Angeles, Dept Biol Chem, Howard Hughes Med Inst, Sch Med, Los Angeles, CA 90095 USA; Univ Regensburg, Lehrstuhl Entwicklungsbiol, Inst Zool, D-93053 Regensburg, Germany; Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Regensburg; Tel Aviv University; Tel Aviv University	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Howard Hughes Med Inst, Sch Med, Los Angeles, CA 90095 USA.		Chamovitz, Daniel/S-5021-2019	Chamovitz, Daniel/0000-0002-2815-2909; Segal, Daniel/0000-0002-6777-505X; Zipursky, Stephen/0000-0001-5630-7181				ASHBURNER M, 1989, DROSPHILA LAB MANUAL; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; CAMPOS AR, 1985, J NEUROGENET, V2, P197, DOI 10.3109/01677068509100150; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; HOMYK T, 1985, J NEUROGENET, V2, P309, DOI 10.3109/01677068509102326; HOPMANN R, 1995, GENETICS, V139, P815; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Karniol B, 2000, CURR OPIN PLANT BIOL, V3, P387, DOI 10.1016/S1369-5266(00)00101-1; Kim TH, 2001, TRENDS PLANT SCI, V6, P379, DOI 10.1016/S1360-1385(01)02015-5; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; Naumann M, 1999, J BIOL CHEM, V274, P35297, DOI 10.1074/jbc.274.50.35297; Newsome TP, 2000, DEVELOPMENT, V127, P851; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Osterlund MT, 1999, TRENDS CELL BIOL, V9, P113, DOI 10.1016/S0962-8924(99)01499-3; PALAZZOLO MJ, 1990, GENE, V88, P25, DOI 10.1016/0378-1119(90)90056-W; Peng ZH, 2001, DEVELOPMENT, V128, P4277; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; PIERCE JC, 1992, METHOD ENZYMOL, V216, P549; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Power ME, 1943, J EXP ZOOL, V94, P33, DOI 10.1002/jez.1400940103; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; SALECKER I, 1995, J COMP NEUROL, V352, P33, DOI 10.1002/cne.903520104; Salecker I, 1998, CELL, V95, P587, DOI 10.1016/S0092-8674(00)81627-X; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Senti KA, 2000, DEVELOPMENT, V127, P2291; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Tio M, 1997, DEVELOPMENT, V124, P343; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; XU T, 1993, DEVELOPMENT, V117, P1223; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7	47	79	81	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					35	46		10.1016/S0896-6273(01)00576-1	http://dx.doi.org/10.1016/S0896-6273(01)00576-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779478	Bronze			2022-12-28	WOS:000173106200008
J	Matthews, G				Matthews, G			Calciurn/calmodulin: A synaptic antidepressant?	NEURON			English	Editorial Material							VESICLES; DEPRESSION; RECOVERY; RELEASE	Synaptic depression contributes, to short-term changes in synaptic efficacy during sustained activity. Sakaba and Neher (2001) have characterized two kinetically distinct pools of releasable vesicles whose depletion underlies depression at a CNS synapse. Calcium/calmodulin dramatically accelerates replenishment of one of these pools-and hence recovery from depression.	SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Matthews, G (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.							DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; Dittman JS, 1998, J NEUROSCI, V18, P6147; Iwasaki S, 2001, J PHYSIOL-LONDON, V534, P861, DOI 10.1111/j.1469-7793.2001.00861.x; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8	12	5	5	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					962	963		10.1016/S0896-6273(01)00546-3	http://dx.doi.org/10.1016/S0896-6273(01)00546-3			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754827	Bronze			2022-12-28	WOS:000172886800003
J	Mao, BQ; Hamzei-Sichani, F; Aronov, D; Froemke, RC; Yuste, R				Mao, BQ; Hamzei-Sichani, F; Aronov, D; Froemke, RC; Yuste, R			Dynamics of spontaneous activity in neocortical slices	NEURON			English	Article							INTRINSIC ELECTROPHYSIOLOGICAL PROPERTIES; RAT VISUAL-CORTEX; PYRAMIDAL NEURONS; FUNCTIONAL ARCHITECTURE; CONNECTIONS; MORPHOLOGY; PATTERNS; CIRCUITS; LAYER-5	The flow of activity in the cortical microcircuitry is poorly understood. We use calcium imaging to reconstruct, with millisecond and single-cell resolution, the spontaneous activity of populations of neurons in unstimulated slices from mouse visual cortex. We find spontaneous activity correlated among networks of layer 5 pyramidal cells. Synchronous ensembles occupy overlapping territories, often share neurons, and are repeatedly activated. Sets of neurons are also sequentially activated numerous times. Network synchronization and sequential correlations are blocked by glutamatergic antagonists, even though spontaneous firing persists in many "autonomously active" neurons. This autonomous activity is periodic and depends on hyperpolarization-activated cationic (H) and persistent sodium (Na-p) currents. We conclude that the isolated neocortical microcircuit generates spontaneous activity, mediated by a combination of intrinsic and circuit mechanisms, and that this activity can be temporally precise.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Yuste, R (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	rmy5@columbia.edu		Froemke, Robert/0000-0002-1230-6811				Abeles M., 1991, CORTICONICS; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Barbour B, 2000, J NEUROSCI METH, V103, P199, DOI 10.1016/S0165-0270(00)00318-6; Braitenberg V., 1998, ANATOMY CORTEX; BURNS BD, 1979, PROC R SOC SER B-BIO, V206, P281, DOI 10.1098/rspb.1979.0105; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Creutzfeldt O., 1995, CORTEX CEREBRI; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.ph.58.030196.002025; de No RL, 1922, TRAB LAB BIOL U MADR, V20, P41; Douglas RJ, 1998, SYNAPTIC ORG BRAIN, P459; Fuster JM, 1995, MEMORY CEREBRAL CORT; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; KASPER EM, 1994, J COMP NEUROL, V339, P459, DOI 10.1002/cne.903390402; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Lorente de No R., 1949, PHYSL NERVOUS SYSTEM, P228; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1990, J NEUROSCI, V10, P1415; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Schwartz T, 1998, NEURON, V20, P1271; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; YUSTE R, 2000, IMAGING NEURONS LAB	39	217	225	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2001	32	5					883	898		10.1016/S0896-6273(01)00518-9	http://dx.doi.org/10.1016/S0896-6273(01)00518-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738033	Bronze			2022-12-28	WOS:000172700700014
J	Tian, N; Copenhagen, DR				Tian, N; Copenhagen, DR			Visual deprivation alters development of synaptic function in inner retina after eye opening	NEURON			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; EARLY POSTNATAL-DEVELOPMENT; GANGLION-CELLS; MONOCULAR DEPRIVATION; OSCILLATORY POTENTIALS; EVOKED-POTENTIALS; CRITICAL PERIOD; DEPRIVED CATS; RAT RETINA; CORTEX	Visual deprivation impedes refinement of neuronal function in higher visual centers of mammals. It is often assumed that visual deprivation has minimal effect, if any, on neuronal function in retina. Here we report that dark rearing reduces the light-evoked responsiveness of inner retinal neurons in young mice. We also find that 1 to 2 weeks after eye opening, there is a surge (>4-fold) in the frequency of spontaneous excitatory and inhibitory synaptic events in ganglion cells. Dark rearing reversibly suppresses this surge, but recovery takes >6 days. Frequency changes are not accompanied by amplitude changes, indicating that synaptic reorganization is likely to be presynaptic. These findings indicate there is a degree of activity-dependent plasticity in the mammalian retina that has not been previously described.	Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tian, N (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, 330 Cedar St, New Haven, CT 06520 USA.							BARO JA, 1990, INVEST OPHTH VIS SCI, V31, P1405; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; BLANTON MG, 1991, J NEUROSCI, V11, P3907; BONAVENT.N, 1967, CR SOC BIOL, V161, P689; BOWEANDERS C, 1975, BRAIN RES, V87, P61, DOI 10.1016/0006-8993(75)90779-9; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; DAW N, 1995, VISUAL DEV; ELAZAZI M, 1990, ACTA OPHTHALMOL, V68, P401; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; FISHER LJ, 1979, J EMBRYOL EXP MORPH, V54, P219; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; Fujikado T, 1996, CURR EYE RES, V15, P79, DOI 10.3109/02713689609017614; Gao BX, 1998, J NEUROPHYSIOL, V79, P2277, DOI 10.1152/jn.1998.79.5.2277; Gillespie DC, 2000, J NEUROSCI, V20, P9174; Gordon JA, 1996, J NEUROSCI, V16, P3274; GORFINKEL J, 1988, DOC OPHTHALMOL, V69, P237, DOI 10.1007/BF00154404; GREINER JV, 1981, EXP EYE RES, V33, P315, DOI 10.1016/S0014-4835(81)80055-3; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; HENDRICKSON A, 1976, VISION RES, V16, P517, DOI 10.1016/0042-6989(76)90033-X; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hollrigel GS, 1997, J NEUROSCI, V17, P5119; Hwang TN, 1999, J NEUROSCI METH, V92, P65, DOI 10.1016/S0165-0270(99)00095-3; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Kapur J, 1999, MOL PHARMACOL, V55, P444; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KRATZ KE, 1979, BRAIN RES, V172, P545, DOI 10.1016/0006-8993(79)90586-9; Matsui K, 1998, J NEUROSCI, V18, P4500; MOVSHON JA, 1976, J PHYSIOL-LONDON, V261, P125, DOI 10.1113/jphysiol.1976.sp011551; MOWER GD, 1981, BRAIN RES, V220, P255, DOI 10.1016/0006-8993(81)91216-6; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; Prange O, 1999, J NEUROSCI, V19, P6427; Protti DA, 1997, J NEUROSCI, V17, P6075; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Redburn DA., 1987, PROGR RETINAL RES, V6, P16, DOI 10.1016/0278-4327(87)90020-4; REUTER JH, 1976, PFLUG ARCH EUR J PHY, V363, P7, DOI 10.1007/BF00587395; Robinson DW, 1998, SEMIN CELL DEV BIOL, V9, P301, DOI 10.1006/scdb.1998.0229; RORIG B, 1993, DEV BRAIN RES, V74, P98, DOI 10.1016/0165-3806(93)90088-R; RUSOFF AC, 1978, INVEST OPHTH VIS SCI, V17, P819; RUSOFF AC, 1977, J NEUROPHYSIOL, V40, P1188, DOI 10.1152/jn.1977.40.5.1188; SassoePognetto M, 1997, J COMP NEUROL, V381, P158, DOI 10.1002/(SICI)1096-9861(19970505)381:2<158::AID-CNE4>3.0.CO;2-2; Sernagor E, 1996, CURR BIOL, V6, P1503, DOI 10.1016/S0960-9822(96)00755-5; SEVERNS ML, 1994, DOC OPHTHALMOL, V86, P23, DOI 10.1007/BF01224625; SHERMAN SM, 1973, BRAIN RES, V60, P224, DOI 10.1016/0006-8993(73)90861-5; SOSULA L, 1971, J COMP NEUROL, V141, P427, DOI 10.1002/cne.901410403; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; SUTOR B, 1995, PERSPECT DEV NEUROBI, V2, P409; TAYLOR WR, 1995, J PHYSIOL-LONDON, V486, P207, DOI 10.1113/jphysiol.1995.sp020803; Tian N, 1998, J NEUROPHYSIOL, V80, P1327, DOI 10.1152/jn.1998.80.3.1327; TOOTLE JS, 1993, J NEUROPHYSIOL, V69, P1645, DOI 10.1152/jn.1993.69.5.1645; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001; WASSLE H, 1988, TRENDS NEUROSCI, V11, P87, DOI 10.1016/0166-2236(88)90147-6; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; WINGATE RJT, 1994, J NEUROSCI, V14, P6621; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29	61	129	131	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					439	449		10.1016/S0896-6273(01)00470-6	http://dx.doi.org/10.1016/S0896-6273(01)00470-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709155	Bronze			2022-12-28	WOS:000172119100010
J	Clandinin, TR; Lee, CH; Herman, T; Lee, RC; Yang, AY; Ovasapyan, S; Zipursky, SL				Clandinin, TR; Lee, CH; Herman, T; Lee, RC; Yang, AY; Ovasapyan, S; Zipursky, SL			Drosophila LAR regulates R1-R6 and R7 target specificity in the visual system	NEURON			English	Article							RECEPTOR TYROSINE PHOSPHATASES; MOTOR AXON GUIDANCE; NERVOUS-SYSTEM; IN-VIVO; PTP-MU; BRAKELESS; EMBRYO; RETINA; DLAR	Different classes of photoreceptor neurons (R cells) in the Drosophila compound eye connect to specific targets in the optic lobe. Using a behavioral screen, we identified LAR, a receptor tyrosine phosphatase, as being required for R cell target specificity. In LAR mutant mosaic eyes, R1-R6 cells target to the lamina correctly, but fail to choose the correct pattern of target neurons. Although mutant R7 axons initially project to the correct layer of the medulla, they retract into inappropriate layers. Using single cell mosaics, we demonstrate that LAR controls targeting of R1-R6 and R7 in a cell-autonomous fashion. The phenotypes of LAR mutant R cells are strikingly similar to those seen in N-cadherin mutants.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Sch Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Sch Med, 5-748 MRL,675 Charles Young Dr S, Los Angeles, CA 90095 USA.		Lee, Chi-Hon/G-9190-2012	Lee, Chi-Hon/0000-0002-6138-711X; Zipursky, Stephen/0000-0001-5630-7181	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008748, Z01HD008748] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08042] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GERRESHEIM F, 1981, THESIS MUNICH U MUNI; GRIGLIATTI T, 1986, MUTAGENESIS DROSOPHI, P39; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; Ren JM, 1998, DIABETES, V47, P493, DOI 10.2337/diabetes.47.3.493; Senti KA, 2000, DEVELOPMENT, V127, P2291; Stowers RS, 1999, GENETICS, V152, P1631; Sun Q, 2000, DEVELOPMENT, V127, P801; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsujikawa K, 2001, MOL ENDOCRINOL, V15, P271, DOI 10.1210/me.15.2.271; Van Vactor D, 1998, CURR OPIN CELL BIOL, V10, P174, DOI 10.1016/S0955-0674(98)80139-7; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Zabolotny JM, 2001, P NATL ACAD SCI USA, V98, P5187, DOI 10.1073/pnas.071050398	38	125	125	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					237	248		10.1016/S0896-6273(01)00474-3	http://dx.doi.org/10.1016/S0896-6273(01)00474-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683994	Bronze			2022-12-28	WOS:000171893700009
J	Matulef, K; Zagotta, WN				Matulef, K; Zagotta, WN			Multimerization of the ligand binding domains of cyclic nucleotide-gated channels	NEURON			English	Article							ION CHANNELS; SUBUNIT STOICHIOMETRY; ACTIVATED CHANNELS; ROD PHOTORECEPTORS; MEMBRANE PATCHES; SITE; GMP; PROTEIN; CONDUCTANCE; RECEPTOR	Cyclic nucleotide-gated (CNG) channels comprise four subunits and are activated by the direct binding of cyclic nucleotide to an intracellular domain on each subunit. This ligand binding domain is thought to contain a beta roll followed by two alpha helices, designated the B and C helices. To examine the quaternary structure of CNG channels and how it changes during ion channel gating, we introduced single cysteines along the C helix of each subunit in an otherwise cysteineless channel. We found that cysteines on the C helices could form intersubunit disulfide bonds, even between diagonal subunits. Disulfide bond formation occurred primarily in closed channels and inhibited channel opening. These data suggest that the C helices from all four channel subunits are in close proximity in the closed state and move apart during channel opening.	Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA.				NATIONAL EYE INSTITUTE [T32EY007031, R01EY010329] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY010329, R01 EY010329-09, EY 10329, T32 EY07031] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		[Anonymous], 1973, CHEM BIOCH SULFHYDRY; Brown RL, 2000, BIOCHEMISTRY-US, V39, P432, DOI 10.1021/bi9920735; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; MOLDAY RS, 1991, J BIOL CHEM, V266, P21917; Molokanova E, 1997, J NEUROSCI, V17, P9068; Molokanova E, 1999, J GEN PHYSIOL, V113, P45, DOI 10.1085/jgp.113.1.45; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Scott SP, 2001, BIOCHEMISTRY-US, V40, P7464, DOI 10.1021/bi002804x; SHABB JB, 1992, J BIOL CHEM, V267, P5723; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WEBER IT, 1987, J BIOL CHEM, V262, P5630; Weber K, 1972, Methods Enzymol, V26, P3; WOHLFART P, 1992, J BIOL CHEM, V267, P644; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; ZIMMERMAN AL, 1988, BIOPHYS J, V54, P351, DOI 10.1016/S0006-3495(88)82966-7; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	40	28	30	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					93	103		10.1016/S0896-6273(02)00878-4	http://dx.doi.org/10.1016/S0896-6273(02)00878-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367509	Bronze			2022-12-28	WOS:000178295100010
J	Matthews, G				Matthews, G			Synaptic vesicle exocytosis: Does a lingering kiss lead to fusion?	NEURON			English	Editorial Material							HIPPOCAMPAL SYNAPSES	Direct optical measurements of single synaptic vesicles undergoing exocytosis at a synapse reveal rapid and complete transfer of membrane marker from the vesicle to the plasma membrane (Zenisek et al., 2002; this issue of Neuron). Contact between the two membranes is consistent with free lipid exchange, such as might result from full fusion of the vesicle and plasma membranes.	SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Matthews, G (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.							Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEIDELBERGER R, 1992, J PHYSL, V207, P623; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	8	4	4	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1013	1014		10.1016/S0896-6273(02)00907-8	http://dx.doi.org/10.1016/S0896-6273(02)00907-8			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354391	Bronze			2022-12-28	WOS:000178040000002
J	Zakharenko, SS; Zablow, L; Siegelbaum, SA				Zakharenko, SS; Zablow, L; Siegelbaum, SA			Altered presynaptic vesicle release and cycling during mGluR-dependent LTD	NEURON			English	Article							LONG-TERM DEPRESSION; FROG NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL PYRAMIDAL CELLS; MOTOR-NERVE TERMINALS; SILENT SYNAPSES; TRANSMITTER RELEASE; SYNAPTIC PLASTICITY; RECEPTOR ACTIVATION; PROTEIN-SYNTHESIS; ARACHIDONIC-ACID	The site of modification of synaptic transmission during long-term plasticity in the mammalian hippocampus remains controversial. Here we used a fluorescent marker of presynaptic activity, FM 1-43, to directly image presynaptic function during metabotropic glutamate receptor-dependent long-term depression (mGluR-LTD) at CA3-CA1 excitatory synapses in acute hippocampal slices. We found a significant decrease in the rate of FM 1-43 release in response to synaptic stimulation following induction of mGluR-LTD, providing direct evidence for altered presynaptic function. Moreover, we found that mGluR-LTD causes several changes in FM dye release properties that are consistent with a change in the mode of vesicle cycling, possibly involving a switch from a full fusion mode of release to a "kiss-and-run" mode of release through the transient opening of a fusion pore.	Columbia Univ, Howard Hughes Med Inst, Dept Pharmacol, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Pharmacol, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.		Zakharenko, Stanislav/D-3287-2013	Zakharenko, Stanislav/0000-0001-8115-202X	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-50733] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; Becherer U, 2001, J NEUROSCI, V21, P782, DOI 10.1523/JNEUROSCI.21-03-00782.2001; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOLSHAKOV VY, 1995, NEUROPHARMACOLOGY, V34, P1581, DOI 10.1016/0028-3908(95)00127-R; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Braunewell KH, 2001, REV NEUROSCIENCE, V12, P121; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Henkel AW, 1995, J NEUROSCI, V15, P8246; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Normandin M, 1996, BRAIN RES, V730, P40; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rouze NC, 1998, J NEUROSCI, V18, P8614; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Stanton PK, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0002.2001; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Watabe AM, 2002, J NEUROPHYSIOL, V87, P1395, DOI 10.1152/jn.00723.2001; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	51	109	111	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1099	1110		10.1016/S0896-6273(02)00898-X	http://dx.doi.org/10.1016/S0896-6273(02)00898-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354399	Bronze			2022-12-28	WOS:000178040000010
J	James, TW; Humphrey, GK; Gati, JS; Menon, RS; Goodale, MA				James, TW; Humphrey, GK; Gati, JS; Menon, RS; Goodale, MA			Differential effects of viewpoint on object-driven activation in dorsal and ventral streams	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; EVENT-RELATED FMRI; FUNCTIONAL-ANATOMY; VISUAL RECOGNITION; FACE RECOGNITION; HUMANS; CORTEX; BRAIN; MECHANISMS; MEMORY	Using fMRI, we showed that an area in the ventral temporo-occipital cortex (area vTO), which is part of the human homolog of the ventral stream of visual processing, exhibited priming for both identical and depth-rotated images of objects. This pattern of activation in area vTO corresponded to performance in a behavioral matching task. An area in the caudal part of the intraparietal sulcus (area cIPS) also showed priming, but only with identical images of objects. This dorsal-stream area treated rotated images as new objects. The difference in the pattern of priming-related activation in the two areas may reflect the respective roles of the ventral and dorsal streams in object recognition and object-directed action.	Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada	Western University (University of Western Ontario)	Goodale, MA (corresponding author), Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada.		Menon, Ravi/ABA-8654-2020; Menon, Ravi S/K-5500-2013; Goodale, Melvyn A/M-5907-2013; Gati, Joseph S/K-5476-2013	Menon, Ravi/0000-0002-7916-0263; Menon, Ravi S/0000-0002-7916-0263; Goodale, Melvyn A/0000-0001-6748-0561; 				Badgaiyan RD, 2000, HUM BRAIN MAPP, V10, P197, DOI 10.1002/1097-0193(200008)10:4<197::AID-HBM50>3.0.CO;2-B; Biederman I, 1997, PHILOS T ROY SOC B, V352, P1203, DOI 10.1098/rstb.1997.0103; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Craighero L, 1996, NEUROREPORT, V8, P347, DOI 10.1097/00001756-199612200-00068; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; ELLIS R, 1989, Q J EXP PSYCHOL-A, V41, P775, DOI 10.1080/14640748908402393; Faillenot I, 1997, CEREB CORTEX, V7, P77, DOI 10.1093/cercor/7.1.77; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; James TW, 2000, CURR BIOL, V10, P1017, DOI 10.1016/S0960-9822(00)00655-2; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; JOLICOEUR P, 1998, PERCEPTUAL CONSTANCY, P69; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kraut M, 1997, NEUROLOGY, V48, P1416, DOI 10.1212/WNL.48.5.1416; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Price CJ, 1996, P ROY SOC B-BIOL SCI, V263, P1501, DOI 10.1098/rspb.1996.0219; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Talairach J., 1988, COPLANAR STEREOTAXIC; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Williams P, 1999, PERCEPT PSYCHOPHYS, V61, P963, DOI 10.3758/BF03206910	41	191	195	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					793	801		10.1016/S0896-6273(02)00803-6	http://dx.doi.org/10.1016/S0896-6273(02)00803-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194877	Bronze			2022-12-28	WOS:000177521000018
J	Higuchi, M; Ishihara, T; Zhang, B; Hong, M; Andreadis, A; Trojanowski, JQ; Lee, VMY				Higuchi, M; Ishihara, T; Zhang, B; Hong, M; Andreadis, A; Trojanowski, JQ; Lee, VMY			Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration	NEURON			English	Article							PAIRED HELICAL FILAMENTS; PROGRESSIVE SUPRANUCLEAR PALSY; TAU-POSITIVE GLIA; HUMAN BRAIN TAU; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; PICKS-DISEASE; CORTICOBASAL DEGENERATION; MONOCLONAL-ANTIBODIES; NEUROFIBRILLARY TANGLES	Frontotemporal dementias (FTDs), including cortico-basal degeneration (CBD) and progressive supranuclear palsy (PSP), are neurodegenerative tauopathies characterized by widespread CNS neuronal and glial tau pathologies, but there are no tau transgenic (Tg) mice that model neurodegeneration with glia tau lesions. Thus, we generated Tg mice overexpressing human tau in neurons and glia. No neuronal tau aggregates were detected, but old mice developed Thioflavin S- and Gallyas-positive glial tau pathology resembling CBD astrocytic plaques. Tau-immunoreactive and Gallyas-positive oligodendroglial coiled bodies (similar to CBD and PSP), glial degeneration, and motor deficits were associated with age-dependent accumulations of insoluble hyperphosphorylated human tau and tau immunopositive filaments in degenerating glial cells. Thus, tau-positive glial lesions similar to human FTDs occur in these Tg mice, and these pathologies are linked to glial and axonal degeneration.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Eunice Kennedy Shriver Ctr Mental Retardat Inc, Dept Biomed Sci, Waltham, MA 02254 USA	University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.							BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Brion JP, 1999, AM J PATHOL, V154, P255, DOI 10.1016/S0002-9440(10)65272-8; CARDEN MJ, 1987, J NEUROSCI, V7, P3489; Chin SSM, 1996, J NEUROPATH EXP NEUR, V55, P499; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Dawson HN, 2001, J CELL SCI, V114, P1179; DELISLE MB, 1999, ACTA NEUROPATHOL BER, V96, P8229; Dickson DW, 1996, J NEURAL TRANSM-SUPP, P31; Feany MB, 1996, J NEUROPATH EXP NEUR, V55, P53, DOI 10.1097/00005072-199601000-00006; FEANY MB, 1995, AM J PATHOL, V146, P1388; Forman MS, 2002, AM J PATHOL, V160, P2045, DOI 10.1016/S0002-9440(10)61154-6; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; Gleckman AM, 1999, ACTA NEUROPATHOL, V98, P55, DOI 10.1007/s004010051051; GLOSTER A, 1994, J NEUROSCI, V14, P7319; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Goedert M, 1999, NAT MED, V5, P454, DOI 10.1038/7454; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Gotz J, 2001, EUR J NEUROSCI, V13, P2131, DOI 10.1046/j.0953-816x.2001.01604.x; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iseki E, 2001, ACTA NEUROPATHOL, V102, P285; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Ishihara T, 2001, AM J PATHOL, V158, P555, DOI 10.1016/S0002-9440(10)63997-1; IWATSUBO T, 1994, ACTA NEUROPATHOL, V88, P129; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; Komori T, 1999, BRAIN PATHOL, V9, P663; Komori T, 1998, ACTA NEUROPATHOL, V96, P401, DOI 10.1007/s004010050911; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; LEE VMY, 1984, J NEUROCHEM, V42, P25, DOI 10.1111/j.1471-4159.1984.tb09692.x; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; LI J, 1997, J CHEM IND ENG, V48, P517; Matsuo A, 1998, AM J PATHOL, V153, P735, DOI 10.1016/S0002-9440(10)65617-9; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MAWALDEWAN M, 1994, J BIOL CHEM, V269, P30981; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; NISHIMURA M, 1995, AM J PATHOL, V146, P1052; NISHIMURA M, 1992, NEUROSCI LETT, V143, P35, DOI 10.1016/0304-3940(92)90227-X; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Oyanagi K, 1997, J NEUROPATH EXP NEUR, V56, P308, DOI 10.1097/00005072-199703000-00010; Piao YS, 2002, ACTA NEUROPATHOL, V103, P469, DOI 10.1007/s00401-001-0488-2; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Richter-Landsberg C, 2001, MICROSC RES TECHNIQ, V52, P628, DOI 10.1002/jemt.1047; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; SUZUKI N, 1994, AM J PATHOL, V145, P452; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; Szendrei GI, 1996, INT J PEPT PROT RES, V47, P289; TU PH, 1995, J CELL BIOL, V129, P1629, DOI 10.1083/jcb.129.6.1629; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; YAMADA T, 1992, NEUROSCI LETT, V135, P99, DOI 10.1016/0304-3940(92)90145-W; YAMAZAKI M, 1994, ACTA NEUROPATHOL, V88, P587; Zhukareva V, 2002, ANN NEUROL, V51, P730, DOI 10.1002/ana.10222	65	109	113	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					433	446		10.1016/S0896-6273(02)00789-4	http://dx.doi.org/10.1016/S0896-6273(02)00789-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165467	Bronze			2022-12-28	WOS:000177331200006
J	Grove, EA				Grove, EA			The telencephalon saved by TLC	NEURON			English	Editorial Material							MOUSE FOREBRAIN; XENOPUS; SPECIFICATION; EXPRESSION		Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Grove, EA (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.							Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Dorsky RI, 2000, BIOESSAYS, V22, P708, DOI 10.1002/1521-1878(200008)22:8<708::AID-BIES4>3.3.CO;2-E; Fernandez AS, 1998, DEVELOPMENT, V125, P2099; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Megason SG, 2002, DEVELOPMENT, V129, P2087; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Ohkubo Y, 2002, NEUROSCIENCE, V111, P1, DOI 10.1016/S0306-4522(01)00616-9; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Weinstein DC, 1997, CURR OPIN NEUROBIOL, V7, P7, DOI 10.1016/S0959-4388(97)80114-6	13	6	6	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					215	217		10.1016/S0896-6273(02)00779-1	http://dx.doi.org/10.1016/S0896-6273(02)00779-1			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160739	Bronze			2022-12-28	WOS:000177034200001
J	Laureys, S; Peigneux, P; Perrin, F; Maquet, P				Laureys, S; Peigneux, P; Perrin, F; Maquet, P			Sleep and motor skill learning	NEURON			English	Editorial Material							CORTEX PLASTICITY; REM-SLEEP; DISCRIMINATION; MEMORY		Univ Liege, Cyclotron Res Ctr, B-4000 Liege, Belgium	University of Liege	Laureys, S (corresponding author), Univ Liege, Cyclotron Res Ctr, B-4000 Liege, Belgium.		Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Laureys, Steven/0000-0002-3096-3807; Peigneux, Philippe/0000-0003-4745-1434; , Pierre/0000-0003-3106-3357				Dijk DJ, 1999, J SLEEP RES, V8, P189, DOI 10.1046/j.1365-2869.1999.00159.x; FOGEL S, 2001, ACTAS FISIOLOGIA, V7, P123; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KARNI A, 1995, NATURE, V377, P155; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; SMITH C, 1994, J SLEEP RES, V3, P206, DOI 10.1111/j.1365-2869.1994.tb00133.x; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8	12	21	23	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					5	7		10.1016/S0896-6273(02)00766-3	http://dx.doi.org/10.1016/S0896-6273(02)00766-3			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123601	Bronze, Green Submitted			2022-12-28	WOS:000176601800003
J	Seeburg, PH				Seeburg, PH			A-to-I editing: New and old sites, functions and speculations	NEURON			English	Review							RNA; CHANNELS; LETHALITY; DEFICIENT; MICE; GENE	Nuclear pre-mRNA editing by selective adenosine deamination (A-to-I editing) occurs in all organisms from C. elegans to humans. This rare posttranscriptional mechanism can alter codons and hence the structure and function of proteins. New findings report new sites, give evidence that the efficiency of editing can be regulated by neurotransmitter, and reveal that an amino acid substitution introduced by editing into a neurotransmitter-gated ion channel subunit serves as a determinant for controlling the maturation, intracellular trafficking, and assembly with other subunits of this transmembrane protein.	Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	Max Planck Society	Seeburg, PH (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.							Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Grauso M, 2002, GENETICS, V160, P1519; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; LI M, 1993, ANN NY ACAD SCI, V707, P51, DOI 10.1111/j.1749-6632.1993.tb38041.x; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; O'Farrell PH, 2001, J CLIN INVEST, V107, P671, DOI 10.1172/JCI12562; Patton DE, 1997, NEURON, V19, P711, DOI 10.1016/S0896-6273(00)80383-9; Reenan RA, 2001, TRENDS GENET, V17, P53, DOI 10.1016/S0168-9525(00)02169-7; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2000, J NEUROCHEM, V74, P1290	18	117	132	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					17	20		10.1016/S0896-6273(02)00760-2	http://dx.doi.org/10.1016/S0896-6273(02)00760-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123604	Bronze			2022-12-28	WOS:000176601800006
J	Morales, J; Hiesinger, PR; Schroeder, AJ; Kume, K; Verstreken, P; Jackson, FR; Nelson, DL; Hassan, BA				Morales, J; Hiesinger, PR; Schroeder, AJ; Kume, K; Verstreken, P; Jackson, FR; Nelson, DL; Hassan, BA			Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain	NEURON			English	Article							MENTAL-RETARDATION PROTEIN; HUMAN HOMOLOG; P190 RHOGAP; DENDRITIC SPINES; MESSENGER-RNAS; CGG REPEAT; FMR-1 GENE; EXPRESSION; RHYTHMS; IDENTIFICATION	Mental retardation is a pervasive societal problem, 25 times more common than blindness for example. Fragile X syndrome, the most common form of inherited mental retardation, is caused by mutations in the FMR1 gene. Fragile X patients display neurite morphology defects in the brain, suggesting that this may be the basis of their mental retardation. Drosophila contains a single homolog of FMR1, dfxr (also called dfmr1). We analyzed the role of dfxr in neurite development in three distinct neuronal classes. We find that DFXR is required for normal neurite extension, guidance, and branching. dfxr mutants also display strong eclosion failure and circadian rhythm defects. Interestingly, distinct neuronal cell types show different phenotypes, suggesting that dfxr differentially regulates diverse targets in the brain.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; Flanders Interuniv Inst Biotechnol VIB, Neurogenet Lab, Ctr Human Genet, B-3000 Louvain, Belgium	Baylor College of Medicine; Baylor College of Medicine; Tufts University; Flanders Institute for Biotechnology (VIB)	Hassan, BA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	bassem.hassan@med.kuleuven.ac.be	Verstreken, Patrik/AAC-7591-2022; Hassan, Bassem A/D-5221-2012	Verstreken, Patrik/0000-0002-5073-5393; Hassan, Bassem A/0000-0001-9533-4908; Schroeder, Andrew/0000-0002-5824-7917; Morales, Joannella/0000-0002-8121-9797; Kume, Kazuhiko/0000-0003-4232-1657	NHLBI NIH HHS [R01 HL059873-05, R01 HL059873-07, R01 HL059873-08, R01 HL059873-06, R01 HL059873, R01 HL59873] Funding Source: Medline; NICHD NIH HHS [R01 HD29256] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029256] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059873] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABITBOL M, 1993, NAT GENET, V4, P147, DOI 10.1038/ng0693-147; Baker JD, 1999, J EXP BIOL, V202, P3037; Billuart P, 1998, PATHOL BIOL, V46, P678; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chen HM, 1997, HUM GENET, V99, P262, DOI 10.1007/s004390050350; CHEN KS, 1995, AM J HUM GENET, V56, P175; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; EWER J, 1992, J NEUROSCI, V12, P3321; Gould EL, 2000, AM J MED GENET, V95, P307; GU YH, 1994, HUM MOL GENET, V3, P1705, DOI 10.1093/hmg/3.9.1705; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hagerman RJ, 1996, FRAGILE X SYNDROME D; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HERGERSBERG M, 1995, HUM MOL GENET, V4, P359, DOI 10.1093/hmg/4.3.359; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; LUGENBEEL KA, 1995, NAT GENET, V10, P483, DOI 10.1038/ng0895-483; MEIJER H, 1994, HUM MOL GENET, V3, P615; Morton JE, 1997, J MED GENET, V34, P1, DOI 10.1136/jmg.34.1.1; NEWBY LM, 1991, GENETICS, V128, P571; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; O'Brien G, 2000, J ROY SOC MED, V93, P618, DOI 10.1177/014107680009301204; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Van Vactor D, 1999, CURR BIOL, V9, pR201; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; WISNIEWSKI KE, 1991, AM J MED GENET, V38, P476, DOI 10.1002/ajmg.1320380267; Wittwer F, 2001, DEVELOPMENT, V128, P791; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	52	196	201	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					961	972		10.1016/S0896-6273(02)00731-6	http://dx.doi.org/10.1016/S0896-6273(02)00731-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086643	Bronze			2022-12-28	WOS:000176249700013
J	Qiu, J; Cai, CM; Dai, HN; McAtee, M; Hoffman, PN; Bregman, BS; Filbin, MT				Qiu, J; Cai, CM; Dai, HN; McAtee, M; Hoffman, PN; Bregman, BS; Filbin, MT			Spinal axon regeneration induced by elevation of cyclic AMP	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; ADULT NEURONS; CORD INJURY; GROWTH; CNS; SURVIVAL; PROMOTE; CELLS; RATS	Myelin inhibitors, including MAG, are major impediments to CNS regeneration. However, CNS axons of DRGs regenerate if the peripheral branch of these neurons is lesioned first. We show that 1 day post-peripheral-lesion, DRG-cAMP levels triple and MAG/myelin no longer inhibit growth, an effect that is PKA dependent. By 1 week post-lesion, DRG-cAMP returns to control, but growth on MAG/myelin improves and is now PKA independent. Inhibiting PKA in vivo blocks the post-lesion growth on MAG/myelin at 1 day and attenuates it at I week. Alone, injection of db-cAMP into the DRG mimics completely a conditioning lesion as DRGs grow on MAG/myelin, initially, in a PKA-dependent manner that becomes PKA independent. Importantly, DRG injection of db-cAMP results in extensive regeneration of dorsal column axons lesioned 1 week later. These results may be relevant to developing therapies for spinal cord injury.	CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; Georgetown Univ, Sch Med, Dept Neurosci, Washington, DC 20007 USA; Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21218 USA	City University of New York (CUNY) System; Hunter College (CUNY); Georgetown University; Johns Hopkins University	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.			Cai, Dongming/0000-0002-0601-6826	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041073, R37NS037060, R01NS037060, R01NS019259] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41073, NS 37060, NS19259] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; Bradbury EJ, 2000, TRENDS PHARMACOL SCI, V21, P389, DOI 10.1016/S0165-6147(00)01536-4; BREGMAN BS, 1993, EXP NEUROL, V123, P3, DOI 10.1006/exnr.1993.1136; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; Filbin MT, 1999, NEURON, V23, P2, DOI 10.1016/S0896-6273(00)80744-8; Fitch MT, 1999, CNS REGENERATION BAS, P55; Hanson MG, 1998, J NEUROSCI, V18, P7361; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; MESULAM MM, 1976, J HISTOCHEM CYTOCHEM, V24, P1273, DOI 10.1177/24.12.63512; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Scherer S.S., 1996, GLIAL CELL DEV, P165; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Smith DS, 1997, J NEUROSCI, V17, P646; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Wiemelt AP, 1997, J BIOL CHEM, V272, P31489, DOI 10.1074/jbc.272.50.31489	26	530	548	4	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					895	903		10.1016/S0896-6273(02)00730-4	http://dx.doi.org/10.1016/S0896-6273(02)00730-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086638	Bronze			2022-12-28	WOS:000176249700008
J	Taha, S; Stryker, MP				Taha, S; Stryker, MP			Rapid ocular dominance plasticity requires cortical but not geniculate protein synthesis	NEURON			English	Article							DEVELOPING VISUAL-CORTEX; LONG-TERM POTENTIATION; EXPERIENCE-DEPENDENT PLASTICITY; TISSUE-PLASMINOGEN ACTIVATOR; FACTOR MESSENGER-RNA; MONOCULAR DEPRIVATION; LATE-PHASE; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; STRUCTURAL-CHANGES	Synaptic plasticity is a multistep process in which rapid, early phases eventually give way to slower, more enduring stages. Diverse forms of synaptic change share a common requirement for protein synthesis in the late stages of plasticity, which are often associated with structural rearrangements. Ocular dominance plasticity in the primary visual cortex (V1) is a long-lasting form of activity-dependent plasticity comprised of well-defined physiological and anatomical stages. The molecular events underlying these stages remain poorly understood. Using the protein synthesis inhibitor cycloheximide, we investigated a role for protein synthesis in ocular dominance plasticity. Suppression of cortical, but not geniculate, protein synthesis impaired rapid ocular dominance plasticity, while leaving neuronal responsiveness intact. These findings suggest that structural changes underlying ocular dominance plasticity occur rapidly following monocular occlusion, and cortical changes guide subsequent alterations in thalamocortical afferents.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu		Stryker, Michael/0000-0003-1546-5831	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033, P50NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033-210017, P01 NS016033, NS 16033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AndroutsellisTheotokis A, 1996, BRAIN RES, V743, P40, DOI 10.1016/S0006-8993(96)00981-X; Antonini A, 1999, J NEUROSCI, V19, P4388; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1989, J NEUROSCI, V9, P1774; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Barea-Rodriguez EJ, 2000, J NEUROSCI, V20, P8528, DOI 10.1523/JNEUROSCI.20-22-08528.2000; BEAR MF, 1990, J NEUROSCI, V10, P909; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; FREEMAN RD, 1982, J NEUROPHYSIOL, V47, P139, DOI 10.1152/jn.1982.47.2.139; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Gillespie DC, 2000, J NEUROSCI, V20, P9174; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; KENNEDY C, 1981, P NATL ACAD SCI-BIOL, V78, P3950, DOI 10.1073/pnas.78.6.3950; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Kurotani T, 1996, NEUROREPORT, V8, P35, DOI 10.1097/00001756-199612200-00008; Lein ES, 2000, J NEUROSCI, V20, P1470; Levenes C, 1998, PROG NEUROBIOL, V55, P79, DOI 10.1016/S0301-0082(97)00096-8; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MOVSHON JA, 1977, J NEUROPHYSIOL, V40, P1255, DOI 10.1152/jn.1977.40.6.1255; Muller CM, 1998, NAT NEUROSCI, V1, P47, DOI 10.1038/248; OLSON CR, 1980, EXP BRAIN RES, V38, P53; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; REITER HO, 1986, EXP BRAIN RES, V65, P182; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Rose SPR, 1999, BEHAV BRAIN RES, V98, P237, DOI 10.1016/S0166-4328(98)00089-8; SCHOUPS AA, 1995, DEV BRAIN RES, V86, P326, DOI 10.1016/0165-3806(95)00043-D; SHAW C, 1984, NATURE, V308, P731, DOI 10.1038/308731a0; Silver MA, 1999, J NEUROSCI, V19, P10829, DOI 10.1523/JNEUROSCI.19-24-10829.1999; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; ZAFRA F, 1992, J NEUROSCI, V12, P4793	52	75	76	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					425	436		10.1016/S0896-6273(02)00673-6	http://dx.doi.org/10.1016/S0896-6273(02)00673-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988173	Bronze			2022-12-28	WOS:000175214700013
J	Stepanyants, A; Hof, PR; Chklovskii, DB				Stepanyants, A; Hof, PR; Chklovskii, DB			Geometry and structural plasticity of synaptic connectivity	NEURON			English	Article							LONG-TERM POTENTIATION; MONKEY VISUAL-CORTEX; CA1 PYRAMIDAL CELLS; DENDRITES IN-VIVO; MACAQUE MONKEY; CEREBRAL-CORTEX; 3-DIMENSIONAL STRUCTURE; NEUROFILAMENT PROTEIN; HIPPOCAMPAL SLICES; PROJECTION NEURONS	Changes in synaptic connectivity patterns through the formation and elimination of dendritic spines may contribute to structural plasticity in the brain. We characterize this contribution quantitatively by estimating the number of different synaptic connectivity patterns attainable without major arbor remodeling. This number depends on the ratio of the synapses on a dendrite to the axons that pass within a spine length of that dendrite. We call this ratio the filling fraction and calculate it from geometrical analysis and anatomical data. The filling fraction is 0.26 in mouse neocortex, 0.22-0.34 in rat hippocampus. In the macaque visual cortex, the filling fraction increases by a factor of 1.6-1.8 from area V1 to areas V2, V4, and 7a. Since the filling fraction is much smaller than 1, spine remodeling can make a large contribution to structural plasticity.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, Kastor Neurobiol Aging Labs, Computat Neurobiol & Imaging Ctr,Adv Imaging Prog, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA	Cold Spring Harbor Laboratory; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Chklovskii, DB (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	mitya@cshl.org			NIA NIH HHS [AG05138] Funding Source: Medline; NIMH NIH HHS [MH58911] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058911] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMARAL DG, 1990, PROG BRAIN RES, V83, P1; AMIR Y, 1993, J COMP NEUROL, V334, P19, DOI 10.1002/cne.903340103; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Baker RE, 1997, DEV BRAIN RES, V98, P21, DOI 10.1016/S0165-3806(96)00163-0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAITENBERG V, 1998, CORTEX STAT GENOMETR; Budd JML, 1998, P ROY SOC B-BIOL SCI, V265, P1037, DOI 10.1098/rspb.1998.0396; CAJAL SRY, 1891, CELLULE, V7, P125; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chklovskii DB, 2000, J NEUROPHYSIOL, V83, P2113, DOI 10.1152/jn.2000.83.4.2113; CHKLOVSKII DB, 2002, IN PRESS NEURON; Dailey ME, 1996, J NEUROSCI, V16, P2983; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; Elston GN, 1997, CEREB CORTEX, V7, P432, DOI 10.1093/cercor/7.5.432; Elston GN, 1998, CEREB CORTEX, V8, P278, DOI 10.1093/cercor/8.3.278; Elston GN, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-18-j0002.2000; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GREENOUGH WT, 1985, BEHAV NEURAL BIOL, V44, P301, DOI 10.1016/S0163-1047(85)90310-3; GUSTAFSSON B, 1990, PROG BRAIN RES, V83, P223; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302; HELLWIG B, 1994, BIOL CYBERN, V71, P1, DOI 10.1007/BF00198906; Hof PR, 1996, J COMP NEUROL, V376, P112; HOF PR, 1995, J COMP NEUROL, V352, P161, DOI 10.1002/cne.903520202; IKARI K, 1981, FOLIA PSYCHIAT NEU J, V35, P477; Jones TA, 1999, J COMP NEUROL, V414, P57; KOCH C, 1993, J NEUROSCI, V13, P413; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Nimchinsky EA, 1996, J COMP NEUROL, V374, P136; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; Page TL, 2002, NEUROSCI LETT, V317, P37, DOI 10.1016/S0304-3940(01)02428-4; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; PETIT TL, 1988, DEV BRAIN RES, V41, P209, DOI 10.1016/0165-3806(88)90183-6; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; PURVES D, 1986, J NEUROSCI, V6, P1051; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; Rajan I, 1998, J NEUROSCI, V18, P7836; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Ramon y Cajal S, 1893, ARCH ANAT PHYSL, P319; Rieke F., 1997, SPIKES EXPLORING NEU; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; SHEPHERD GMG, 2002, IN PRESS P NATL ACAD; SORRA KE, 1993, J NEUROSCI, V13, P3736; SPACEK J, 1983, ANAT EMBRYOL, V167, P289, DOI 10.1007/BF00298517; Stern JE, 1998, J NEUROSCI, V18, P841; SWINDALE NV, 1981, TRENDS NEUROSCI, V4, P240, DOI 10.1016/0166-2236(81)90075-8; Tanzi E., 1893, RIV SPER FRENIAT MED, V19, P419; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; VALVERDE F, 1978, ANAT EMBRYOL, V154, P305, DOI 10.1007/BF00345659; WEST MJ, 1978, CELL TISSUE RES, V188, P345; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Wong WT, 2000, J NEUROSCI, V20, P5024; WOOLLEY CS, 1999, DENDRITES, P339; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598	66	235	236	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 11	2002	34	2					275	288		10.1016/S0896-6273(02)00652-9	http://dx.doi.org/10.1016/S0896-6273(02)00652-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970869	Bronze			2022-12-28	WOS:000174976200013
J	Isaac, J				Isaac, J			Protein phosphatase 1 and LTD: Synapses are the architects of depression	NEURON			English	Editorial Material							LONG-TERM DEPRESSION; AREA CA1; HIPPOCAMPUS; SPINOPHILIN; MODULATION; CHANNELS	NMDAR-dependent long-term depression involves the activation of protein phosphatase 1 (PP1) and 2B (calcineurin) and the subsequent dephosphorylation of synaptic proteins. In this issue of Neuron, Morishita et al. (2001) provide evidence that precise targeting of PP1 to synaptic substrates is critical for the expression of LTD.	Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Isaac, J (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.							Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516	12	20	21	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					963	966		10.1016/S0896-6273(01)00545-1	http://dx.doi.org/10.1016/S0896-6273(01)00545-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754828	Bronze			2022-12-28	WOS:000172886800004
J	Feng, RB; Rampon, C; Tang, YP; Shrom, D; Jin, J; Kim, M; Sopher, B; Martin, GM; Kim, SH; Langdon, RB; Sisodia, SS; Tsien, JZ				Feng, RB; Rampon, C; Tang, YP; Shrom, D; Jin, J; Kim, M; Sopher, B; Martin, GM; Kim, SH; Langdon, RB; Sisodia, SS; Tsien, JZ			Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces	NEURON			English	Article							ELECTRON-MICROSCOPIC ANALYSIS; RAT DENTATE GYRUS; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; ADULT-RAT; ENRICHED ENVIRONMENT; TRANSGENIC MICE; SPATIAL MEMORY; LONG-TERM; NEURONS	To examine the in vivo function of presenilin-1 (PS1), we selectively deleted the PS1 gene in excitatory neurons of the adult mouse forebrain. These conditional knockout mice were viable and grew normally, but they exhibited a pronounced deficiency in enrichment-induced neurogenesis in the dentate gyrus. This reduction in neurogenesis did not result in appreciable learning deficits, indicating that addition of new neurons is not required for memory formation. However, our postlearning enrichment experiments lead us to postulate that adult dentate neurogenesis may play a role in the periodic clearance of outdated hippocampal memory traces after cortical memory consolidation, thereby ensuring that the hippocampus is continuously available to process new memories. A chronic, abnormal clearance process in the hippocampus may conceivably lead to memory disorders in the mammalian brain.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Washington, Dept Lab Med, Seattle, WA 98995 USA; Univ Washington, Dept Mol Med, Seattle, WA 98995 USA; Seton Hall Univ, New Jersey Neurosci Inst, Edison, NJ 08818 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; E China Normal Univ, Shanghai Inst Brain Funct Genom, Shanghai, Peoples R China	Princeton University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seton Hall University; University of Chicago; East China Normal University	Tsien, JZ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	jtsien@princeton.edu	Tang, Ya-Ping/A-1035-2011	Tang, Ya-Ping/0000-0002-0445-4072; rampon, claire/0000-0001-8551-8682				ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BAYER SA, 1980, J COMP NEUROL, V194, P845, DOI 10.1002/cne.901940409; Bayer TA, 1997, ACTA NEUROPATHOL, V94, P519, DOI 10.1007/s004010050745; Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; DALRYMPLEALFORD JC, 1984, BEHAV NEUROSCI, V98, P23, DOI 10.1037/0735-7044.98.1.23; DAVIS M, 1987, PSYCHOL LEARN MOTIV, V21, P263; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; GAARSKJAER FB, 1986, BRAIN RES REV, V11, P335, DOI 10.1016/0165-0173(86)90004-4; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Greenough WT, 1999, NAT NEUROSCI, V2, P203, DOI 10.1038/6300; GREENOUGH WT, 1990, SYMP MED H, V23, P159; Haass C, 1997, NEURON, V18, P687, DOI 10.1016/S0896-6273(00)80309-8; Handler M, 2000, DEVELOPMENT, V127, P2593; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Holst BD, 1998, P NATL ACAD SCI USA, V95, P2597, DOI 10.1073/pnas.95.5.2597; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KIM JJ, 1992, BEHAV NEUROSCI, V106, P591, DOI 10.1037/0735-7044.106.4.591; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kim TW, 1997, CURR OPIN NEUROBIOL, V7, P683, DOI 10.1016/S0959-4388(97)80089-X; Kisby GE, 1999, DRUG METAB REV, V31, P589, DOI 10.1081/DMR-100101937; KORDOWER JH, 1992, DEV BRAIN RES, V68, P9, DOI 10.1016/0165-3806(92)90242-O; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; Liu JL, 1998, J NEUROSCI, V18, P7768; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Mehl A, 2000, NEUROTOXICOLOGY, V21, P165; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Nowakowski R, 2000, SCIENCE, V288, p771a, DOI DOI 10.1126/SCIENCE.288.5467.771A; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rampon C, 2000, HIPPOCAMPUS, V10, P605, DOI 10.1002/1098-1063(2000)10:5<605::AID-HIPO11>3.0.CO;2-3; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; Selkoe DJ, 2000, CURR OPIN NEUROBIOL, V10, P50, DOI 10.1016/S0959-4388(99)00054-9; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Squire L. R., 1987, MEMORY BRAIN; St George-Hyslop PH, 2000, SCI AM, V283, P76, DOI 10.1038/scientificamerican1200-76; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Traub R.D., 1991, NEURONAL NETWORKS HI; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2	68	371	389	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2001	32	5					911	926		10.1016/S0896-6273(01)00523-2	http://dx.doi.org/10.1016/S0896-6273(01)00523-2			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738035	Bronze			2022-12-28	WOS:000172700700016
J	Polo-Parada, L; Bose, CM; Landmesser, LT				Polo-Parada, L; Bose, CM; Landmesser, LT			Alterations in transmission, vesicle dynamics, and transmitter release machinery at NCAM-deficient neuromuscular junctions	NEURON			English	Article							MOTOR-NERVE TERMINALS; CELL-ADHESION MOLECULE; PROTEIN-KINASE-C; PRESYNAPTIC ACTIVE ZONES; LIGHT-CHAIN KINASE; SYNAPTIC PLASTICITY; ACETYLCHOLINE-RELEASE; CYTOSOLIC CA2+; LONG-TERM; IN-VITRO	Although functional neuromuscular junctions (NMJs) form in NCAM-deficient mice, they exhibit multiple alterations in presynaptic organization and function. Profound depression and unusual periodic total transmission failures with repetitive stimulation point to a defect in vesicle mobilization/cycling, and these defects were mimicked in (+/+) NMJs by inhibitors of myosin light chain kinase, known to affect vesicle mobilization. Two separate release mechanisms, utilizing different endocytic machinery and Ca2+ channels, were shown to coexist in (-/-) terminals, with the mature process targeted to presynaptic membrane opposed to muscle, and an abnormally retained immature process targeted to the remainder of the presynaptic terminal and axon. Thus, NCAM plays a critical and heretofore unsuspected role in the molecular organization of the presynaptic NMJ.	Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Landmesser, LT (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.			Polo-Parada, Luis/0000-0002-5221-6060	NINDS NIH HHS [NS 23678, NS 19640] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023678, R01NS019640] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Cabaniols JP, 1999, MOL BIOL CELL, V10, P4033, DOI 10.1091/mbc.10.12.4033; CHOW I, 1985, J NEUROSCI, V5, P1076; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; DAHM LM, 1991, J NEUROSCI, V11, P238; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; David G, 2000, J NEUROSCI, V20, P7290; Day NC, 1997, J NEUROSCI, V17, P6226; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Fykse EM, 1998, J NEUROCHEM, V71, P1661; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; GERSDORFF HV, 1999, ANNU REV PHYSIOL, V61, P725; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GLAVINOVIC MI, 1979, J PHYSIOL-LONDON, V290, P467, DOI 10.1113/jphysiol.1979.sp012784; HONG SJ, 1995, J PHYSIOL-LONDON, V482, P283, DOI 10.1113/jphysiol.1995.sp020517; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Katz E, 1996, J PHYSIOL-LONDON, V497, P687, DOI 10.1113/jphysiol.1996.sp021800; Kolkova K, 2000, J NEUROSCI, V20, P2238; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; LUPA MT, 1989, J NEUROSCI, V9, P3937; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NIELANDER HB, 1995, J NEUROCHEM, V65, P1712; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; PREKERIS R, 1997, NEURON, V18, P599; Rafuse VF, 2000, J NEUROSCI, V20, P6529, DOI 10.1523/JNEUROSCI.20-17-06529.2000; Reid B, 1999, J NEUROSCI, V19, P2511; RIBCHESTER RR, 1994, P ROY SOC B-BIOL SCI, V255, P61, DOI 10.1098/rspb.1994.0009; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Roos J, 2000, NAT NEUROSCI, V3, P415, DOI 10.1038/74773; Ryan TA, 1999, J NEUROSCI, V19, P1317; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; SAITOH M, 1987, J BIOL CHEM, V262, P7796; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaefer AM, 2001, CURR OPIN NEUROBIOL, V11, P127, DOI 10.1016/S0959-4388(00)00183-5; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; TIAN LJ, 1994, J PHYSIOL-LONDON, V476, P517, DOI 10.1113/jphysiol.1994.sp020151; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; Verona M, 2000, J NEUROCHEM, V74, P209, DOI 10.1046/j.1471-4159.2000.0740209.x; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Yawo H, 1999, J PHYSIOL-LONDON, V515, P169, DOI 10.1111/j.1469-7793.1999.169ad.x; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507; ZHU H, 1995, J NEUROSCI, V15, P4173	64	129	130	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					815	+		10.1016/S0896-6273(01)00521-9	http://dx.doi.org/10.1016/S0896-6273(01)00521-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738028	Bronze			2022-12-28	WOS:000172700700009
J	Petersen, RS; Panzeri, S; Diamond, ME				Petersen, RS; Panzeri, S; Diamond, ME			Population coding of stimulus location in rat somatosensory cortex	NEURON			English	Article							BARREL CORTEX; NEURONS; INFORMATION; ORGANIZATION; RESPONSES; DYNAMICS; PATTERNS; SYNCHRONIZATION; VARIABILITY; DISCHARGE	This study explores the nature of population coding in sensory cortex by applying information theoretic analyses to neuron pairs recorded simultaneously from rat barrel cortex. We quantified the roles of individual spikes and spike patterns in encoding whisker stimulus location. 82%-85% of the total information was contained in the timing of individual spikes: first spike time was particularly crucial. Spike patterns within neurons accounted for the remaining 15%-18%. Neuron pairs located in the same barrel column coded redundantly, whereas pairs in neighboring barrel columns coded independently. The barrel cortical population code for stimulus location appears to be the time of single neurons' first poststimulus spikes-a fast, robust coding mechanism that does not rely on "synergy" in crossneuronal spike patterns.	Scuola Int Super Studi Avanzati, Cognit Neurosci Sector, I-34014 Trieste, Italy; Newcastle Univ, Dept Psychol, Neural Syst Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	International School for Advanced Studies (SISSA); Newcastle University - UK	Petersen, RS (corresponding author), Scuola Int Super Studi Avanzati, Cognit Neurosci Sector, Via Beirut 2-4, I-34014 Trieste, Italy.	petersen@sissa.it	Panzeri, Stefano/L-5977-2013	Panzeri, Stefano/0000-0003-1700-8909; DIAMOND, Mathew Ernest/0000-0003-2286-4566; Petersen, Rasmus/0000-0002-5607-977X	Telethon [984] Funding Source: Medline; Fondazione Telethon Funding Source: Custom	Telethon(Fondazione Telethon); Fondazione Telethon(Fondazione Telethon)		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Buonomano DV, 1999, NEURAL COMPUT, V11, P103, DOI 10.1162/089976699300016836; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; DeWeese M, 1996, NETWORK-COMP NEURAL, V7, P325, DOI 10.1088/0954-898X/7/2/013; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Furukawa S, 2000, J NEUROSCI, V20, P1216, DOI 10.1523/JNEUROSCI.20-03-01216.2000; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; Golomb D, 1997, NEURAL COMPUT, V9, P649, DOI 10.1162/neco.1997.9.3.649; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Jenison RL, 2001, NEUROCOMPUTING, V38, P239, DOI 10.1016/S0925-2312(01)00355-1; Jung MW, 2000, J NEUROSCI, V20, P6166, DOI 10.1523/JNEUROSCI.20-16-06166.2000; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; KYRIAZI HT, 1993, J NEUROSCI, V13, P1601; Kyriazi HT, 1996, J NEUROPHYSIOL, V75, P547, DOI 10.1152/jn.1996.75.2.547; Lebedev MA, 2000, CEREB CORTEX, V10, P23, DOI 10.1093/cercor/10.1.23; Lee D, 1998, J NEUROSCI, V18, P1161; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Panzeri S, 2001, NEURAL COMPUT, V13, P1311, DOI 10.1162/08997660152002870; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Petersen RS, 2000, J NEUROSCI, V20, P6135, DOI 10.1523/JNEUROSCI.20-16-06135.2000; Reich DS, 2001, J NEUROPHYSIOL, V85, P1039, DOI 10.1152/jn.2001.85.3.1039; Reich DS, 2000, J NEUROSCI, V20, P1964; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; Schultz SR, 2001, PHYS REV LETT, V86, P5823, DOI 10.1103/PhysRevLett.86.5823; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIMONS DJ, 1984, J COMP NEUROL, V230, P119, DOI 10.1002/cne.902300111; Snippe HP, 1996, NEURAL COMPUT, V8, P511, DOI 10.1162/neco.1996.8.3.511; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VAITSCHANOFF JG, 1993, NEUROSCI LETT, V157, P157; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Villa AEP, 1999, P NATL ACAD SCI USA, V96, P1106, DOI 10.1073/pnas.96.3.1106; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	52	181	181	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2001	32	3					503	514		10.1016/S0896-6273(01)00481-0	http://dx.doi.org/10.1016/S0896-6273(01)00481-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709160	Bronze			2022-12-28	WOS:000172119100015
J	Wang, CY; Yang, F; He, XP; Chow, A; Du, J; Russell, JT; Lu, B				Wang, CY; Yang, F; He, XP; Chow, A; Du, J; Russell, JT; Lu, B			Ca2+ binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release	NEURON			English	Article							DEVELOPING NEUROMUSCULAR SYNAPSES; LONG-TERM POTENTIATION; BDNF KNOCKOUT MICE; NEUROTROPHIC FACTOR; NEUROTRANSMITTER RELEASE; SYNAPTIC TRANSMISSION; CALCIUM CHANNELS; DOPAMINERGIC-NEURONS; MOTOR-NEURONS; HIPPOCAMPUS	Molecular mechanisms underlying long-term neurotrophic regulation of synaptic transmission and plasticity are unknown. We report here that long-term treatment of neuromuscular synapses with glial cell line-derived neurotrophic factor (GDNF) potentiates spontaneous and evoked transmitter release, in ways very similar to presynaptic expression of the Ca2+ binding protein frequenin. GDNF enhances the expression of frequenin in motoneurons, and inhibition of frequenin expression or activity prevents the synaptic action of GDNF. GDNF also facilitates Ca2+ influx into the nerve terminals during evoked transmission by enhancing Ca2+ currents. The effect of GDNF on Ca2+ currents is blocked by inhibition of frequenin expression, occluded by overexpression of frequenin, and is selective to N-type Ca2+ channels. These results identify an important molecular target that mediates the long-term, synaptic action of a neurotrophic factor.	NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; George Washington Univ, Grad Program Genet, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); George Washington University	Lu, B (corresponding author), NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA.		Lu, Bai/A-4018-2012; Du, Jing/A-9023-2012; Yang, Feng/C-9530-2011; Du, Jing/GWC-9642-2022	Du, Jing/0000-0003-3128-9997; Lu, Bai/0000-0001-5418-9759; Yang, Feng/0000-0003-1275-6641	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD001206, Z01HD001206] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALDER J, 1992, NEURON, V9, P759, DOI 10.1016/0896-6273(92)90038-F; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Chang SH, 1999, P NATL ACAD SCI USA, V96, P4095, DOI 10.1073/pnas.96.7.4095; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gervasi C, 2000, J COMP NEUROL, V423, P512; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; Gottschalk W, 1998, J NEUROSCI, V18, P6830; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; He XP, 2000, J CELL BIOL, V149, P783, DOI 10.1083/jcb.149.4.783; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Jones LP, 1999, BIOPHYS J, V76, P2530, DOI 10.1016/S0006-3495(99)77407-2; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liou JC, 1997, J NEUROSCI, V17, P2459; LLINAS RR, 1982, SCI AM, V247, P56, DOI 10.1038/scientificamerican1082-56; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Nick TA, 2000, NAT NEUROSCI, V3, P142, DOI 10.1038/72082; OLAFSSON P, 1995, P NATL ACAD SCI USA, V92, P8001, DOI 10.1073/pnas.92.17.8001; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; WANG T, 1995, J NEUROSCI, V15, P4796; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Wiedemann C, 1998, J NEUROSCI, V18, P5594; Xie KW, 1997, J NEUROSCI, V17, P2947; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858; Yazejian B, 1997, J NEUROSCI, V17, P2990; Zhao MD, 1996, BIOPHYS J, V70, P896, DOI 10.1016/S0006-3495(96)79633-9; Zhao YG, 1997, J COMP NEUROL, V377, P351, DOI 10.1002/(SICI)1096-9861(19970120)377:3<351::AID-CNE4>3.0.CO;2-1; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	58	96	101	4	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					99	112		10.1016/S0896-6273(01)00434-2	http://dx.doi.org/10.1016/S0896-6273(01)00434-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604142	Bronze			2022-12-28	WOS:000171525200012
J	Krylova, O; Herreros, J; Cleverley, KE; Ehler, E; Henriquez, JP; Hughes, SM; Salinas, PC				Krylova, O; Herreros, J; Cleverley, KE; Ehler, E; Henriquez, JP; Hughes, SM; Salinas, PC			WNT-3, expressed by motoneurons, regulates terminal arborization of neurotrophin-3-responsive spinal sensory neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; DORSAL-ROOT AXONS; SEMAPHORIN-III; SYNAPSIN-I; FAMILY; GUIDANCE; CORD; NEUROTROPHINS; COLLAPSIN; PROTEINS	Sensory axons from dorsal root ganglia neurons are guided to spinal targets by molecules differentially expressed along the dorso-ventral axis of the neural tube. NT-3-responsive muscle afferents; project ventrally, cease extending, and branch upon contact with motoneurons (MNs), their synaptic partners. We have identified WNT-3 as a candidate molecule that regulates this process. Wnt-3 is expressed by MNs of the lateral motor column at the time when MNs form synapses with sensory neurons. WNT-3 increases branching and growth cone size while inhibiting axonal extension in NT-3- but not NGF-responsive axons. Ventral spinal cord secretes factors with axonal remodeling activity for NT-3-responsive neurons. This activity is present at limb levels and is blocked by a WNT antagonist. We propose that WNT-3, expressed by MNs, acts as a retrograde signal that controls terminal arborization of muscle afferents.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 AY, England; Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England	Imperial College London; University of London; King's College London	Salinas, PC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 AY, England.	p.salinas@ic.ac.uk	Herreros, Judit/B-5809-2009; Hughes, Simon M/S-1073-2016	Herreros, Judit/0000-0003-4200-0853; Hughes, Simon M/0000-0001-8227-9225; Salinas, Patricia C./0000-0002-5748-083X; Ehler, Elisabeth/0000-0001-5646-5964				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; BRADLEY RS, 1993, J CELL BIOL, V123, P1857, DOI 10.1083/jcb.123.6.1857; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Brown AG, 1981, ORG SPINAL CORD; Chen HH, 1999, CURR OPIN NEUROBIOL, V9, P405, DOI 10.1016/S0959-4388(99)80061-0; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Cook G, 1998, CURR OPIN NEUROBIOL, V8, P64, DOI 10.1016/S0959-4388(98)80009-3; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Davenport RW, 1999, NAT NEUROSCI, V2, P254, DOI 10.1038/6360; Eide AL, 1997, ANAT EMBRYOL, V195, P237, DOI 10.1007/s004290050043; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; Hughes SM, 1999, CURR OPIN NEUROBIOL, V9, P54, DOI 10.1016/S0959-4388(99)80007-5; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KANDEL ER, 1991, PRINCIPLES NEURONAL; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KLEITMAN N, 1991, CULTURING NERVE CELL, P351; KUDO N, 1987, J PHYSIOL-LONDON, V389, P441, DOI 10.1113/jphysiol.1987.sp016665; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; Lentz SI, 1999, J NEUROSCI, V19, P1038; LIGHT AR, 1979, J COMP NEUROL, V186, P117, DOI 10.1002/cne.901860202; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MIMICS K, 1995, J COMP NEUROL, V355, P601; MU XJ, 1993, J NEUROSCI, V13, P4029; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Ozaki S, 1997, J COMP NEUROL, V380, P215; Perrin JM, 2001, AMBUL PEDIATR, V1, P1; PERRY MJ, 1991, J NEUROCYTOL, V20, P746, DOI 10.1007/BF01187848; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Sharma K, 1998, DEVELOPMENT, V125, P635; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; SNIDER WD, 1992, J NEUROSCI, V12, P3494; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Szebenyi G, 2001, J NEUROSCI, V21, P3932, DOI 10.1523/JNEUROSCI.21-11-03932.2001; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Windle WF, 1936, J COMP NEUROL, V63, P189, DOI 10.1002/cne.900630203; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Yagi T, 2000, GENE DEV, V14, P1169; ZHANG L, 1994, J NEUROSCI, V14, P5187	68	157	163	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1043	1056		10.1016/S0896-6273(02)00860-7	http://dx.doi.org/10.1016/S0896-6273(02)00860-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354395	Bronze			2022-12-28	WOS:000178040000006
J	Raoul, C; Estevez, AG; Nishimune, H; Cleveland, DW; deLapeyriere, O; Henderson, CE; Haase, G; Pettmann, B				Raoul, C; Estevez, AG; Nishimune, H; Cleveland, DW; deLapeyriere, O; Henderson, CE; Haase, G; Pettmann, B			Motoneuron death triggered by a specific pathway downstream of Fas: Potentiation by ALS-linked SOD1 mutations	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NITRIC-OXIDE SYNTHASE; SIGNAL-REGULATING KINASE; TRANSGENIC MOUSE MODEL; CU/ZN SUPEROXIDE-DISMUTASE; TROPHIC FACTOR DEPRIVATION; NEURONAL CELL-DEATH; IN-VITRO; NECROSIS-FACTOR; C-JUN	Death pathways restricted to specific neuronal classes could potentially allow for precise control of developmental neuronal death and also underlie the selectivity of neuronal loss in neurodegenerative disease. We show that Fas-triggered death of normal embryonic motoneurons requires transcriptional upregulation of neuronal NOS and involves Daxx, ASK1, and p38 together with the classical FADD/caspase-8 cascade. No evidence for involvement of this pathway was found in cells other than motoneurons. Motoneurons from transgenic mice overexpressing ALS-linked SOD1 mutants (G37R, G85R, or G93A) displayed increased susceptibility to activation of this pathway: they were more sensitive to Fas- or NO-triggered cell death but not to trophic deprivation or excitotoxic stimulation. Thus, triggering of a motoneuron-restricted cell death pathway by neighboring cells might contribute to motoneuron loss in ALS.	Univ Mediterranee, Dev Biol Inst Marseille, CNRS, INSERM,U382, F-13288 Marseille 09, France; Univ Alabama Birmingham, Ctr Free Rad Biol, Dept Physiol & Biophys, Birmingham, AL 35294 USA; Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Alabama System; University of Alabama Birmingham; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Henderson, CE (corresponding author), Univ Mediterranee, Dev Biol Inst Marseille, CNRS, INSERM,U382, Campus Luminy,Case 907, F-13288 Marseille 09, France.	chris@ibdm.univ-mrs.fr	Raoul, Cedric/H-6517-2016; Nishimune, Hiroshi/B-7226-2013; Cleveland, Don/AAN-9783-2021	Raoul, Cedric/0000-0003-0561-6851; Cleveland, Don/0000-0002-1934-3682; Henderson, Christopher/0000-0002-9936-3279				ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Anneser JMH, 2001, EXP NEUROL, V171, P418, DOI 10.1006/exnr.2001.7756; Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.0.CO;2-6; Babu BR, 1998, CURR OPIN CHEM BIOL, V2, P491, DOI 10.1016/S1367-5931(98)80125-7; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Borasio GD, 1998, NEUROREPORT, V9, P1435, DOI 10.1097/00001756-199805110-00034; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Catania MV, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-11-j0002.2001; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Ciesielski-Treska J, 2001, J BIOL CHEM, V276, P13113, DOI 10.1074/jbc.M009711200; Ciriolo MR, 2000, J BIOL CHEM, V275, P5065, DOI 10.1074/jbc.275.7.5065; Cisterni C, 2001, NEUROBIOL DIS, V8, P240, DOI 10.1006/nbdi.2000.0374; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DaSilva J, 1997, J BIOL CHEM, V272, P28373, DOI 10.1074/jbc.272.45.28373; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Estevez AG, 1998, PROG BRAIN RES, V118, P269; Estevez AG, 1998, J NEUROSCI, V18, P923; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Facchinetti F, 1999, NEUROSCIENCE, V90, P1483, DOI 10.1016/S0306-4522(98)00492-8; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Fisher GH, 1996, CELL IMMUNOL, V169, P99, DOI 10.1006/cimm.1996.0096; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Frey D, 2000, J NEUROSCI, V20, P2534; Ghadge GD, 1997, J NEUROSCI, V17, P8756; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HANDY RLC, 1995, BRIT J PHARMACOL, V116, P2349, DOI 10.1111/j.1476-5381.1995.tb15078.x; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Henderson C.E., 1995, NERVE CELL CULTURE P, P69; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kanamoto T, 2000, MOL CELL BIOL, V20, P196, DOI 10.1128/MCB.20.1.196-204.2000; Kennel PF, 1996, NEUROREPORT, V7, P1427, DOI 10.1097/00001756-199605310-00021; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Lowry KS, 2001, AMYOTROPH LATERAL SC, V2, P127, DOI 10.1080/146608201753275463; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MANTHORPE M, 1986, DEV BRAIN RES, V25, P191, DOI 10.1016/0165-3806(86)90208-7; Maroney AC, 1998, J NEUROSCI, V18, P104; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Matsushita K, 2000, J NEUROSCI, V20, P6879, DOI 10.1523/JNEUROSCI.20-18-06879.2000; MATSUYAMA T, 1995, MOL BRAIN RES, V34, P166, DOI 10.1016/0169-328X(95)00162-L; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Migheli A, 1999, NAT MED, V5, P966, DOI 10.1038/12381; MIGHELI A, 1994, J NEUROPATH EXP NEUR, V53, P606, DOI 10.1097/00005072-199411000-00008; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; Pettmann B, 1991, Growth Factors, V5, P209, DOI 10.3109/08977199109000285; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Raoul C, 2000, CURR OPIN NEUROBIOL, V10, P111, DOI 10.1016/S0959-4388(99)00055-0; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; Robertson J, 2001, J CELL BIOL, V155, P217, DOI 10.1083/jcb.200107058; ROTHSTEIN JD, 1995, ADV NEUROL, V68, P7; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sasaki M, 2000, P NATL ACAD SCI USA, V97, P8617, DOI 10.1073/pnas.97.15.8617; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Shaw PJ, 2000, J NEUROL, V247, P17; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Srinivasan A, 1998, J BIOL CHEM, V273, P4523, DOI 10.1074/jbc.273.8.4523; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Terrado J, 2000, EUR J NEUROSCI, V12, P3443, DOI 10.1046/j.1460-9568.2000.00240.x; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Upton-Rice MN, 1999, ANN NEUROL, V45, P413, DOI 10.1002/1531-8249(199903)45:3<413::AID-ANA24>3.0.CO;2-5; VARON S, 1981, DEV BRAIN RES, V1, P73, DOI 10.1016/0165-3806(81)90095-X; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yi FH, 2000, J NEUROIMMUNOL, V109, P211, DOI 10.1016/S0165-5728(00)00288-5; Zhang HQ, 1997, J MED CHEM, V40, P3869, DOI 10.1021/jm970550g	92	341	361	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1067	1083		10.1016/S0896-6273(02)00905-4	http://dx.doi.org/10.1016/S0896-6273(02)00905-4			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354397	Bronze			2022-12-28	WOS:000178040000008
J	Koo, SJ; Pfaff, SL				Koo, SJ; Pfaff, SL			Fine-tuning motor neuron properties: Signaling from the periphery	NEURON			English	Review							NEUROTROPHIC FACTOR; SPINAL-CORD; MOTONEURONS; EXPRESSION; SUBTYPES; MUSCLE	Our understanding of motor neuron differentiation is rapidly evolving. New studies demonstrate that cells in the periphery of the embryo provide feedback signals for spinal cord motor neurons that are instrumental in the timing and regulation of their development. Two papers in this issue of Neuron (Haase et al., 2002; Livet et al., 2002) identify a motor neuron survival factor, GDNF, and the ETS transcription factor, PEA3, as key components of a signal transduction pathway whose goals are 2-fold: to cluster motor pool-specific cell bodies and to promote axon arborization.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Chang Q, 2000, BRAIN RES REV, V32, P242, DOI 10.1016/S0165-0173(99)00085-5; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Garces A, 2000, J NEUROSCI, V20, P4992; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Oppenheim RW, 2000, J NEUROSCI, V20, P5001; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Soler RM, 1999, J NEUROSCI, V19, P9160; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2	21	15	16	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					823	826		10.1016/S0896-6273(02)00870-X	http://dx.doi.org/10.1016/S0896-6273(02)00870-X			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372278	Bronze			2022-12-28	WOS:000177779800006
J	Pirvola, U; Ylikoski, J; Trokovic, R; Hebert, JM; McConnell, SK; Partanen, J				Pirvola, U; Ylikoski, J; Trokovic, R; Hebert, JM; McConnell, SK; Partanen, J			FGFR1 is required for the development of the auditory sensory epithelium	NEURON			English	Article							FIBROBLAST-GROWTH-FACTOR; NEURAL STEM-CELLS; INNER-EAR; HAIR-CELLS; PROLIFERATION; GENE; MORPHOGENESIS; RECOMBINATION; TELENCEPHALON; DROSOPHILA	The mammalian auditory sensory epithelium, the organ of Corti, comprises the hair cells and supporting cells that are pivotal for hearing function. The origin and development of their precursors are poorly understood. Here we show that loss-of-function mutations in mouse fibroblast growth factor receptor 1 (Fgfr1) cause a dose-dependent disruption of the organ of Corti. Full inactivation of Fgfr1 in the inner ear epithelium by Foxg1-Cre-mediated deletion leads to an 85% reduction in the number of auditory hair cells. The primary cause appears to be reduced precursor cell proliferation in the early cochlear duct. Thus, during development, FGFR1 is required for the generation of the precursor pool, which gives rise to the auditory sensory epithelium. Our data also suggest that FGFR1 might have a distinct later role in intercellular signaling within the differentiating auditory sensory epithelium.	Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Otolaryngol, FIN-00014 Helsinki, Finland; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Helsinki; University of Helsinki; Stanford University	Pirvola, U (corresponding author), Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland.	ulla.pirvola@helsinki.fi	Trokovic, Ras/AAC-7309-2022	Trokovic, Ras/0000-0002-3065-6663; Partanen, Juha/0000-0001-8850-4825				Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Chen P, 1999, DEVELOPMENT, V126, P1581; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Fekete DM, 1998, J NEUROSCI, V18, P7811; Freeman M, 1997, DEVELOPMENT, V124, P261; Fritzsch B, 1997, J NEUROSCI, V17, P6213; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Lu WQ, 1999, J BIOL CHEM, V274, P12827, DOI 10.1074/jbc.274.18.12827; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; Martens DJ, 2000, J NEUROSCI, V20, P1085, DOI 10.1523/JNEUROSCI.20-03-01085.2000; Partanen J, 1998, GENE DEV, V12, P2332, DOI 10.1101/gad.12.15.2332; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Vendrell V, 2000, DEVELOPMENT, V127, P2011; VONBARTHELD CS, 1991, DEVELOPMENT, V113, P455; WERNER S, 1992, MOL CELL BIOL, V12, P82, DOI 10.1128/MCB.12.1.82; Wilkinson D. G., 1990, POSTIMPLANTATION MAM, P155; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032	36	217	227	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					671	680		10.1016/S0896-6273(02)00824-3	http://dx.doi.org/10.1016/S0896-6273(02)00824-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194867	Green Submitted, Bronze			2022-12-28	WOS:000177521000008
J	Murase, S; Mosser, E; Schuman, EM				Murase, S; Mosser, E; Schuman, EM			Depolarization drives beta-catenin into neuronal spines promoting changes in synaptic structure and function	NEURON			English	Article							CELL-CELL-ADHESION; PROTEIN-TYROSINE-PHOSPHATASE; LONG-TERM POTENTIATION; TUMOR-SUPPRESSOR PROTEIN; N-CADHERIN; ALPHA-CATENIN; POSTSYNAPTIC DENSITIES; COMPLEX-FORMATION; DENDRITIC SPINES; SILENT SYNAPSES	Activity-induced changes in adhesion molecules may coordinate presynaptic and postsynaptic plasticity. Here, we demonstrate that beta-catenin, which mediates interactions between cadherins and the actin cytoskeleton, moves from dendritic shafts into spines upon depolarization, increasing its association with cadherins. beta-catenin's redistribution was mimicked or prevented by a tyrosine kinase or phosphatase inhibitor, respectively. Point mutations of beta-catenin's tyrosine 654 altered the shaft/spine distribution: Y654F-beta-catenin-GFP (phosphorylation-prevented) was concentrated in spines, whereas Y654E-beta-catenin-GFP (phosphorylation-mimic) accumulated in dendritic shafts. In Y654F-expressing neurons, the PSD-95 or associated synapsin-I clusters were larger than those observed in either wild-type-beta-catenin or also Y654E-expressing neurons. Y654F-expressing neurons exhibited a higher minifrequency. Thus, neural activity induces beta-catenin's redistribution into spines, where it interacts with cadherin to influence synaptic size and strength.	CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 216-76,1200 E Calif Blvd, Pasadena, CA 91125 USA.		Murase, Sachiko/AAC-5496-2022; Schuman, Erin M/D-6204-2011	Murase, Sachiko/0000-0002-9078-0471; 				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Balsamo J, 1998, J CELL BIOL, V143, P523, DOI 10.1083/jcb.143.2.523; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; BEESLEY PW, 1995, J NEUROCHEM, V64, P2288; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Bonvini P, 2001, CANCER RES, V61, P1671; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; COHEN RS, 1977, J CELL BIOL, V74, P181, DOI 10.1083/jcb.74.1.181; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Fuchs M, 1996, J BIOL CHEM, V271, P16712, DOI 10.1074/jbc.271.28.16712; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; HAMAGUCHI M, 1993, EMBO J, V12, P307, DOI 10.1002/j.1460-2075.1993.tb05658.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1988, J NEUROSCI, V8, P4455; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Honjo Y, 2000, GENES CELLS, V5, P309, DOI 10.1046/j.1365-2443.2000.00327.x; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; Muller T, 1999, J BIOL CHEM, V274, P10173, DOI 10.1074/jbc.274.15.10173; Munemitsu S, 1996, MOL CELL BIOL, V16, P4088; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pathre P, 2001, J NEUROSCI RES, V63, P143, DOI 10.1002/1097-4547(20010115)63:2<143::AID-JNR1006>3.0.CO;2-1; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SOMMERS CL, 1994, CANCER RES, V54, P3544; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2	60	282	289	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					91	105		10.1016/S0896-6273(02)00764-X	http://dx.doi.org/10.1016/S0896-6273(02)00764-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123611	Bronze			2022-12-28	WOS:000176601800013
J	Giasson, BI; Duda, JE; Quinn, SM; Zhang, B; Trojanowski, JQ; Lee, VMY				Giasson, BI; Duda, JE; Quinn, SM; Zhang, B; Trojanowski, JQ; Lee, VMY			Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein	NEURON			English	Article							MULTIPLE SYSTEM ATROPHY; PERIPHERAL NERVOUS-SYSTEM; CORTICAL LEWY BODIES; PARKINSONS-DISEASE; TRANSGENIC MICE; ALZHEIMERS-DISEASE; PROTEIN DOMAINS; MOUSE MODEL; WILD-TYPE; NEUROPATHOLOGY	alpha-Synucleinopathies are neurodegenerative disorders that range pathologically from the demise of select groups of nuclei to pervasive degeneration throughout the neuraxis. Although mounting evidence suggests that alpha-synuclein lesions lead to neurodegeneration, this remains controversial. To explore this issue, we generated transgenic mice expressing wild-type and A53T human alpha-synuclein in CNS neurons. Mice expressing mutant, but not wild-type, alpha-synuclein developed a severe and complex motor impairment leading to paralysis and death. These animals developed age-dependent intracytoplasmic neuronal alpha-synuclein inclusions paralleling disease onset, and the alpha-synuclein inclusions recapitulated features of human counterparts. Moreover, immunoelectron microscopy revealed that the alpha-synuclein inclusions contained 10-16 nm wide fibrils similar to human pathological inclusions. These mice demonstrate that A53T alpha-synuclein leads to the formation of toxic filamentous alpha-synuclein neuronal inclusions that cause neurodegeneration.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Philadelphia Vet Adm Hosp, Parkinsons Dis Res Educ & Clin Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, 3600 Spruce St, Philadelphia, PA 19104 USA.							Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Baba M, 1998, AM J PATHOL, V152, P879; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; DUDA JE, 2002, IN PRESS ANN NEUROL; DUDA JE, 2002, IN PRESS ACTA NEUROP; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, EXP NEUROL, V172, P354, DOI 10.1006/exnr.2001.7805; Golbe LI, 1999, MOVEMENT DISORD, V14, P6, DOI 10.1002/1531-8257(199901)14:1<6::AID-MDS1004>3.0.CO;2-L; Golbe LI, 1996, ANN NEUROL, V40, P767, DOI 10.1002/ana.410400513; Hsu LJ, 1998, J NEUROCHEM, V71, P338; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; LOVE S, 1992, NEUROPATH APPL NEURO, V18, P585, DOI 10.1111/j.1365-2990.1992.tb00830.x; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RODRIGUEZ EM, 1984, HISTOCHEMISTRY, V81, P253, DOI 10.1007/BF00495636; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SCHMIDT ML, 1991, AM J PATHOL, V139, P53; Shoji M, 2000, J NEUROL NEUROSUR PS, V68, P605, DOI 10.1136/jnnp.68.5.605; SIMUNI T, 2000, NEURODEGENERATIVE DE, P193; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6	49	875	911	2	43	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					521	533		10.1016/S0896-6273(02)00682-7	http://dx.doi.org/10.1016/S0896-6273(02)00682-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062037	Bronze			2022-12-28	WOS:000175665700007
J	Jackson, GR; Wiedau-Pazos, M; Sang, TK; Wagle, N; Brown, CA; Massachi, S; Geschwind, DH				Jackson, GR; Wiedau-Pazos, M; Sang, TK; Wagle, N; Brown, CA; Massachi, S; Geschwind, DH			Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila	NEURON			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PAIRED HELICAL FILAMENTS; DISEASE-LIKE PHOSPHORYLATION; NUCLEAR LAMIN ISOFORMS; HUMAN BRAIN-TAU; ALZHEIMERS-DISEASE; BETA-CATENIN; NEURONAL APOPTOSIS; PROTEIN-KINASE; NEURODEGENERATIVE DISEASES	Pathologic alterations in the microtubule-associated protein tau have been implicated in a number of neurodegenerative disorders, including Alzheimer's disease (AD), progressive supranuclear palsy (PSP), and frontotemporal dementia (FTD). Here, we show that tau overexpression, in combination with phosphorylation by the Drosophila glycogen synthase kinase-3 (GSK-3) homolog and wingless pathway component (Shaggy), exacerbated neurodegeneration induced by tau overexpression alone, leading to neurofibrillary pathology in the fly. Furthermore, manipulation of other wingless signaling molecules downstream from shaggy demonstrated that components of the Wnt signaling pathway modulate neurodegeneration induced by tau pathology in vivo but suggested that tau phosphorylation by GSK-3beta differs from canonical Wnt effects on beta-catenin stability and TCF activity. The genetic system we have established provides a powerful reagent for identification of novel modifiers of tau-induced neurodegeneration that may serve as future therapeutic targets.	Univ Calif Los Angeles, Sch Med, Dept Neurol, Neurogenet Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jackson, GR (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurol, Neurogenet Program, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	grjackson@mednet.ucla.edu	Wagle, Nikhil/Q-7428-2019	Sang, Tzu-Kang/0000-0001-7924-9359				Ahmed Y, 1998, CELL, V93, P1171, DOI 10.1016/S0092-8674(00)81461-0; Anderton BH, 2000, MOL MED TODAY, V6, P54, DOI 10.1016/S1357-4310(99)01640-8; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BRAAK H, 1994, NEUROBIOL AGING, V15, P355, DOI 10.1016/0197-4580(94)90032-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brion JP, 2001, BIOCHEM SOC SYMP, V67, P81; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; CROWTHER RA, 1992, FEBS LETT, V309, P199, DOI 10.1016/0014-5793(92)81094-3; Dale TC, 1998, BIOCHEM J, V329, P209; Elyaman W, 2002, EUR J NEUROSCI, V15, P651, DOI 10.1046/j.1460-9568.2002.01899.x; Fan SS, 1997, DEVELOPMENT, V124, P1497; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fortini ME, 2000, TRENDS GENET, V16, P161, DOI 10.1016/S0168-9525(99)01939-3; Freeman M, 2001, EMBO REP, V2, P157, DOI 10.1093/embo-reports/kve019; Furukawa K, 2000, NEUROREPORT, V11, P57, DOI 10.1097/00001756-200001170-00011; Geschwind DH, 2001, AM J MED GENET, V101, P370; Geschwind DH, 2001, ANN NEUROL, V50, P741, DOI 10.1002/ana.10024; Godemann R, 1999, FEBS LETT, V454, P157, DOI 10.1016/S0014-5793(99)00741-3; Goedert M, 1998, NEURON, V21, P955, DOI 10.1016/S0896-6273(00)80615-7; Goedert M, 2000, ANN NY ACAD SCI, V920, P74; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Greaves S, 1999, GENETICS, V153, P1753; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hasegawa S, 2002, P NATL ACAD SCI USA, V99, P297, DOI 10.1073/pnas.012264999; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; HAY BA, 1994, DEVELOPMENT, V120, P2121; Heidary G, 2001, MECH DEVELOP, V108, P171, DOI 10.1016/S0925-4773(01)00487-7; Hetman M, 2000, J NEUROSCI, V20, P2567; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Houlden H, 1999, ANN NEUROL, V46, P243, DOI 10.1002/1531-8249(199908)46:2<243::AID-ANA14>3.0.CO;2-L; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; JACKSON GR, 2000, MOL MECH NEURODEGENE, P373; JUDD BH, 1972, GENETICS, V71, P139; Killick R, 2001, J BIOL CHEM, V276, P48554, DOI 10.1074/jbc.M108332200; Kirschenbaum F, 2001, J BIOL CHEM, V276, P30701, DOI 10.1074/jbc.M102849200; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; MA CY, 1995, DEVELOPMENT, V121, P2279; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; McCall K, 1998, SCIENCE, V279, P230, DOI 10.1126/science.279.5348.230; Morris HR, 2001, ARCH NEUROL-CHICAGO, V58, P1813, DOI 10.1001/archneur.58.11.1813; Mudher A, 2001, J NEUROSCI, V21, P4987, DOI 10.1523/JNEUROSCI.21-14-04987.2001; MULOT SFC, 1994, FEBS LETT, V349, P359, DOI 10.1016/0014-5793(94)00702-0; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; OBERHAMMER FA, 1994, J CELL BIOL, V126, P827, DOI 10.1083/jcb.126.4.827; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pai LM, 1997, DEVELOPMENT, V124, P2255; Palacino JJ, 2001, J BIOL CHEM, V276, P38563, DOI 10.1074/jbc.M105376200; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sang TK, 2002, DEVELOPMENT, V129, P143; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; SMITH DE, 1989, J CELL BIOL, V108, P255, DOI 10.1083/jcb.108.2.255; SMITH DE, 1987, J CELL BIOL, V105, P771, DOI 10.1083/jcb.105.2.771; SPERBER BR, 1995, NEUROSCI LETT, V197, P149, DOI 10.1016/0304-3940(95)11902-9; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Steitz MC, 1998, DEV BIOL, V197, P218, DOI 10.1006/dbio.1998.8884; Su JH, 2000, EXP NEUROL, V163, P9, DOI 10.1006/exnr.2000.7340; Sun W, 2002, J BIOL CHEM, V277, P11933, DOI 10.1074/jbc.M107182200; Therrien M, 1999, P NATL ACAD SCI USA, V96, P13259, DOI 10.1073/pnas.96.23.13259; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; WIESCHAUS E, 1987, CELL, V49, P177, DOI 10.1016/0092-8674(87)90558-7; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Williams DW, 2000, J COMP NEUROL, V428, P630, DOI 10.1002/1096-9861(20001225)428:4<630::AID-CNE4>3.0.CO;2-X; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	89	387	399	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 16	2002	34	4					509	519		10.1016/S0896-6273(02)00706-7	http://dx.doi.org/10.1016/S0896-6273(02)00706-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062036	Bronze			2022-12-28	WOS:000175665700006
J	Chklovskii, DB; Schikorski, T; Stevens, CF				Chklovskii, DB; Schikorski, T; Stevens, CF			Wiring optimization in cortical circuits	NEURON			English	Article							COMPONENT PLACEMENT; ORIENTATION; PATTERNS; NEURONS; ARBORS	Wiring a brain presents a formidable problem because neural circuits require an enormous number of fast and durable connections. We propose that evolution was likely to have optimized neural circuits to minimize conduction delays in axons, passive cable attenuation in dendrites, and the length of "wire" used to construct circuits, and to have maximized the density of synapses. Here we ask the question: "What fraction of the volume should be taken up by axons and dendrites (i.e., wire) when these variables are at their optimal values?" The biophysical properties of axons and dendrites dictate that wire should occupy 3/5 of the volume in an optimally wired gray matter. We have measured the fraction of the volume occupied by each cellular component and find that the volume of wire is close to the predicted optimal value.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Salk Institute; Cold Spring Harbor Laboratory	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@salk.edu		Schikorski, Thomas/0000-0003-3902-2461				ALLMAN JM, 1974, BRAIN RES, V76, P247, DOI 10.1016/0006-8993(74)90458-2; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BEKKERS JM, 1990, PROG BRAIN RES, V83, P37; Braitenberg V, 1998, CORTEX STAT GEOMETRY; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; CHERNIAK C, 1995, TRENDS NEUROSCI, V18, P522, DOI 10.1016/0166-2236(95)98373-7; CHERNIAK C, 1992, BIOL CYBERN, V66, P503, DOI 10.1007/BF00204115; Chklovskii DB, 2000, VISION RES, V40, P1765, DOI 10.1016/S0042-6989(00)00023-7; Chklovskii DB, 2000, J NEUROPHYSIOL, V83, P2113, DOI 10.1152/jn.2000.83.4.2113; COWEY A, 1979, Q J EXP PSYCHOL, V31, P1, DOI 10.1080/14640747908400703; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; IKARI K, 1981, FOLIA PSYCHIAT NEU J, V35, P477; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; MITCHISON G, 1991, P ROY SOC B-BIOL SCI, V245, P151, DOI 10.1098/rspb.1991.0102; RALL W, 1992, PHYSIOL REV, V72, pS159, DOI 10.1152/physrev.1992.72.suppl_4.S159; Ramon y Cajal S., 1995, HISTOLOGY NERVOUS SY, V1; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; RUPPIN E, 1993, BIOL CYBERN, V70, P89, DOI 10.1007/BF00202570; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655	21	316	318	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					341	347		10.1016/S0896-6273(02)00679-7	http://dx.doi.org/10.1016/S0896-6273(02)00679-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988166	Bronze			2022-12-28	WOS:000175214700006
J	Nestler, EJ; Barrot, M; DiLeone, RJ; Eisch, AJ; Gold, SJ; Monteggia, LM				Nestler, EJ; Barrot, M; DiLeone, RJ; Eisch, AJ; Gold, SJ; Monteggia, LM			Neurobiology of depression	NEURON			English	Review							ANTIDEPRESSANT ADMINISTRATION INCREASES; BRAIN-STIMULATION REWARD; LONG-TERM POTENTIATION; NEUROTROPHIC FACTOR; MAJOR DEPRESSION; MESSENGER-RNA; EXTENDED AMYGDALA; RAT HIPPOCAMPUS; ANIMAL-MODELS; STRESS	Current treatments for depression are inadequate for many individuals, and progress in understanding the neurobiology of depression is slow. Several promising hypotheses of depression and antidepressant action have been formulated recently. These hypotheses are based largely on dysregulation of the hypothalamic-pituitary-adrenal axis and hippocampus and implicate corticotropin-releasing factor, glucocorticoids, brain-derived neurotrophic factor, and CREB. Recent work has looked beyond hippocampus to other brain areas that are also likely involved. For example, nucleus accumbens, amygdala, and certain hypothalamic nuclei are critical in regulating motivation, eating, sleeping, energy level, circadian rhythm, and responses to rewarding and aversive stimuli, which are all abnormal in depressed patients. A neurobiologic understanding of depression also requires identification of the genes that make individuals vulnerable or resistant to the syndrome. These advances will fundamentally improve the treatment and prevention of depression.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu		DiLeone, Ralph/0000-0002-4770-2590; Eisch, Amelia/0000-0001-6476-5385				Ahima RS, 2001, TRENDS MOL MED, V7, P205, DOI 10.1016/S1471-4914(01)01989-X; AKISKAL HS, 2000, COMPREHENSIVE TXB PS, P1284; Altar CA, 1999, TRENDS PHARMACOL SCI, V20, P59, DOI 10.1016/S0165-6147(99)01309-7; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Belanoff JK, 2001, J CLIN PSYCHOPHARM, V21, P516, DOI 10.1097/00004714-200110000-00009; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Blazer DG, 2000, COMPR TEXTB PSYCHIAT, V7th, P1298; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; BROWN AS, 1993, J NEURAL TRANSM-GEN, V91, P75, DOI 10.1007/BF01245227; Burmeister M, 1999, BIOL PSYCHIAT, V45, P522, DOI 10.1016/S0006-3223(98)00316-3; Cahill L, 1999, NEURON, V23, P227, DOI 10.1016/S0896-6273(00)80774-6; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chen ACH, 2001, BIOL PSYCHIAT, V49, P753, DOI 10.1016/S0006-3223(00)01114-8; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; CONTI AC, 2002, IN PRESS J NEUROSCI; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; de Olmos JS, 1999, ANN NY ACAD SCI, V877, P1; DEKLOET ER, 1988, PROG BRAIN RES, V73, P101; Di Chiara G, 1999, BIOL PSYCHIAT, V46, P1624, DOI 10.1016/S0006-3223(99)00236-X; Dowlatshahi D, 1998, LANCET, V352, P1754, DOI 10.1016/S0140-6736(05)79827-5; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Francis DD, 1999, CURR OPIN NEUROBIOL, V9, P128, DOI 10.1016/S0959-4388(99)80016-6; Frazer A, 1997, J CLIN PSYCHOPHARM, V17, pS2, DOI 10.1097/00004714-199704001-00002; Fuchs E, 2000, EUR J NEUROSCI, V12, P2211, DOI 10.1046/j.1460-9568.2000.00130.x; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Gonzalez MI, 1996, PEPTIDES, V17, P171, DOI 10.1016/0196-9781(95)02092-6; Hall J, 2001, EUR J NEUROSCI, V13, P1453, DOI 10.1046/j.0953-816x.2001.01531.x; HALL RD, 1977, NEUROSCI RES PROG B, V15, P139; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Hitzemann R, 2000, ALCOHOL RES HEALTH, V24, P149; Holsboer F, 2001, J AFFECT DISORDERS, V62, P77, DOI 10.1016/S0165-0327(00)00352-9; Horger BA, 1999, J NEUROSCI, V19, P4110; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; JENTSCH JD, 2002, IN PRESS BIOL PSYCHI; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kasckow JW, 2001, PEPTIDES, V22, P845, DOI 10.1016/S0196-9781(01)00399-0; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Korte M, 1996, J PHYSIOLOGY-PARIS, V90, P157, DOI 10.1016/S0928-4257(97)81415-5; Kuhar MJ, 1999, TRENDS NEUROSCI, V22, P316, DOI 10.1016/S0166-2236(98)01377-0; Kuroda Y, 1998, MOL BRAIN RES, V59, P35, DOI 10.1016/S0169-328X(98)00130-2; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liotti M, 2001, J CLIN EXP NEUROPSYC, V23, P121, DOI 10.1076/jcen.23.1.121.1223; Lucki I, 2001, PSYCHOPHARMACOLOGY, V153, P395, DOI 10.1007/s002130000561; Macey DJ, 2000, BRAIN RES, V866, P82, DOI 10.1016/S0006-8993(00)02229-0; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Monzon ME, 2001, PEPTIDES, V22, P1043, DOI 10.1016/S0196-9781(01)00439-9; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; NESTLER EJ, 1989, J NEUROCHEM, V53, P1644, DOI 10.1111/j.1471-4159.1989.tb08564.x; Nibuya M, 1996, J NEUROSCI, V16, P2365; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Norrholm SD, 2001, SYNAPSE, V42, P151, DOI 10.1002/syn.10006; Pallis E, 2001, EUR J NEUROSCI, V14, P763, DOI 10.1046/j.0953-816x.2001.01698.x; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; Rajkowska G, 2000, PROG BRAIN RES, V126, P397; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; SACHAR EJ, 1979, ANNU REV NEUROSCI, V2, P505, DOI 10.1146/annurev.ne.02.030179.002445; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Sanders A. R., 1999, NEUROBIOLOGY MENTAL, P299; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SHAWLUTCHMAN TZ, 2002, IN PRESS J NEUROSCI; Sheline YI, 1999, J NEUROSCI, V19, P5034; SHIRAYAMA Y, IN PRESS J NEUROSCI; Silva AJ, 1999, BRAIN RES BULL, V50, P441, DOI 10.1016/S0361-9230(99)00124-0; SMITH MA, 1995, ENDOCRINOLOGY, V136, P3743, DOI 10.1210/en.136.9.3743; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Takahashi M, 1999, J NEUROSCI, V19, P610; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Thome J, 2000, J NEUROSCI, V20, P4030; Uramura K, 2001, NEUROREPORT, V12, P1885, DOI 10.1097/00001756-200107030-00024; Vaidya VA, 1997, J NEUROSCI, V17, P2785; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; WILLNER P, 1995, ADV BIOCHEM PSYCHOPH, V49, P19; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Zhu MY, 1999, BIOL PSYCHIAT, V46, P1275, DOI 10.1016/S0006-3223(99)00135-3; 2000, DIAGNOSTIC STAT MANU, V4	88	2306	2427	19	653	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 28	2002	34	1					13	25		10.1016/S0896-6273(02)00653-0	http://dx.doi.org/10.1016/S0896-6273(02)00653-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931738	Bronze			2022-12-28	WOS:000174695100006
J	Sokolov, M; Lyubarsky, AL; Strissel, KJ; Savchenko, AB; Govardovskii, VI; Pugh, EN; Arshavsky, VY				Sokolov, M; Lyubarsky, AL; Strissel, KJ; Savchenko, AB; Govardovskii, VI; Pugh, EN; Arshavsky, VY			Massive light-driven translocation of transducin between the two major compartments of rod cells: A novel mechanism of light adaptation	NEURON			English	Article							DARK-ADAPTATION; OUTER SEGMENTS; A-WAVE; CRAYFISH PHOTORECEPTORS; RETINAL RODS; CYCLIC-GMP; RAT RETINA; G-PROTEIN; PHOTOTRANSDUCTION; ELECTRORETINOGRAM	We report a new cellular mechanism of rod photoreceptor adaptation in vivo, which is triggered by daylight levels of illumination. The mechanism involves a massive light-dependent translocation of the photoreceptor-specific G protein, transducin, between the functional compartments of rods. To characterize the mechanism, we developed a novel technique that combines serial tangential cryodissection of the rat retina with Western blot analysis of protein distribution in the sections. Up to 90% of transducin translocates from rod outer segments to other cellular compartments on the time scale of tens of minutes. The reduction in the transducin content of the rod outer segments is accompanied by a corresponding reduction in the amplification of the rod photoresponse, allowing rods to operate in illumination up to 10-fold higher than would otherwise be possible.	Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; University of Pennsylvania	Arshavsky, VY (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA.		Govardovskii, Victor I/K-2655-2018		NEI NIH HHS [EY-02660, EY 10336] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010336, R01EY002660] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BLAZYNSKI C, 1986, J BIOL CHEM, V261, P14142; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; DEAZEREDO FAM, 1981, J BIOL CHEM, V256, P2731; Fain GL, 1996, TRENDS NEUROSCI, V19, P502, DOI 10.1016/S0166-2236(96)10056-4; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; GOVARDOVSKII VI, 1981, BIOPHYS STRUCT MECH, V7, P125, DOI 10.1007/BF00539174; GrayKeller MP, 1996, NEURON, V17, P323, DOI 10.1016/S0896-6273(00)80163-4; HAGINS WA, 1970, BIOPHYS J, V10, P380, DOI 10.1016/S0006-3495(70)86308-1; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; HOOD DC, 1993, VISION RES, V33, P1605, DOI 10.1016/0042-6989(93)90027-T; JONES GJ, 1995, J PHYSIOL-LONDON, V487, P441, DOI 10.1113/jphysiol.1995.sp020891; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; KUHN H, 1981, CURR TOP MEMBR TRANS, V15, P171; LAGNADO L, 1994, NATURE, V367, P273, DOI 10.1038/367273a0; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Leibrock CS, 1998, EYE, V12, P511, DOI 10.1038/eye.1998.139; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; LOLLEY RN, 1975, EXP EYE RES, V20, P585, DOI 10.1016/0014-4835(75)90225-0; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; ORGANISCIAK DT, 1991, EXP EYE RES, V53, P773, DOI 10.1016/0014-4835(91)90113-S; ORR HT, 1976, P NATL ACAD SCI USA, V73, P4442, DOI 10.1073/pnas.73.12.4442; Pennesi ME, 1998, INVEST OPHTH VIS SCI, V39, P2148; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Rodieck R.W., 1998, 1 STEPS SEEING; ROOF DJ, 1988, SCIENCE, V241, P845, DOI 10.1126/science.3136548; Smith NP, 1997, VISION RES, V37, P2943, DOI 10.1016/S0042-6989(97)00094-1; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Terakita A, 1996, VISUAL NEUROSCI, V13, P539, DOI 10.1017/S095252380000821X; Terakita A, 1998, J COMP PHYSIOL A, V183, P411, DOI 10.1007/s003590050267; Thomas MM, 1999, J PHYSIOL-LONDON, V518, P479, DOI 10.1111/j.1469-7793.1999.0479p.x; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216	40	287	295	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					95	106		10.1016/S0896-6273(02)00636-0	http://dx.doi.org/10.1016/S0896-6273(02)00636-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931744	Bronze			2022-12-28	WOS:000174695100012
J	Lei, SB; McBain, CJ				Lei, SB; McBain, CJ			Distinct NMDA receptors provide differential modes of transmission at mossy fiber-interneuron synapses	NEURON			English	Article							LONG-TERM POTENTIATION; CA2+-PERMEABLE AMPA RECEPTORS; CALCIUM-PERMEABLE AMPA; D-ASPARTATE RECEPTOR; PYRAMIDAL CELLS; SILENT SYNAPSES; HIPPOCAMPAL CA3; INWARD RECTIFICATION; DENTATE GYRUS; NR2A SUBUNIT	Dentate gyrus granule cells innervate inhibitory interneurons via a continuum of synapses comprised of either Ca2+-impermeable (CI) or Ca2+-permeable (CP) AMPA receptors. Synapses at the extreme ends of this continuum engage distinct postsynaptic responses, with activity at CI synapses being strongly influenced by NMDA receptor activation. NMDARs at CI synapses have a lower NR2B subunit composition and a higher open probability, which generate larger amplitude and more rapid EPSCs than their CP counterparts. A novel form of NMDAR-dependent long-term depression (iLTD) is associated with CI-mossy fiber synapses, whereas iLTD at CP synapses is dependent on Ca2+-permeable AMPA receptor activation. Induction of both forms of iLTD required elevation of postsynaptic calcium. Thus mossy fibers engage CA3 interneurons via multiple synapse types that will act to expand the computational repertoire of the mossy fiber-CA3 network.	NICHHD, Lab Cellular & Mol Neurophysiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	McBain, CJ (corresponding author), NICHHD, Lab Cellular & Mol Neurophysiol, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	chrismcb@codon.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRAGIN A, 1995, J NEUROPHYSIOL, V73, P1691, DOI 10.1152/jn.1995.73.4.1691; Cathala L, 2000, J NEUROSCI, V20, P5899, DOI 10.1523/JNEUROSCI.20-16-05899.2000; CHATTARJI S, 1989, BRAIN RES, V495, P145, DOI 10.1016/0006-8993(89)91228-6; Dingledine R, 1999, PHARMACOL REV, V51, P7; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Flint AC, 1997, J NEUROSCI, V17, P2469; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; He Y, 1998, EXP NEUROL, V150, P1, DOI 10.1006/exnr.1997.6720; HERLITZE S, 1993, NEURON, V10, P1131, DOI 10.1016/0896-6273(93)90061-U; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; LANGDON RB, 1995, J NEUROBIOL, V26, P370, DOI 10.1002/neu.480260309; Leranth C, 1996, NEUROSCIENCE, V70, P631, DOI 10.1016/S0306-4522(96)83003-X; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; Pickard L, 2000, J NEUROSCI, V20, P7922; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; ROBINSON HPC, 1991, BIOPHYS J, V59, P295, DOI 10.1016/S0006-3495(91)82223-8; Rohrbough J, 1999, J NEUROSCI, V19, P8528; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	58	124	126	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 14	2002	33	6					921	933		10.1016/S0896-6273(02)00608-6	http://dx.doi.org/10.1016/S0896-6273(02)00608-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906698	Bronze			2022-12-28	WOS:000174389600009
J	Nonet, ML				Nonet, ML			AEXpulsing a retrograde signal	NEURON			English	Editorial Material							CAENORHABDITIS-ELEGANS; SYNAPTIC TRANSMISSION; UNC-13; RELEASE	A variety of secreted components have been identified as retrograde signals mediating diverse aspects of synaptic development, maintenance, and plasticity; however, little is known about the mechanisms mediating the release of secreted retrograde signals. Doi and Iwasaki (this issue of Neuron) implicate AEX-1, a protein distantly related to the UNC-13/Munc13 family, as an attractive candidate regulator of the retrograde release machinery in muscle.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nonet, ML (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.							Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; Doi M, 2002, NEURON, V33, P249, DOI 10.1016/S0896-6273(01)00587-6; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaefer AM, 2001, CURR OPIN NEUROBIOL, V11, P127, DOI 10.1016/S0959-4388(00)00183-5; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Thacker C, 2000, BIOESSAYS, V22, P545, DOI 10.1002/(SICI)1521-1878(200006)22:6&lt;545::AID-BIES7&gt;3.0.CO;2-F; THOMAS JH, 1990, GENETICS, V124, P855	13	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					155	156		10.1016/S0896-6273(02)00562-7	http://dx.doi.org/10.1016/S0896-6273(02)00562-7			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804562	Bronze			2022-12-28	WOS:000173387700002
J	Casado, M; Isope, P; Ascher, P				Casado, M; Isope, P; Ascher, P			Involvement of presynaptic N-methyl-D-aspartate receptors in cerebellar long-term depression	NEURON			English	Article							PURKINJE-CELL SYNAPSE; RAT HIPPOCAMPUS; DENDRITIC SPINES; CALCIUM-RELEASE; NMDA RECEPTORS; ACID RECEPTOR; AREA CA1; GLUTAMATE; POTENTIATION; STIMULATION	At the cerebellar synapses between parallel fibers (PFs) and Purkinje cells (PCs), long-term depression (LTD) of the excitatory synaptic current has been assumed to be Independent of the N-methyl-D-aspartate (NMDA) receptor activation because PCs lack NMDA receptors. However, we now report that LTD is suppressed by NMDA receptor antagonists that act on presynaptic NMDA receptors of the PFs. This effect is still observed when the input Is restricted to a single fiber. Therefore, LTD does not require the spatial integration of multiple inputs. In contrast, it involves a temporal integration, since reliable LTD induction requires the PFs to fire two action potentials in close succession. This implies that LTD will selectively depress the response to a burst of presynaptic action potentials.	Ecole Normale Super, Neurobiol Lab, CNRS, UMR 8544, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Casado, M (corresponding author), Ecole Normale Super, Neurobiol Lab, CNRS, UMR 8544, 46 Rue Ulm, F-75005 Paris, France.			Casado, Mariano/0000-0001-8049-8096; Isope, Philippe/0000-0002-0630-5935				Atluri PP, 1996, J NEUROSCI, V16, P5661; Barbour B, 2000, J NEUROSCI METH, V103, P199, DOI 10.1016/S0165-0270(00)00318-6; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Boxall AR, 1996, EUR J NEUROSCI, V8, P2209, DOI 10.1111/j.1460-9568.1996.tb00743.x; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Casado M, 2000, P NATL ACAD SCI USA, V97, P11593, DOI 10.1073/pnas.200354297; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; Dehnes Y, 1998, J NEUROSCI, V18, P3606; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Dzubay JA, 1996, J NEUROSCI, V16, P4129; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Hamann M, 1996, EUR J NEUROSCI, V8, P1510, DOI 10.1111/j.1460-9568.1996.tb01613.x; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pananceau M, 1997, BRAIN RES, V752, P255, DOI 10.1016/S0006-8993(96)01471-0; ROSEMUND C, 1992, J NEUROPHYSIOL, V68, P1901, DOI 10.1152/jn.1992.68.5.1901; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SALT TE, 1986, NATURE, V322, P263, DOI 10.1038/322263a0; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	41	136	139	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					123	130		10.1016/S0896-6273(01)00568-2	http://dx.doi.org/10.1016/S0896-6273(01)00568-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779485	Bronze			2022-12-28	WOS:000173106200015
J	Zemelman, BV; Lee, GA; Ng, M; Miesenbock, G				Zemelman, BV; Lee, GA; Ng, M; Miesenbock, G			Selective photostimulation of genetically ChARGed neurons	NEURON			English	Article							VISUAL TRANSDUCTION; DROSOPHILA PHOTORECEPTORS; PHOTOTRANSDUCTION CASCADE; SIGNALING COMPLEX; BOVINE RHODOPSIN; XENOPUS-OOCYTES; BINDING PROTEIN; CA2+ CHANNEL; COMPOUND EYE; GENE	To permit direct functional analyses of neural circuits, we have developed a method for stimulating groups of genetically designated neurons optically. Coexpression of the Drosophila photoreceptor genes encoding arrestin-2, rhodopsin (formed by liganding opsin with retinal), and the alpha subunit of the cognate heterotrimeric G protein-an explosive combination we term "chARGe" - sensitizes generalist vertebrate neurons to light. Illumination of a mixed population of neurons elicits action potentials selectively and cell-autonomously in its genetically chARGed members. In contrast to bath-applied photostimulants or caged neurotransmitters, which act indiscriminately throughout the illuminated volume, chARGe localizes the responsiveness to light. Distributed activity may thus be fed directly into a circumscribed population of neurons in Intact tissue, irrespective of the spatial arrangement of its elements.	Mem Sloan Kettering Canc Ctr, Lab Neural Syst, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Miesenbock, G (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Neural Syst, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.			Miesenboeck, Gero/0000-0003-2940-3228; Zemelman, Boris/0000-0003-2463-4887				[Anonymous], [No title captured]; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Bohm A, 1997, CURR OPIN BIOTECH, V8, P480, DOI 10.1016/S0958-1669(97)80072-9; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Crick F, 1999, PHILOS T ROY SOC B, V354, P2021, DOI 10.1098/rstb.1999.0541; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; FARBER IC, 1983, SCIENCE, V222, P1025, DOI 10.1126/science.6648515; FROMHERZ P, 1995, PHYS REV LETT, V75, P1670, DOI 10.1103/PhysRevLett.75.1670; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARDIE RC, 1983, PROGR SENSORY PHYSL, P1; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; HYDE DR, 1990, P NATL ACAD SCI USA, V87, P1008, DOI 10.1073/pnas.87.3.1008; INOUE H, 1985, BIOCHEM BIOPH RES CO, V132, P513, DOI 10.1016/0006-291X(85)91163-5; Julesz B., 1971, FDN CYCLOPEAN PERCEP; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; KISELEV A, 1994, SCIENCE, V266, P1369, DOI 10.1126/science.7973725; Kiselev A, 1997, BIOCHEMISTRY-US, V36, P2188, DOI 10.1021/bi9621268; KNOX BE, 1993, J PHYSIOL-LONDON, V466, P157; Kovacs G., 1994, ENABLING TECHNOLOGIE, P121; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LEVINE H, 1990, MECH DEVELOP, V33, P19, DOI 10.1016/0925-4773(90)90131-5; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Penfield W., 1950, CEREBRAL CORTEX MAN; Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PINE J, 1980, J NEUROSCI METH, V2, P19, DOI 10.1016/0165-0270(80)90042-4; RANDO RR, 1992, PHOTOCHEM PHOTOBIOL, V56, P1145, DOI 10.1111/j.1751-1097.1992.tb09739.x; RANGANATHAN R, 1995, CELL, V81, P841, DOI 10.1016/0092-8674(95)90004-7; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; REGEHR WG, 1989, J NEUROSCI METH, V30, P91, DOI 10.1016/0165-0270(89)90055-1; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schulz S, 1999, J BIOL CHEM, V274, P37605, DOI 10.1074/jbc.274.53.37605; Scott K, 1997, TRENDS BIOCHEM SCI, V22, P350, DOI 10.1016/S0968-0004(97)01100-6; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; SHIEH BH, 1995, NEURON, V14, P201, DOI 10.1016/0896-6273(95)90255-4; STRYER L, 1991, J BIOL CHEM, V266, P10711; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; VOGT K, 1984, NATURWISSENSCHAFTEN, V71, P211, DOI 10.1007/BF00490436; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B; Yuste R, 2000, METHOD ENZYMOL, V327, P522, DOI 10.1016/S0076-6879(00)27300-X; Zemelman BV, 2001, CURR OPIN NEUROBIOL, V11, P409, DOI 10.1016/S0959-4388(00)00227-0; ZUKER CS, 1988, CELL, V53, P475, DOI 10.1016/0092-8674(88)90167-5; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	62	316	368	0	66	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					15	22		10.1016/S0896-6273(01)00574-8	http://dx.doi.org/10.1016/S0896-6273(01)00574-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779476	Bronze			2022-12-28	WOS:000173106200006
J	Regalado, MP; Villarroel, A; Lerma, J				Regalado, MP; Villarroel, A; Lerma, J			Intersubunit cooperativity in the NMDA receptor	NEURON			English	Article							D-ASPARTATE RECEPTORS; CULTURED HIPPOCAMPAL-NEURONS; ACID-BINDING-PROTEINS; CALCIUM-DEPENDENT INACTIVATION; MOUSE-BRAIN NEURONS; GLUTAMATE RECEPTORS; INTRACELLULAR CALCIUM; KINETIC-ANALYSIS; XENOPUS-OOCYTES; GLYCINE SITE	Opening of the NMDA receptor channel requires simultaneous binding of glutamate and glycine. Although the binding sites for each agonist are in different subunits, the presence of one agonist influences the binding of the other. We have localized regions in the S1 binding domain of both subunits required for the transmission of allosteric signals from the glutamate binding NR2A subunit to the glycine binding NR1 subunit. Three-dimensional modeling indicates that these segments are not directly involved in ligand binding, but likely form solvent-accessible loops protruding out of the binding pocket, making them suitable to relay interactions between adjacent subunits. Thus, these segments mediate negative allosteric coupling between the two subunit types that form the NMDA receptor.	CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Lerma, J (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.		Villarroel, Alvaro/H-5580-2015; Lerma, Juan/G-7907-2015	Lerma, Juan/0000-0001-7838-5199				Anson LC, 1998, J NEUROSCI, V18, P581; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; Casado M, 1996, J PHYSIOL-LONDON, V490, P391, DOI 10.1113/jphysiol.1996.sp021153; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Fucile S, 2000, NEURON, V28, P571, DOI 10.1016/S0896-6273(00)00134-3; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Honer M, 1998, J BIOL CHEM, V273, P11158, DOI 10.1074/jbc.273.18.11158; JOHNSON JW, 1992, J PHYSIOL-LONDON, V455, P339, DOI 10.1113/jphysiol.1992.sp019305; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Jones MV, 1998, J NEUROSCI, V18, P8590; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; Kendrick SJ, 1996, J NEUROCHEM, V67, P608; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; KYROZIS A, 1995, J PHYSIOL-LONDON, V485, P373, DOI 10.1113/jphysiol.1995.sp020736; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LERMA J, 1990, P NATL ACAD SCI USA, V87, P2354, DOI 10.1073/pnas.87.6.2354; LERMA J, 1998, ION CHANNEL PHARM, P399; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; LYNCH DR, 1994, MOL PHARMACOL, V45, P540; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MAYER ML, 1995, EXCITATORY AMINO ACI, P89; MEDINA I, 1995, J PHYSIOL-LONDON, V482, P567, DOI 10.1113/jphysiol.1995.sp020540; Mendieta J, 2001, PROTEINS, V44, P460, DOI 10.1002/prot.1111; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Paas Y, 1998, TRENDS NEUROSCI, V21, P117, DOI 10.1016/S0166-2236(97)01184-3; PRIESTLEY T, 1994, MOL PHARMACOL, V46, P1191; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; THOMSON AM, 1989, NATURE, V338, P422, DOI 10.1038/338422a0; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; VILLARROEL A, 1997, TECHNICAL TIPS ONLIN; VYKLICKY L, 1993, J PHYSIOL-LONDON, V470, P575, DOI 10.1113/jphysiol.1993.sp019876; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894; ZILBERTER Y, 1991, MOL PHARMACOL, V40, P337; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	57	57	57	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1085	1096		10.1016/S0896-6273(01)00539-6	http://dx.doi.org/10.1016/S0896-6273(01)00539-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754839	Bronze			2022-12-28	WOS:000172886800014
J	Vanduffel, W; Fize, D; Mandeville, JB; Nelissen, K; Van Hecke, P; Rosen, BR; Tootell, RBH; Orban, GA				Vanduffel, W; Fize, D; Mandeville, JB; Nelissen, K; Van Hecke, P; Rosen, BR; Tootell, RBH; Orban, GA			Visual motion processing investigated using contrast agent-enhanced fMRI in awake behaving monkeys	NEURON			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; CEREBRAL BLOOD-VOLUME; FRONTAL EYE FIELD; AREA MT; MACAQUE MONKEY; EXTRASTRIATE CORTEX; RESPONSE PROPERTIES; FUNCTIONAL-ANALYSIS; INTRAPARIETAL AREA; HUMAN BRAIN	To reduce the information gap between human neuroimaging and macaque physiology and anatomy, we mapped fMRI signals produced by moving and stationary stimuli (random dots or lines) in fixating monkeys. Functional sensitivity was increased by a factor of similar to5 relative to the BOLD technique by injecting a contrast agent (monocrystalline iron oxide nanoparticle [MION]). Areas identified as motion sensitive included V2, V3, MT/V5, vMST, FST, VIP, and FEF (with moving dots), as well as V4, TE, LIP, and PIP (with random lines). These regions sensitive for moving dots are largely in agreement with monkey single unit data and (except for V3A) with human fMRI results. Moving lines activate some regions that have not been previously implicated in motion processing. Overall, the results clarify the relationship between the motion pathway and the dorsal stream in primates.	Katholieke Univ Leuven, Neuro & Psychofysiol Lab, Louvain, Belgium; UZ Gasthuisberg, Afdeling Radiol, B-3000 Louvain, Belgium; Massachusetts Gen Hosp, NMR Ctr, Charlestown, MA 02129 USA	KU Leuven; KU Leuven; University Hospital Leuven; Harvard University; Massachusetts General Hospital	Vanduffel, W (corresponding author), Katholieke Univ Leuven, Neuro & Psychofysiol Lab, Campus Gasthuisberg,Herestr 49, Louvain, Belgium.		Fize, Denis/F-4525-2011	Orban, Guy/0000-0002-8179-9584				ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Andersen RA, 1997, NEURON, V18, P865, DOI 10.1016/S0896-6273(00)80326-8; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; BIZZI E, 1968, EXP BRAIN RES, V6, P69; Bizzi E, 1970, Exp Brain Res, V10, P150; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Disbrow EA, 2000, P NATL ACAD SCI USA, V97, P9718, DOI 10.1073/pnas.170205497; Dubowitz DJ, 1998, NEUROREPORT, V9, P2213, DOI 10.1097/00001756-199807130-00012; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FELLEMAN DJ, 1987, J NEUROPHYSIOL, V57, P889, DOI 10.1152/jn.1987.57.4.889; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FUKUSHIMA K, 1999, ANN NY ACAD SCI, V87, P1248; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; GASKA JP, 1988, VISION RES, V28, P1179, DOI 10.1016/0042-6989(88)90035-1; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P559; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; Hayashi T, 1999, EUR J NEUROSCI, V11, P4451, DOI 10.1046/j.1460-9568.1999.00892.x; Holmes AP, 1997, NEUROIMAGE, V5, pS480; Joris P. X., 1997, Society for Neuroscience Abstracts, V23, P457; JOSEPHSON L, 1990, MAGN RESON IMAGING, V8, P637, DOI 10.1016/0730-725X(90)90143-P; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Mandeville JB, 1999, MAGNET RESON MED, V42, P591, DOI 10.1002/(SICI)1522-2594(199909)42:3<591::AID-MRM23>3.0.CO;2-8; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Orban G. A., 1996, FUNCTIONAL NEUROANAT, P23; ORBAN GA, 1986, J NEUROPHYSIOL, V56, P462, DOI 10.1152/jn.1986.56.2.462; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PETIT L, 1995, EUR J NEUROSCI, V7, P169, DOI 10.1111/j.1460-9568.1995.tb01031.x; RODMAN HR, 1990, J NEUROSCI, V10, P1154; SCHAFFER BK, 1993, MAGN RESON IMAGING, V11, P411, DOI 10.1016/0730-725X(93)90074-N; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Siegel RM, 1997, CEREB CORTEX, V7, P327, DOI 10.1093/cercor/7.4.327; STANDAGE GP, 1983, BRAIN RES, V262, P288, DOI 10.1016/0006-8993(83)91020-X; Stefanacci L, 1998, NEURON, V20, P1051, DOI 10.1016/S0896-6273(00)80485-7; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; TANAKA K, 1993, J NEUROPHYSIOL, V69, P128, DOI 10.1152/jn.1993.69.1.128; TANAKA K, 1986, J NEUROSCI, V6, P134; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Ungerleider L.G., 1982, ANAL VISUAL BEHAV; UNGERLEIDER LG, 1984, J COMP NEUROL, V223, P368, DOI 10.1002/cne.902230304; van Bruggen N, 1998, J CEREBR BLOOD F MET, V18, P1178, DOI 10.1097/00004647-199811000-00003; Vanduffel W., 1998, Society for Neuroscience Abstracts, V24, P11; WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474; ZEKI S, 1991, J NEUROSCI, V11, P641	61	350	355	1	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					565	577		10.1016/S0896-6273(01)00502-5	http://dx.doi.org/10.1016/S0896-6273(01)00502-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719199	Bronze			2022-12-28	WOS:000172363900005
J	Thiele, A; Dobkins, KR; Albright, TD				Thiele, A; Dobkins, KR; Albright, TD			Neural correlates of chromatic motion perception	NEURON			English	Article							MIDDLE TEMPORAL AREA; MACAQUE MONKEY; CHANGES COLOR; HUMAN VISION; HAPPENS IF; MT; INPUT; MECHANISM; LUMINANCE; PATHWAYS	A variety of psychophysical and neurophysiological studies suggest that chromatic motion perception in the primate brain may be performed outside the classical motion processing pathway. We addressed this provocative proposal directly by assessing the sensitivity of neurons in motion area MT to moving colored stimuli while simultaneously determining perceptual sensitivity in nonhuman primate observers. The results of these studies demonstrate a strong correspondence between neuronal and perceptual measures. Our findings testify that area MT is indeed a principal component of the neuronal substrate for color-based motion processing.	Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Albright, TD (corresponding author), Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Thiele, Alexander/0000-0003-4894-0213				CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; CAVANAGH P, 1991, VISION RES, V31, P2109, DOI 10.1016/0042-6989(91)90169-6; CHICHILNISKY EJ, 1993, VISION RES, V33, P2113, DOI 10.1016/0042-6989(93)90010-T; Cropper SJ, 1996, NATURE, V379, P72, DOI 10.1038/379072a0; Dobkins K., 1998, HIGH LEVEL MOTION PR, P53; Dobkins KR, 2000, J OPT SOC AM A, V17, P545, DOI 10.1364/JOSAA.17.000545; DOBKINS KR, 1993, VISION RES, V33, P1019, DOI 10.1016/0042-6989(93)90238-R; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; Dougherty RF, 1999, NEURON, V24, P893, DOI 10.1016/S0896-6273(00)81036-3; Gegenfurtner KR, 1996, TRENDS NEUROSCI, V19, P394, DOI 10.1016/S0166-2236(96)10036-9; GEGENFURTNER KR, 1994, VISUAL NEUROSCI, V11, P455, DOI 10.1017/S095252380000239X; GEGENFURTNER KR, 1995, VISION RES, V35, P1547, DOI 10.1016/0042-6989(94)00264-M; GOREA A, 1993, P NATL ACAD SCI USA, V90, P11197, DOI 10.1073/pnas.90.23.11197; HAWKEN MJ, 1994, NATURE, V367, P268, DOI 10.1038/367268a0; Jacobs GH, 1997, VISUAL NEUROSCI, V14, P921, DOI 10.1017/S0952523800011639; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Lu ZL, 1999, P NATL ACAD SCI USA, V96, P8289, DOI 10.1073/pnas.96.14.8289; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; MOLLON JD, 1992, NATURE, V360, P677, DOI 10.1038/360677a0; RAMACHANDRAN VS, 1978, NATURE, V275, P55, DOI 10.1038/275055a0; REZEC AA, 2000, INVEST OPHTH VIS SCI, P3841; SAITO H, 1989, EXP BRAIN RES, V75, P1; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; STROMEYER CF, 1995, J PHYSIOL-LONDON, V485, P221, DOI 10.1113/jphysiol.1995.sp020726; Thiele A, 1999, J NEUROSCI, V19, P6571; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	26	43	44	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					351	358		10.1016/S0896-6273(01)00463-9	http://dx.doi.org/10.1016/S0896-6273(01)00463-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11684003	Bronze			2022-12-28	WOS:000171893700018
J	Henkemeyer, M; Frisen, J				Henkemeyer, M; Frisen, J			Eph receptors tingle the spine	NEURON			English	Editorial Material							JUNCTION	During the development of excitatory synapses, molecules cluster on dendrites to form postsynaptic densities, and specialized structures known as spines appear. EphB2 is demonstrated to control this process by associating with and phosphorylating a key postsynaptic molecule, syndecan-2, thereby initiating the maturation of dendritic spines.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Karolinska Institutet	Henkemeyer, M (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.			Henkemeyer, Mark/0000-0002-7525-1061				Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Rapraeger AC, 2001, SEMIN CELL DEV BIOL, V12, P107, DOI 10.1006/scdb.2000.0239; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	11	1	1	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					876	877		10.1016/S0896-6273(01)00441-X	http://dx.doi.org/10.1016/S0896-6273(01)00441-X			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580887	Bronze			2022-12-28	WOS:000171281300002
J	Rice, DS; Nusinowitz, S; Azimi, AM; Martinez, A; Soriano, E; Curran, T				Rice, DS; Nusinowitz, S; Azimi, AM; Martinez, A; Soriano, E; Curran, T			The reelin pathway modulates the structure and function of retinal synaptic circuitry	NEURON			English	Article							INNER PLEXIFORM LAYER; MESSENGER-RNA EXPRESSION; MOUSE-BRAIN DEVELOPMENT; INTACT MACAQUE EYE; APOE RECEPTOR 2; TYROSINE PHOSPHORYLATION; HIPPOCAMPAL CONNECTIONS; EXTRACELLULAR-MATRIX; RETINITIS-PIGMENTOSA; LAMINAR ORGANIZATION	The formation of synaptic connections requires the coordination of specific guidance molecules and spontaneous neuronal activity. The visual system has provided a useful model for understanding the role of these cues in shaping the precise connections from the neural retina to the brain. Here, we demonstrate that two essential genes in the Reelin signaling pathway function during the patterning of synaptic connectivity in the retina. Physiological studies of mice deficient in either reelin or disabled-1 reveal an attenuation of rod-driven retinal responses. This defect is associated with a decrease in rod bipolar cell density and an abnormal distribution of processes in the inner plexiform layer. These results imply that, in addition to its essential role during neuronal migration, the Reelin pathway contributes to the formation of neuronal circuits in the central nervous system.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Univ Barcelona, Dept Cell Biol & Neurosci, Res Ctr CERN, E-08028 Barcelona, Spain	St Jude Children's Research Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Barcelona	Curran, T (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	fos1@aol.com	Curran, Tom/D-7515-2011; Curran, Thomas/AAE-7631-2019; Curran, Tom/C-1164-2008; Curran, Tom/F-5234-2018	Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Martinez, Albert/0000-0003-0831-9916	NCI NIH HHS [P30 CA21765] Funding Source: Medline; NEI NIH HHS [F32 EY06972] Funding Source: Medline; NINDS NIH HHS [R01 NS36558] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY006972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036558] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcantara S, 1998, J NEUROSCI, V18, P7779; Borrell V, 1999, J NEUROSCI, V19, P1345; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DELONG GR, 1970, DEV BIOL, V22, P584, DOI 10.1016/0012-1606(70)90170-3; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Granit R, 1935, J PHYSIOL-LONDON, V85, P421, DOI 10.1113/jphysiol.1935.sp003329; Granit R., 1955, RECEPTORS SENSORY PE; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Gunhan-Agar E, 2000, J NEUROSCI, V20, P306, DOI 10.1523/JNEUROSCI.20-01-00306.2000; Haverkamp S, 2000, J COMP NEUROL, V424, P1; HEYNEN H, 1985, VISION RES, V25, P697, DOI 10.1016/0042-6989(85)90176-2; HEYNEN H, 1985, VISION RES, V25, P709, DOI 10.1016/0042-6989(85)90177-4; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HOFFARTH RM, 1995, J NEUROSCI, V15, P4838; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; Lewis GP, 1998, INVEST OPHTH VIS SCI, V39, P424; LI ZY, 1995, J NEUROSCI, V15, P5429; LILLIEN L, 1994, PERSPECT DEV NEUROBI, V2, P175; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Peng YW, 2000, NAT NEUROSCI, V3, P1121, DOI 10.1038/80639; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; PITTLER SJ, 1993, P NATL ACAD SCI USA, V90, P9616, DOI 10.1073/pnas.90.20.9616; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; Rice DS, 1998, DEVELOPMENT, V125, P3719; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; STRETTOI E, 1990, J COMP NEUROL, V295, P449, DOI 10.1002/cne.902950309; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Sweet HO, 1996, MAMM GENOME, V7, P798, DOI 10.1007/s003359900240; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; WASSLE H, 1991, VISUAL NEUROSCI, V7, P99, DOI 10.1017/S095252380001097X; Williams RR, 2001, VISUAL NEUROSCI, V18, P233, DOI 10.1017/S0952523801182088; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	50	100	105	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2001	31	6					929	941		10.1016/S0896-6273(01)00436-6	http://dx.doi.org/10.1016/S0896-6273(01)00436-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580894	Bronze			2022-12-28	WOS:000171281300009
J	Ranganath, C; D'Esposito, M				Ranganath, C; D'Esposito, M			Medial temporal lobe activity associated with active maintenance of novel information	NEURON			English	Article							SHORT-TERM-MEMORY; SPATIAL WORKING-MEMORY; RECOGNITION MEMORY; PERIRHINAL CORTEX; AMNESIC SUBJECTS; FUNCTIONAL MRI; FRONTAL-CORTEX; VISUAL MEMORY; PLACE MEMORY; TO-SAMPLE	Using event-related functional magnetic resonance imaging, we investigated the role of medial temporal regions during active maintenance of information over short delays or working memory. In experiment 1, we observed sustained bilateral hippocampal activation during maintenance of novel faces across a short delay period but not during face encoding or recognition. In contrast, we observed transient right parahippocampal activation during encoding and recognition but not during maintenance. We replicated these findings in experiment 2 and further determined that anterior hippocampal activation was greater during maintenance of novel than familiar faces. Our results reveal the importance of medial temporal lobe regions for the active maintenance of novel information in the absence of perceptual stimulation.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ranganath, C (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	charan@socrates.berkeley.edu						Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; AGGLETON JP, 1992, CORTEX, V28, P359, DOI 10.1016/S0010-9452(13)80146-3; Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Aguirre GK, 2000, MED RAD DIA IMG, P369; Baddeley A.D., 1986, WORKING MEMORY THOUG; Baxter MG, 2001, HIPPOCAMPUS, V11, P61, DOI 10.1002/1098-1063(2001)11:1<61::AID-HIPO1021>3.3.CO;2-Q; Buffalo EA, 1998, HIPPOCAMPUS, V8, P330, DOI 10.1002/(SICI)1098-1063(1998)8:4<330::AID-HIPO3>3.0.CO;2-L; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; CAHUSAC PMB, 1989, BEHAV BRAIN RES, V33, P229, DOI 10.1016/S0166-4328(89)80118-4; CAVE CB, 1992, HIPPOCAMPUS, V2, P151, DOI 10.1002/hipo.450020207; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Curtis CE, 2000, NEUROREPORT, V11, P2203, DOI 10.1097/00001756-200007140-00028; D'Esposito M, 1999, PSYCHOL BULL, V125, P155, DOI 10.1037/0033-2909.125.1.155; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Elliott R, 1999, J NEUROSCI, V19, P5066; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; FRIEDMAN HR, 1988, J NEUROSCI, V8, P4693; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Fuster J., 2015, PREFRONTAL CORTEX, V5th; FUSTER JM, 1982, J NEUROSCI, V2, P361; Fuster JM, 1995, MEMORY CEREBRAL CORT; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Haxby JV, 1995, HUM BRAIN MAPP, V3, P68, DOI 10.1002/hbm.460030204; Henson RNA, 1999, J NEUROSCI, V19, P3962; Holdstock JS, 1995, NEUROPSYCHOLOGIA, V33, P1583, DOI 10.1016/0028-3932(95)00145-X; Johnson Marcia K., 1994, P311; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kimberg DY, 1997, CURR DIR PSYCHOL SCI, V6, P185, DOI 10.1111/1467-8721.ep10772959; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MILLER EK, 1993, J NEUROSCI, V13, P1460; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MISHKIN M, 1975, J EXP PSYCHOL-ANIM B, V1, P326, DOI 10.1037/0097-7403.1.4.326; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MURRAY EA, 1986, J NEUROSCI, V6, P1991; OReilly R., 1999, MODELS WORKING MEMOR, P375, DOI [10.1017/cbo9781139174909.014, DOI 10.1017/CBO9781139174909.014]; OWEN AM, 1995, NEUROPSYCHOLOGIA, V33, P1, DOI 10.1016/0028-3932(94)00098-A; Parker A, 1998, J COGNITIVE NEUROSCI, V10, P691, DOI 10.1162/089892998563103; Petrides M., 1989, HDB NEUROPSYCHOLOGY, P601; Postle BR, 1999, J COGNITIVE NEUROSCI, V11, P585, DOI 10.1162/089892999563652; Postle BR, 2000, BRAIN RES PROTOC, V5, P57, DOI 10.1016/S1385-299X(99)00053-7; Postle BR, 2000, PSYCHOBIOLOGY, V28, P132; SIDMAN M, 1968, NEUROPSYCHOLOGIA, V6, P245, DOI 10.1016/0028-3932(68)90023-7; SQUIRE LR, 1988, BEHAV NEUROSCI, V102, P210, DOI 10.1037/0735-7044.102.2.210; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Stern CE, 1999, HIPPOCAMPUS, V9, P45, DOI 10.1002/(SICI)1098-1063(1999)9:1<45::AID-HIPO5>3.3.CO;2-K; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Sybirska E, 2000, J NEUROSCI, V20, P5827, DOI 10.1523/JNEUROSCI.20-15-05827.2000; Talairach J., 1988, COPLANAR STEREOTAXIC; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; WATANABE T, 1985, BRAIN RES, V325, P241, DOI 10.1016/0006-8993(85)90320-8; WICKELGREN WA, 1968, NEUROPSYCHOLOGIA, V6, P235, DOI 10.1016/0028-3932(68)90022-5; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279; ZOLAMORGAN S, 1985, BEHAV NEUROSCI, V99, P22, DOI 10.1037/0735-7044.99.1.22; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355; ZOLAMORGAN S, 1993, J NEUROSCI, V13, P251	69	300	303	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 13	2001	31	5					865	873		10.1016/S0896-6273(01)00411-1	http://dx.doi.org/10.1016/S0896-6273(01)00411-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	472YV	11567623	Bronze			2022-12-28	WOS:000171013300018
J	Stevens, CF				Stevens, CF			Predicting functional properties of visual cortex from an evolutionary scaling law	NEURON			English	Article							MAGNIFICATION FACTORS; CEBUS MONKEY; TOPOGRAPHY; STRIATE; FIELD	The number of neurons in the primary visual cortex (V1) is, across primate species, related to the number of neurons in the visual thalamus (the lateral geniculate nucleus [LGN]) by a power law with an exponent of 3/2. This evolutionary scaling law is explained by a simple relation according to which the fineness of resolution in cortex is related to the number of neurons in the area of cortex used to process the information from a single point of light (the point-spread area). The same theory provides a link between two functional properties of the visual cortex, the areal cortical magnification factor (ACMF) and the receptive field (RF) area.	Salk Inst Biol Studies, Howard Hughes Med Inst, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Mol Neurobiol Lab, La Jolla, CA 92037 USA.							[Anonymous], 1941, AM J OPHTHALMOL, DOI [10.1016/S0002-9394(41)91363-6, DOI 10.1016/S0002-9394(41)91363-6]; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; GATTASS R, 1987, J COMP NEUROL, V259, P529, DOI 10.1002/cne.902590404; Hetherington PA, 1999, VISUAL NEUROSCI, V16, P637, DOI 10.1017/S0952523899164046; HOLMES G, 1945, PROC R SOC SER B-BIO, V132, P348, DOI 10.1098/rspb.1945.0002; McIlwain J. T., 1976, INT REV PHYSIOL, Vii, P223; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; ROLLS ET, 1970, EXP BRAIN RES, V10, P298; Rosa MGP, 1997, J COMP NEUROL, V387, P547, DOI 10.1002/(SICI)1096-9861(19971103)387:4<547::AID-CNE6>3.0.CO;2-2; Rosa MGP, 1997, J NEUROPHYSIOL, V77, P3193, DOI 10.1152/jn.1997.77.6.3193; Schutz B., 1980, GEOMETRICAL METHODS; SILVEIRA LCL, 1989, VISION RES, V29, P1471, DOI 10.1016/0042-6989(89)90131-4; Stevens CF, 2001, NATURE, V411, P193, DOI 10.1038/35075572	14	15	15	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					139	142		10.1016/S0896-6273(02)00902-9	http://dx.doi.org/10.1016/S0896-6273(02)00902-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367512	Bronze			2022-12-28	WOS:000178295100013
J	Sakai, KL; Noguchi, Y; Takeuchi, T; Watanabe, E				Sakai, KL; Noguchi, Y; Takeuchi, T; Watanabe, E			Selective priming of syntactic processing by event-related transcranial magnetic stimulation of Broca's area	NEURON			English	Article							SENTENCE COMPREHENSION; COGNITIVE NEUROSCIENCE; BRAIN; SPEECH; CORTEX; INHIBITION; SAFETY; FORM; FLOW	It remains controversial whether Brocals aphasia is an articulatory deficit, a lexical-access problem, or agrammatism. In spite of recent neuroimaging studies, the causal link between cortical activity and linguistic sub-components has not been elucidated. Here we report an experiment with event-related transcranial magnetic stimulation (TMS) to clarify the role of Brocals area, more specifically, the left inferior frontal gyrus (F3op/F3t), in syntactic processing. An experimental paradigm contrasted sentences requiring syntactic decisions with those requiring semantic decisions. We found selective priming effects on syntactic decisions when TMS was administered to the left F3op/F3t at a specific timing, but not to the left middle frontal gyrus (F2). Our results provide direct evidence of the involvement of the left F3op/F3t in syntactic processing.	Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, Tokyo 1538902, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan; Tokyo Metropolitan Police Hosp, Dept Neurosurg, Tokyo 1028161, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Sakai, KL (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.							Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Epstein CM, 1996, NEUROLOGY, V47, P1590, DOI 10.1212/WNL.47.6.1590; GOODMAN GO, 1981, MEM COGNITION, V9, P580, DOI 10.3758/BF03202352; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Indefrey P, 2001, NEUROIMAGE, V14, P546, DOI 10.1006/nimg.2001.0867; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; MOHR JP, 1976, STUDIES NEUROLINGUIS, V1, P201; Moro A, 2001, NEUROIMAGE, V13, P110, DOI 10.1006/nimg.2000.0668; Mottaghy FM, 1999, NEUROLOGY, V53, P1806, DOI 10.1212/WNL.53.8.1806; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; Noguchi Y, 2002, HUM BRAIN MAPP, V17, P89, DOI 10.1002/hbm.10050; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; PASCUALLEONE A, 1993, ELECTROEN CLIN NEURO, V89, P120, DOI 10.1016/0168-5597(93)90094-6; Sakai KL, 2001, NEUROSCI RES, V39, P1, DOI 10.1016/S0168-0102(00)00205-4; Shapiro KA, 2001, J COGNITIVE NEUROSCI, V13, P713, DOI 10.1162/08989290152541386; Smith N., 1979, MODERN LINGUISTICS R; Stewart L, 2001, NEUROIMAGE, V13, P472, DOI 10.1006/nimg.2000.0701; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Terao Y, 1998, J NEUROPHYSIOL, V80, P936, DOI 10.1152/jn.1998.80.2.936; Trompetto C, 1999, CLIN NEUROPHYSIOL, V110, P1106, DOI 10.1016/S1388-2457(99)00043-7; Walsh V, 1998, P ROY SOC B-BIOL SCI, V265, P537, DOI 10.1098/rspb.1998.0328; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	29	63	65	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1177	1182		10.1016/S0896-6273(02)00873-5	http://dx.doi.org/10.1016/S0896-6273(02)00873-5			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354406	Bronze, Green Published			2022-12-28	WOS:000178040000017
J	Bixby, S; Kruger, GM; Mosher, JT; Joseph, NM; Morrison, SJ				Bixby, S; Kruger, GM; Mosher, JT; Joseph, NM; Morrison, SJ			Cell-intrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity	NEURON			English	Article							BONE MORPHOGENETIC PROTEINS; ZONE PROGENITOR CELLS; IN-VIVO; NEURONAL DIFFERENTIATION; CREST CELLS; SYMPATHETIC NEURONS; MOUSE DEVELOPMENT; SELF-RENEWAL; SPINAL-CORD; TRANSPLANTATION	Stem cells in different regions of the nervous system give rise to different types of mature cells. This diversity is assumed to arise in response to local environmental differences, but the contribution of cell-intrinsic differences between stem cells has been unclear. At embryonic day (E)14, neural crest stem cells (NCSCs) undergo primarily neurogenesis in the gut but gliogenesis in nerves. Yet gliogenic and neurogenic factors are expressed in both locations. NCSCs isolated by flow-cytometry from E14 sciatic nerve and gut exhibited heritable, cell-intrinsic differences in their responsiveness to lineage determination factors. Gut NCSCs were more responsive to neurogenic factors, while sciatic nerve NCSCs were more responsive to gliogenic factors. Upon transplantation of uncultured NCSCs into developing peripheral nerves in vivo, sciatic nerve NCSCs gave rise only to glia, while gut NCSCs gave rise primarily to neurons. Thus, cell fate in the nerve was stem cell determined.	Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021; Crane, Genevieve M/AAK-9224-2020	Crane, Genevieve M/0000-0001-9274-0214; Morrison, Sean/0000-0003-1587-8329	NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310, P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER; NCI NIH HHS [CA46592] Funding Source: Medline; NIAMS NIH HHS [AR20557, P30 AR48310] Funding Source: Medline; NIDDK NIH HHS [5P60-DK20572] Funding Source: Medline; NINDS NIH HHS [R01 NS40750-01, R01 NS040750-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON DJ, 1985, CELL, V42, P649, DOI 10.1016/0092-8674(85)90122-9; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; BARTHEL LK, 1993, J NEUROSCI METH, V50, P145, DOI 10.1016/0165-0270(93)90002-9; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Brustle O, 1997, P NATL ACAD SCI USA, V94, P14809, DOI 10.1073/pnas.94.26.14809; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; Couly G, 2002, DEVELOPMENT, V129, P1061; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hagedorn L, 1999, DEVELOPMENT, V126, P3781; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kubu CJ, 2002, DEV BIOL, V244, P199, DOI 10.1006/dbio.2002.0568; LELIEVRE CS, 1980, DEV BIOL, V77, P362, DOI 10.1016/0012-1606(80)90481-9; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; Lillien L, 1997, CURR BIOL, V7, pR168, DOI 10.1016/S0960-9822(97)70080-0; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Na E, 1998, CURR BIOL, V8, P987, DOI 10.1016/S0960-9822(98)70403-8; Olsson M, 1997, NEURON, V19, P761, DOI 10.1016/S0896-6273(00)80959-9; Palmer TD, 1999, J NEUROSCI, V19, P8487; Panchision D, 1998, CURR OPIN CELL BIOL, V10, P727, DOI 10.1016/S0955-0674(98)80114-2; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; Pisano JM, 2000, DEV BIOL, V227, P1, DOI 10.1006/dbio.2000.9876; Power J, 2002, DEV BIOL, V245, P362, DOI 10.1006/dbio.2002.0610; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Trainor PA, 2002, SCIENCE, V295, P1288, DOI 10.1126/science.1064540; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; White PM, 1999, DEVELOPMENT, V126, P4351; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; WILLIAMS R, 1995, MECH DEVELOP, V53, P357, DOI 10.1016/0925-4773(95)00451-3; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Zappone MV, 2000, DEVELOPMENT, V127, P2367	65	226	233	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					643	656		10.1016/S0896-6273(02)00825-5	http://dx.doi.org/10.1016/S0896-6273(02)00825-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194865	Bronze			2022-12-28	WOS:000177521000006
J	Lonze, BE; Ginty, DD				Lonze, BE; Ginty, DD			Function and regulation of CREB family transcription factors in the nervous system	NEURON			English	Review							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; CAMP-RESPONSIVE ELEMENT; CONSTITUTIVE ACTIVATION DOMAIN; MEDIATED GENE-EXPRESSION; C-FOS TRANSCRIPTION; MULTIPLE SEQUENCE ELEMENTS; APLYSIA SENSORY NEURONS; IMMEDIATE-EARLY GENES; RNA-POLYMERASE-II	CREB and its close relatives are now widely accepted as prototypical stimulus-inducible transcription factors. In many cell types, these factors function as effector molecules that bring about cellular changes in response to discrete sets of instructions. In neurons, a wide range of extracellular stimuli are capable of activating CREB family members, and CREB-dependent gene expression has been implicated in complex and diverse processes ranging from development to plasticity to disease. In this review, we focus on the current level of understanding of where, when, and how CREB family members function in the nervous system.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Lonze, Bonnie/0000-0002-0973-1657	NINDS NIH HHS [NS34814] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034814, R29NS034814, R37NS034814] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; ALBERTS AS, 1994, J BIOL CHEM, V269, P7623; ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Blendy JA, 1998, J MOL MED-JMM, V76, P104, DOI 10.1007/s001090050197; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CAMBI F, 1989, J NEUROCHEM, V53, P1656, DOI 10.1111/j.1471-4159.1989.tb08567.x; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Dawson TM, 2002, NAT MED, V8, P450, DOI 10.1038/nm0502-450; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Felinski EA, 1999, J BIOL CHEM, V274, P11672, DOI 10.1074/jbc.274.17.11672; Felinski EA, 2001, MOL CELL BIOL, V21, P1001, DOI 10.1128/MCB.21.4.1001-1010.2001; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; Foulkes NS, 1997, TRENDS NEUROSCI, V20, P487, DOI 10.1016/S0166-2236(97)01109-0; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Freeland K, 2001, MOL BRAIN RES, V92, P98, DOI 10.1016/S0169-328X(01)00158-9; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gass P, 1998, LEARN MEMORY, V5, P274; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GENOUX D, 2002, IN PRESS NATURE; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Hu BR, 1999, NEUROSCIENCE, V89, P437, DOI 10.1016/S0306-4522(98)00352-2; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Iordanov M, 1997, EMBO J, V16, P1009, DOI 10.1093/emboj/16.5.1009; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; KANO T, 1995, NEUROREPORT, V6, P2197, DOI 10.1097/00001756-199511000-00023; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kornhauser JM, 1996, BEHAV GENET, V26, P221, DOI 10.1007/BF02359382; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lee MM, 1999, J NEUROSCI RES, V55, P702, DOI 10.1002/(SICI)1097-4547(19990315)55:6<702::AID-JNR5>3.3.CO;2-E; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu YZ, 1999, NEUROREPORT, V10, P1239, DOI 10.1097/00001756-199904260-00016; Liu YZ, 1998, J BIOL CHEM, V273, P32400, DOI 10.1074/jbc.273.49.32400; Long FX, 2001, DEVELOPMENT, V128, P541; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Maldonado R, 1996, SCIENCE, V273, P657, DOI 10.1126/science.273.5275.657; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Matthies H, 1997, J NEUROSCI METH, V78, P173, DOI 10.1016/S0165-0270(97)00149-0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Parker D, 1996, MOL CELL BIOL, V16, P694; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Poser S, 2001, INT J DEV NEUROSCI, V19, P387, DOI 10.1016/S0736-5748(00)00094-0; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; QUINN PG, 1993, J BIOL CHEM, V268, P16999; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Roberson ED, 1999, J NEUROSCI, V19, P4337; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; Schulz S, 1999, J NEUROSCI, V19, P5683; Self DW, 1998, J NEUROSCI, V18, P1848; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stanciu M, 2001, MOL BRAIN RES, V94, P15, DOI 10.1016/S0169-328X(01)00174-7; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Tanaka K, 2000, EXP NEUROL, V161, P462, DOI 10.1006/exnr.1999.7313; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Viola HE, 2000, J NEUROSCI, V20; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Wagner BL, 2000, J BIOL CHEM, V275, P8263, DOI 10.1074/jbc.275.12.8263; Walker WH, 1996, J BIOL CHEM, V271, P20145, DOI 10.1074/jbc.271.33.19668; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Walton M, 1999, J NEUROCHEM, V73, P1836; Walton M, 1999, BRAIN RES REV, V29, P137, DOI 10.1016/S0165-0173(98)00053-8; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Widnell KL, 1996, J PHARMACOL EXP THER, V276, P306; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; XING LP, 1995, J BIOL CHEM, V270, P17488, DOI 10.1074/jbc.270.29.17488; XING LP, 1994, J BIOL CHEM, V269, P28732; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zanger K, 2001, MOL CELL, V7, P551, DOI 10.1016/S1097-2765(01)00202-7	190	1643	1719	0	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					605	623		10.1016/S0896-6273(02)00828-0	http://dx.doi.org/10.1016/S0896-6273(02)00828-0			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194863	Bronze			2022-12-28	WOS:000177521000004
J	Field, GD; Rieke, F				Field, GD; Rieke, F			Nonlinear signal transfer from mouse rods to bipolar cells and implications for visual sensitivity	NEURON			English	Article							TEMPORAL CONTRAST ADAPTATION; TIGER SALAMANDER RETINA; SINGLE-PHOTON DETECTION; MAMMALIAN RETINA; GANGLION-CELLS; ALTERNATIVE PATHWAY; TRANSMITTER RELEASE; SYNAPTIC TRANSFER; LIGHT ADAPTATION; OUTER SEGMENTS	We investigated the impact of rod-bipolar signal transfer on visual sensitivity. Two observations indicate that rod-rod bipolar signal transfer is nonlinear. First, responses of rods increased linearly with flash strength, while those of rod bipolars increased supralinearly. Second, fluctuations in the responses of rod bipolars were larger than expected from linear summation of the rod inputs. Rod-OFF bipolar signal transfer did not share this strong nonlinearity. Surprisingly, nonlinear rod-rod bipolar signal transfer eliminated many of the rod's single-photon responses. The impact on sensitivity, however, was more than compensated for by rejection of noise from rods that did not absorb photons. As a consequence, rod bipolars provide a near-optimal readout of rod signals at light levels near visual threshold.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.		Field, Greg/AAI-1428-2021	Field, Greg/0000-0001-5942-2679	NEI NIH HHS [EY-11850] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P151, DOI 10.1113/jphysiol.1980.sp013156; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BELGUM JH, 1988, J PHYSIOL-LONDON, V396, P225, DOI 10.1113/jphysiol.1988.sp016960; BIALEK W, 1990, BIOPHYS J, V58, P1227, DOI 10.1016/S0006-3495(90)82463-2; DACHEUX RF, 1986, J NEUROSCI, V6, P331; DEVRIES H, 1961, PRINCIPLES SENSORY C, P159; DEVRIES SH, 1995, P NATL ACAD SCI USA, V92, P10658, DOI 10.1073/pnas.92.23.10658; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; NAKATANI K, 1991, J GEN PHYSIOL, V97, P413, DOI 10.1085/jgp.97.3.413; RAO R, 1994, BIOPHYS J, V67, P57, DOI 10.1016/S0006-3495(94)80454-0; RAOMIROTZNIK R, 1995, NEURON, V14, P561, DOI 10.1016/0896-6273(95)90312-7; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 1998, REV MOD PHYS, V70, P1027, DOI 10.1103/RevModPhys.70.1027; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rieke F, 2000, METHOD ENZYMOL, V316, P186; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; Schneeweis DM, 2000, VISUAL NEUROSCI, V17, P659, DOI 10.1017/S0952523800175017; SMITH RG, 1986, J NEUROSCI, V6, P3505; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; STERLING P, 1988, J NEUROSCI, V8, P623; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; van Rossum MCW, 1998, VISUAL NEUROSCI, V15, P809, DOI 10.1017/S0952523898155037; Walraven J, 1990, VISUAL PERCEPTION NE, P53; WERBLIN FS, 1978, J PHYSIOL-LONDON, V280, P449, DOI 10.1113/jphysiol.1978.sp012394; Witkovsky P, 1997, J NEUROSCI, V17, P7297; WU SMS, 1987, J NEUROSCI METH, V20, P139, DOI 10.1016/0165-0270(87)90046-X	34	215	217	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					773	785		10.1016/S0896-6273(02)00700-6	http://dx.doi.org/10.1016/S0896-6273(02)00700-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062023	Bronze, Green Submitted			2022-12-28	WOS:000175951800011
J	Greger, IH; Khatri, L; Ziff, EB				Greger, IH; Khatri, L; Ziff, EB			RNA editing at Arg607 controls AMPA receptor exit from the endoplasmic reticulum	NEURON			English	Article							DOMAIN-CONTAINING PROTEIN; ER RETENTION SIGNAL; KINASE-C-ALPHA; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; BINDING-PROTEIN; SUBUNIT STOICHIOMETRY; MOLECULAR MECHANISMS; SECRETORY PATHWAY; SPLICE VARIANTS	AMPA-receptor (AMPAR) transport to synapses plays a critical role in the modulation of synaptic strength. We show that the functionally critical GluR2 subunit stably resides in an intracellular pool in the endoplasmic reticulum (ER). GluR2 in this pool is extensively complexed with GluR3 but not with GluR1, which is mainly confined to the cell surface. Mutagenesis revealed that elements in the C terminus including the PDZ motif are required for GluR2 forward-transport from the ER. Surprisingly, ER retention of GluR2 is controlled by Arg607 at the Q/R-editing site. Reversion to Gln (R607Q) resulted in rapid release from the pool and elevated surface expression of GluR2 in neurons. Therefore, Arg607 is a central regulator. In addition to channel gating, it also controls ER exit and may thereby ensure the availability of GluR2 for assembly into AMPARs.	NYU, Sch Med, Howard Hughes Med Inst, Dept Biochem, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University	Ziff, EB (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, Dept Biochem, New York, NY 10016 USA.			Ziff, Edward/0000-0001-7389-8649	NIA NIH HHS [AG13620] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013620, R37AG013620] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hall RA, 1997, NEUROSCIENCE, V78, P361, DOI 10.1016/S0306-4522(96)00525-8; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALLABIABARRENA A, 1995, EMBO J, V14, P2257, DOI 10.1002/j.1460-2075.1995.tb07220.x; Mammen AL, 1997, J NEUROSCI, V17, P7351; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Rao A, 1998, J NEUROSCI, V18, P1217; Rubio ME, 1999, J NEUROSCI, V19, P5549; Rubio ME, 1999, J NEUROCHEM, V73, P942, DOI 10.1046/j.1471-4159.1999.0730942.x; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sprengel R, 2001, TRENDS PHARMACOL SCI, V22, P7, DOI 10.1016/S0165-6147(00)01588-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	59	268	281	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					759	772		10.1016/S0896-6273(02)00693-1	http://dx.doi.org/10.1016/S0896-6273(02)00693-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062022	Bronze			2022-12-28	WOS:000175951800010
J	Gurevich, I; Tamir, H; Arango, V; Dwork, AJ; Mann, JJ; Schmauss, C				Gurevich, I; Tamir, H; Arango, V; Dwork, AJ; Mann, JJ; Schmauss, C			Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims	NEURON			English	Article							MESSENGER-RNA; 5-HT2C RECEPTOR; DEAMINASE ADAR1; GENE; 5-HYDROXYTRYPTAMINE(2C); SCHIZOPHRENIA; CLONING; VARIANT; BRAIN	Five adenosines within the coding sequence of the serotonin 2C receptor (5-HT2C) pre-mRNA are converted to inosines by RNA editing (named A, B, C' (E), C, and D sites). In human prefrontal cortex (PFC), the most abundant 5-HT2C mRNA sequences result from editing at the A site, or from the editing combinations AC'C, ABCD, and ABD. In suicide victims with a history of major depression, C' site editing is significantly increased, D site editing is significantly decreased, and the C site shows a trend toward increased editing. Treatment of mice with the antidepressant drug fluoxetine (Prozac(TM)) causes changes in C', C, and D site editing that are exactly opposite to those seen in suicide victims. Thus, one outcome of fluoxetine treatment may be to reverse the abnormalities in 5-HT2C pre-mRNA editing seen in depressed suicide victims.	Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Div Neurosci, New York, NY 10032 USA; Mt Sinai Grad Sch Biol Sci, New York, NY 10029 USA	Columbia University; Columbia University	Schmauss, C (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 630 W 168th St, New York, NY 10032 USA.		Arango, Victoria/K-9377-2015	Arango, Victoria/0000-0001-8811-400X	NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH046745, R56MH061906, P50MH046745, R01MH061906] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 46745, MH 61906] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Canton H, 1996, MOL PHARMACOL, V50, P799; Fitzgerald LW, 1999, NEUROPSYCHOPHARMACOL, V21, pS82, DOI 10.1038/sj.npp.1395328; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Huntsman MM, 1998, P NATL ACAD SCI USA, V95, P15066, DOI 10.1073/pnas.95.25.15066; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Mann JJ, 2000, ARCH GEN PSYCHIAT, V57, P729, DOI 10.1001/archpsyc.57.8.729; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; MORO O, 1993, J BIOL CHEM, V268, P22273; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Niswender CM, 2001, NEUROPSYCHOPHARMACOL, V24, P478, DOI 10.1016/S0893-133X(00)00223-2; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; SALTZMAN AG, 1991, BIOCHEM BIOPH RES CO, V181, P1469, DOI 10.1016/0006-291X(91)92105-S; Schmauss C, 1996, J NEUROSCI, V16, P7902; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Seeburg PH, 2000, NEURON, V25, P261, DOI 10.1016/S0896-6273(00)80891-0; Sodhi MS, 2001, MOL PSYCHIATR, V6, P373, DOI 10.1038/sj.mp.4000920; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2000, J NEUROCHEM, V74, P1290	22	307	321	3	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					349	356		10.1016/S0896-6273(02)00660-8	http://dx.doi.org/10.1016/S0896-6273(02)00660-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988167	Bronze			2022-12-28	WOS:000175214700007
J	Gauthier, I; Hayward, WG; Tarr, MJ; Anderson, AW; Skudlarski, P; Gore, JC				Gauthier, I; Hayward, WG; Tarr, MJ; Anderson, AW; Skudlarski, P; Gore, JC			BOLD activity during mental rotation and viewpoint-dependent object recognition	NEURON			English	Article							3-DIMENSIONAL OBJECTS; FUNCTIONAL ACTIVATION; SHAPE-RECOGNITION; NETWORK; FACES; TIME; FMRI; PERFORMANCE; INVARIANCE; ATTENTION	We measured brain activity during mental rotation and object recognition with objects rotated around three different axes. Activity in the superior parietal lobe (SPL) increased proportionally to viewpoint disparity during mental rotation, but not during object recognition. In contrast, the fusiform gyrus was preferentially recruited in a viewpoint-dependent manner in recognition as compared to mental rotation. In addition, independent of the effect of viewpoint, object recognition was associated with ventral areas and mental rotation with dorsal areas. These results indicate that the similar behavioral effects of viewpoint obtained in these two tasks are based on different neural substrates. Such findings call into question the hypothesis that mental rotation is used to compensate for changes in viewpoint during object recognition.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA; Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA; Yale Univ, Sch Med, Dept Radiol, New Haven, CT 06510 USA	Vanderbilt University; Chinese University of Hong Kong; Brown University; Yale University	Gauthier, I (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, 502 Wilson Hall, Nashville, TN 37203 USA.	isabel.gauthier@vanderbilt.edu	Hayward, William G/C-2369-2009; Hayward, William Gordon/D-4911-2009	Hayward, William/0000-0002-7248-0301; Gauthier, Isabel/0000-0002-6249-4769	NINDS NIH HHS [NS 33332] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033332] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; BIEDERMAN I, 1995, J EXP PSYCHOL HUMAN, V21, P1506, DOI 10.1037/0096-1523.21.6.1506; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; CORBALLIS MC, 1984, J EXP PSYCHOL HUMAN, V10, P318, DOI 10.1037/0096-1523.10.2.318; CORBALLIS MC, 1982, SPATIAL ABILITIES DE, P173; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Coull JT, 1998, J NEUROSCI, V18, P7426; FOLK MD, 1987, J EXP PSYCHOL HUMAN, V13, P395, DOI 10.1037/0096-1523.13.3.395; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hayward WG, 2000, PSYCHOL SCI, V11, P7, DOI 10.1111/1467-9280.00207; Hayward WG, 1997, J EXP PSYCHOL HUMAN, V23, P1511, DOI 10.1037/0096-1523.23.5.1511; Hinton G., 1981, ATTENTION PERFORM, P261; HOCHBERG J, 1977, MEM COGNITION, V5, P23, DOI 10.3758/BF03209187; HUMMEL JE, 1992, PSYCHOL REV, V99, P480, DOI 10.1037/0033-295X.99.3.480; HUMPHREY GK, 1992, CAN J PSYCHOL, V46, P170, DOI 10.1037/h0084320; JOLICOEUR P, 1985, MEM COGNITION, V13, P289, DOI 10.3758/BF03202498; Jolicoeur P., 1990, MIND LANG, V5, P387, DOI [10.1111/j.1468-0017.1990.tb00170.x, DOI 10.1111/J.1468-0017.1990.TB00170.X]; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; LAWSON R, 1994, PERCEPTION, V23, P595, DOI 10.1068/p230595; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; Luna B, 1998, CEREB CORTEX, V8, P40, DOI 10.1093/cercor/8.1.40; Milner A. D., 1995, VISUAL BRAIN ACTION; Perrett DI, 1998, COGNITION, V67, P111, DOI 10.1016/S0010-0277(98)00015-8; PERRETT DI, 1987, TRENDS NEUROSCI, V10, P358, DOI 10.1016/0166-2236(87)90071-3; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Richter W, 1997, NEUROREPORT, V8, P3697, DOI 10.1097/00001756-199712010-00008; ROCK I, 1989, COGNITIVE PSYCHOL, V21, P185, DOI 10.1016/0010-0285(89)90007-8; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shepard RN., 1982, J HIST BEHAV SCI, V19, P301, DOI 10.2307/1422825; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; SUZUKI S, 1997, 4 ANN M COGN NEUR SO; Tagaris GA, 1996, NEUROREPORT, V7, P773, DOI 10.1097/00001756-199602290-00022; Tagaris GA, 1997, J COGNITIVE NEUROSCI, V9, P419, DOI 10.1162/jocn.1997.9.4.419; Talairach J., 1988, COPLANAR STEREOTAXIC; TARR MJ, 1989, COGNITIVE PSYCHOL, V21, P233, DOI 10.1016/0010-0285(89)90009-1; TARR MJ, 1995, J EXP PSYCHOL HUMAN, V21, P1494, DOI 10.1037/0096-1523.21.6.1494; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; TARR MJ, 1995, PSYCHON B REV, V2, P55, DOI 10.3758/BF03214412; Tarr MJ, 2001, VISION RES, V41, P1981, DOI 10.1016/S0042-6989(01)00024-4; Tarr MJ, 1998, COGNITION, V67, P73, DOI 10.1016/S0010-0277(98)00023-7; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WILSON KD, 1999, SOC NEUR ABSTR; YUILLE JC, 1982, PERCEPT PSYCHOPHYS, V31, P201, DOI 10.3758/BF03202524	49	150	154	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 28	2002	34	1					161	171		10.1016/S0896-6273(02)00622-0	http://dx.doi.org/10.1016/S0896-6273(02)00622-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931750	Bronze			2022-12-28	WOS:000174695100018
J	Wyszynski, M; Kim, E; Dunah, AW; Passafaro, M; Valtschanoff, JG; Serra-Pages, C; Streuli, M; Weinberg, RJ; Sheng, M				Wyszynski, M; Kim, E; Dunah, AW; Passafaro, M; Valtschanoff, JG; Serra-Pages, C; Streuli, M; Weinberg, RJ; Sheng, M			Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting	NEURON			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; FAMILY; LAR; SUBUNIT; BINDING; EXPRESSION; CLUSTER; DLAR	Interaction with the multi-PDZ protein GRIP is required for the synaptic targeting of AMPA receptors, but the underlying mechanism is unknown. We show that GRIP binds to the liprin-alpha/SYD2 family of proteins that interact with LAR receptor protein tyrosine phosphatases (LAR-RPTPs) and that are implicated in presynaptic development. In neurons, liprin-alpha and LAR-RPTP are enriched at synapses and coimmunoprecipitate with GRIP and AMPA receptors. Dominant-negative constructs that interfere with the GRIP-liprin interaction disrupt the surface expression and dendritic clustering of AMPA receptors in cultured neurons. Thus, by mediating the targeting of liprin/GRIP-associated proteins, liprin-alpha is important for postsynaptic as well as presynaptic maturation.	Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; MIT, Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Korea Advanced Institute of Science & Technology (KAIST); University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sheng, M (corresponding author), Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA.	msheng@mit.edu	Weinberg, Richard/AAC-1898-2020; Kim, Eunjoon/C-1566-2011	Sheng, Morgan/0000-0002-8703-5366; Weinberg, Richard/0000-0001-9689-7278	NCI NIH HHS [CA 55547] Funding Source: Medline; NINDS NIH HHS [NS35050] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banker G., 1991, CULTURING NERVE CELL; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Dai ZS, 1998, J CELL BIOL, V141, P1613, DOI 10.1083/jcb.141.7.1613; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; NIETHAMMER M, 1999, METHOD ENZYMOL, P104; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; PHEND KD, 1992, J HISTOCHEM CYTOCHEM, V40, P1011, DOI 10.1177/40.7.1376741; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Valtschanoff JG, 1999, J COMP NEUROL, V410, P599; Van Vactor D, 1998, CURR OPIN CELL BIOL, V10, P174, DOI 10.1016/S0955-0674(98)80139-7; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Wyszynski M, 1998, NEUROPHARMACOLOGY, V37, P1335, DOI 10.1016/S0028-3908(98)00120-8; WYSZYNSKI M, 1999, METHOD ENZYMOL, P371; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	34	195	209	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 28	2002	34	1					39	52		10.1016/S0896-6273(02)00640-2	http://dx.doi.org/10.1016/S0896-6273(02)00640-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931740	Bronze, Green Published			2022-12-28	WOS:000174695100008
J	Philpot, BD; Bear, MF				Philpot, BD; Bear, MF			Synaptic plasticity in an altered state	NEURON			English	Editorial Material								In this issue of Neuron, Montgomery and Madison (2002) record from synaptically coupled pairs of CA3 neurons to closely examine the induction of synaptic depression at a small number of identified synapses. The authors provide convincing evidence that the activation history of a synapse determines both the ability of a synapse to depress and the mechanism of depression.	Brown Univ, Howard Hughes Med Inst, Dept Neurosci, Providence, RI 02912 USA	Brown University; Howard Hughes Medical Institute	Philpot, BD (corresponding author), Brown Univ, Howard Hughes Med Inst, Dept Neurosci, Box 1953, Providence, RI 02912 USA.			Bear, Mark/0000-0002-9903-2541				Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; Bear MF, 2001, SYNAPSES, P455; COLMAN H, 1993, DEV BIOL, V156, P1, DOI 10.1006/dbio.1993.1054; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; XLAO MY, 1994, EUR J NEUROSCI, V6, P1055	11	3	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					665	667		10.1016/S0896-6273(02)00618-9	http://dx.doi.org/10.1016/S0896-6273(02)00618-9			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879642	Bronze			2022-12-28	WOS:000174286200001
J	Greer, JM; Capecchi, MR				Greer, JM; Capecchi, MR			Hoxb8 is required for normal grooming behavior in mice	NEURON			English	Article							PROTOONCOGENE INT-2; SERIAL ORDER; EXPRESSION; DISRUPTION; SEQUENCES; CHAINS; GENES; SITE; HIPPOCAMPAL; TRANSGENE	Repertoires of grooming behaviors critical to survival are exhibited by most animal species, including humans. Genes that influence this complex behavior are unknown. We report that mice with disruptions of Hoxb8 show, with 100% penetrance, excessive grooming leading to hair removal and lesions. Additionally, these mice excessively groom normal cagemates. We have been unable to detect any skin or PNS abnormalities In Hoxb8 mutants. These observations suggest that the excessive, pathological grooming exhibited by these mice results from CNS abnormalities. Consistent with this Interpretation, we demonstrate Hoxb8 expression in regions of the adult mouse CNS previously implicated in the control of grooming. The aberrant behavior observed in Hoxb8 mutants is not unlike that of humans suffering from the OC-spectrum disorder, trichotillomania. Interestingly, Hoxb8 is expressed in regions of the CNS known as the "OCD-circuit."	Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA.	mario.capecchi@genetics.utah.edu						ALDRIDGE JW, 1993, PSYCHOL SCI, V4, P391, DOI 10.1111/j.1467-9280.1993.tb00587.x; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; BERNTSON GG, 1988, ANN NY ACAD SCI, V525, P350, DOI 10.1111/j.1749-6632.1988.tb38619.x; BERRIDGE KC, 1987, BEHAV BRAIN RES, V23, P59, DOI 10.1016/0166-4328(87)90242-7; BERRIDGE KC, 1989, PSYCHOBIOLOGY, V17, P377; BERRIDGE KC, 1987, PSYCHOBIOLOGY, V15, P336; BERRIDGE KC, 1992, EXP BRAIN RES, V90, P275; BERRIDGE KC, 1989, BEHAV BRAIN RES, V33, P241, DOI 10.1016/S0166-4328(89)80119-6; CANNON RL, 1992, PSYCHOBIOLOGY, V20, P205; Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; Chen F, 1999, P NATL ACAD SCI USA, V96, P541, DOI 10.1073/pnas.96.2.541; Cohen-Tannoudji M, 2000, MECH DEVELOP, V90, P29, DOI 10.1016/S0925-4773(99)00226-9; Cromwell HC, 1996, J NEUROSCI, V16, P3444; DESCHAMPS J, 1993, DEV BIOL, V156, P473, DOI 10.1006/dbio.1993.1093; FENTRESS JC, 1988, ANN NY ACAD SCI, V525, P18, DOI 10.1111/j.1749-6632.1988.tb38592.x; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Graybiel AM, 1997, SCHIZOPHRENIA BULL, V23, P459, DOI 10.1093/schbul/23.3.459; Guy LG, 1997, NUCLEIC ACIDS RES, V25, P4400, DOI 10.1093/nar/25.21.4400; Horwath E, 2000, PSYCHIAT CLIN N AM, V23, P493, DOI 10.1016/S0193-953X(05)70176-3; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; MACLEAN PD, 1985, ARCH GEN PSYCHIAT, V42, P405; MACLEAN PD, 1985, PSYCHOL MED, V15, P219, DOI 10.1017/S0033291700023485; MACLEAN PD, 1978, BRAIN RES, V149, P175, DOI 10.1016/0006-8993(78)90597-8; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; McGrath MJ, 1999, BEHAV NEUROSCI, V113, P1249, DOI 10.1037/0735-7044.113.6.1249; ODENWALD WF, 1987, GENE DEV, V1, P482, DOI 10.1101/gad.1.5.482; RANCOURT DE, 1995, GENE DEV, V9, P108, DOI 10.1101/gad.9.1.108; Rauch SL, 1998, OBSESSIVE COMPULSIVE, P289; RICHMOND G, 1980, BEHAVIOUR, V75, P82, DOI 10.1163/156853980X00573; Robertson BJ, 1999, BRAIN RES, V838, P234, DOI 10.1016/S0006-8993(99)01743-6; SACHS BD, 1988, ANN NY ACAD SCI, V525, P1, DOI 10.1111/j.1749-6632.1988.tb38591.x; Sarna JR, 2000, BEHAV BRAIN RES, V108, P39, DOI 10.1016/S0166-4328(99)00137-0; Saxena S, 1998, BRIT J PSYCHIAT, V173, P26; STEIN DJ, 1992, COMPR PSYCHIAT, V33, P274, DOI 10.1016/0010-440X(92)90053-S; STROZIK E, 1981, LAB ANIM, V15, P309, DOI 10.1258/002367781780953040; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOREY IS, 1993, DEV BIOL, V160, P519, DOI 10.1006/dbio.1993.1326; van den Akker E, 1999, MECH DEVELOP, V89, P103, DOI 10.1016/S0925-4773(99)00212-9; WISE S, 1989, OBSESSIVE COMPULSIVE, P327	43	250	257	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 3	2002	33	1					23	34		10.1016/S0896-6273(01)00564-5	http://dx.doi.org/10.1016/S0896-6273(01)00564-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779477	Bronze			2022-12-28	WOS:000173106200007
J	Kayser, AS; Miller, KD				Kayser, AS; Miller, KD			Opponent inhibition: A developmental model of layer 4 of the neocortical circuit	NEURON			English	Article							CAT VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; LONG-TERM POTENTIATION; CELL RECEPTIVE-FIELDS; RAT BARREL CORTEX; ORIENTATION SELECTIVITY; OCULAR DOMINANCE; STRIATE CORTEX; SYNAPTIC TRANSMISSION; THALAMIC INPUT	We model the development of the functional circuit of layer 4 (the input-recipient layer) of cat primary visual cortex. The observed thalamocortical and intracortical circuitry codevelop under Hebb-like synaptic plasticity. Hebbian development yields opponent inhibition: Inhibition evoked by stimuli anticorrelated with those that excite a cell. Strong opponent inhibition enables recognition of stimulus orientation in a manner invariant to stimulus contrast. These principles may apply to cortex more generally: Hebb-like plasticity can guide layer 4 of any piece of cortex to create opposition between anticorrelated stimulus pairs, and this enables recognition of specific stimulus patterns in a manner invariant to stimulus magnitude. Properties that are invariant across a cortical column are predicted to be those shared by opponent stimulus pairs; this contrasts with the common idea that a column represents cells with similar response properties.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kayser, AS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.				NATIONAL EYE INSTITUTE [R01EY011001] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY11001] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Bartsch AP, 2001, BIOL CYBERN, V84, P41, DOI 10.1007/s004220170003; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; CALLAWAY EM, 1992, J NEUROSCI, V12, P570; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Chapman B, 2000, J NEUROSCI, V20, P1922; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Erwin E, 1998, J NEUROSCI, V18, P9870; ERWIN E, 1995, NEURAL COMPUT, V7, P425, DOI 10.1162/neco.1995.7.3.425; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; FERSTER D, 1988, J NEUROSCI, V8, P1172; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FERSTER D, 1992, J NEUROSCI, V12, P1262; FREGNAC Y, 1984, PHYSIOL REV, V64, P325, DOI 10.1152/physrev.1984.64.1.325; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gillespie DC, 2001, NAT NEUROSCI, V4, P1014, DOI 10.1038/nn731; GOODHILL GJ, 1993, BIOL CYBERN, V69, P109, DOI 10.1007/BF00226194; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Kayser A, 2001, J NEUROPHYSIOL, V85, P2130, DOI 10.1152/jn.2001.85.5.2130; KAYSER AS, 1999, THESIS U CALIFORNIA; Komatsu Y, 1996, J NEUROSCI, V16, P6342; KOMATSU Y, 1994, J NEUROSCI, V14, P6488; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; Krukowski AE, 2001, NAT NEUROSCI, V4, P424, DOI 10.1038/86084; Lauritzen TZ, 2001, J NEUROPHYSIOL, V86, P1803, DOI 10.1152/jn.2001.86.4.1803; LEVINE MW, 1986, J PHYSIOL-LONDON, V375, P339, DOI 10.1113/jphysiol.1986.sp016120; LIU Z, 1992, VISION RES, V32, P1193, DOI 10.1016/0042-6989(92)90213-3; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Miller K. D., 1996, MODELS NEURAL NETWOR, P55, DOI [10.1007/978-1-4612-0723-8_2, DOI 10.1007/978-1-4612-0723-8_2]; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; MILLER KD, 1994, J NEUROSCI, V14, P409; Miller KD, 1998, NEURAL COMPUT, V10, P529, DOI 10.1162/089976698300017647; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Olson SJ, 1998, NEURAL NETWORKS, V11, P189, DOI 10.1016/S0893-6080(98)00003-3; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; POLLEN DA, 1981, SCIENCE, V212, P1409, DOI 10.1126/science.7233231; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SAUL AB, 1992, J NEUROPHYSIOL, V68, P1190, DOI 10.1152/jn.1992.68.4.1190; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SCLAR G, 1987, EXP BRAIN RES, V66, P589, DOI 10.1007/BF00270692; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Sirosh J, 1997, NEURAL COMPUT, V9, P577, DOI 10.1162/neco.1997.9.3.577; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; Troyer TW, 1998, J NEUROSCI, V18, P5908; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; von der Malsburg C, 1973, Kybernetik, V14, P85; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Wolfe J, 1998, VISUAL NEUROSCI, V15, P653, DOI 10.1017/S0952523898154068; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29	68	23	23	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					131	142		10.1016/S0896-6273(01)00570-0	http://dx.doi.org/10.1016/S0896-6273(01)00570-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779486	Bronze			2022-12-28	WOS:000173106200016
J	Campbell, DS; Holt, CE				Campbell, DS; Holt, CE			Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation	NEURON			English	Article							UBIQUITIN-PROTEASOME PATHWAY; ACTIN MESSENGER-RNA; AXON GUIDANCE; NEURONAL CONNECTIVITY; SYNAPTIC PLASTICITY; CELL-CYCLE; NETRIN-1; PROTEOLYSIS; MEMBRANE; SUBUNIT	Growth cones contain mRNAs, translation machinery, and, as we report here, protein degradation machinery. We show that isolated retinal growth cones immediately lose their ability to turn in a chemotropic gradient of netrin-1 or Sema3A when translation is inhibited. Translation inhibition also prevents Sema3A-induced collapse, while LPA-induced collapse is not affected. Inhibition of proteasome function blocks responses to netrin-1 and LPA but does not affect Sema3A responses. We further demonstrate in isolated growth cones that netrin-1 and Sema3A activate translation initiation factors and stimulate a marked rise in protein synthesis within minutes, while netrin-1 and LPA elicit similar rises in ubiquitin-protein conjugates. These results suggest that guidance molecules steer axon growth by triggering rapid local changes in protein levels in growth cones.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.			Holt, Christine Elizabeth/0000-0003-2829-121X; Campbell, Douglas/0000-0002-7371-9484				Aguilera M, 2000, GENETICS, V155, P1231; Bassell GJ, 1998, J NEUROSCI, V18, P251; BOCHNIG P, 1987, EUR J BIOCHEM, V168, P461, DOI 10.1111/j.1432-1033.1987.tb13439.x; BREHM P, 1987, DEV BIOL, V123, P222, DOI 10.1016/0012-1606(87)90444-1; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chain DG, 1999, MOL NEUROBIOL, V20, P125, DOI 10.1007/BF02742438; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; DAVIS L, 1992, J NEUROSCI, V12, P4867; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Everett RD, 2000, J VIROL, V74, P9994, DOI 10.1128/JVI.74.21.9994-10005.2000; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fraser CS, 1999, J BIOL CHEM, V274, P196, DOI 10.1074/jbc.274.1.196; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GUTHRIE PB, 1989, J NEUROSCI, V9, P3596; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOLLENBECK PJ, 1987, J CELL BIOL, V105, P2827, DOI 10.1083/jcb.105.6.2827; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ishizuka T, 1997, BIOCHEM BIOPH RES CO, V230, P386, DOI 10.1006/bbrc.1996.5967; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Karniol B, 2000, CURR OPIN PLANT BIOL, V3, P387, DOI 10.1016/S1369-5266(00)00101-1; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; LOHOF AM, 1992, J NEUROSCI, V12, P1253; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; MINICH WB, 1994, P NATL ACAD SCI USA, V91, P7668, DOI 10.1073/pnas.91.16.7668; Mohanty S, 2001, GENE DEV, V15, P1435, DOI 10.1101/gad.871101; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; OBRIG TG, 1971, J BIOL CHEM, V246, P174; OH CE, 1994, J NEUROSCI, V14, P3166; Ohta K, 1999, DEV BIOL, V211, P124, DOI 10.1006/dbio.1999.9312; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; POPOV S, 1993, SCIENCE, V259, P244, DOI 10.1126/science.7678471; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Saito S, 1997, NEUROSCI LETT, V229, P73, DOI 10.1016/S0304-3940(97)00397-2; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; STEWARD O, 1982, J NEUROSCI, V2, P284; TENNYSON VM, 1970, J CELL BIOL, V44, P62, DOI 10.1083/jcb.44.1.62; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tokumoto M, 1999, GENE, V239, P301, DOI 10.1016/S0378-1119(99)00406-0; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X; Zakharenko S, 2000, NEUROSCIENCE, V97, P185, DOI 10.1016/S0306-4522(00)00022-1; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	74	595	605	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1013	1026		10.1016/S0896-6273(01)00551-7	http://dx.doi.org/10.1016/S0896-6273(01)00551-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754834	Bronze			2022-12-28	WOS:000172886800009
J	Traynelis, SF; Chesler, M				Traynelis, SF; Chesler, M			Proton release as a modulator of presynaptic function	NEURON			English	Editorial Material							RAT HIPPOCAMPAL SLICES; PH; TRANSMISSION	In this issue of Neuron, DeVries (2001) describes experiments suggesting that acidification of the synaptic cleft can reduce Ca2+ channel activity and thereby act as a brake on tonic synaptic release of glutamate from cone cells. This work hints at a potentially important new facet to the regulation of synaptic transmission.	Emory Univ, Sch Med, Rollins Res Ctr, Dept Pharmacol, Atlanta, GA 30322 USA; NYU Med Ctr, Dept Physiol & Neurosci, New York, NY 10016 USA	Emory University; New York University	Traynelis, SF (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.							Billups B, 1996, NATURE, V379, P171, DOI 10.1038/379171a0; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; GOTTFRIED JA, 1994, J PHYSIOL-LONDON, V478, P373, DOI 10.1113/jphysiol.1994.sp020258; KAILA K, 1987, NATURE, V330, P163, DOI 10.1038/330163a0; KALIA K, 1998, PH BRAIN FUNCTION, P309; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; SCHWIENING CJ, 1993, P ROY SOC B-BIOL SCI, V253, P285, DOI 10.1098/rspb.1993.0115; TAIRA T, 1993, NEUROREPORT, V4, P93, DOI 10.1097/00001756-199301000-00024; Tombaugh Geoffrey C., 1998, P395; Tong CK, 2000, J NEUROSCI, V20, P8247, DOI 10.1523/JNEUROSCI.20-22-08247.2000; Traynelis Stephen F., 1998, P417	12	23	23	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					960	962		10.1016/S0896-6273(01)00549-9	http://dx.doi.org/10.1016/S0896-6273(01)00549-9			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754826	Bronze			2022-12-28	WOS:000172886800002
J	Becerra, L; Breiter, HC; Wise, R; Gonzalez, RG; Borsook, D				Becerra, L; Breiter, HC; Wise, R; Gonzalez, RG; Borsook, D			Reward circuitry activation by noxious thermal stimuli	NEURON			English	Review							POSITRON-EMISSION-TOMOGRAPHY; ANTERIOR CINGULATE CORTEX; NUCLEUS-ACCUMBENS NEURONS; HUMAN BRAIN; PREFRONTAL CORTEX; ELECTROPHYSIOLOGICAL EVIDENCE; PERIAQUEDUCTAL GRAY; PAIN PERCEPTION; SOMATOSENSORY CORTEX; ORBITOFRONTAL CORTEX	Using functional magnetic resonance imaging (fMRI), we observed that noxious thermal stimuli (46 degreesC) produce significant signal change in putative reward circuitry as well as in classic pain circuitry. Increases in signal were observed in the sublenticular extended amygdala of the basal forebrain (SLEA) and the ventral tegmentum/periaqueductal gray (VT/PAG), while foci of increased signal and decreased signal were observed in the ventral striatum and nucleus accumbens (NAc). Early and late phases were observed for signals in most brain regions, with early activation in reward related regions such as the SLEA, VT/PAG, and ventral striatum, In contrast, structures associated with somatosensory perception, including SI somatosensory cortex, thalamus, and insula, showed delayed activation. These data support the notion that there may be a shared neural system for evaluation of aversive and rewarding stimuli.	Massachusetts Gen Hosp, Ctr Funct Pain Neuroimaging & Therapy Res, Boston, MA 02129 USA; Massachusetts Gen Hosp, Motivat & Emot Neurosci Ctr, Boston, MA 02129 USA; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02129 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02129 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02129 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02129 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02129 USA; NIDA, NIH, Baltimore, MD 21224 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Borsook, D (corresponding author), Massachusetts Gen Hosp, Ctr Funct Pain Neuroimaging & Therapy Res, Boston, MA 02129 USA.		Wise, Roy A/A-6465-2012		PHS HHS [09467, 13650, 01258, 034626, 00265] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALTIER N, 1997, BEHAV BRAIN RES, V89, P161; Apkarian AV, 1999, J NEUROPHYSIOL, V81, P2956, DOI 10.1152/jn.1999.81.6.2956; Arvanitogiannis A, 1996, PHYSIOL BEHAV, V59, P795, DOI 10.1016/0031-9384(95)02157-4; Barbas H, 2000, ADV NEUROL, V84, P87; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Becerra LR, 1999, MAGN RESON MED, V41, P1044, DOI 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO;2-M; Bechara A, 1998, J NEUROSCI, V18, P428; BERNARD JF, 1992, J NEUROPHYSIOL, V68, P551; BERNARD JF, 1990, J NEUROPHYSIOL, V63, P473, DOI 10.1152/jn.1990.63.3.473; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Besson JM, 1999, LANCET, V353, P1610, DOI 10.1016/S0140-6736(99)01313-6; Bonhomme V, 2001, J NEUROPHYSIOL, V85, P1299, DOI 10.1152/jn.2001.85.3.1299; BORSOOK D, 2000, AM PAIN SOC ATL GA; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Boye SM, 1996, J NEUROSCI, V16, P3511; Bozarth M A, 1986, NIDA Res Monogr, V67, P190; Breiter H.C., 1996, NEUROIMAGE, V3, pS220, DOI 10.1016/S1053-8119(96)80222-9; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; BREITER HC, 2000, AM PAIN SOC ATL GA; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bushnell MC, 1999, P NATL ACAD SCI USA, V96, P7705, DOI 10.1073/pnas.96.14.7705; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Carlezon WA, 1996, J NEUROSCI, V16, P3112; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; CONDESLARA M, 1991, J PHYSIOLOGY PARIS, V85, P188; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; Derbyshire SWG, 1999, EUR J PAIN, V3, P103, DOI 10.1053/eujp.1998.0102; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dubner R, 1999, PAIN, pS45, DOI 10.1016/S0304-3959(99)00137-2; Dubner R, 1999, P NATL ACAD SCI USA, V96, P7627, DOI 10.1073/pnas.96.14.7627; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; FIELDS HL, 1991, ANNU REV NEUROSCI, V14, P219, DOI 10.1146/annurev.neuro.14.1.219; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; FRANKLIN KBJ, 1989, NEUROSCI BIOBEHAV R, V13, P149, DOI 10.1016/S0149-7634(89)80024-7; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; Gallistel C. R., 1990, ORG LEARNING; Gear RW, 1999, J NEUROSCI, V19, P7175, DOI 10.1523/JNEUROSCI.19-16-07175.1999; GRACELY RH, 1988, PAIN, V35, P279, DOI 10.1016/0304-3959(88)90138-8; GREEN L, 1991, J EXP ANAL BEHAV, V55, P133, DOI 10.1901/jeab.1991.55-133; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Haber SN, 1997, CRIT REV NEUROBIOL, V11, P323, DOI 10.1615/CritRevNeurobiol.v11.i4.40; HARDY SGP, 1985, BRAIN RES, V339, P285; HARDY SGP, 1985, BRAIN RES, V339, P281; HARMANN PA, 1988, BRAIN RES, V441, P87, DOI 10.1016/0006-8993(88)91386-8; Hauber W, 2000, J NEUROSCI, V20, P6282, DOI 10.1523/JNEUROSCI.20-16-06282.2000; Heimer L, 1997, J NEUROPSYCH CLIN N, V9, P354; HEINRICHER MM, 1987, J NEUROSCI, V7, P271; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Hofbauer RK, 2001, J NEUROPHYSIOL, V86, P402, DOI 10.1152/jn.2001.86.1.402; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; IADAROLA MJ, 1995, PAIN, V63, P55, DOI 10.1016/0304-3959(95)00015-K; Iadarola MJ, 1998, BRAIN, V121, P931, DOI 10.1093/brain/121.5.931; JONES AKP, 1991, P ROY SOC B-BIOL SCI, V244, P39, DOI 10.1098/rspb.1991.0048; Kern MK, 1998, GASTROENTEROLOGY, V115, P1353, DOI 10.1016/S0016-5085(98)70013-7; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; Kwan CL, 2000, PAIN, V85, P359, DOI 10.1016/S0304-3959(99)00287-0; LeDoux J., 1998, EMOTIONAL BRAIN MYST; Lee RS, 1998, BRAIN RES, V799, P317, DOI 10.1016/S0006-8993(98)00477-6; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Manning BH, 1998, J NEUROSCI, V18, P9453; MANTYH PW, 1982, J COMP NEUROL, V211, P50, DOI 10.1002/cne.902110106; MAZUR JE, 1986, J EXP ANAL BEHAV, V46, P67, DOI 10.1901/jeab.1986.46-67; MELZACK R, 1968, P423; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Merboldt KD, 2001, NEUROIMAGE, V14, P253, DOI 10.1006/nimg.2001.0802; MILIARESSIS E, 1987, PHYSIOL BEHAV, V41, P595, DOI 10.1016/0031-9384(87)90316-7; MORGAN MJ, 1990, BRAIN RES, V519, P144, DOI 10.1016/0006-8993(90)90072-J; NOLTE J, 1999, HUMAN BRAIN; ODonnell P, 1996, NEUROPSYCHOPHARMACOL, V15, P87, DOI 10.1016/0893-133X(95)00177-F; OLDS ME, 1982, BRAIN RES, V237, P429, DOI 10.1016/0006-8993(82)90454-1; Paulson PE, 1998, PAIN, V76, P223, DOI 10.1016/S0304-3959(98)00048-7; PORTER J, 1980, NEW ENGL J MED, V302, P123; Posse S, 1997, AM J NEURORADIOL, V18, P1763; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; PRICE DD, 2000, PROGR PAIN RES MANAG, V15; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROLLS ET, 1999, BRAIN EMOTION; Schneirla TC, 1959, NEBRASKA S MOTIVATIO, P1; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Serratrice G, 1999, REV RHUM, V66, P331; Shizgal P, 1996, CURR DIR PSYCHOL SCI, V5, P37, DOI 10.1111/1467-8721.ep10772715; Shizgal P., 1999, WELL BEING FDN HEDON, P502; SPINOZA B, 1883, ETHICS, P1; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; Svensson P, 1997, SOMATOSENS MOT RES, V14, P113, DOI 10.1080/08990229771114; Talairach J., 1988, COPLANAR STEREOTAXIC; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; TAYLOR SF, 2000, HUM BRAIN MAP SAN AN; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; TREEDE RD, 1995, J PHYSIOL-LONDON, V483, P747, DOI 10.1113/jphysiol.1995.sp020619; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tsujimoto T, 2000, NEUROSCI LETT, V283, P69, DOI 10.1016/S0304-3940(00)00913-7; Vogt BA, 1998, EXP NEUROL, V153, P8, DOI 10.1006/exnr.1998.6852; Vogt BA, 1996, EUR J NEUROSCI, V8, P1461, DOI 10.1111/j.1460-9568.1996.tb01608.x; Watanabe M, 1998, REV NEUROSCIENCE, V9, P225; WHITE FJ, 1986, J NEUROSCI, V6, P274; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; WISE RA, 1978, BRAIN RES, V152, P215, DOI 10.1016/0006-8993(78)90253-6; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	121	376	378	0	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					927	946		10.1016/S0896-6273(01)00533-5	http://dx.doi.org/10.1016/S0896-6273(01)00533-5			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738036	Bronze			2022-12-28	WOS:000172700700017
J	Bonhoeffer, T; Yuste, R				Bonhoeffer, T; Yuste, R			Spine motility: Phenomenology, mechanisms, and function	NEURON			English	Review							CULTURED HIPPOCAMPAL-NEURONS; LINKED MENTAL-RETARDATION; LONG-TERM POTENTIATION; ACTIN-BASED PLASTICITY; RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; DENDRITIC SPINES; RHO-GTPASES; GROWTH CONE; IN-VIVO	Throughout the history of neuroscience, dendritic spines have been considered stable structures, but in recent years, imaging techniques have revealed that spines are constantly changing shape. Spine motility is difficult to categorize, has different forms, and possibly even represents multiple phenomena. It is influenced by synaptic transmission, intracellular calcium, and a multitude of ions and other molecules. An actin-based cascade mediates this phenomenon, and while the precise signaling pathways are still unclear, the Rho family of GTPases could well be a "common denominator" controlling spine morphology. One role of spine motility might be to enable a searching function during synaptogenesis, allowing for more efficacious neuronal connectivity in the neuronal thicket. This idea revisits concepts originally formulated by Cajal, who proposed over a hundred years ago that spines might help to increase and modify synaptic connections.	Max Planck Inst Neurobiol, Munich, Germany; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Max Planck Society; Columbia University	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Munich, Germany.	tobias.bonhoeffer@neuro.mpg.de	Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634	NEI NIH HHS [EY13237] Funding Source: Medline; NINDS NIH HHS [NS40726] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040726] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Allison DW, 1998, J NEUROSCI, V18, P2423; Anderson JC, 2001, NAT NEUROSCI, V4, P1166, DOI 10.1038/nn772; Arai Y, 2002, BRAIN DEV-JPN, V24, P67, DOI 10.1016/S0387-7604(01)00405-3; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BLOMBERG F, 1977, J CELL BIOL, V86, P831; CORNELLBELL AH, 1990, GLIA, V3, P322, DOI 10.1002/glia.440030503; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Edwards FA, 1998, NATURE, V394, P129, DOI 10.1038/28050; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; GRAY EG, 1959, J ANAT, V93, P420; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hirai H, 2000, EUR J NEUROSCI, V12, P563, DOI 10.1046/j.1460-9568.2000.00938.x; Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7; Horch HW, 1999, NEURON, V23, P353; JONES EG, 1969, J CELL SCI, V5, P509; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kaech S, 1999, P NATL ACAD SCI USA, V96, P10433, DOI 10.1073/pnas.96.18.10433; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Kirov SA, 1999, J NEUROSCI, V19, P2876; KOCH C, 1993, J NEUROSCI, V13, P413; Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LUND JS, 1977, J COMP NEUROL, V176, P149, DOI 10.1002/cne.901760203; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Majewska A, 2000, J NEUROSCI, V20, P1722; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MASON CA, 1983, J COMP NEUROL, V217, P458, DOI 10.1002/cne.902170410; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MOREST DK, 1969, Z ANAT ENTWICKLUNGS, V128, P265; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Peters A., 1976, FINE STRUCTURE NERVO; PHELPS PE, 1983, DEV BRAIN RES, V10, P1, DOI 10.1016/0165-3806(83)90116-5; RAMOA AS, 1987, SCIENCE, V237, P522, DOI 10.1126/science.3603038; Ramon y Cajal S., 1899, TEXTURA SISTEMA NERV; Ramon y Cajal S, 1891, REV CIENCIAS MED, V22, P23; Ramon y Cajal S S, 1888, REV TRIM HISTOL NORM, V1, P1; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Saito Y, 1997, J NEUROSCI, V17, P8792; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Segal M, 2000, CURR OPIN NEUROBIOL, V10, P582, DOI 10.1016/S0959-4388(00)00123-9; Sotelo C, 1978, Prog Brain Res, V48, P149; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; SWINDALE NV, 1981, TRENDS NEUROSCI, V4, P240, DOI 10.1016/0166-2236(81)90075-8; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x; WONG ROL, 1992, EUR J NEUROSCI, V4, P1387, DOI 10.1111/j.1460-9568.1992.tb00164.x; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wong WT, 2000, J NEUROSCI, V20, P5024; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zheng JQ, 1996, J NEUROSCI, V16, P1140; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	98	271	281	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1019	1027		10.1016/S0896-6273(02)00906-6	http://dx.doi.org/10.1016/S0896-6273(02)00906-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354393	Bronze			2022-12-28	WOS:000178040000004
J	Chance, FS; Abbott, LF; Reyes, AD				Chance, FS; Abbott, LF; Reyes, AD			Gain modulation from background synaptic input	NEURON			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; VISUAL-CORTEX; PARIETAL CORTEX; IN-VIVO; INTEGRATIVE PROPERTIES; SHUNTING INHIBITION; ATTENTION; CELLS; CONDUCTANCES; RESPONSES	Gain modulation is a prominent feature of neuronal activity recorded in behaving animals, but the mechanism by which it occurs is unknown. By introducing a barrage of excitatory and inhibitory synaptic conductances that mimics conditions encountered in vivo into pyramidal neurons in slices of rat somatosensory cortex, we show that the gain of a neuronal response to excitatory drive can be modulated by varying the level of "background" synaptic input. Simultaneously increasing both excitatory and inhibitory background firing rates in a balanced manner results in a divisive gain modulation of the neuronal response without appreciable signal-independent increases in firing rate or spike-train variability. These results suggest that, within active cortical circuits, the overall level of synaptic input to a neuron acts as a gain control signal that modulates responsiveness to excitatory drive.	NYU, Ctr Neural Sci, New York, NY 10003 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	New York University; Brandeis University; Brandeis University	Chance, FS (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.			Chance, Frances/0000-0003-1420-4664	NEI NIH HHS [T32-EY-7136] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007136] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSEN RA, 1983, J NEUROSCI, V3, P532; ANDERSEN RA, 1985, SCIENCE, V230, P450; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BASTIAN J, 1986, J NEUROSCI, V6, P553; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; DAYAN P, 2001, THEORETICAL NEUROSCI, P164; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Doiron B, 2001, NEURAL COMPUT, V13, P227, DOI 10.1162/089976601300014691; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Koch C., 1992, SINGLE NEURON COMPUT, P315; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; RAPP M, 1992, NEURAL COMPUT, V4, P518, DOI 10.1162/neco.1992.4.4.518; Reyes A, 1999, J NEUROSCI, V19, P3827; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Ricciardi L.M., 1977, DIFFUSION PROCESSES, V14; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Salinas E, 1997, J NEUROPHYSIOL, V77, P3267, DOI 10.1152/jn.1997.77.6.3267; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; SALINAS E, 1995, J NEUROSCI, V15, P6461; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SRINIVASAN MV, 1976, BIOL CYBERN, V21, P227, DOI 10.1007/BF00344168; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; TIESINGA PHE, 2001, TOPICS, V62, P8413; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	46	706	722	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					773	782		10.1016/S0896-6273(02)00820-6	http://dx.doi.org/10.1016/S0896-6273(02)00820-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194875	Bronze			2022-12-28	WOS:000177521000016
J	Kruger, GM; Mosher, JT; Bixby, S; Joseph, N; Iwashita, T; Morrison, SJ				Kruger, GM; Mosher, JT; Bixby, S; Joseph, N; Iwashita, T; Morrison, SJ			Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness	NEURON			English	Article							RAT GASTROINTESTINAL-TRACT; PERIPHERAL NERVOUS-SYSTEM; IN-VIVO; SEROTONERGIC NEURONS; SYMPATHETIC NEURONS; MYENTERIC PLEXUS; GROWTH-FACTOR; DIFFERENTIATION; IDENTIFICATION; NEUROGENESIS	We found neural crest stem cells (NCSCs) in the adult gut. Postnatal gut NCSCs were isolated by flow-cytometry and compared to fetal gut NCSCs. They self-renewed extensively in culture but less than fetal gut NCSCs. Postnatal gut NCSCs made neurons that expressed a variety of neurotransmitters but lost the ability to make certain subtypes of neurons that are generated during fetal development. Postnatal gut NCSCs also differed in their responsiveness to lineage determination factors, affecting cell fate determination in vivo and possibly explaining their reduced neuronal subtype potential. These perinatal changes in gut NCSCs parallel perinatal changes in hematopoietic stem cells, suggesting that stem cells in different tissues undergo similar developmental transitions. The persistence of NCSCs in the adult PNS opens up new possibilities for regeneration after injury or disease.	Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.		Morrison, Sean/ABD-5326-2021; Crane, Genevieve M/AAK-9224-2020	Crane, Genevieve M/0000-0001-9274-0214; Morrison, Sean/0000-0003-1587-8329	NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310, P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA046592, CA46592] Funding Source: Medline; NIAMS NIH HHS [1 P30 AR48310, AR20557, P30 AR048310] Funding Source: Medline; NIDDK NIH HHS [P60 DK020572, 5P60-DK20572] Funding Source: Medline; NIGMS NIH HHS [T32 GM007863, GM07863] Funding Source: Medline; NINDS NIH HHS [R01 NS40750-01, R01 NS040750-01, R01 NS040750] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ANDERSON DJ, 1985, CELL, V42, P649, DOI 10.1016/0092-8674(85)90122-9; BARBE MF, 1991, J NEUROSCI, V11, P519; BAROFFIO A, 1991, DEVELOPMENT, V112, P301; BELIN MF, 1991, NEUROSCI LETT, V125, P101, DOI 10.1016/0304-3940(91)90001-A; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Blaugrund E, 1996, DEVELOPMENT, V122, P309; Burns AJ, 1998, DEVELOPMENT, V125, P4335; Cai L, 1997, J NEUROSCI, V17, P2088; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Desai AR, 2000, DEVELOPMENT, V127, P2863; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; GERSHON MD, 1977, P NATL ACAD SCI USA, V74, P3086, DOI 10.1073/pnas.74.7.3086; Gershon Michael D., 1994, P381; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Jarvinen MK, 1999, ANAT EMBRYOL, V199, P99, DOI 10.1007/s004290050213; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Kil SH, 1998, DEV BIOL, V202, P29, DOI 10.1006/dbio.1998.8985; Kubu CJ, 2002, DEV BIOL, V244, P199, DOI 10.1006/dbio.2002.0568; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; Lim DA, 1997, P NATL ACAD SCI USA, V94, P14832, DOI 10.1073/pnas.94.26.14832; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrison SJ, 2000, J NEUROSCI, V20, P7370; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; Pisano JM, 1999, DEVELOPMENT, V126, P2855; Pisano JM, 2000, DEV BIOL, V227, P1, DOI 10.1006/dbio.2000.9876; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Reissmann E, 1996, DEVELOPMENT, V122, P2079; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; ROTHMAN TP, 1990, DEVELOPMENT, V109, P411; Schafer KH, 1997, BRAIN RES PROTOC, V1, P109, DOI 10.1016/S1385-299X(96)00017-7; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5	51	424	441	3	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					657	669		10.1016/S0896-6273(02)00827-9	http://dx.doi.org/10.1016/S0896-6273(02)00827-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194866	Green Accepted, Bronze			2022-12-28	WOS:000177521000007
J	Simmons, PJ				Simmons, PJ			Presynaptic depolarization rate controls transmission at an invertebrate synapse	NEURON			English	Article							LARGE 2ND-ORDER NEURONS; AMPA RECEPTOR DESENSITIZATION; RETINAL BIPOLAR; CALCIUM CURRENT; TRANSMITTER RELEASE; LOCAL INTERNEURONS; 3RD-ORDER NEURONS; GRADED POTENTIALS; GLUTAMATE RELEASE; CLIMBING FIBER	Second-order neurons L1-3 of the locust ocellar pathway make inhibitory synapses with each other. Although the synapses transmit graded potentials, transmission depresses rapidly and completely so that a synapse only transmits when the presynaptic terminal depolarizes rapidly. The rate at which a presynaptic neuron depolarizes determines the rate at which a postsynaptic neuron hyperpolarizes, and neurotransmitter is only released during a fixed 2 ms long period. Consequently, the amplitude of a postsynaptic potential depends on the rate rather than the amplitude of a presynaptic depolarization. Following a postsynaptic potential, a synapse recovers from depression over about a second. The synapse recovers from depression even if the presynaptic terminal is held depolarized.	Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Newcastle Univ, Sch Neurosci & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Simmons, PJ (corresponding author), Newcastle Univ, Sch Biol, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	p.j.simmons@ncl.ac.uk		Simmons, Peter/0000-0002-1630-5082				AMAR M, 1995, NEUROSCI LETT, V199, P107, DOI 10.1016/0304-3940(95)12033-Z; AMMERMULLER J, 1986, J COMP PHYSIOL A, V159, P363, DOI 10.1007/BF00603982; BLIGHT A R, 1980, Philosophical Transactions of the Royal Society of London B Biological Sciences, V290, P219, DOI 10.1098/rstb.1980.0092; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; BURROWS M, 1992, J NEUROSCI, V12, P1477; BURROWS M, 1978, J PHYSIOL-LONDON, V285, P231, DOI 10.1113/jphysiol.1978.sp012569; Dittman JS, 1998, J NEUROSCI, V18, P6147; Eliasof S, 1997, VISUAL NEUROSCI, V14, P13, DOI 10.1017/S0952523800008713; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Fortune ES, 2001, TRENDS NEUROSCI, V24, P381, DOI 10.1016/S0166-2236(00)01835-X; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GOODMAN C, 1974, J COMP PHYSIOL, V95, P185, DOI 10.1007/BF00625443; HAYASHI JH, 1985, J PHYSIOL-LONDON, V368, P179, DOI 10.1113/jphysiol.1985.sp015852; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; KATZ B, 1967, J PHYSIOL-LONDON, V192, P407, DOI 10.1113/jphysiol.1967.sp008307; KLEIN M, 1980, P NATL ACAD SCI-BIOL, V77, P6912, DOI 10.1073/pnas.77.11.6912; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; Leitinger G, 2000, J COMP NEUROL, V416, P345; Leitinger G, 2002, J NEUROBIOL, V50, P93, DOI 10.1002/neu.10018; LIN JW, 1993, J GEN PHYSIOL, V101, P45, DOI 10.1085/jgp.101.1.45; LITTLEWOOD PMH, 1992, J COMP NEUROL, V325, P493, DOI 10.1002/cne.903250404; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Lu T, 1998, NEUROSCI RES, V31, P123, DOI 10.1016/S0168-0102(98)00031-5; Maguire G, 1999, EUR J NEUROSCI, V11, P353, DOI 10.1046/j.1460-9568.1999.00439.x; Manor Y, 1997, J NEUROSCI, V17, P5610; MAYNARD DM, 1975, J COMP PHYSIOL, V97, P215, DOI 10.1007/BF00617544; Msghina M, 1999, J NEUROSCI, V19, P8419; Otis T, 1996, J NEUROSCI, V16, P7496; PARKER D, 1995, J NEUROPHYSIOL, V74, P529, DOI 10.1152/jn.1995.74.2.529; ROWELL CHF, 1983, J EXP BIOL, V103, P265; Sabatini BL, 1997, J NEUROSCI, V17, P3425; SHAW SR, 1975, NATURE, V255, P480, DOI 10.1038/255480a0; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SIMMONS P, 1980, J EXP BIOL, V85, P281; SIMMONS PJ, 1985, J EXP BIOL, V117, P193; SIMMONS PJ, 1993, J COMP PHYSIOL A, V173, P635, DOI 10.1007/BF00197771; Simmons PJ, 2002, MICROSC RES TECHNIQ, V56, P270, DOI 10.1002/jemt.10030; SIMMONS PJ, 1981, J COMP PHYSIOL, V145, P265, DOI 10.1007/BF00605039; SIMMONS PJ, 1995, J EXP BIOL, V198, P537; SIMMONS PJ, 1989, J COMP NEUROL, V283, P129, DOI 10.1002/cne.902830111; SIMMONS PJ, 1982, J COMP PHYSIOL, V149, P389, DOI 10.1007/BF00619154; SIMMONS PJ, 1982, J COMP PHYSIOL, V147, P401, DOI 10.1007/BF00609674; SIMMONS PJ, 1986, J COMP PHYSIOL A, V159, P97, DOI 10.1007/BF00612500; Simmons PJ, 1999, J NEUROSCI, V19, P10584; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; van den Beukel I, 1998, BRAIN RES, V789, P263, DOI 10.1016/S0006-8993(98)00007-9; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1996, J NEUROSCI, V16, P115; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; WECKSTROM M, 1991, J PHYSIOL-LONDON, V440, P635, DOI 10.1113/jphysiol.1991.sp018729; WILSON M, 1978, J COMP PHYSIOL, V124, P297, DOI 10.1007/BF00661380; WILSON M, 1978, J COMP PHYSIOL, V124, P317, DOI 10.1007/BF00661381	58	14	14	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					749	758		10.1016/S0896-6273(02)00791-2	http://dx.doi.org/10.1016/S0896-6273(02)00791-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194873	Bronze			2022-12-28	WOS:000177521000014
J	Rosenthal, JJC; Bezanilla, F				Rosenthal, JJC; Bezanilla, F			Extensive editing of mRNAs for the squid delayed rectifier K+ channel regulates subunit tetramerization	NEURON			English	Article							DOUBLE-STRANDED-RNA; SHAKER POTASSIUM CHANNEL; MESSENGER-RNA; ADENOSINE-DEAMINASE; GIANT-AXON; T1 DOMAIN; KINETIC-PROPERTIES; RECEPTOR CHANNELS; SODIUM-CHANNELS; SINGLE-CHANNEL	We report the extensive editing of mRNAs that encode the classical delayed rectifier K+ channel (SqK(v)1.1A) in the squid giant axon. Using a quantitative RNA editing assay, 14 adenosine to guanine transitions were identified, and editing efficiency varied tremendously between positions. Interestingly, half of the sites are targeted to the T1 domain, important for subunit assembly. Other sites occur in the channel's transmembrane spans. The effects of editing on K+ channel function are elaborate. Edited codons affect channel gating, and several T1 sites regulate functional expression as well. In particular, the edit R87G, a phylogenetically conserved position, reduces expression close to 50-fold by regulating the channel's ability to form tetramers. These data suggest that RNA editing plays a dynamic role in regulating action potential repolarization in the giant axon.	Univ Calif Los Angeles, Sch Med, Dept Physiol & Anesthesiol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bezanilla, F (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol & Anesthesiol, Los Angeles, CA 90024 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030376, R01GM030376] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM20314, GM30376] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; BASS BL, 1989, CELL, V56, P331, DOI 10.1016/0092-8674(89)90234-1; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1970, J PHYSIOL-LONDON, V207, P151, DOI 10.1113/jphysiol.1970.sp009054; BEZANILLA F, 1970, J PHYSIOL-LONDON, V211, P729, DOI 10.1113/jphysiol.1970.sp009301; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Hanrahan CJ, 2000, GENETICS, V155, P1149; Hanrahan CJ, 1999, ANN NY ACAD SCI, V868, P51, DOI 10.1111/j.1749-6632.1999.tb11273.x; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holland LZ, 1997, BIOCHEMISTRY-US, V36, P3207, DOI 10.1021/bi962664k; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; LI M, 1993, ANN NY ACAD SCI, V707, P51, DOI 10.1111/j.1749-6632.1993.tb38041.x; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu TI, 2001, J NEUROPHYSIOL, V85, P61, DOI 10.1152/jn.2001.85.1.61; LLANO I, 1988, J GEN PHYSIOL, V92, P179, DOI 10.1085/jgp.92.2.179; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; OConnell MA, 1997, J BIOL CHEM, V272, P473; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Panyi G, 1996, J GEN PHYSIOL, V107, P409, DOI 10.1085/jgp.107.3.409; Patton DE, 1997, NEURON, V19, P711, DOI 10.1016/S0896-6273(00)80383-9; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Petschek JP, 1996, J MOL BIOL, V259, P885, DOI 10.1006/jmbi.1996.0365; Petschek JP, 1997, GENE, V204, P267, DOI 10.1016/S0378-1119(97)00465-4; PFAFFINGER PJ, 1995, J BIOL CHEM, V270, P28595, DOI 10.1074/jbc.270.48.28595; Polson AG, 1996, NATURE, V380, P454; POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11507, DOI 10.1021/bi00113a004; Pongs O, 1999, FEBS LETT, V452, P31, DOI 10.1016/S0014-5793(99)00535-9; Rosenthal JC, 1996, J GEN PHYSIOL, V108, P207, DOI 10.1085/jgp.108.3.207; ROSENTHAL JJC, 1993, P NATL ACAD SCI USA, V90, P10026, DOI 10.1073/pnas.90.21.10026; Rosenthal JJC, 1997, J NEUROSCI, V17, P5070; Sambrook J., 2002, MOL CLONING LAB MANU; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x; SHEN NV, 1993, NEURON, V11, P67; Sheng ZF, 1997, BIOCHEMISTRY-US, V36, P15501; Smith L A, 1998, J Neurogenet, V12, P227; Smith LA, 1996, J NEUROSCI, V16, P7868; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; TU LW, 1995, BIOPHYS J, V68, P147, DOI 10.1016/S0006-3495(95)80169-4; VANDENBERG CA, 1991, BIOPHYS J, V60, P1499, DOI 10.1016/S0006-3495(91)82185-3; Xu J, 1998, METHOD ENZYMOL, V293, P3; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761	65	61	65	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					743	757		10.1016/S0896-6273(02)00701-8	http://dx.doi.org/10.1016/S0896-6273(02)00701-8			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062021	Bronze			2022-12-28	WOS:000175951800009
J	Saleem, KS; Pauls, JM; Augath, M; Trinath, T; Prause, BA; Hashikawa, T; Logothetis, NK				Saleem, KS; Pauls, JM; Augath, M; Trinath, T; Prause, BA; Hashikawa, T; Logothetis, NK			Magnetic resonance imaging of neuronal connections in the macaque monkey	NEURON			English	Article							SUPERIOR TEMPORAL SULCUS; INFEROTEMPORAL AREA TE; SLOW AXONAL-TRANSPORT; PRIMATE BASAL GANGLIA; CAT VISUAL-CORTEX; TRANSNEURONAL TRANSPORT; CROSS-CORRELATION; GLOBUS-PALLIDUS; SQUIRREL-MONKEY; RHESUS-MONKEY	Recently, an MRI-detectable, neuronal tract-tracing method in living animals was introduced that exploits the anterogracle transport of manganese (Mn2+). We present the results of experiments simultaneously tracing manganese chloride and wheat germ agglutinin conjugated to horseradish peroxidase (WGA-HRP) to evaluate the specificity of the former by tracing the neuronal connections of the basal ganglia of the monkey. Mn2+ and WGA-HRP yielded remarkably similar and highly specific projection patterns. By showing the sequential transport of Mn2+ from striatum to pallidum-substantia nigra and then to thalamus, we demonstrated MRI visualization of transport across at least one synapse in the CNS of the primate. Transsynaptic tract tracing in living primates will allow chronic studies of development and plasticity and provide valuable anatomical information for fMRI and electrophysiological experiments in primates.	Riken Brain Sci Inst, Wako, Saitama 3510198, Japan; Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	RIKEN; Max Planck Society	Saleem, KS (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	saleemk@pcg.wustl.edu; nikos.logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019	Saleem, Kadharbatcha S/0000-0002-4450-9234				AERTSEN AMHJ, 1985, BRAIN RES, V340, P341, DOI 10.1016/0006-8993(85)90931-X; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ASCHNER M, 1991, NEUROSCI BIOBEHAV R, V15, P333, DOI 10.1016/S0149-7634(05)80026-0; BAIZER JS, 1991, J NEUROSCI, V11, P168; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Cheng K, 1997, J NEUROSCI, V17, P7902; DEVITO JL, 1982, EXP BRAIN RES, V46, P107; ENOCHS WS, 1993, EXP NEUROL, V123, P235, DOI 10.1006/exnr.1993.1156; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; FLAHERTY AW, 1993, J NEUROSCI, V13, P1120; GIBSON AR, 1984, BRAIN RES, V298, P235, DOI 10.1016/0006-8993(84)91423-9; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; GULLBERG GT, 1987, RADIOLOGY, V165, P241, DOI 10.1148/radiology.165.1.3628776; Haber SN, 2000, J NEUROSCI, V20, P2369; HABER SN, 1995, J NEUROSCI, V15, P4851; HABER SN, 1993, J COMP NEUROL, V329, P111, DOI 10.1002/cne.903290108; HAZRATI LN, 1992, BRAIN RES, V592, P213, DOI 10.1016/0006-8993(92)91679-9; HAZRATI LN, 1991, BRAIN RES, V567, P212, DOI 10.1016/0006-8993(91)90798-Z; HEDREEN JC, 1991, J COMP NEUROL, V304, P569, DOI 10.1002/cne.903040406; Henriksson J, 1999, TOXICOL APPL PHARM, V156, P119, DOI 10.1006/taap.1999.8639; Hoover JE, 1999, J NEUROSCI, V19, P1446; Horsley V, 1908, BRAIN, V31, P45, DOI 10.1093/brain/31.1.45; ILINSKY IA, 1987, J COMP NEUROL, V262, P331, DOI 10.1002/cne.902620303; ILINSKY IA, 1985, J COMP NEUROL, V236, P315, DOI 10.1002/cne.902360304; JOHNSON TN, 1971, EXP NEUROL, V33, P584, DOI 10.1016/0014-4886(71)90129-4; JONES EG, 1970, BRAIN, V93, P37, DOI 10.1093/brain/93.1.37; KUYPERS HGJM, 1990, TRENDS NEUROSCI, V13, P71, DOI 10.1016/0166-2236(90)90071-H; LEE JH, 1995, MAGN RESON MED, V34, P308, DOI 10.1002/mrm.1910340305; Lin CP, 2001, NEUROIMAGE, V14, P1035, DOI 10.1006/nimg.2001.0882; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; LOGOTHETIS NK, 2002, IN PRESS J NEUROSCI; LONDON RE, 1989, BRAIN RES BULL, V23, P229, DOI 10.1016/0361-9230(89)90152-4; Middleton FA, 1996, P NATL ACAD SCI USA, V93, P8683, DOI 10.1073/pnas.93.16.8683; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; NAUTA WALLE J. H., 1966, BRAIN RES, V1, P3, DOI 10.1016/0006-8993(66)90103-X; NEWLAND MC, 1989, EXP NEUROL, V106, P251, DOI 10.1016/0014-4886(89)90157-X; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; PARENT A, 1994, J COMP NEUROL, V344, P305, DOI 10.1002/cne.903440211; Parent M, 1999, J CHEM NEUROANAT, V16, P153, DOI 10.1016/S0891-0618(99)00008-3; Parent M, 2001, J COMP NEUROL, V439, P162, DOI 10.1002/cne.1340; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; PAUTLER RG, 2002, IN PRESS NEUROIMAGE; RAGSDALE CW, 1981, BRAIN RES, V208, P259, DOI 10.1016/0006-8993(81)90556-4; Ryu S, 2002, RADIAT RES, V157, P500, DOI 10.1667/0033-7587(2002)157[0500:NDORIO]2.0.CO;2; SAINTCYR JA, 1990, J COMP NEUROL, V298, P129, DOI 10.1002/cne.902980202; Saleem KS, 1996, J NEUROSCI, V16, P4757; Saleem KS, 2000, J NEUROSCI, V20, P5083; SCHWARZ C, 1991, J NEUROSCI, V11, P2995; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Sidibe M, 1997, J COMP NEUROL, V382, P323; SLOOT WN, 1994, BRAIN RES, V657, P124, DOI 10.1016/0006-8993(94)90959-8; SMITH Y, 1986, NEUROSCIENCE, V18, P347, DOI 10.1016/0306-4522(86)90159-4; Takeda A, 1998, BRAIN RES BULL, V45, P149, DOI 10.1016/S0361-9230(97)00330-4; Tjalve H, 1996, PHARMACOL TOXICOL, V79, P347; TJALVE H, 1995, PHARMACOL TOXICOL, V77, P23; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; VANEVERDINGEN KJ, 1994, RADIOLOGY, V193, P485, DOI 10.1148/radiology.193.2.7526413; Walker AE, 1940, J COMP NEUROL, V73, P59, DOI 10.1002/cne.900730106; Watanabe T, 2001, MAGNET RESON MED, V46, P424, DOI 10.1002/mrm.1209; WEHRLI FW, 1986, RADIOLOGY, V160, P781, DOI 10.1148/radiology.160.3.3526407; WIESEL TN, 1974, BRAIN RES, V79, P273, DOI 10.1016/0006-8993(74)90416-8; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; ZEMANICK MC, 1991, P NATL ACAD SCI USA, V88, P8048, DOI 10.1073/pnas.88.18.8048	68	183	187	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					685	700		10.1016/S0896-6273(02)00718-3	http://dx.doi.org/10.1016/S0896-6273(02)00718-3			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062017	Bronze			2022-12-28	WOS:000175951800005
J	Maffei, L; Berardi, N				Maffei, L; Berardi, N			Protein synthesis in the visual cortex is needed for ocular dominance plasticity	NEURON			English	Editorial Material								Experience-dependent remodelling of neural connections progresses through stages, and early phases eventually give way to later long-lasting ones. The transition from early to late stages, often associated with structural changes, depends on protein synthesis. Suppression of cortical but not geniculate protein synthesis blocks ocular dominance plasticity at its earliest stage, suggesting that structural changes occur rapidly in the visual cortex following monocular deprivation.	CNR, Ist Neurosci, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Maffei, L (corresponding author), CNR, Ist Neurosci, Via G Moruzzi 1, I-56100 Pisa, Italy.							BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	7	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					328	331		10.1016/S0896-6273(02)00688-8	http://dx.doi.org/10.1016/S0896-6273(02)00688-8			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988162	Bronze			2022-12-28	WOS:000175214700002
J	Spors, H; Grinvald, A				Spors, H; Grinvald, A			Spatio-temporal dynamics of odor representations in the mammalian olfactory bulb	NEURON			English	Article							VOLTAGE-SENSITIVE DYES; OSCILLATING NEURAL ASSEMBLIES; FUNCTIONAL ARCHITECTURE; SYNAPTIC INHIBITION; UNIT-ACTIVITY; RAT; PATTERNS; RESPONSES; STIMULATION; INFORMATION	We explored the spatio-temporal dynamics of odor-evoked activity in the rat and mouse main olfactory bulb (MOB) using voltage-sensitive dye imaging (VSDI) with a new probe. The high temporal resolution of VSDI revealed odor-specific sequences of glomerular activation. Increasing odor concentrations reduced response latencies, increased response amplitudes, and recruited new glomerular units. However, the sequence of glomerular activation was maintained. Furthermore, we found distributed MOB activity locked to the nasal respiration cycle. The spatial distribution of its amplitude and phase was heterogeneous and changed by sensory input in an odor-specific manner. Our data show that in the mammalian olfactory bulb, odor identity and concentration are represented by spatio-temporal patterns, rather than spatial patterns alone.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Max Planck Society	Spors, H (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.			Spors, Hartwig/0000-0003-3153-9001				Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Carlson GC, 2000, J NEUROSCI, V20, P2011; CHAPUT M, 1979, J PHYSIOL-PARIS, V75, P939; CHAPUT MA, 1992, EUR J NEUROSCI, V4, P813, DOI 10.1111/j.1460-9568.1992.tb00191.x; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; COOPERSMITH R, 1984, SCIENCE, V225, P849, DOI 10.1126/science.6474157; DOTY RL, 1986, EXPERIENTIA, V42, P257, DOI 10.1007/BF01942506; EZEH PI, 1995, J NEUROPHYSIOL, V73, P2207, DOI 10.1152/jn.1995.73.6.2207; FREEMAN WJ, 1986, BEHAV NEUROSCI, V100, P753, DOI 10.1037/0735-7044.100.5.753; FREEMAN WJ, 1987, BEHAV NEUROSCI, V101, P393, DOI 10.1037/0735-7044.101.3.393; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 2001, CURR OPIN NEUROBIOL, V11, P468, DOI 10.1016/S0959-4388(00)00236-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galizia CG, 2000, J INSECT PHYSIOL, V46, P877, DOI 10.1016/S0022-1910(99)00194-8; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; HARRISON TA, 1986, J NEUROPHYSIOL, V56, P1571, DOI 10.1152/jn.1986.56.6.1571; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; Kent PF, 1996, J NEUROSCI, V16, P345; KONNERTH A, 1986, NEUROSCI LETT, V66, P49, DOI 10.1016/0304-3940(86)90164-3; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; LEVETEAU J, 1966, SCIENCE, V175, P170; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MATHEWS DF, 1972, BRAIN RES, V47, P389, DOI 10.1016/0006-8993(72)90647-6; MEISAMI E, 1993, DEV BRAIN RES, V71, P253, DOI 10.1016/0165-3806(93)90177-C; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P649, DOI 10.1152/jn.1981.46.3.649; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; ORBACH HS, 1983, J NEUROSCI, V3, P2251; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Pelosi P, 1996, J NEUROBIOL, V30, P3; Philpot BD, 1997, J NEUROBIOL, V33, P374, DOI 10.1002/(SICI)1097-4695(199710)33:4<374::AID-NEU3>3.0.CO;2-7; Reisert J, 1999, J PHYSIOL-LONDON, V519, P801, DOI 10.1111/j.1469-7793.1999.0801n.x; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; ROSS WN, 1979, J MEMBRANE BIOL, V48, P343, DOI 10.1007/BF01869445; ROYET JP, 1987, BRAIN RES, V417, P1, DOI 10.1016/0006-8993(87)90173-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Teyke T, 1999, NEUROREPORT, V10, P1061, DOI 10.1097/00001756-199904060-00030; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; WALSH RR, 1956, AM J PHYSIOL, V186, P255, DOI 10.1152/ajplegacy.1956.186.2.255; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Xu FQ, 2000, J COMP NEUROL, V422, P489, DOI 10.1002/1096-9861(20000710)422:4<489::AID-CNE1>3.0.CO;2-#; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	78	253	256	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					301	315		10.1016/S0896-6273(02)00644-X	http://dx.doi.org/10.1016/S0896-6273(02)00644-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970871	Bronze			2022-12-28	WOS:000174976200015
J	Kim, EY; Bae, K; Ng, FS; Glossop, NRJ; Hardin, PE; Edery, I				Kim, EY; Bae, K; Ng, FS; Glossop, NRJ; Hardin, PE; Edery, I			Drosophila CLOCK protein is under posttranscriptional control and influences light-induced activity	NEURON			English	Article							PER-TIM COMPLEX; CIRCADIAN CLOCK; FEEDBACK LOOPS; NUCLEAR ENTRY; DARK CYCLES; GENE; TIMELESS; TRANSCRIPTION; RHYTHMS; MUTANTS	In the Drosophila circadian clock, daily cycles in the RNA levels of dclock (dClk) are antiphase to those of period (per). We altered the timing/levels of dClk expression by generating transgenic flies whereby per circadian regulatory sequences were used to drive rhythmic transcription of dClk. The results indicate that posttranscriptional mechanisms make substantial contributions to the temporal changes in the abundance of the dCLK protein. Circadian regulation is largely unaffected in the transgenic per-dClk flies despite higher mean levels of dCLK. However, in per-dClk flies the duration of morning activity is lengthened in light-dark cycles and light pulses evoke longer lasting bouts of activity. Our findings suggest that, in addition to a role in generating circadian rhythms, dCLK modulates the direct effects of light on locomotion.	Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	Rutgers State University New Brunswick; University of Houston System; University of Houston	Edery, I (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.			Hardin, Paul/0000-0002-3370-9011				Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bae K, 2000, J NEUROSCI, V20, P1746; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng YZ, 1998, MOL CELL BIOL, V18, P6505, DOI 10.1128/MCB.18.11.6505; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Edery I, 1999, CHRONOBIOL INT, V16, P377, DOI 10.3109/07420529908998716; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Hao HP, 1999, J NEUROSCI, V19, P987; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hastings J.W., 1991, NEURAL INTEGRATIVE A, P435; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Helfrich-Forster C, 2001, J INSECT PHYSIOL, V47, P877, DOI 10.1016/S0022-1910(01)00060-9; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naylor E, 2000, J NEUROSCI, V20, P8138; Ousley A, 1998, GENETICS, V148, P815; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x	51	109	109	0	46	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					69	81		10.1016/S0896-6273(02)00639-6	http://dx.doi.org/10.1016/S0896-6273(02)00639-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931742	Bronze			2022-12-28	WOS:000174695100010
J	Puce, A				Puce, A			Should bad workmen always blame their tools?	NEURON			English	Editorial Material									W Virginia Univ, Dept Radiol, Ctr Adv Imaging, Morgantown, WV 26506 USA	West Virginia University	Puce, A (corresponding author), W Virginia Univ, Dept Radiol, Ctr Adv Imaging, Morgantown, WV 26506 USA.		Puce, Aina/V-5335-2019	Puce, Aina/0000-0002-0716-4185				Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Wheaton KJ, 2001, VISUAL NEUROSCI, V18, P401, DOI 10.1017/S0952523801183069	7	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 28	2002	34	1					6	7		10.1016/S0896-6273(02)00648-7	http://dx.doi.org/10.1016/S0896-6273(02)00648-7			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931736	Bronze			2022-12-28	WOS:000174695100004
J	Peleg, S; Varon, D; Ivanina, T; Dessauer, CW; Dascal, N				Peleg, S; Varon, D; Ivanina, T; Dessauer, CW; Dascal, N			G alpha(i) controls the gating of the G protein-activated K+ channel, GIRK	NEURON			English	Article							BETA-GAMMA-SUBUNITS; MUSCARINIC POTASSIUM CHANNEL; XENOPUS-OOCYTES; ATRIAL MYOCYTES; I-KACH; RECEPTORS; BINDING; CELLS; G(BETA-GAMMA); SPECIFICITY	GIRK (Kir3) channels are activated by neurotransmitters; coupled to G proteins, via a direct binding of Gbetagamma. The role of Galpha subunits in GIRK gating is elusive. Here we demonstrate that Galpha(i) is not only a donor of Gbetagamma but also regulates GIRK gating. When overexpressed in Xenopus oocytes, GIRK channels show excessive basal activity and poor activation by agonist or Gbetagamma. Coexpression of Galpha(i3) or Galpha(i1), restores the correct gating parameters. Galpha(i) acts neither as a pure Gbetagamma scavenger nor as an allosteric cofactor for Gbetagamma. It inhibits only the basal activity without interfering with Gbetagamma-induced response. Thus, GIRK is regulated, in distinct ways, by both arms of the G protein. Gal probably acts in its GDP bound form, alone or as a part of Galphabetagamma heterotrimer.	Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; Univ Texas, Houston Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Texas System; University of Texas Health Science Center Houston	Dascal, N (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.		Dascal, Nathan/O-3915-2015; Dessauer, Carmen/N-6933-2018	Dascal, Nathan/0000-0002-5397-4146; Dessauer, Carmen/0000-0003-1210-4280	NIGMS NIH HHS [R01 GM060419-02, R01 GM060419, GM 56260-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419, R01GM056260] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bender K, 1998, FEBS LETT, V439, P115, DOI 10.1016/S0014-5793(98)01350-7; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; IVANINA T, 1994, BIOCHEMISTRY-US, V33, P8786, DOI 10.1021/bi00195a021; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; IvanovaNikolova TT, 1997, J GEN PHYSIOL, V109, P245, DOI 10.1085/jgp.109.2.245; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Kim D, 1997, AM J PHYSIOL-HEART C, V272, pH195, DOI 10.1152/ajpheart.1997.272.1.H195; Kozasa T, 1996, NEUROSCI RES, V26, P289, DOI 10.1016/S0168-0102(96)01111-X; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Leaney JL, 2000, P NATL ACAD SCI USA, V97, P5651, DOI 10.1073/pnas.080572297; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; Lei QB, 2000, P NATL ACAD SCI USA, V97, P9771, DOI 10.1073/pnas.97.17.9771; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; Logothetis DE, 1999, J PHYSIOL-LONDON, V520, P630, DOI 10.1111/j.1469-7793.1999.00630.x; Lutz LB, 2000, J BIOL CHEM, V275, P41512, DOI 10.1074/jbc.M006757200; Nemec J, 1999, BIOPHYS J, V76, P246, DOI 10.1016/S0006-3495(99)77193-6; Petit-Jacques J, 1999, J GEN PHYSIOL, V114, P673, DOI 10.1085/jgp.114.5.673; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; ROSS EM, 1995, RECENT PROG HORM RES, V50, P207; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Singer-Lahat D, 2000, PFLUG ARCH EUR J PHY, V440, P627, DOI 10.1007/s004240000341; Sorota S, 1999, J PHYSIOL-LONDON, V514, P413, DOI 10.1111/j.1469-7793.1999.413ae.x; Sowell MO, 1997, P NATL ACAD SCI USA, V94, P7921, DOI 10.1073/pnas.94.15.7921; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Vorobiov D, 2000, J BIOL CHEM, V275, P4166, DOI 10.1074/jbc.275.6.4166; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Yakubovich D, 2000, J PHYSIOL-LONDON, V524, P737, DOI 10.1111/j.1469-7793.2000.00737.x; Yamada M, 1998, PHARMACOL REV, V50, P723; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0	43	132	135	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					87	99		10.1016/S0896-6273(01)00567-0	http://dx.doi.org/10.1016/S0896-6273(01)00567-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779482	Bronze			2022-12-28	WOS:000173106200012
J	DeVries, SH				DeVries, SH			Exocytosed protons feedback to suppress the Ca2+ current in mammalian cone photoreceptors	NEURON			English	Article							RETINAL BIPOLAR NEURONS; SYNAPTIC TRANSMISSION; SALAMANDER RETINA; INNER SEGMENTS; RECEPTOR DESENSITIZATION; GLUTAMATE-TRANSPORTER; EXTRACELLULAR PROTONS; TIGER SALAMANDER; HORIZONTAL CELLS; CALCIUM CHANNELS	A proton pump acidifies synaptic vesicles and provides the electrochemical gradient for transmitter uptake. Although external protons can modulate membrane voltage- and ligand-gated conductances, the fate of the protons released when vesicles fuse with the plasma membrane is unclear. In the dark, the glutamate-laden vesicles of cone photoreceptors fuse continuously with the plasma membrane. I now show that vesicular protons feed back to block the nearby calcium channels that mediate release. This local proton-mediated feedback is a novel mechanism through which neurons may regulate the release of transmitter.	Univ Texas, Houston Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	DeVries, SH (corresponding author), Northwestern Univ, Sch Med, Dept Ophthalmol, Tarry 5-715,300 E Super St, Chicago, IL 60611 USA.	s-devries@northwestern.edu			NATIONAL EYE INSTITUTE [R01EY012141] Funding Source: NIH RePORTER; NEI NIH HHS [EY12141] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; BARNES S, 1991, J NEUROSCI, V11, P4015; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Chen XH, 1996, J GEN PHYSIOL, V108, P363, DOI 10.1085/jgp.108.5.363; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dmitriev AV, 2001, J NEUROSCI, V21, P2897, DOI 10.1523/JNEUROSCI.21-08-02897.2001; Eliasof S, 1998, J NEUROSCI, V18, P698; ELIASOF S, 1993, J NEUROSCI, V13, P402; Eliasof S, 1997, VISUAL NEUROSCI, V14, P13, DOI 10.1017/S0952523800008713; Hare WA, 1998, VISUAL NEUROSCI, V15, P263, DOI 10.1017/S0952523898152069; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; Ihle EC, 2000, MOL PHARMACOL, V58, P1204, DOI 10.1124/mol.58.6.1204; Kamermans M, 1999, VISION RES, V39, P2449, DOI 10.1016/S0042-6989(99)00043-7; KLOCKNER U, 1994, J GEN PHYSIOL, V103, P665, DOI 10.1085/jgp.103.4.665; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; KRAFTE DS, 1988, J GEN PHYSIOL, V91, P641, DOI 10.1085/jgp.91.5.641; Krishek BJ, 1996, J PHYSIOL-LONDON, V492, P431, DOI 10.1113/jphysiol.1996.sp021319; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; LINSER PJ, 1984, DEV BRAIN RES, V13, P65, DOI 10.1016/0165-3806(84)90077-4; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER AM, 1983, J PHYSIOL-LONDON, V334, P325, DOI 10.1113/jphysiol.1983.sp014497; Morgans CW, 1998, J NEUROSCI, V18, P2467; Pattnaik B, 2000, J NEUROSCI, V20, P6789, DOI 10.1523/JNEUROSCI.20-18-06789.2000; PICAUD SA, 1995, J NEUROPHYSIOL, V74, P1760, DOI 10.1152/jn.1995.74.4.1760; PRODHOM B, 1987, NATURE, V329, P243, DOI 10.1038/329243a0; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; Rose B. D., 1989, CLIN PHYSL ACID BASE; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Taylor WR, 1998, VISUAL NEUROSCI, V15, P541; Thoreson WB, 1997, J NEUROPHYSIOL, V77, P2175, DOI 10.1152/jn.1997.77.4.2175; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; WEST RW, 1976, J COMP NEUROL, V168, P355, DOI 10.1002/cne.901680304; WINEGAR BD, 1990, J PHYSIOL-LONDON, V425, P563, DOI 10.1113/jphysiol.1990.sp018118; WU SM, 1993, VISION RES, V33, P2611, DOI 10.1016/0042-6989(93)90219-M; YAGI T, 1994, J NEUROPHYSIOL, V71, P656, DOI 10.1152/jn.1994.71.2.656; YAMAMOTO F, 1992, EXP EYE RES, V54, P685, DOI 10.1016/0014-4835(92)90023-L; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	49	215	221	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					1107	1117		10.1016/S0896-6273(01)00535-9	http://dx.doi.org/10.1016/S0896-6273(01)00535-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754841	Bronze			2022-12-28	WOS:000172886800016
J	Monuki, ES; Porter, FD; Walsh, CA				Monuki, ES; Porter, FD; Walsh, CA			Patterning of the dorsal telencephalon and cerebral cortex by a roof plate-Lhx2 pathway	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-SITU HYBRIDIZATION; PROMOTER DIRECTS EXPRESSION; REGULATORY GENES; TRANSGENIC MICE; NEURAL CREST; FOREBRAIN DEVELOPMENT; CORTICAL-NEURONS; SPINAL-CORD; DLX GENES	The organizing centers and molecules that pattern the cerebral cortex have been elusive. Here we show that cortical patterning involves regulation of the Lhx2 homeobox gene by the roof plate. Roof plate ablation results in reduced cortical size and Lhx2 expression defects that implicate roof plate signals in the bimodal regulation of Lhx2 in vivo. Bimodal Lhx2 regulation can be recapitulated in explants using two roof plate-derived signaling molecules, Bmp4 and Bmp2. Loss of Lhx2 function results in profound losses of cortical progenitors and neurons, but Lhx2 mutants continue to generate cortical neurons from dorsal sources that may include the roof plate region itself. These findings provide evidence for the roof plate as an organizing center of the developing cortex and for a roof plate-Lhx2 pathway in cortical patterning.	Beth Israel Deaconess Med Ctr, Div Neurogenet, Boston, MA 02115 USA; Childrens Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Walsh, CA (corresponding author), Univ Calif Irvine, Coll Med, Dept Pathol, Irvine, CA 92697 USA.			Walsh, Christopher/0000-0002-0156-2238; Monuki, Edwin/0000-0001-5130-781X	NIMH NIH HHS [MH K08] Funding Source: Medline; NINDS NIH HHS [R01 NS32457] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032457] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Bayer S.A., 1991, NEOCORTICAL DEV; Bertuzzi S, 1999, MECH DEVELOP, V81, P193, DOI 10.1016/S0925-4773(98)00233-0; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DEBLOCK M, 1993, ANAL BIOCHEM, V215, P86, DOI 10.1006/abio.1993.1558; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Dou CL, 1999, CEREB CORTEX, V9, P543, DOI 10.1093/cercor/9.6.543; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Golden JA, 1999, P NATL ACAD SCI USA, V96, P2439, DOI 10.1073/pnas.96.5.2439; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; GRLESHAMMER U, 1998, DEV BIOL, V197, P234; Grove EA, 1998, DEVELOPMENT, V125, P2315; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Kaufman M.H., 1992, ATLAS MOUSE DEV; Knecht AK, 1997, DEVELOPMENT, V124, P2477; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lee SMK, 2000, DEVELOPMENT, V127, P457; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; MESSING A, 1992, NEURON, V8, P507, DOI 10.1016/0896-6273(92)90279-M; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Porter FD, 1997, DEVELOPMENT, V124, P2935; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; Retaux S, 1999, J NEUROSCI, V19, P783; Rincon-Limas DE, 1999, P NATL ACAD SCI USA, V96, P2165, DOI 10.1073/pnas.96.5.2165; ROBERSON MS, 1994, MOL CELL BIOL, V14, P2985, DOI 10.1128/MCB.14.5.2985; Rubenstein JLR, 1997, MOL CELLULAR APPROAC, P356; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Trousse F, 2001, J NEUROSCI, V21, P1292; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	63	229	235	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					591	604		10.1016/S0896-6273(01)00504-9	http://dx.doi.org/10.1016/S0896-6273(01)00504-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719201	Bronze			2022-12-28	WOS:000172363900007
J	Aharon, I; Etcoff, N; Ariely, D; Chabris, CF; O'Connor, E; Breiter, HC				Aharon, I; Etcoff, N; Ariely, D; Chabris, CF; O'Connor, E; Breiter, HC			Beautiful faces have variable reward value: fMRI and behavioral evidence	NEURON			English	Article							DIFFERENTIAL NEURAL RESPONSE; FACIAL ATTRACTIVENESS; SELF-STIMULATION; HUMAN BRAIN; INFANT PREFERENCES; PREFRONTAL CORTEX; DECISION-MAKING; HUMAN AMYGDALA; EXPRESSION; FOREBRAIN	The brain circuitry processing rewarding and aversive stimuli is hypothesized to be at the core of motivated behavior. In this study, discrete categories of beautiful faces are shown to have differing reward values and to differentially activate reward circuitry in human subjects. In particular, young heterosexual males rate pictures of beautiful males and females as attractive, but exert effort via a keypress procedure only to view pictures of attractive females. Functional magnetic resonance imaging at 3 T shows that passive viewing of beautiful female faces activates reward circuitry, in particular the nucleus accumbens. An extended set of subcortical and paralimbic reward regions also appear to follow aspects of the keypress rather than the rating procedures, suggesting that reward circuitry function does not include aesthetic assessment.	Massachusetts Gen Hosp, Dept Radiol, Motivat & Emot Neurosci Ctr, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Massachusetts Gen Hosp, MIT, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; MIT, Cambridge, MA 02139 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University	Breiter, HC (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Motivat & Emot Neurosci Ctr, Boston, MA 02129 USA.				PHS HHS [09467, 00265] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ariely D, 2000, J EXP PSYCHOL GEN, V129, P508, DOI 10.1037//0096-3445.129.4.508; ARIELY D, 2001, 4158 MIT; Arvanitogiannis A, 1996, PHYSIOL BEHAV, V59, P795, DOI 10.1016/0031-9384(95)02157-4; Arvanitogiannis A, 2000, BEHAV BRAIN RES, V107, P123, DOI 10.1016/S0166-4328(99)00120-5; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; BECERRA L, 2001, IN PRESS NEURON; Bechara A, 1998, J NEUROSCI, V18, P428; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BERRIDGE KC, 2000, PSYCHOL LEARNING MOT, V40; Breiter H.C., 1996, NEUROIMAGE, V3, pS220, DOI 10.1016/S1053-8119(96)80222-9; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; BREITER HC, 1998, INT SOC MAGN RES MED; BREITER HC, 2000, AM PAIN SOC ATL US; Brown VJ, 1996, BRAIN RES BULL, V39, P163, DOI 10.1016/0361-9230(95)02088-8; BUSH G, 1996, 2 INT C FUNCT MAPP H; CABANAC M, 1979, Q REV BIOL, V54, P1, DOI 10.1086/410981; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; EVERITT B J, 1992, P401; Flores C, 1997, BEHAV BRAIN RES, V87, P239, DOI 10.1016/S0166-4328(97)02288-2; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; FRIEZE IH, 1991, J APPL SOC PSYCHOL, V21, P1039, DOI 10.1111/j.1559-1816.1991.tb00458.x; FRIEZE IH, 1990, J APPL SOC PSYCHOL, V20, P46, DOI 10.1111/j.1559-1816.1990.tb00377.x; Gallistel C. R., 1990, ORG LEARNING; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; JONES D, 1993, HUM NATURE-INT BIOS, V4, P271, DOI 10.1007/BF02692202; Kant Immanuel, 1960, OBSERVATIONS FEELING; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; KNUTSON B, 2001, J NEUROSCI, V15, P1; LANGLOIS JH, 1991, DEV PSYCHOL, V27, P79, DOI 10.1037/0012-1649.27.1.79; LANGLOIS JH, 1987, DEV PSYCHOL, V23, P363, DOI 10.1037/0012-1649.23.3.363; LOUILOT A, 1989, BRAIN BEHAV EVOLUT, V33, P157, DOI 10.1159/000115920; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Marlowe CM, 1996, J APPL PSYCHOL, V81, P11, DOI 10.1037/0021-9010.81.1.11; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Nakahara D, 1999, NEUROSCIENCE, V90, P1013, DOI 10.1016/S0306-4522(98)00510-7; Nakamura K, 1998, NEUROREPORT, V9, P753, DOI 10.1097/00001756-199803090-00035; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; PERRETT DI, 1994, NATURE, V368, P239, DOI 10.1038/368239a0; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Phillips ML, 1999, PSYCHIAT RES-NEUROIM, V92, P11, DOI 10.1016/S0925-4927(99)00031-1; ROBLEDO P, 1993, BEHAV BRAIN RES, V55, P159, DOI 10.1016/0166-4328(93)90112-4; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; ROLLS ET, 1999, BRAIN EMOTION; RUSKIN J, 1997, LECT ART; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Shizgal P., 1999, WELL BEING FDN HEDON, P502; Slater A, 1998, INFANT BEHAV DEV, V21, P345, DOI 10.1016/S0163-6383(98)90011-X; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; Symons D., 1995, SEXUAL NATURE SEXUAL; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; WISE RA, 1978, SCIENCE, V201, P262, DOI 10.1126/science.566469; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143	76	748	787	8	181	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					537	551		10.1016/S0896-6273(01)00491-3	http://dx.doi.org/10.1016/S0896-6273(01)00491-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	491QE	11709163	Bronze			2022-12-28	WOS:000172119100018
J	Murphey, RK; Godenschwege, TA				Murphey, RK; Godenschwege, TA			New roles for ubiquitin in the assembly and function of neuronal circuits	NEURON			English	Review							GROWTH CONE GUIDANCE; SYNAPTIC GROWTH; DROSOPHILA; PROTEIN; ENCODES; CONNECTIVITY; BENDLESS; MIDLINE	A series of recent papers highlight a prominent role for ubiquitin in the formation and function of neural circuits. These new results focus attention on the molecular remodeling that occurs at various decision points in the life of growth cones and synapses.	Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; Univ Massachusetts, Grad Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Murphey, RK (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.		Godenschwege, Tanja A/A-2830-2010	Godenschwege, Tanja A/0000-0003-3322-4134				Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fischer JA, 2002, BIOESSAYS, V24, P13, DOI 10.1002/bies.10030; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; OH CE, 1994, J NEUROSCI, V14, P3166; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; THOMAS JB, 1984, J NEUROSCI, V4, P530; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wolf B, 1998, DEVELOPMENT, V125, P3853	21	57	59	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					5	8		10.1016/S0896-6273(02)00943-1	http://dx.doi.org/10.1016/S0896-6273(02)00943-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367500	Bronze			2022-12-28	WOS:000178295100003
J	Martinez-Trujillo, JC; Treue, S				Martinez-Trujillo, JC; Treue, S			Attentional modulation strength in cortical area MT depends on stimulus contrast	NEURON			English	Article							STRIATE CORTEX; MOTION; NEURONS; V4; RESPONSES; MONKEY; CAT	The attentional modulation of sensory information processing in the visual system is the result of top-down influences, which can cause a multiplicative modulation of the firing rate of sensory neurons in extrastriate visual cortex, an effect reminiscent of the bottom-up effect of changes in stimulus contrast. This similarity could simply reflect the multiplicity of both effects. But, here we show that in direction-selective neurons in monkey visual cortical area MT, stimulus and attentional effects share a nonlinearity. These neurons show higher response gain for both contrast and attentional changes for intermediate contrast stimuli and smaller gain for low- and high-contrast stimuli. This finding suggests a close relationship between the neural encoding of stimulus contrast and the modulating effect of the behavioral relevance of stimuli.	German Primate Ctr, Cognit Neurosci Lab, D-37077 Gottingen, Germany; York Univ, Ctr Vis Res, Toronto, ON M3J 1P3, Canada	Deutsches Primatenzentrum (DPZ); York University - Canada	Treue, S (corresponding author), German Primate Ctr, Cognit Neurosci Lab, Kellnerweg 4, D-37077 Gottingen, Germany.		Martinez-Trujillo, Julio C/M-2146-2015	Martinez-Trujillo, Julio C/0000-0003-3338-578X				ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; DEAN AF, 1981, EXP BRAIN RES, V44, P437; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KUKKONEN H, 1993, VISION RES, V33, P1431, DOI 10.1016/0042-6989(93)90049-3; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOULDEN B, 1990, PERCEPTION, V19, P79, DOI 10.1068/p190079; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; TOLHURST DJ, 1973, J PHYSIOL-LONDON, V231, P385, DOI 10.1113/jphysiol.1973.sp010239; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985	19	277	281	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					365	370		10.1016/S0896-6273(02)00778-X	http://dx.doi.org/10.1016/S0896-6273(02)00778-X			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160753	Bronze			2022-12-28	WOS:000177034200015
J	Burbea, M; Dreier, L; Dittman, JS; Grunwald, ME; Kaplan, JM				Burbea, M; Dreier, L; Dittman, JS; Grunwald, ME; Kaplan, JM			Ubiquitin and AP180 regulate the abundance of GLR-1 glutamate receptors at postsynaptic elements in C-elegans	NEURON			English	Article							LONG-TERM FACILITATION; AMPA RECEPTORS; DEUBIQUITINATING ENZYME; CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; NERVOUS-SYSTEM; MECHANISMS; EXPRESSION; SYNAPSES; PROTEINS	Regulated delivery and removal of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptors (GluRs) from postsynaptic elements has been proposed as a mechanism for regulating synaptic strength. Here we test the role of ubiquitin in regulating synapses that contain a C. elegans GluR, GLR-1. GLR-1 receptors were ubiquitinated in vivo. Mutations that decreased ubiquitination of GLR-1 increased the abundance of GLR-1 at synapses and altered locomotion behavior in a manner that is consistent with increased synaptic strength. By contrast, overexpression of ubiquitin decreased the abundance of GLR-1 at synapses and decreased the density of GLR-1-containing synapses, and these effects were prevented by mutations in the unc-11 gene, which encodes a clathrin adaptin protein (AP180). These results suggest that ubiquitination of GLR-1 receptors regulates synaptic strength and the formation or stability of GLR-1 -containing synapses.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Wellman 8, Boston, MA 02114 USA.	joshkap@socrates.berkeley.edu		Dittman, Jeremy S./0000-0002-3850-9078	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032196, R37NS032196, F32NS041705] Funding Source: NIH RePORTER; NINDS NIH HHS [F32 NS41705, NS32196] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; CHALFIE M, 1985, J NEUROSCI, V5, P956; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Liang F, 2001, J NEUROCHEM, V77, P1626, DOI 10.1046/j.1471-4159.2001.00377.x; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	52	219	231	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					107	120		10.1016/S0896-6273(02)00749-3	http://dx.doi.org/10.1016/S0896-6273(02)00749-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123612	Bronze			2022-12-28	WOS:000176601800014
J	Roskies, A				Roskies, A			Neuroethics for the new millenium	NEURON			English	Editorial Material									MIT, Dept Linguist & Philosophy, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Roskies, A (corresponding author), MIT, Dept Linguist & Philosophy, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Damasio A, 1995, DESCARTES ERROR EMOT; Fukuyama Francis, 2002, OUR POSTHUMAN FUTURE; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Phelps EA, 2001, NAT NEUROSCI, V4, P775, DOI 10.1038/90467; SAFIRE W, 2002, NY TIMES        0516; 2002, ECONOMIST       0523	6	205	219	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					21	23		10.1016/S0896-6273(02)00763-8	http://dx.doi.org/10.1016/S0896-6273(02)00763-8			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123605	Bronze			2022-12-28	WOS:000176601800007
J	Humbert, S; Saudou, F				Humbert, S; Saudou, F			Toward cell specificity in SCA1	NEURON			English	Editorial Material							TRANSCRIPTION; ACTIVATION; DISEASE	Transcriptional dysregulation appears as an emerging and unifying pathogenic mechanism in polyQ neurodegenerative disorders such as Spinocerebellar ataxias and Huntington's disease. It is unclear how cell death specificity occurs in these diseases. In this issue of Neuron, Okazawa et al. (2002) link polymerase II, a general component of the transcriptional machinery, to PQBP-1, a cerebellar enriched protein, thus providing insight into the selectivity of neuronal death in SCA1.	Ctr Univ Orsay, Inst Curie, CNRS, UMR 146, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Humbert, S (corresponding author), Ctr Univ Orsay, Inst Curie, CNRS, UMR 146, Bldg 110, F-91405 Orsay, France.		Humbert, Sandrine/S-2981-2016; SAUDOU, Frédéric/L-3454-2014	SAUDOU, Frédéric/0000-0001-6107-1046; Humbert, Sandrine/0000-0002-9501-2658				DUNAH AW, 2002, IN PRESS SCIENCE; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Margolis RL, 2001, TRENDS MOL MED, V7, P479, DOI 10.1016/S1471-4914(01)02179-7; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	11	11	11	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					669	670		10.1016/S0896-6273(02)00715-8	http://dx.doi.org/10.1016/S0896-6273(02)00715-8			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062012	Bronze			2022-12-28	WOS:000175951800001
J	Kleinschmidt, A; Buchel, C; Hutton, C; Friston, KJ; Frackowiak, RSJ				Kleinschmidt, A; Buchel, C; Hutton, C; Friston, KJ; Frackowiak, RSJ			The neural structures expressing perceptual hysteresis in visual letter recognition	NEURON			English	Article							PERIRHINAL CORTEX; MEMORY; ACTIVATION; MECHANISMS; AWARENESS; ATTENTION; RIVALRY; OBJECTS; SIGNAL; MODEL	Perception can change nonlinearly with stimulus contrast, and perceptual threshold may depend on the direction of contrast change. Such hysteresis effects in neurometric functions provide a signature of perceptual awareness. We recorded brain activity with functional neuroimaging in observers exposed to gradual contrast changes of initially hidden visual stimuli. Lateral occipital, frontal, and parietal regions all displayed both transient activations and hysteresis that correlated with change and maintenance of a percept, respectively. Medial temporal activity did not follow perception but increased during hysteresis and showed transient deactivations during perceptual transitions. These findings identify a set of brain regions sensitive to visual awareness and suggest that medial temporal structures may provide backward signals that account for neural and, thereby, perceptual hysteresis.	Goethe Univ Frankfurt, Dept Neurol, D-60590 Frankfurt, Germany; Univ Hamburg, Dept Neurol, D-20246 Hamburg, Germany; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	Goethe University Frankfurt; University of Hamburg; University of London; University College London	Kleinschmidt, A (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	akleins@em.uni-frankfurt.de	Frackowiak, Richard/H-4383-2011; Frackowiak, Richard S/I-1809-2013; Friston, Karl/D-9230-2011	Frackowiak, Richard/0000-0002-3151-822X; Friston, Karl/0000-0001-7984-8909				Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Buckley MJ, 1998, J NEUROSCI, V18, P2268; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; CARPENTER GA, 1993, TRENDS NEUROSCI, V16, P131, DOI 10.1016/0166-2236(93)90118-6; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Farah MJ, 1997, SEMIN NEUROL, V17, P145, DOI 10.1055/s-2008-1040924; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; GLUCK MA, 1993, HIPPOCAMPUS, V3, P491, DOI 10.1002/hipo.450030410; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Hinton GE, 1997, PHILOS T ROY SOC B, V352, P1177, DOI 10.1098/rstb.1997.0101; James TW, 2000, CURR BIOL, V10, P1017, DOI 10.1016/S0960-9822(00)00655-2; Kelso J.A.S., 1995, DYNAMIC PATTERNS; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Logothetis N, 1998, CURR OPIN NEUROBIOL, V8, P536; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Miyashita Y, 1996, COGNITIVE BRAIN RES, V5, P81, DOI 10.1016/S0926-6410(96)00043-2; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Polk TA, 2002, J COGNITIVE NEUROSCI, V14, P145, DOI 10.1162/089892902317236803; Polk TA, 1998, P NATL ACAD SCI USA, V95, P847, DOI 10.1073/pnas.95.3.847; Portas CM, 2000, P ROY SOC B-BIOL SCI, V267, P845, DOI 10.1098/rspb.2000.1080; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rees G, 1997, SCIENCE, V275, P835, DOI 10.1126/science.275.5301.835; Rees G, 2001, CURR OPIN NEUROBIOL, V11, P150, DOI 10.1016/S0959-4388(00)00190-2; Rees G, 2001, NEUROPSYCHOLOGIA, V39, P1343, DOI 10.1016/S0028-3932(01)00122-1; Samuel AG, 2001, J EXP PSYCHOL HUMAN, V27, P1433, DOI 10.1037/0096-1523.27.6.1433; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Sekuler R, 1996, PERCEPTION, V25, P1243, DOI 10.1068/p251243; SOLOMON JA, 1994, NATURE, V369, P395, DOI 10.1038/369395a0; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Treisman AM, 1998, CURR OPIN NEUROBIOL, V8, P218, DOI 10.1016/S0959-4388(98)80143-8; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1; ZOLAMORGAN S, 1994, HIPPOCAMPUS, V4, P483, DOI 10.1002/hipo.450040410	44	82	83	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 16	2002	34	4					659	666		10.1016/S0896-6273(02)00694-3	http://dx.doi.org/10.1016/S0896-6273(02)00694-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	553FT	12062048	Bronze			2022-12-28	WOS:000175665700018
J	Zhang, XD; Kim-Miller, MJ; Fukuda, M; Kowalchyk, JA; Martin, TFJ				Zhang, XD; Kim-Miller, MJ; Fukuda, M; Kowalchyk, JA; Martin, TFJ			Ca2+-dependent synaptotagmin binding to SNAP-25 is essential for Ca2+-triggered exocytosis	NEURON			English	Article							MEMBRANE-FUSION COMPLEX; SNARE COMPLEX; NEUROTRANSMITTER RELEASE; SYNAPTIC TRANSMISSION; PC12 CELLS; KINETIC COMPONENTS; BOTULINUM TOXIN; CA2+ SENSOR; C2B DOMAIN; IN-VIVO	Synaptotagmin is a proposed Ca2+ sensor on the vesicle for regulated exocytosis and exhibits Ca2+-dependent binding to phospholipids, syntaxin, and SNAP-25 in vitro, but the mechanism by which Call triggers membrane fusion is uncertain. Previous studies suggested that SNAP-25 plays a role in the Ca2+ regulation of secretion. We found that synaptotagmins I and IX associate with SNAP-25 during Ca2+-dependent exocytosis in PC12 cells, and we identified C-terminal amino acids in SNAP-25 (Asp179, Asp186, Asp193) that are required for Ca2+-dependent synaptotagmin binding. Replacement of SNAP-25 in PC12 cells with SNAP-25 containing C-terminal Asp mutations led to a loss-of-function in regulated exocytosis at the Ca2+-dependent fusion step. These results indicate that the Ca2+-dependent interaction of synaptotagmin with SNAP-25 is essential for the Ca2+-dependent triggering of membrane fusion.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; RIKEN	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.		Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025861, R37DK025861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK25861] Funding Source: Medline; NIGMS NIH HHS [T32 GM07507] Funding Source: Medline; NIMH NIH HHS [MH12694] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANERJEE A, 1996, J BIOL CHEM, V271; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Budker V, 1996, GENE THER, V3, P593; Capogna M, 1997, J NEUROSCI, V17, P7190; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 2001, J BIOL CHEM, V276, P26680, DOI 10.1074/jbc.M103522200; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P453, DOI DOI 10.1111/J.1476-5381.1968.TB08474.X; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HAY JC, 1992, J CELL BIOL, V119, P131; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Ibata K, 2000, J NEUROCHEM, V74, P518, DOI 10.1046/j.1471-4159.2000.740518.x; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; Kee Y, 1996, J NEUROSCI, V16, P1975; Kida Y, 2000, J CELL BIOL, V150, P719, DOI 10.1083/jcb.150.4.719; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P1088; LUNDH H, 1977, J NEUROL SCI, V32, P29, DOI 10.1016/0022-510X(77)90037-5; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; Martin TFJ, 1997, J BIOL CHEM, V272, P14447, DOI 10.1074/jbc.272.22.14447; Martin Thomas F. J., 1994, Current Opinion in Neurobiology, V4, P626, DOI 10.1016/0959-4388(94)90002-7; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; SIMPSON LL, 1978, J PHARMACOL EXP THER, V206, P661; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WICK PF, 1993, J BIOL CHEM, V268, P10983; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	68	195	205	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					599	611		10.1016/S0896-6273(02)00671-2	http://dx.doi.org/10.1016/S0896-6273(02)00671-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062043	Bronze			2022-12-28	WOS:000175665700013
J	Beaumont, V; Zhong, N; Froemke, RC; Ball, RW; Zucker, RS				Beaumont, V; Zhong, N; Froemke, RC; Ball, RW; Zucker, RS			Temporal synaptic tagging by I-h activation and actin: Involvement in long-term facilitation and cAMP-induced synaptic enhancement	NEURON			English	Article							CRAYFISH NEUROMUSCULAR-JUNCTION; NEUROTRANSMITTER RELEASE; POSTTETANIC POTENTIATION; GANGLION NEURONS; NERVE-TERMINALS; CATION CURRENT; CYCLIC-AMP; CALCIUM; CYTOSKELETON; ACCUMULATION	Presynaptic I-h channels become activated during a tetanus through membrane hyperpolarization resulting from Na+ accumulation and electrogenic Na+/K+ exchange. I-h activation is obligatory for inducing long-term facilitation (LTF), a long-lasting synaptic strengthening. cAMP-induced synaptic enhancement also requires I-h activation, and both processes are sensitive to actin depolymerization. Other mechanisms are responsible for expression of the responses. Once initiated, continued response to cAMP is I-h and actin independent. Moreover, LTF-induced activation of I-h renders subsequent cAMP enhancement insensitive to both I-h blockers and actin depolymerization. This actin-stabilized "temporal synaptic tagging" set by I-h activation is prolonged when I-h is activated concurrent with an elevation in presynaptic calcium concentration ([Ca2+](i)), permitting the further strengthening of synapses given appropriate additional stimuli.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Beaumont, V (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Hills Rd, Cambridge CB2 2QH, England.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343; Zhong, Ning/0000-0002-3696-5301; Froemke, Robert/0000-0002-1230-6811; Beaumont, Vahri/0000-0002-6488-2175				ATWOOD HL, 1975, BRAIN RES, V100, P198, DOI 10.1016/0006-8993(75)90260-7; Beaumont V, 2001, NEURON, V32, P489, DOI 10.1016/S0896-6273(01)00483-4; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; CECCALDI PE, 1995, J CELL BIOL, V128, P905, DOI 10.1083/jcb.128.5.905; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DIXON D, 1989, J NEUROSCI, V9, P4246; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Janigro D, 1997, J MEMBRANE BIOL, V160, P101, DOI 10.1007/s002329900299; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; LNENICKA GA, 1985, J NEUROBIOL, V16, P97, DOI 10.1002/neu.480160203; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; MULKEY RM, 1992, J NEUROSCI, V12, P4327; PAPE HC, 1994, NEUROSCIENCE, V59, P363, DOI 10.1016/0306-4522(94)90602-5; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Petrecca K, 2000, J NEUROSCI, V20, P8736; Raes A, 1998, BRIT J PHARMACOL, V125, P741, DOI 10.1038/sj.bjp.0702153; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; TRIFARO JM, 1993, TRENDS NEUROSCI, V16, P466, DOI 10.1016/0166-2236(93)90079-2; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang C, 1998, NEURON, V21, P155, DOI 10.1016/S0896-6273(00)80523-1; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; WOJTOWICZ JM, 1994, J NEUROSCI, V14, P3688; WOJTOWICZ JM, 1988, J NEUROSCI, V8, P4667; WOJTOWICZ JM, 1988, NEUROSCI LETT, V90, P152, DOI 10.1016/0304-3940(88)90803-8; WOJTOWICZ JM, 1986, J NEUROPHYSIOL, V55, P484, DOI 10.1152/jn.1986.55.3.484; WOJTOWICZ JM, 1985, J NEUROPHYSIOL, V54, P220, DOI 10.1152/jn.1985.54.2.220; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	38	60	62	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					601	613		10.1016/S0896-6273(02)00581-0	http://dx.doi.org/10.1016/S0896-6273(02)00581-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856533	Bronze			2022-12-28	WOS:000173911100012
J	Keshishian, H				Keshishian, H			Is synaptic homeostasis just wishful thinking?	NEURON			English	Editorial Material							DROSOPHILA; GROWTH; SOG	The bone morphogenetic proteins (BMPs) are secreted polypeptides of the TGF-beta family, whose diverse functions include primary neural induction and the dorsoventral patterning of the neural tube. In this issue of Neuron, Aberle et al (2002) and Marques et al (2002) present evidence that BMP receptors may also influence the development of synapses. The results suggest a novel mechanism for regulating neuronal growth and synaptic homeostasis during development.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Keshishian, H (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.							Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Newfeld SJ, 1999, GENETICS, V152, P783; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9	12	11	11	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					491	492		10.1016/S0896-6273(02)00597-4	http://dx.doi.org/10.1016/S0896-6273(02)00597-4			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856522	Bronze			2022-12-28	WOS:000173911100002
J	Lyon, DC; Kaas, JH				Lyon, DC; Kaas, JH			Evidence for a modified V3 with dorsal and ventral halves in macaque monkeys	NEURON			English	Article							DORSOMEDIAL VISUAL AREA; CYTOCHROME-OXIDASE STRIPES; CORTICAL CONNECTIONS; STRIATE CORTEX; OWL MONKEY; EXTRASTRIATE CORTEX; AOTUS-TRIVIRGATUS; V2; ORGANIZATION; NEURONS	Through more than 30 years of research, the nature of the third visual area, V3, and even its existence have been in question. Here, we used injections of up to five distinguishable tracers into both dorsal and ventral portions of V1 of macaque monkeys (representing the lower and upper visual quadrant, respectively) to provide compelling evidence for a V3 that is smaller than V2. This V3 includes both dorsal and ventral halves mirroring dorsal and ventral V2 in retinotopic organization. Of the approximately ten areas with V1 connections, V3 appears to account for about 20%.	Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University	Kaas, JH (corresponding author), Vanderbilt Univ, Dept Psychol, 301 Wilson Hall,111 21st Ave S, Nashville, TN 37203 USA.			Lyon, David C./0000-0002-4367-5636	NEI NIH HHS [EY02686] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002686] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLMAN JM, 1975, BRAIN RES, V100, P473, DOI 10.1016/0006-8993(75)90153-5; Beck PD, 1999, J COMP NEUROL, V406, P487; Beck PD, 1998, J COMP NEUROL, V400, P18, DOI 10.1002/(SICI)1096-9861(19981012)400:1<18::AID-CNE2>3.0.CO;2-W; BURKE DS, 1986, ARBOVIRUSES EPIDEMIO, V3, P63; BURKHALTER A, 1986, J NEUROSCI, V6, P2327; CRAGG BG, 1969, VISION RES, V9, P733, DOI 10.1016/0042-6989(69)90011-X; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; ERICSON H, 1988, J NEUROSCI METH, V24, P225, DOI 10.1016/0165-0270(88)90167-7; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Felleman DJ, 1997, J COMP NEUROL, V379, P21, DOI 10.1002/(SICI)1096-9861(19970303)379:1<21::AID-CNE3>3.0.CO;2-K; FELLEMAN DJ, 1987, J NEUROPHYSIOL, V57, P889, DOI 10.1152/jn.1987.57.4.889; Gallyas F, 1979, Neurol Res, V1, P203; GATTASS R, 1988, J NEUROSCI, V8, P1831; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; HORTON JC, 1981, NATURE, V292, P762, DOI 10.1038/292762a0; Kaas JH, 2001, PROG BRAIN RES, V134, P285; KEIZER K, 1983, EXP BRAIN RES, V51, P179; KRUBITZER LA, 1993, J COMP NEUROL, V334, P497, DOI 10.1002/cne.903340402; KUYPERS HGJ, 1980, EXP BRAIN RES, V40, P382; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; LIN CS, 1982, J COMP NEUROL, V211, P165, DOI 10.1002/cne.902110206; LIVINGSTONE MS, 1983, NATURE, V304, P531, DOI 10.1038/304531a0; Lyon DC, 2001, J NEUROSCI, V21, P249, DOI 10.1523/JNEUROSCI.21-01-00249.2001; MALACH R, 1994, CEREB CORTEX, V4, P151, DOI 10.1093/cercor/4.2.151; NEWSOME WT, 1986, J COMP NEUROL, V252, P139, DOI 10.1002/cne.902520202; Novikova L, 1997, J NEUROSCI METH, V74, P9, DOI 10.1016/S0165-0270(97)02227-9; Olavarria JF, 1997, CEREB CORTEX, V7, P395, DOI 10.1093/cercor/7.5.395; PERKEL DJ, 1986, J COMP NEUROL, V253, P374, DOI 10.1002/cne.902530307; ROSA MGP, 1995, J COMP NEUROL, V359, P272, DOI 10.1002/cne.903590207; Sakai ST, 2000, J COMP NEUROL, V417, P164; SCHMUED L, 1990, BRAIN RES, V526, P127, DOI 10.1016/0006-8993(90)90258-D; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SHIPP S, 1995, NEUROIMAGE, V2, P125, DOI 10.1006/nimg.1995.1015; Smith AT, 1998, J NEUROSCI, V18, P3816; Stepniewska I, 1996, J COMP NEUROL, V371, P129; TOOTELL RBH, 1983, SCIENCE, V220, P737, DOI 10.1126/science.6301017; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tootell RBH, 1997, J NEUROSCI, V17, P7060; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P147, DOI 10.1002/cne.902480202; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VANESSEN DC, 1986, J COMP NEUROL, V244, P451, DOI 10.1002/cne.902440405; WELLER RE, 1983, J COMP NEUROL, V220, P253, DOI 10.1002/cne.902200302; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; ZEKI SM, 1969, BRAIN RES, V14, P271, DOI 10.1016/0006-8993(69)90110-3; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272	45	80	80	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					453	461		10.1016/S0896-6273(02)00580-9	http://dx.doi.org/10.1016/S0896-6273(02)00580-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832231	Bronze			2022-12-28	WOS:000173643200014
J	Plump, AS; Erskine, L; Sabatier, C; Brose, K; Epstein, CJ; Goodman, CS; Mason, CA; Tessier-Lavigne, M				Plump, AS; Erskine, L; Sabatier, C; Brose, K; Epstein, CJ; Goodman, CS; Mason, CA; Tessier-Lavigne, M			Slit1 and Slit2 cooperate to prevent premature midline crossing of retinal axons in the mouse visual system	NEURON			English	Article							GANGLION-CELL AXONS; GROWTH CONE BEHAVIOR; OPTIC CHIASM; CHONDROITIN SULFATE; NEURONAL MIGRATION; UNCROSSED AXONS; EPHRINA LIGANDS; VERTEBRATE SLIT; NERVOUS-SYSTEM; GUIDANCE	During development, retinal ganglion cell (RGC) axons either cross or avoid the midline at the optic chiasm. In Drosophila, the Slit protein regulates midline axon crossing through repulsion. To determine the role of Slit proteins in RGC axon guidance, we disrupted Slit1 and Slit2, two of three known mouse Slit genes. Mice defective in either gene alone exhibited few RGC axon guidance defects, but in double mutant mice a large additional chiasm developed anterior to the true chiasm, many retinal axons projected into the contralateral optic nerve, and some extended ectopically-dorsal and lateral to the chiasm. Our results indicate that Slit proteins repel retinal axons in vivo and cooperate to establish a corridor through which the axons are channeled, thereby helping define the site in the ventral diencephalon where the optic chiasm forms.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Med Genet, San Francisco, CA 94143 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Anat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Cell Biol, New York, NY 10032 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tessier-Lavigne, M (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	marctl@stanford.edu	Erskine, Lynda/AAE-9281-2020	Erskine, Lynda/0000-0001-6538-9406	NEI NIH HHS [EY 12736] Funding Source: Medline; NINDS NIH HHS [P0 NS 30532] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS030532] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P433, DOI 10.1006/mcne.1995.1032; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chan SO, 1999, J COMP NEUROL, V406, P251, DOI 10.1002/(SICI)1096-9861(19990405)406:2<251::AID-CNE8>3.0.CO;2-E; Chung KY, 2000, DEVELOPMENT, V127, P2673; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; Deiner MS, 1999, J NEUROSCI, V19, P9900; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Dutting D, 1999, DEV BIOL, V216, P297, DOI 10.1006/dbio.1999.9489; Erskine L, 2000, J NEUROSCI, V20, P4975; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; LEE VMY, 1987, J NEUROSCI, V7, P3474; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; MARCUS RC, 1995, J NEUROSCI, V15, P3716; Mason C, 2000, J NEUROBIOL, V44, P260, DOI 10.1002/1097-4695(200008)44:2<260::AID-NEU14>3.0.CO;2-H; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Niclou SP, 2000, J NEUROSCI, V20, P4962; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SILVER J, 1987, J NEUROSCI, V7, P2264; SILVER J, 1984, J COMP NEUROL, V223, P238, DOI 10.1002/cne.902230207; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; SNOW DM, 1991, DEVELOPMENT, V113, P1473; SRETAVAN DW, 1994, NEURON, V12, P957, DOI 10.1016/0896-6273(94)90307-7; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Tuttle R, 1998, DEVELOPMENT, V125, P791; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	49	325	336	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					219	232		10.1016/S0896-6273(01)00586-4	http://dx.doi.org/10.1016/S0896-6273(01)00586-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804570	Bronze			2022-12-28	WOS:000173387700010
J	Chi, ZY; Margoliash, D				Chi, ZY; Margoliash, D			Temporal precision and temporal drift in brain and behavior of zebra finch song	NEURON			English	Article							SYNCHRONOUS ACTIVITY; MOVEMENT DIRECTION; CORTICAL-NEURONS; VISUAL-SYSTEM; NUCLEUS; REPRESENTATION; INFORMATION; DISCHARGE; PATTERNS; BIRDSONG	In the zebra finch forebrain nucleus robustus archistriatalis (RA), neurons burst during singing. We showed that the internal structure of spike bursts was regulated with a precision of circa 0.2 ms, and yielded alignment of acoustic features of song with a precision of circa I ms. In addition, interburst intervals and corresponding syllable durations displayed systematic variation within song (average elongation 0.3 ms/s song), and slower "drift" across songs. Systematic variation on even a coarser time scale might be difficult to detect in other systems, but could affect the analysis of temporal patterning. The close relationship between precise timing of individual spikes and stereotypic behavior suggests that song is represented in RA by a temporal code.	Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Chi, ZY (corresponding author), Univ Chicago, Dept Stat, Chicago, IL 60637 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059831, R01MH060276] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60276, MH59831] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Baker SN, 2000, J NEUROPHYSIOL, V84, P1770, DOI 10.1152/jn.2000.84.4.1770; CARR CE, 1986, J NEUROSCI, V6, P107; Date A, 1998, TEMPORAL RESOLUTION; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Laurent G, 1996, J NEUROSCI, V16, P3837; MOONEY R, 1992, J NEUROSCI, V12, P2464; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Pauluis Q, 2000, NEURAL COMPUT, V12, P647, DOI 10.1162/089976600300015736; Searcy William A., 1996, P454; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	23	112	115	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					899	910		10.1016/S0896-6273(01)00524-4	http://dx.doi.org/10.1016/S0896-6273(01)00524-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738034	Bronze			2022-12-28	WOS:000172700700015
J	Miller, FD; Kaplan, DR				Miller, FD; Kaplan, DR			On Trk for retrograde signaling	NEURON			English	Review							RAT SYMPATHETIC NEURONS; NERVE GROWTH-FACTOR; INDUCED DIFFERENTIATION; COMPARTMENTED CULTURES; NGF; SYSTEM; PHOSPHORYLATION; TRANSPORT; SURVIVAL	Target-derived neurotrophins like nerve growth factor (NGF) mediate biological effects by binding to and activating Trk neurotrophin receptors at nerve terminals. The activated Trk receptors then stimulate local effects at nerve terminals, and retrograde effects at neuronal cell bodies that often reside at considerable distances from the terminals. However, the nature of the retrograde signal has been mysterious. Recent experiments suggest that the major retrograde signal required for survival and gene expression consists of activated Trk itself. Remarkably, signaling by Trk may differ at the terminal versus the neuronal cell body as a consequence of the retrograde transport mechanism, thereby allowing NGF to not only promote growth locally, but to specifically support survival and gene expression retrogradely.	McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, Brain Tumor Res Ctr, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Miller, FD (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, 3801 Rue Univ, Montreal, PQ H3A 2B4, Canada.	freda.miller@mcgill.ca; david.kaplan@mcgill.ca						Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; EHLERS MD, 1995, J CELL BIOL, V130, P149, DOI 10.1083/jcb.130.1.149; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Matsuda M, 2001, J CELL BIOL, V153, P599, DOI 10.1083/jcb.153.3.599; Neet KE, 2001, CELL MOL LIFE SCI, V58, P1021, DOI 10.1007/PL00000917; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Ure DR, 1997, J NEUROSCI, V17, P1282; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	20	130	131	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2001	32	5					767	770		10.1016/S0896-6273(01)00529-3	http://dx.doi.org/10.1016/S0896-6273(01)00529-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738023	Bronze			2022-12-28	WOS:000172700700004
J	Ryan, TA				Ryan, TA			NCAM and vesicle cycling: The importance of good glue in the long run	NEURON			English	Editorial Material							NEUROMUSCULAR-JUNCTIONS; DOMAIN; MICE	Careful functional dissection of mouse neuromuscular junctions (NMJs) formed in the absence of NCAM reveal that in spite of relatively normal morphology and ultrastructure, the presynaptic terminals have profound alterations in the mechanisms of recycling of synaptic vesicles. These alterations, including the appearance of a brefeldin-sensitive pathway, leave synaptic transmission impaired for certain types of activity. NCAMs thus appear to play a critical role in the molecular organization and function of synaptic terminals.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.		Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Rafuse VF, 2000, J NEUROSCI, V20, P6529, DOI 10.1523/JNEUROSCI.20-17-06529.2000; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507	9	7	7	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					759	761		10.1016/S0896-6273(01)00527-X	http://dx.doi.org/10.1016/S0896-6273(01)00527-X			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738020	Bronze			2022-12-28	WOS:000172700700001
J	Whitford, KL; Ghosh, A				Whitford, KL; Ghosh, A			Plexin signaling via off-track and Rho family GTPases	NEURON			English	Editorial Material							SEMAPHORIN RECEPTOR; ACTIVE RAC; GUIDANCE	Two papers in this issue of Neuron examine new aspects of Semaphorin signaling via Plexin receptors. Winberg et al. present evidence that the transmembrane protein Off-track (OTK) interacts biochemically and genetically with Plexin A and is important for Sema la repulsive signaling. Hu et al. examine the coupling of Plexin B to Rac and RhoA and propose that Plexin B signaling involves inhibition of Rac function by direct sequestration and simultaneous activation of RhoA.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Whitford, KL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.							Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; BILLUART P, 2001, IN PRESS CELL; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Jin Z, 1997, J NEUROSCI, V17, P6256; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Yu HH, 2000, GENETICS, V156, P723	16	33	33	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					1	3		10.1016/S0896-6273(01)00459-7	http://dx.doi.org/10.1016/S0896-6273(01)00459-7			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604131	Bronze			2022-12-28	WOS:000171525200001
J	Saint-Amant, L; Drapeau, P				Saint-Amant, L; Drapeau, P			Synchronization of an embryonic network of identified spinal interneurons solely by electrical coupling	NEURON			English	Article							DEVELOPING NEURAL CIRCUITS; ZEBRAFISH EMBRYO; NEONATAL HIPPOCAMPUS; MOTONEURON ACTIVITY; LOCOMOTOR NETWORK; AXONAL OUTGROWTH; GAP-JUNCTIONS; IN-VIVO; NEURONS; CORD	There is a need to understand the mechanisms of neural synchronization during development because correlated rhythmic activity is thought to be critical for the establishment of proper connectivity. The relative importance of chemical and electrical synapses for synchronization of electrical activity during development is unclear. We examined the activity patterns of identified spinal neurons at the onset of motor activity in zebrafish embryos. Rhythmic activity appeared early and persisted upon blocking chemical neurotransmission but was abolished by inhibitors of gap junctions. Paired recordings revealed that active spinal neurons were electrically coupled and formed a simple network of motoneurons and a subset of interneurons. Thus, the earliest spinal central pattern generator consists of synchronously active, electrically coupled neurons.	McGill Univ, Montreal Gen Hosp, Inst Res, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Biol, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University	Drapeau, P (corresponding author), McGill Univ, Montreal Gen Hosp, Inst Res, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada.	pierre.drapeau@mcgill.ca						Ali DW, 2000, J NEUROPHYSIOL, V83, P181, DOI 10.1152/jn.2000.83.1.181; BARRY MAJ, 1987, DEV BRAIN RES, V36, P271, DOI 10.1016/0165-3806(87)90030-7; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; BERNHARDT RR, 1990, J COMP NEUROL, V302, P603, DOI 10.1002/cne.903020315; BRODIN L, 1985, BRAIN RES, V325, P302, DOI 10.1016/0006-8993(85)90328-2; Buss RR, 2001, J NEUROPHYSIOL, V86, P197, DOI 10.1152/jn.2001.86.1.197; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Chang Q, 2000, BRAIN RES REV, V32, P242, DOI 10.1016/S0165-0173(99)00085-5; Chub N, 1998, J NEUROSCI, V18, P294; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; Eisen JS, 1998, CURR OPIN NEUROBIOL, V8, P697, DOI 10.1016/S0959-4388(98)80110-4; EISEN JS, 1991, J NEUROSCI, V11, P311; ELMANIRA A, 1994, J NEUROPHYSIOL, V72, P1852, DOI 10.1152/jn.1994.72.4.1852; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; FETCHO JR, 1988, J NEUROSCI, V8, P4192; FISCHBACH GD, 1972, DEV BIOL, V28, P407, DOI 10.1016/0012-1606(72)90023-1; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; GRILLNER S, 1991, ANNU REV NEUROSCI, V14, P169, DOI 10.1146/annurev.neuro.14.1.169; GRUNWALD DJ, 1988, DEV BIOL, V126, P115, DOI 10.1016/0012-1606(88)90245-X; HAMBURGER V, 1963, Q REV BIOL, V38, P342, DOI 10.1086/403941; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kristan WB, 2000, BRAIN RES BULL, V53, P561, DOI 10.1016/S0361-9230(00)00390-7; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; KUWADA JY, 1990, J COMP NEUROL, V302, P617, DOI 10.1002/cne.903020316; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; MENDELSON B, 1986, J COMP NEUROL, V251, P172, DOI 10.1002/cne.902510204; Milner LD, 1999, J NEUROSCI, V19, P3007; Myers P. Z., 1997, Journal of Computer-Assisted Microscopy, V9, P169; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Peinado A, 2000, J NEUROSCI, V20; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; POWELL SL, 1984, BRAIN RES, V294, P9, DOI 10.1016/0006-8993(84)91304-0; Rekling JC, 2000, J NEUROSCI, V20, part. no.; ROBERTS A, 1990, SCI PROG, V74, P31; Roerig B, 2000, BRAIN RES REV, V32, P86, DOI 10.1016/S0165-0173(99)00069-7; Rossignol Serge, 1994, Current Opinion in Neurobiology, V4, P894, DOI 10.1016/0959-4388(94)90139-2; Saint-Amant L, 2000, J NEUROSCI, V20, P3964; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; ScrymgeourWedderburn JF, 1997, EUR J NEUROSCI, V9, P1473, DOI 10.1111/j.1460-9568.1997.tb01501.x; Selverston A., 1997, NEURONS NETWORKS MOT, P105; SMITH JC, 1988, FASEB J, V2, P2283, DOI 10.1096/fasebj.2.7.2450802; Soffe SR, 1996, J NEUROPHYSIOL, V75, P1815, DOI 10.1152/jn.1996.75.5.1815; Stein P. S. G., 1997, NEURONS NETWORKS MOT; Strata F, 1997, J NEUROSCI, V17, P1435; TAKENSKWAK BR, 1992, AM J PHYSIOL, V262, pC1531, DOI 10.1152/ajpcell.1992.262.6.C1531; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0	58	118	119	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2001	31	6					1035	1046		10.1016/S0896-6273(01)00416-0	http://dx.doi.org/10.1016/S0896-6273(01)00416-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580902	Bronze			2022-12-28	WOS:000171281300017
J	Satterlee, JS; Sasakura, H; Kuhara, A; Berkeley, M; Mori, I; Sengupta, P				Satterlee, JS; Sasakura, H; Kuhara, A; Berkeley, M; Mori, I; Sengupta, P			Specification of thermosensory neuron fate in C-elegans requires ttx-1, a homolog of otd/Otx	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; LIM HOMEOBOX GENE; DROSOPHILA HEAD DEVELOPMENT; CONTROLLING DAUER FORMATION; NUCLEOTIDE-GATED CHANNEL; CONE-ROD DYSTROPHY; HUMAN OTX GENES; CHEMOSENSORY NEURONS; BRAIN-DEVELOPMENT; ANTERIOR NEUROECTODERM	Temperature is a critical modulator of animal metabolism and behavior, yet the mechanisms underlying the development and function of thermosensory neurons are poorly understood. C. elegans senses temperature using the AFD thermosensory neurons. Mutations in the gene ttx-1 affect AFD neuron function. Here, we show that ttx-1 regulates all differentiated characteristics of the AFD neurons. ttx-1 mutants are defective in a thermotactic behavior and exhibit deregulated thermosensory inputs into a neuroendocrine signaling pathway. ttx-1 encodes a member of the conserved OTD/ OTX homeodomain protein family and is expressed in the AFD neurons. Misexpression of ttx-1 converts other sensory neurons to an AFD-like fate. Our results extend a previously noted conservation of developmental mechanisms between the thermosensory circuit in C. elegans and the vertebrate photosensory circuit, suggesting an evolutionary link between thermosensation and phototransduction.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; Nagoya Univ, Grad Sch Sci, Mol Neurobiol Lab, Div Biol Sci, Nagoya, Aichi 4648602, Japan	Brandeis University; Brandeis University; Nagoya University	Sengupta, P (corresponding author), Brandeis Univ, Dept Biol, 415 South St, Waltham, MA 02454 USA.		Kuhara, Atsushi/S-5855-2018	Kuhara, Atsushi/0000-0003-2994-8658	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020048, R01GM056223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM20048, R01 GM56223] Funding Source: Medline; NINDS NIH HHS [T32 NS07292] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Acampora D, 2000, GENE, V246, P23, DOI 10.1016/S0378-1119(00)00070-6; Acampora D, 1998, DEVELOPMENT, V125, P1691; Acampora D, 1997, DEVELOPMENT, V124, P3639; Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; Ailion M, 2000, GENETICS, V156, P1047; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Barabino SML, 1997, MECH DEVELOP, V63, P133, DOI 10.1016/S0925-4773(97)00036-1; BARGMANN CI, 1990, COLD SPRING HARB SYM, V55, P529; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bligh J, 1973, TEMPERATURE REGULATI; BRENNER S, 1974, GENETICS, V77, P71; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; BURR AH, 1985, PHOTOCHEM PHOTOBIOL, V41, P577, DOI 10.1111/j.1751-1097.1985.tb03529.x; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chen CMA, 2000, MECH DEVELOP, V90, P293; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Collet J, 1998, GENETICS, V148, P187; CRAWFORD EC, 1982, COMPANION ANIMAL PHY, P198; CRAWSHAW LI, 1980, ANNU REV PHYSIOL, V42, P473, DOI 10.1146/annurev.ph.42.030180.002353; Daniels SA, 2000, GENETICS, V156, P123; FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forrester WC, 1998, GENETICS, V148, P151; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gall H, 1999, HAUTARZT, V50, P186, DOI 10.1007/s001050050887; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; GOTTLIEB S, 1994, GENETICS, V137, P107; Hart AC, 1999, J NEUROSCI, V19, P1952; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HENSEL H, 1973, PHYSIOL REV, V53, P948, DOI 10.1152/physrev.1973.53.4.948; Hirth F, 1999, BIOESSAYS, V21, P677, DOI 10.1002/(SICI)1521-1878(199908)21:8<677::AID-BIES7>3.3.CO;2-#; HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hobert O, 1998, J NEUROSCI, V18, P2084; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; IGGO A, 1990, THERMORECEPTION AND TEMPERATURE REGULATION, P9; Jakubowski J, 1999, GENETICS, V153, P743; Klein WH, 1999, BIOCHEM BIOPH RES CO, V258, P229, DOI 10.1006/bbrc.1999.0449; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; KUPFERMANN I, 2000, PRINCIPLES NEURAL SC, P998; Leuzinger S, 1998, DEVELOPMENT, V125, P1703; LEVINE EM, 1994, J COMP NEUROL, V348, P596, DOI 10.1002/cne.903480409; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; MELLO C, 1995, CAENORHABDITIS ELEGA, P452; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Morsli H, 1999, DEVELOPMENT, V126, P2335; Nagao T, 1998, P NATL ACAD SCI USA, V95, P3737, DOI 10.1073/pnas.95.7.3737; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Reichling DB, 2000, NEURON, V26, P555, DOI 10.1016/S0896-6273(00)81191-5; Riddle DL, 1997, C ELEGANS, P739; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; ROYET J, 1995, DEVELOPMENT, V121, P3561; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; Sarafi-Reinach TR, 2000, GENE DEV, V14, P2472, DOI 10.1101/gad.832300; Sarafi-Reinach TR, 2001, DEVELOPMENT, V128, P3269; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Simeone A, 1998, EMBO J, V17, P6790, DOI 10.1093/emboj/17.23.6790; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; SPRAY DC, 1986, ANNU REV PHYSIOL, V48, P625; STARICH TA, 1995, GENETICS, V139, P171; Suda Y, 1997, MECH DEVELOP, V69, P125, DOI 10.1016/S0925-4773(97)00161-5; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SVENDSEN PC, 1995, DEVELOPMENT, V121, P1253; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; THOMAS JH, 1993, GENETICS, V134, P1105; Tissenbaum HA, 2000, P NATL ACAD SCI USA, V97, P460, DOI 10.1073/pnas.97.1.460; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; VOWELS JJ, 1992, GENETICS, V130, P105; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; White J., 1988, NEMATODE CAENORHABDI, V17, P81; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	93	109	116	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					943	956		10.1016/S0896-6273(01)00431-7	http://dx.doi.org/10.1016/S0896-6273(01)00431-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580895	Bronze			2022-12-28	WOS:000171281300010
J	Xiong, ZQ; McNamara, JO				Xiong, ZQ; McNamara, JO			Fas(t) balls and Lou Gehrig disease: A clue to selective vulnerability of motor neurons?	NEURON			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; APOPTOSIS; TOXICITY; ALS	The molecular basis of the selective death of motor neurons in amyotrophic lateral sclerosis (ALS) has been an enigma since its description by Charcot in 1869 (Cleveland and Rothstein, 2001; Julien, 2001). In this issue of Neuron, Raoul et al. (2002) demonstrate a motor neuron-specific death pathway which involves Fas and NO. Remarkably, motor neurons from mice carrying ALS-linked mutant forms of superoxide dismutase 1 (SOD1) exhibit an increased sensitivity to death triggered by Fas but not other insults. These data suggest new insights into the mechanisms of, and potential therapeutic strategies for, death of motor neurons in ALS.	Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Mol Canc Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Xiong, ZQ (corresponding author), Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA.							Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Yi FH, 2000, J NEUROIMMUNOL, V109, P211, DOI 10.1016/S0165-5728(00)00288-5; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	10	7	9	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1011	1013		10.1016/S0896-6273(02)00910-8	http://dx.doi.org/10.1016/S0896-6273(02)00910-8			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354390	Bronze			2022-12-28	WOS:000178040000001
J	Krauzlis, RJ; Dill, N				Krauzlis, RJ; Dill, N			Neural correlates of target choice for pursuit and saccades in the primate superior colliculus	NEURON			English	Article							FRONTAL EYE FIELD; COUNTERMANDING SACCADES; NEURONAL-ACTIVITY; VISUAL-MOTION; REACTION-TIME; AREAS MT; MOVEMENTS; SELECTION; MONKEY; RESPONSES	We have examined the role of the superior colliculus (SC) in choosing targets for pursuit and saccades by comparing neuronal activity at sites representing the possible choices. After recording during a two-alternative forced-choice paradigm, we measured the difference in activity of the populations representing the two choices by computing receiver operating characteristic (ROC) curves on a millisecond timescale. A signal indicating the correct choice emerged from noise over time, forming a tradeoff between speed and accuracy. The observed performance corresponded to particular points along the predicted speed-accuracy curves-pursuit emphasizing speed and saccades emphasizing accuracy. These results show that activity from the same set of neurons in the superior colliculus can predict target choices for both pursuit and saccades.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Krauzlis, RJ (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Richard, Krauzlis/0000-0002-1826-0447	NATIONAL EYE INSTITUTE [R01EY012212] Funding Source: NIH RePORTER; NEI NIH HHS [EY12212] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Basso MA, 1998, J NEUROSCI, V18, P7519; Basso MA, 2000, J NEUROPHYSIOL, V84, P892, DOI 10.1152/jn.2000.84.2.892; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940, DOI 10.1152/jn.1988.60.3.940; Ferrera VP, 1997, J NEUROPHYSIOL, V78, P1433, DOI 10.1152/jn.1997.78.3.1433; Gandhi NJ, 1999, J NEUROPHYSIOL, V82, P3236, DOI 10.1152/jn.1999.82.6.3236; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; GLIMCHER PW, 1993, J NEUROPHYSIOL, V69, P953, DOI 10.1152/jn.1993.69.3.953; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GRICE GR, 1968, PSYCHOL REV, V75, P359, DOI 10.1037/h0026287; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HANES DP, 1995, VISUAL NEUROSCI, V12, P929, DOI 10.1017/S0952523800009482; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; Hanes DP, 1999, VISION RES, V39, P2777, DOI 10.1016/S0042-6989(99)00011-5; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2527, DOI 10.1152/jn.2001.86.5.2527; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; KELLER EL, 1991, NEUROSCI RES, V11, P79, DOI 10.1016/0168-0102(91)90048-4; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Krauzlis RJ, 1999, TRENDS NEUROSCI, V22, P544, DOI 10.1016/S0166-2236(99)01464-2; Krauzlis RJ, 1998, J NEUROPHYSIOL, V80, P2046, DOI 10.1152/jn.1998.80.4.2046; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; Krauzlis RJ, 1999, J COGNITIVE NEUROSCI, V11, P641, DOI 10.1162/089892999563706; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Miyashita N, 1996, EXP BRAIN RES, V112, P187; MORDKOFF JT, 1993, J EXP PSYCHOL HUMAN, V19, P981, DOI 10.1037/0096-1523.19.5.981; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; NAZIR TA, 1991, PSYCHOL RES-PSYCH FO, V53, P281, DOI 10.1007/BF00920481; NEWSOME WT, 1985, J NEUROSCI, V5, P825; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Recanzone GH, 1997, J NEUROPHYSIOL, V78, P2904, DOI 10.1152/jn.1997.78.6.2904; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P777, DOI 10.1152/jn.2000.83.2.777; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; SCHWARZ W, 1993, PSYCHOL RES-PSYCH FO, V55, P200, DOI 10.1007/BF00419607; SPARKS DL, 1990, ANNU REV NEUROSCI, V13, P309, DOI 10.1146/annurev.ne.13.030190.001521; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; Tanaka M, 2001, NATURE, V409, P191, DOI 10.1038/35051582; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201; Zee DS., 1999, NEUROLOGY EYE MOVEME	57	93	93	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					355	363		10.1016/S0896-6273(02)00756-0	http://dx.doi.org/10.1016/S0896-6273(02)00756-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	576YF	12160752	Bronze			2022-12-28	WOS:000177034200014
J	LaMonte, BH; Wallace, KE; Holloway, BA; Shelly, SS; Ascano, J; Tokito, M; Van Winkle, T; Howland, DS; Holzbaur, ELF				LaMonte, BH; Wallace, KE; Holloway, BA; Shelly, SS; Ascano, J; Tokito, M; Van Winkle, T; Howland, DS; Holzbaur, ELF			Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration	NEURON			English	Article							CYTOPLASMIC DYNEIN; DYNACTIN COMPLEX; P150(GLUED) COMPONENT; NEUROFILAMENT SUBUNIT; TRANSGENIC MICE; PROTEIN; SOD1; SPECTRIN; REVEALS; DISEASE	To test the hypothesis that inhibition of axonal transport is sufficient to cause motor neuron degeneration such as that observed in amyotrophic lateral sclerosis (ALS), we engineered a targeted disruption of the dynein-dynactin complex in postnatal motor neurons of transgenic mice. Dynamitin overexpression was found to disassemble dynactin, a required activator of cytoplasmic dynein, resulting in an inhibition of retrograde axonal transport. Mice overexpressing dynamitin demonstrate a late-onset progressive motor neuron degenerative disease characterized by decreased strength and endurance, motor neuron degeneration and loss, and denervation of muscle. Previous transgenic mouse models of ALS have shown abnormalities in microtubule-based axonal transport. In this report, we describe a mouse model that confirms the critical role of disrupted axonal transport in the pathogenesis of motor neuron degenerative disease.	Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol Anim, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Wyeth Ayerst Res, Princeton, NJ 08543 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pfizer	Holzbaur, ELF (corresponding author), Univ Penn, Sch Med, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu			NIGMS NIH HHS [GM56707, GM48661] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048661, R01GM056707] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Borchelt DR, 1998, BRAIN PATHOL, V8, P735, DOI 10.1111/j.1750-3639.1998.tb00198.x; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Dillman JF, 1996, J NEUROSCI, V16, P6742; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; Elder GA, 1998, J CELL BIOL, V143, P195, DOI 10.1083/jcb.143.1.195; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Julien JP, 1997, TRENDS CELL BIOL, V7, P243, DOI 10.1016/S0962-8924(97)01049-0; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Karki S, 1998, J CELL BIOL, V142, P1023, DOI 10.1083/jcb.142.4.1023; Karki S, 2000, J BIOL CHEM, V275, P4834, DOI 10.1074/jbc.275.7.4834; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Li JY, 2000, J NEUROSCI RES, V61, P151, DOI 10.1002/1097-4547(20000715)61:2<151::AID-JNR6>3.3.CO;2-E; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; MELLONI RH, 1995, J COMP NEUROL, V357, P15, DOI 10.1002/cne.903570103; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Murphey RK, 1999, DEV BIOL, V209, P86, DOI 10.1006/dbio.1999.9217; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Pagala MK, 1998, MUSCLE NERVE, V21, P1729, DOI 10.1002/(SICI)1097-4598(199812)21:12<1729::AID-MUS16>3.0.CO;2-V; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reddy S, 1997, J NEUROBIOL, V33, P711, DOI 10.1002/(SICI)1097-4695(19971120)33:6<711::AID-NEU1>3.0.CO;2-C; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SCHMUED L, 1994, ELSEVIERS NEUROSCIEN, V50, P1; Shah JV, 2000, MOL BIOL CELL, V11, P3495, DOI 10.1091/mbc.11.10.3495; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Tokito MK, 1996, MOL BIOL CELL, V7, P1167, DOI 10.1091/mbc.7.8.1167; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Xu ZS, 1996, J CELL BIOL, V133, P1061, DOI 10.1083/jcb.133.5.1061; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	48	413	432	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					715	727		10.1016/S0896-6273(02)00696-7	http://dx.doi.org/10.1016/S0896-6273(02)00696-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062019	Bronze			2022-12-28	WOS:000175951800007
J	Critchley, HD; Mathias, CJ; Dolan, RJ				Critchley, HD; Mathias, CJ; Dolan, RJ			Fear conditioning in humans: The influence of awareness and autonomic arousal on functional neuroanatomy	NEURON			English	Article							SKIN-CONDUCTANCE RESPONSES; FACIAL EXPRESSIONS; HUMAN AMYGDALA; STIMULI; ACTIVATION; MEMORY; ACQUISITION; KNOWLEDGE; SYSTEMS; DAMAGE	The degree to which perceptual awareness of threat stimuli and bodily states of arousal modulates neural activity associated with fear conditioning is unknown. We used functional magnetic neuroimaging (fMRI) to study healthy subjects and patients with peripheral autonomic denervation to examine how the expression of conditioning-related activity is modulated by stimulus awareness and autonomic arousal. In controls, enhanced amygdala activity was evident during conditioning to both "seen" (unmasked) and "unseen" (backward masked) stimuli, whereas insula activity was modulated by perceptual awareness of a threat stimulus. Absent peripheral autonomic arousal, in patients with autonomic denervation, was associated with decreased conditioning-related activity in insula and amygdala. The findings indicate that the expression of conditioning-related neural activity is modulated by both awareness and representations of bodily states of autonomic arousal.	Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCl, Inst Cognit Neurosci, London WC1N 3BG, England; UCL, Natl Hosp Neurol & Neurosurg, Auton Unit, London, England; UCL, ION, London, England; St Marys Hosp, ICSM, Neurovasc Med Unit, London W2 1NY, England	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London	Critchley, HD (corresponding author), Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.		critchley, hugo d/G-9267-2011	critchley, hugo d/0000-0002-2445-9284; Dolan, Ray/0000-0001-9356-761X				BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Bunce SC, 1999, J PSYCHIATR RES, V33, P341, DOI 10.1016/S0022-3956(99)00003-5; Cahill L, 1999, NEURON, V23, P227, DOI 10.1016/S0896-6273(00)80774-6; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 2000, PROG BRAIN RES, V126, P29; Canli T, 2000, J NEUROSCI, V20; Casey KL, 2001, J NEUROPHYSIOL, V85, P951, DOI 10.1152/jn.2001.85.2.951; CECHETTO DF, 1990, CENTRAL REGULATION A, P208; CLARK CV, 1988, DOC OPHTHALMOL, V70, P309, DOI 10.1007/BF00157061; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2000, J NEUROSCI, V20, P3033; Critchley HD, 2001, BRAIN, V124, P1003, DOI 10.1093/brain/124.5.1003; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DAVIS M, 1992, P255; Dolan RS, 2000, NEUROIMAGE, V11, P203, DOI 10.1006/nimg.2000.0538; Ekman P., 1976, PICTURES FACIAL AFFE; ESTEVES F, 1994, PSYCHOPHYSIOLOGY, V31, P375, DOI 10.1111/j.1469-8986.1994.tb02446.x; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; KAPP B S, 1992, P229; KAPP BS, 1981, AMYGDALOID COMPLEX, P355; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux J.E., 1996, EMOTIONAL BRAIN MYST; LEDOUX JE, 1992, COGNITIVE NEUROSCIEN, P1049; LOVIBOND PF, 2002, IN PRESS J EXPT PSYC; Magnifico F, 1998, CLIN AUTON RES, V8, P133, DOI 10.1007/BF02281117; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; MAREN S, 1994, BEHAV NEUROSCI, V108, P645, DOI 10.1037/0735-7044.108.3.645; Mathias CJ, 1999, AUTONOMIC FAILURE TX, V4, P169; MATHIAS CJ, 2000, NEUROLOGY CLIN PRACT, P2131; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 1997, P ROY SOC B-BIOL SCI, V264, P769, DOI 10.1098/rspb.1997.0109; OHMAN A, 1993, J ABNORM PSYCHOL, V102, P121; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Talairach J., 1988, COPLANAR STEREOTAXIC; TRANEL D, 1989, NEUROPSYCHOLOGIA, V27, P381, DOI 10.1016/0028-3932(89)90046-8; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 1998, J NEUROSCI, V18, P411; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; YOUNG SL, 1995, NEUROBIOL LEARN MEM, V63, P174, DOI 10.1006/nlme.1995.1018	49	336	337	2	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					653	663		10.1016/S0896-6273(02)00588-3	http://dx.doi.org/10.1016/S0896-6273(02)00588-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856537	Bronze			2022-12-28	WOS:000173911100016
J	Wang, J; Zugates, CT; Liang, IH; Lee, CHJ; Lee, TM				Wang, J; Zugates, CT; Liang, IH; Lee, CHJ; Lee, TM			Drosophila Dscam is required for divergent segregation of sister branches and suppresses ectopic bifurcation of axons	NEURON			English	Article							GROWTH CONE FORM; MUSHROOM BODIES; CNS MIDLINE; GUIDANCE; NEURONS; PATTERN; PROTEIN; BODY; MELANOGASTER; SEMAPHORINS	Axon bifurcation results in the formation of sister branches, and divergent segregation of the sister branches is essential for efficient innervation of multiple targets. From a genetic mosaic screen, we find that a lethal mutation in the Drosophila Down syndrome cell adhesion molecule (Dscam) specifically perturbs segregation of axonal branches in the mushroom bodies. Single axon analysis further reveals that Dscam mutant axons generate additional branches, which randomly segregate among the available targets. Moreover, when only one target remains, branching is suppressed in wild-type axons while Dscam mutant axons still form multiple branches at the original bifurcation point. Taken together, we conclude that Dscam controls axon branching and guidance such that a neuron can innervate multiple targets with minimal branching.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Med, Hematol Oncol Sect, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lee, TM (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.			Zugates, Christopher/0000-0003-1882-3665	NIGMS NIH HHS [T32 GM07283] Funding Source: Medline; NINDS NIH HHS [R01-NS42049] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042049] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acebes A, 2000, TRENDS NEUROSCI, V23, P557, DOI 10.1016/S0166-2236(00)01646-5; Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V281, P697, DOI 10.1006/bbrc.2001.4420; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Fashena D, 1999, J COMP NEUROL, V406, P415, DOI 10.1002/(SICI)1096-9861(19990412)406:3<415::AID-CNE9>3.0.CO;2-2; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HEITZLER P, 1993, GENETICS, V135, P105; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Lawrence PA, 1999, DEVELOPMENT, V126, P2431; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Mason CA, 1997, J NEUROSCI, V17, P1086; Matheson SF, 1999, J NEUROBIOL, V38, P27, DOI 10.1002/(SICI)1097-4695(199901)38:1<27::AID-NEU3>3.3.CO;2-L; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; PIKE SH, 1992, DEVELOPMENT, V114, P825; SATO M, 1994, NEURON, V13, P791, DOI 10.1016/0896-6273(94)90246-1; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Scott EK, 2001, CURR BIOL, V11, P99, DOI 10.1016/S0960-9822(01)00020-3; SHAW G, 1977, EXP CELL RES, V104, P55, DOI 10.1016/0014-4827(77)90068-4; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Sugihara I, 1999, J COMP NEUROL, V414, P131; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; TRUMAN JW, 1988, DEV BIOL, V125, P146; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; YANG MY, 1995, NEURON, V15, P45	50	160	161	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					559	571		10.1016/S0896-6273(02)00570-6	http://dx.doi.org/10.1016/S0896-6273(02)00570-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856530	Bronze			2022-12-28	WOS:000173911100009
J	Hutson, LD; Chien, CB				Hutson, LD; Chien, CB			Pathfinding and error correction by retinal axons: The role of astray/robo2	NEURON			English	Article							GROWTH CONE MORPHOLOGY; TRANSIENT RETINOTECTAL PROJECTION; GANGLION-CELL AXONS; MOUSE OPTIC CHIASM; ZEBRAFISH EMBRYO; NITRIC-OXIDE; TIME-LAPSE; MULTIPLE ASPECTS; CNS MIDLINE; IN-VIVO	To address how the highly stereotyped retinotectal pathway develops in zebrafish, we used fixed-tissue and time-lapse imaging to analyze morphology and behavior of wild-type and mutant retinal growth cones. Wild-type growth cones increase in complexity and pause at the midline. Intriguingly, they make occasional ipsilateral projections and other path-finding errors, which are always eventually corrected. In the astray/robo2 mutant, growth cones are larger and more complex than wild-type. astray axons make midline errors not seen in wild-type, as well as errors both before and after the midline. astray errors are rarely corrected. The presumed Robo ligands Slit2 and Slit3 are expressed near the pathway in patterns consistent with their mediating pathfinding through Robo2. Thus, Robo2 does not control midline crossing of retinal axons, but rather shapes their pathway, by both preventing and correcting pathfinding errors.	Univ Utah, Med Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Chien, CB (corresponding author), Univ Utah, Med Ctr, Dept Neurobiol & Anat, 20 North 1900 East, Salt Lake City, UT 84132 USA.	chi-bin.chien@hsc.utah.edu			NEI NIH HHS [F32-EY07017, R01-EY12873] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY007017, R01EY012873] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baier H, 1996, DEVELOPMENT, V123, P415; Battye R, 1999, DEVELOPMENT, V126, P2475; BERNHARDT RR, 1992, J COMP NEUROL, V326, P263, DOI 10.1002/cne.903260208; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; Brand M, 1996, DEVELOPMENT, V123, P179; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P433, DOI 10.1006/mcne.1995.1032; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; BURRILL J D, 1989, Investigative Ophthalmology and Visual Science, V30, P226; BURRILL JD, 1994, J COMP NEUROL, V346, P583, DOI 10.1002/cne.903460410; CAUDY M, 1986, J NEUROSCI, V6, P364; CAUDY M, 1987, DEV BIOL, V119, P454, DOI 10.1016/0012-1606(87)90049-2; Challa AK, 2001, MECH DEVELOP, V101, P249, DOI 10.1016/S0925-4773(00)00570-0; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Ernst AF, 1998, PROG BRAIN RES, V118, P115; Ernst AF, 1999, J NEUROSCI, V19, P229, DOI 10.1523/JNEUROSCI.19-01-00229.1999; Erskine L, 2000, J NEUROSCI, V20, P4975; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Halloran MC, 1999, DEV DYNAM, V214, P13, DOI 10.1002/(SICI)1097-0177(199901)214:1<13::AID-DVDY2>3.0.CO;2-3; HALLORAN MC, 1994, J NEUROSCI, V14, P2161; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HOLT CE, 1989, J NEUROSCI, V9, P3123; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KIM GJ, 1991, J NEUROBIOL, V22, P629, DOI 10.1002/neu.480220608; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lee JS, 2001, DEV DYNAM, V221, P216, DOI 10.1002/dvdy.1136; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Macdonald R, 1997, DEVELOPMENT, V124, P2397; Marcus RC, 2000, DEV BIOL, V221, P132, DOI 10.1006/dbio.2000.9660; Mason C, 2000, J NEUROBIOL, V44, P260, DOI 10.1002/1097-4695(200008)44:2<260::AID-NEU14>3.0.CO;2-H; Mason CA, 1997, J NEUROSCI, V17, P1086; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; MCLOON SC, 1982, EXP BRAIN RES, V45, P277; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Murray MJ, 1999, J NEUROSCI, V19, P7901; MYERS PZ, 1993, J NEUROSCI, V13, P127; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Niclou SP, 2000, J NEUROSCI, V20, P4962; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; OLEARY DDM, 1983, DEV BRAIN RES, V10, P93, DOI 10.1016/0165-3806(83)90124-4; RAPER JA, 1990, EXP NEUROL, V109, P70, DOI 10.1016/S0014-4886(05)80009-3; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; SRETAVAN DW, 1994, NEURON, V12, P957, DOI 10.1016/0896-6273(94)90307-7; SRETAVAN DW, 1993, NEURON, V10, P761, DOI 10.1016/0896-6273(93)90176-R; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; Strahle U, 1997, MECH DEVELOP, V62, P147, DOI 10.1016/S0925-4773(97)00657-6; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; STUERMER CAO, 1990, J NEUROSCI, V10, P3615; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; Walz A, 1997, DEVELOPMENT, V124, P2421; WILSON SW, 1991, DEVELOPMENT, V112, P723; WIZENMANN A, 1993, DEVELOPMENT, V117, P725; WU HH, 1994, SCIENCE, V265, P1593, DOI 10.1126/science.7521541; Yeo SY, 2001, DEV BIOL, V230, P1, DOI 10.1006/dbio.2000.0105; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	71	139	139	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					205	217		10.1016/S0896-6273(01)00579-7	http://dx.doi.org/10.1016/S0896-6273(01)00579-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804569	Bronze			2022-12-28	WOS:000173387700009
J	Phillips, WD; Froehner, SC				Phillips, WD; Froehner, SC			GABARAP and GABA(A) receptor clustering	NEURON			English	Editorial Material							GEPHYRIN; INTERACTS	Coyle et al. (2002), in this issue of Neuron, reveal the crystal structure for the GABA(A) receptor binding protein, GABARAP. They show GABARAP can switch from a monomer to an extended linear polymer form that may function to assemble microtubules during the intracellular trafficking or postsynaptic clustering of GABA(A) receptors.	Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Sydney; University of Washington; University of Washington Seattle	Phillips, WD (corresponding author), Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia.			Phillips, William/0000-0002-5405-8422				Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; KNIGHT D, 2001, IN PRESS J BIOL CHEM; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264	11	8	8	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					4	6		10.1016/S0896-6273(01)00569-4	http://dx.doi.org/10.1016/S0896-6273(01)00569-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779472	Bronze			2022-12-28	WOS:000173106200003
J	Fernandez, I; Arac, D; Ubach, J; Gerber, SH; Shin, OH; Gao, Y; Anderson, RGW; Sudhof, TC; Rizo, J				Fernandez, I; Arac, D; Ubach, J; Gerber, SH; Shin, OH; Gao, Y; Anderson, RGW; Sudhof, TC; Rizo, J			Three-dimensional structure of the synaptotagmin 1 C2B-domain: Synaptotagmin 1 as a phospholipid binding machine	NEURON			English	Article							PROTEIN-KINASE-C; C2B DOMAIN; FUNCTIONAL DIVERSITY; TRANSMITTER RELEASE; CRYSTAL-STRUCTURE; CALCIUM SENSOR; SNARE COMPLEX; C-2 DOMAIN; CA2+; SENSITIVITY	Synaptotagmin 1 probably functions as a Ca2+ sensor in neurotransmitter release via its two C-2-domains, but no common Ca2+-dependent activity that could underlie a cooperative action between them has been described. The NMR structure of the C2B-domain now reveals a beta sandwich that exhibits striking similarities and differences with the C(2)A-domain. Whereas the bottom face of the C2B-domain has two additional a helices that may be involved in specialized Ca2+-independent functions, the top face binds two Ca2+ ions and is remarkably similar to the C(2)A-domain. Consistent with these results, but in contrast to previous studies, we find that the C2B-domain binds phospholipids in a Ca2+-dependent manner similarly to the C(2)A-domain. These results suggest a novel view of synaptotagmin function whereby the two C-2-domains cooperate in a common activity, Ca2+-dependent phospholipid binding, to trigger neurotransmitter release.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Rizo, J (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.				NINDS NIH HHS [NS40944] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040944] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; Bennett MR, 1999, PROG NEUROBIOL, V59, P243, DOI 10.1016/S0301-0082(99)00004-0; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; Edwards AS, 1997, BIOCHEMISTRY-US, V36, P15615, DOI 10.1021/bi9718752; Essen LO, 1997, BIOCHEMISTRY-US, V36, P2753, DOI 10.1021/bi962466t; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2000, P NATL ACAD SCI USA, V97, P14715, DOI 10.1073/pnas.260491197; Garcia RA, 2000, P NATL ACAD SCI USA, V97, P5883, DOI 10.1073/pnas.100127197; Gerber SH, 2001, EMBO J, V20, P1605, DOI 10.1093/emboj/20.7.1605; GERBER SH, 2002, IN PRESS DIABETES; Jarousse N, 2001, J CELL BIOL, V154, P857, DOI 10.1083/jcb.200103040; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1993, J AM CHEM SOC, V115, P2055, DOI 10.1021/ja00058a072; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P3089, DOI 10.1021/bi001968a; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Williams RL, 1996, STRUCTURE, V4, P1387, DOI 10.1016/S0969-2126(96)00146-3; ZHANG C, 1998, INT SER ON ADVANC FR, V2, P1; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	57	303	307	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1057	1069		10.1016/S0896-6273(01)00548-7	http://dx.doi.org/10.1016/S0896-6273(01)00548-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754837	Bronze			2022-12-28	WOS:000172886800012
J	Chiba, A				Chiba, A			Precision networking: A look through the eyes of a fly	NEURON			English	Review							MOTOR AXON GUIDANCE; DROSOPHILA EMBRYO; PHOSPHATASE DLAR; RECEPTOR; CADHERIN	The establishment of the proper connectivity in the nervous system requires specific target selection between individual presynaptic and postsynaptic cells. It has been postulated that cell adhesion molecules likely participate in these local recognition events. However, the broad developmental roles of many of these molecules have presented an obstacle for loss-of-function analyses. A recent series of genetic studies in the Drosophila visual system has demonstrated roles for several cell adhesion molecules, including N-cadherin and the receptor protein tyrosine phosphatase LAR in proper synaptic targeting of photoreceptor axons.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chiba, A (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.							Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Desai CJ, 1997, DEVELOPMENT, V124, P1941; GARRITY PA, 1995, CELL, V83, P177, DOI 10.1016/0092-8674(95)90159-0; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sun Q, 2000, DEVELOPMENT, V127, P801; Takeichi M, 2000, PHILOS T ROY SOC B, V355, P885, DOI 10.1098/rstb.2000.0624; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0	19	7	7	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					381	384		10.1016/S0896-6273(01)00498-6	http://dx.doi.org/10.1016/S0896-6273(01)00498-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709149	Bronze			2022-12-28	WOS:000172119100004
J	Kerchner, GA; Wang, GD; Qiu, CS; Huettner, JE; Zhuo, M				Kerchner, GA; Wang, GD; Qiu, CS; Huettner, JE; Zhuo, M			Direct presynaptic regulation of GABA/glycine release by kainate receptors in the dorsal horn: An ionotropic mechanism	NEURON			English	Article							RAT SPINAL-CORD; SYNAPTIC TRANSMISSION; HIPPOCAMPAL INTERNEURONS; GABA RELEASE; GLUR6-DEFICIENT MICE; AMPA RECEPTORS; IN-VITRO; NEURONS; ACTIVATION; GLYCINE	In the spinal cord dorsal horn, excitatory sensory fibers terminate adjacent to interneuron terminals. Here, we show that kainate (KA) receptor activation triggered action potential-independent release of GABA and glycine from dorsal horn interneurons. This release was transient, because KA receptors desensitized, and it required Na+ entry and Ca2+ channel activation. KA modulated evoked inhibitory transmission in a dose-dependent, biphasic manner, with suppression being more prominent. In recordings from isolated neuron pairs, this suppression required GABA(B) receptor activation, suggesting that KA-triggered GABA release activated presynaptic GABA(B) autoreceptors. Finally, glutamate released from sensory fibers caused a KA and GABA(B) receptor-dependent suppression of inhibitory transmission in spinal slices. Thus, we show how presynaptic KA receptors are linked to changes in GABA/glycine release and highlight a novel role for these receptors in regulating sensory transmission.	Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zhuo, M (corresponding author), Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA.		Huettner, James E/C-5219-2012; Zhuo, Min/A-2072-2008	Zhuo, Min/0000-0001-9062-3241	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030888, R01NS038680] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38680, R01 NS030888, NS30888] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali AB, 2001, J NEUROSCI, V21, P2992, DOI 10.1523/JNEUROSCI.21-09-02992.2001; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; Bureau I, 1999, J NEUROSCI, V19, P653; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chergui K, 2000, J NEUROSCI, V20, P2175; Chery N, 2000, J NEUROPHYSIOL, V84, P1006, DOI 10.1152/jn.2000.84.2.1006; Chery N, 1999, J NEUROSCI, V19, P7342, DOI 10.1523/JNEUROSCI.19-17-07342.1999; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; CHRISTENSEN H, 1991, NEUROSCI LETT, V129, P217, DOI 10.1016/0304-3940(91)90465-6; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; DAVIES J, 1979, J PHYSIOL-PARIS, V75, P641; Deisz RA, 1999, NEUROSCIENCE, V93, P1241, DOI 10.1016/S0306-4522(99)00203-1; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; Glitsch M, 1999, J NEUROSCI, V19, P511; HAMMOND DL, 1993, EUR J PHARMACOL, V234, P255, DOI 10.1016/0014-2999(93)90961-G; Hille B., 1992, IONIC CHANNELS EXCIT; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Huettner JE, 1998, NEUROPHARMACOLOGY, V37, P1239, DOI 10.1016/S0028-3908(98)00082-3; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Jones KA, 1997, NEUROPHARMACOLOGY, V36, P853, DOI 10.1016/S0028-3908(97)00066-X; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Kerchner GA, 2001, J NEUROSCI, V21, P59, DOI 10.1523/JNEUROSCI.21-01-00059.2001; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Liu QS, 1999, J NEUROPHYSIOL, V82, P1059, DOI 10.1152/jn.1999.82.2.1059; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; RANSOM BR, 1977, J NEUROPHYSIOL, V40, P1163, DOI 10.1152/jn.1977.40.5.1163; RIBEIRODASILVA A, 1982, J COMP NEUROL, V209, P176, DOI 10.1002/cne.902090205; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; SAWYNOK J, 1987, PHARMACOL BIOCHEM BE, V26, P463, DOI 10.1016/0091-3057(87)90148-1; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Todd AJ, 1996, EUR J NEUROSCI, V8, P2492, DOI 10.1111/j.1460-9568.1996.tb01543.x; TOLLE TR, 1993, J NEUROSCI, V13, P5009, DOI 10.1523/JNEUROSCI.13-12-05009.1993; TSIEN RW, 1995, TRENDS NEUROSCI, V18, P52; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Wilding TJ, 1997, J NEUROSCI, V17, P2713; Wilding TJ, 2001, J PHYSIOL-LONDON, V532, P411, DOI 10.1111/j.1469-7793.2001.0411f.x; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; YOSHIMURA M, 1995, J PHYSIOL-LONDON, V482, P29, DOI 10.1113/jphysiol.1995.sp020497	60	92	97	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					477	488		10.1016/S0896-6273(01)00479-2	http://dx.doi.org/10.1016/S0896-6273(01)00479-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709158	Bronze			2022-12-28	WOS:000172119100013
J	Parnas, D; Haghighi, AP; Fetter, RD; Kim, SW; Goodman, CS				Parnas, D; Haghighi, AP; Fetter, RD; Kim, SW; Goodman, CS			Regulation of postsynaptic structure and protein localization by the Rho-type guanine nucleotide exchange factor dPix	NEURON			English	Article							GLUTAMATE RECEPTORS; FASCICLIN-II; DROSOPHILA REVEALS; GENETIC-ANALYSIS; SYNAPTIC GROWTH; PAK; ACTIN; EXPRESSION; KINASE; INTERACTS	Mutations in dpix were recovered from a large-scale screen in Drosophila for genes that control synaptic structure. dpix encodes dPix, a Rho-type guanine nucleotide exchange factor (RtGEF) homologous to mammalian Pix. Here we show that dPix plays a major role in regulating postsynaptic structure and protein localization at the Drosophila glutamatergic neuromuscular junction. dpix mutations lead to decreased synaptic levels of the PDZ protein Dig, the cell adhesion molecule Fas II, and the glutamate receptor subunit GluRIIA, and to a complete reduction of the serine/threonine kinase Pak and the subsynaptic reticulum. The electrophysiology of these mutant synapses is nearly normal. Many, but not all, dpix defects are mediated through dPak, a member of the family of Cdc42/Rac1-activated kinases. Thus, a Rho-type GEF and Rho-type effector kinase regulate postsynaptic structure.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Renovis Inc, 270 Littlefield Ave, San Francisco, CA 94080 USA.	goodman@uclink4.berkeley.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060711] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60711] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DW, 1998, J NEUROSCI, V18, P2423; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bai CY, 2000, NUCLEIC ACIDS RES, V28, P1078, DOI 10.1093/nar/28.5.1078; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Fehon RG, 1997, GENETICS, V146, P245; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hirai H, 2000, EUR J NEUROSCI, V12, P563, DOI 10.1046/j.1460-9568.2000.00938.x; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1995, J NEUROSCI, V15, P4148; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; PATEL N, 1994, IMAGING NEURONAL SUB, P7; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Sheng MHT, 2001, SYNAPSES, P315; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Sone M, 2000, DEVELOPMENT, V127, P4157; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; TOWER J, 1993, GENETICS, V133, P347; Trinidad JC, 2000, J NEUROSCI, V20, P8762; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Werner LA, 1997, GENE, V187, P107, DOI 10.1016/S0378-1119(96)00732-9; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	45	228	230	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2001	32	3					415	424		10.1016/S0896-6273(01)00485-8	http://dx.doi.org/10.1016/S0896-6273(01)00485-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709153	Bronze			2022-12-28	WOS:000172119100008
J	Giasson, BI; Lee, VMY				Giasson, BI; Lee, VMY			Parkin and the molecular pathways of Parkinson's disease	NEURON			English	Review							UBIQUITIN-PROTEIN LIGASE; RECESSIVE JUVENILE PARKINSONISM; GENE; NEUROPATHOLOGY; MUTATIONS; FAMILY; ONSET	Parkinson's disease (PD) is a neurodegenerative disease characterized by the selective demise of specific neuronal populations leading to impairment of motor functions. Recent genetic studies have uncovered several genes involved in inherited forms of the disease. These gene products are implicated in the biochemical pathways underlying the etiology of sporadic PD. Mutations in the parkin gene causal of autosomal recessive juvenile parkinsonism highlight that ubiquitin-mediated proteolysis may play an important role in the pathobiology of PD.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.							Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; CHUNG KKK, 2001, IN PRESS NAT MED; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Dawson VL, 2000, SCIENCE, V288, P631, DOI 10.1126/science.288.5466.631; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; FARRER M, 2001, IN PRESS ANN NEUROL; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Hayashi S, 2000, MOVEMENT DISORD, V15, P884, DOI 10.1002/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein C, 2000, ANN NEUROL, V48, P65, DOI 10.1002/1531-8249(200007)48:1<65::AID-ANA10>3.0.CO;2-L; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	21	118	121	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					885	888		10.1016/S0896-6273(01)00439-1	http://dx.doi.org/10.1016/S0896-6273(01)00439-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580890	Bronze			2022-12-28	WOS:000171281300005
J	Orr, HT				Orr, HT			Qs in the nucleus	NEURON			English	Editorial Material							DISEASE; GENES; SCA1	The polyglutamine diseases include at least nine neurodegenerative disorders. Accumulation of mutant protein with a toxic gain-in function in the nucleus appears to be the pathological basis of these diseases. In this issue of Neuron, La Spada et al. (2001) provide insight into the cell specificity of pathology for a polyglutamine disease by relating SCA7-induced retinal degeneration to a disruption of the photoreceptor-specific transcription factor CRX.	Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Orr, HT (corresponding author), Univ Minnesota, Inst Human Genet, Mayo Mail Code 206, Minneapolis, MN 55455 USA.			Orr, Harry/0000-0001-6118-741X				Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; KOLCHIRO N, 2001, HUM MOL GENET, V10, P1441; LA SA, 1991, NATURE, V352, P77; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; MCCAMPBELL A, 2000, HUM MOL GENET, V8, P731; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784	8	7	7	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					875	876		10.1016/S0896-6273(01)00435-4	http://dx.doi.org/10.1016/S0896-6273(01)00435-4			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580886	Bronze			2022-12-28	WOS:000171281300001
